Unnamed: 0,row ID,row ID.1,Molecule ChEMBL ID,Molecule Name,Molecule Max Phase,Molecular Weight,Compound Key,Standard Type,Standard Relation,IC50,Standard Units,Structure,Data Validity Comment,Comment,Assay ChEMBL ID,Assay Description,Assay Type,BAO Format ID,BAO Label,Assay Organism,Target ChEMBL ID,Target Name,Target Organism,Target Type,Document ChEMBL ID,Source ID,Source Description,Document Journal,Document Year,smiles,Properties,Cluster,Cluster (to number),Tanimoto,inout,cluster
0,Row1092,Row3391,CHEMBL3684436,,0,380.46,BDBM103149,IC50,=,99.0,nM,NC1(CCC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,220871.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,NC1(CCC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,Row3391,71,0.3117240369319916,out,6
1,Row1155,Row1089,CHEMBL3684528,,0,459.35,BDBM103242,IC50,=,130.0,nM,NC1(CCC1)c2ccc(cc2)-c3nnc4-c5cc(Br)ccc5Nc6ncccc6-n34,,220956.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,NC1(CCC1)c2ccc(cc2)-c3nnc4-c5cc(Br)ccc5Nc6ncccc6-n34,,Row3391,71,0.2793972492218017,out,6
2,Row1178,Row3118,CHEMBL3684531,,0,366.43,BDBM103245,IC50,=,140.0,nM,NC1(CC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,220959.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,NC1(CC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,Row3391,71,0.2767584025859833,out,6
3,Row1538,Row2867,CHEMBL3684532,,0,394.48,BDBM103246,IC50,=,490.0,nM,Cc1cc2Nc3ncccc3-n4c(nnc4-c5ccc(cc5)C6(N)CCC6)-c2cc1,,220960.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cc1cc2Nc3ncccc3-n4c(nnc4-c5ccc(cc5)C6(N)CCC6)-c2cc1,,Row3391,71,0.2895677983760834,out,6
4,Row1547,Row1081,CHEMBL3684526,,0,408.51,BDBM103240,IC50,=,500.0,nM,NC1(CCCCC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,220954.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,NC1(CCCCC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,Row3391,71,0.2928719222545624,out,6
5,Row1718,Row3918,CHEMBL3684525,,0,394.48,BDBM103239,IC50,=,960.0,nM,Cc1cc2-c3nnc(-c4ccc(cc4)C5(N)CCC5)n3-c6cccnc6Nc2cc1,,220953.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cc1cc2-c3nnc(-c4ccc(cc4)C5(N)CCC5)n3-c6cccnc6Nc2cc1,,Row3391,71,0.2851356565952301,out,6
6,Row1779,Row3641,CHEMBL3684533,,0,456.55,BDBM103247,IC50,=,1200.0,nM,NC1(CCC1)c2ccc(cc2)-c3nnc4-c5cc(ccc5Nc6ncccc6-n34)-c7ccccc7,,220961.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,NC1(CCC1)c2ccc(cc2)-c3nnc4-c5cc(ccc5Nc6ncccc6-n34)-c7ccccc7,,Row3391,71,0.3168384730815887,out,6
7,Row1807,Row2866,CHEMBL3684527,,0,394.48,BDBM103241,IC50,=,1400.0,nM,Cc1cccc-2c1Nc3ncccc3-n4c(nnc42)-c5ccc(cc5)C6(N)CCC6,,220955.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cc1cccc-2c1Nc3ncccc3-n4c(nnc42)-c5ccc(cc5)C6(N)CCC6,,Row3391,71,0.2860289514064789,out,6
8,Row1919,Row811,CHEMBL3684539,,0,456.55,BDBM103253,IC50,=,2600.0,nM,NC1(CCC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncc(cc6-n34)-c7ccccc7,,220967.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,NC1(CCC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncc(cc6-n34)-c7ccccc7,,Row3391,71,0.3229322433471679,out,6
9,Row2019,Row1142,CHEMBL3684529,,0,380.46,BDBM103243,IC50,=,5000.0,nM,NC1(CCC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ccncc6-n43,,220957.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,NC1(CCC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ccncc6-n43,,Row3391,71,0.3196254670619964,out,6
10,Row0,Row2590,CHEMBL3899716,,0,514.45,BDBM182489,IC50,=,0.1,nM,Cc1cc(ccc1F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5Br,,329930.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5Br,,Row2590,1,0.1249608844518661,out,6
11,Row1,Row3802,CHEMBL3966806,,0,525.5,BDBM182480,IC50,=,0.15,nM,CC(C)c1cc(ccn1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5Br,,329921.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(C)c1cc(ccn1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5Br,,Row2590,1,0.1257001310586929,out,6
12,Row2,Row1726,CHEMBL379300,A-443654,0,397.48,A-443654,IC50,=,0.16,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,Row1726,2,0.1264473348855972,out,6
13,Row3,Row121,CHEMBL573326,,0,464.53,124,IC50,=,0.17,nM,N[C@H](COc1cncc(c1)-c2ccc3NC(=O)C(c3c2)c4ccco4)Cc5c[nH]c6ccccc65,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@H](COc1cncc(c1)-c2ccc3NC(=O)C(c3c2)c4ccco4)Cc5c[nH]c6ccccc65,,Row124,3,0.1244436576962471,out,6
14,Row4,Row1915,CHEMBL210954,,0,520.63,11n,IC50,=,0.17,nM,CC(C)(Cc1ccco1)C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC(C)(Cc1ccco1)C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65,,Row236,4,0.1189066916704177,out,6
15,Row5,Row2185,CHEMBL3936990,,0,463.61,BDBM182699,IC50,=,0.3,nM,CN1CC(C1)Cn2cc(nc2C3CCN(CC3)c4ncnc(N)c4CC)-c5ccc(F)c(C)c5,,330140.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN1CC(C1)Cn2cc(nc2C3CCN(CC3)c4ncnc(N)c4CC)-c5ccc(F)c(C)c5,,Row3798,5,0.1167329549789428,out,6
16,Row6,Row122,CHEMBL376569,,0,398.47,67,IC50,=,0.34,nM,Cc1n[nH]c2cnc(cc21)-c3cc(cnc3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Cc1n[nH]c2cnc(cc21)-c3cc(cnc3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,Row1726,2,0.1164239346981048,out,6
17,Row9,Row3026,CHEMBL3906990,,0,498.05,BDBM182551,IC50,=,0.4,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(Cl)c(F)cc5,,329992.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(Cl)c(F)cc5,,Row3753,7,0.1228620186448097,out,6
18,Row10,Row3239,CHEMBL3969572,,0,558.67,BDBM187363,IC50,=,0.4,nM,CNC(=O)C1CCN(CC1)c2cnc(cc2-n3cc(nc3)C4CC4)C(=O)Nc5csc(n5)-c6nncn6C7CC7,,337101.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,CNC(=O)C1CCN(CC1)c2cnc(cc2-n3cc(nc3)C4CC4)C(=O)Nc5csc(n5)-c6nncn6C7CC7,,Row2917,8,0.0840933695435524,out,6
19,Row11,Row2962,CHEMBL1171647,,0,400.43,42,IC50,=,0.5,nM,CCc1c[nH]c2ncnc(c21)N3C[C@@](N)(CNC(=O)c4ccc(F)cc4F)CC3,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,CCc1c[nH]c2ncnc(c21)N3C[C@@](N)(CNC(=O)c4ccc(F)cc4F)CC3,,Row2553,9,0.12421265989542,out,6
20,Row12,Row493,CHEMBL3943127,,0,535.59,BDBM182473,IC50,=,0.52,nM,CC(C)Oc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCNCC)-c4ccc(F)c(c4)C(F)(F)F,,329914.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(C)Oc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCNCC)-c4ccc(F)c(c4)C(F)(F)F,,Row2188,10,0.1083777919411659,out,6
21,Row13,Row673,CHEMBL388311,,0,436.52,109,IC50,=,0.6,nM,N[C@@H](Cc1ccccc1)COc2cncc(c2)-c3cc\4c(cc3)NC(=O)/C4=C\c5ccc[nH]5,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1ccccc1)COc2cncc(c2)-c3cc\4c(cc3)NC(=O)/C4=C\c5ccc[nH]5,,Row1976,11,0.1366508156061172,out,6
22,Row14,Row1169,CHEMBL226330,,0,384.44,9f,IC50,=,0.6,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)-c4cc5cn[nH]c5cn4,,,CHEMBL903964,Inhibition of Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142911,1,Scientific Literature,Bioorg. Med. Chem.,2007.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)-c4cc5cn[nH]c5cn4,,Row1726,2,0.1132790446281433,out,6
23,Row15,Row1261,CHEMBL226898,,0,427.43,37c,IC50,=,0.6,nM,Cc1n[nH]c2cnc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(ccc4)C(F)(F)F,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2cnc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(ccc4)C(F)(F)F,,Row535,12,0.1032048463821411,out,6
24,Row16,Row1596,CHEMBL494089,GSK-690693,1,425.49,GSK690693,IC50,=,0.6,nM,CCn1c2c(cnc(C#CC(C)(C)O)c2nc1-c3nonc3N)OC[C@@H]4CNCCC4,,,CHEMBL3364070,Inhibition of AKT1 (unknown origin) after 1 hr by Z'-LYTE kinase assay in presence of 75 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3297689,1,Scientific Literature,ACS Med. Chem. Lett.,2014.0,CCn1c2c(cnc(C#CC(C)(C)O)c2nc1-c3nonc3N)OC[C@@H]4CNCCC4,,Row1541,13,0.1307543218135833,out,6
25,Row17,Row1697,CHEMBL1098938,,0,461.53,28,IC50,=,0.6,nM,CCn1c(nc2c(C#CC(C)(C)O)nc(cc12)OC[C@H](N)Cc3ccccc3)-c4nonc4N,,,CHEMBL1109952,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157000,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CCn1c(nc2c(C#CC(C)(C)O)nc(cc12)OC[C@H](N)Cc3ccccc3)-c4nonc4N,,Row167,14,0.1328213810920715,out,6
26,Row18,Row28,CHEMBL575631,,0,478.55,126,IC50,=,0.7,nM,Cc1ccc(o1)C2C(=O)Nc3ccc(cc32)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Cc1ccc(o1)C2C(=O)Nc3ccc(cc32)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65,,Row124,3,0.1222007572650909,out,6
27,Row19,Row256,CHEMBL426140,,0,534.66,11o,IC50,=,0.7,nM,Cc1ccc(CC(C)(C)C2C(=O)Nc3ccc(cc32)-c4cc(cnc4)OC[C@@H](N)Cc5c[nH]c6ccccc65)o1,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Cc1ccc(CC(C)(C)C2C(=O)Nc3ccc(cc32)-c4cc(cnc4)OC[C@@H](N)Cc5c[nH]c6ccccc65)o1,,Row236,4,0.117319107055664,out,6
28,Row21,Row2788,CHEMBL3980521,,0,530.57,BDBM182671,IC50,=,0.7,nM,CC(C)CNCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4ccc(F)c(c4)C(F)(F)F,,330112.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(C)CNCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4ccc(F)c(c4)C(F)(F)F,,Row2188,10,0.1064852625131607,out,6
29,Row22,Row3663,CHEMBL3927358,,0,488.62,BDBM182688,IC50,=,0.7,nM,Cc1cc(ccc1F)-c2cn(CCNC3CCCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,330129.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCNC3CCCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,Row3798,5,0.1162382438778877,out,6
30,Row23,Row64,CHEMBL207544,,0,418.5,10e,IC50,=,0.8,nM,C#Cc1ncc(cc1-c2cc3ccncc3cc2)OC[C@@H](N)Cc4c[nH]c5ccccc45,,,CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1147830,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,C#Cc1ncc(cc1-c2cc3ccncc3cc2)OC[C@@H](N)Cc4c[nH]c5ccccc45,,Row1996,15,0.1324576139450073,out,6
31,Row24,Row75,CHEMBL572908,,0,422.53,33,IC50,=,0.8,nM,CCc1ncc(cc1-c2cc3ccncc3cc2)OC[C@@H](N)Cc4c[nH]c5ccccc45,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,CCc1ncc(cc1-c2cc3ccncc3cc2)OC[C@@H](N)Cc4c[nH]c5ccccc45,,Row1996,15,0.1341795176267624,out,6
32,Row25,Row373,CHEMBL3986943,,0,495.65,BDBM182602,IC50,=,0.8,nM,Cc1cc(ccc1F)-c2cn(CCN(CC)CC)c(n2)C3CCN(CC3)c4ncnc(N)c4OCC,,330043.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCN(CC)CC)c(n2)C3CCN(CC3)c4ncnc(N)c4OCC,,Row2590,1,0.1285985112190246,out,6
33,Row26,Row1183,CHEMBL607374,,0,481.53,17b,IC50,=,0.8,nM,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4cocc4)OC[C@@H](N)Cc5c[nH]c6cc(F)ccc56,,,CHEMBL1071952,Inhibition of full length AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4cocc4)OC[C@@H](N)Cc5c[nH]c6cc(F)ccc56,,Row1726,2,0.1184800267219543,out,6
34,Row27,Row1887,CHEMBL595939,,0,477.57,9q,IC50,=,0.8,nM,Cc1n[nH]c2ccc(cc12)-c3cc(cnc3-c4ccoc4C)OC[C@@H](N)Cc5c[nH]c6ccccc56,,,CHEMBL1071952,Inhibition of full length AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc12)-c3cc(cnc3-c4ccoc4C)OC[C@@H](N)Cc5c[nH]c6ccccc56,,Row1726,2,0.1348519325256347,out,6
35,Row28,Row2812,CHEMBL3960355,,0,542.59,BDBM182680,IC50,=,0.8,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCNC4CCCC4)-c5cc(c(F)cc5)C(F)(F)F,,330121.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCNC4CCCC4)-c5cc(c(F)cc5)C(F)(F)F,,Row2188,10,0.1125839054584503,out,6
36,Row29,Row152,CHEMBL209826,,0,536.7,11m,IC50,=,0.9,nM,CC(C)(Cc1cccs1)C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC(C)(Cc1cccs1)C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65,,Row236,4,0.1181505993008613,out,6
37,Row30,Row771,CHEMBL229320,,0,484.34,13m,IC50,=,0.9,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cccc(I)c4,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cccc(I)c4,,Row1976,11,0.1137269362807273,out,6
38,Row31,Row1727,CHEMBL572884,,0,480.59,125,IC50,=,0.9,nM,N[C@H](COc1cncc(c1)-c2ccc3NC(=O)C(c3c2)c4cccs4)Cc5c[nH]c6ccccc65,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@H](COc1cncc(c1)-c2ccc3NC(=O)C(c3c2)c4cccs4)Cc5c[nH]c6ccccc65,,Row124,3,0.1305290162563324,out,6
39,Row32,Row2304,CHEMBL3971598,,0,448.55,BDBM182624,IC50,=,0.9,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4cc(C)c(F)cc4,,330065.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4cc(C)c(F)cc4,,Row3798,5,0.1138714626431465,out,6
40,Row33,Row3522,CHEMBL3975211,,0,498.58,BDBM187354,IC50,=,0.9,nM,N#CC1CN(C1)c2cnc(cc2-n3cnc(c3)C4CC4)C(=O)Nc5csc(n5)-c6nncn6C7CC7,,337092.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,N#CC1CN(C1)c2cnc(cc2-n3cnc(c3)C4CC4)C(=O)Nc5csc(n5)-c6nncn6C7CC7,,Row2917,8,0.0895929485559463,out,6
41,Row34,Row3973,CHEMBL4441825,,0,499.35,E20,IC50,=,0.98,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@H](CCO)C[C@H]3c4ccc(F)c(F)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@H](CCO)C[C@H]3c4ccc(F)c(F)c4,,Row3515,16,0.0904248654842376,out,6
42,Row35,Row147,CHEMBL593490,,0,463.54,1,IC50,=,1.0,nM,Cc1[nH]nc2ccc(cc21)-c3cc(cnc3-c4cocc4)OC[C@@H](N)Cc5c[nH]c6ccccc56,,,CHEMBL1069941,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153227,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1[nH]nc2ccc(cc21)-c3cc(cnc3-c4cocc4)OC[C@@H](N)Cc5c[nH]c6ccccc56,,Row1726,2,0.1130215600132942,out,6
43,Row36,Row149,CHEMBL603197,,0,465.52,2d,IC50,=,1.0,nM,Cc1n[nH]c2cnc(nc21)-c3cc(cnc3-c4cocc4)OC[C@@H](N)Cc5c[nH]c6ccccc56,,,CHEMBL1069941,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153227,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2cnc(nc21)-c3cc(cnc3-c4cocc4)OC[C@@H](N)Cc5c[nH]c6ccccc56,,Row1726,2,0.1103043556213378,out,6
44,Row37,Row254,CHEMBL1258664,,0,398.9,46,IC50,=,1.0,nM,Cc1c[nH]c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1c[nH]c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,Row854,17,0.0997336506843566,out,6
45,Row38,Row284,CHEMBL470597,,0,455.38,39,IC50,=,1.0,nM,NC[C@H](Cc1ccccc1)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NC[C@H](Cc1ccccc1)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34,,Row284,18,0.1345445215702057,out,6
46,Row39,Row589,CHEMBL1632373,,0,417.97,21,IC50,=,1.0,nM,C[C@@H]1SCc2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,,CHEMBL1632819,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1629708,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,C[C@@H]1SCc2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,Row3589,19,0.0968385264277458,out,6
47,Row40,Row818,CHEMBL605410,,0,519.57,25b,IC50,=,1.0,nM,Cc1occc1-c2nc(N)c(cc2-c3cnc4[nH]nc(C)c4n3)OC[C@@H](N)Cc5c(C#N)[nH]c6ccccc56,,,CHEMBL1072610,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153244,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1occc1-c2nc(N)c(cc2-c3cnc4[nH]nc(C)c4n3)OC[C@@H](N)Cc5c(C#N)[nH]c6ccccc56,,Row2116,20,0.1028347685933113,out,6
48,Row41,Row830,CHEMBL596583,,0,479.54,1b,IC50,=,1.0,nM,Cc1occc1-c2ncc(cc2-c3cnc4[nH]nc(C)c4n3)OC[C@@H](N)Cc5c[nH]c6ccccc56,,,CHEMBL1072610,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153244,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1occc1-c2ncc(cc2-c3cnc4[nH]nc(C)c4n3)OC[C@@H](N)Cc5c[nH]c6ccccc56,,Row2116,20,0.1109863594174385,out,6
49,Row42,Row902,CHEMBL226148,,0,417.9,2,IC50,=,1.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc5[nH]nc(Cl)c5c4,,,CHEMBL903964,Inhibition of Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142911,1,Scientific Literature,Bioorg. Med. Chem.,2007.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc5[nH]nc(Cl)c5c4,,Row1726,2,0.1348893642425537,out,6
50,Row43,Row1016,CHEMBL470598,,0,461.43,40,IC50,=,1.0,nM,NC[C@H](CC1CCCCC1)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NC[C@H](CC1CCCCC1)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34,,Row284,18,0.1250849068164825,out,6
51,Row44,Row1101,CHEMBL596072,,0,464.53,2a,IC50,=,1.0,nM,Cc1n[nH]c2ncc(cc21)-c3cc(cnc3-c4cocc4)OC[C@@H](N)Cc5c[nH]c6ccccc56,,,CHEMBL1069941,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153227,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ncc(cc21)-c3cc(cnc3-c4cocc4)OC[C@@H](N)Cc5c[nH]c6ccccc56,,Row1726,2,0.1257063895463943,out,6
52,Row45,Row1121,CHEMBL2016893,,0,609.5,11b,IC50,=,1.0,nM,Cc1c(cc(cc1N2CCN(CC2)c3ncnc4[nH]nc(Br)c34)C(=O)CCC(F)(F)F)NCCN5CCCC5,,,CHEMBL2020583,Inhibition of AKT1 after 3 hrs by luciferase based chemiluminescence assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2016487,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2012.0,Cc1c(cc(cc1N2CCN(CC2)c3ncnc4[nH]nc(Br)c34)C(=O)CCC(F)(F)F)NCCN5CCCC5,,Row2025,21,0.0927932187914848,out,6
53,Row46,Row1150,CHEMBL593813,,0,529.0,25a,IC50,=,1.0,nM,Cc1occc1-c2nc(N)c(cc2-c3cnc4[nH]nc(C)c4n3)OC[C@@H](N)Cc5c(Cl)[nH]c6ccccc56,,,CHEMBL1072610,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153244,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1occc1-c2nc(N)c(cc2-c3cnc4[nH]nc(C)c4n3)OC[C@@H](N)Cc5c(Cl)[nH]c6ccccc56,,Row2116,20,0.1044908761978149,out,6
54,Row47,Row1182,CHEMBL594309,,0,481.53,17c,IC50,=,1.0,nM,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4cocc4)OC[C@@H](N)Cc5c[nH]c6c(F)cccc56,,,CHEMBL1071952,Inhibition of full length AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4cocc4)OC[C@@H](N)Cc5c[nH]c6c(F)cccc56,,Row1726,2,0.1209764629602432,out,6
55,Row48,Row1184,CHEMBL605528,,0,481.53,17a,IC50,=,1.0,nM,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4cocc4)OC[C@@H](N)Cc5c[nH]c6ccc(F)cc56,,,CHEMBL1071952,Inhibition of full length AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4cocc4)OC[C@@H](N)Cc5c[nH]c6ccc(F)cc56,,Row1726,2,0.1159825921058654,out,6
56,Row49,Row1267,CHEMBL1099276,,0,447.5,30,IC50,=,1.0,nM,CCn1c(nc2c(C#CC(C)(C)O)nc(cc12)O[C@@H](CN)c3ccccc3)-c4nonc4N,,,CHEMBL1109952,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157000,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CCn1c(nc2c(C#CC(C)(C)O)nc(cc12)O[C@@H](CN)c3ccccc3)-c4nonc4N,,Row167,14,0.145544484257698,out,6
57,Row50,Row1315,CHEMBL4435124,,0,455.39,1d,IC50,=,1.0,nM,Cn1ncc(Cl)c1-c2ccc(s2)C(=O)N[C@@H]3CNCC[C@H]3c4cc(F)ccc4,,,CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4304777,1,Scientific Literature,Eur J Med Chem,2019.0,Cn1ncc(Cl)c1-c2ccc(s2)C(=O)N[C@@H]3CNCC[C@H]3c4cc(F)ccc4,,Row1315,22,0.106856919825077,out,6
58,Row51,Row1332,CHEMBL595459,,0,493.57,14d,IC50,=,1.0,nM,Cc1n[nH]c2cnc(cc12)-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c(N)nc3-c6ccoc6C,,,CHEMBL1072610,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153244,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2cnc(cc12)-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c(N)nc3-c6ccoc6C,,Row2116,20,0.1096897721290588,out,6
59,Row52,Row1524,CHEMBL482536,,0,523.38,47,IC50,=,1.0,nM,NC[C@H](Cc1cc(ccc1)C(F)(F)F)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NC[C@H](Cc1cc(ccc1)C(F)(F)F)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34,,Row284,18,0.1090453937649726,out,6
60,Row53,Row1819,CHEMBL469590,,0,455.38,rac-32,IC50,=,1.0,nM,NCC(Cc1ccccc1)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NCC(Cc1ccccc1)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34,,Row284,18,0.1345445215702057,out,6
61,Row54,Row1938,CHEMBL488428,,0,555.64,9,IC50,=,1.0,nM,O=c1ccc(c[nH]1)-c2[nH]c(nn2)C3CCN(Cc4ccc(cc4)-c5nc6cc[nH]c(=O)c6cc5-c7ccccc7)CC3,,,CHEMBL947431,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,O=c1ccc(c[nH]1)-c2[nH]c(nn2)C3CCN(Cc4ccc(cc4)-c5nc6cc[nH]c(=O)c6cc5-c7ccccc7)CC3,,Row1163,23,0.2008463889360427,out,6
62,Row55,Row2003,CHEMBL594933,,0,464.53,2e,IC50,=,1.0,nM,Cc1n[nH]c2cnc(cc21)-c3cc(cnc3-c4cocc4)OC[C@@H](N)Cc5c[nH]c6ccccc56,,,CHEMBL1069941,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153227,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2cnc(cc21)-c3cc(cnc3-c4cocc4)OC[C@@H](N)Cc5c[nH]c6ccccc56,,Row1726,2,0.1109189391136169,out,6
63,Row56,Row2104,CHEMBL1258781,,0,419.32,49,IC50,=,1.0,nM,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4[nH]cc(Cl)c34,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4[nH]cc(Cl)c34,,Row854,17,0.0984054133296012,out,6
64,Row57,Row2116,CHEMBL595944,,0,494.56,14c,IC50,=,1.0,nM,Cc1occc1-c2nc(N)c(cc2-c3cnc4[nH]nc(C)c4n3)OC[C@@H](N)Cc5c[nH]c6ccccc56,,,CHEMBL1072610,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153244,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1occc1-c2nc(N)c(cc2-c3cnc4[nH]nc(C)c4n3)OC[C@@H](N)Cc5c[nH]c6ccccc56,,Row2116,20,0.107499711215496,out,6
65,Row58,Row2537,CHEMBL3919089,,0,523.97,BDBM182517,IC50,=,1.0,nM,Nc1ncnc(c1Cl)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,329958.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Cl)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row643,24,0.1248784735798835,out,6
66,Row59,Row2561,CHEMBL496690,,0,473.37,45,IC50,=,1.0,nM,NC[C@H](Cc1ccc(F)cc1)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NC[C@H](Cc1ccc(F)cc1)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34,,Row284,18,0.1034977585077285,out,6
67,Row60,Row2621,CHEMBL498052,,0,473.37,43,IC50,=,1.0,nM,NC[C@H](Cc1ccccc1F)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NC[C@H](Cc1ccccc1F)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34,,Row284,18,0.1221508830785751,out,6
68,Row61,Row2630,CHEMBL523586,,0,473.37,44,IC50,=,1.0,nM,NC[C@H](Cc1cc(F)ccc1)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NC[C@H](Cc1cc(F)ccc1)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34,,Row284,18,0.1149870902299881,out,6
69,Row62,Row2694,CHEMBL1170448,,0,386.41,40,IC50,=,1.0,nM,Cc1c[nH]c2ncnc(c21)N3C[C@@](N)(CNC(=O)c4ccc(F)cc4F)CC3,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,Cc1c[nH]c2ncnc(c21)N3C[C@@](N)(CNC(=O)c4ccc(F)cc4F)CC3,,Row2553,9,0.1240188255906105,out,6
70,Row63,Row3000,CHEMBL3941283,,0,531.56,BDBM182586,IC50,=,1.0,nM,Nc1ncnc(c1C=O)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)c(c5)C(F)(F)F,,330027.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C=O)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row643,24,0.1201232299208641,out,6
71,Row64,Row3092,CHEMBL593375,,0,493.57,14b,IC50,=,1.0,nM,Cc1n[nH]c2ncc(cc12)-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c(N)nc3-c6ccoc6C,,,CHEMBL1072610,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153244,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ncc(cc12)-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c(N)nc3-c6ccoc6C,,Row2116,20,0.123811736702919,out,6
72,Row65,Row3178,CHEMBL594072,,0,537.58,25c,IC50,=,1.0,nM,Cc1occc1-c2nc(N)c(cc2-c3cnc4[nH]nc(C)c4n3)OC[C@@H](N)Cc5c([nH]c6ccccc56)C(N)=O,,,CHEMBL1072610,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153244,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1occc1-c2nc(N)c(cc2-c3cnc4[nH]nc(C)c4n3)OC[C@@H](N)Cc5c([nH]c6ccccc56)C(N)=O,,Row2116,20,0.1076596081256866,out,6
73,Row66,Row3589,CHEMBL1632384,,0,474.07,34,IC50,=,1.0,nM,CC(C)NC[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4CS[C@@H](C)c43,,,CHEMBL1632819,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1629708,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,CC(C)NC[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4CS[C@@H](C)c43,,Row3589,19,0.0843490213155746,out,6
74,Row67,Row1155,CHEMBL3922577,,0,499.6,BDBM187369,IC50,=,1.1,nM,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CC6CC6C5)-n7cc(nc7)C8CC8,,337107.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CC6CC6C5)-n7cc(nc7)C8CC8,,Row2917,8,0.0832643881440162,out,6
75,Row68,Row2699,CHEMBL1169623,,0,406.82,41,IC50,=,1.1,nM,N[C@@]1(CNC(=O)c2ccc(F)cc2F)CN(CC1)c3ncnc4[nH]cc(Cl)c34,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,N[C@@]1(CNC(=O)c2ccc(F)cc2F)CN(CC1)c3ncnc4[nH]cc(Cl)c34,,Row2553,9,0.1207540035247802,out,6
76,Row69,Row123,CHEMBL574087,,0,411.51,54,IC50,=,1.15,nM,CCc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,CCc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,Row1726,2,0.1253967434167862,out,6
77,Row70,Row522,CHEMBL226625,,0,426.44,13ac,IC50,=,1.2,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(ccc4)C(F)(F)F,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(ccc4)C(F)(F)F,,Row1976,11,0.1126065328717231,out,6
78,Row71,Row733,CHEMBL227322,,0,444.43,13ah,IC50,=,1.2,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(ccc4F)C(F)(F)F,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(ccc4F)C(F)(F)F,,Row1976,11,0.1040707826614379,out,6
79,Row72,Row1193,CHEMBL3902880,,0,640.62,BDBM187385,IC50,=,1.2,nM,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CCN(CC4)CC(F)(F)F)-n5cc(nc5)C6CC6)C(F)(F)F,,337123.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CCN(CC4)CC(F)(F)F)-n5cc(nc5)C6CC6)C(F)(F)F,,Row1789,25,0.0835580825805664,out,6
80,Row73,Row1455,CHEMBL210940,,0,519.65,11i,IC50,=,1.2,nM,CC(C)(Cc1c[nH]cc1)C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC(C)(Cc1c[nH]cc1)C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65,,Row236,4,0.1229899376630783,out,6
81,Row74,Row3730,CHEMBL572670,,0,448.53,61,IC50,=,1.2,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5c(n[nH]c5cc4)-c6ccc[nH]6,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5c(n[nH]c5cc4)-c6ccc[nH]6,,Row1726,2,0.1224255710840225,out,6
82,Row75,Row1688,CHEMBL4451854,,0,455.39,1o,IC50,=,1.26,nM,Cn1ncc(Cl)c1-c2cc(sc2)C(=O)N[C@@H]3CNCC[C@H]3c4cc(F)ccc4,,,CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4304777,1,Scientific Literature,Eur J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(sc2)C(=O)N[C@@H]3CNCC[C@H]3c4cc(F)ccc4,,Row1315,22,0.097155213356018,out,6
83,Row76,Row1944,CHEMBL227367,,0,455.33,13t,IC50,=,1.3,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(Br)c(F)c4,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(Br)c(F)c4,,Row1976,11,0.102408729493618,out,6
84,Row77,Row1956,CHEMBL3966203,,0,481.97,BDBM182504,IC50,=,1.3,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cnc(F)c(Cl)c5,,329945.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cnc(F)c(Cl)c5,,Row3990,26,0.1031874120235443,out,6
85,Row78,Row1996,CHEMBL383264,,0,394.48,13a(S-),IC50,=,1.3,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)-c4cc5ccncc5cc4,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)-c4cc5ccncc5cc4,,Row1996,15,0.1348099261522293,out,6
86,Row79,Row2350,CHEMBL576733,,0,465.58,58,IC50,=,1.3,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc5[nH]nc(-c6cccs6)c5c4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc5[nH]nc(-c6cccs6)c5c4,,Row1726,2,0.1318235993385315,out,6
87,Row80,Row1806,CHEMBL4440965,,0,526.37,E22,IC50,=,1.37,nM,CNC(=O)C[C@@H]1C[C@H]([C@@H](CN1)NC(=O)c2cc(c(Cl)o2)-c3c(Cl)cnn3C)c4ccc(F)c(F)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,CNC(=O)C[C@@H]1C[C@H]([C@@H](CN1)NC(=O)c2cc(c(Cl)o2)-c3c(Cl)cnn3C)c4ccc(F)c(F)c4,,Row3515,16,0.0885170474648475,out,6
88,Row81,Row590,CHEMBL3954981,,0,476.6,BDBM182689,IC50,=,1.4,nM,Cc1cc(ccc1F)-c2cn(CCNCC(C)C)c(n2)C3CCN(CC3)c4ncnc(N)c4C#N,,330130.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCNCC(C)C)c(n2)C3CCN(CC3)c4ncnc(N)c4C#N,,Row2188,10,0.1087964549660682,out,6
89,Row82,Row1994,CHEMBL1170261,,0,382.44,34,IC50,=,1.4,nM,CCc1c[nH]c2ncnc(c21)N3C[C@@](N)(CNC(=O)c4ccc(F)cc4)CC3,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,CCc1c[nH]c2ncnc(c21)N3C[C@@](N)(CNC(=O)c4ccc(F)cc4)CC3,,Row2553,9,0.1262067556381225,out,6
90,Row83,Row2081,CHEMBL226849,,0,437.5,36,IC50,=,1.4,nM,N[C@@H](Cc1ccccc1)COc2cncc(c2)-c3cc\4c(cc3)NC(=O)/C4=C/c5ccco5,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,N[C@@H](Cc1ccccc1)COc2cncc(c2)-c3cc\4c(cc3)NC(=O)/C4=C/c5ccco5,,Row1976,11,0.1375361979007721,out,6
91,Row84,Row2379,CHEMBL575811,,0,439.52,108,IC50,=,1.4,nM,N[C@H](COc1cncc(c1)-c2ccc3NC(=O)C(Cc4ccco4)c3c2)Cc5ccccc5,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@H](COc1cncc(c1)-c2ccc3NC(=O)C(Cc4ccco4)c3c2)Cc5ccccc5,,Row1976,11,0.1353002339601516,out,6
92,Row85,Row2407,CHEMBL3948454,,0,480.93,BDBM182471,IC50,=,1.4,nM,CNCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3Cl)-c4cc(ncc4)C(F)(F)F,,329912.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CNCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3Cl)-c4cc(ncc4)C(F)(F)F,,Row2188,10,0.1158699318766594,out,6
93,Row86,Row2502,CHEMBL3890352,,0,517.53,BDBM182584,IC50,=,1.4,nM,Nc1ncnc(c1C=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,330025.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row643,24,0.1201232299208641,out,6
94,Row87,Row3803,CHEMBL3893968,,0,568.59,BDBM187376,IC50,=,1.4,nM,CC1(CN(C1)c2cnc(cc2-n3cc(nc3)C4CC4)C(=O)Nc5csc(n5)-c6nncn6[C@@H](C)C(F)(F)F)C#N,,337114.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,CC1(CN(C1)c2cnc(cc2-n3cc(nc3)C4CC4)C(=O)Nc5csc(n5)-c6nncn6[C@@H](C)C(F)(F)F)C#N,,Row1789,25,0.0864334106445312,out,6
95,Row88,Row1130,CHEMBL4554668,,0,589.31,E18,IC50,=,1.41,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@H](CC(=O)NCCO)C[C@H]3c4cc(Cl)c(Cl)cc4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@H](CC(=O)NCCO)C[C@H]3c4cc(Cl)c(Cl)cc4,,Row3515,16,0.0861436501145362,out,6
96,Row91,Row52,CHEMBL3967010,,0,495.01,BDBM182606,IC50,=,1.5,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(Cl)c(F)cc5,,330047.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(Cl)c(F)cc5,,Row3990,26,0.1185212731361389,out,6
97,Row92,Row82,CHEMBL388978,STAUROSPORINE,0,466.54,Staurosporine,IC50,=,1.5,nM,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)n3c4c(c5ccccc35)c6CNC(=O)c6c7c4n2c8ccccc87)NC,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)n3c4c(c5ccccc35)c6CNC(=O)c6c7c4n2c8ccccc87)NC,,Row2387,28,0.1328857243061065,out,6
98,Row93,Row177,CHEMBL576348,,0,463.54,119,IC50,=,1.5,nM,N[C@H](COc1cncc(c1)-c2ccc3NC(=O)C(c3c2)c4ccc[nH]4)Cc5c[nH]c6ccccc65,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@H](COc1cncc(c1)-c2ccc3NC(=O)C(c3c2)c4ccc[nH]4)Cc5c[nH]c6ccccc65,,Row124,3,0.1237079128623008,out,6
99,Row94,Row229,CHEMBL377603,,0,519.65,11f,IC50,=,1.5,nM,CC(C)(Cc1ccc[nH]1)C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC(C)(Cc1ccc[nH]1)C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65,,Row236,4,0.1197579205036163,out,6
100,Row95,Row231,CHEMBL212067,,0,601.56,9t,IC50,=,1.5,nM,O=C1Nc2ccc(cc2C1(F)F)-c3cncc(c3)OC[C@H](Cc4c[nH]c5ccccc45)Nc6cc7c(cc6)NC(=O)C7(F)F,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,O=C1Nc2ccc(cc2C1(F)F)-c3cncc(c3)OC[C@H](Cc4c[nH]c5ccccc45)Nc6cc7c(cc6)NC(=O)C7(F)F,,Row837,29,0.1259050369262695,out,6
101,Row96,Row1389,CHEMBL374805,,0,383.46,1,IC50,=,1.5,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc5[nH]ncc5c4,,,CHEMBL903964,Inhibition of Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142911,1,Scientific Literature,Bioorg. Med. Chem.,2007.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc5[nH]ncc5c4,,Row1726,2,0.1240671351552009,out,6
102,Row97,Row1659,CHEMBL378843,,0,460.54,10d,IC50,=,1.5,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cnc(-c4ccco4)c(c3)-c5cc6ccncc6cc5,,,CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1147830,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cnc(-c4ccco4)c(c3)-c5cc6ccncc6cc5,,Row1996,15,0.140507310628891,out,6
103,Row98,Row1789,CHEMBL3976987,,0,625.6,BDBM187384,IC50,=,1.5,nM,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CCC(CC4)C(F)(F)F)-n5cc(nc5)C6CC6)C(F)(F)F,,337122.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CCC(CC4)C(F)(F)F)-n5cc(nc5)C6CC6)C(F)(F)F,,Row1789,25,0.0824974700808525,out,6
104,Row99,Row2188,CHEMBL3894849,,0,488.49,BDBM182673,IC50,=,1.5,nM,CNCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4ccc(F)c(c4)C(F)(F)F,,330114.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CNCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4ccc(F)c(c4)C(F)(F)F,,Row2188,10,0.1093636751174926,out,6
105,Row100,Row3228,CHEMBL577377,,0,434.45,114,IC50,=,1.5,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc5NC(=O)C(F)(F)c5c4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc5NC(=O)C(F)(F)c5c4,,Row124,3,0.1415117681026458,out,6
106,Row101,Row3237,CHEMBL3912471,,0,535.59,BDBM182697,IC50,=,1.5,nM,CC(C)NCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3OCC)-c4ccc(F)c(c4)C(F)(F)F,,330138.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(C)NCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3OCC)-c4ccc(F)c(c4)C(F)(F)F,,Row2188,10,0.1086299419403076,out,6
107,Row102,Row3943,CHEMBL3899490,,0,525.38,BDBM182465,IC50,=,1.5,nM,CNCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3Br)-c4cc(ncc4)C(F)(F)F,,329906.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CNCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3Br)-c4cc(ncc4)C(F)(F)F,,Row2188,10,0.1130948066711425,out,6
108,Row103,Row3980,CHEMBL4207231,,0,503.83,10m,IC50,=,1.5,nM,O=C(N1CCN(CC1)c2ncnc3[nH]cc(Br)c23)C4(CCNCC4)c5ccc(Cl)cc5,,,CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4190265,1,Scientific Literature,Eur J Med Chem,2017.0,O=C(N1CCN(CC1)c2ncnc3[nH]cc(Br)c23)C4(CCNCC4)c5ccc(Cl)cc5,,Row3980,30,0.1285547018051147,out,6
109,Row104,Row1857,CHEMBL3941451,,0,556.57,BDBM182408,IC50,=,1.6,nM,Nc1ncnc(c1-c2cnoc2)N3CCC(CC3)c4nc(cn4CCN5CCC5)-c6ccc(F)c(c6)C(F)(F)F,,329849.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1-c2cnoc2)N3CCC(CC3)c4nc(cn4CCN5CCC5)-c6ccc(F)c(c6)C(F)(F)F,,Row643,24,0.1173264235258102,out,6
110,Row105,Row2805,CHEMBL3983282,,0,528.56,BDBM182657,IC50,=,1.6,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCNCC4CC4)-c5ccc(F)c(c5)C(F)(F)F,,330098.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCNCC4CC4)-c5ccc(F)c(c5)C(F)(F)F,,Row2188,10,0.1055818125605583,out,6
111,Row108,Row488,CHEMBL3930015,,0,579.56,BDBM187378,IC50,=,1.7,nM,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CC(C4)C(F)F)-n5cc(nc5)C6CC6)C(F)(F)F,,337116.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CC(C4)C(F)F)-n5cc(nc5)C6CC6)C(F)(F)F,,Row1789,25,0.0824165269732475,out,6
112,Row109,Row490,CHEMBL3917308,,0,582.62,BDBM187381,IC50,=,1.7,nM,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CCC(CC4)C#N)-n5cnc(c5)C6CC6)C(F)(F)F,,337119.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CCC(CC4)C#N)-n5cnc(c5)C6CC6)C(F)(F)F,,Row1789,25,0.0887358784675598,out,6
113,Row110,Row527,CHEMBL3962884,,0,575.6,BDBM187386,IC50,=,1.7,nM,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CCC(F)CC4)-n5cc(nc5)C6CC6)C(F)(F)F,,337124.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CCC(F)CC4)-n5cc(nc5)C6CC6)C(F)(F)F,,Row1789,25,0.0836183726787567,out,6
114,Row111,Row768,CHEMBL3948085,,0,467.59,BDBM182592,IC50,=,1.7,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3OCC)-c4cc(C)c(F)cc4,,330033.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3OCC)-c4cc(C)c(F)cc4,,Row2164,32,0.1144897863268852,out,6
115,Row112,Row2253,CHEMBL3949795,,0,471.49,BDBM182468,IC50,=,1.7,nM,CNCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4cc(ncc4)C(F)(F)F,,329909.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CNCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4cc(ncc4)C(F)(F)F,,Row2188,10,0.1107792630791664,out,6
116,Row113,Row2276,CHEMBL3969016,,0,434.52,BDBM182693,IC50,=,1.7,nM,Cc1cc(ccc1F)-c2cn(CCNC)c(n2)C3CCN(CC3)c4ncnc(N)c4C#N,,330134.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCNC)c(n2)C3CCN(CC3)c4ncnc(N)c4C#N,,Row2188,10,0.1119119152426719,out,6
117,Row114,Row2717,CHEMBL3640733,,0,531.66,BDBM108426,IC50,=,1.7,nM,CC(C)(C)C(=O)Nc1cc(ccc1)-c2ccc3nc(-c4cccnc4N)n(c3n2)-c5ccc(cc5)C6(N)CCC6,,286558.0,CHEMBL3705364,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3639036,37,BindingDB Database,,2015.0,CC(C)(C)C(=O)Nc1cc(ccc1)-c2ccc3nc(-c4cccnc4N)n(c3n2)-c5ccc(cc5)C6(N)CCC6,,Row366,27,0.235112577676773,out,6
118,Row115,Row2833,CHEMBL3944201,,0,532.44,BDBM182525,IC50,=,1.7,nM,Nc1ncnc(c1Br)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)c(F)cc5,,329966.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Br)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)c(F)cc5,,Row2590,1,0.1273247301578521,out,6
119,Row116,Row1700,CHEMBL4169791,,0,523.55,11d,IC50,=,1.72,nM,Cc1nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc(c1C(=O)OCC)-c5ccc(cc5)OC,,,CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4130433,1,Scientific Literature,Eur J Med Chem,2017.0,Cc1nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc(c1C(=O)OCC)-c5ccc(cc5)OC,,Row2772,33,0.1395298689603805,out,6
120,Row117,Row2505,CHEMBL3640747,,0,565.7,BDBM108440,IC50,=,1.79,nM,Nc1ncccc1-c2nc3ccc(nc3n2-c4ccc(cc4)C5(N)CCC5)-c6cc(ccc6)N7CCS(=O)(=O)CC7,,286571.0,CHEMBL3705364,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3639036,37,BindingDB Database,,2015.0,Nc1ncccc1-c2nc3ccc(nc3n2-c4ccc(cc4)C5(N)CCC5)-c6cc(ccc6)N7CCS(=O)(=O)CC7,,Row366,27,0.2380842566490173,out,6
121,Row118,Row74,CHEMBL378963,,0,428.92,29,IC50,=,1.8,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(c(Cl)nc3)-c4cc5ccncc5cc4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(c(Cl)nc3)-c4cc5ccncc5cc4,,Row1996,15,0.1342600733041763,out,6
122,Row119,Row548,CHEMBL374808,,0,451.45,3,IC50,=,1.8,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc5[nH]nc(c5c4)C(F)(F)F,,,CHEMBL903964,Inhibition of Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142911,1,Scientific Literature,Bioorg. Med. Chem.,2007.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc5[nH]nc(c5c4)C(F)(F)F,,Row1726,2,0.12196946144104,out,6
123,Row120,Row731,CHEMBL229968,,0,427.34,13q,IC50,=,1.8,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(Cl)c(Cl)cc4,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(Cl)c(Cl)cc4,,Row1976,11,0.1047836318612098,out,6
124,Row121,Row1058,CHEMBL1170446,,0,398.9,38,IC50,=,1.8,nM,CCc1c[nH]c2ncnc(c21)N3C[C@@](N)(CNC(=O)c4ccc(Cl)cc4)CC3,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,CCc1c[nH]c2ncnc(c21)N3C[C@@](N)(CNC(=O)c4ccc(Cl)cc4)CC3,,Row2553,9,0.1251504868268966,out,6
125,Row122,Row1300,CHEMBL3925596,,0,598.66,BDBM187394,IC50,=,1.8,nM,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CCN(CC4)C5CC5)-n6cc(nc6)C7CC7)C(F)(F)F,,337132.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CCN(CC4)C5CC5)-n6cc(nc6)C7CC7)C(F)(F)F,,Row1789,25,0.0826819390058517,out,6
126,Row123,Row2079,CHEMBL3980219,,0,548.89,BDBM182567,IC50,=,1.8,nM,Nc1ncnc(c1Br)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(Cl)c(F)cc5,,330008.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Br)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(Cl)c(F)cc5,,Row2590,1,0.1211685165762901,out,6
127,Row124,Row2172,CHEMBL3979677,,0,598.66,BDBM187389,IC50,=,1.8,nM,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CC5CCCN5CC4)-n6cc(nc6)C7CC7)C(F)(F)F,,337127.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CC5CCCN5CC4)-n6cc(nc6)C7CC7)C(F)(F)F,,Row1789,25,0.0871927142143249,out,6
128,Row125,Row2431,CHEMBL4202879,,0,503.83,10h,IC50,=,1.8,nM,O=C(N1CCN(CC1)c2ncnc3[nH]cc(Cl)c23)C4(CCNCC4)c5ccc(Br)cc5,,,CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4190265,1,Scientific Literature,Eur J Med Chem,2017.0,O=C(N1CCN(CC1)c2ncnc3[nH]cc(Cl)c23)C4(CCNCC4)c5ccc(Br)cc5,,Row3980,30,0.1256337761878967,out,6
129,Row126,Row2944,CHEMBL226627,,0,444.43,13af,IC50,=,1.8,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(F)c(c4)C(F)(F)F,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(F)c(c4)C(F)(F)F,,Row1976,11,0.1029941439628601,out,6
130,Row127,Row3500,CHEMBL3897512,,0,612.69,BDBM187395,IC50,=,1.8,nM,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CCN(CC5CC5)CC4)-n6cc(nc6)C7CC7)C(F)(F)F,,337133.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CCN(CC5CC5)CC4)-n6cc(nc6)C7CC7)C(F)(F)F,,Row1789,25,0.0835290104150772,out,6
131,Row128,Row3632,CHEMBL3905950,,0,517.62,BDBM187356,IC50,=,1.8,nM,CC1(CN(C1)c2cnc(cc2-n3cc(nc3)C4CC4)C(=O)Nc5csc(n5)-c6nncn6C7CC7)OC,,337094.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,CC1(CN(C1)c2cnc(cc2-n3cc(nc3)C4CC4)C(=O)Nc5csc(n5)-c6nncn6C7CC7)OC,,Row2917,8,0.0910519659519195,out,6
132,Row129,Row3994,CHEMBL4454791,,0,471.84,1b,IC50,=,1.8,nM,Cn1ncc(Cl)c1-c2ccc(s2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,,CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4304777,1,Scientific Literature,Eur J Med Chem,2019.0,Cn1ncc(Cl)c1-c2ccc(s2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,Row1315,22,0.0974161848425865,out,6
133,Row130,Row366,CHEMBL3640743,,0,584.73,BDBM108436,IC50,=,1.84,nM,Nc1ncccc1-c2nc3ccc(nc3n2-c4ccc(cc4)C5(N)CCC5)-c6cc(ccc6)N7CCN(CC7)C(=O)C8CC8,,286568.0,CHEMBL3705364,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3639036,37,BindingDB Database,,2015.0,Nc1ncccc1-c2nc3ccc(nc3n2-c4ccc(cc4)C5(N)CCC5)-c6cc(ccc6)N7CCN(CC7)C(=O)C8CC8,,Row366,27,0.2387804687023162,out,6
134,Row131,Row432,CHEMBL3895898,,0,530.57,BDBM182674,IC50,=,1.9,nM,CC(C)(C)NCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4ccc(F)c(c4)C(F)(F)F,,330115.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(C)(C)NCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4ccc(F)c(c4)C(F)(F)F,,Row2188,10,0.1090776249766349,out,6
135,Row132,Row1856,CHEMBL3965271,,0,554.6,BDBM182409,IC50,=,1.9,nM,Nc1ncnc(c1-c2c[nH]cc2)N3CCC(CC3)c4nc(cn4CCN5CCC5)-c6ccc(F)c(c6)C(F)(F)F,,329850.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1-c2c[nH]cc2)N3CCC(CC3)c4nc(cn4CCN5CCC5)-c6ccc(F)c(c6)C(F)(F)F,,Row643,24,0.1211939305067062,out,6
136,Row133,Row1860,CHEMBL3984164,,0,481.62,BDBM182593,IC50,=,1.9,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3OC(C)C)-c4cc(C)c(F)cc4,,330034.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3OC(C)C)-c4cc(C)c(F)cc4,,Row2164,32,0.1112461984157562,out,6
137,Row134,Row2532,CHEMBL3909615,,0,573.61,BDBM187380,IC50,=,1.9,nM,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CC(CC4)OC)-n5cc(nc5)C6CC6)C(F)(F)F,,337118.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CC(CC4)OC)-n5cc(nc5)C6CC6)C(F)(F)F,,Row1789,25,0.0821122676134109,out,6
138,Row135,Row3351,CHEMBL3924482,,0,614.66,BDBM187393,IC50,=,1.9,nM,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CC(C4)N5CCOCC5)-n6cc(nc6)C7CC7)C(F)(F)F,,337131.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CC(C4)N5CCOCC5)-n6cc(nc6)C7CC7)C(F)(F)F,,Row1789,25,0.078637808561325,out,6
139,Row136,Row3479,CHEMBL3935565,,0,512.6,BDBM187355,IC50,=,1.9,nM,CC1(CN(C1)c2cnc(cc2-n3cc(nc3)C4CC4)C(=O)Nc5csc(n5)-c6nncn6C7CC7)C#N,,337093.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,CC1(CN(C1)c2cnc(cc2-n3cc(nc3)C4CC4)C(=O)Nc5csc(n5)-c6nncn6C7CC7)C#N,,Row2917,8,0.0891728103160858,out,6
140,Row137,Row3652,CHEMBL3940867,,0,480.98,BDBM182374,IC50,=,1.9,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(Cl)c(F)cc5,,329815.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(Cl)c(F)cc5,,Row3990,26,0.1185212731361389,out,6
141,Row138,Row3862,CHEMBL4204854,,0,459.38,10g,IC50,=,1.9,nM,O=C(N1CCN(CC1)c2ncnc3[nH]cc(Cl)c23)C4(CCNCC4)c5ccc(Cl)cc5,,,CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4190265,1,Scientific Literature,Eur J Med Chem,2017.0,O=C(N1CCN(CC1)c2ncnc3[nH]cc(Cl)c23)C4(CCNCC4)c5ccc(Cl)cc5,,Row3980,30,0.1290668994188308,out,6
142,Row139,Row3900,CHEMBL3954144,,0,573.61,BDBM187388,IC50,=,1.9,nM,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CCOCCC4)-n5cc(nc5)C6CC6)C(F)(F)F,,337126.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CCOCCC4)-n5cc(nc5)C6CC6)C(F)(F)F,,Row1789,25,0.0875085517764091,out,6
143,Row140,Row3961,CHEMBL3948895,,0,543.66,BDBM187373,IC50,=,1.9,nM,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CCC6(COC6)CC5)-n7cc(nc7)C8CC8,,337111.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CCC6(COC6)CC5)-n7cc(nc7)C8CC8,,Row2917,8,0.0959607064723968,out,6
144,Row141,Row3461,CHEMBL4447967,,0,546.24,E13,IC50,=,1.94,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@H](CC(O)=O)C[C@H]3c4ccc(Cl)c(Cl)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@H](CC(O)=O)C[C@H]3c4ccc(Cl)c(Cl)c4,,Row3515,16,0.0890680477023124,out,6
145,Row143,Row60,CHEMBL2325992,,0,455.99,45,IC50,=,2.0,nM,CN(C)CCC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc32)c4ccc(Cl)cc4,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,CN(C)CCC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc32)c4ccc(Cl)cc4,,Row3863,35,0.1209663525223732,out,6
146,Row144,Row166,CHEMBL1099290,,0,369.43,18,IC50,=,2.0,nM,CN(C)Cc1cc2c(nc(-c3nonc3N)n2CC)c(C#CC(C)(C)O)n1,,,CHEMBL1109952,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157000,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CN(C)Cc1cc2c(nc(-c3nonc3N)n2CC)c(C#CC(C)(C)O)n1,,Row167,14,0.1010040491819381,out,6
147,Row145,Row591,CHEMBL3904291,,0,528.08,BDBM182589,IC50,=,2.0,nM,CC(C)Oc1c(ncnc1N)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)c(Cl)c5,,330030.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(C)Oc1c(ncnc1N)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)c(Cl)c5,,Row3753,7,0.1179467216134071,out,6
148,Row146,Row1026,CHEMBL258837,,0,330.4,2,IC50,=,2.0,nM,N#Cc1c[nH]c2ncnc(c21)N3CC4(CCNCC4)c5ccccc35,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,N#Cc1c[nH]c2ncnc(c21)N3CC4(CCNCC4)c5ccccc35,,Row2845,36,0.1321566551923751,out,6
149,Row147,Row1053,CHEMBL209513,,0,420.52,10c,IC50,=,2.0,nM,C=Cc1ncc(cc1-c2cc3ccncc3cc2)OC[C@@H](N)Cc4c[nH]c5ccccc45,,,CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1147830,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,C=Cc1ncc(cc1-c2cc3ccncc3cc2)OC[C@@H](N)Cc4c[nH]c5ccccc45,,Row1996,15,0.1417781412601471,out,6
150,Row148,Row1151,CHEMBL1099297,,0,461.53,32,IC50,=,2.0,nM,CCn1c(nc2c(C#CC(C)(C)O)nc(cc12)O[C@@H](CCN)c3ccccc3)-c4nonc4N,,,CHEMBL1109952,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157000,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CCn1c(nc2c(C#CC(C)(C)O)nc(cc12)O[C@@H](CCN)c3ccccc3)-c4nonc4N,,Row167,14,0.1432573199272155,out,6
151,Row149,Row1166,CHEMBL1258665,,0,412.93,47,IC50,=,2.0,nM,CCc1c[nH]c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,CCc1c[nH]c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,Row854,17,0.1096615716814994,out,6
152,Row150,Row1291,CHEMBL2177387,,0,454.02,26,IC50,=,2.0,nM,CC(C)NC[C@H](c1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4CC[C@@H](C=C)c34,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,CC(C)NC[C@H](c1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4CC[C@@H](C=C)c34,,Row2863,37,0.0913551896810531,out,6
153,Row151,Row1607,CHEMBL521642,,0,425.49,21,IC50,=,2.0,nM,CCn1c2c(cnc(C#CC(C)(C)O)c2nc1-c3nonc3N)OC[C@H]4CNCCC4,,,CHEMBL1111477,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1155389,1,Scientific Literature,J. Med. Chem.,2010.0,CCn1c2c(cnc(C#CC(C)(C)O)c2nc1-c3nonc3N)OC[C@H]4CNCCC4,,Row1541,13,0.1307543218135833,out,6
154,Row152,Row1713,CHEMBL1632375,,0,435.96,23,IC50,=,2.0,nM,C[C@@H]1SCc2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)Cc4cc(F)c(Cl)cc4,,,CHEMBL1632819,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1629708,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,C[C@@H]1SCc2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)Cc4cc(F)c(Cl)cc4,,Row3589,19,0.0959803685545921,out,6
155,Row153,Row1829,CHEMBL523523,,0,357.37,12c,IC50,=,2.0,nM,CCn1c2c(cnc(C#CCO)c2nc1-c3nonc3N)OCCCN,,,CHEMBL1028090,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140130,1,Scientific Literature,J. Med. Chem.,2008.0,CCn1c2c(cnc(C#CCO)c2nc1-c3nonc3N)OCCCN,,Row2429,38,0.107123464345932,out,6
156,Row154,Row1830,CHEMBL469591,,0,469.41,33,IC50,=,2.0,nM,CNCC(Cc1ccccc1)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CNCC(Cc1ccccc1)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34,,Row284,18,0.1251317411661148,out,6
157,Row155,Row1868,CHEMBL3953748,,0,573.61,BDBM187377,IC50,=,2.0,nM,CC1(CN(C1)c2cnc(cc2-n3cc(nc3)C4CC4)C(=O)Nc5csc(n5)-c6nncn6[C@@H](C)C(F)(F)F)OC,,337115.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,CC1(CN(C1)c2cnc(cc2-n3cc(nc3)C4CC4)C(=O)Nc5csc(n5)-c6nncn6[C@@H](C)C(F)(F)F)OC,,Row1789,25,0.0881728157401084,out,6
158,Row156,Row2175,CHEMBL453510,,0,371.4,3c,IC50,=,2.0,nM,CCn1c(nc2c(C#CC(C)(C)O)ncc(OCCN)c12)-c3nonc3N,,,CHEMBL1028090,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140130,1,Scientific Literature,J. Med. Chem.,2008.0,CCn1c(nc2c(C#CC(C)(C)O)ncc(OCCN)c12)-c3nonc3N,,Row2429,38,0.1055212542414665,out,6
159,Row157,Row2283,CHEMBL3946920,,0,573.61,BDBM187375,IC50,=,2.0,nM,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CC(C4)COC)-n5cc(nc5)C6CC6)C(F)(F)F,,337113.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CC(C4)COC)-n5cc(nc5)C6CC6)C(F)(F)F,,Row1789,25,0.08237174898386,out,6
160,Row158,Row2358,CHEMBL1257512,,0,453.76,58,IC50,=,2.0,nM,NC[C@@H](C(=O)N1CCN(CC1)c2ncnc3[nH]cc(Cl)c23)c4cc(Cl)c(Cl)cc4,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,NC[C@@H](C(=O)N1CCN(CC1)c2ncnc3[nH]cc(Cl)c23)c4cc(Cl)c(Cl)cc4,,Row854,17,0.0955851748585701,out,6
161,Row159,Row2435,CHEMBL2177378,,0,488.03,39,IC50,=,2.0,nM,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CNC(C)(C)CO)c4ccc(Cl)cc4,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CNC(C)(C)CO)c4ccc(Cl)cc4,,Row2863,37,0.0902231857180595,out,6
162,Row160,Row2591,CHEMBL1760759,,0,584.79,3b,IC50,=,2.0,nM,CCOCCN(C[C@@H](O)CN1CC2(CN(CC2)c3ncnc4[nH]cc(C)c34)CCC1)S(=O)(=O)c5c(C)cccc5C,,,CHEMBL1763788,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759869,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CCOCCN(C[C@@H](O)CN1CC2(CN(CC2)c3ncnc4[nH]cc(C)c34)CCC1)S(=O)(=O)c5c(C)cccc5C,,Row2370,39,0.1005081087350845,out,6
163,Row161,Row2771,CHEMBL1258780,,0,424.94,48,IC50,=,2.0,nM,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4[nH]cc(C5CC5)c43,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4[nH]cc(C5CC5)c43,,Row854,17,0.1117573752999305,out,6
164,Row162,Row3088,CHEMBL3961056,,0,460.56,BDBM182421,IC50,=,2.0,nM,Cc1cc(ccc1F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,329862.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,Row3990,26,0.1221987605094909,out,6
165,Row163,Row3138,CHEMBL596290,,0,465.52,2c,IC50,=,2.0,nM,Cc1n[nH]c2ncc(nc21)-c3cc(cnc3-c4cocc4)OC[C@@H](N)Cc5c[nH]c6ccccc56,,,CHEMBL1069941,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153227,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ncc(nc21)-c3cc(cnc3-c4cocc4)OC[C@@H](N)Cc5c[nH]c6ccccc56,,Row2116,20,0.1109411045908927,out,6
166,Row164,Row3177,CHEMBL1632368,,0,492.06,32,IC50,=,2.0,nM,CC(C)NCC(Cc1cc(F)c(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4CS[C@@H](C)c43,,,CHEMBL1632819,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1629708,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,CC(C)NCC(Cc1cc(F)c(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4CS[C@@H](C)c43,,Row3589,19,0.084236703813076,out,6
167,Row165,Row3217,CHEMBL1258900,,0,412.93,51,IC50,=,2.0,nM,Cc1c[nH]c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CN)Cc4ccc(Cl)cc4,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1c[nH]c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CN)Cc4ccc(Cl)cc4,,Row854,17,0.0989163443446159,out,6
168,Row166,Row3220,CHEMBL482537,,0,523.38,48,IC50,=,2.0,nM,NC[C@H](Cc1ccc(cc1)C(F)(F)F)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NC[C@H](Cc1ccc(cc1)C(F)(F)F)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34,,Row284,18,0.099502719938755,out,6
169,Row167,Row3653,CHEMBL1257402,,0,384.87,56,IC50,=,2.0,nM,NC[C@@H](C(=O)N1CCN(CC1)c2ncnc3[nH]ccc23)c4ccc(Cl)cc4,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,NC[C@@H](C(=O)N1CCN(CC1)c2ncnc3[nH]ccc23)c4ccc(Cl)cc4,,Row854,17,0.097488097846508,out,6
170,Row168,Row489,CHEMBL3961734,,0,579.56,BDBM187379,IC50,=,2.1,nM,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CCC(F)(F)C4)-n5cc(nc5)C6CC6)C(F)(F)F,,337117.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CCC(F)(F)C4)-n5cc(nc5)C6CC6)C(F)(F)F,,Row1789,25,0.0966478511691093,out,6
171,Row169,Row1406,CHEMBL3928772,,0,514.05,BDBM182588,IC50,=,2.1,nM,CCOc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(Cl)c(F)cc5,,330029.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCOc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(Cl)c(F)cc5,,Row3753,7,0.1208150386810302,out,6
172,Row170,Row1910,CHEMBL3916178,,0,479.6,BDBM182476,IC50,=,2.1,nM,Cc1cc(ccc1F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5OCC,,329917.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5OCC,,Row2590,1,0.1234985366463661,out,6
173,Row171,Row2019,CHEMBL390372,,0,437.34,13k,IC50,=,2.1,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cccc(Br)c4,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cccc(Br)c4,,Row1976,11,0.1143269911408424,out,6
174,Row172,Row3355,CHEMBL3961404,,0,599.64,BDBM187396,IC50,=,2.1,nM,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CCC5(COC5)CC4)-n6cc(nc6)C7CC7)C(F)(F)F,,337134.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CCC5(COC5)CC4)-n6cc(nc6)C7CC7)C(F)(F)F,,Row1789,25,0.0939198285341262,out,6
175,Row173,Row4001,CHEMBL3910789,,0,474.54,BDBM182470,IC50,=,2.1,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCNC)-c4cc(ncc4)C(F)(F)F,,329911.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCNC)-c4cc(ncc4)C(F)(F)F,,Row2164,32,0.1140961050987243,out,6
176,Row175,Row402,CHEMBL3218297,,0,422.49,5g-Mes,IC50,=,2.16,nM,Oc1cc(CNC(=O)Nc2nc(cs2)-c3ccncc3)ccc1,,,CHEMBL3224479,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3217586,1,Scientific Literature,MedChemComm,2012.0,Oc1cc(CNC(=O)Nc2nc(cs2)-c3ccncc3)ccc1,,Row3192,40,0.1027001738548278,out,6
177,Row176,Row643,CHEMBL3986793,,0,537.99,BDBM182508,IC50,=,2.2,nM,Nc1ncnc(c1Cl)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)c(c5)C(F)(F)F,,329949.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Cl)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row643,24,0.1248784735798835,out,6
178,Row177,Row1115,CHEMBL3977147,,0,551.42,BDBM182425,IC50,=,2.2,nM,Nc1ncnc(c1Br)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ncc5)C(F)(F)F,,329866.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Br)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ncc5)C(F)(F)F,,Row2590,1,0.1223769038915634,out,6
179,Row178,Row1208,CHEMBL3908126,,0,523.57,BDBM187353,IC50,=,2.2,nM,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CC(C5)C(F)F)-n6cnc(c6)C7CC7,,337091.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CC(C5)C(F)F)-n6cnc(c6)C7CC7,,Row2917,8,0.0839292705059051,out,6
180,Row179,Row1470,CHEMBL3891980,,0,472.64,BDBM182481,IC50,=,2.2,nM,CC(C)c1cc(ccn1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C=C,,329922.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(C)c1cc(ccn1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C=C,,Row3753,7,0.1230660080909729,out,6
181,Row180,Row1597,CHEMBL3898363,,0,526.63,BDBM187361,IC50,=,2.2,nM,N#CC1CCN(CC1)c2cnc(cc2-n3cnc(c3)C4CC4)C(=O)Nc5csc(n5)-c6nncn6C7CC7,,337099.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,N#CC1CCN(CC1)c2cnc(cc2-n3cnc(c3)C4CC4)C(=O)Nc5csc(n5)-c6nncn6C7CC7,,Row2917,8,0.0904763266444206,out,6
182,Row181,Row2280,CHEMBL3893936,,0,601.66,BDBM187387,IC50,=,2.2,nM,CC1(CCN(CC1)c2cnc(cc2-n3cc(nc3)C4CC4)C(=O)Nc5csc(n5)-c6nncn6[C@@H](C)C(F)(F)F)OC,,337125.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,CC1(CCN(CC1)c2cnc(cc2-n3cc(nc3)C4CC4)C(=O)Nc5csc(n5)-c6nncn6[C@@H](C)C(F)(F)F)OC,,Row1789,25,0.0958525314927101,out,6
183,Row182,Row3350,CHEMBL3953359,,0,555.59,BDBM187392,IC50,=,2.2,nM,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CC5CC5C4)-n6cc(nc6)C7CC7)C(F)(F)F,,337130.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CC5CC5C4)-n6cc(nc6)C7CC7)C(F)(F)F,,Row1789,25,0.0819146186113357,out,6
184,Row183,Row1168,CHEMBL3927877,,0,542.59,BDBM182611,IC50,=,2.3,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCCCC4)-c5ccc(F)c(c5)C(F)(F)F,,330052.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCCCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row3990,26,0.1170775964856147,out,6
185,Row184,Row1207,CHEMBL3972479,,0,474.59,BDBM182677,IC50,=,2.3,nM,Cc1cc(ccc1F)-c2cn(CCNCC3CC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,330118.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCNCC3CC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,Row3798,5,0.1090339943766594,out,6
186,Row185,Row1211,CHEMBL3904498,,0,587.63,BDBM187382,IC50,=,2.3,nM,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CCC(CC4)OC)-n5cnc(c5)C6CC6)C(F)(F)F,,337120.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CCC(CC4)OC)-n5cnc(c5)C6CC6)C(F)(F)F,,Row1789,25,0.0821523517370224,out,6
187,Row186,Row1350,CHEMBL3908356,,0,614.66,BDBM187383,IC50,=,2.3,nM,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CCC(CC4)C(=O)NC)-n5cc(nc5)C6CC6)C(F)(F)F,,337121.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CCC(CC4)C(=O)NC)-n5cc(nc5)C6CC6)C(F)(F)F,,Row1789,25,0.081565648317337,out,6
188,Row187,Row1491,CHEMBL3981085,,0,451.55,BDBM182483,IC50,=,2.3,nM,Cc1cc(ccc1F)-c2cn(CC3CNC3)c(n2)C4CCN(CC4)c5ncnc(N)c5OC,,329924.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CC3CNC3)c(n2)C4CCN(CC4)c5ncnc(N)c5OC,,Row3798,5,0.1249411553144455,out,6
189,Row188,Row1526,CHEMBL3894578,,0,568.42,BDBM182516,IC50,=,2.3,nM,Nc1ncnc(c1Br)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,329957.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Br)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row643,24,0.1213854625821113,out,6
190,Row190,Row2261,CHEMBL3903522,,0,583.61,BDBM182518,IC50,=,2.3,nM,Nc1ncnc(c1-c2ccc(F)cc2)N3CCC(CC3)c4nc(cn4CCN5CCC5)-c6cc(c(F)cc6)C(F)(F)F,,329959.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1-c2ccc(F)cc2)N3CCC(CC3)c4nc(cn4CCN5CCC5)-c6cc(c(F)cc6)C(F)(F)F,,Row643,24,0.1242662891745567,out,6
191,Row191,Row2565,CHEMBL3967750,,0,449.58,BDBM182487,IC50,=,2.3,nM,Cc1cc(ccc1F)-c2cn(CC3CNC3)c(n2)C4CCN(CC4)c5ncnc(N)c5CC,,329928.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CC3CNC3)c(n2)C4CCN(CC4)c5ncnc(N)c5CC,,Row3798,5,0.1182612404227256,out,6
192,Row192,Row2714,CHEMBL3986247,,0,558.67,BDBM187370,IC50,=,2.3,nM,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CC(C5)N6CCOCC6)-n7cc(nc7)C8CC8,,337108.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CC(C5)N6CCOCC6)-n7cc(nc7)C8CC8,,Row2917,8,0.080106496810913,out,6
193,Row193,Row3899,CHEMBL3926976,,0,614.61,BDBM187391,IC50,=,2.3,nM,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CC5COC(=O)N5CC4)-n6cc(nc6)C7CC7)C(F)(F)F,,337129.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CC5COC(=O)N5CC4)-n6cc(nc6)C7CC7)C(F)(F)F,,Row1789,25,0.0832553729414939,out,6
194,Row194,Row1525,CHEMBL3933597,,0,494.58,BDBM182420,IC50,=,2.4,nM,COc1cc(ccc1F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,329861.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,COc1cc(ccc1F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,Row1206,41,0.1338882893323898,out,6
195,Row195,Row2941,CHEMBL227050,,0,390.46,13z,IC50,=,2.4,nM,Cc1n[nH]c2ccc(cc12)-c3cncc(c3)OC[C@@H](N)Cc4ccc(C)c(F)c4,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc12)-c3cncc(c3)OC[C@@H](N)Cc4ccc(C)c(F)c4,,Row1976,11,0.1058380603790283,out,6
196,Row196,Row3238,CHEMBL3938454,,0,476.56,BDBM182419,IC50,=,2.4,nM,COc1cc(ccc1F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,329860.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,COc1cc(ccc1F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,Row3990,26,0.129313588142395,out,6
197,Row197,Row3342,CHEMBL3899813,,0,598.66,BDBM187390,IC50,=,2.4,nM,CN1CC2CN(CC2C1)c3cnc(cc3-n4cc(nc4)C5CC5)C(=O)Nc6csc(n6)-c7nncn7[C@@H](C)C(F)(F)F,,337128.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,CN1CC2CN(CC2C1)c3cnc(cc3-n4cc(nc4)C5CC5)C(=O)Nc6csc(n6)-c7nncn7[C@@H](C)C(F)(F)F,,Row1789,25,0.080616109073162,out,6
198,Row198,Row3795,CHEMBL3912769,,0,481.05,BDBM182479,IC50,=,2.4,nM,CC(C)c1cc(ccn1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5Cl,,329920.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(C)c1cc(ccn1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5Cl,,Row643,24,0.1299727410078048,out,6
199,Row200,Row3947,CHEMBL4460525,,0,540.4,E24,IC50,=,2.49,nM,CC(=O)NCC[C@@H]1C[C@H]([C@@H](CN1)NC(=O)c2cc(-c3c(Cl)cnn3C)c(Cl)o2)c4cc(F)c(F)cc4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,CC(=O)NCC[C@@H]1C[C@H]([C@@H](CN1)NC(=O)c2cc(-c3c(Cl)cnn3C)c(Cl)o2)c4cc(F)c(F)cc4,,Row3515,16,0.0875515192747116,out,6
200,Row201,Row1668,CHEMBL226996,,0,451.37,13w,IC50,=,2.5,nM,Cc1cc(C[C@H](N)COc2cncc(c2)-c3cc4c(cc3)[nH]nc4C)ccc1Br,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1cc(C[C@H](N)COc2cncc(c2)-c3cc4c(cc3)[nH]nc4C)ccc1Br,,Row1976,11,0.1050601825118064,out,6
201,Row202,Row1732,CHEMBL573359,,0,391.45,84,IC50,=,2.5,nM,Cc1cc(C[C@H](N)COc2cncc(c2)-c3cc4c(cn3)[nH]nc4C)ccc1F,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Cc1cc(C[C@H](N)COc2cncc(c2)-c3cc4c(cn3)[nH]nc4C)ccc1F,,Row535,12,0.0956234633922576,out,6
202,Row203,Row1760,CHEMBL517163,,0,512.57,37,IC50,=,2.5,nM,CN(C)CC(=O)N1CCc2cc(OC)c(cc12)Nc3nc4[nH]ccc4c(Nc5cccc6CNC(=O)c65)n3,,,CHEMBL1025728,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154545,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CN(C)CC(=O)N1CCc2cc(OC)c(cc12)Nc3nc4[nH]ccc4c(Nc5cccc6CNC(=O)c65)n3,,Row1867,42,0.1184896975755691,out,6
203,Row204,Row2412,CHEMBL3980922,,0,506.96,BDBM182443,IC50,=,2.5,nM,Nc1ncnc(c1Cl)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ncc5)C(F)(F)F,,329884.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Cl)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ncc5)C(F)(F)F,,Row643,24,0.1265346258878708,out,6
204,Row205,Row2511,CHEMBL3978053,,0,556.7,BDBM187372,IC50,=,2.5,nM,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CCN(CC6CC6)CC5)-n7cc(nc7)C8CC8,,337110.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CCN(CC6CC6)CC5)-n7cc(nc7)C8CC8,,Row2917,8,0.0848631262779235,out,6
205,Row206,Row2530,CHEMBL3920406,,0,519.61,BDBM187360,IC50,=,2.5,nM,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CCC(F)CC5)-n6cc(nc6)C7CC7,,337098.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CCC(F)CC5)-n6cc(nc6)C7CC7,,Row2917,8,0.0851468071341514,out,6
206,Row207,Row2848,CHEMBL3903066,,0,532.55,BDBM182663,IC50,=,2.5,nM,COCCNCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4ccc(F)c(c4)C(F)(F)F,,330104.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,COCCNCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4ccc(F)c(c4)C(F)(F)F,,Row2188,10,0.1067441180348396,out,6
207,Row208,Row3010,CHEMBL3919834,,0,534.56,BDBM182669,IC50,=,2.5,nM,CC(C)NCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4ccc(F)c(c4)C(F)(F)F,,330110.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(C)NCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4ccc(F)c(c4)C(F)(F)F,,Row2044,43,0.1115146651864051,out,6
208,Row209,Row3431,CHEMBL4552655,,0,455.29,"(3R,4S)-A6",IC50,=,2.5,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CNCC[C@@H]3c4ccc(F)c(F)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CNCC[C@@H]3c4ccc(F)c(F)c4,,Row39,44,0.0945671945810318,out,6
209,Row210,Row3650,CHEMBL3896910,,0,476.6,BDBM182625,IC50,=,2.5,nM,Cc1cc(ccc1F)-c2cn(CCN(CC)CC)c(n2)C3CCN(CC3)c4ncnc(N)c4C#N,,330066.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCN(CC)CC)c(n2)C3CCN(CC3)c4ncnc(N)c4C#N,,Row3798,5,0.1272945255041122,out,6
210,Row211,Row232,CHEMBL3640738,,0,586.74,BDBM108431,IC50,=,2.51,nM,CN(C)C(=O)C1CCN(CC1)c2cc(ccc2)-c3ccc4nc(-c5cccnc5N)n(c4n3)-c6ccc(cc6)C7(N)CCC7,,286563.0,CHEMBL3705364,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3639036,37,BindingDB Database,,2015.0,CN(C)C(=O)C1CCN(CC1)c2cc(ccc2)-c3ccc4nc(-c5cccnc5N)n(c4n3)-c6ccc(cc6)C7(N)CCC7,,Row366,27,0.2385731339454651,out,6
211,Row212,Row3975,CHEMBL4451765,,0,546.28,E3,IC50,=,2.56,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@H](CCCO)C[C@H]3c4ccc(Cl)c(Cl)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@H](CCCO)C[C@H]3c4ccc(Cl)c(Cl)c4,,Row3515,16,0.0963312610983848,out,6
212,Row213,Row381,CHEMBL3962807,,0,514.53,BDBM182373,IC50,=,2.6,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,329814.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row3990,26,0.1182040348649025,out,6
213,Row214,Row1060,CHEMBL1169610,,0,388.83,33,IC50,=,2.6,nM,N[C@@]1(CNC(=O)c2ccc(F)cc2)CN(CC1)c3ncnc4[nH]cc(Cl)c43,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,N[C@@]1(CNC(=O)c2ccc(F)cc2)CN(CC1)c3ncnc4[nH]cc(Cl)c43,,Row2553,9,0.1226397529244422,out,6
214,Row215,Row2680,CHEMBL572907,,0,423.52,59,IC50,=,2.6,nM,N[C@H](COc1cncc(c1)-c2cc3c(n[nH]c3cc2)C4CC4)Cc5c[nH]c6ccccc65,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@H](COc1cncc(c1)-c2cc3c(n[nH]c3cc2)C4CC4)Cc5c[nH]c6ccccc65,,Row1726,2,0.1400737166404724,out,6
215,Row216,Row3331,CHEMBL3903012,,0,599.64,BDBM187397,IC50,=,2.6,nM,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CC5(C4)CCOCC5)-n6cc(nc6)C7CC7)C(F)(F)F,,337135.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,C[C@H](n1cnnc1-c2nc(cs2)NC(=O)c3cc(c(cn3)N4CC5(C4)CCOCC5)-n6cc(nc6)C7CC7)C(F)(F)F,,Row1789,25,0.0925828963518142,out,6
216,Row217,Row3954,CHEMBL3913659,,0,509.67,BDBM182603,IC50,=,2.6,nM,Cc1cc(ccc1F)-c2cn(CCN(CC)CC)c(n2)C3CCN(CC3)c4ncnc(N)c4OC(C)C,,330044.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCN(CC)CC)c(n2)C3CCN(CC3)c4ncnc(N)c4OC(C)C,,Row2590,1,0.1254938244819641,out,6
217,Row218,Row3996,CHEMBL3891820,,0,479.65,BDBM182595,IC50,=,2.6,nM,Cc1cc(ccc1F)-c2cn(CCN(CC)CC)c(n2)C3CCN(CC3)c4ncnc(N)c4CC,,330036.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCN(CC)CC)c(n2)C3CCN(CC3)c4ncnc(N)c4CC,,Row3753,7,0.1310078650712967,out,6
218,Row219,Row3472,CHEMBL4475923,,0,559.28,E15,IC50,=,2.64,nM,CNC(=O)C[C@@H]1C[C@H]([C@@H](CN1)NC(=O)c2cc(c(Cl)o2)-c3c(Cl)cnn3C)c4ccc(Cl)c(Cl)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,CNC(=O)C[C@@H]1C[C@H]([C@@H](CN1)NC(=O)c2cc(c(Cl)o2)-c3c(Cl)cnn3C)c4ccc(Cl)c(Cl)c4,,Row3515,16,0.0885103940963745,out,6
219,Row220,Row270,CHEMBL3897066,,0,521.52,BDBM182316,IC50,=,2.7,nM,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4ccc(cc4)C#N)-c5cc(c(F)cc5)C(F)(F)F,,329781.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4ccc(cc4)C#N)-c5cc(c(F)cc5)C(F)(F)F,,Row3758,45,0.1155614629387855,out,6
220,Row221,Row378,CHEMBL3909180,,0,530.57,BDBM182659,IC50,=,2.7,nM,CN(CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4ccc(F)c(c4)C(F)(F)F)C(C)C,,330100.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4ccc(F)c(c4)C(F)(F)F)C(C)C,,Row2188,10,0.1102248355746269,out,6
221,Row222,Row472,CHEMBL3927590,,0,534.52,BDBM182582,IC50,=,2.7,nM,Nc1ncnc(c1[N+]([O-])=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,330023.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1[N+]([O-])=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row2044,43,0.1204139366745948,out,6
222,Row223,Row1241,CHEMBL3908552,,0,539.57,BDBM182467,IC50,=,2.7,nM,Nc1ncnc(c1-c2conc2)N3CCC(CC3)c4nc(cn4CCN5CCC5)-c6cc(ncc6)C(F)(F)F,,329908.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1-c2conc2)N3CCC(CC3)c4nc(cn4CCN5CCC5)-c6cc(ncc6)C(F)(F)F,,Row2044,43,0.1188490688800811,out,6
223,Row224,Row2408,CHEMBL3985943,,0,493.63,BDBM182477,IC50,=,2.7,nM,Cc1cc(ccc1F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5OC(C)C,,329918.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5OC(C)C,,Row2590,1,0.1205094531178474,out,6
224,Row225,Row2427,CHEMBL3964706,,0,542.67,BDBM187367,IC50,=,2.7,nM,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CC6CCCN6CC5)-n7cc(nc7)C8CC8,,337105.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CC6CCCN6CC5)-n7cc(nc7)C8CC8,,Row2917,8,0.0892764553427696,out,6
225,Row226,Row2490,CHEMBL3963056,,0,476.6,BDBM182678,IC50,=,2.7,nM,CN(CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4cc(C)c(F)cc4)C(C)C,,330119.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4cc(C)c(F)cc4)C(C)C,,Row3798,5,0.1119773015379905,out,6
226,Row227,Row2726,CHEMBL3963748,,0,558.63,BDBM187368,IC50,=,2.7,nM,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CC6COC(=O)N6CC5)-n7cc(nc7)C8CC8,,337106.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CC6COC(=O)N6CC5)-n7cc(nc7)C8CC8,,Row2917,8,0.0849776864051818,out,6
227,Row228,Row3515,CHEMBL4517950,,0,532.26,E4,IC50,=,2.74,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@H](CCO)C[C@H]3c4ccc(Cl)c(Cl)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@H](CCO)C[C@H]3c4ccc(Cl)c(Cl)c4,,Row3515,16,0.0898375436663627,out,6
228,Row229,Row2525,CHEMBL3957940,,0,509.55,BDBM187357,IC50,=,2.8,nM,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CC(F)(F)C5)-n6cc(nc6)C7CC7,,337095.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CC(F)(F)C5)-n6cc(nc6)C7CC7,,Row2917,8,0.0915295481681823,out,6
229,Row230,Row2917,CHEMBL3954180,,0,542.67,BDBM187371,IC50,=,2.8,nM,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CCN(CC5)C6CC6)-n7cc(nc7)C8CC8,,337109.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CCN(CC5)C6CC6)-n7cc(nc7)C8CC8,,Row2917,8,0.0845181569457054,out,6
230,Row231,Row3933,CHEMBL3957053,,0,490.63,BDBM182626,IC50,=,2.8,nM,Cc1cc(ccc1F)-c2cn(CCN(CC)C(C)C)c(n2)C3CCN(CC3)c4ncnc(N)c4C#N,,330067.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCN(CC)C(C)C)c(n2)C3CCN(CC3)c4ncnc(N)c4C#N,,Row3798,5,0.1120706796646118,out,6
231,Row232,Row3951,CHEMBL3951747,,0,587.88,BDBM182426,IC50,=,2.8,nM,Nc1ncnc(c1Br)N2CCC(CC2)c3nc(cn3CCNCCCCl)-c4cc(ncc4)C(F)(F)F,,329867.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Br)N2CCC(CC2)c3nc(cn3CCNCCCCl)-c4cc(ncc4)C(F)(F)F,,Row2590,1,0.1142464280128479,out,6
232,Row233,Row3998,CHEMBL3895494,,0,517.62,BDBM187358,IC50,=,2.8,nM,COC1CN(CC1)c2cnc(cc2-n3cc(nc3)C4CC4)C(=O)Nc5csc(n5)-c6nncn6C7CC7,,337096.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,COC1CN(CC1)c2cnc(cc2-n3cc(nc3)C4CC4)C(=O)Nc5csc(n5)-c6nncn6C7CC7,,Row2917,8,0.0846525207161903,out,6
233,Row234,Row292,CHEMBL4213657,,0,493.83,10i,IC50,=,2.9,nM,O=C(N1CCN(CC1)c2ncnc3[nH]cc(Cl)c23)C4(CCNCC4)c5cc(Cl)c(Cl)cc5,,,CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4190265,1,Scientific Literature,Eur J Med Chem,2017.0,O=C(N1CCN(CC1)c2ncnc3[nH]cc(Cl)c23)C4(CCNCC4)c5cc(Cl)c(Cl)cc5,,Row3980,30,0.127793401479721,out,6
234,Row235,Row537,CHEMBL4445510,,0,488.2,B1,IC50,=,2.9,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)c(Cl)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)c(Cl)c4,,Row39,44,0.0945674777030944,out,6
235,Row236,Row1349,CHEMBL3911853,,0,514.45,BDBM182526,IC50,=,2.9,nM,Nc1ncnc(c1Br)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)cc5,,329967.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Br)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)cc5,,Row2590,1,0.1281808614730835,out,6
236,Row237,Row1984,CHEMBL388312,,0,447.85,37b,IC50,=,2.9,nM,N[C@@H](Cc1cc(ccc1)C(F)(F)F)COc2cncc(c2)-c3cc4c(Cl)n[nH]c4cn3,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,N[C@@H](Cc1cc(ccc1)C(F)(F)F)COc2cncc(c2)-c3cc4c(Cl)n[nH]c4cn3,,Row535,12,0.1093836650252342,out,6
237,Row238,Row2566,CHEMBL3968352,,0,514.53,BDBM182446,IC50,=,2.9,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CC4CCCN4)-c5cc(c(F)cc5)C(F)(F)F,,329887.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CC4CCCN4)-c5cc(c(F)cc5)C(F)(F)F,,Row2188,10,0.1196937561035156,out,6
238,Row239,Row2669,CHEMBL577795,,0,398.47,55,IC50,=,2.9,nM,Nc1n[nH]c2ccc(cc12)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc54,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Nc1n[nH]c2ccc(cc12)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc54,,Row1726,2,0.12764972448349,out,6
239,Row240,Row3316,CHEMBL3953443,,0,584.63,BDBM187365,IC50,=,2.9,nM,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CCN(CC(F)(F)F)CC5)-n6cc(nc6)C7CC7,,337103.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CCN(CC(F)(F)F)CC5)-n6cc(nc6)C7CC7,,Row2917,8,0.0837363079190254,out,6
240,Row241,Row3549,CHEMBL3890076,,0,462.58,BDBM182679,IC50,=,2.9,nM,Cc1cc(ccc1F)-c2cn(CCNC(C)C)c(n2)C3CCN(CC3)c4ncnc(N)c4C#N,,330120.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCNC(C)C)c(n2)C3CCN(CC3)c4ncnc(N)c4C#N,,Row2188,10,0.109326034784317,out,6
241,Row242,Row24,CHEMBL523859,,0,475.55,3d,IC50,=,3.0,nM,CCn1c2c(cnc(C#CC(C)(C)O)c2nc1-c3nonc3N)OCC[C@@H](N)Cc4ccccc4,,,CHEMBL1028090,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140130,1,Scientific Literature,J. Med. Chem.,2008.0,CCn1c2c(cnc(C#CC(C)(C)O)c2nc1-c3nonc3N)OCC[C@@H](N)Cc4ccccc4,,Row2429,38,0.1360857784748077,out,6
242,Row243,Row165,CHEMBL1098316,,0,355.4,17,IC50,=,3.0,nM,CCn1c2cc(CNC)nc(C#CC(C)(C)O)c2nc1-c3nonc3N,,,CHEMBL1109952,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157000,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CCn1c2cc(CNC)nc(C#CC(C)(C)O)c2nc1-c3nonc3N,,Row167,14,0.1007752269506454,out,6
243,Row244,Row186,CHEMBL470410,,0,455.38,28,IC50,=,3.0,nM,CNCC(NC(=O)c1cc(Br)c(s1)-c2ccnc3[nH]ccc23)c4ccccc4,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CNCC(NC(=O)c1cc(Br)c(s1)-c2ccnc3[nH]ccc23)c4ccccc4,,Row1178,46,0.125239685177803,out,6
244,Row245,Row225,CHEMBL1099296,,0,447.5,31,IC50,=,3.0,nM,CCn1c(nc2c(C#CC(C)(C)O)nc(cc12)O[C@H](CN)c3ccccc3)-c4nonc4N,,,CHEMBL1109952,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157000,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CCn1c(nc2c(C#CC(C)(C)O)nc(cc12)O[C@H](CN)c3ccccc3)-c4nonc4N,,Row167,14,0.145544484257698,out,6
245,Row246,Row302,CHEMBL1632381,,0,486.09,30,IC50,=,3.0,nM,C[C@@H]1SCc2ncnc(c21)N3CCN(CC3)C(=O)C(CN4CCCC4)Cc5ccc(Cl)cc5,,,CHEMBL1632819,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1629708,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,C[C@@H]1SCc2ncnc(c21)N3CCN(CC3)C(=O)C(CN4CCCC4)Cc5ccc(Cl)cc5,,Row3589,19,0.0933015272021293,out,6
246,Row247,Row421,CHEMBL1257282,,0,382.44,54,IC50,=,3.0,nM,Cc1c[nH]c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(F)cc4,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1c[nH]c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(F)cc4,,Row854,17,0.1010950654745101,out,6
247,Row248,Row474,CHEMBL594523,,0,479.54,16,IC50,=,3.0,nM,Cc1nc(c(cc1OC[C@@H](N)Cc2c[nH]c3ccccc23)-c4cnc5[nH]nc(C)c5n4)-c6cocc6,,,CHEMBL1072610,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153244,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1nc(c(cc1OC[C@@H](N)Cc2c[nH]c3ccccc23)-c4cnc5[nH]nc(C)c5n4)-c6cocc6,,Row2116,20,0.1085515692830085,out,6
248,Row249,Row557,CHEMBL2177388,,0,460.0,33,IC50,=,3.0,nM,CC(C)NC[C@H](c1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4CC[C@@H](CF)c34,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,CC(C)NC[C@H](c1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4CC[C@@H](CF)c34,,Row2863,37,0.0851649865508079,out,6
249,Row250,Row636,CHEMBL1080569,,0,429.47,1,IC50,=,3.0,nM,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2nnc(s2)-c3cc4ccncc4cc3,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2nnc(s2)-c3cc4ccncc4cc3,,Row240,47,0.108318492770195,out,6
250,Row251,Row681,CHEMBL2177372,,0,476.0,50,IC50,=,3.0,nM,CC(C)NC[C@@H](C(=O)N1CCN(CC1)c2ncnc3[C@H](O)C[C@@H](C)c32)c4ccc(Cl)c(F)c4,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,CC(C)NC[C@@H](C(=O)N1CCN(CC1)c2ncnc3[C@H](O)C[C@@H](C)c32)c4ccc(Cl)c(F)c4,,Row2863,37,0.0999217256903648,out,6
251,Row252,Row705,CHEMBL1632382,,0,453.66,31,IC50,=,3.0,nM,Cc1ccc(CC(CNC(C)C)C(=O)N2CCN(CC2)c3ncnc4CS[C@@H](C)c43)cc1,,,CHEMBL1632819,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1629708,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1ccc(CC(CNC(C)C)C(=O)N2CCN(CC2)c3ncnc4CS[C@@H](C)c43)cc1,,Row3589,19,0.0847083330154419,out,6
252,Row253,Row746,CHEMBL1760776,,0,505.65,27i,IC50,=,3.0,nM,Cc1onc(C)c1S(=O)(=O)NC[C@@H](O)CN2C[C@@]3(CN(CC3)c4ncnc(N)c4C5CC5)CCC2,,,CHEMBL1763788,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759869,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,Cc1onc(C)c1S(=O)(=O)NC[C@@H](O)CN2C[C@@]3(CN(CC3)c4ncnc(N)c4C5CC5)CCC2,,Row315,48,0.1003495380282402,out,6
253,Row254,Row848,CHEMBL520788,,0,523.38,46,IC50,=,3.0,nM,NC[C@H](Cc1ccccc1C(F)(F)F)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NC[C@H](Cc1ccccc1C(F)(F)F)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34,,Row284,18,0.1188842430710792,out,6
254,Row255,Row939,CHEMBL2325727,,0,455.99,50,IC50,=,3.0,nM,CN(C)CC[C@H](NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc32)c4ccc(Cl)cc4,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,CN(C)CC[C@H](NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc32)c4ccc(Cl)cc4,,Row3863,35,0.1209663525223732,out,6
255,Row256,Row1148,CHEMBL1096634,GSK-943949A,0,447.5,26,IC50,=,3.0,nM,CCn1c(nc2c(C#CC(C)(C)O)nc(cc12)OC[C@H](N)c3ccccc3)-c4nonc4N,,,CHEMBL1109952,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157000,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CCn1c(nc2c(C#CC(C)(C)O)nc(cc12)OC[C@H](N)c3ccccc3)-c4nonc4N,,Row167,14,0.1348812729120254,out,6
256,Row257,Row1282,CHEMBL1632386,,0,490.05,36,IC50,=,3.0,nM,C[C@@H]1SCc2ncnc(c21)N3CCN(CC3)C(=O)C(CC4(N)CC4)Cc5cc(F)c(Cl)cc5,,,CHEMBL1632819,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1629708,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,C[C@@H]1SCc2ncnc(c21)N3CCN(CC3)C(=O)C(CC4(N)CC4)Cc5cc(F)c(Cl)cc5,,Row3589,19,0.1191343143582344,out,6
257,Row258,Row1517,CHEMBL2178597,,0,523.58,51,IC50,=,3.0,nM,CC(C)(C)NC[C@@H](C(=O)N1CCN(CC1)c2ncnc3[C@H](O)C[C@@H](C)c32)c4ccc(c(F)c4)C(F)(F)F,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,CC(C)(C)NC[C@@H](C(=O)N1CCN(CC1)c2ncnc3[C@H](O)C[C@@H](C)c32)c4ccc(c(F)c4)C(F)(F)F,,Row2863,37,0.0996707007288932,out,6
258,Row259,Row1680,CHEMBL522351,,0,459.51,14b,IC50,=,3.0,nM,CCn1c2c(cnc(C#CC(C)(C)O)c2nc1-c3nonc3N)OCCCNC[C@H](O)CO,,,CHEMBL1028090,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140130,1,Scientific Literature,J. Med. Chem.,2008.0,CCn1c2c(cnc(C#CC(C)(C)O)c2nc1-c3nonc3N)OCCCNC[C@H](O)CO,,Row2429,38,0.1037051752209663,out,6
259,Row260,Row1808,CHEMBL1632380,,0,474.07,29,IC50,=,3.0,nM,CC(C)NCC(Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4CS[C@@H](C)c43,,,CHEMBL1632819,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1629708,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,CC(C)NCC(Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4CS[C@@H](C)c43,,Row3589,19,0.0843490213155746,out,6
260,Row261,Row1905,CHEMBL446966,,0,569.67,12,IC50,=,3.0,nM,COc1ccc(cn1)-c2[nH]c(nn2)C3CCN(Cc4ccc(cc4)-c5nc6cc[nH]c(=O)c6cc5-c7ccccc7)CC3,,,CHEMBL947431,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,COc1ccc(cn1)-c2[nH]c(nn2)C3CCN(Cc4ccc(cc4)-c5nc6cc[nH]c(=O)c6cc5-c7ccccc7)CC3,,Row1163,23,0.2183955907821655,out,6
261,Row262,Row1952,CHEMBL1098939,,0,461.53,29,IC50,=,3.0,nM,CCn1c(nc2c(C#CC(C)(C)O)nc(cc12)OC[C@@H](N)Cc3ccccc3)-c4nonc4N,,,CHEMBL1109952,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157000,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CCn1c(nc2c(C#CC(C)(C)O)nc(cc12)OC[C@@H](N)Cc3ccccc3)-c4nonc4N,,Row167,14,0.1328213810920715,out,6
262,Row263,Row1986,CHEMBL1097974,,0,369.43,16,IC50,=,3.0,nM,CCn1c2cc(CCCN)nc(C#CC(C)(C)O)c2nc1-c3nonc3N,,,CHEMBL1109952,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157000,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CCn1c2cc(CCCN)nc(C#CC(C)(C)O)c2nc1-c3nonc3N,,Row167,14,0.1098736524581909,out,6
263,Row264,Row2073,CHEMBL2177368,,0,514.07,46,IC50,=,3.0,nM,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CNCC4CCOCC4)c5ccc(Cl)cc5,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CNCC4CCOCC4)c5ccc(Cl)cc5,,Row2863,37,0.0903262868523597,out,6
264,Row265,Row2553,CHEMBL1171994,,0,368.42,32,IC50,=,3.0,nM,Cc1c[nH]c2ncnc(c21)N3C[C@@](N)(CNC(=O)c4ccc(F)cc4)CC3,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,Cc1c[nH]c2ncnc(c21)N3C[C@@](N)(CNC(=O)c4ccc(F)cc4)CC3,,Row2553,9,0.1260253936052322,out,6
265,Row266,Row2631,CHEMBL512480,,0,362.46,19,IC50,=,3.0,nM,NCC(C(=O)Nc1ccc(s1)-c2ccnc3[nH]ccc23)c4ccccc4,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NCC(C(=O)Nc1ccc(s1)-c2ccnc3[nH]ccc23)c4ccccc4,,Row1178,46,0.1378557085990905,out,6
266,Row267,Row3044,CHEMBL2177379,,0,455.99,43,IC50,=,3.0,nM,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H]([C@@H]4CCCN4)c5ccc(Cl)cc5,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H]([C@@H]4CCCN4)c5ccc(Cl)cc5,,Row2863,37,0.1039391383528709,out,6
267,Row268,Row3100,CHEMBL593374,,0,492.58,14a,IC50,=,3.0,nM,Cc1occc1-c2nc(N)c(cc2-c3cc4c(cc3)[nH]nc4C)OC[C@@H](N)Cc5c[nH]c6ccccc65,,,CHEMBL1072610,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153244,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1occc1-c2nc(N)c(cc2-c3cc4c(cc3)[nH]nc4C)OC[C@@H](N)Cc5c[nH]c6ccccc65,,Row2116,20,0.1280248016119003,out,6
268,Row269,Row3163,CHEMBL3961556,,0,536.0,BDBM182509,IC50,=,3.0,nM,Nc1ncnc(c1Cl)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(c(O)cc5)C(F)(F)F,,329950.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Cl)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(c(O)cc5)C(F)(F)F,,Row643,24,0.1248058453202247,out,6
269,Row270,Row3180,CHEMBL524998,,0,485.41,42,IC50,=,3.0,nM,COc1ccc(C[C@@H](CN)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34)cc1,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,COc1ccc(C[C@@H](CN)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34)cc1,,Row284,18,0.1104450300335884,out,6
270,Row271,Row3265,CHEMBL4457064,,0,605.38,"A12; (3S,4S)-A6",IC50,=,3.0,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(F)c(F)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(F)c(F)c4,,Row39,44,0.0945671945810318,out,6
271,Row272,Row3421,CHEMBL2177361,,0,521.56,53,IC50,=,3.0,nM,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CNCC4CC4)c5cc(F)c(cc5)C(F)(F)F,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CNCC4CC4)c5cc(F)c(cc5)C(F)(F)F,,Row2863,37,0.1001443937420845,out,6
272,Row273,Row3517,CHEMBL1632391,,0,458.01,41,IC50,=,3.0,nM,CC(C)NC[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4CO[C@@H](C)c43,,,CHEMBL1632819,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1629708,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,CC(C)NC[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4CO[C@@H](C)c43,,Row3589,19,0.0835581570863723,out,6
273,Row274,Row3719,CHEMBL605733,,0,484.99,9h,IC50,=,3.0,nM,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4cc(Cl)ccc4O)OC[C@@H](N)Cc5ccccc5,,,CHEMBL1071952,Inhibition of full length AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4cc(Cl)ccc4O)OC[C@@H](N)Cc5ccccc5,,Row1976,11,0.1439264714717865,out,6
274,Row275,Row3861,CHEMBL2325993,,0,470.02,46,IC50,=,3.0,nM,CN(C)CCCC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc32)c4ccc(Cl)cc4,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,CN(C)CCCC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc32)c4ccc(Cl)cc4,,Row3863,35,0.1291207373142242,out,6
275,Row276,Row3937,CHEMBL2325741,CAPIVASERTIB,3,428.92,"64, AZD5363",IC50,=,3.0,nM,NC1(CCN(CC1)c2ncnc3[nH]ccc32)C(=O)N[C@@H](CCO)c4ccc(Cl)cc4,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,NC1(CCN(CC1)c2ncnc3[nH]ccc32)C(=O)N[C@@H](CCO)c4ccc(Cl)cc4,,Row3863,35,0.12691330909729,out,6
276,Row278,Row773,CHEMBL375717,,0,444.43,13ai,IC50,=,3.1,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(F)c(cc4)C(F)(F)F,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(F)c(cc4)C(F)(F)F,,Row1976,11,0.1032946556806564,out,6
277,Row279,Row2701,CHEMBL375919,,0,410.88,13n,IC50,=,3.1,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(F)c(Cl)c4,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(F)c(Cl)c4,,Row1976,11,0.1024929583072662,out,6
278,Row280,Row2951,CHEMBL407718,,0,323.38,13c,IC50,=,3.1,nM,Fc1ccc2c(c1)C3(CN2c4ncnc5[nH]ccc45)CCNCC3,,,CHEMBL936668,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143084,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Fc1ccc2c(c1)C3(CN2c4ncnc5[nH]ccc45)CCNCC3,,Row2845,36,0.1178769916296005,out,6
279,Row281,Row3971,CHEMBL4593086,,0,619.33,E19,IC50,=,3.13,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@H](CC(=O)NCC(O)CO)C[C@H]3c4cc(Cl)c(Cl)cc4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@H](CC(=O)NCC(O)CO)C[C@H]3c4cc(Cl)c(Cl)cc4,,Row3515,16,0.0867464840412139,out,6
280,Row282,Row593,CHEMBL3959291,,0,528.56,BDBM182604,IC50,=,3.2,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)c(c5)C(F)(F)F,,330045.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row3990,26,0.1182040348649025,out,6
281,Row283,Row1538,CHEMBL212566,,0,529.6,9e,IC50,=,3.2,nM,O=C1Cc2cc(ccc2N1)-c3cncc(c3)OC[C@H](Cc4c[nH]c5ccccc45)Nc6cc7CC(=O)Nc7cc6,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,O=C1Cc2cc(ccc2N1)-c3cncc(c3)OC[C@H](Cc4c[nH]c5ccccc45)Nc6cc7CC(=O)Nc7cc6,,Row837,29,0.1208940669894218,out,6
282,Row284,Row2167,CHEMBL3943452,,0,531.65,BDBM187362,IC50,=,3.2,nM,COC1CCN(CC1)c2cnc(cc2-n3cnc(c3)C4CC4)C(=O)Nc5csc(n5)-c6nncn6C7CC7,,337100.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,COC1CCN(CC1)c2cnc(cc2-n3cnc(c3)C4CC4)C(=O)Nc5csc(n5)-c6nncn6C7CC7,,Row2917,8,0.0847605094313621,out,6
283,Row285,Row2326,CHEMBL579246,,0,398.47,112,IC50,=,3.2,nM,N[C@H](COc1cncc(c1)-c2cc3CC(=O)Nc3cc2)Cc4c[nH]c5ccccc45,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@H](COc1cncc(c1)-c2cc3CC(=O)Nc3cc2)Cc4c[nH]c5ccccc45,,Row1996,15,0.1359189003705978,out,6
284,Row286,Row3692,CHEMBL3940627,,0,487.99,BDBM182537,IC50,=,3.2,nM,Nc1ncnc(c1Cl)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)c(F)cc5,,329978.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Cl)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)c(F)cc5,,Row643,24,0.1317845582962036,out,6
285,Row287,Row3859,CHEMBL3924518,,0,569.62,BDBM187359,IC50,=,3.2,nM,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CCC(CC5)C(F)(F)F)-n6cc(nc6)C7CC7,,337097.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CCC(CC5)C(F)(F)F)-n6cc(nc6)C7CC7,,Row2917,8,0.0826908349990844,out,6
286,Row288,Row3462,CHEMBL4438877,,0,545.25,E14,IC50,=,3.24,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@H](CC(N)=O)C[C@H]3c4ccc(Cl)c(Cl)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@H](CC(N)=O)C[C@H]3c4ccc(Cl)c(Cl)c4,,Row3515,16,0.0985491499304771,out,6
287,Row289,Row3335,CHEMBL4441416,,0,576.45,E23,IC50,=,3.29,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@@H](C[C@H]3c4ccc(F)c(F)c4)CCNS(C)(=O)=O,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@@H](C[C@H]3c4ccc(F)c(F)c4)CCNS(C)(=O)=O,,Row3515,16,0.0840140283107757,out,6
288,Row290,Row519,CHEMBL227271,,0,442.44,13al,IC50,=,3.3,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(ccc4)OC(F)(F)F,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(ccc4)OC(F)(F)F,,Row1976,11,0.1117738783359527,out,6
289,Row291,Row790,CHEMBL574269,,0,438.53,115,IC50,=,3.3,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc5NC(=O)C(C6CC6)c5c4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc5NC(=O)C(C6CC6)c5c4,,Row124,3,0.1391888707876205,out,6
290,Row292,Row1341,CHEMBL378827,,0,494.64,11a,IC50,=,3.3,nM,CC(C)(CC1CC1)C2C(=O)Nc3ccc(cc32)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc56,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC(C)(CC1CC1)C2C(=O)Nc3ccc(cc32)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc56,,Row236,4,0.1336289048194885,out,6
291,Row293,Row2064,CHEMBL1170445,,0,405.29,37,IC50,=,3.3,nM,N[C@@]1(CNC(=O)c2ccc(Cl)cc2)CN(CC1)c3ncnc4[nH]cc(Cl)c34,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,N[C@@]1(CNC(=O)c2ccc(Cl)cc2)CN(CC1)c3ncnc4[nH]cc(Cl)c34,,Row2553,9,0.1242280453443527,out,6
292,Row294,Row3691,CHEMBL3912632,,0,470.0,BDBM182536,IC50,=,3.3,nM,Nc1ncnc(c1Cl)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)cc5,,329977.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Cl)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)cc5,,Row643,24,0.132803663611412,out,6
293,Row295,Row3516,CHEMBL4567295,,0,529.37,E21,IC50,=,3.31,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@H](CC(O)CO)C[C@H]3c4ccc(F)c(F)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@H](CC(O)CO)C[C@H]3c4ccc(F)c(F)c4,,Row3515,16,0.0863840878009796,out,6
294,Row297,Row1821,CHEMBL210390,,0,409.49,39,IC50,=,3.4,nM,Nc1cc2cc(ccc2cn1)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc54,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Nc1cc2cc(ccc2cn1)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc54,,Row1996,15,0.1303051859140396,out,6
295,Row298,Row2897,CHEMBL4531735,,0,541.38,E25,IC50,=,3.4,nM,CC(=O)OCC[C@@H]1C[C@H]([C@@H](CN1)NC(=O)c2cc(c(Cl)o2)-c3c(Cl)cnn3C)c4ccc(F)c(F)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,CC(=O)OCC[C@@H]1C[C@H]([C@@H](CN1)NC(=O)c2cc(c(Cl)o2)-c3c(Cl)cnn3C)c4ccc(F)c(F)c4,,Row3515,16,0.0946342870593071,out,6
296,Row299,Row3514,CHEMBL4590906,,0,559.33,E7,IC50,=,3.4,nM,CN(C)CC[C@@H]1C[C@H]([C@@H](CN1)NC(=O)c2cc(-c3c(Cl)cnn3C)c(Cl)o2)c4ccc(Cl)c(Cl)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,CN(C)CC[C@@H]1C[C@H]([C@@H](CN1)NC(=O)c2cc(-c3c(Cl)cnn3C)c(Cl)o2)c4ccc(Cl)c(Cl)c4,,Row3515,16,0.0868258327245712,out,6
297,Row302,Row76,CHEMBL210246,,0,412.47,35,IC50,=,3.5,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5cc(F)ncc5cc4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5cc(F)ncc5cc4,,Row1996,15,0.1293401271104812,out,6
298,Row303,Row120,CHEMBL446134,,0,541.66,1,IC50,=,3.5,nM,O=C1NCCc2nc(-c3ccc(CN4CCC(CC4)c5[nH]c(nn5)-c6ccccn6)cc3)c(cc21)-c7ccccc7,,,CHEMBL947431,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,O=C1NCCc2nc(-c3ccc(CN4CCC(CC4)c5[nH]c(nn5)-c6ccccn6)cc3)c(cc21)-c7ccccc7,,Row1163,23,0.1974771916866302,out,6
299,Row304,Row409,CHEMBL262341,,0,539.64,17,IC50,=,3.5,nM,O=C1N=CC=C2N=C(c3ccc(CN4CCC(CC4)c5nc([nH]n5)-c6ccccn6)cc3)C(=CC21)c7ccccc7,,,CHEMBL937417,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143097,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,O=C1N=CC=C2N=C(c3ccc(CN4CCC(CC4)c5nc([nH]n5)-c6ccccn6)cc3)C(=CC21)c7ccccc7,,Row996,49,0.1772463619709015,out,6
300,Row305,Row1251,CHEMBL3972635,,0,474.59,BDBM182623,IC50,=,3.5,nM,Cc1cc(ccc1F)-c2cn(CCN3CCCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,330064.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCN3CCCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,Row3990,26,0.1221987605094909,out,6
301,Row306,Row2153,CHEMBL3899777,,0,474.47,BDBM182457,IC50,=,3.6,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN)-c4ccc(F)c(c4)C(F)(F)F,,329898.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN)-c4ccc(F)c(c4)C(F)(F)F,,Row2188,10,0.1108915731310844,out,6
302,Row307,Row2602,CHEMBL229917,,0,410.88,13o,IC50,=,3.6,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(Cl)c(F)c4,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(Cl)c(F)c4,,Row1976,11,0.1029543802142143,out,6
303,Row308,Row2827,CHEMBL3931731,,0,506.96,BDBM182472,IC50,=,3.6,nM,Nc1ncnc(c1Cl)N2CCC(CC2)c3nc(cn3CCNC4CC4)-c5cc(ncc5)C(F)(F)F,,329913.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Cl)N2CCC(CC2)c3nc(cn3CCNC4CC4)-c5cc(ncc5)C(F)(F)F,,Row643,24,0.1137034520506858,out,6
304,Row310,Row2921,CHEMBL4470606,,0,562.28,E5,IC50,=,3.79,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@H](CC(O)CO)C[C@H]3c4ccc(Cl)c(Cl)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@H](CC(O)CO)C[C@H]3c4ccc(Cl)c(Cl)c4,,Row3515,16,0.0857604295015335,out,6
305,Row311,Row998,CHEMBL254099,,0,570.73,13i,IC50,=,3.8,nM,CSc1nc2nc(-c3ccc(CN4CCC(CC4)c5[nH]c(nn5)-c6ccccn6)cc3)c(cc2cn1)-c7ccccc7,,,CHEMBL928491,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141509,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CSc1nc2nc(-c3ccc(CN4CCC(CC4)c5[nH]c(nn5)-c6ccccn6)cc3)c(cc2cn1)-c7ccccc7,,Row1163,23,0.1930115818977356,out,6
306,Row312,Row2719,CHEMBL3893943,,0,517.62,BDBM187366,IC50,=,3.8,nM,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CCOCCC5)-n6cc(nc6)C7CC7,,337104.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CCOCCC5)-n6cc(nc6)C7CC7,,Row2917,8,0.0891508907079696,out,6
307,Row313,Row1107,CHEMBL573133,,0,391.45,83,IC50,=,3.9,nM,Cc1n[nH]c2cnc(cc12)-c3cncc(c3)OC[C@@H](N)Cc4cc(F)ccc4C,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Cc1n[nH]c2cnc(cc12)-c3cncc(c3)OC[C@@H](N)Cc4cc(F)ccc4C,,Row535,12,0.1091937273740768,out,6
308,Row314,Row1736,CHEMBL574764,,0,459.55,57,IC50,=,3.9,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc5[nH]nc(c5c4)-c6ccccc6,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc5[nH]nc(c5c4)-c6ccccc6,,Row1726,2,0.1501075178384781,out,6
309,Row315,Row3048,CHEMBL227368,,0,390.46,13v,IC50,=,3.9,nM,Cc1n[nH]c2ccc(cc12)-c3cncc(c3)OC[C@@H](N)Cc4cc(F)ccc4C,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc12)-c3cncc(c3)OC[C@@H](N)Cc4cc(F)ccc4C,,Row1976,11,0.1091341376304626,out,6
310,Row316,Row3564,CHEMBL4589576,,0,585.32,E16,IC50,=,3.95,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@H](CC(=O)NC4CC4)C[C@H]3c5cc(Cl)c(Cl)cc5,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@H](CC(=O)NC4CC4)C[C@H]3c5cc(Cl)c(Cl)cc5,,Row3515,16,0.0878598168492317,out,6
311,Row317,Row56,CHEMBL208761,,0,557.65,9p,IC50,=,4.0,nM,CC1c2cc(ccc2NC1=O)N[C@@H](Cc3c[nH]c4ccccc34)COc5cncc(c5)-c6cc7C(C)C(=O)Nc7cc6,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC1c2cc(ccc2NC1=O)N[C@@H](Cc3c[nH]c4ccccc34)COc5cncc(c5)-c6cc7C(C)C(=O)Nc7cc6,,Row837,29,0.1155503764748573,out,6
312,Row318,Row59,CHEMBL2325729,,0,496.06,52,IC50,=,4.0,nM,NC1(CCN(CC1)c2ncnc3[nH]ccc32)C(=O)N[C@@H](CCN4CCCCC4)c5ccc(Cl)cc5,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,NC1(CCN(CC1)c2ncnc3[nH]ccc32)C(=O)N[C@@H](CCN4CCCCC4)c5ccc(Cl)cc5,,Row3863,35,0.1286481916904449,out,6
313,Row319,Row128,CHEMBL2325728,,0,482.03,51,IC50,=,4.0,nM,NC1(CCN(CC1)c2ncnc3[nH]ccc32)C(=O)N[C@@H](CCN4CCCC4)c5ccc(Cl)cc5,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,NC1(CCN(CC1)c2ncnc3[nH]ccc32)C(=O)N[C@@H](CCN4CCCC4)c5ccc(Cl)cc5,,Row3863,35,0.1299516707658767,out,6
314,Row320,Row188,CHEMBL471059,,0,483.44,34,IC50,=,4.0,nM,CCNCC(Cc1ccccc1)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CCNCC(Cc1ccccc1)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34,,Row284,18,0.1307189017534256,out,6
315,Row321,Row669,CHEMBL1632377,,0,419.5,25,IC50,=,4.0,nM,C[C@@H]1SCc2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(F)c(F)c4,,,CHEMBL1632819,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1629708,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,C[C@@H]1SCc2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(F)c(F)c4,,Row3589,19,0.0990499034523963,out,6
316,Row322,Row744,CHEMBL1760768,,0,514.7,27a,IC50,=,4.0,nM,Cc1cccc(C)c1S(=O)(=O)NC[C@@H](O)CN2C[C@]3(CCN(C3)c4ncnc(N)c4C5CC5)CCC2,,,CHEMBL1763788,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759869,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,Cc1cccc(C)c1S(=O)(=O)NC[C@@H](O)CN2C[C@]3(CCN(C3)c4ncnc(N)c4C5CC5)CCC2,,Row315,48,0.1199323982000351,out,6
317,Row323,Row749,CHEMBL443661,,0,679.88,2,IC50,=,4.0,nM,CN(C)CCN1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,,CHEMBL947431,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN(C)CCN1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,Row1163,23,0.177771508693695,out,6
318,Row324,Row828,CHEMBL2325743,,0,398.9,34,IC50,=,4.0,nM,C[C@H](NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc32)c4ccc(Cl)cc4,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,C[C@H](NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc32)c4ccc(Cl)cc4,,Row3863,35,0.1286319941282272,out,6
319,Row325,Row1093,CHEMBL1173350,,0,291.79,7,IC50,=,4.0,nM,Clc1c[nH]c2ncnc(c21)N3CC4(CC3)CCNCC4,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,Clc1c[nH]c2ncnc(c21)N3CC4(CC3)CCNCC4,,Row3980,30,0.0947139710187912,out,6
320,Row326,Row1189,CHEMBL253693,,0,559.7,11,IC50,=,4.0,nM,CSc1nc2nc(c(cc2cn1)-c3ccccc3)-c4ccc(CN5CCC(CC5)n6ncc7c(N)ncnc67)cc4,,,CHEMBL928491,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141509,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CSc1nc2nc(c(cc2cn1)-c3ccccc3)-c4ccc(CN5CCC(CC5)n6ncc7c(N)ncnc67)cc4,,Row3742,50,0.1910611689090728,out,6
321,Row327,Row1213,CHEMBL1099298,,0,461.53,33,IC50,=,4.0,nM,CCn1c(nc2c(C#CC(C)(C)O)nc(cc12)O[C@H](CCN)c3ccccc3)-c4nonc4N,,,CHEMBL1109952,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157000,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CCn1c(nc2c(C#CC(C)(C)O)nc(cc12)O[C@H](CCN)c3ccccc3)-c4nonc4N,,Row167,14,0.1432573199272155,out,6
322,Row328,Row1446,CHEMBL2325738,,0,428.92,61,IC50,=,4.0,nM,NC1(CCN(CC1)c2ncnc3[nH]ccc32)C(=O)NC(CCO)c4ccc(Cl)cc4,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,NC1(CCN(CC1)c2ncnc3[nH]ccc32)C(=O)NC(CCO)c4ccc(Cl)cc4,,Row3863,35,0.12691330909729,out,6
323,Row329,Row1484,CHEMBL3973987,,0,547.6,BDBM182385,IC50,=,4.0,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3/C=C/OCC)-c4ccc(F)c(c4)C(F)(F)F,,329826.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3/C=C/OCC)-c4ccc(F)c(c4)C(F)(F)F,,Row2164,32,0.1076640486717224,out,6
324,Row330,Row1543,CHEMBL2325994,,0,496.06,47,IC50,=,4.0,nM,NC1(CCN(CC1)c2ncnc3[nH]ccc32)C(=O)NC(CCCN4CCCC4)c5ccc(Cl)cc5,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,NC1(CCN(CC1)c2ncnc3[nH]ccc32)C(=O)NC(CCCN4CCCC4)c5ccc(Cl)cc5,,Row3863,35,0.1370610147714615,out,6
325,Row331,Row2011,CHEMBL502393,,0,554.66,10,IC50,=,4.0,nM,Nc1ccc(cn1)-c2[nH]c(nn2)C3CCN(Cc4ccc(cc4)-c5nc6cc[nH]c(=O)c6cc5-c7ccccc7)CC3,,,CHEMBL947431,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Nc1ccc(cn1)-c2[nH]c(nn2)C3CCN(Cc4ccc(cc4)-c5nc6cc[nH]c(=O)c6cc5-c7ccccc7)CC3,,Row1163,23,0.2201584130525589,out,6
326,Row332,Row2068,CHEMBL447328,,0,563.67,16,IC50,=,4.0,nM,C(c1ccc(cc1)-c2nc3ccn4cnnc4c3cc2-c5ccccc5)N6CCC(CC6)c7n[nH]c(n7)-c8ccccn8,,,CHEMBL1111477,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1155389,1,Scientific Literature,J. Med. Chem.,2010.0,C(c1ccc(cc1)-c2nc3ccn4cnnc4c3cc2-c5ccccc5)N6CCC(CC6)c7n[nH]c(n7)-c8ccccn8,,Row1163,23,0.2231771349906921,out,6
327,Row333,Row2325,CHEMBL574262,,0,412.49,110,IC50,=,4.0,nM,CC1C(=O)Nc2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc54,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,CC1C(=O)Nc2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc54,,Row124,3,0.130698561668396,out,6
328,Row334,Row2382,CHEMBL1632371,,0,417.97,19,IC50,=,4.0,nM,CC1SCc2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,,CHEMBL1632819,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1629708,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,CC1SCc2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,Row3589,19,0.0968385264277458,out,6
329,Row335,Row2438,CHEMBL1095624,,0,355.4,15,IC50,=,4.0,nM,CCn1c2cc(CCN)nc(C#CC(C)(C)O)c2nc1-c3nonc3N,,,CHEMBL1109952,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157000,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CCn1c2cc(CCN)nc(C#CC(C)(C)O)c2nc1-c3nonc3N,,Row167,14,0.1108330562710762,out,6
330,Row336,Row2523,CHEMBL1202518,,0,579.46,4,IC50,=,4.0,nM,COc1ccc(O)c(c1F)C(=O)c2ccc(cc2)C(=O)N[C@@H]3CCCNCC3NC(=O)c4ccncc4,,,CHEMBL766409,Inhibition of Protein kinase B alpha,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1149095,1,Scientific Literature,J. Med. Chem.,2004.0,COc1ccc(O)c(c1F)C(=O)c2ccc(cc2)C(=O)N[C@@H]3CCCNCC3NC(=O)c4ccncc4,,Row2523,51,0.1096837967634201,out,6
331,Row337,Row2624,CHEMBL2177381,,0,460.0,30,IC50,=,4.0,nM,CC(C)NC[C@@H](C(=O)N1CCN(CC1)c2ncnc3[C@H](F)C[C@@H](C)c32)c4ccc(Cl)cc4,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,CC(C)NC[C@@H](C(=O)N1CCN(CC1)c2ncnc3[C@H](F)C[C@@H](C)c32)c4ccc(Cl)cc4,,Row2863,37,0.0810266137123107,out,6
332,Row338,Row3124,CHEMBL444136,,0,540.63,11,IC50,=,4.0,nM,O=c1[nH]ccc2nc(-c3ccc(CN4CCC(CC4)c5[nH]c(nn5)-c6cnccn6)cc3)c(cc21)-c7ccccc7,,,CHEMBL947431,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,O=c1[nH]ccc2nc(-c3ccc(CN4CCC(CC4)c5[nH]c(nn5)-c6cnccn6)cc3)c(cc21)-c7ccccc7,,Row1163,23,0.211158275604248,out,6
333,Row339,Row587,CHEMBL3932390,,0,533.57,BDBM182401,IC50,=,4.1,nM,CCOc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,329842.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCOc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row643,24,0.1204980090260505,out,6
334,Row340,Row630,CHEMBL3972741,,0,512.54,BDBM182613,IC50,=,4.1,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(F)c(cc5)OC(F)F,,330054.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(F)c(cc5)OC(F)F,,Row3990,26,0.1176017150282859,out,6
335,Row341,Row4011,CHEMBL3922798,,0,517.58,BDBM182529,IC50,=,4.1,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,329970.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row2164,32,0.1224366351962089,out,6
336,Row343,Row454,CHEMBL3640739,,0,614.8,BDBM108432,IC50,=,4.15,nM,CCN(CC)C(=O)C1CCN(CC1)c2cc(ccc2)-c3ccc4nc(-c5cccnc5N)n(c4n3)-c6ccc(cc6)C7(N)CCC7,,286564.0,CHEMBL3705364,"Alpha Screen Assay: AKT1 activity was assayed using the GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology. AKT1 activation was achieved by the addition of the activating kinases PDK1 and MAPKAPK2, lipid vesicles, and ATP. The extent of peptide phosphorylation was determined using a phospho-AKT substrate antibody and acceptor beads conjugated to Protein A and donor beads conjugated to streptavidin that bind to the biotin on the peptide. Excitation of the donor beads converted ambient oxygen to excited singlet oxygen which, when in close proximity to acceptor beads, reacted with acceptor beads resulting in signal amplification.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3639036,37,BindingDB Database,,2015.0,CCN(CC)C(=O)C1CCN(CC1)c2cc(ccc2)-c3ccc4nc(-c5cccnc5N)n(c4n3)-c6ccc(cc6)C7(N)CCC7,,Row366,27,0.2292333543300628,out,6
337,Row344,Row707,CHEMBL3906488,,0,564.45,BDBM182566,IC50,=,4.2,nM,Nc1ncnc(c1Br)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(ccc5)C(F)(F)F,,330007.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Br)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(ccc5)C(F)(F)F,,Row2590,1,0.1324604153633117,out,6
338,Row345,Row2850,CHEMBL3931504,,0,515.56,BDBM182519,IC50,=,4.2,nM,C=Cc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,329960.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,C=Cc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row643,24,0.1182645484805107,out,6
339,Row346,Row3926,CHEMBL3944209,,0,474.66,BDBM182478,IC50,=,4.2,nM,CC(C)c1cc(ccn1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5CC,,329919.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(C)c1cc(ccn1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5CC,,Row3753,7,0.1264262199401855,out,6
340,Row348,Row540,CHEMBL575824,,0,400.44,105,IC50,=,4.3,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5oc(=O)[nH]c5cc4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5oc(=O)[nH]c5cc4,,Row1996,15,0.1383007764816284,out,6
341,Row349,Row849,CHEMBL209503,,0,565.68,9m,IC50,=,4.3,nM,Oc1nc2ccc(cc2s1)-c3cc(cnc3)OC[C@H](Cc4c[nH]c5ccccc45)Nc6ccc7nc(O)sc7c6,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Oc1nc2ccc(cc2s1)-c3cc(cnc3)OC[C@H](Cc4c[nH]c5ccccc45)Nc6ccc7nc(O)sc7c6,,Row837,29,0.1077243983745575,out,6
342,Row351,Row2711,CHEMBL4207643,,0,538.28,10n,IC50,=,4.3,nM,O=C(N1CCN(CC1)c2ncnc3[nH]cc(Br)c23)C4(CCNCC4)c5cc(Cl)c(Cl)cc5,,,CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4190265,1,Scientific Literature,Eur J Med Chem,2017.0,O=C(N1CCN(CC1)c2ncnc3[nH]cc(Br)c23)C4(CCNCC4)c5cc(Cl)c(Cl)cc5,,Row3980,30,0.1273305863142013,out,6
343,Row352,Row3349,CHEMBL3891300,,0,544.6,BDBM182681,IC50,=,4.3,nM,CC(C)(CC)NCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4ccc(F)c(c4)C(F)(F)F,,330122.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(C)(CC)NCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4ccc(F)c(c4)C(F)(F)F,,Row2188,10,0.1074282154440879,out,6
344,Row356,Row2573,CHEMBL4519793,,0,583.31,E12,IC50,=,4.47,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@H](CCn4cncn4)C[C@H]3c5ccc(Cl)c(Cl)c5,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@H](CCn4cncn4)C[C@H]3c5ccc(Cl)c(Cl)c5,,Row3515,16,0.0862361565232276,out,6
345,Row357,Row281,CHEMBL404554,,0,569.74,13h,IC50,=,4.5,nM,CSc1nc2nc(-c3ccc(CN4CCC(CC4)c5cc([nH]n5)-c6ccncc6)cc3)c(cc2cn1)-c7ccccc7,,,CHEMBL928491,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141509,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CSc1nc2nc(-c3ccc(CN4CCC(CC4)c5cc([nH]n5)-c6ccncc6)cc3)c(cc2cn1)-c7ccccc7,,Row996,49,0.1923996657133102,out,6
346,Row358,Row468,CHEMBL3974201,,0,463.61,BDBM182488,IC50,=,4.5,nM,Cc1cc(ccc1F)-c2cn(CC3CNC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(C)C,,329929.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CC3CNC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(C)C,,Row3798,5,0.1144133433699607,out,6
347,Row359,Row1301,CHEMBL3973753,,0,543.66,BDBM187374,IC50,=,4.5,nM,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CC6(C5)CCOCC6)-n7cc(nc7)C8CC8,,337112.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,O=C(Nc1csc(n1)-c2nncn2C3CC3)c4cc(c(cn4)N5CC6(C5)CCOCC6)-n7cc(nc7)C8CC8,,Row2917,8,0.0945432558655738,out,6
348,Row360,Row2251,CHEMBL3925183,,0,533.57,BDBM182474,IC50,=,4.5,nM,CC(C)Oc1c(ncnc1N)N2CCC(CC2)c3nc(cn3CC4CNC4)-c5ccc(F)c(c5)C(F)(F)F,,329915.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(C)Oc1c(ncnc1N)N2CCC(CC2)c3nc(cn3CC4CNC4)-c5ccc(F)c(c5)C(F)(F)F,,Row3798,5,0.1099334359169006,out,6
349,Row361,Row1364,CHEMBL379209,,0,419.49,10b,IC50,=,4.6,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(c(C#N)nc3)-c4cc5ccncc5cc4,,,CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1147830,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(c(C#N)nc3)-c4cc5ccncc5cc4,,Row1996,15,0.1322332024574279,out,6
350,Row362,Row2772,CHEMBL4163627,,0,493.52,11a,IC50,=,4.7,nM,Cc1nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc(c1C(=O)OCC)-c5ccccc5,,,CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4130433,1,Scientific Literature,Eur J Med Chem,2017.0,Cc1nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc(c1C(=O)OCC)-c5ccccc5,,Row2772,33,0.1455260515213012,out,6
351,Row363,Row3410,CHEMBL3137336,UPROSERTIB,2,429.25,GSK2141795; GSK-795,IC50,=,4.7,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@H](CN)Cc3cc(F)c(F)cc3,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@H](CN)Cc3cc(F)c(F)cc3,,Row39,44,0.0968995988368988,out,6
352,Row366,Row546,CHEMBL3900512,,0,517.58,BDBM182390,IC50,=,4.8,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C4CC4)-c5cc(c(F)cc5)C(F)(F)F,,329831.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C4CC4)-c5cc(c(F)cc5)C(F)(F)F,,Row2164,32,0.113814391195774,out,6
353,Row367,Row1273,CHEMBL259163,,0,319.41,13h,IC50,=,4.8,nM,Cc1c[nH]c2ncnc(c21)N3CC4(CCNCC4)c5ccccc35,,,CHEMBL936668,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143084,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Cc1c[nH]c2ncnc(c21)N3CC4(CCNCC4)c5ccccc35,,Row2845,36,0.137287437915802,out,6
354,Row368,Row2306,CHEMBL449964,,0,339.83,13b,IC50,=,4.8,nM,Clc1ccc2c(c1)C3(CN2c4ncnc5[nH]ccc45)CCNCC3,,,CHEMBL936668,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143084,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Clc1ccc2c(c1)C3(CN2c4ncnc5[nH]ccc45)CCNCC3,,Row2845,36,0.1141624078154563,out,6
355,Row369,Row2997,CHEMBL3935483,,0,479.6,BDBM182407,IC50,=,4.8,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(OC)c(F)cc5,,329848.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(OC)c(F)cc5,,Row3753,7,0.1326127052307129,out,6
356,Row370,Row3794,CHEMBL3957657,,0,489.6,BDBM182462,IC50,=,4.8,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4c[nH]nc4)-c5cc(C)c(F)cc5,,329903.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4c[nH]nc4)-c5cc(C)c(F)cc5,,Row2164,32,0.1117719411849975,out,6
357,Row371,Row240,CHEMBL1081263,,0,428.48,9,IC50,=,4.9,nM,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2ncc(s2)-c3cc4ccncc4cc3,,,CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154944,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2ncc(s2)-c3cc4ccncc4cc3,,Row240,47,0.1179168373346328,out,6
358,Row372,Row2791,CHEMBL3952378,,0,524.09,BDBM182561,IC50,=,4.9,nM,Nc1ncnc(c1C2CCC2)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6cc(Cl)c(F)cc6,,330002.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C2CCC2)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6cc(Cl)c(F)cc6,,Row3753,7,0.1193838417530059,out,6
359,Row374,Row37,CHEMBL2016891,,0,543.47,10,IC50,=,5.0,nM,Cc1c(cc(cc1N2CCN(CC2)c3ncnc4[nH]nc(Br)c34)C(=O)OC)NCCN5CCCC5,,,CHEMBL2020583,Inhibition of AKT1 after 3 hrs by luciferase based chemiluminescence assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2016487,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2012.0,Cc1c(cc(cc1N2CCN(CC2)c3ncnc4[nH]nc(Br)c34)C(=O)OC)NCCN5CCCC5,,Row2025,21,0.0967265218496322,out,6
360,Row375,Row129,CHEMBL2325996,,0,510.09,49,IC50,=,5.0,nM,NC1(CCN(CC1)c2ncnc3[nH]ccc32)C(=O)NC(CCCN4CCCCC4)c5ccc(Cl)cc5,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,NC1(CCN(CC1)c2ncnc3[nH]ccc32)C(=O)NC(CCCN4CCCCC4)c5ccc(Cl)cc5,,Row3863,35,0.1356975883245468,out,6
361,Row376,Row167,CHEMBL1096291,,0,371.4,20,IC50,=,5.0,nM,CCn1c(nc2c(C#CC(C)(C)O)nc(cc12)OCCN)-c3nonc3N,,,CHEMBL1109952,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157000,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CCn1c(nc2c(C#CC(C)(C)O)nc(cc12)OCCN)-c3nonc3N,,Row167,14,0.0997068509459495,out,6
362,Row377,Row198,CHEMBL494060,,0,519.61,14a,IC50,=,5.0,nM,COc1ccc(CCNCCCOc2cnc(C#CC(C)(C)O)c3nc(-c4nonc4N)n(CC)c32)cc1,,,CHEMBL1028090,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140130,1,Scientific Literature,J. Med. Chem.,2008.0,COc1ccc(CCNCCCOc2cnc(C#CC(C)(C)O)c3nc(-c4nonc4N)n(CC)c32)cc1,,Row2429,38,0.110307864844799,out,6
363,Row378,Row258,CHEMBL488654,,0,609.74,5,IC50,=,5.0,nM,C(c1ccc(cc1)-c2nc3nc(ncc3cc2-c4ccccc4)N5CCOCC5)N6CCC(CC6)c7[nH]c(nn7)-c8ccccn8,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,C(c1ccc(cc1)-c2nc3nc(ncc3cc2-c4ccccc4)N5CCOCC5)N6CCC(CC6)c7[nH]c(nn7)-c8ccccn8,,Row1163,23,0.1856037825345993,out,6
364,Row379,Row554,CHEMBL2177367,,0,528.1,45,IC50,=,5.0,nM,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CN[C@@H]4CC[C@H](CC4)OC)c5ccc(Cl)cc5,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CN[C@@H]4CC[C@H](CC4)OC)c5ccc(Cl)cc5,,Row2863,37,0.0895447880029678,out,6
365,Row380,Row555,CHEMBL2177366,,0,500.04,44,IC50,=,5.0,nM,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CNC4CCOCC4)c5ccc(Cl)cc5,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CNC4CCOCC4)c5ccc(Cl)cc5,,Row2863,37,0.0900740623474121,out,6
366,Row381,Row854,CHEMBL1258552,,0,384.87,44,IC50,=,5.0,nM,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4[nH]ccc34,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4[nH]ccc34,,Row854,17,0.1000885367393493,out,6
367,Row382,Row878,CHEMBL3216643,,0,580.44,1,IC50,=,5.0,nM,COc1ccc(O)c(c1F)C(=O)c2ccc(cc2)C(=O)O[C@@H]3CCCNCC3NC(=O)c4ccncc4,,,CHEMBL766409,Inhibition of Protein kinase B alpha,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1149095,1,Scientific Literature,J. Med. Chem.,2004.0,COc1ccc(O)c(c1F)C(=O)c2ccc(cc2)C(=O)O[C@@H]3CCCNCC3NC(=O)c4ccncc4,,Row2523,51,0.1052375435829162,out,6
368,Row383,Row991,CHEMBL1236822,,0,398.9,50,IC50,=,5.0,nM,NC[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4[nH]ccc34,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,NC[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4[nH]ccc34,,Row854,17,0.0992626920342445,out,6
369,Row384,Row1149,CHEMBL1096626,GSK-938890A,0,447.5,27,IC50,=,5.0,nM,CCn1c(nc2c(C#CC(C)(C)O)nc(cc12)OC[C@@H](N)c3ccccc3)-c4nonc4N,,,CHEMBL1109952,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157000,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CCn1c(nc2c(C#CC(C)(C)O)nc(cc12)OC[C@@H](N)c3ccccc3)-c4nonc4N,,Row167,14,0.1348812729120254,out,6
370,Row385,Row1162,CHEMBL448926,,0,590.7,17,IC50,=,5.0,nM,C(c1ccc(cc1)-c2nc3nc(ncc3cc2-c4ccccc4)-n5cncc5)N6CCC(CC6)c7[nH]c(nn7)-c8ccccn8,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,C(c1ccc(cc1)-c2nc3nc(ncc3cc2-c4ccccc4)-n5cncc5)N6CCC(CC6)c7[nH]c(nn7)-c8ccccn8,,Row1163,23,0.1933933496475219,out,6
371,Row386,Row1376,CHEMBL2016892,,0,541.5,11a,IC50,=,5.0,nM,Cc1c(cc(cc1N2CCN(CC2)c3ncnc4[nH]nc(Br)c34)C(=O)CC)NCCN5CCCC5,,,CHEMBL2020583,Inhibition of AKT1 after 3 hrs by luciferase based chemiluminescence assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2016487,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2012.0,Cc1c(cc(cc1N2CCN(CC2)c3ncnc4[nH]nc(Br)c34)C(=O)CC)NCCN5CCCC5,,Row2025,21,0.0974543318152427,out,6
372,Row387,Row1381,CHEMBL2325983,,0,424.94,36,IC50,=,5.0,nM,NC1(CCN(CC1)c2ncnc3[nH]ccc23)C(=O)NC(C4CC4)c5ccc(Cl)cc5,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,NC1(CCN(CC1)c2ncnc3[nH]ccc23)C(=O)NC(C4CC4)c5ccc(Cl)cc5,,Row3863,35,0.1310027241706848,out,6
373,Row388,Row1711,CHEMBL2325995,,0,512.06,48,IC50,=,5.0,nM,NC1(CCN(CC1)c2ncnc3[nH]ccc32)C(=O)NC(CCCN4CCOCC4)c5ccc(Cl)cc5,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,NC1(CCN(CC1)c2ncnc3[nH]ccc32)C(=O)NC(CCCN4CCOCC4)c5ccc(Cl)cc5,,Row3863,35,0.1265970170497894,out,6
374,Row389,Row1812,CHEMBL453586,,0,650.79,18,IC50,=,5.0,nM,CC(=O)N1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CC(=O)N1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,Row1163,23,0.1847099661827087,out,6
375,Row390,Row1929,CHEMBL427422,,0,395.41,37d,IC50,=,5.0,nM,Cc1n[nH]c2cnc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cccc(F)c4F,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2cnc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cccc(F)c4F,,Row535,12,0.1215429306030273,out,6
376,Row392,Row2252,CHEMBL3900660,,0,519.55,BDBM182475,IC50,=,5.0,nM,CCOc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CC4CNC4)-c5ccc(F)c(c5)C(F)(F)F,,329916.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCOc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CC4CNC4)-c5ccc(F)c(c5)C(F)(F)F,,Row3798,5,0.1131027340888977,out,6
377,Row393,Row2603,CHEMBL229855,,0,437.34,13l,IC50,=,5.0,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(Br)cc4,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(Br)cc4,,Row1976,11,0.1068946346640586,out,6
378,Row394,Row2700,CHEMBL573778,,0,438.33,82,IC50,=,5.0,nM,Cc1n[nH]c2cnc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(Br)cc4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Cc1n[nH]c2cnc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(Br)cc4,,Row535,12,0.0972597524523735,out,6
379,Row395,Row2863,CHEMBL2177390,IPATASERTIB,3,458.01,"28, GDC-0068",IC50,=,5.0,nM,CC(C)NC[C@@H](C(=O)N1CCN(CC1)c2ncnc3[C@H](O)C[C@@H](C)c23)c4ccc(Cl)cc4,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,CC(C)NC[C@@H](C(=O)N1CCN(CC1)c2ncnc3[C@H](O)C[C@@H](C)c23)c4ccc(Cl)cc4,,Row2863,37,0.0928995683789253,out,6
380,Row396,Row3629,CHEMBL2177374,,0,470.02,35,IC50,=,5.0,nM,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CNCC4CC4)c5ccc(Cl)cc5,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CNCC4CC4)c5ccc(Cl)cc5,,Row2863,37,0.0939582958817482,out,6
381,Row397,Row2050,CHEMBL4529738,,0,420.85,D2,IC50,=,5.1,nM,Cn1ncc(Cl)c1-c2cc(oc2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(F)c(F)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(F)c(F)c4,,Row39,44,0.0890827253460884,out,6
382,Row398,Row2845,CHEMBL259265,,0,305.39,13a,IC50,=,5.3,nM,C1N(c2ccccc2C13CCNCC3)c4ncnc5[nH]ccc45,,,CHEMBL936668,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143084,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,C1N(c2ccccc2C13CCNCC3)c4ncnc5[nH]ccc45,,Row2845,36,0.1389182657003402,out,6
383,Row399,Row1587,CHEMBL574268,,0,412.45,104,IC50,=,5.4,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5c(cc4)NC(=O)C5=O,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5c(cc4)NC(=O)C5=O,,Row837,29,0.1294066458940506,out,6
384,Row400,Row2638,CHEMBL3924599,,0,516.55,BDBM182668,IC50,=,5.4,nM,CC(C)NCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4ccc(F)c(c4)C(F)(F)F,,330109.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(C)NCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4ccc(F)c(c4)C(F)(F)F,,Row2188,10,0.1069427952170372,out,6
385,Row401,Row2971,CHEMBL211281,,0,533.68,9a,IC50,=,5.4,nM,C([C@@H](COc1cc(cnc1)-c2cc3ccncc3s2)Nc4cc5ccncc5s4)c6c[nH]c7ccccc67,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,C([C@@H](COc1cc(cnc1)-c2cc3ccncc3s2)Nc4cc5ccncc5s4)c6c[nH]c7ccccc67,,Row837,29,0.1129614040255546,out,6
386,Row402,Row401,CHEMBL4444441,,0,499.84,1e,IC50,=,5.46,nM,Cn1ncc(Br)c1-c2ccc(s2)C(=O)N[C@@H]3CNCC[C@H]3c4cc(F)ccc4,,,CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4304777,1,Scientific Literature,Eur J Med Chem,2019.0,Cn1ncc(Br)c1-c2ccc(s2)C(=O)N[C@@H]3CNCC[C@H]3c4cc(F)ccc4,,Row1315,22,0.1064867600798606,out,6
387,Row403,Row2154,CHEMBL3922949,,0,501.61,BDBM182463,IC50,=,5.5,nM,Cc1cc(ccc1F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5-c6c[nH]nc6,,329904.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5-c6c[nH]nc6,,Row2590,1,0.1208905205130577,out,6
388,Row404,Row2155,CHEMBL3970663,,0,517.66,BDBM182464,IC50,=,5.5,nM,Cc1cc(ccc1F)-c2cn(CCNC(C)(C)C)c(n2)C3CCN(CC3)c4ncnc(N)c4-c5cn[nH]c5,,329905.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCNC(C)(C)C)c(n2)C3CCN(CC3)c4ncnc(N)c4-c5cn[nH]c5,,Row2590,1,0.1091711744666099,out,6
389,Row405,Row2961,CHEMBL1080911,,0,432.48,19,IC50,=,5.5,nM,Cc1n[nH]c2ccc(cc21)-c3nnc(NC[C@@H](N)Cc4ccc(cc4)C(F)(F)F)s3,,,CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154933,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3nnc(NC[C@@H](N)Cc4ccc(cc4)C(F)(F)F)s3,,Row1834,53,0.1006512343883514,out,6
390,Row406,Row2663,CHEMBL4217723,,0,503.83,10f,IC50,=,5.6,nM,O=C(N1CCN(CC1)c2ncnc3[nH]cc(Cl)c23)C4(CCNCC4)c5cc(Br)ccc5,,,CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4190265,1,Scientific Literature,Eur J Med Chem,2017.0,O=C(N1CCN(CC1)c2ncnc3[nH]cc(Cl)c23)C4(CCNCC4)c5cc(Br)ccc5,,Row3980,30,0.1257040500640869,out,6
391,Row407,Row2665,CHEMBL3934916,,0,506.63,BDBM182690,IC50,=,5.6,nM,Cc1cc(ccc1F)-c2cn(CCNC3CCCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,330131.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCNC3CCCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,Row1206,41,0.1210595592856407,out,6
392,Row408,Row2778,CHEMBL259753,,0,523.64,16,IC50,=,5.6,nM,C(c1ccc(cc1)-c2nc3cccnc3cc2-c4ccccc4)N5CCC(CC5)c6n[nH]c(n6)-c7ccccn7,,,CHEMBL937417,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143097,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,C(c1ccc(cc1)-c2nc3cccnc3cc2-c4ccccc4)N5CCC(CC5)c6n[nH]c(n6)-c7ccccn7,,Row996,49,0.2136354297399521,out,6
393,Row409,Row3055,CHEMBL229918,,0,427.34,13p,IC50,=,5.6,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cccc(Cl)c4Cl,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cccc(Cl)c4Cl,,Row1976,11,0.1133162826299667,out,6
394,Row410,Row3728,CHEMBL4524940,,0,599.39,E9,IC50,=,5.65,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@@H](C[C@H]3c4cc(Cl)c(Cl)cc4)CCN5CCCCC5,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@@H](C[C@H]3c4cc(Cl)c(Cl)cc4)CCN5CCCCC5,,Row3515,16,0.094000406563282,out,6
395,Row414,Row3405,CHEMBL411515,,0,339.83,13g,IC50,=,5.8,nM,Clc1c[nH]c2ncnc(c21)N3CC4(CCNCC4)c5ccccc35,,,CHEMBL936668,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143084,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Clc1c[nH]c2ncnc(c21)N3CC4(CCNCC4)c5ccccc35,,Row2845,36,0.1333606094121933,out,6
396,Row415,Row124,CHEMBL577379,,0,474.56,116,IC50,=,5.9,nM,N[C@H](COc1cncc(c1)-c2ccc3NC(=O)C(c3c2)c4ccccc4)Cc5c[nH]c6ccccc65,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@H](COc1cncc(c1)-c2ccc3NC(=O)C(c3c2)c4ccccc4)Cc5c[nH]c6ccccc65,,Row124,3,0.1357074677944183,out,6
397,Row416,Row1114,CHEMBL3949523,,0,514.45,BDBM182527,IC50,=,5.9,nM,Nc1ncnc(c1Br)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)ccc5,,329968.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Br)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)ccc5,,Row2590,1,0.1379801034927368,out,6
398,Row417,Row1265,CHEMBL229799,,0,392.89,13h,IC50,=,5.9,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cccc(Cl)c4,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cccc(Cl)c4,,Row1976,11,0.1202764064073562,out,6
399,Row419,Row3458,CHEMBL210034,,0,530.67,11b,IC50,=,5.9,nM,CC(C)(Cc1ccccc1)C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC(C)(Cc1ccccc1)C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65,,Row236,4,0.1323889195919037,out,6
400,Row420,Row2920,CHEMBL4518523,,0,615.39,E11,IC50,=,5.99,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@@H](C[C@H]3c4ccc(Cl)c(Cl)c4)CCN5CCC(O)CC5,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@@H](C[C@H]3c4ccc(Cl)c(Cl)c4)CCN5CCC(O)CC5,,Row3515,16,0.09629637748003,out,6
401,Row421,Row131,CHEMBL2325734,,0,492.01,57,IC50,=,6.0,nM,NC1(CCN(CC1)c2ncnc3[nH]ccc23)C(=O)NC(CCS(N)(=O)=O)c4ccc(Cl)cc4,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,NC1(CCN(CC1)c2ncnc3[nH]ccc23)C(=O)NC(CCS(N)(=O)=O)c4ccc(Cl)cc4,,Row3863,35,0.1205789223313331,out,6
402,Row422,Row213,CHEMBL2178598,,0,539.57,52,IC50,=,6.0,nM,CC(C)(CO)NC[C@@H](C(=O)N1CCN(CC1)c2ncnc3[C@H](O)C[C@@H](C)c23)c4cc(F)c(cc4)C(F)(F)F,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,CC(C)(CO)NC[C@@H](C(=O)N1CCN(CC1)c2ncnc3[C@H](O)C[C@@H](C)c23)c4cc(F)c(cc4)C(F)(F)F,,Row2863,37,0.0980798974633216,out,6
403,Row423,Row226,CHEMBL471034,,0,362.46,7,IC50,=,6.0,nM,NCC(NC(=O)c1ccc(s1)-c2ccnc3[nH]ccc23)c4ccccc4,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NCC(NC(=O)c1ccc(s1)-c2ccnc3[nH]ccc23)c4ccccc4,,Row1178,46,0.1404449492692947,out,6
404,Row424,Row333,CHEMBL252857,,0,553.67,1,IC50,=,6.0,nM,CNc1nc2nc(-c3ccc(CN4CCC(CC4)c5[nH]c(nn5)-c6ccccn6)cc3)c(cc2cn1)-c7ccccc7,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CNc1nc2nc(-c3ccc(CN4CCC(CC4)c5[nH]c(nn5)-c6ccccn6)cc3)c(cc2cn1)-c7ccccc7,,Row1163,23,0.1920037567615509,out,6
405,Row425,Row371,CHEMBL1081628,,0,418.45,28,IC50,=,6.0,nM,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2nnc(s2)-c3cc4cn[nH]c4cc3,,,CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154933,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2nnc(s2)-c3cc4cn[nH]c4cc3,,Row1834,53,0.0945384204387664,out,6
406,Row426,Row650,CHEMBL213618,,0,436.37,2aa,IC50,=,6.0,nM,CNc1nccc(n1)-c2ccc(s2)C(=O)N[C@H](CN)Cc3ccc(Cl)cc3Cl,,,CHEMBL868045,Inhibition of AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146851,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CNc1nccc(n1)-c2ccc(s2)C(=O)N[C@H](CN)Cc3ccc(Cl)cc3Cl,,Row284,18,0.1004382073879242,out,6
407,Row427,Row1080,CHEMBL1096290,GSK-1000163A,0,395.47,19,IC50,=,6.0,nM,CCn1c2cc(CN3CCCC3)nc(C#CC(C)(C)O)c2nc1-c4nonc4N,,,CHEMBL1109952,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157000,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CCn1c2cc(CN3CCCC3)nc(C#CC(C)(C)O)c2nc1-c4nonc4N,,Row167,14,0.1202348843216896,out,6
408,Row428,Row1159,CHEMBL512858,,0,402.52,22,IC50,=,6.0,nM,NCC(NC(=O)c1cc(C2CC2)c(s1)-c3ccnc4[nH]ccc34)c5ccccc5,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NCC(NC(=O)c1cc(C2CC2)c(s1)-c3ccnc4[nH]ccc34)c5ccccc5,,Row1178,46,0.1522765755653381,out,6
409,Row430,Row1671,CHEMBL1098241,,0,341.38,14,IC50,=,6.0,nM,CCn1c2cc(CN)nc(C#CC(C)(C)O)c2nc1-c3nonc3N,,,CHEMBL1109952,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157000,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CCn1c2cc(CN)nc(C#CC(C)(C)O)c2nc1-c3nonc3N,,Row167,14,0.1034787595272064,out,6
410,Row431,Row1733,CHEMBL575427,,0,391.45,85,IC50,=,6.0,nM,Cc1n[nH]c2cnc(cc12)-c3cncc(c3)OC[C@@H](N)Cc4ccc(F)cc4C,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Cc1n[nH]c2cnc(cc12)-c3cncc(c3)OC[C@@H](N)Cc4ccc(F)cc4C,,Row535,12,0.1068774089217186,out,6
411,Row432,Row1773,CHEMBL447168,,0,693.86,21,IC50,=,6.0,nM,CN(C)CC(=O)N1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN(C)CC(=O)N1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,Row1163,23,0.1802357733249664,out,6
412,Row433,Row1898,CHEMBL1632387,,0,474.07,37,IC50,=,6.0,nM,C[C@@H]1SCc2ncnc(c21)N3CCN(CC3)C(=O)C(Cc4ccc(Cl)cc4)CC(C)(C)N,,,CHEMBL1632819,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1629708,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,C[C@@H]1SCc2ncnc(c21)N3CCN(CC3)C(=O)C(Cc4ccc(Cl)cc4)CC(C)(C)N,,Row3589,19,0.0938339978456497,out,6
413,Row434,Row2074,CHEMBL2177363,,0,502.03,40,IC50,=,6.0,nM,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CN4CCC(F)CC4)c5ccc(Cl)cc5,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CN4CCC(F)CC4)c5ccc(Cl)cc5,,Row2863,37,0.0944332927465438,out,6
414,Row435,Row2429,CHEMBL493874,,0,385.43,12b,IC50,=,6.0,nM,CCn1c2c(cnc(C#CC(C)(C)O)c2nc1-c3nonc3N)OCCCN,,,CHEMBL1028090,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140130,1,Scientific Literature,J. Med. Chem.,2008.0,CCn1c2c(cnc(C#CC(C)(C)O)c2nc1-c3nonc3N)OCCCN,,Row2429,38,0.1116050407290458,out,6
415,Row436,Row2625,CHEMBL2177385,,0,442.01,3,IC50,=,6.0,nM,CC(C)NC[C@@H](C(=O)N1CCN(CC1)c2ncnc3CC[C@@H](C)c32)c4ccc(Cl)cc4,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,CC(C)NC[C@@H](C(=O)N1CCN(CC1)c2ncnc3CC[C@@H](C)c32)c4ccc(Cl)cc4,,Row2863,37,0.0853605568408966,out,6
416,Row437,Row2931,CHEMBL594755,,0,455.52,26a,IC50,=,6.0,nM,Cc1n[nH]c2ncc(nc12)-c3cc(OC[C@@H](N)Cc4ccccc4)c(N)nc3-c5ccoc5C,,,CHEMBL1072610,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153244,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ncc(nc12)-c3cc(OC[C@@H](N)Cc4ccccc4)c(N)nc3-c5ccoc5C,,Row2116,20,0.122264064848423,out,6
417,Row438,Row3047,CHEMBL376394,,0,390.46,13y,IC50,=,6.0,nM,Cc1n[nH]c2ccc(cc12)-c3cncc(c3)OC[C@@H](N)Cc4ccc(F)cc4C,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc12)-c3cncc(c3)OC[C@@H](N)Cc4ccc(F)cc4C,,Row1976,11,0.1067519709467887,out,6
418,Row439,Row3390,CHEMBL1632390,,0,476.0,40,IC50,=,6.0,nM,CC(C)NCC(Cc1cc(F)c(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4CO[C@@H](C)c43,,,CHEMBL1632819,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1629708,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,CC(C)NCC(Cc1cc(F)c(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4CO[C@@H](C)c43,,Row3589,19,0.0834856778383255,out,6
419,Row440,Row3878,CHEMBL2016890,,0,567.5,9,IC50,=,6.0,nM,Cc1c(cc(cc1N2CCN(CC2)c3ncnc4[nH]nc(Br)c34)-c5nc(C)no5)NCCN6CCCC6,,,CHEMBL2020583,Inhibition of AKT1 after 3 hrs by luciferase based chemiluminescence assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2016487,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2012.0,Cc1c(cc(cc1N2CCN(CC2)c3ncnc4[nH]nc(Br)c34)-c5nc(C)no5)NCCN6CCCC6,,Row2025,21,0.1112626567482948,out,6
420,Row441,Row3938,CHEMBL2325739,,0,442.95,62,IC50,=,6.0,nM,NC1(CCN(CC1)c2ncnc3[nH]ccc32)C(=O)NC(CCCO)c4ccc(Cl)cc4,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,NC1(CCN(CC1)c2ncnc3[nH]ccc32)C(=O)NC(CCCO)c4ccc(Cl)cc4,,Row3863,35,0.1329095959663391,out,6
421,Row442,Row534,CHEMBL375485,,0,411.47,70,IC50,=,6.1,nM,N[C@@H](Cc1ccccc1)COc2cncc(c2)-c3cc4c(n[nH]c4cn3)-c5ccco5,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1ccccc1)COc2cncc(c2)-c3cc4c(n[nH]c4cn3)-c5ccco5,,Row535,12,0.129147008061409,out,6
422,Row443,Row2562,CHEMBL3954017,,0,519.55,BDBM182396,IC50,=,6.1,nM,COc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,329837.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,COc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row643,24,0.1301918774843216,out,6
423,Row444,Row2583,CHEMBL1080561,,0,432.48,17,IC50,=,6.1,nM,Cc1n[nH]c2ccc(cc21)-c3nnc(NC[C@@H](N)Cc4cc(ccc4)C(F)(F)F)s3,,,CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154933,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3nnc(NC[C@@H](N)Cc4cc(ccc4)C(F)(F)F)s3,,Row1834,53,0.1078207865357399,out,6
424,Row446,Row2264,CHEMBL404556,,0,567.66,14c,IC50,=,6.2,nM,NC(=O)c1nc2nc(-c3ccc(CN4CCC(CC4)c5[nH]c(nn5)-c6ccccn6)cc3)c(cc2cn1)-c7ccccc7,,,CHEMBL928491,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141509,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,NC(=O)c1nc2nc(-c3ccc(CN4CCC(CC4)c5[nH]c(nn5)-c6ccccn6)cc3)c(cc2cn1)-c7ccccc7,,Row1163,23,0.206983208656311,out,6
425,Row447,Row3456,CHEMBL3957616,,0,506.1,BDBM182563,IC50,=,6.2,nM,Nc1ncnc(c1C2CCC2)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6cc(Cl)ccc6,,330004.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C2CCC2)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6cc(Cl)ccc6,,Row643,24,0.1336750984191894,out,6
426,Row449,Row2830,CHEMBL3904672,,0,523.7,BDBM182601,IC50,=,6.3,nM,Cc1cc(ccc1F)-c2cn(CCN(CC)C(C)C)c(n2)C3CCN(CC3)c4ncnc(N)c4OC(C)C,,330042.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCN(CC)C(C)C)c(n2)C3CCN(CC3)c4ncnc(N)c4OC(C)C,,Row2590,1,0.1118441075086593,out,6
427,Row450,Row2151,CHEMBL3987123,,0,479.6,BDBM182486,IC50,=,6.4,nM,Cc1cc(ccc1F)-c2cn(CC3CNC3)c(n2)C4CCN(CC4)c5ncnc(N)c5OC(C)C,,329927.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CC3CNC3)c(n2)C4CCN(CC4)c5ncnc(N)c5OC(C)C,,Row3798,5,0.1123835146427154,out,6
428,Row451,Row3504,CHEMBL4465572,,0,605.38,A6,IC50,=,6.4,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)NC3CNCCC3c4ccc(F)c(F)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)NC3CNCCC3c4ccc(F)c(F)c4,,Row39,44,0.0945671945810318,out,6
429,Row452,Row3566,CHEMBL4546392,,0,585.36,E8,IC50,=,6.41,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@@H](C[C@H]3c4ccc(Cl)c(Cl)c4)CCN5CCCC5,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@@H](C[C@H]3c4ccc(Cl)c(Cl)c4)CCN5CCCC5,,Row3515,16,0.0948717966675758,out,6
430,Row453,Row2600,CHEMBL376959,,0,587.6,9h,IC50,=,6.5,nM,Oc1[nH]c2ccc(cc2c1N=O)-c3cncc(c3)OC[C@H](Cc4c[nH]c5ccccc45)Nc6cc7c(N=O)c(O)[nH]c7cc6,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Oc1[nH]c2ccc(cc2c1N=O)-c3cncc(c3)OC[C@H](Cc4c[nH]c5ccccc45)Nc6cc7c(N=O)c(O)[nH]c7cc6,,Row837,29,0.1104815304279327,out,6
431,Row454,Row592,CHEMBL3900809,,0,493.63,BDBM182597,IC50,=,6.6,nM,Cc1cc(ccc1F)-c2cn(CCN3CCCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5OCC,,330038.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCN3CCCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5OCC,,Row2590,1,0.1234985366463661,out,6
432,Row455,Row1240,CHEMBL3968744,,0,477.51,BDBM182438,IC50,=,6.6,nM,CCc1c(ncnc1N)N2CCC(CC2)c3nc(cn3CCN)-c4ccc(F)c(c4)C(F)(F)F,,329879.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(ncnc1N)N2CCC(CC2)c3nc(cn3CCN)-c4ccc(F)c(c4)C(F)(F)F,,Row2164,32,0.1154271811246872,out,6
433,Row456,Row1828,CHEMBL3917410,,0,531.6,BDBM182413,IC50,=,6.6,nM,CC(C)c1c(ncnc1N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(c(F)cc5)C(F)(F)F,,329854.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(C)c1c(ncnc1N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(c(F)cc5)C(F)(F)F,,Row2044,43,0.1198343113064765,out,6
434,Row457,Row2563,CHEMBL3895450,,0,587.54,BDBM182402,IC50,=,6.6,nM,Nc1ncnc(c1OCC(F)(F)F)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,329843.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1OCC(F)(F)F)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row643,24,0.1172677502036094,out,6
435,Row458,Row2724,CHEMBL3975180,,0,477.63,BDBM182596,IC50,=,6.6,nM,Cc1cc(ccc1F)-c2cn(CCN3CCCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5CC,,330037.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCN3CCCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5CC,,Row3753,7,0.1256684213876724,out,6
436,Row459,Row3344,CHEMBL3943569,,0,465.58,BDBM182484,IC50,=,6.6,nM,Cc1cc(ccc1F)-c2cn(CC3CNC3)c(n2)C4CCN(CC4)c5ncnc(N)c5OCC,,329925.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CC3CNC3)c(n2)C4CCN(CC4)c5ncnc(N)c5OCC,,Row3798,5,0.1156703904271125,out,6
437,Row460,Row271,CHEMBL3932421,,0,529.59,BDBM182359,IC50,=,6.8,nM,C=Cc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)c(c5)C(F)(F)F,,329800.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,C=Cc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row643,24,0.1182645484805107,out,6
438,Row461,Row1824,CHEMBL576372,,0,472.59,77,IC50,=,6.8,nM,Cc1n[nH]c2cnc(cc21)-c3cc(cnc3)OC[C@@H](N)Cc4cc(ccc4)OCC5CCNCC5,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Cc1n[nH]c2cnc(cc21)-c3cc(cnc3)OC[C@@H](N)Cc4cc(ccc4)OCC5CCNCC5,,Row535,12,0.1149739697575569,out,6
439,Row462,Row1979,CHEMBL226745,,0,471.61,13at,IC50,=,6.8,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(ccc4)OCC5CCNCC5,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(ccc4)OCC5CCNCC5,,Row1976,11,0.1239638030529022,out,6
440,Row463,Row1009,CHEMBL3927188,,0,555.58,BDBM182397,IC50,=,6.9,nM,Nc1ncnc(c1-c2cn[nH]c2)N3CCC(CC3)c4nc(cn4CCN5CCC5)-c6ccc(F)c(c6)C(F)(F)F,,329838.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1-c2cn[nH]c2)N3CCC(CC3)c4nc(cn4CCN5CCC5)-c6ccc(F)c(c6)C(F)(F)F,,Row643,24,0.1170536056160926,out,6
441,Row464,Row36,CHEMBL2016889,,0,569.6,8,IC50,=,7.0,nM,Cc1c(cc(CCC(C)(C)C)cc1N2CCN(CC2)c3ncnc4[nH]nc(Br)c34)NCCN5CCCC5,,,CHEMBL2020583,Inhibition of AKT1 after 3 hrs by luciferase based chemiluminescence assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2016487,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2012.0,Cc1c(cc(CCC(C)(C)C)cc1N2CCN(CC2)c3ncnc4[nH]nc(Br)c34)NCCN5CCCC5,,Row2025,21,0.091613546013832,out,6
442,Row465,Row132,CHEMBL2325736,,0,506.03,59,IC50,=,7.0,nM,CS(=O)(=O)NCCC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc32)c4ccc(Cl)cc4,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,CS(=O)(=O)NCCC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc32)c4ccc(Cl)cc4,,Row3863,35,0.1184914261102676,out,6
443,Row466,Row250,CHEMBL1823655,,0,386.28,(R)-29,IC50,=,7.0,nM,O=C(N[C@H](C1CNC1)c2ccc(Cl)c(Cl)c2)c3ccc4cnccc4c3,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,O=C(N[C@H](C1CNC1)c2ccc(Cl)c(Cl)c2)c3ccc4cnccc4c3,,Row3192,40,0.0983943864703178,out,6
444,Row467,Row748,CHEMBL447114,,0,540.63,8,IC50,=,7.0,nM,O=c1[nH]ccc2nc(-c3ccc(CN4CCC(CC4)c5[nH]c(nn5)-c6ncccn6)cc3)c(cc21)-c7ccccc7,,,CHEMBL947431,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,O=c1[nH]ccc2nc(-c3ccc(CN4CCC(CC4)c5[nH]c(nn5)-c6ncccn6)cc3)c(cc21)-c7ccccc7,,Row1163,23,0.2108786851167678,out,6
445,Row468,Row1103,CHEMBL500993,,0,623.77,6,IC50,=,7.0,nM,OC1CCN(CC1)c2ncc3cc(-c4ccccc4)c(nc3n2)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,OC1CCN(CC1)c2ncc3cc(-c4ccccc4)c(nc3n2)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,Row1163,23,0.1886733025312423,out,6
446,Row469,Row1869,CHEMBL1632372,,0,431.99,20,IC50,=,7.0,nM,CCC1SCc2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,,CHEMBL1632819,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1629708,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,CCC1SCc2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,Row875,55,0.1013048291206359,out,6
447,Row470,Row2009,CHEMBL1632388,,0,492.06,38,IC50,=,7.0,nM,C[C@@H]1SCc2ncnc(c21)N3CCN(CC3)C(=O)C(Cc4cc(F)c(Cl)cc4)CC(C)(C)N,,,CHEMBL1632819,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1629708,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,C[C@@H]1SCc2ncnc(c21)N3CCN(CC3)C(=O)C(Cc4cc(F)c(Cl)cc4)CC(C)(C)N,,Row3589,19,0.0931792706251144,out,6
448,Row472,Row3134,CHEMBL502426,,0,686.85,19,IC50,=,7.0,nM,CS(=O)(=O)N1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CS(=O)(=O)N1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,Row1163,23,0.1842556446790695,out,6
449,Row473,Row3189,CHEMBL1632378,,0,401.9,27,IC50,=,7.0,nM,C[C@@H]1OCc2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,,CHEMBL1632819,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1629708,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,C[C@@H]1OCc2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,Row875,55,0.0960832834243774,out,6
450,Row474,Row3378,CHEMBL2325737,,0,414.9,60,IC50,=,7.0,nM,NC1(CCN(CC1)c2ncnc3[nH]ccc32)C(=O)NC(CO)c4ccc(Cl)cc4,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,NC1(CCN(CC1)c2ncnc3[nH]ccc32)C(=O)NC(CO)c4ccc(Cl)cc4,,Row3863,35,0.1289418786764145,out,6
451,Row475,Row3600,CHEMBL1823663,,0,400.31,36,IC50,=,7.0,nM,CN1CC(C1)[C@@H](NC(=O)c2ccc3cnccc3c2)c4ccc(Cl)c(Cl)c4,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CN1CC(C1)[C@@H](NC(=O)c2ccc3cnccc3c2)c4ccc(Cl)c(Cl)c4,,Row3192,40,0.1077165529131889,out,6
452,Row476,Row3863,CHEMBL2325982,,0,412.93,35,IC50,=,7.0,nM,CCC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc32)c4ccc(Cl)cc4,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,CCC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc32)c4ccc(Cl)cc4,,Row3863,35,0.1295955628156662,out,6
453,Row477,Row3574,CHEMBL4568343,,0,546.28,E6,IC50,=,7.01,nM,COCC[C@@H]1C[C@H]([C@@H](CN1)NC(=O)c2cc(-c3c(Cl)cnn3C)c(Cl)o2)c4ccc(Cl)c(Cl)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,COCC[C@@H]1C[C@H]([C@@H](CN1)NC(=O)c2cc(-c3c(Cl)cnn3C)c(Cl)o2)c4ccc(Cl)c(Cl)c4,,Row3515,16,0.0887874364852905,out,6
454,Row478,Row732,CHEMBL225789,,0,432.92,9e,IC50,=,7.1,nM,Nc1cc2[nH]nc(Cl)c2cc1-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,,CHEMBL903964,Inhibition of Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142911,1,Scientific Literature,Bioorg. Med. Chem.,2007.0,Nc1cc2[nH]nc(Cl)c2cc1-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,Row1726,2,0.125785544514656,out,6
455,Row479,Row3548,CHEMBL3976254,,0,519.55,BDBM182485,IC50,=,7.1,nM,Cc1cc(ccc1F)-c2cn(CC3CNC3)c(n2)C4CCN(CC4)c5ncnc(N)c5OCC(F)(F)F,,329926.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CC3CNC3)c(n2)C4CCN(CC4)c5ncnc(N)c5OCC(F)(F)F,,Row3798,5,0.1111971735954284,out,6
456,Row481,Row170,CHEMBL210209,,0,520.64,11k,IC50,=,7.2,nM,CC(C)(Cc1[nH]ccn1)C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC(C)(Cc1[nH]ccn1)C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65,,Row236,4,0.1206298321485519,out,6
457,Row482,Row755,CHEMBL579053,,0,464.53,122,IC50,=,7.2,nM,N[C@H](COc1cncc(c1)-c2ccc3NC(=O)C(c3c2)c4[nH]ccn4)Cc5c[nH]c6ccccc65,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@H](COc1cncc(c1)-c2ccc3NC(=O)C(c3c2)c4[nH]ccn4)Cc5c[nH]c6ccccc65,,Row124,3,0.1250581741333007,out,6
458,Row483,Row1204,CHEMBL4536780,,0,637.4,A5,IC50,=,7.2,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)NC3CNCCC3c4ccc(cc4)C(F)(F)F,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)NC3CNCCC3c4ccc(cc4)C(F)(F)F,,Row39,44,0.0908821895718574,out,6
459,Row484,Row1487,CHEMBL226850,,0,413.4,37a,IC50,=,7.2,nM,N[C@@H](Cc1cc(ccc1)C(F)(F)F)COc2cncc(c2)-c3cc4cn[nH]c4cn3,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,N[C@@H](Cc1cc(ccc1)C(F)(F)F)COc2cncc(c2)-c3cc4cn[nH]c4cn3,,Row535,12,0.0957920178771019,out,6
460,Row486,Row2193,CHEMBL3948660,,0,543.61,BDBM182579,IC50,=,7.3,nM,Nc1ncnc(c1C2CCC2)N3CCC(CC3)c4nc(cn4CCN5CCC5)-c6cc(F)c(cc6)C(F)(F)F,,330020.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C2CCC2)N3CCC(CC3)c4nc(cn4CCN5CCC5)-c6cc(F)c(cc6)C(F)(F)F,,Row2044,43,0.119753360748291,out,6
461,Row487,Row3473,CHEMBL3975500,,0,509.67,BDBM182600,IC50,=,7.3,nM,Cc1cc(ccc1F)-c2cn(CCN(CC)C(C)C)c(n2)C3CCN(CC3OCC)c4cc(N)ncn4,,330041.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCN(CC)C(C)C)c(n2)C3CCN(CC3OCC)c4cc(N)ncn4,,Row2590,1,0.1096774861216545,out,6
462,Row488,Row835,CHEMBL209281,,0,533.54,9l,IC50,=,7.4,nM,Oc1nc2ccc(cc2o1)-c3cc(cnc3)OC[C@H](Cc4c[nH]c5ccccc45)Nc6ccc7nc(O)oc7c6,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Oc1nc2ccc(cc2o1)-c3cc(cnc3)OC[C@H](Cc4c[nH]c5ccccc45)Nc6ccc7nc(O)oc7c6,,Row837,29,0.1243035346269607,out,6
463,Row489,Row1665,CHEMBL575385,,0,399.45,103,IC50,=,7.4,nM,N[C@H](COc1cncc(c1)-c2cc3CC(=O)Nc3nc2)Cc4c[nH]c5ccccc45,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@H](COc1cncc(c1)-c2cc3CC(=O)Nc3nc2)Cc4c[nH]c5ccccc45,,Row1996,15,0.1288429051637649,out,6
464,Row490,Row2765,CHEMBL1171673,,0,368.42,30,IC50,=,7.4,nM,Cc1c[nH]c2ncnc(c21)N3CC(N)(CNC(=O)c4ccc(F)cc4)CC3,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,Cc1c[nH]c2ncnc(c21)N3CC(N)(CNC(=O)c4ccc(F)cc4)CC3,,Row2553,9,0.1260253936052322,out,6
465,Row491,Row3449,CHEMBL259967,,0,523.64,15,IC50,=,7.4,nM,C(c1ccc(cc1)-c2nc3ccncc3cc2-c4ccccc4)N5CCC(CC5)c6n[nH]c(n6)-c7ccccn7,,,CHEMBL937417,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143097,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,C(c1ccc(cc1)-c2nc3ccncc3cc2-c4ccccc4)N5CCC(CC5)c6n[nH]c(n6)-c7ccccn7,,Row996,49,0.2196278274059295,out,6
466,Row492,Row1858,CHEMBL3962020,,0,498.99,BDBM182378,IC50,=,7.5,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(Cl)c(F)cc5,,329819.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(Cl)c(F)cc5,,Row1206,41,0.1234824955463409,out,6
467,Row493,Row1097,CHEMBL3890225,,0,478.55,BDBM182605,IC50,=,7.6,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)c(F)cc5,,330046.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)c(F)cc5,,Row3990,26,0.124388188123703,out,6
468,Row494,Row1486,CHEMBL3905494,,0,535.59,BDBM182591,IC50,=,7.6,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3OC(C)C)-c4cc(c(F)cc4)C(F)(F)F,,330032.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3OC(C)C)-c4cc(c(F)cc4)C(F)(F)F,,Row2164,32,0.1095025092363357,out,6
469,Row495,Row2290,CHEMBL3896892,,0,510.57,BDBM182609,IC50,=,7.6,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(ccc5)C(F)(F)F,,330050.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(ccc5)C(F)(F)F,,Row3990,26,0.1294675022363662,out,6
470,Row496,Row3928,CHEMBL3927440,,0,531.6,BDBM182507,IC50,=,7.6,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)c(c5)C(F)(F)F,,329948.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row3753,7,0.1224366351962089,out,6
471,Row497,Row3979,CHEMBL4212000,,0,548.28,10k,IC50,=,7.6,nM,O=C(N1CCN(CC1)c2ncnc3[nH]cc(Br)c23)C4(CCNCC4)c5cc(Br)ccc5,,,CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4190265,1,Scientific Literature,Eur J Med Chem,2017.0,O=C(N1CCN(CC1)c2ncnc3[nH]cc(Br)c23)C4(CCNCC4)c5cc(Br)ccc5,,Row3980,30,0.1291415691375732,out,6
472,Row498,Row1412,CHEMBL226577,,0,406.46,13ab,IC50,=,7.7,nM,Cc1n[nH]c2ccc(cc12)-c3cncc(c3)OC[C@@H](N)Cc4cc(F)ccc4OC,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc12)-c3cncc(c3)OC[C@@H](N)Cc4cc(F)ccc4OC,,Row1976,11,0.1192550510168075,out,6
473,Row499,Row1558,CHEMBL3963881,,0,531.6,BDBM182392,IC50,=,7.7,nM,CC1CN(C1)CCn2cc(nc2C3CCN(CC3)c4ncnc(N)c4CC)-c5ccc(F)c(c5)C(F)(F)F,,329833.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC1CN(C1)CCn2cc(nc2C3CCN(CC3)c4ncnc(N)c4CC)-c5ccc(F)c(c5)C(F)(F)F,,Row2164,32,0.1142071783542633,out,6
474,Row500,Row3242,CHEMBL1170447,,0,397.39,39,IC50,=,7.7,nM,N[C@@]1(CNC(=O)c2ccc(F)cc2F)CN(CC1)c3ncnc4[nH]cc(C#N)c34,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,N[C@@]1(CNC(=O)c2ccc(F)cc2F)CN(CC1)c3ncnc4[nH]cc(C#N)c34,,Row2553,9,0.1295715123414993,out,6
475,Row501,Row3382,CHEMBL3127379,,0,439.75,60c,IC50,=,7.7,nM,Nc1ncnc(c1Br)N2CCN(CC2)C(=O)C(N)Cc3ccc(Cl)cc3,,,CHEMBL3131349,Inhibition of AKT1 (unknown origin) using ATP/eNOS as substrate incubated for 5 mins prior to substrate addition measured after 30 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3124803,1,Scientific Literature,Eur. J. Med. Chem.,2014.0,Nc1ncnc(c1Br)N2CCN(CC2)C(=O)C(N)Cc3ccc(Cl)cc3,,Row875,55,0.0979331880807876,out,6
476,Row503,Row2554,CHEMBL1171993,,0,379.4,31,IC50,=,7.8,nM,N[C@@]1(CNC(=O)c2ccc(F)cc2)CN(CC1)c3ncnc4[nH]cc(C#N)c43,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,N[C@@]1(CNC(=O)c2ccc(F)cc2)CN(CC1)c3ncnc4[nH]cc(C#N)c43,,Row2553,9,0.1317671835422516,out,6
477,Row504,Row457,CHEMBL3904712,,0,547.6,BDBM182395,IC50,=,7.9,nM,CC(C)Oc1c(ncnc1N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,329836.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(C)Oc1c(ncnc1N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row643,24,0.1176648959517479,out,6
478,Row505,Row2998,CHEMBL3931848,,0,503.55,BDBM182372,IC50,=,7.9,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C=C)-c4cc(c(F)cc4)C(F)(F)F,,329813.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C=C)-c4cc(c(F)cc4)C(F)(F)F,,Row2164,32,0.110906183719635,out,6
479,Row506,Row4020,CHEMBL4447158,,0,599.35,E17,IC50,=,7.98,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@H](CC(=O)NC4CCC4)C[C@H]3c5cc(Cl)c(Cl)cc5,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@H](CC(=O)NC4CCC4)C[C@H]3c5cc(Cl)c(Cl)cc5,,Row3515,16,0.0936086177825927,out,6
480,Row507,Row221,CHEMBL1258331,,0,383.88,40,IC50,=,8.0,nM,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ccnc4[nH]ccc34,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ccnc4[nH]ccc34,,Row854,17,0.117747351527214,out,6
481,Row508,Row278,CHEMBL469781,,0,376.49,21,IC50,=,8.0,nM,Cc1cc(sc1-c2ccnc3[nH]ccc23)C(=O)NC(CN)c4ccccc4,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,Cc1cc(sc1-c2ccnc3[nH]ccc23)C(=O)NC(CN)c4ccccc4,,Row1178,46,0.1495902687311172,out,6
482,Row509,Row420,CHEMBL2177377,,0,474.01,38,IC50,=,8.0,nM,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CNCCOC)c4ccc(Cl)cc4,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CNCCOC)c4ccc(Cl)cc4,,Row2863,37,0.0914597585797309,out,6
483,Row510,Row745,CHEMBL1760773,,0,518.66,27f,IC50,=,8.0,nM,Cc1cc(F)ccc1S(=O)(=O)NC[C@@H](O)CN2C[C@]3(CCN(C3)c4ncnc(N)c4C5CC5)CCC2,,,CHEMBL1763788,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759869,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,Cc1cc(F)ccc1S(=O)(=O)NC[C@@H](O)CN2C[C@]3(CCN(C3)c4ncnc(N)c4C5CC5)CCC2,,Row315,48,0.1130537763237953,out,6
484,Row511,Row758,CHEMBL1098944,,0,385.43,24,IC50,=,8.0,nM,CCn1c2cc(nc(C#CC(C)(C)O)c2nc1-c3nonc3N)OC[C@@H](C)N,,,CHEMBL1109952,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157000,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CCn1c2cc(nc(C#CC(C)(C)O)c2nc1-c3nonc3N)OC[C@@H](C)N,,Row167,14,0.0982541814446449,out,6
485,Row513,Row1102,CHEMBL503980,,0,622.78,10,IC50,=,8.0,nM,C[C@@H]1CN(CCN1)c2nc3nc(-c4ccc(CN5CCC(CC5)c6[nH]c(nn6)-c7ccccn7)cc4)c(cc3cn2)-c8ccccc8,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,C[C@@H]1CN(CCN1)c2nc3nc(-c4ccc(CN5CCC(CC5)c6[nH]c(nn6)-c7ccccn7)cc4)c(cc3cn2)-c8ccccc8,,Row1163,23,0.1793897449970245,out,6
486,Row514,Row1158,CHEMBL469802,,0,455.38,30,IC50,=,8.0,nM,NCCC(NC(=O)c1cc(Br)c(s1)-c2ccnc3[nH]ccc23)c4ccccc4,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NCCC(NC(=O)c1cc(Br)c(s1)-c2ccnc3[nH]ccc23)c4ccccc4,,Row1178,46,0.1347899436950683,out,6
487,Row515,Row1178,CHEMBL512135,,0,441.35,rac-8,IC50,=,8.0,nM,NCC(NC(=O)c1cc(Br)c(s1)-c2ccnc3[nH]ccc23)c4ccccc4,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NCC(NC(=O)c1cc(Br)c(s1)-c2ccnc3[nH]ccc23)c4ccccc4,,Row1178,46,0.1368529051542282,out,6
488,Row516,Row1541,CHEMBL494088,,0,411.47,3e,IC50,=,8.0,nM,CCn1c2c(cnc(C#CC(C)(C)O)c2nc1-c3nonc3N)OCC4CNCC4,,,CHEMBL1028090,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140130,1,Scientific Literature,J. Med. Chem.,2008.0,CCn1c2c(cnc(C#CC(C)(C)O)c2nc1-c3nonc3N)OCC4CNCC4,,Row1541,13,0.1236337795853614,out,6
489,Row517,Row1723,CHEMBL1794066,GSK-619487A,0,525.49,3f,IC50,=,8.0,nM,CCn1c2c(cnc(C#CC(C)(C)O)c2nc1-c3nonc3N)OC4CCNCC4,,,CHEMBL1028090,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140130,1,Scientific Literature,J. Med. Chem.,2008.0,CCn1c2c(cnc(C#CC(C)(C)O)c2nc1-c3nonc3N)OC4CCNCC4,,Row1541,13,0.1345403343439102,out,6
490,Row518,Row1931,CHEMBL1081852,,0,434.44,37,IC50,=,8.0,nM,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2ncc(s2)-c3cc4oc(=O)[nH]c4cc3,,,CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154944,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2ncc(s2)-c3cc4oc(=O)[nH]c4cc3,,Row240,47,0.1216637790203094,out,6
491,Row519,Row1942,CHEMBL594310,,0,464.53,18a,IC50,=,8.0,nM,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4cocc4)OC[C@@H](N)Cc5c[nH]c6ncccc56,,,CHEMBL1071952,Inhibition of full length AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4cocc4)OC[C@@H](N)Cc5c[nH]c6ncccc56,,Row1726,2,0.1270480006933212,out,6
492,Row520,Row3259,CHEMBL2325997,,0,398.9,32,IC50,=,8.0,nM,CC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc32)c4ccc(Cl)cc4,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,CC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc32)c4ccc(Cl)cc4,,Row3863,35,0.1286319941282272,out,6
493,Row521,Row3471,CHEMBL3976247,,0,521.56,BDBM182590,IC50,=,8.0,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3OCC)-c4ccc(F)c(c4)C(F)(F)F,,330031.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3OCC)-c4ccc(F)c(c4)C(F)(F)F,,Row2164,32,0.1126517429947853,out,6
494,Row522,Row3703,CHEMBL4585120,,0,487.31,B2,IC50,=,8.0,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CNCC[C@H]3c4cccc(c4)C(F)(F)F,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CNCC[C@H]3c4cccc(c4)C(F)(F)F,,Row39,44,0.099564790725708,out,6
495,Row523,Row3748,CHEMBL2016888,,0,597.48,7,IC50,=,8.0,nM,Cc1c(cc(COCC(F)(F)F)cc1N2CCN(CC2)c3ncnc4[nH]nc(Br)c34)NCCN5CCCC5,,,CHEMBL2020583,Inhibition of AKT1 after 3 hrs by luciferase based chemiluminescence assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2016487,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2012.0,Cc1c(cc(COCC(F)(F)F)cc1N2CCN(CC2)c3ncnc4[nH]nc(Br)c34)NCCN5CCCC5,,Row2025,21,0.092080533504486,out,6
496,Row524,Row12,CHEMBL3978595,,0,470.0,BDBM182535,IC50,=,8.1,nM,Nc1ncnc(c1Cl)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)ccc5,,329976.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Cl)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)ccc5,,Row643,24,0.1425359100103378,out,6
497,Row525,Row2536,CHEMBL3981168,,0,539.65,BDBM182560,IC50,=,8.1,nM,Nc1ncnc(c1C2CCC2)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6cc(ccc6)C(F)(F)F,,330001.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C2CCC2)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6cc(ccc6)C(F)(F)F,,Row643,24,0.1305399537086486,out,6
498,Row526,Row1369,CHEMBL379963,,0,533.68,11h,IC50,=,8.2,nM,Cn1cccc1CC(C)(C)C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Cn1cccc1CC(C)(C)C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65,,Row236,4,0.1298532336950302,out,6
499,Row527,Row1765,CHEMBL3959379,,0,516.57,BDBM182415,IC50,=,8.2,nM,CCOc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ncc5)C(F)(F)F,,329856.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCOc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ncc5)C(F)(F)F,,Row2044,43,0.1220513209700584,out,6
500,Row528,Row2415,CHEMBL583705,,0,477.57,120,IC50,=,8.2,nM,Cn1cccc1C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Cn1cccc1C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65,,Row124,3,0.1328136622905731,out,6
501,Row529,Row2869,CHEMBL4160193,,0,511.51,11b,IC50,=,8.2,nM,Cc1nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc(c1C(=O)OCC)-c5ccccc5F,,,CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4130433,1,Scientific Literature,Eur J Med Chem,2017.0,Cc1nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc(c1C(=O)OCC)-c5ccccc5F,,Row2772,33,0.103941909968853,out,6
502,Row531,Row3753,CHEMBL3954781,,0,481.6,BDBM182532,IC50,=,8.2,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)c(F)cc5,,329973.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)c(F)cc5,,Row3753,7,0.1290994137525558,out,6
503,Row532,Row2574,CHEMBL226383,,0,421.5,25d,IC50,=,8.3,nM,N[C@@H](Cc1ccccc1)COc2cncc(c2)-c3cc4c(n[nH]c4cn3)-c5ccccc5,,,CHEMBL903964,Inhibition of Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142911,1,Scientific Literature,Bioorg. Med. Chem.,2007.0,N[C@@H](Cc1ccccc1)COc2cncc(c2)-c3cc4c(n[nH]c4cn3)-c5ccccc5,,Row535,12,0.1469505876302719,out,6
504,Row533,Row851,CHEMBL229314,,0,376.44,13a,IC50,=,8.4,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cccc(F)c4,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cccc(F)c4,,Row1976,11,0.118027277290821,out,6
505,Row534,Row1650,CHEMBL3951639,,0,560.6,BDBM182686,IC50,=,8.4,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCNC4CCCC4)-c5cc(c(F)cc5)C(F)(F)F,,330127.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCNC4CCCC4)-c5cc(c(F)cc5)C(F)(F)F,,Row2044,43,0.1172556430101394,out,6
506,Row535,Row1728,CHEMBL573592,,0,377.42,72,IC50,=,8.4,nM,Cc1n[nH]c2cnc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cccc(F)c4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Cc1n[nH]c2cnc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cccc(F)c4,,Row535,12,0.1081438213586807,out,6
507,Row536,Row2285,CHEMBL3974713,,0,492.6,BDBM182682,IC50,=,8.4,nM,Cc1cc(ccc1F)-c2cn(CCNCC3CC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,330123.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCNCC3CC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,Row1206,41,0.1137888953089714,out,6
508,Row537,Row2291,CHEMBL3918965,,0,477.02,BDBM182610,IC50,=,8.4,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(Cl)ccc5,,330051.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(Cl)ccc5,,Row3990,26,0.1324863582849502,out,6
509,Row538,Row295,CHEMBL403356,,0,525.71,13e,IC50,=,8.5,nM,CSc1ncc2cc(-c3ccccc3)c(nc2n1)-c4ccc(CN5CCC(CC5)c6nnc(N)s6)cc4,,,CHEMBL928491,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141509,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CSc1ncc2cc(-c3ccccc3)c(nc2n1)-c4ccc(CN5CCC(CC5)c6nnc(N)s6)cc4,,Row1163,23,0.2151671648025512,out,6
510,Row539,Row718,CHEMBL1081829,,0,417.46,34,IC50,=,8.5,nM,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2ncc(s2)-c3cc4cn[nH]c4cc3,,,CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154944,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2ncc(s2)-c3cc4cn[nH]c4cc3,,Row240,47,0.1047870367765426,out,6
511,Row540,Row1565,CHEMBL438483,,0,394.43,13b,IC50,=,8.5,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cccc(F)c4F,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cccc(F)c4F,,Row1976,11,0.1219014301896095,out,6
512,Row542,Row708,CHEMBL4450403,,0,601.36,E10,IC50,=,8.78,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@@H](C[C@H]3c4cc(Cl)c(Cl)cc4)CCN5CCOCC5,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@@H](C[C@H]3c4cc(Cl)c(Cl)cc4)CCN5CCOCC5,,Row3515,16,0.086860716342926,out,6
513,Row543,Row987,CHEMBL1080740,,0,398.92,18,IC50,=,8.9,nM,Cc1n[nH]c2ccc(cc21)-c3nnc(NC[C@@H](N)Cc4ccc(Cl)cc4)s3,,,CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154933,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3nnc(NC[C@@H](N)Cc4ccc(Cl)cc4)s3,,Row1834,53,0.1013149619102478,out,6
514,Row544,Row3931,CHEMBL3939239,,0,507.66,BDBM182598,IC50,=,8.9,nM,Cc1cc(ccc1F)-c2cn(CCN3CCCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5OC(C)C,,330039.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCN3CCCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5OC(C)C,,Row2590,1,0.1205094531178474,out,6
515,Row545,Row3953,CHEMBL3968774,,0,493.68,BDBM182599,IC50,=,8.9,nM,Cc1cc(ccc1F)-c2cn(CCN(CC)C(C)C)c(n2)C3CCN(CC3)c4ncnc(N)c4CC,,330040.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCN(CC)C(C)C)c(n2)C3CCN(CC3)c4ncnc(N)c4CC,,Row3753,7,0.1149558573961258,out,6
516,Row546,Row261,CHEMBL453995,,0,652.81,23,IC50,=,9.0,nM,OCCN1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,OCCN1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,Row1163,23,0.1836086511611938,out,6
517,Row547,Row315,CHEMBL1760769,,0,500.67,27b,IC50,=,9.0,nM,Cc1ccccc1S(=O)(=O)NC[C@@H](O)CN2C[C@@]3(CCC2)CCN(C3)c4ncnc(N)c4C5CC5,,,CHEMBL1763788,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759869,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,Cc1ccccc1S(=O)(=O)NC[C@@H](O)CN2C[C@@]3(CCC2)CCN(C3)c4ncnc(N)c4C5CC5,,Row315,48,0.1296419203281402,out,6
518,Row548,Row334,CHEMBL3938237,,0,552.02,BDBM182515,IC50,=,9.0,nM,Nc1ncnc(c1Cl)N2CCC(CC2)c3nc(cn3CCN4CCCCC4)-c5ccc(F)c(c5)C(F)(F)F,,329956.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Cl)N2CCC(CC2)c3nc(cn3CCN4CCCCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row643,24,0.1236354708671569,out,6
519,Row549,Row344,CHEMBL1760771,,0,521.09,27d,IC50,=,9.0,nM,Nc1ncnc(c1C2CC2)N3C[C@@]4(CN(C[C@H](O)CNS(=O)(=O)c5ccccc5Cl)CCC4)CC3,,,CHEMBL1763788,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759869,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,Nc1ncnc(c1C2CC2)N3C[C@@]4(CN(C[C@H](O)CNS(=O)(=O)c5ccccc5Cl)CCC4)CC3,,Row315,48,0.1262572556734085,out,6
520,Row550,Row515,CHEMBL1761090,,0,556.73,38,IC50,=,9.0,nM,CCOCCN(C[C@@H](O)CN1CC2(CCC1)CCc3c(ccc4[nH]ncc43)O2)S(=O)(=O)c5c(C)cccc5C,,,CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759945,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CCOCCN(C[C@@H](O)CN1CC2(CCC1)CCc3c(ccc4[nH]ncc43)O2)S(=O)(=O)c5c(C)cccc5C,,Row2370,39,0.1127707958221435,out,6
521,Row551,Row1163,CHEMBL504251,,0,622.78,12,IC50,=,9.0,nM,CN1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,Row1163,23,0.1884247064590454,out,6
522,Row552,Row1373,CHEMBL2016886,,0,557.54,5b,IC50,=,9.0,nM,Cc1c(cc(cc1N2CCN(CC2)c3ncnc4[nH]nc(Br)c34)OCC(C)C)NCCN5CCCC5,,,CHEMBL2020583,Inhibition of AKT1 after 3 hrs by luciferase based chemiluminescence assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2016487,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2012.0,Cc1c(cc(cc1N2CCN(CC2)c3ncnc4[nH]nc(Br)c34)OCC(C)C)NCCN5CCCC5,,Row2025,21,0.0962526723742485,out,6
523,Row553,Row2434,CHEMBL2177364,,0,498.07,41,IC50,=,9.0,nM,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CNC4CCCCC4)c5ccc(Cl)cc5,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CNC4CCCCC4)c5ccc(Cl)cc5,,Row2863,37,0.0988425686955452,out,6
524,Row554,Row2495,CHEMBL1760765,,0,554.76,23a,IC50,=,9.0,nM,Cc1cccc(C)c1S(=O)(=O)N2CCC[C@H]2[C@@H](O)CN3C[C@@]4(CN(CC4)c5ncnc(N)c5C6CC6)CCC3,,,CHEMBL1763788,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759869,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,Cc1cccc(C)c1S(=O)(=O)N2CCC[C@H]2[C@@H](O)CN3C[C@@]4(CN(CC4)c5ncnc(N)c5C6CC6)CCC3,,Row315,48,0.1198687553405761,out,6
525,Row555,Row2645,CHEMBL493269,,0,399.46,3a,IC50,=,9.0,nM,CCn1c2c(cnc(C#CC(C)(C)O)c2nc1-c3nonc3N)OCCCCN,,,CHEMBL1028090,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140130,1,Scientific Literature,J. Med. Chem.,2008.0,CCn1c2c(cnc(C#CC(C)(C)O)c2nc1-c3nonc3N)OCCCCN,,Row2429,38,0.1110239028930664,out,6
526,Row556,Row2754,CHEMBL2325987,,0,382.44,40,IC50,=,9.0,nM,CC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc32)c4ccc(F)cc4,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,CC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc32)c4ccc(F)cc4,,Row3863,35,0.1312000304460525,out,6
527,Row557,Row2840,CHEMBL3956468,,0,596.47,BDBM182360,IC50,=,9.0,nM,Nc1ncnc(c1Br)N2CCC(CC2)c3nc(cn3CCN4CCCCC4)-c5ccc(F)c(c5)C(F)(F)F,,329801.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Br)N2CCC(CC2)c3nc(cn3CCN4CCCCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row643,24,0.1201828941702842,out,6
528,Row558,Row3605,CHEMBL2177369,,0,470.02,47,IC50,=,9.0,nM,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H]([C@@H]4CCCCN4)c5ccc(Cl)cc5,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H]([C@@H]4CCCCN4)c5ccc(Cl)cc5,,Row2863,37,0.1005335077643394,out,6
529,Row559,Row3995,CHEMBL4579551,,0,434.97,1g,IC50,=,9.0,nM,Cc1cnn(C)c1-c2ccc(s2)C(=O)N[C@@H]3CNCC[C@H]3c4cccc(F)c4,,,CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4304777,1,Scientific Literature,Eur J Med Chem,2019.0,Cc1cnn(C)c1-c2ccc(s2)C(=O)N[C@@H]3CNCC[C@H]3c4cccc(F)c4,,Row1315,22,0.1075601279735565,out,6
530,Row560,Row2192,CHEMBL3915954,,0,557.64,BDBM182553,IC50,=,9.1,nM,Nc1ncnc(c1C2CCC2)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6cc(F)c(cc6)C(F)(F)F,,329994.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C2CCC2)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6cc(F)c(cc6)C(F)(F)F,,Row643,24,0.119753360748291,out,6
531,Row561,Row3334,CHEMBL3916864,,0,502.52,BDBM182307,IC50,=,9.1,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4cc(c(F)cc4)C(F)(F)F,,329774.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4cc(c(F)cc4)C(F)(F)F,,Row2188,10,0.111991561949253,out,6
532,Row562,Row3889,CHEMBL3927446,,0,530.6,BDBM182416,IC50,=,9.1,nM,CC(C)Oc1c(ncnc1N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccnc(c5)C(F)(F)F,,329857.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(C)Oc1c(ncnc1N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccnc(c5)C(F)(F)F,,Row2044,43,0.1191458851099014,out,6
533,Row563,Row1859,CHEMBL3985540,,0,484.02,BDBM182580,IC50,=,9.2,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(Cl)c(F)cc5,,330021.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(Cl)c(F)cc5,,Row3753,7,0.1228620186448097,out,6
534,Row564,Row594,CHEMBL3899177,,0,545.63,BDBM182575,IC50,=,9.3,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCCC4)-c5ccc(F)c(c5)C(F)(F)F,,330016.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row3753,7,0.1212335899472236,out,6
535,Row565,Row1419,CHEMBL3961106,,0,556.41,BDBM182366,IC50,=,9.3,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3Br)-c4cc(c(F)cc4)C(F)(F)F,,329807.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3Br)-c4cc(c(F)cc4)C(F)(F)F,,Row2164,32,0.1138224899768829,out,6
536,Row566,Row3503,CHEMBL4591854,,0,637.4,"A10; (3S,4S)-A5",IC50,=,9.3,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(cc4)C(F)(F)F,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(cc4)C(F)(F)F,,Row39,44,0.0908821895718574,out,6
537,Row567,Row3990,CHEMBL3950203,,0,464.52,BDBM182612,IC50,=,9.3,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(F)c(F)cc5,,330053.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(F)c(F)cc5,,Row3990,26,0.124388188123703,out,6
538,Row568,Row1244,CHEMBL3961562,,0,507.63,BDBM182554,IC50,=,9.4,nM,Nc1ncnc(c1C2CCC2)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6cc(F)c(F)cc6,,329995.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C2CCC2)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6cc(F)c(F)cc6,,Row3753,7,0.1254010498523712,out,6
539,Row569,Row50,CHEMBL3982706,,0,513.61,BDBM182571,IC50,=,9.6,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(ccc5)C(F)(F)F,,330012.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(ccc5)C(F)(F)F,,Row3753,7,0.1341653764247894,out,6
540,Row570,Row342,CHEMBL203624,,0,369.47,16c,IC50,=,9.7,nM,N[C@@H](Cc1c[nH]c2ccccc12)CNc3cncc(c3)/C=C/c4ccncc4,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)CNc3cncc(c3)/C=C/c4ccncc4,,Row77,56,0.1106668785214424,out,6
541,Row571,Row588,CHEMBL3904852,,0,548.59,BDBM182676,IC50,=,9.7,nM,CC(C)(C)NCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4ccc(F)c(c4)C(F)(F)F,,330117.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(C)(C)NCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4ccc(F)c(c4)C(F)(F)F,,Row2044,43,0.1137893572449684,out,6
542,Row572,Row770,CHEMBL3947888,,0,497.53,BDBM182424,IC50,=,9.7,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ncc5)C(F)(F)F,,329865.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ncc5)C(F)(F)F,,Row3990,26,0.1197688430547714,out,6
543,Row573,Row813,CHEMBL252856,,0,546.7,13f,IC50,=,9.7,nM,CSc1nc2nc(-c3ccc(CN4CCC(CC4)C(=O)Nc5ccncc5)cc3)c(cc2cn1)-c6ccccc6,,,CHEMBL928491,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141509,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CSc1nc2nc(-c3ccc(CN4CCC(CC4)C(=O)Nc5ccncc5)cc3)c(cc2cn1)-c6ccccc6,,Row3742,50,0.1981437802314758,out,6
544,Row574,Row2683,CHEMBL3913177,,0,479.58,BDBM182541,IC50,=,9.7,nM,C=Cc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)c(F)cc5,,329982.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,C=Cc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)c(F)cc5,,Row3753,7,0.1245682388544082,out,6
545,Row575,Row1010,CHEMBL574995,,0,466.57,60,IC50,=,9.8,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)-c4cc5c(cc4)[nH]nc5-c6nccs6,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)-c4cc5c(cc4)[nH]nc5-c6nccs6,,Row1726,2,0.123463787138462,out,6
546,Row576,Row18,CHEMBL2325740,,0,442.95,63,IC50,=,10.0,nM,COCCC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc32)c4ccc(Cl)cc4,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,COCCC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc32)c4ccc(Cl)cc4,,Row3863,35,0.1250929534435272,out,6
547,Row577,Row105,CHEMBL454859,,0,650.83,16,IC50,=,10.0,nM,CN(C)C1CCN(CC1)c2ncc3cc(-c4ccccc4)c(nc3n2)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN(C)C1CCN(CC1)c2ncc3cc(-c4ccccc4)c(nc3n2)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,Row1163,23,0.1820642352104187,out,6
548,Row578,Row308,CHEMBL1632383,,0,475.61,33,IC50,=,10.0,nM,CC(C)NCC(Cc1cc(F)c(F)cc1)C(=O)N2CCN(CC2)c3ncnc4CS[C@@H](C)c43,,,CHEMBL1632819,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1629708,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,CC(C)NCC(Cc1cc(F)c(F)cc1)C(=O)N2CCN(CC2)c3ncnc4CS[C@@H](C)c43,,Row3589,19,0.0866397023200988,out,6
549,Row579,Row516,CHEMBL1761089,,0,571.74,35,IC50,=,10.0,nM,CCOCCN(C[C@@H](O)CN1CC2(CCC1)CCc3cc4c(CNC4=O)cc3O2)S(=O)(=O)c5c(C)cccc5C,,,CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759945,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CCOCCN(C[C@@H](O)CN1CC2(CCC1)CCc3cc4c(CNC4=O)cc3O2)S(=O)(=O)c5c(C)cccc5C,,Row2370,39,0.1214898079633712,out,6
550,Row580,Row765,CHEMBL211065,,0,548.69,11p,IC50,=,10.0,nM,CC(C)(Cc1cc(C)c(C)o1)C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC(C)(Cc1cc(C)c(C)o1)C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65,,Row236,4,0.1148496642708778,out,6
551,Row582,Row1561,CHEMBL3905309,,0,492.6,BDBM182649,IC50,=,10.0,nM,Cc1cc(ccc1F)-c2cn(CCN3CCCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,330090.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCN3CCCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,Row1206,41,0.1271932125091552,out,6
552,Row583,Row1692,CHEMBL595709,,0,424.5,9j,IC50,=,10.0,nM,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4cocc4)OC[C@@H](N)Cc5ccccc5,,,CHEMBL1071952,Inhibition of full length AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4cocc4)OC[C@@H](N)Cc5ccccc5,,Row1976,11,0.1518466174602508,out,6
553,Row585,Row2114,CHEMBL499554,,0,679.88,39,IC50,=,10.0,nM,CN(C)CCN1CCN(CC1)c2ccc3nc(c(nc3n2)-c4ccc(CN5CCC(CC5)c6[nH]c(nn6)-c7ccccn7)cc4)-c8ccccc8,,,CHEMBL947433,Inhibition of Akt1 by cellular assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN(C)CCN1CCN(CC1)c2ccc3nc(c(nc3n2)-c4ccc(CN5CCC(CC5)c6[nH]c(nn6)-c7ccccn7)cc4)-c8ccccc8,,Row1163,23,0.1585322171449661,out,6
554,Row586,Row2373,CHEMBL605838,,0,464.53,18c,IC50,=,10.0,nM,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4cocc4)OC[C@@H](N)Cc5c[nH]c6cccnc56,,,CHEMBL1071952,Inhibition of full length AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4cocc4)OC[C@@H](N)Cc5c[nH]c6cccnc56,,Row1726,2,0.1276992857456207,out,6
555,Row587,Row2428,CHEMBL577797,,0,492.58,127,IC50,=,10.0,nM,Cc1oc(cc1C)C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc56,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Cc1oc(cc1C)C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc56,,Row124,3,0.1214118972420692,out,6
556,Row588,Row2538,CHEMBL606467,,0,490.53,15,IC50,=,10.0,nM,Cc1n[nH]c2ncc(nc21)-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c(C#N)nc3-c6cocc6,,,CHEMBL1072610,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153244,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ncc(nc21)-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c(C#N)nc3-c6cocc6,,Row2116,20,0.1044098138809204,out,6
557,Row589,Row2560,CHEMBL470596,,0,497.46,35,IC50,=,10.0,nM,CC(C)NCC(Cc1ccccc1)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CC(C)NCC(Cc1ccccc1)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34,,Row284,18,0.1219335198402404,out,6
558,Row590,Row2816,CHEMBL594517,,0,468.53,9f,IC50,=,10.0,nM,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4cc(F)ccc4O)OC[C@@H](N)Cc5ccccc5,,,CHEMBL1071953,Inhibition of truncated AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4cc(F)ccc4O)OC[C@@H](N)Cc5ccccc5,,Row1976,11,0.1479768007993698,out,6
559,Row592,Row3054,CHEMBL227366,,0,455.33,13s,IC50,=,10.0,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(Br)cc4F,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(Br)cc4F,,Row1976,11,0.1018299832940101,out,6
560,Row594,Row3182,CHEMBL1794065,GSK-554170A,0,539.52,3b,IC50,=,10.0,nM,CCn1c2c(cnc(C#CC(C)(C)O)c2nc1-c3nonc3N)OCC4CCNCC4,,,CHEMBL1028090,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140130,1,Scientific Literature,J. Med. Chem.,2008.0,CCn1c2c(cnc(C#CC(C)(C)O)c2nc1-c3nonc3N)OCC4CCNCC4,,Row1541,13,0.1241910010576248,out,6
561,Row596,Row3992,CHEMBL3910308,,0,517.58,BDBM182514,IC50,=,10.0,nM,Cc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)c(c5)C(F)(F)F,,329955.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row643,24,0.1227798461914062,out,6
562,Row597,Row3491,CHEMBL4438248,,0,437.4,1a,IC50,=,10.2,nM,Cn1nccc1-c2ccc(s2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,,CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4304777,1,Scientific Literature,Eur J Med Chem,2019.0,Cn1nccc1-c2ccc(s2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,Row1315,22,0.0965801328420639,out,6
563,Row598,Row676,CHEMBL211774,,0,531.66,11e,IC50,=,10.3,nM,CC(C)(Cc1ccccn1)C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC(C)(Cc1ccccn1)C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65,,Row236,4,0.122649148106575,out,6
564,Row599,Row2745,CHEMBL573334,,0,475.55,118,IC50,=,10.3,nM,N[C@H](COc1cncc(c1)-c2ccc3NC(=O)C(c3c2)c4ccccn4)Cc5c[nH]c6ccccc65,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@H](COc1cncc(c1)-c2ccc3NC(=O)C(c3c2)c4ccccn4)Cc5c[nH]c6ccccc65,,Row124,3,0.1267191618680954,out,6
565,Row600,Row754,CHEMBL576386,,0,475.55,117,IC50,=,10.4,nM,N[C@H](COc1cncc(c1)-c2ccc3NC(=O)C(c3c2)c4cnccc4)Cc5c[nH]c6ccccc65,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@H](COc1cncc(c1)-c2ccc3NC(=O)C(c3c2)c4cnccc4)Cc5c[nH]c6ccccc65,,Row124,3,0.1263160407543182,out,6
566,Row601,Row1748,CHEMBL211690,,0,531.66,11d,IC50,=,10.4,nM,CC(C)(Cc1cnccc1)C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC(C)(Cc1cnccc1)C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65,,Row236,4,0.1249407902359962,out,6
567,Row602,Row753,CHEMBL4467439,,0,530.28,E1,IC50,=,10.44,nM,CCC[C@@H]1C[C@H]([C@@H](CN1)NC(=O)c2cc(-c3c(Cl)cnn3C)c(Cl)o2)c4ccc(Cl)c(Cl)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,CCC[C@@H]1C[C@H]([C@@H](CN1)NC(=O)c2cc(-c3c(Cl)cnn3C)c(Cl)o2)c4ccc(Cl)c(Cl)c4,,Row3515,16,0.0905758887529373,out,6
568,Row603,Row1314,CHEMBL4445702,,0,420.94,1c,IC50,=,10.6,nM,Cn1nccc1-c2ccc(s2)C(=O)N[C@@H]3CNCC[C@H]3c4cc(F)ccc4,,,CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4304777,1,Scientific Literature,Eur J Med Chem,2019.0,Cn1nccc1-c2ccc(s2)C(=O)N[C@@H]3CNCC[C@H]3c4cc(F)ccc4,,Row1315,22,0.1083127334713935,out,6
569,Row604,Row456,CHEMBL3980207,,0,560.6,BDBM182636,IC50,=,11.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCCCC4)-c5ccc(F)c(c5)C(F)(F)F,,330077.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCCCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row2044,43,0.1218592673540115,out,6
570,Row605,Row1135,CHEMBL3966620,,0,471.61,BDBM182616,IC50,=,11.0,nM,CC(C)c1cc(ccn1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,330057.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(C)c1cc(ccn1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,Row3990,26,0.1229611560702323,out,6
571,Row606,Row1959,CHEMBL2347053,,0,332.32,3s,IC50,=,11.0,nM,[O-][N+](=O)c1ccccc1-c2n[nH]cc2/C=C\3/c4ccccc4NC3=O,,,CHEMBL2353277,Inhibition of AKT1 (unknown origin) after 10 mins by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2346519,1,Scientific Literature,Bioorg. Med. Chem.,2013.0,[O-][N+](=O)c1ccccc1-c2n[nH]cc2/C=C\3/c4ccccc4NC3=O,,Row837,29,0.1100063025951385,out,6
572,Row608,Row2383,CHEMBL1632376,,0,401.51,24,IC50,=,11.0,nM,C[C@@H]1SCc2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(F)cc4,,,CHEMBL1632819,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1629708,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,C[C@@H]1SCc2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(F)cc4,,Row3589,19,0.0992370396852493,out,6
573,Row609,Row2541,CHEMBL229800,,0,392.89,13i,IC50,=,11.0,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(Cl)cc4,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(Cl)cc4,,Row1976,11,0.1074274703860282,out,6
574,Row610,Row2640,CHEMBL427426,,0,390.46,13x,IC50,=,11.0,nM,Cc1cc(C[C@H](N)COc2cncc(c2)-c3cc4c(cc3)[nH]nc4C)ccc1F,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1cc(C[C@H](N)COc2cncc(c2)-c3cc4c(cc3)[nH]nc4C)ccc1F,,Row1976,11,0.1050896570086479,out,6
575,Row611,Row3018,CHEMBL3892575,,0,489.64,BDBM182555,IC50,=,11.0,nM,Nc1ncnc(c1C2CCC2)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6ccc(F)cc6,,329996.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C2CCC2)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6ccc(F)cc6,,Row3753,7,0.1261995583772659,out,6
576,Row612,Row3580,CHEMBL3976678,,0,548.59,BDBM182660,IC50,=,11.0,nM,CN(CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4ccc(F)c(c4)C(F)(F)F)C(C)C,,330101.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4ccc(F)c(c4)C(F)(F)F)C(C)C,,Row2044,43,0.1137810423970222,out,6
577,Row613,Row3932,CHEMBL3935986,,0,500.5,BDBM182436,IC50,=,11.0,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3C4CNCC4)-c5cc(c(F)cc5)C(F)(F)F,,329877.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3C4CNCC4)-c5cc(c(F)cc5)C(F)(F)F,,Row2188,10,0.1083833500742912,out,6
578,Row614,Row2552,CHEMBL1170263,,0,384.87,36,IC50,=,11.4,nM,Cc1c[nH]c2ncnc(c21)N3C[C@@](N)(CNC(=O)c4ccc(Cl)cc4)CC3,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,Cc1c[nH]c2ncnc(c21)N3C[C@@](N)(CNC(=O)c4ccc(Cl)cc4)CC3,,Row2553,9,0.1249453872442245,out,6
579,Row616,Row842,CHEMBL1081295,,0,443.5,27,IC50,=,11.6,nM,Nc1cc2cc(ccc2cn1)-c3cnc(NC[C@@H](N)Cc4ccc(cc4)C(F)(F)F)s3,,,CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154944,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Nc1cc2cc(ccc2cn1)-c3cnc(NC[C@@H](N)Cc4ccc(cc4)C(F)(F)F)s3,,Row240,47,0.1132386103272438,out,6
580,Row617,Row14,CHEMBL3901741,,0,609.63,BDBM182523,IC50,=,12.0,nM,Nc1ncnc(c1-c2ccc(cc2)C(O)=O)N3CCC(CC3)c4nc(cn4CCN5CCC5)-c6ccc(F)c(c6)C(F)(F)F,,329964.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1-c2ccc(cc2)C(O)=O)N3CCC(CC3)c4nc(cn4CCN5CCC5)-c6ccc(F)c(c6)C(F)(F)F,,Row2044,43,0.1209387481212616,out,6
581,Row618,Row161,CHEMBL2325733,,0,477.98,56,IC50,=,12.0,nM,NC1(CCN(CC1)c2ncnc3[nH]ccc23)C(=O)NC(CS(N)(=O)=O)c4ccc(Cl)cc4,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,NC1(CCN(CC1)c2ncnc3[nH]ccc23)C(=O)NC(CS(N)(=O)=O)c4ccc(Cl)cc4,,Row3863,35,0.1212582290172576,out,6
582,Row619,Row419,CHEMBL2177362,,0,518.03,54,IC50,=,12.0,nM,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CNC4CCOCC4)c5cc(F)c(Cl)cc5,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CNC4CCOCC4)c5cc(F)c(Cl)cc5,,Row2863,37,0.0967747643589973,out,6
583,Row620,Row553,CHEMBL2177370,,0,471.99,48,IC50,=,12.0,nM,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H]([C@@H]4COCCN4)c5ccc(Cl)cc5,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H]([C@@H]4COCCN4)c5ccc(Cl)cc5,,Row2863,37,0.088757999241352,out,6
584,Row621,Row697,CHEMBL3972216,,0,543.61,BDBM182364,IC50,=,12.0,nM,C=Cc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCCC4)-c5ccc(F)c(c5)C(F)(F)F,,329805.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,C=Cc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row643,24,0.1171256601810455,out,6
585,Row622,Row702,CHEMBL3905187,,0,480.06,BDBM182573,IC50,=,12.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(Cl)ccc5,,330014.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(Cl)ccc5,,Row3753,7,0.1374048590660095,out,6
586,Row623,Row712,CHEMBL1760764,,0,586.8,(+/-)-11,IC50,=,12.0,nM,CCOCCN(C[C@@H](O)CN1CC2(CCN(C2)c3ncnc(N)c3C4CC4)CCC1)S(=O)(=O)c5c(C)cccc5C,,,CHEMBL1763788,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759869,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CCOCCN(C[C@@H](O)CN1CC2(CCN(C2)c3ncnc(N)c3C4CC4)CCC1)S(=O)(=O)c5c(C)cccc5C,,Row315,48,0.1113648116588592,out,6
587,Row624,Row1238,CHEMBL2177371,,0,449.48,49,IC50,=,12.0,nM,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CN)c4ccc(cc4)C(F)(F)F,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CN)c4ccc(cc4)C(F)(F)F,,Row2863,37,0.1045058593153953,out,6
588,Row625,Row1427,CHEMBL210089,,0,428.92,34,IC50,=,12.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3Cl)-c4cc5ccncc5cc4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3Cl)-c4cc5ccncc5cc4,,Row1996,15,0.1369577646255493,out,6
589,Row626,Row1458,CHEMBL2177375,,0,461.97,36,IC50,=,12.0,nM,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CNCCF)c4ccc(Cl)cc4,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CNCCF)c4ccc(Cl)cc4,,Row2863,37,0.0924139320850372,out,6
590,Row627,Row1731,CHEMBL574986,,0,413.4,81,IC50,=,12.0,nM,Cc1n[nH]c2cnc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(F)c(F)c4F,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Cc1n[nH]c2cnc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(F)c(F)c4F,,Row535,12,0.1126489266753196,out,6
591,Row628,Row1895,CHEMBL448991,,0,677.86,25,IC50,=,12.0,nM,CN1CC(C1)N2CCN(CC2)c3nc4nc(c(cc4cn3)-c5ccccc5)-c6ccc(CN7CCC(CC7)c8[nH]c(nn8)-c9ccccn9)cc6,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN1CC(C1)N2CCN(CC2)c3nc4nc(c(cc4cn3)-c5ccccc5)-c6ccc(CN7CCC(CC7)c8[nH]c(nn8)-c9ccccn9)cc6,,Row1163,23,0.1793980896472931,out,6
592,Row629,Row1906,CHEMBL3960331,,0,623.66,BDBM182524,IC50,=,12.0,nM,Nc1ncnc(c1-c2ccc(cc2)C(O)=O)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6ccc(F)c(c6)C(F)(F)F,,329965.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1-c2ccc(cc2)C(O)=O)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6ccc(F)c(c6)C(F)(F)F,,Row2044,43,0.1209387481212616,out,6
593,Row630,Row2000,CHEMBL596073,,0,464.53,2b,IC50,=,12.0,nM,Cc1n[nH]c2ccc(nc21)-c3cc(cnc3-c4cocc4)OC[C@@H](N)Cc5c[nH]c6ccccc56,,,CHEMBL1069941,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153227,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(nc21)-c3cc(cnc3-c4cocc4)OC[C@@H](N)Cc5c[nH]c6ccccc56,,Row1726,2,0.1116537898778915,out,6
594,Row631,Row2164,CHEMBL3911401,,0,505.56,BDBM182381,IC50,=,12.0,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3CC)-c4ccc(F)c(c4)C(F)(F)F,,329822.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3CC)-c4ccc(F)c(c4)C(F)(F)F,,Row2164,32,0.1142822429537773,out,6
595,Row632,Row2186,CHEMBL3900963,,0,546.57,BDBM182658,IC50,=,12.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCNCC4CC4)-c5ccc(F)c(c5)C(F)(F)F,,330099.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCNCC4CC4)-c5ccc(F)c(c5)C(F)(F)F,,Row2044,43,0.1101907268166542,out,6
596,Row633,Row2187,CHEMBL3919344,,0,548.59,BDBM182672,IC50,=,12.0,nM,CC(C)CNCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4ccc(F)c(c4)C(F)(F)F,,330113.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(C)CNCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4ccc(F)c(c4)C(F)(F)F,,Row2044,43,0.1109605431556701,out,6
597,Row634,Row2494,CHEMBL1760763,,0,571.79,6,IC50,=,12.0,nM,CCOCCN(C[C@@H](O)CN1CC2(CCN(C2)c3ncncc3C4CC4)CCC1)S(=O)(=O)c5c(C)cccc5C,,,CHEMBL1763788,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759869,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CCOCCN(C[C@@H](O)CN1CC2(CCN(C2)c3ncncc3C4CC4)CCC1)S(=O)(=O)c5c(C)cccc5C,,Row2370,39,0.1120036989450454,out,6
598,Row635,Row2542,CHEMBL229798,,0,412.42,13e,IC50,=,12.0,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(F)c(F)c4F,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(F)c(F)c4F,,Row1976,11,0.112721748650074,out,6
599,Row636,Row2604,CHEMBL1098943,,0,385.43,23,IC50,=,12.0,nM,CCn1c2cc(nc(C#CC(C)(C)O)c2nc1-c3nonc3N)OCCNC,,,CHEMBL1109952,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157000,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CCn1c2cc(nc(C#CC(C)(C)O)c2nc1-c3nonc3N)OCCNC,,Row167,14,0.0971713662147522,out,6
600,Row638,Row2862,CHEMBL2177382,,0,460.0,31,IC50,=,12.0,nM,CC(C)NC[C@@H](C(=O)N1CCN(CC1)c2ncnc3[C@@H](F)C[C@@H](C)c32)c4ccc(Cl)cc4,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,CC(C)NC[C@@H](C(=O)N1CCN(CC1)c2ncnc3[C@@H](F)C[C@@H](C)c32)c4ccc(Cl)cc4,,Row2863,37,0.0810266137123107,out,6
601,Row639,Row3040,CHEMBL4173126,,0,473.53,11h,IC50,=,12.0,nM,Cc1nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc(CC(C)C)c1C(=O)OCC,,,CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4130433,1,Scientific Literature,Eur J Med Chem,2017.0,Cc1nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc(CC(C)C)c1C(=O)OCC,,Row2772,33,0.088915929198265,out,6
602,Row640,Row2943,CHEMBL227323,,0,444.43,13aj,IC50,=,12.1,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(cc4F)C(F)(F)F,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(cc4F)C(F)(F)F,,Row1976,11,0.1021980643272399,out,6
603,Row641,Row2922,CHEMBL4449509,,0,528.27,E2,IC50,=,12.41,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@@H](C[C@H]3c4cc(Cl)c(Cl)cc4)CC=C,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CN[C@@H](C[C@H]3c4cc(Cl)c(Cl)cc4)CC=C,,Row3515,16,0.0874655842781066,out,6
604,Row643,Row1305,CHEMBL258838,,0,319.41,13d,IC50,=,12.7,nM,CN1CCC2(CN(c3ncnc4[nH]ccc43)c5ccccc25)CC1,,,CHEMBL936668,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143084,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN1CCC2(CN(c3ncnc4[nH]ccc43)c5ccccc25)CC1,,Row2845,36,0.1377979218959808,out,6
605,Row644,Row812,CHEMBL3899172,,0,460.56,BDBM182607,IC50,=,13.0,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)cc5,,330048.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)cc5,,Row3990,26,0.1251718699932098,out,6
606,Row645,Row1147,CHEMBL1099281,,0,385.43,25,IC50,=,13.0,nM,CCn1c2cc(nc(C#CC(C)(C)O)c2nc1-c3nonc3N)OC[C@H](C)N,,,CHEMBL1109952,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157000,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CCn1c2cc(nc(C#CC(C)(C)O)c2nc1-c3nonc3N)OC[C@H](C)N,,Row167,14,0.0982541814446449,out,6
607,Row646,Row1245,CHEMBL3932866,,0,447.52,BDBM182505,IC50,=,13.0,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(F)ncc5,,329946.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(F)ncc5,,Row3990,26,0.1251762360334396,out,6
608,Row647,Row1428,CHEMBL226382,,0,371.44,69,IC50,=,13.0,nM,C=Cc1n[nH]c2cnc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccccc4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,C=Cc1n[nH]c2cnc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccccc4,,Row535,12,0.1267382949590683,out,6
609,Row648,Row1580,CHEMBL449989,,0,652.81,36,IC50,=,13.0,nM,OCCN1CCN(CC1)c2ccc3nc(c(nc3n2)-c4ccc(CN5CCC(CC5)c6[nH]c(nn6)-c7ccccn7)cc4)-c8ccccc8,,,CHEMBL947433,Inhibition of Akt1 by cellular assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,OCCN1CCN(CC1)c2ccc3nc(c(nc3n2)-c4ccc(CN5CCC(CC5)c6[nH]c(nn6)-c7ccccn7)cc4)-c8ccccc8,,Row1163,23,0.1640500873327255,out,6
610,Row649,Row1924,CHEMBL3983708,,0,562.62,BDBM182687,IC50,=,13.0,nM,CC(C)(CC)NCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4ccc(F)c(c4)C(F)(F)F,,330128.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(C)(CC)NCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4ccc(F)c(c4)C(F)(F)F,,Row2044,43,0.1119458377361297,out,6
611,Row650,Row2182,CHEMBL3980667,,0,477.02,BDBM182621,IC50,=,13.0,nM,Cc1ccc(cc1Cl)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,330062.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1ccc(cc1Cl)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,Row3990,26,0.1202956810593605,out,6
612,Row651,Row2612,CHEMBL226744,,0,488.44,13aq,IC50,=,13.0,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc5OC(F)(F)C(F)(F)Oc5cc4,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc5OC(F)(F)C(F)(F)Oc5cc4,,Row1976,11,0.1307128667831421,out,6
613,Row652,Row2806,CHEMBL593142,,0,464.53,18b,IC50,=,13.0,nM,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4cocc4)OC[C@@H](N)Cc5c[nH]c6ccncc56,,,CHEMBL1071952,Inhibition of full length AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4cocc4)OC[C@@H](N)Cc5c[nH]c6ccncc56,,Row1726,2,0.1215102672576904,out,6
614,Row653,Row3077,CHEMBL598194,,0,384.87,3,IC50,=,13.0,nM,NC1(CCN(CC1)c2ncnc3[nH]ccc32)C(=O)NCc4ccc(Cl)cc4,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,NC1(CCN(CC1)c2ncnc3[nH]ccc32)C(=O)NCc4ccc(Cl)cc4,,Row3863,35,0.1305879950523376,out,6
615,Row654,Row3586,CHEMBL3974261,,0,494.62,BDBM182691,IC50,=,13.0,nM,Cc1cc(ccc1F)-c2cn(CCNCC(C)C)c(n2)C3CCN(CC3)c4ncnc(N)c4C(N)=O,,330132.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCNCC(C)C)c(n2)C3CCN(CC3)c4ncnc(N)c4C(N)=O,,Row1206,41,0.1134614646434784,out,6
616,Row655,Row3735,CHEMBL3920419,,0,500.57,BDBM182404,IC50,=,13.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ncc5)C(F)(F)F,,329845.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ncc5)C(F)(F)F,,Row3753,7,0.1240656971931457,out,6
617,Row656,Row3877,CHEMBL2016887,,0,604.56,6,IC50,=,13.0,nM,Cc1c(cc(cc1N2CCN(CC2)c3ncnc4[nH]nc(Br)c34)C(=O)Nc5ccccc5)NCCN6CCCC6,,,CHEMBL2020583,Inhibition of AKT1 after 3 hrs by luciferase based chemiluminescence assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2016487,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2012.0,Cc1c(cc(cc1N2CCN(CC2)c3ncnc4[nH]nc(Br)c34)C(=O)Nc5ccccc5)NCCN6CCCC6,,Row2025,21,0.1312382668256759,out,6
618,Row657,Row2642,CHEMBL375716,,0,444.43,13ag,IC50,=,13.3,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(F)cc(c4)C(F)(F)F,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(F)cc(c4)C(F)(F)F,,Row1976,11,0.1138519942760467,out,6
619,Row658,Row502,CHEMBL4442226,,0,435.38,1n,IC50,=,13.7,nM,Cn1ncc(Cl)c1-c2cc(sc2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,,CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4304777,1,Scientific Literature,Eur J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(sc2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,Row39,44,0.0872663334012031,out,6
620,Row659,Row3271,CHEMBL4450141,,0,419.31,D5,IC50,=,13.7,nM,Cn1ncc(Cl)c1-c2ccc(o2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2ccc(o2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,Row39,44,0.0895150378346443,out,6
621,Row660,Row77,CHEMBL383541,,0,370.46,1b,IC50,=,14.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)/C=C/c4ccncc4,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)/C=C/c4ccncc4,,Row77,56,0.113852635025978,out,6
622,Row661,Row535,CHEMBL376570,,0,359.43,71,IC50,=,14.0,nM,Cc1n[nH]c2cnc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccccc4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Cc1n[nH]c2cnc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccccc4,,Row535,12,0.1329818367958068,out,6
623,Row662,Row988,CHEMBL1080913,,0,400.46,21,IC50,=,14.0,nM,Cc1n[nH]c2ccc(cc21)-c3nnc(NC[C@@H](N)Cc4cc(F)c(F)cc4)s3,,,CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154933,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3nnc(NC[C@@H](N)Cc4cc(F)c(F)cc4)s3,,Row1834,53,0.1039174422621727,out,6
624,Row664,Row1206,CHEMBL3972162,,0,478.58,BDBM182423,IC50,=,14.0,nM,Cc1cc(ccc1F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,329864.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,Row1206,41,0.1271932125091552,out,6
625,Row665,Row1662,CHEMBL253458,,0,528.62,2,IC50,=,14.0,nM,Nc1ncnc2nc(c(cc12)-c3ccccc3)-c4ccc(CN5CCC(CC5)n6ncc7c6ncnc7N)cc4,,,CHEMBL928491,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141509,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Nc1ncnc2nc(c(cc12)-c3ccccc3)-c4ccc(CN5CCC(CC5)n6ncc7c6ncnc7N)cc4,,Row996,49,0.1984656006097793,out,6
626,Row666,Row1729,CHEMBL576135,,0,439.42,75,IC50,=,14.0,nM,Cc1n[nH]c2cnc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cccc5OC(F)(F)Oc45,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Cc1n[nH]c2cnc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cccc5OC(F)(F)Oc45,,Row535,12,0.1367936581373214,out,6
627,Row667,Row1976,CHEMBL379218,,0,358.45,7,IC50,=,14.0,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccccc4,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccccc4,,Row1976,11,0.144334390759468,out,6
628,Row668,Row1983,CHEMBL227326,,0,438.43,13ap,IC50,=,14.0,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cccc5OC(F)(F)Oc45,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cccc5OC(F)(F)Oc45,,Row1976,11,0.1387002170085907,out,6
629,Row669,Row2044,CHEMBL3949501,,0,532.55,BDBM182377,IC50,=,14.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,329818.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row2044,43,0.1230379417538642,out,6
630,Row671,Row3375,CHEMBL3982415,,0,582.44,BDBM182355,IC50,=,14.0,nM,Nc1ncnc(c1Br)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)c(c5)C(F)(F)F,,329796.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Br)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row643,24,0.1213854625821113,out,6
631,Row672,Row3555,CHEMBL3973734,,0,513.02,BDBM182629,IC50,=,14.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(Cl)c(F)cc5,,330070.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(Cl)c(F)cc5,,Row1206,41,0.1234824955463409,out,6
632,Row673,Row3978,CHEMBL4216977,,0,499.41,10l,IC50,=,14.1,nM,COc1ccc(cc1)C2(CCNCC2)C(=O)N3CCN(CC3)c4ncnc5[nH]cc(Br)c45,,,CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4190265,1,Scientific Literature,Eur J Med Chem,2017.0,COc1ccc(cc1)C2(CCNCC2)C(=O)N3CCN(CC3)c4ncnc5[nH]cc(Br)c45,,Row3980,30,0.1368727684020996,out,6
633,Row674,Row1850,CHEMBL3981380,,0,545.67,BDBM187364,IC50,=,14.2,nM,CC1(CCN(CC1)c2cnc(cc2-n3cc(nc3)C4CC4)C(=O)Nc5csc(n5)-c6nncn6C7CC7)OC,,337102.0,CHEMBL3887422,"Time-Resolved Fluorescence Resonance energy transfer (TR-FRET) Immunoassay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection. This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio. Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase were incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP was added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1xEu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 were added to stop the reaction and phosphorylated peptide substrate was detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence was measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm was calculated for each well.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886314,37,BindingDB Database,,2015.0,CC1(CCN(CC1)c2cnc(cc2-n3cc(nc3)C4CC4)C(=O)Nc5csc(n5)-c6nncn6C7CC7)OC,,Row2917,8,0.099138393998146,out,6
634,Row675,Row277,CHEMBL252456,,0,505.65,2,IC50,=,15.0,nM,CSc1nc2nc(-c3ccc(CNCCC(=O)c4ccccc4N)cc3)c(cc2cn1)-c5ccccc5,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CSc1nc2nc(-c3ccc(CNCCC(=O)c4ccccc4N)cc3)c(cc2cn1)-c5ccccc5,,Row3742,50,0.1763199269771576,out,6
635,Row676,Row609,CHEMBL3975681,,0,480.59,BDBM182685,IC50,=,15.0,nM,Cc1cc(ccc1F)-c2cn(CCNC(C)C)c(n2)C3CCN(CC3)c4ncnc(N)c4C(N)=O,,330126.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCNC(C)C)c(n2)C3CCN(CC3)c4ncnc(N)c4C(N)=O,,Row1206,41,0.1140963286161422,out,6
636,Row677,Row1431,CHEMBL380196,,0,409.49,40,IC50,=,15.0,nM,Nc1c2ccncc2ccc1-c3cc(cnc3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Nc1c2ccncc2ccc1-c3cc(cnc3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,Row1996,15,0.1248591914772987,out,6
637,Row678,Row1702,CHEMBL595476,,0,450.54,9b,IC50,=,15.0,nM,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4ccccc4O)OC[C@@H](N)Cc5ccccc5,,,CHEMBL1071952,Inhibition of full length AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4ccccc4O)OC[C@@H](N)Cc5ccccc5,,Row1976,11,0.1507400274276733,out,6
638,Row679,Row2248,CHEMBL3926535,,0,492.48,BDBM182458,IC50,=,15.0,nM,NCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4ccc(F)c(c4)C(F)(F)F,,329899.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,NCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4ccc(F)c(c4)C(F)(F)F,,Row2044,43,0.1157988458871841,out,6
639,Row680,Row2300,CHEMBL594749,,0,423.52,9m,IC50,=,15.0,nM,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4ccc[nH]4)OC[C@@H](N)Cc5ccccc5,,,CHEMBL1071952,Inhibition of full length AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4ccc[nH]4)OC[C@@H](N)Cc5ccccc5,,Row1976,11,0.1497324705123901,out,6
640,Row681,Row2457,CHEMBL247797,,0,479.49,41,IC50,=,15.0,nM,CNC(=O)Nc1ccc(CNc2c(cnn2C)C(=O)Nc3ccc(cc3)SC(F)(F)F)cn1,,,CHEMBL922918,Inhibition of pAkt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140657,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CNC(=O)Nc1ccc(CNc2c(cnn2C)C(=O)Nc3ccc(cc3)SC(F)(F)F)cn1,,Row3848,57,0.0799813419580459,out,6
641,Row682,Row2879,CHEMBL3936879,,0,457.59,BDBM182617,IC50,=,15.0,nM,CCc1cc(ccn1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,330058.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1cc(ccn1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,Row3990,26,0.1251628398895263,out,6
642,Row684,Row3241,CHEMBL3955767,,0,546.57,BDBM182630,IC50,=,15.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)c(c5)C(F)(F)F,,330071.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row2044,43,0.1230379417538642,out,6
643,Row685,Row3521,CHEMBL3954073,,0,517.58,BDBM182371,IC50,=,15.0,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(C)=C)-c4ccc(F)c(c4)C(F)(F)F,,329812.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(C)=C)-c4ccc(F)c(c4)C(F)(F)F,,Row2164,32,0.1135204285383224,out,6
644,Row686,Row3798,CHEMBL3943038,,0,446.53,BDBM182490,IC50,=,15.0,nM,Cc1cc(ccc1F)-c2cn(CC3CNC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,329931.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CC3CNC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,Row3798,5,0.1139028593897819,out,6
645,Row687,Row2544,CHEMBL226529,,0,442.44,13ak,IC50,=,15.3,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccccc4OC(F)(F)F,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccccc4OC(F)(F)F,,Row1976,11,0.1258996427059173,out,6
646,Row688,Row911,CHEMBL1082016,,0,447.49,39,IC50,=,15.4,nM,Cn1c(=O)[nH]c2ccc(cc12)-c3cnc(NC[C@@H](N)Cc4ccc(cc4)C(F)(F)F)s3,,,CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154944,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cn1c(=O)[nH]c2ccc(cc12)-c3cnc(NC[C@@H](N)Cc4ccc(cc4)C(F)(F)F)s3,,Row240,47,0.1226663589477539,out,6
647,Row689,Row47,CHEMBL1096292,,0,385.43,21,IC50,=,16.0,nM,CCn1c2cc(nc(C#CC(C)(C)O)c2nc1-c3nonc3N)OCCCN,,,CHEMBL1109952,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157000,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CCn1c2cc(nc(C#CC(C)(C)O)c2nc1-c3nonc3N)OCCCN,,Row167,14,0.1059653908014297,out,6
648,Row690,Row49,CHEMBL3968655,,0,548.89,BDBM182565,IC50,=,16.0,nM,Nc1ncnc(c1Br)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)c(Cl)cc5,,330006.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Br)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)c(Cl)cc5,,Row2590,1,0.1230619400739669,out,6
649,Row691,Row631,CHEMBL3899097,,0,462.62,BDBM182493,IC50,=,16.0,nM,Cc1cc(ccc1F)-c2cn(CC3CNC3)c(n2)C4CCC(CC4)c5ncnc(N)c5C(C)C,,329934.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CC3CNC3)c(n2)C4CCC(CC4)c5ncnc(N)c5C(C)C,,Row3798,5,0.1203416809439659,out,6
650,Row692,Row1591,CHEMBL226848,,0,359.43,107,IC50,=,16.0,nM,N[C@@H](Cc1ccccc1)COc2cncc(c2)-c3cc4CC(=O)Nc4cc3,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1ccccc1)COc2cncc(c2)-c3cc4CC(=O)Nc4cc3,,Row1976,11,0.1499455869197845,out,6
651,Row693,Row1625,CHEMBL3940462,,0,452.54,BDBM182696,IC50,=,16.0,nM,Cc1cc(ccc1F)-c2cn(CCNC)c(n2)C3CCN(CC3)c4ncnc(N)c4C(N)=O,,330137.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCNC)c(n2)C3CCN(CC3)c4ncnc(N)c4C(N)=O,,Row1206,41,0.116829439997673,out,6
652,Row694,Row1847,CHEMBL1171840,,0,366.43,rac-24,IC50,=,16.0,nM,Cc1c[nH]c2ncnc(c21)N3CC(N)(CNC(=O)Oc4ccccc4)CC3,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,Cc1c[nH]c2ncnc(c21)N3CC(N)(CNC(=O)Oc4ccccc4)CC3,,Row2553,9,0.1537400335073471,out,6
653,Row695,Row1899,CHEMBL1632389,,0,437.59,39,IC50,=,16.0,nM,Cc1ccc(CC(CNC(C)C)C(=O)N2CCN(CC2)c3ncnc4CO[C@@H](C)c43)cc1,,,CHEMBL1632819,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1629708,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1ccc(CC(CNC(C)C)C(=O)N2CCN(CC2)c3ncnc4CO[C@@H](C)c43)cc1,,Row3589,19,0.0839125216007232,out,6
654,Row696,Row2018,CHEMBL470192,,0,362.46,9,IC50,=,16.0,nM,NCC(NC(=O)c1ccc(s1)-c2c[nH]c3ncccc23)c4ccccc4,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NCC(NC(=O)c1ccc(s1)-c2c[nH]c3ncccc23)c4ccccc4,,Row1178,46,0.1393509954214096,out,6
655,Row698,Row2639,CHEMBL3974191,,0,461.59,BDBM182540,IC50,=,16.0,nM,C=Cc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)cc5,,329981.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,C=Cc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)cc5,,Row3753,7,0.1253399550914764,out,6
656,Row699,Row2811,CHEMBL3939097,,0,466.03,BDBM182422,IC50,=,16.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(Cl)ccc5,,330019.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(Cl)ccc5,,Row3753,7,0.1374048590660095,out,6
657,Row701,Row3731,CHEMBL3980688,,0,515.58,BDBM182399,IC50,=,16.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ccc5)OC(F)(F)F,,329840.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ccc5)OC(F)(F)F,,Row3753,7,0.130851000547409,out,6
658,Row702,Row3797,CHEMBL2325735,,0,492.01,58,IC50,=,16.0,nM,CS(=O)(=O)NCC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc23)c4ccc(Cl)cc4,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,CS(=O)(=O)NCC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc23)c4ccc(Cl)cc4,,Row3863,35,0.1201505661010742,out,6
659,Row703,Row3955,CHEMBL3923786,,0,557.64,BDBM182511,IC50,=,16.0,nM,CC(=C)c1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCCC4)-c5ccc(F)c(c5)C(F)(F)F,,329952.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(=C)c1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row2044,43,0.1206700354814529,out,6
660,Row704,Row1230,CHEMBL3923440,,0,467.02,BDBM182403,IC50,=,16.5,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(Cl)ncc5,,329844.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(Cl)ncc5,,Row3753,7,0.1266706883907318,out,6
661,Row705,Row3801,CHEMBL3897233,,0,509.94,BDBM182447,IC50,=,16.5,nM,Nc1ncnc(c1Cl)N2CCC(CC2)c3nc(cn3CC4CNC4)-c5ccc(F)c(c5)C(F)(F)F,,329888.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Cl)N2CCC(CC2)c3nc(cn3CC4CNC4)-c5ccc(F)c(c5)C(F)(F)F,,Row643,24,0.1152714341878891,out,6
662,Row706,Row3362,CHEMBL2219422,AFURESERTIB,2,427.33,GSK-2110183,IC50,=,16.9,nM,Cn1ncc(Cl)c1-c2cc(sc2Cl)C(=O)N[C@H](CN)Cc3cc(F)ccc3,,,CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4304777,1,Scientific Literature,Eur J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(sc2Cl)C(=O)N[C@H](CN)Cc3cc(F)ccc3,,Row1315,22,0.0966242924332618,out,6
663,Row707,Row579,CHEMBL3127378,,0,395.29,60b,IC50,=,16.98,nM,Nc1ncnc(c1Cl)N2CCN(CC2)C(=O)C(N)Cc3ccc(Cl)cc3,,,CHEMBL3131349,Inhibition of AKT1 (unknown origin) using ATP/eNOS as substrate incubated for 5 mins prior to substrate addition measured after 30 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3124803,1,Scientific Literature,Eur. J. Med. Chem.,2014.0,Nc1ncnc(c1Cl)N2CCN(CC2)C(=O)C(N)Cc3ccc(Cl)cc3,,Row854,17,0.1023858487606048,out,6
664,Row708,Row276,CHEMBL508754,,0,622.78,11,IC50,=,17.0,nM,C[C@H]1CN(CCN1)c2nc3nc(-c4ccc(CN5CCC(CC5)c6[nH]c(nn6)-c7ccccn7)cc4)c(cc3cn2)-c8ccccc8,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,C[C@H]1CN(CCN1)c2nc3nc(-c4ccc(CN5CCC(CC5)c6[nH]c(nn6)-c7ccccn7)cc4)c(cc3cn2)-c8ccccc8,,Row1163,23,0.1793897449970245,out,6
665,Row709,Row314,CHEMBL1760760,,0,571.75,3c,IC50,=,17.0,nM,CCOCCN(C[C@@H](O)CN1CC2(CN(CC2)c3ncnc4[nH]nc(C)c34)CC1)S(=O)(=O)c5c(C)cccc5C,,,CHEMBL1763788,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759869,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CCOCCN(C[C@@H](O)CN1CC2(CN(CC2)c3ncnc4[nH]nc(C)c34)CC1)S(=O)(=O)c5c(C)cccc5C,,Row2370,39,0.0966891199350357,out,6
666,Row710,Row533,CHEMBL1081104,,0,412.42,15,IC50,=,17.0,nM,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2cc(no2)-c3cc4ccncc4cc3,,,CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154944,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2cc(no2)-c3cc4ccncc4cc3,,Row240,47,0.1083633676171302,out,6
667,Row711,Row1693,CHEMBL1760772,,0,565.54,27e,IC50,=,17.0,nM,Nc1ncnc(c1C2CC2)N3C[C@@]4(CN(C[C@H](O)CNS(=O)(=O)c5ccccc5Br)CCC4)CC3,,,CHEMBL1763788,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759869,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,Nc1ncnc(c1C2CC2)N3C[C@@]4(CN(C[C@H](O)CNS(=O)(=O)c5ccccc5Br)CCC4)CC3,,Row315,48,0.1300439983606338,out,6
668,Row715,Row39,CHEMBL4443488,,0,603.84,A4,IC50,=,17.3,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)NC3CNCCC3c4ccc(Cl)cc4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)NC3CNCCC3c4ccc(Cl)cc4,,Row39,44,0.0947440266609191,out,6
669,Row716,Row3844,CHEMBL4554683,,0,453.76,B3,IC50,=,17.3,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,Row39,44,0.0947440266609191,out,6
670,Row717,Row1059,CHEMBL1170262,,0,395.85,35,IC50,=,17.5,nM,N[C@@]1(CNC(=O)c2ccc(Cl)cc2)CN(CC1)c3ncnc4[nH]cc(C#N)c43,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,N[C@@]1(CNC(=O)c2ccc(Cl)cc2)CN(CC1)c3ncnc4[nH]cc(C#N)c43,,Row2553,9,0.1307463496923446,out,6
671,Row718,Row984,CHEMBL4471578,,0,569.4,A3,IC50,=,17.6,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)NC3CNCCC3c4ccccc4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)NC3CNCCC3c4ccccc4,,Row39,44,0.1265138536691665,out,6
672,Row719,Row304,CHEMBL1632392,,0,476.0,42,IC50,=,18.0,nM,C[C@@H]1OCc2ncnc(c21)N3CCN(CC3)C(=O)C(Cc4cc(F)c(Cl)cc4)CC(C)(C)N,,,CHEMBL1632819,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1629708,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,C[C@@H]1OCc2ncnc(c21)N3CCN(CC3)C(=O)C(Cc4cc(F)c(Cl)cc4)CC(C)(C)N,,Row3589,19,0.0924707949161529,out,6
673,Row721,Row505,CHEMBL578418,,0,468.56,62,IC50,=,18.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc5[nH]nc(c5c4)N6CCOCC6,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc5[nH]nc(c5c4)N6CCOCC6,,Row1726,2,0.1385553032159805,out,6
674,Row722,Row536,CHEMBL253457,,0,529.62,13c,IC50,=,18.0,nM,Nc1ncnc2nc(-c3ccc(CN4CCC(CC4)c5[nH]c6cc(F)ccc6n5)cc3)c(cc21)-c7ccccc7,,,CHEMBL951085,Inhibition of human recombinant Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142344,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Nc1ncnc2nc(-c3ccc(CN4CCC(CC4)c5[nH]c6cc(F)ccc6n5)cc3)c(cc21)-c7ccccc7,,Row996,49,0.1939542591571808,out,6
675,Row723,Row1106,CHEMBL572418,,0,427.43,74,IC50,=,18.0,nM,Cc1n[nH]c2cnc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(cc4)C(F)(F)F,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Cc1n[nH]c2cnc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(cc4)C(F)(F)F,,Row535,12,0.0961782038211822,out,6
676,Row724,Row1450,CHEMBL2177365,,0,472.03,42,IC50,=,18.0,nM,CN(C[C@@H](C(=O)N1CCN(CC1)c2ncnc3[C@H](O)C[C@@H](C)c23)c4ccc(Cl)cc4)C(C)C,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,CN(C[C@@H](C(=O)N1CCN(CC1)c2ncnc3[C@H](O)C[C@@H](C)c23)c4ccc(Cl)cc4)C(C)C,,Row2863,37,0.0946547016501426,out,6
677,Row725,Row1576,CHEMBL4214539,,0,434.72,2,IC50,=,18.0,nM,O=C(Cc1ccc(Cl)cc1)N2CCN(CC2)c3ncnc4[nH]cc(Br)c34,,,CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4190265,1,Scientific Literature,Eur J Med Chem,2017.0,O=C(Cc1ccc(Cl)cc1)N2CCN(CC2)c3ncnc4[nH]cc(Br)c34,,Row3980,30,0.0896828770637512,out,6
678,Row726,Row1667,CHEMBL389438,,0,426.44,13ad,IC50,=,18.0,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(cc4)C(F)(F)F,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(cc4)C(F)(F)F,,Row1976,11,0.1056164279580116,out,6
679,Row727,Row1861,CHEMBL3921412,,0,499.59,BDBM182576,IC50,=,18.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ccc5)C(F)(F)F,,330017.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ccc5)C(F)(F)F,,Row3753,7,0.1341653764247894,out,6
680,Row728,Row2268,CHEMBL443620,,0,622.78,32,IC50,=,18.0,nM,CN1CCN(CC1)c2ccc3nc(c(nc3n2)-c4ccc(CN5CCC(CC5)c6[nH]c(nn6)-c7ccccn7)cc4)-c8ccccc8,,,CHEMBL947433,Inhibition of Akt1 by cellular assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN1CCN(CC1)c2ccc3nc(c(nc3n2)-c4ccc(CN5CCC(CC5)c6[nH]c(nn6)-c7ccccn7)cc4)-c8ccccc8,,Row1163,23,0.1670420616865158,out,6
681,Row730,Row2398,CHEMBL572905,,0,426.52,56,IC50,=,18.0,nM,CN(C)c1n[nH]c2ccc(cc12)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,CN(C)c1n[nH]c2ccc(cc12)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,Row1726,2,0.1242370307445526,out,6
682,Row731,Row2646,CHEMBL1257165,,0,412.93,52,IC50,=,18.0,nM,CNC[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4[nH]ccc34,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,CNC[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4[nH]ccc34,,Row854,17,0.0893914848566055,out,6
683,Row732,Row2800,CHEMBL3951221,,0,500.57,BDBM182398,IC50,=,18.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cncc(c5)C(F)(F)F,,329839.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cncc(c5)C(F)(F)F,,Row3753,7,0.1082819476723671,out,6
684,Row733,Row3140,CHEMBL447348,,0,679.83,20,IC50,=,18.0,nM,CN(C)C(=O)N1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN(C)C(=O)N1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,Row1163,23,0.1823965311050415,out,6
685,Row734,Row3223,CHEMBL442718,,0,607.77,4,IC50,=,18.0,nM,C(c1ccc(cc1)-c2nc3nc(ncc3cc2-c4ccccc4)N5CCCCC5)N6CCC(CC6)c7[nH]c(nn7)-c8ccccn8,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,C(c1ccc(cc1)-c2nc3nc(ncc3cc2-c4ccccc4)N5CCCCC5)N6CCC(CC6)c7[nH]c(nn7)-c8ccccn8,,Row1163,23,0.1973860263824463,out,6
686,Row735,Row3254,CHEMBL1080912,,0,433.37,20,IC50,=,18.0,nM,Cc1n[nH]c2ccc(cc21)-c3nnc(NC[C@@H](N)Cc4ccc(Cl)cc4Cl)s3,,,CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154933,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3nnc(NC[C@@H](N)Cc4ccc(Cl)cc4Cl)s3,,Row1834,53,0.1012335941195488,out,6
687,Row736,Row1140,CHEMBL1081831,,0,432.47,36,IC50,=,18.3,nM,N[C@H](CNc1ncc(s1)-c2cc3CC(=O)Nc3cc2)Cc4ccc(cc4)C(F)(F)F,,,CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154944,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](CNc1ncc(s1)-c2cc3CC(=O)Nc3cc2)Cc4ccc(cc4)C(F)(F)F,,Row240,47,0.1153700500726699,out,6
688,Row737,Row743,CHEMBL1760767,,0,554.76,23c,IC50,=,19.0,nM,Cc1cccc(C)c1S(=O)(=O)N2CCC[C@@H]2[C@@H](O)CN3C[C@@]4(CN(CC4)c5ncnc(N)c5C6CC6)CCC3,,,CHEMBL1763788,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759869,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,Cc1cccc(C)c1S(=O)(=O)N2CCC[C@@H]2[C@@H](O)CN3C[C@@]4(CN(CC4)c5ncnc(N)c5C6CC6)CCC3,,Row315,48,0.1198687553405761,out,6
689,Row738,Row901,CHEMBL203384,,0,403.92,16a,IC50,=,19.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)CNc3cc(/C=C/c4ccncc4)c(Cl)nc3,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)CNc3cc(/C=C/c4ccncc4)c(Cl)nc3,,Row77,56,0.110412910580635,out,6
690,Row739,Row1112,CHEMBL1080893,,0,398.92,16,IC50,=,19.0,nM,Cc1n[nH]c2ccc(cc21)-c3nnc(NC[C@@H](N)Cc4cccc(Cl)c4)s3,,,CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154933,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3nnc(NC[C@@H](N)Cc4cccc(Cl)c4)s3,,Row1834,53,0.1140117645263671,out,6
691,Row740,Row1908,CHEMBL3892286,,0,503.55,BDBM182450,IC50,=,19.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CC4CNC4)-c5ccc(F)c(c5)C(F)(F)F,,329891.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CC4CNC4)-c5ccc(F)c(c5)C(F)(F)F,,Row2164,32,0.1154350489377975,out,6
692,Row742,Row3150,CHEMBL447044,,0,646.76,22,IC50,=,19.0,nM,C(c1ccc(cc1)-c2nc3nc(ncc3cc2-c4ccccc4)N5Cc6nncn6CC5)N7CCC(CC7)c8[nH]c(nn8)-c9ccccn9,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,C(c1ccc(cc1)-c2nc3nc(ncc3cc2-c4ccccc4)N5Cc6nncn6CC5)N7CCC(CC7)c8[nH]c(nn8)-c9ccccn9,,Row1163,23,0.1751015186309814,out,6
693,Row744,Row109,CHEMBL445212,,0,637.8,14,IC50,=,20.0,nM,CN1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8cnc(N)cc8)cc5,,,CHEMBL947433,Inhibition of Akt1 by cellular assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8cnc(N)cc8)cc5,,Row1163,23,0.1939689666032791,out,6
694,Row745,Row187,CHEMBL470620,,0,469.41,29,IC50,=,20.0,nM,CN(C)CC(NC(=O)c1cc(Br)c(s1)-c2ccnc3[nH]ccc23)c4ccccc4,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CN(C)CC(NC(=O)c1cc(Br)c(s1)-c2ccnc3[nH]ccc23)c4ccccc4,,Row1178,46,0.1249675750732421,out,6
695,Row746,Row875,CHEMBL1258330,,0,395.89,4,IC50,=,20.0,nM,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4ccccc34,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4ccccc34,,Row875,55,0.1250585913658142,out,6
696,Row747,Row1400,CHEMBL408151,,0,579.67,2d,IC50,=,20.0,nM,O=c1[nH]c2ccccc2n1C3CCN(Cc4ccc(cc4)-c5nc6cc(ccc6nc5-c7ccccc7)-c8nn[nH]n8)CC3,,,CHEMBL948032,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,O=c1[nH]c2ccccc2n1C3CCN(Cc4ccc(cc4)-c5nc6cc(ccc6nc5-c7ccccc7)-c8nn[nH]n8)CC3,,Row2123,58,0.194807544350624,out,6
697,Row748,Row2135,CHEMBL3969159,,0,489.64,BDBM182556,IC50,=,20.0,nM,Nc1ncnc(c1C2CCC2)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6cc(F)ccc6,,329997.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C2CCC2)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6cc(F)ccc6,,Row3753,7,0.1359482556581497,out,6
698,Row749,Row2420,CHEMBL3894577,,0,463.61,BDBM182531,IC50,=,20.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)cc5,,329972.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)cc5,,Row3753,7,0.1299848109483719,out,6
699,Row750,Row2540,CHEMBL513019,,0,469.41,31,IC50,=,20.0,nM,NCCCC(NC(=O)c1cc(Br)c(s1)-c2ccnc3[nH]ccc23)c4ccccc4,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NCCCC(NC(=O)c1cc(Br)c(s1)-c2ccnc3[nH]ccc23)c4ccccc4,,Row1178,46,0.1407824903726577,out,6
700,Row751,Row2747,CHEMBL574289,,0,579.67,132,IC50,=,20.0,nM,O=c1[nH]c2ccccc2n1C3CCN(Cc4ccc(cc4)-c5nc6cc(ccc6nc5-c7ccccc7)-n8cnnn8)CC3,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,O=c1[nH]c2ccccc2n1C3CCN(Cc4ccc(cc4)-c5nc6cc(ccc6nc5-c7ccccc7)-n8cnnn8)CC3,,Row2123,58,0.1841807663440704,out,6
701,Row752,Row2759,CHEMBL1823653,,0,414.34,27,IC50,=,20.0,nM,O=C(NC(C1CNCCC1)c2cc(Cl)c(Cl)cc2)c3cc4ccncc4cc3,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,O=C(NC(C1CNCCC1)c2cc(Cl)c(Cl)cc2)c3cc4ccncc4cc3,,Row3192,40,0.1058179289102554,out,6
702,Row753,Row2773,CHEMBL3901242,,0,543.61,BDBM182512,IC50,=,20.0,nM,CC(=C)c1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)c(c5)C(F)(F)F,,329953.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(=C)c1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row2044,43,0.1218253895640373,out,6
703,Row754,Row3137,CHEMBL451961,,0,629.72,3,IC50,=,20.0,nM,FC1(F)CN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,FC1(F)CN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,Row1163,23,0.2018271684646606,out,6
704,Row755,Row3260,CHEMBL1823651,,0,432.33,24,IC50,=,20.0,nM,O=C(NC(C1CCNCC1)c2ccc(Cl)c(Cl)c2)c3ccc4cnc(F)cc4c3,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,O=C(NC(C1CCNCC1)c2ccc(Cl)c(Cl)c2)c3ccc4cnc(F)cc4c3,,Row3192,40,0.0951215326786041,out,6
705,Row756,Row3577,CHEMBL574646,,0,277.33,"4, EF31",IC50,=,20.0,nM,O=C\1/C(/CNC/C1=C\c2ccccn2)=C/c3ccccn3,,,CHEMBL2344124,Inhibition of recombinant AKT1 (unknown origin) by FRET-based Z'-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2331439,1,Scientific Literature,J. Med. Chem.,2013.0,O=C\1/C(/CNC/C1=C\c2ccccn2)=C/c3ccccn3,,Row1473,59,0.1313183903694152,out,6
706,Row757,Row3824,CHEMBL1823630,,0,433.46,2,IC50,=,20.0,nM,N[C@H](CNc1nnc(s1)-c2cc3CC(=O)Nc3cc2)Cc4ccc(cc4)C(F)(F)F,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,N[C@H](CNc1nnc(s1)-c2cc3CC(=O)Nc3cc2)Cc4ccc(cc4)C(F)(F)F,,Row1834,53,0.1061972081661224,out,6
707,Row758,Row291,CHEMBL4217841,,0,469.39,10j,IC50,=,20.3,nM,O=C(N1CCN(CC1)c2ncnc3[nH]cc(Br)c23)C4(CCNCC4)c5ccccc5,,,CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4190265,1,Scientific Literature,Eur J Med Chem,2017.0,O=C(N1CCN(CC1)c2ncnc3[nH]cc(Br)c23)C4(CCNCC4)c5ccccc5,,Row3980,30,0.1546788215637207,out,6
708,Row759,Row1411,CHEMBL227324,,0,442.44,13am,IC50,=,20.3,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(cc4)OC(F)(F)F,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(cc4)OC(F)(F)F,,Row1976,11,0.1036606431007385,out,6
709,Row760,Row730,CHEMBL376118,,0,427.34,13r,IC50,=,20.7,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(Cl)cc(Cl)c4,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(Cl)cc(Cl)c4,,Row1976,11,0.1105860844254493,out,6
710,Row762,Row1316,CHEMBL3965033,,0,570.54,BDBM182417,IC50,=,21.0,nM,Nc1ncnc(c1OCC(F)(F)F)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ncc5)C(F)(F)F,,329858.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1OCC(F)(F)F)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ncc5)C(F)(F)F,,Row2044,43,0.1187863647937774,out,6
711,Row763,Row1489,CHEMBL3890310,,0,502.55,BDBM182414,IC50,=,21.0,nM,COc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ncc5)C(F)(F)F,,329855.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,COc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ncc5)C(F)(F)F,,Row2044,43,0.1318777352571487,out,6
712,Row764,Row1670,CHEMBL229315,,0,394.43,13c,IC50,=,21.0,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(F)cc4F,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccc(F)cc4F,,Row1976,11,0.1074899584054946,out,6
713,Row765,Row1805,CHEMBL255348,,0,609.74,10d,IC50,=,21.0,nM,Nc1nn(CCc2c[nH]cn2)c3nc(-c4ccc(CN5CCC(CC5)n6c(=O)[nH]c7ccccc67)cc4)c(cc31)-c8ccccc8,,,CHEMBL951085,Inhibition of human recombinant Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142344,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Nc1nn(CCc2c[nH]cn2)c3nc(-c4ccc(CN5CCC(CC5)n6c(=O)[nH]c7ccccc67)cc4)c(cc31)-c8ccccc8,,Row2123,58,0.1964274048805236,out,6
714,Row766,Row1950,CHEMBL259968,,0,523.64,14,IC50,=,21.0,nM,C(c1ccc(cc1)-c2nc3cnccc3cc2-c4ccccc4)N5CCC(CC5)c6nc([nH]n6)-c7ccccn7,,,CHEMBL937417,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143097,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,C(c1ccc(cc1)-c2nc3cnccc3cc2-c4ccccc4)N5CCC(CC5)c6nc([nH]n6)-c7ccccn7,,Row996,49,0.2189928293228149,out,6
715,Row767,Row2556,CHEMBL3968052,,0,460.56,BDBM182608,IC50,=,21.0,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)ccc5,,330049.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)ccc5,,Row3990,26,0.1347473859786987,out,6
716,Row768,Row2610,CHEMBL255835,,0,538.66,13d,IC50,=,21.0,nM,Nc1ncnc2nc(-c3ccc(CN4CCC(CC4)c5cc([nH]n5)-c6ccncc6)cc3)c(cc21)-c7ccccc7,,,CHEMBL951085,Inhibition of human recombinant Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142344,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Nc1ncnc2nc(-c3ccc(CN4CCC(CC4)c5cc([nH]n5)-c6ccncc6)cc3)c(cc21)-c7ccccc7,,Row996,49,0.2002190947532653,out,6
717,Row769,Row2734,CHEMBL3928074,,0,461.59,BDBM182539,IC50,=,21.0,nM,C=Cc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)ccc5,,329980.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,C=Cc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)ccc5,,Row3753,7,0.13499815762043,out,6
718,Row770,Row2781,CHEMBL1760761,,0,585.77,4,IC50,=,21.0,nM,CCOCCN(C[C@@H](O)CN1CC2(CN(CC2)c3ncnc4[nH]nc(C)c34)CCC1)S(=O)(=O)c5c(C)cccc5C,,,CHEMBL1763788,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759869,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CCOCCN(C[C@@H](O)CN1CC2(CN(CC2)c3ncnc4[nH]nc(C)c34)CCC1)S(=O)(=O)c5c(C)cccc5C,,Row2370,39,0.1028892248868942,out,6
719,Row771,Row2849,CHEMBL3913969,,0,475.58,BDBM182461,IC50,=,21.0,nM,Cc1cc(ccc1F)-c2cn(CCNC)c(n2)C3CCN(CC3)c4ncnc(N)c4-c5cn[nH]c5,,329902.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCNC)c(n2)C3CCN(CC3)c4ncnc(N)c4-c5cn[nH]c5,,Row2188,10,0.1109817698597908,out,6
720,Row772,Row3976,CHEMBL4460756,,0,396.44,D19,IC50,=,21.6,nM,Cn1nccc1-c2ccc(cc2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(F)c(F)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1nccc1-c2ccc(cc2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(F)c(F)c4,,Row1315,22,0.1146541014313697,out,6
721,Row773,Row157,CHEMBL377764,,0,420.52,10s,IC50,=,22.0,nM,C=Cc1cc2cc(ccc2cn1)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,,CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1147830,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,C=Cc1cc2cc(ccc2cn1)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,Row1996,15,0.127562329173088,out,6
722,Row774,Row867,CHEMBL1632369,,0,403.94,17,IC50,=,22.0,nM,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4CSCc43,,,CHEMBL1632819,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1629708,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4CSCc43,,Row875,55,0.1013451665639877,out,6
723,Row775,Row1714,CHEMBL1235979,,0,422.56,26,IC50,=,22.0,nM,C[C@@H]1SCc2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)Cc4c[nH]c5ccccc54,,,CHEMBL1632819,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1629708,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,C[C@@H]1SCc2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)Cc4c[nH]c5ccccc54,,Row3589,19,0.1194658726453781,out,6
724,Row776,Row13,CHEMBL3960833,,0,451.59,BDBM182594,IC50,=,23.0,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3CC)-c4cc(C)c(F)cc4,,330035.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3CC)-c4cc(C)c(F)cc4,,Row2164,32,0.1162623241543769,out,6
725,Row779,Row1564,CHEMBL229854,,0,437.34,13j,IC50,=,23.0,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccccc4Br,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccccc4Br,,Row1976,11,0.1277908533811569,out,6
726,Row780,Row2466,CHEMBL379914,,0,404.9,2s,IC50,=,23.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(/C=C/c4ccncc4)c(Cl)nc3,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(/C=C/c4ccncc4)c(Cl)nc3,,Row77,56,0.1114799305796623,out,6
727,Row781,Row3698,CHEMBL3968742,,0,469.6,BDBM182618,IC50,=,23.0,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ncc5)C6CC6,,330059.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ncc5)C6CC6,,Row3990,26,0.1247985959053039,out,6
728,Row782,Row3799,CHEMBL3895789,,0,521.54,BDBM182510,IC50,=,23.0,nM,Nc1ncnc(c1F)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(c(F)cc5)C(F)(F)F,,329951.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1F)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(c(F)cc5)C(F)(F)F,,Row643,24,0.1243711188435554,out,6
729,Row783,Row2240,CHEMBL404347,,0,554.66,14a,IC50,=,23.6,nM,COc1nc2nc(-c3ccc(CN4CCC(CC4)c5[nH]c(nn5)-c6ccccn6)cc3)c(cc2cn1)-c7ccccc7,,,CHEMBL928491,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141509,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,COc1nc2nc(-c3ccc(CN4CCC(CC4)c5[nH]c(nn5)-c6ccccn6)cc3)c(cc2cn1)-c7ccccc7,,Row1163,23,0.2036819905042648,out,6
730,Row784,Row815,CHEMBL1081451,,0,384.9,27,IC50,=,24.0,nM,N[C@@H](Cc1ccc(Cl)cc1)CNc2nnc(s2)-c3cc4cn[nH]c4cc3,,,CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154933,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@@H](Cc1ccc(Cl)cc1)CNc2nnc(s2)-c3cc4cn[nH]c4cc3,,Row1834,53,0.0952602550387382,out,6
731,Row785,Row1069,CHEMBL404555,,0,549.64,14b,IC50,=,24.0,nM,N#Cc1nc2nc(-c3ccc(CN4CCC(CC4)c5[nH]c(nn5)-c6ccccn6)cc3)c(cc2cn1)-c7ccccc7,,,CHEMBL928491,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141509,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,N#Cc1nc2nc(-c3ccc(CN4CCC(CC4)c5[nH]c(nn5)-c6ccccn6)cc3)c(cc2cn1)-c7ccccc7,,Row1163,23,0.1923202276229858,out,6
732,Row786,Row2456,CHEMBL247250,,0,462.44,43,IC50,=,24.0,nM,CNC(=O)Nc1ccc(CNc2ncsc2C(=O)Nc3cc4OC(F)(F)Oc4cc3)cn1,,,CHEMBL922918,Inhibition of pAkt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140657,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CNC(=O)Nc1ccc(CNc2ncsc2C(=O)Nc3cc4OC(F)(F)Oc4cc3)cn1,,Row3186,60,0.0926086232066154,out,6
733,Row788,Row3012,CHEMBL3912123,,0,467.57,BDBM182581,IC50,=,24.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(F)c(F)cc5,,330022.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(F)c(F)cc5,,Row3753,7,0.1290994137525558,out,6
734,Row789,Row3531,CHEMBL2177373,,0,415.93,34,IC50,=,24.0,nM,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CN)c4ccc(Cl)cc4,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CN)c4ccc(Cl)cc4,,Row2863,37,0.1058221608400344,out,6
735,Row791,Row3756,CHEMBL3949201,,0,510.57,BDBM182615,IC50,=,24.0,nM,Cc1ccc(cc1C(F)(F)F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,330056.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1ccc(cc1C(F)(F)F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,Row3990,26,0.1207177937030792,out,6
736,Row792,Row113,CHEMBL4285143,,0,494.81,10h,IC50,=,24.3,nM,O=C(N1CCN(CC1)c2ncnc3[nH]nc(Cl)c23)C4(CCNCC4)c5ccc(Cl)c(Cl)c5,,,CHEMBL4259693,Inhibition of AKT1 (unknown origin) using biotin-labelled STK as substrate measured after 45 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4257535,1,Scientific Literature,MedChemComm,2018.0,O=C(N1CCN(CC1)c2ncnc3[nH]nc(Cl)c23)C4(CCNCC4)c5ccc(Cl)c(Cl)c5,,Row3980,30,0.13680200278759,out,6
737,Row793,Row1664,CHEMBL211011,,0,585.71,9o,IC50,=,24.6,nM,CC1(C)c2cc(ccc2NC1=O)N[C@@H](Cc3c[nH]c4ccccc34)COc5cncc(c5)-c6cc7c(cc6)NC(=O)C7(C)C,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC1(C)c2cc(ccc2NC1=O)N[C@@H](Cc3c[nH]c4ccccc34)COc5cncc(c5)-c6cc7c(cc6)NC(=O)C7(C)C,,Row837,29,0.1234520450234413,out,6
738,Row794,Row70,CHEMBL1076565,,0,418.45,25,IC50,=,25.0,nM,N[C@@H](Cc1cc(ccc1)C(F)(F)F)CNc2nnc(s2)-c3cc4cn[nH]c4cc3,,,CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154933,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@@H](Cc1cc(ccc1)C(F)(F)F)CNc2nnc(s2)-c3cc4cn[nH]c4cc3,,Row1834,53,0.1009688004851341,out,6
739,Row795,Row184,CHEMBL512305,,0,362.46,11,IC50,=,25.0,nM,NCC(NC(=O)c1cc(cs1)-c2c[nH]c3ncccc23)c4ccccc4,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NCC(NC(=O)c1cc(cs1)-c2c[nH]c3ncccc23)c4ccccc4,,Row1178,46,0.1262112706899643,out,6
740,Row796,Row185,CHEMBL472291,,0,441.35,20,IC50,=,25.0,nM,NCC(C(=O)Nc1cc(Br)c(s1)-c2ccnc3[nH]ccc23)c4ccccc4,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NCC(C(=O)Nc1cc(Br)c(s1)-c2ccnc3[nH]ccc23)c4ccccc4,,Row1178,46,0.1342946738004684,out,6
741,Row798,Row696,CHEMBL4108380,,0,549.59,BDBM182545,IC50,=,25.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4C[C@H](F)CC4)-c5cc(F)c(cc5)C(F)(F)F,,329986.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4C[C@H](F)CC4)-c5cc(F)c(cc5)C(F)(F)F,,Row3753,7,0.113382838666439,out,6
742,Row799,Row1973,CHEMBL453288,,0,623.77,13,IC50,=,25.0,nM,CN1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ncccn8)cc5,,,CHEMBL947433,Inhibition of Akt1 by cellular assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ncccn8)cc5,,Row1163,23,0.1876288801431656,out,6
743,Row801,Row3151,CHEMBL499683,,0,624.75,15,IC50,=,25.0,nM,O[C@@H]1CN(CCN1)c2nc3nc(-c4ccc(CN5CCC(CC5)c6[nH]c(nn6)-c7ccccn7)cc4)c(cc3cn2)-c8ccccc8,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,O[C@@H]1CN(CCN1)c2nc3nc(-c4ccc(CN5CCC(CC5)c6[nH]c(nn6)-c7ccccn7)cc4)c(cc3cn2)-c8ccccc8,,Row1163,23,0.1797191053628921,out,6
744,Row802,Row725,CHEMBL1761088,,0,559.73,30,IC50,=,26.0,nM,CCOCCN(C[C@@H](O)CN1CC2(CCC1)CCc3cc(ccc3O2)C(N)=O)S(=O)(=O)c4c(C)cccc4C,,,CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759945,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CCOCCN(C[C@@H](O)CN1CC2(CCC1)CCc3cc(ccc3O2)C(N)=O)S(=O)(=O)c4c(C)cccc4C,,Row2370,39,0.1194857433438301,out,6
745,Row803,Row1414,CHEMBL3974022,,0,546.57,BDBM182662,IC50,=,26.0,nM,CN(CCOC)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4ccc(F)c(c4)C(F)(F)F,,330103.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(CCOC)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4ccc(F)c(c4)C(F)(F)F,,Row2188,10,0.1150545850396156,out,6
746,Row805,Row2491,CHEMBL381187,,0,394.48,13b(R-),IC50,=,26.0,nM,N[C@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)-c4cc5ccncc5cc4,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)-c4cc5ccncc5cc4,,Row1996,15,0.1348099261522293,out,6
747,Row806,Row3082,CHEMBL4212569,,0,424.94,10c,IC50,=,26.5,nM,O=C(N1CCN(CC1)c2ncnc3[nH]ccc23)C4(CCNCC4)c5ccc(Cl)cc5,,,CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4190265,1,Scientific Literature,Eur J Med Chem,2017.0,O=C(N1CCN(CC1)c2ncnc3[nH]ccc23)C4(CCNCC4)c5ccc(Cl)cc5,,Row3980,30,0.1300583779811859,out,6
748,Row807,Row1342,CHEMBL4281435,,0,504.82,10j,IC50,=,26.9,nM,O=C(N1CCN(CC1)c2ncnc3[nH]nc(Br)c32)C4(CCNCC4)c5ccc(Cl)cc5,,,CHEMBL4259693,Inhibition of AKT1 (unknown origin) using biotin-labelled STK as substrate measured after 45 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4257535,1,Scientific Literature,MedChemComm,2018.0,O=C(N1CCN(CC1)c2ncnc3[nH]nc(Br)c32)C4(CCNCC4)c5ccc(Cl)cc5,,Row3980,30,0.1289626061916351,out,6
749,Row808,Row16,CHEMBL3942663,,0,518.52,BDBM182439,IC50,=,27.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CC4CNC4)-c5ccc(F)c(c5)C(F)(F)F,,329880.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CC4CNC4)-c5ccc(F)c(c5)C(F)(F)F,,Row2044,43,0.1149046048521995,out,6
750,Row809,Row529,CHEMBL1081853,,0,450.51,38,IC50,=,27.0,nM,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2ncc(s2)-c3cc4sc(=O)[nH]c4cc3,,,CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154944,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2ncc(s2)-c3cc4sc(=O)[nH]c4cc3,,Row240,47,0.106943130493164,out,6
751,Row810,Row3788,CHEMBL4211584,,0,469.39,10d,IC50,=,27.1,nM,O=C(N1CCN(CC1)c2ncnc3[nH]ccc23)C4(CCNCC4)c5ccc(Br)cc5,,,CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4190265,1,Scientific Literature,Eur J Med Chem,2017.0,O=C(N1CCN(CC1)c2ncnc3[nH]ccc23)C4(CCNCC4)c5ccc(Br)cc5,,Row3980,30,0.1310973763465881,out,6
752,Row811,Row471,CHEMBL4574492,,0,430.89,D20,IC50,=,27.3,nM,Cn1ncc(Cl)c1-c2ccc(cc2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(F)c(F)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2ccc(cc2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(F)c(F)c4,,Row1315,22,0.1141930893063545,out,6
753,Row812,Row1582,CHEMBL448826,,0,637.79,7,IC50,=,28.0,nM,C[C@@H]1CN(C[C@H](C)O1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,C[C@@H]1CN(C[C@H](C)O1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,Row1163,23,0.1831143945455551,out,6
754,Row813,Row3595,CHEMBL3891427,,0,571.67,BDBM182552,IC50,=,28.0,nM,Nc1ncnc(c1C2CCC2)N3CCC(CC3)c4nc(cn4CCN5CCCCC5)-c6cc(F)c(cc6)C(F)(F)F,,329993.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C2CCC2)N3CCC(CC3)c4nc(cn4CCN5CCCCC5)-c6cc(F)c(cc6)C(F)(F)F,,Row643,24,0.1185882911086082,out,6
755,Row814,Row323,CHEMBL390371,,0,392.89,13g,IC50,=,29.0,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccccc4Cl,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccccc4Cl,,Row1976,11,0.1266666650772094,out,6
756,Row815,Row1704,CHEMBL252457,,0,469.61,13a,IC50,=,29.0,nM,CSc1nc2nc(-c3ccc(CN4CCC(CC4)C(N)=O)cc3)c(cc2cn1)-c5ccccc5,,,CHEMBL928491,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141509,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CSc1nc2nc(-c3ccc(CN4CCC(CC4)C(N)=O)cc3)c(cc2cn1)-c5ccccc5,,Row3742,50,0.2190103381872177,out,6
757,Row816,Row3231,CHEMBL3954717,,0,530.56,BDBM182637,IC50,=,29.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)OC(F)F,,330078.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)OC(F)F,,Row1206,41,0.1208111122250557,out,6
758,Row817,Row3593,CHEMBL4518386,,0,384.87,D1,IC50,=,29.4,nM,Cn1nccc1-c2cc(oc2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1nccc1-c2cc(oc2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,Row39,44,0.0890330672264099,out,6
759,Row818,Row3892,CHEMBL4439720,,0,542.66,D9,IC50,=,29.8,nM,Cn1ncc(Br)c1-c2oc(cc2Br)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Br)c1-c2oc(cc2Br)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,Row39,44,0.0882418975234031,out,6
760,Row819,Row556,CHEMBL1257283,,0,390.49,55,IC50,=,30.0,nM,Cc1c[nH]c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)C4Cc5ccccc5C4,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1c[nH]c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)C4Cc5ccccc5C4,,Row1872,62,0.1334392875432968,out,6
761,Row820,Row653,CHEMBL1823654,,0,400.31,"28, diastereomeric mixture",IC50,=,30.0,nM,O=C(NC(C1CNCC1)c2cc(Cl)c(Cl)cc2)c3cc4ccncc4cc3,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,O=C(NC(C1CNCC1)c2cc(Cl)c(Cl)cc2)c3cc4ccncc4cc3,,Row3192,40,0.0995252281427383,out,6
762,Row821,Row855,CHEMBL1258662,,0,440.35,9,IC50,=,30.0,nM,N[C@H](Cc1ccc(Br)cc1)C(=O)N2CCN(CC2)c3ncnc4ccccc34,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccc(Br)cc1)C(=O)N2CCN(CC2)c3ncnc4ccccc34,,Row875,55,0.1245344281196594,out,6
763,Row822,Row1447,CHEMBL2325730,,0,427.9,53,IC50,=,30.0,nM,NC(=O)C(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc32)c4ccc(Cl)cc4,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,NC(=O)C(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc32)c4ccc(Cl)cc4,,Row3863,35,0.1250299364328384,out,6
764,Row823,Row2662,CHEMBL1257401,,0,413.88,25,IC50,=,30.0,nM,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4cc(F)ccc34,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4cc(F)ccc34,,Row875,55,0.1035407036542892,out,6
765,Row825,Row1512,CHEMBL4284849,,0,539.27,10l,IC50,=,30.5,nM,O=C(N1CCN(CC1)c2ncnc3[nH]nc(Br)c32)C4(CCNCC4)c5ccc(Cl)c(Cl)c5,,,CHEMBL4259693,Inhibition of AKT1 (unknown origin) using biotin-labelled STK as substrate measured after 45 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4257535,1,Scientific Literature,MedChemComm,2018.0,O=C(N1CCN(CC1)c2ncnc3[nH]nc(Br)c32)C4(CCNCC4)c5ccc(Cl)c(Cl)c5,,Row3980,30,0.1277419179677963,out,6
766,Row826,Row545,CHEMBL3950150,,0,543.61,BDBM182389,IC50,=,31.0,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C=4CCCC4)-c5cc(c(F)cc5)C(F)(F)F,,329830.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C=4CCCC4)-c5cc(c(F)cc5)C(F)(F)F,,Row2164,32,0.1283000111579895,out,6
767,Row827,Row612,CHEMBL3943041,,0,493.02,BDBM182622,IC50,=,31.0,nM,COc1ccc(cc1Cl)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,330063.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,COc1ccc(cc1Cl)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,Row3990,26,0.1274438500404358,out,6
768,Row828,Row1000,CHEMBL388809,,0,412.42,13f,IC50,=,31.0,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4c(F)cc(F)cc4F,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4c(F)cc(F)cc4F,,Row1976,11,0.1212342455983161,out,6
769,Row829,Row1422,CHEMBL3906193,,0,500.5,BDBM182445,IC50,=,31.0,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CC4CCN4)-c5cc(c(F)cc5)C(F)(F)F,,329886.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CC4CCN4)-c5cc(c(F)cc5)C(F)(F)F,,Row2188,10,0.1119671091437339,out,6
770,Row831,Row2313,CHEMBL2325732,,0,455.95,55,IC50,=,31.0,nM,CC(=O)NCC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc23)c4ccc(Cl)cc4,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,CC(=O)NCC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc23)c4ccc(Cl)cc4,,Row3863,35,0.1270387768745422,out,6
771,Row833,Row3011,CHEMBL3907940,,0,467.02,BDBM182400,IC50,=,31.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cncc(Cl)c5,,329841.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cncc(Cl)c5,,Row3753,7,0.1094437316060066,out,6
772,Row834,Row3936,CHEMBL2325985,,0,475.0,38,IC50,=,31.0,nM,NC1(CCN(CC1)c2ncnc3[nH]ccc32)C(=O)NC(Cc4ccccc4)c5ccc(Cl)cc5,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,NC1(CCN(CC1)c2ncnc3[nH]ccc32)C(=O)NC(Cc4ccccc4)c5ccc(Cl)cc5,,Row3863,35,0.1551563888788223,out,6
773,Row835,Row3464,CHEMBL4578995,,0,463.76,D6,IC50,=,31.2,nM,Cn1ncc(Br)c1-c2ccc(o2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Br)c1-c2ccc(o2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,Row39,44,0.0870430395007133,out,6
774,Row836,Row283,CHEMBL513728,,0,455.38,38,IC50,=,32.0,nM,NC[C@@H](Cc1ccccc1)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NC[C@@H](Cc1ccccc1)NC(=O)c2cc(Br)c(s2)-c3ccnc4[nH]ccc34,,Row284,18,0.1345445215702057,out,6
775,Row837,Row1403,CHEMBL3977710,,0,466.57,BDBM182647,IC50,=,32.0,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4cc(C)c(F)cc4,,330088.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4cc(C)c(F)cc4,,Row1206,41,0.117692120373249,out,6
776,Row838,Row1792,CHEMBL523057,,0,368.4,11c,IC50,=,32.0,nM,CCn1c2c(cnc(c2nc1-c3nonc3N)-c4c[nH]cc4)OCCCN,,,CHEMBL1028090,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140130,1,Scientific Literature,J. Med. Chem.,2008.0,CCn1c2c(cnc(c2nc1-c3nonc3N)-c4c[nH]cc4)OCCCN,,Row2429,38,0.1180848255753517,out,6
777,Row839,Row2940,CHEMBL493251,,0,368.4,11a,IC50,=,32.0,nM,CCn1c2c(cnc(c2nc1-c3nonc3N)-c4ccc[nH]4)OCCCN,,,CHEMBL1028090,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140130,1,Scientific Literature,J. Med. Chem.,2008.0,CCn1c2c(cnc(c2nc1-c3nonc3N)-c4ccc[nH]4)OCCCN,,Row2429,38,0.1159850284457206,out,6
778,Row840,Row2995,CHEMBL4282775,,0,504.82,10g,IC50,=,32.9,nM,O=C(N1CCN(CC1)c2ncnc3[nH]nc(Cl)c32)C4(CCNCC4)c5ccc(Br)cc5,,,CHEMBL4259693,Inhibition of AKT1 (unknown origin) using biotin-labelled STK as substrate measured after 45 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4257535,1,Scientific Literature,MedChemComm,2018.0,O=C(N1CCN(CC1)c2ncnc3[nH]nc(Cl)c32)C4(CCNCC4)c5ccc(Br)cc5,,Row3980,30,0.1348384916782379,out,6
779,Row841,Row85,CHEMBL455071,,0,695.88,24,IC50,=,33.0,nM,CN(C)CCN1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8cc[n+]([O-])cc8)cc5,,,CHEMBL947433,Inhibition of Akt1 by cellular assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN(C)CCN1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8cc[n+]([O-])cc8)cc5,,Row1163,23,0.170444831252098,out,6
780,Row843,Row1556,CHEMBL3979190,,0,597.62,BDBM182388,IC50,=,33.0,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4ccc(cc4)C(O)=O)-c5cc(c(F)cc5)C(F)(F)F,,329829.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4ccc(cc4)C(O)=O)-c5cc(c(F)cc5)C(F)(F)F,,Row2164,32,0.1139437556266784,out,6
781,Row844,Row2789,CHEMBL3967166,,0,506.51,BDBM182675,IC50,=,33.0,nM,CNCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4ccc(F)c(c4)C(F)(F)F,,330116.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CNCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4ccc(F)c(c4)C(F)(F)F,,Row2044,43,0.1140705645084381,out,6
782,Row845,Row40,CHEMBL260184,,0,538.66,7d,IC50,=,34.0,nM,O=c1ccc(c[nH]1)-c2cc(n[nH]2)C3CCN(Cc4ccc(cc4)-c5nc6ncccc6cc5-c7ccccc7)CC3,,,CHEMBL937417,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143097,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,O=c1ccc(c[nH]1)-c2cc(n[nH]2)C3CCN(Cc4ccc(cc4)-c5nc6ncccc6cc5-c7ccccc7)CC3,,Row996,49,0.1934343576431274,out,6
783,Row846,Row1164,CHEMBL505848,,0,680.86,21,IC50,=,35.0,nM,CN(C)CCN1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ncccn8)cc5,,,CHEMBL947433,Inhibition of Akt1 by cellular assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN(C)CCN1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ncccn8)cc5,,Row1163,23,0.1770482957363128,out,6
784,Row848,Row1935,CHEMBL1081296,,0,429.47,28,IC50,=,35.0,nM,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2ncc(s2)-c3cc4ncncc4cc3,,,CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154944,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2ncc(s2)-c3cc4ncncc4cc3,,Row240,47,0.1180499866604805,out,6
785,Row849,Row2936,CHEMBL4545734,,0,539.84,1p,IC50,=,35.3,nM,Cn1ncc(Cl)c1-c2cc(sc2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)c(c4)C(F)(F)F,,,CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4304777,1,Scientific Literature,Eur J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(sc2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)c(c4)C(F)(F)F,,Row1315,22,0.0942787826061248,out,6
786,Row851,Row3370,CHEMBL4217489,,0,420.52,10b,IC50,=,35.6,nM,COc1ccc(cc1)C2(CCNCC2)C(=O)N3CCN(CC3)c4ncnc5[nH]ccc45,,,CHEMBL4192490,Inhibition of AKT1 (unknown origin) using biotinylated-STK as substrate after 45 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4190265,1,Scientific Literature,Eur J Med Chem,2017.0,COc1ccc(cc1)C2(CCNCC2)C(=O)N3CCN(CC3)c4ncnc5[nH]ccc45,,Row3980,30,0.1398062705993652,out,6
787,Row852,Row3534,CHEMBL4465905,,0,463.76,D3,IC50,=,35.6,nM,Cn1ncc(Br)c1-c2cc(oc2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Br)c1-c2cc(oc2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,Row39,44,0.0868002325296402,out,6
788,Row855,Row1495,CHEMBL503270,,0,694.89,22,IC50,=,37.0,nM,CN(C)CCN1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8cnc(N)cc8)cc5,,,CHEMBL947433,Inhibition of Akt1 by cellular assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN(C)CCN1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8cnc(N)cc8)cc5,,Row1163,23,0.1830669194459915,out,6
789,Row856,Row1496,CHEMBL455226,,0,653.79,17,IC50,=,37.0,nM,OCCN1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ncccn8)cc5,,,CHEMBL947433,Inhibition of Akt1 by cellular assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,OCCN1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ncccn8)cc5,,Row1163,23,0.1828411519527435,out,6
790,Row857,Row2912,CHEMBL3928144,,0,489.63,BDBM182631,IC50,=,37.0,nM,CC(C)c1cc(ccn1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,330072.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(C)c1cc(ccn1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,Row1206,41,0.1279228627681732,out,6
791,Row858,Row1786,CHEMBL1760762,,0,581.78,5,IC50,=,38.0,nM,CCOCCN(C[C@@H](O)CN1CC2(CN(CC2)c3ncnc4ccccc43)CCC1)S(=O)(=O)c5c(C)cccc5C,,,CHEMBL1763788,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759869,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CCOCCN(C[C@@H](O)CN1CC2(CN(CC2)c3ncnc4ccccc43)CCC1)S(=O)(=O)c5c(C)cccc5C,,Row2370,39,0.1123191714286804,out,6
792,Row859,Row1865,CHEMBL450772,,0,657.8,8,IC50,=,38.0,nM,O=S1(=O)CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,O=S1(=O)CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,Row1163,23,0.1855194717645645,out,6
793,Row860,Row2171,CHEMBL3896152,,0,509.94,BDBM182448,IC50,=,38.0,nM,Nc1ncnc(c1Cl)N2CCC(CC2)c3nc(cn3CC4CCN4)-c5cc(c(F)cc5)C(F)(F)F,,329889.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Cl)N2CCC(CC2)c3nc(cn3CC4CCN4)-c5cc(c(F)cc5)C(F)(F)F,,Row643,24,0.117070235311985,out,6
794,Row861,Row2447,CHEMBL1171672,,0,368.42,29,IC50,=,38.0,nM,Cc1c[nH]c2ncnc(c21)N3CC(N)(CNC(=O)c4cc(F)ccc4)CC3,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,Cc1c[nH]c2ncnc(c21)N3CC(N)(CNC(=O)c4cc(F)ccc4)CC3,,Row2553,9,0.1382152736186981,out,6
795,Row862,Row2702,CHEMBL1076553,,0,382.47,15,IC50,=,38.0,nM,Cc1n[nH]c2ccc(cc21)-c3nnc(NC[C@@H](N)Cc4cccc(F)c4)s3,,,CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154933,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3nnc(NC[C@@H](N)Cc4cccc(F)c4)s3,,Row1834,53,0.1118725761771202,out,6
796,Row863,Row2883,CHEMBL3544960,AT-13148,1,313.79,AT13148,IC50,=,38.0,nM,NC[C@](O)(c1ccc(cc1)-c2c[nH]nc2)c3ccc(Cl)cc3,,,CHEMBL4022195,Inhibition of recombinant full length human His-tagged AKT1 expressed in baculovirus expression system using ser/thr 6 as substrate after 1 hr by FRET-based Z'-Lyte assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4020778,1,Scientific Literature,Bioorg Med Chem Lett,2017.0,NC[C@](O)(c1ccc(cc1)-c2c[nH]nc2)c3ccc(Cl)cc3,,Row2632,65,0.1162545010447502,out,6
797,Row864,Row2958,CHEMBL503810,,0,667.82,18,IC50,=,38.0,nM,Nc1ccc(cn1)-c2[nH]c(nn2)C3CCN(Cc4ccc(cc4)-c5nc6nc(ncc6cc5-c7ccccc7)N8CCN(CCO)CC8)CC3,,,CHEMBL947433,Inhibition of Akt1 by cellular assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Nc1ccc(cn1)-c2[nH]c(nn2)C3CCN(Cc4ccc(cc4)-c5nc6nc(ncc6cc5-c7ccccc7)N8CCN(CCO)CC8)CC3,,Row1163,23,0.1890264898538589,out,6
798,Row865,Row3450,CHEMBL3112595,,0,339.87,22c,IC50,=,38.0,nM,CC(C)(C)NC(c1ccc(Cl)cc1)c2ccc(cc2)-c3c[nH]nc3,,,CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3112393,1,Scientific Literature,Eur. J. Med. Chem.,2014.0,CC(C)(C)NC(c1ccc(Cl)cc1)c2ccc(cc2)-c3c[nH]nc3,,Row2632,65,0.0926793739199638,out,6
799,Row867,Row523,CHEMBL227051,,0,400.53,13aa,IC50,=,39.0,nM,Cc1cc(C)c(C[C@H](N)COc2cncc(c2)-c3cc4c(cc3)[nH]nc4C)c(C)c1,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1cc(C)c(C[C@H](N)COc2cncc(c2)-c3cc4c(cc3)[nH]nc4C)c(C)c1,,Row1976,11,0.108741819858551,out,6
800,Row868,Row1429,CHEMBL572417,,0,401.51,73,IC50,=,39.0,nM,Cc1cc(C)c(C[C@H](N)COc2cncc(c2)-c3cc4c(cn3)[nH]nc4C)c(C)c1,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Cc1cc(C)c(C[C@H](N)COc2cncc(c2)-c3cc4c(cn3)[nH]nc4C)c(C)c1,,Row535,12,0.08872801810503,out,6
801,Row869,Row3602,CHEMBL1823649,,0,444.36,22,IC50,=,39.0,nM,COc1cc2cnccc2cc1C(=O)NC(C3CCNCC3)c4ccc(Cl)c(Cl)c4,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,COc1cc2cnccc2cc1C(=O)NC(C3CCNCC3)c4ccc(Cl)c(Cl)c4,,Row3192,40,0.1048468351364135,out,6
802,Row870,Row263,CHEMBL1076581,,0,419.34,29,IC50,=,40.0,nM,N[C@@H](Cc1ccc(Cl)cc1Cl)CNc2nnc(s2)-c3cc4cn[nH]c4cc3,,,CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154933,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@@H](Cc1ccc(Cl)cc1Cl)CNc2nnc(s2)-c3cc4cn[nH]c4cc3,,Row1834,53,0.0943266674876213,out,6
803,Row871,Row530,CHEMBL1081105,,0,411.43,18,IC50,=,40.0,nM,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CCc2cc(no2)-c3cc4ccncc4cc3,,,CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154944,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CCc2cc(no2)-c3cc4ccncc4cc3,,Row240,47,0.1079770475625991,out,6
804,Row872,Row1028,CHEMBL1823641,,0,397.88,13,IC50,=,40.0,nM,O=C(NC(C1CCNCC1)c2cc(F)c(Cl)cc2)c3ccc4cnccc4c3,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,O=C(NC(C1CCNCC1)c2cc(F)c(Cl)cc2)c3ccc4cnccc4c3,,Row3192,40,0.1071007177233696,out,6
805,Row873,Row1161,CHEMBL512148,,0,441.35,27,IC50,=,40.0,nM,NC(CNC(=O)c1cc(Br)c(s1)-c2ccnc3[nH]ccc23)c4ccccc4,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NC(CNC(=O)c1cc(Br)c(s1)-c2ccnc3[nH]ccc23)c4ccccc4,,Row1178,46,0.1364676207304,out,6
806,Row874,Row1880,CHEMBL512672,,0,362.46,10,IC50,=,40.0,nM,NCC(NC(=O)c1cc(cs1)-c2ccnc3[nH]ccc23)c4ccccc4,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NCC(NC(=O)c1cc(cs1)-c2ccnc3[nH]ccc23)c4ccccc4,,Row1178,46,0.127664715051651,out,6
807,Row875,Row2368,CHEMBL1761085,,0,532.7,"23, 1:1diastereomeric mixture",IC50,=,40.0,nM,CCOCCN(C[C@@H](O)CN1CC2(CCC1)CCc3cc(O)ccc3O2)S(=O)(=O)c4c(C)cccc4C,,,CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759945,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CCOCCN(C[C@@H](O)CN1CC2(CCC1)CCc3cc(O)ccc3O2)S(=O)(=O)c4c(C)cccc4C,,Row2370,39,0.1090212762355804,out,6
808,Row876,Row3192,CHEMBL1823643,,0,414.34,"15,17,26",IC50,=,40.0,nM,O=C(NC(C1CCNCC1)c2ccc(Cl)c(Cl)c2)c3ccc4cnccc4c3,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,O=C(NC(C1CCNCC1)c2ccc(Cl)c(Cl)c2)c3ccc4cnccc4c3,,Row3192,40,0.0999082773923873,out,6
809,Row877,Row3935,CHEMBL4583911,,0,498.21,D8,IC50,=,40.0,nM,Cn1ncc(Cl)c1-c2oc(cc2Br)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2oc(cc2Br)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,Row39,44,0.0888003706932067,out,6
810,Row878,Row722,CHEMBL577567,,0,519.65,123,IC50,=,40.3,nM,CCc1c(C)[nH]c(C2C(=O)Nc3ccc(cc32)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65)c1C,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,CCc1c(C)[nH]c(C2C(=O)Nc3ccc(cc32)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65)c1C,,Row124,3,0.1190832257270813,out,6
811,Row879,Row1750,CHEMBL380004,,0,575.76,11l,IC50,=,40.3,nM,CCc1c(C)[nH]c(CC(C)(C)C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc56)c1C,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CCc1c(C)[nH]c(CC(C)(C)C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc56)c1C,,Row236,4,0.1143211647868156,out,6
812,Row880,Row2279,CHEMBL207217,,0,503.52,9c,IC50,=,41.0,nM,C([C@@H](COc1cc(cnc1)-c2ccc3nonc3c2)Nc4ccc5nonc5c4)c6c[nH]c7ccccc67,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,C([C@@H](COc1cc(cnc1)-c2ccc3nonc3c2)Nc4ccc5nonc5c4)c6c[nH]c7ccccc67,,Row837,29,0.1050983220338821,out,6
813,Row882,Row2595,CHEMBL247619,,0,509.42,40,IC50,=,41.0,nM,CNC(=O)Nc1ccc(CNc2c(cnn2C)C(=O)Nc3ccc4OC(F)(F)C(F)(F)Oc4c3)cn1,,,CHEMBL922918,Inhibition of pAkt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140657,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CNC(=O)Nc1ccc(CNc2c(cnn2C)C(=O)Nc3ccc4OC(F)(F)C(F)(F)Oc4c3)cn1,,Row3848,57,0.1076372936367988,out,6
814,Row883,Row2633,CHEMBL2325984,,0,460.97,37,IC50,=,41.0,nM,NC1(CCN(CC1)c2ncnc3[nH]ccc23)C(=O)NC(c4ccccc4)c5ccc(Cl)cc5,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,NC1(CCN(CC1)c2ncnc3[nH]ccc23)C(=O)NC(c4ccccc4)c5ccc(Cl)cc5,,Row3863,35,0.1638893187046051,out,6
815,Row884,Row2780,CHEMBL1760758,,0,598.81,3a,IC50,=,41.0,nM,CCOCCN(C[C@@H](O)CN1CC2(CCC1)CCN(CC2)c3ncnc4[nH]cc(C)c34)S(=O)(=O)c5c(C)cccc5C,,,CHEMBL1763788,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759869,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CCOCCN(C[C@@H](O)CN1CC2(CCC1)CCN(CC2)c3ncnc4[nH]cc(C)c34)S(=O)(=O)c5c(C)cccc5C,,Row2370,39,0.1014040261507034,out,6
816,Row885,Row776,CHEMBL227325,,0,402.45,13ao,IC50,=,42.0,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc5OCOc5cc4,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc5OCOc5cc4,,Row1976,11,0.1166915073990821,out,6
817,Row886,Row914,CHEMBL259833,,0,274.72,8b,IC50,=,42.0,nM,Clc1c[nH]c2ncnc(c21)N3Cc4nc[nH]c4CC3,,,CHEMBL936668,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143084,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Clc1c[nH]c2ncnc(c21)N3Cc4nc[nH]c4CC3,,Row1872,62,0.07426618039608,out,6
818,Row887,Row1807,CHEMBL1632379,,0,458.03,28,IC50,=,42.0,nM,C[C@@H]1SCc2ncnc(c21)N3CCN(CC3)C(=O)C(Cc4ccc(Cl)cc4)C5(N)CC5,,,CHEMBL1632819,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1629708,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,C[C@@H]1SCc2ncnc(c21)N3CCN(CC3)C(=O)C(Cc4ccc(Cl)cc4)C5(N)CC5,,Row3589,19,0.1232397258281707,out,6
819,Row888,Row2025,CHEMBL2016771,,0,519.88,2b,IC50,=,42.0,nM,Cc1c(cc(Cl)cc1N2CCN(CC2)c3ncnc4[nH]nc(Br)c34)NCCN5CCCC5,,,CHEMBL2020583,Inhibition of AKT1 after 3 hrs by luciferase based chemiluminescence assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2016487,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2012.0,Cc1c(cc(Cl)cc1N2CCN(CC2)c3ncnc4[nH]nc(Br)c34)NCCN5CCCC5,,Row2025,21,0.0946193784475326,out,6
820,Row889,Row2033,CHEMBL3946371,,0,494.62,BDBM182684,IC50,=,42.0,nM,CN(CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4cc(C)c(F)cc4)C(C)C,,330125.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4cc(C)c(F)cc4)C(C)C,,Row1206,41,0.1156269535422325,out,6
821,Row890,Row3371,CHEMBL2325731,,0,469.98,54,IC50,=,42.0,nM,CN(C)C(=O)CC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc32)c4ccc(Cl)cc4,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,CN(C)C(=O)CC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc32)c4ccc(Cl)cc4,,Row3863,35,0.1275650262832641,out,6
822,Row891,Row216,CHEMBL1257629,,0,410.91,29,IC50,=,43.0,nM,Nc1ccc2ncnc(c2c1)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Nc1ccc2ncnc(c2c1)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,Row875,55,0.0985585749149322,out,6
823,Row893,Row450,CHEMBL3987000,,0,623.66,BDBM182521,IC50,=,43.0,nM,COC(=O)c1ccc(cc1)-c2c(N)ncnc2N3CCC(CC3)c4nc(cn4CCN5CCC5)-c6ccc(F)c(c6)C(F)(F)F,,329962.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,COC(=O)c1ccc(cc1)-c2c(N)ncnc2N3CCC(CC3)c4nc(cn4CCN5CCC5)-c6ccc(F)c(c6)C(F)(F)F,,Row2044,43,0.1208594515919685,out,6
824,Row895,Row1896,CHEMBL454210,,0,636.81,13,IC50,=,43.0,nM,C[C@@H]1CN[C@@H](C)CN1c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,C[C@@H]1CN[C@@H](C)CN1c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,Row1163,23,0.1781105995178222,out,6
825,Row896,Row2303,CHEMBL3903026,,0,543.61,BDBM182384,IC50,=,43.0,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3/C=C/C4CC4)-c5cc(c(F)cc5)C(F)(F)F,,329825.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3/C=C/C4CC4)-c5cc(c(F)cc5)C(F)(F)F,,Row2164,32,0.110792689025402,out,6
826,Row897,Row2839,CHEMBL3895298,,0,554.6,BDBM182368,IC50,=,43.0,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4ccncc4)-c5cc(c(F)cc5)C(F)(F)F,,329809.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4ccncc4)-c5cc(c(F)cc5)C(F)(F)F,,Row2164,32,0.1199589073657989,out,6
827,Row898,Row760,CHEMBL475400,,0,270.24,(+)-11a,IC50,=,44.0,nM,O=C1C[C@H]2OCC3=C([C@H]2O1)C(=O)c4ccccc4C3=O,,,CHEMBL1018804,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153413,1,Scientific Literature,J. Med. Chem.,2009.0,O=C1C[C@H]2OCC3=C([C@H]2O1)C(=O)c4ccccc4C3=O,,Row2387,28,0.1192060187458992,out,6
828,Row899,Row1995,CHEMBL1171501,,0,368.42,28,IC50,=,44.0,nM,Cc1c[nH]c2ncnc(c21)N3CC(N)(CNC(=O)c4ccccc4F)CC3,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,Cc1c[nH]c2ncnc(c21)N3CC(N)(CNC(=O)c4ccccc4F)CC3,,Row2553,9,0.1408095359802246,out,6
829,Row900,Row2384,CHEMBL259982,,0,522.66,7c,IC50,=,44.0,nM,C(c1ccc(cc1)-c2nc3ncccc3cc2-c4ccccc4)N5CCC(CC5)c6cc([nH]n6)-c7ccccn7,,,CHEMBL937417,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143097,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,C(c1ccc(cc1)-c2nc3ncccc3cc2-c4ccccc4)N5CCC(CC5)c6cc([nH]n6)-c7ccccn7,,Row996,49,0.197500854730606,out,6
830,Row902,Row1718,CHEMBL260670,,0,523.64,13,IC50,=,45.0,nM,C(c1ccc(cc1)-c2nc3ncccc3cc2-c4ccccc4)N5CCC(CC5)c6n[nH]c(n6)-c7ccccn7,,,CHEMBL937417,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143097,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,C(c1ccc(cc1)-c2nc3ncccc3cc2-c4ccccc4)N5CCC(CC5)c6n[nH]c(n6)-c7ccccn7,,Row996,49,0.2147196531295776,out,6
831,Row903,Row3136,CHEMBL450545,,0,636.81,9,IC50,=,45.0,nM,C[C@@H]1CN(C[C@H](C)N1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,C[C@@H]1CN(C[C@H](C)N1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,Row1163,23,0.185134544968605,out,6
832,Row904,Row220,CHEMBL1258101,,0,394.91,36,IC50,=,46.0,nM,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ccnc4ccccc34,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ccnc4ccccc34,,Row875,55,0.1484173983335495,out,6
833,Row905,Row1987,CHEMBL252455,,0,485.64,12k,IC50,=,46.0,nM,CSc1ncc2cc(c(nc2n1)-c3ccc(CNCCc4nnc(N)s4)cc3)-c5ccccc5,,,CHEMBL928491,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141509,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CSc1ncc2cc(c(nc2n1)-c3ccc(CNCCc4nnc(N)s4)cc3)-c5ccccc5,,Row3742,50,0.1858852952718734,out,6
834,Row906,Row2078,CHEMBL3969229,,0,463.61,BDBM182530,IC50,=,46.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)ccc5,,329971.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)ccc5,,Row3753,7,0.1397263258695602,out,6
835,Row907,Row2753,CHEMBL4467970,,0,446.98,1h,IC50,=,46.9,nM,Cn1ncc(C=C)c1-c2ccc(s2)C(=O)N[C@@H]3CNCC[C@H]3c4cc(F)ccc4,,,CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4304777,1,Scientific Literature,Eur J Med Chem,2019.0,Cn1ncc(C=C)c1-c2ccc(s2)C(=O)N[C@@H]3CNCC[C@H]3c4cc(F)ccc4,,Row1315,22,0.1047929376363754,out,6
836,Row908,Row245,CHEMBL1080891,,0,398.92,13,IC50,=,47.0,nM,Cc1n[nH]c2ccc(cc21)-c3nnc(NC[C@@H](N)Cc4ccccc4Cl)s3,,,CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154933,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3nnc(NC[C@@H](N)Cc4ccccc4Cl)s3,,Row1834,53,0.1202911213040351,out,6
837,Row909,Row723,CHEMBL226798,,0,417.51,13aw,IC50,=,47.0,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(ccc4)OCCN,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(ccc4)OCCN,,Row1976,11,0.1101438999176025,out,6
838,Row910,Row2100,CHEMBL574979,,0,418.5,79,IC50,=,47.0,nM,Cc1n[nH]c2cnc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(ccc4)OCCN,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Cc1n[nH]c2cnc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(ccc4)OCCN,,Row535,12,0.1009030416607856,out,6
839,Row912,Row3466,CHEMBL3897830,,0,439.5,BDBM182692,IC50,=,47.0,nM,Cc1cc(ccc1F)-c2cn(CCO)c(n2)C3CCN(CC3)c4ncnc(N)c4C(N)=O,,330133.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCO)c(n2)C3CCN(CC3)c4ncnc(N)c4C(N)=O,,Row1206,41,0.121844083070755,out,6
840,Row913,Row801,CHEMBL3684500,,0,566.67,BDBM103214,IC50,=,48.0,nM,O=c1[nH]c(cn1C2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2)-c8ccccc8,,220936.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=c1[nH]c(cn1C2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2)-c8ccccc8,,Row2452,66,0.1720209121704101,out,6
841,Row914,Row2076,CHEMBL3908761,,0,508.65,BDBM182650,IC50,=,48.0,nM,Cc1cc(ccc1F)-c2cn(CCN(CC)C(C)C)c(n2)C3CCN(CC3)c4ncnc(N)c4C(N)=O,,330091.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCN(CC)C(C)C)c(n2)C3CCN(CC3)c4ncnc(N)c4C(N)=O,,Row1206,41,0.116722285747528,out,6
842,Row915,Row4014,CHEMBL3965676,,0,460.56,BDBM182619,IC50,=,48.0,nM,Cc1ccc(cc1F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,330060.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1ccc(cc1F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,Row3990,26,0.1238103210926055,out,6
843,Row916,Row596,CHEMBL4554198,,0,449.0,1i,IC50,=,48.9,nM,CCc1cnn(C)c1-c2ccc(s2)C(=O)N[C@@H]3CNCC[C@H]3c4cc(F)ccc4,,,CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4304777,1,Scientific Literature,Eur J Med Chem,2019.0,CCc1cnn(C)c1-c2ccc(s2)C(=O)N[C@@H]3CNCC[C@H]3c4cc(F)ccc4,,Row1315,22,0.1080694794654846,out,6
844,Row918,Row3057,CHEMBL376792,,0,473.32,13u,IC50,=,49.0,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4c(Br)cc(F)cc4F,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4c(Br)cc(F)cc4F,,Row1976,11,0.1145893931388855,out,6
845,Row919,Row3997,CHEMBL3962465,,0,492.6,BDBM182405,IC50,=,49.0,nM,CCc1c(ncnc1N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(c(F)cc5)C(N)=O,,329846.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(ncnc1N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(c(F)cc5)C(N)=O,,Row3753,7,0.1240045055747032,out,6
846,Row920,Row354,CHEMBL605732,,0,434.54,9a,IC50,=,50.0,nM,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4ccccc4)OC[C@@H](N)Cc5ccccc5,,,CHEMBL1071952,Inhibition of full length AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4ccccc4)OC[C@@H](N)Cc5ccccc5,,Row1976,11,0.1772932857275009,out,6
847,Row921,Row1523,CHEMBL493875,,0,371.4,12d,IC50,=,50.0,nM,CCn1c2c(cnc(C#CCCO)c2nc1-c3nonc3N)OCCCN,,,CHEMBL1028090,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140130,1,Scientific Literature,J. Med. Chem.,2008.0,CCn1c2c(cnc(C#CCCO)c2nc1-c3nonc3N)OCCCN,,Row2429,38,0.1069323122501373,out,6
848,Row922,Row2120,CHEMBL470200,,0,438.56,23,IC50,=,50.0,nM,NCC(NC(=O)c1cc(c(s1)-c2ccnc3[nH]ccc23)-c4ccccc4)c5ccccc5,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NCC(NC(=O)c1cc(c(s1)-c2ccnc3[nH]ccc23)-c4ccccc4)c5ccccc5,,Row1178,46,0.1526755094528198,out,6
849,Row923,Row3721,CHEMBL604060,,0,440.57,9l,IC50,=,50.0,nM,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4cscc4)OC[C@@H](N)Cc5ccccc5,,,CHEMBL1071952,Inhibition of full length AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4cscc4)OC[C@@H](N)Cc5ccccc5,,Row1976,11,0.1619998067617416,out,6
850,Row924,Row1070,CHEMBL4540052,,0,370.84,C2,IC50,=,50.3,nM,O=C(N[C@@H]1CNCC[C@H]1c2ccc(Cl)cc2)c3ccc(o3)-c4c[nH]nc4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,O=C(N[C@@H]1CNCC[C@H]1c2ccc(Cl)cc2)c3ccc(o3)-c4c[nH]nc4,,Row39,44,0.0792202726006507,out,6
851,Row925,Row549,CHEMBL388729,,0,398.47,9d,IC50,=,51.0,nM,Nc1cc2[nH]ncc2cc1-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,,CHEMBL903964,Inhibition of Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142911,1,Scientific Literature,Bioorg. Med. Chem.,2007.0,Nc1cc2[nH]ncc2cc1-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,Row1726,2,0.1124319657683372,out,6
852,Row926,Row1795,CHEMBL1258898,,0,430.34,13,IC50,=,51.0,nM,N[C@H](Cc1ccc(Cl)c(Cl)c1)C(=O)N2CCN(CC2)c3ncnc4ccccc43,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccc(Cl)c(Cl)c1)C(=O)N2CCN(CC2)c3ncnc4ccccc43,,Row875,55,0.1250916272401809,out,6
853,Row927,Row3828,CHEMBL4533641,,0,605.38,"A13; (3R,4R)-A6",IC50,=,51.2,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@H]3CNCC[C@@H]3c4ccc(F)c(F)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@H]3CNCC[C@@H]3c4ccc(F)c(F)c4,,Row39,44,0.0945671945810318,out,6
854,Row928,Row4013,CHEMBL3899565,,0,504.54,BDBM182583,IC50,=,51.5,nM,Nc1ncnc(c1N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,330024.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row643,24,0.122704841196537,out,6
855,Row929,Row3762,CHEMBL4292059,,0,549.27,10k,IC50,=,51.9,nM,O=C(N1CCN(CC1)c2ncnc3[nH]nc(Br)c32)C4(CCNCC4)c5ccc(Br)cc5,,,CHEMBL4259693,Inhibition of AKT1 (unknown origin) using biotin-labelled STK as substrate measured after 45 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4257535,1,Scientific Literature,MedChemComm,2018.0,O=C(N1CCN(CC1)c2ncnc3[nH]nc(Br)c32)C4(CCNCC4)c5ccc(Br)cc5,,Row3980,30,0.1296531111001968,out,6
856,Row930,Row931,CHEMBL1632370,,0,435.94,18,IC50,=,52.0,nM,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4CS(=O)(=O)Cc43,,,CHEMBL1632819,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1629708,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4CS(=O)(=O)Cc43,,Row875,55,0.0943487808108329,out,6
857,Row931,Row1579,CHEMBL508098,,0,623.77,34,IC50,=,52.0,nM,CN1CCN(CC1)c2ccc3nc(c(nc3n2)-c4ccc(CN5CCC(CC5)c6[nH]c(nn6)-c7ncccn7)cc4)-c8ccccc8,,,CHEMBL947433,Inhibition of Akt1 by cellular assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN1CCN(CC1)c2ccc3nc(c(nc3n2)-c4ccc(CN5CCC(CC5)c6[nH]c(nn6)-c7ncccn7)cc4)-c8ccccc8,,Row1163,23,0.1663443595170974,out,6
858,Row933,Row1233,CHEMBL577375,,0,426.52,111,IC50,=,52.7,nM,CCC1c2cc(ccc2NC1=O)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc54,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,CCC1c2cc(ccc2NC1=O)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc54,,Row124,3,0.1280088424682617,out,6
859,Row934,Row3459,CHEMBL211932,,0,609.73,9s,IC50,=,52.7,nM,CC(C)=C1c2cc(ccc2NC1=O)-c3cncc(c3)OC[C@H](Cc4c[nH]c5ccccc45)Nc6cc7C(C(=O)Nc7cc6)=C(C)C,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC(C)=C1c2cc(ccc2NC1=O)-c3cncc(c3)OC[C@H](Cc4c[nH]c5ccccc45)Nc6cc7C(C(=O)Nc7cc6)=C(C)C,,Row837,29,0.1142036691308021,out,6
860,Row935,Row1436,CHEMBL2012702,,0,493.84,2a,IC50,=,53.0,nM,CN(C)CCNc1cc(Cl)cc(c1C)N2CCN(CC2)c3ncnc4[nH]nc(Br)c34,,,CHEMBL2020583,Inhibition of AKT1 after 3 hrs by luciferase based chemiluminescence assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2016487,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2012.0,CN(C)CCNc1cc(Cl)cc(c1C)N2CCN(CC2)c3ncnc4[nH]nc(Br)c34,,Row2025,21,0.0843899399042129,out,6
861,Row936,Row2243,CHEMBL3684358,,0,474.48,BDBM103070,IC50,=,53.0,nM,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6cc7OCOc7cc6,,220792.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6cc7OCOc7cc6,,Row2783,67,0.1491136699914932,out,6
862,Row938,Row2006,CHEMBL1257511,,0,409.92,27,IC50,=,54.0,nM,Cc1cc2c(cc1)ncnc2N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1cc2c(cc1)ncnc2N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,Row875,55,0.100247748196125,out,6
863,Row939,Row1568,CHEMBL180058,,0,593.7,16f,IC50,=,55.0,nM,Cn1nc(nn1)-c2cc3nc(c(nc3cc2)-c4ccccc4)-c5ccc(CN6CCC(CC6)n7c(O)nc8ccccc78)cc5,,,CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141888,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,Cn1nc(nn1)-c2cc3nc(c(nc3cc2)-c4ccccc4)-c5ccc(CN6CCC(CC6)n7c(O)nc8ccccc78)cc5,,Row31,68,0.2006154954433441,out,6
864,Row941,Row2838,CHEMBL3976090,,0,494.62,BDBM182648,IC50,=,55.0,nM,Cc1cc(ccc1F)-c2cn(CCN(CC)CC)c(n2)C3CCN(CC3)c4ncnc(N)c4C(N)=O,,330089.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCN(CC)CC)c(n2)C3CCN(CC3)c4ncnc(N)c4C(N)=O,,Row1206,41,0.1323854625225067,out,6
865,Row942,Row156,CHEMBL378211,,0,494.6,10x,IC50,=,56.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5cc(C#Cc6ccccc6)ncc5cc4,,,CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1147830,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5cc(C#Cc6ccccc6)ncc5cc4,,Row1996,15,0.1348625868558883,out,6
866,Row943,Row640,CHEMBL3974777,,0,493.63,BDBM182698,IC50,=,56.0,nM,Cc1cc(ccc1F)-c2cn(CC3CN(CO)C3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(C)C,,330139.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CC3CN(CO)C3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(C)C,,Row3798,5,0.1119288280606269,out,6
867,Row944,Row1153,CHEMBL4172716,,0,479.5,12a,IC50,=,56.0,nM,Cc1nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc(c1C(=O)OC)-c5ccccc5,,,CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4130433,1,Scientific Literature,Eur J Med Chem,2017.0,Cc1nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc(c1C(=O)OC)-c5ccccc5,,Row2772,33,0.1496939659118652,out,6
868,Row945,Row1721,CHEMBL521823,,0,343.39,7,IC50,=,56.0,nM,CCn1c2c(cncc2nc1-c3nonc3N)OCC4CCNCC4,,,CHEMBL1028090,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140130,1,Scientific Literature,J. Med. Chem.,2008.0,CCn1c2c(cncc2nc1-c3nonc3N)OCC4CCNCC4,,Row1117,69,0.1273676306009292,out,6
869,Row946,Row2555,CHEMBL1173384,"N-((3-AMINO-1-(5-METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PYRROLIDIN-3-YL)METHYL)FORMAMIDE (RACEMIC)",0,274.33,"19b, enantiomer-2",IC50,=,56.0,nM,Cc1c[nH]c2ncnc(c21)N3CC(N)(CNC=O)CC3,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,Cc1c[nH]c2ncnc(c21)N3CC(N)(CNC=O)CC3,,Row2553,9,0.1163643524050712,out,6
870,Row947,Row3386,CHEMBL2016885,,0,529.49,5a,IC50,=,56.0,nM,Cc1c(cc(cc1N2CCN(CC2)c3ncnc4[nH]nc(Br)c34)OCC)NCCN5CCCC5,,,CHEMBL2020583,Inhibition of AKT1 after 3 hrs by luciferase based chemiluminescence assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2016487,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2012.0,Cc1c(cc(cc1N2CCN(CC2)c3ncnc4[nH]nc(Br)c34)OCC)NCCN5CCCC5,,Row2025,21,0.0978373065590858,out,6
871,Row948,Row2343,CHEMBL475401,,0,352.37,(+)-anti-11b,IC50,=,57.0,nM,O=C1C=2[C@H](O[C@@H]3CC(=O)O[C@@H]3C2C(=O)c4ccccc14)c5cccs5,,,CHEMBL1018804,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153413,1,Scientific Literature,J. Med. Chem.,2009.0,O=C1C=2[C@H](O[C@@H]3CC(=O)O[C@@H]3C2C(=O)c4ccccc14)c5cccs5,,Row2387,28,0.1140245720744133,out,6
872,Row949,Row2908,CHEMBL210333,,0,460.54,10t,IC50,=,57.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5cc(ncc5cc4)-c6ccco6,,,CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1147830,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5cc(ncc5cc4)-c6ccco6,,Row1996,15,0.1256815195083618,out,6
873,Row950,Row3046,CHEMBL226626,,0,494.44,13ae,IC50,=,57.0,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(cc(c4)C(F)(F)F)C(F)(F)F,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(cc(c4)C(F)(F)F)C(F)(F)F,,Row1976,11,0.1042107492685318,out,6
874,Row951,Row1180,CHEMBL4528834,,0,397.43,D23,IC50,=,57.7,nM,Cn1nccc1-c2ccc(cn2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(F)c(F)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1nccc1-c2ccc(cn2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(F)c(F)c4,,Row1315,22,0.097437135875225,out,6
875,Row954,Row427,CHEMBL258844,,0,551.65,1,IC50,=,58.0,nM,O=c1[nH]c2ccccc2n1C3CCN(Cc4ccc(cc4)-c5nc6cc7[nH]cnc7cc6nc5-c8ccccc8)CC3,,,CHEMBL948032,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,O=c1[nH]c2ccccc2n1C3CCN(Cc4ccc(cc4)-c5nc6cc7[nH]cnc7cc6nc5-c8ccccc8)CC3,,Row2123,58,0.1906323730945587,out,6
876,Row955,Row1846,CHEMBL1171299,,0,308.77,rac-21,IC50,=,58.0,nM,Cc1c[nH]c2ncnc(c21)N3CC(N)(CNC(=O)Cl)CC3,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,Cc1c[nH]c2ncnc(c21)N3CC(N)(CNC(=O)Cl)CC3,,Row2553,9,0.11744324862957,out,6
877,Row956,Row17,CHEMBL3948379,,0,476.56,BDBM182620,IC50,=,59.0,nM,COc1ccc(cc1F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,330061.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,COc1ccc(cc1F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,Row3990,26,0.1303016394376754,out,6
878,Row958,Row1814,CHEMBL226332,,0,379.85,68,IC50,=,59.0,nM,N[C@@H](Cc1ccccc1)COc2cncc(c2)-c3cc4c(Cl)n[nH]c4cn3,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1ccccc1)COc2cncc(c2)-c3cc4c(Cl)n[nH]c4cn3,,Row535,12,0.1403257399797439,out,6
879,Row960,Row2065,CHEMBL1171485,,0,342.32,22,IC50,=,61.0,nM,Cc1c[nH]c2ncnc(c21)N3CC(N)(CNC(=O)C(F)(F)F)CC3,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,Cc1c[nH]c2ncnc(c21)N3CC(N)(CNC(=O)C(F)(F)F)CC3,,Row2553,9,0.1148801445960998,out,6
880,Row961,Row2260,CHEMBL3941240,,0,487.61,BDBM182641,IC50,=,61.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ncc5)C6CC6,,330082.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ncc5)C6CC6,,Row1206,41,0.1299602687358856,out,6
881,Row962,Row2592,CHEMBL3805228,,0,488.2,25e,IC50,=,61.0,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)NC3(CCNCC3)c4ccc(Cl)c(Cl)c4,,,CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3804794,1,Scientific Literature,Eur. J. Med. Chem.,2016.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)NC3(CCNCC3)c4ccc(Cl)c(Cl)c4,,Row3848,57,0.1406541764736175,out,6
882,Row963,Row3083,CHEMBL1171842,,0,350.43,27,IC50,=,62.0,nM,Cc1c[nH]c2ncnc(c21)N3CC(N)(CNC(=O)c4ccccc4)CC3,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,Cc1c[nH]c2ncnc(c21)N3CC(N)(CNC(=O)c4ccccc4)CC3,,Row2553,9,0.1609624922275543,out,6
883,Row966,Row3681,CHEMBL4455194,,0,450.97,1k,IC50,=,62.2,nM,Cn1ncc(CO)c1-c2ccc(s2)C(=O)N[C@@H]3CNCC[C@H]3c4cc(F)ccc4,,,CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4304777,1,Scientific Literature,Eur J Med Chem,2019.0,Cn1ncc(CO)c1-c2ccc(s2)C(=O)N[C@@H]3CNCC[C@H]3c4cc(F)ccc4,,Row1315,22,0.1060156598687172,out,6
884,Row967,Row727,CHEMBL271091,,0,579.67,2c,IC50,=,63.0,nM,O=c1[nH]c2ccccc2n1C3CCN(Cc4ccc(cc4)-c5nc6ccc(cc6nc5-c7ccccc7)-c8nn[nH]n8)CC3,,,CHEMBL948032,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,O=c1[nH]c2ccccc2n1C3CCN(Cc4ccc(cc4)-c5nc6ccc(cc6nc5-c7ccccc7)-c8nn[nH]n8)CC3,,Row2123,58,0.194807544350624,out,6
885,Row968,Row1201,CHEMBL469357,,0,439.54,24,IC50,=,63.0,nM,NCC(NC(=O)c1cc(c(s1)-c2ccnc3[nH]ccc23)-c4cnccc4)c5ccccc5,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NCC(NC(=O)c1cc(c(s1)-c2ccnc3[nH]ccc23)-c4cnccc4)c5ccccc5,,Row1178,46,0.1522130668163299,out,6
886,Row969,Row1278,CHEMBL252261,,0,529.67,12j,IC50,=,63.0,nM,CSc1nc2nc(-c3ccc(CNCCc4nc([nH]n4)-c5ccccc5)cc3)c(cc2cn1)-c6ccccc6,,,CHEMBL928491,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141509,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CSc1nc2nc(-c3ccc(CNCCc4nc([nH]n4)-c5ccccc5)cc3)c(cc2cn1)-c6ccccc6,,Row3742,50,0.1676489114761352,out,6
887,Row970,Row1405,CHEMBL3973291,,0,453.54,BDBM182542,IC50,=,63.0,nM,Nc1cc(ncn1)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)c(F)cc5,,329983.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1cc(ncn1)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)c(F)cc5,,Row3753,7,0.1336801499128341,out,6
888,Row971,Row2037,CHEMBL470202,,0,428.52,25,IC50,=,63.0,nM,NCC(NC(=O)c1cc(c(s1)-c2ccnc3[nH]ccc23)-c4cn[nH]c4)c5ccccc5,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NCC(NC(=O)c1cc(c(s1)-c2ccnc3[nH]ccc23)-c4cn[nH]c4)c5ccccc5,,Row1178,46,0.1332160085439682,out,6
889,Row972,Row2263,CHEMBL596379,,0,486.52,9g,IC50,=,63.0,nM,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4cc(F)cc(F)c4O)OC[C@@H](N)Cc5ccccc5,,,CHEMBL1071952,Inhibition of full length AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4cc(F)cc(F)c4O)OC[C@@H](N)Cc5ccccc5,,Row1976,11,0.1563379317522049,out,6
890,Row973,Row3098,CHEMBL1096636,,0,399.46,22,IC50,=,63.0,nM,CCn1c2cc(nc(C#CC(C)(C)O)c2nc1-c3nonc3N)OCCCCN,,,CHEMBL1109952,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157000,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CCn1c2cc(nc(C#CC(C)(C)O)c2nc1-c3nonc3N)OCCCCN,,Row167,14,0.1055206879973411,out,6
891,Row974,Row3430,CHEMBL574476,,0,579.67,131,IC50,=,63.0,nM,O=c1[nH]c2ccccc2n1C3CCN(Cc4ccc(cc4)-c5nc6ccc(cc6nc5-c7ccccc7)-n8cnnn8)CC3,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,O=c1[nH]c2ccccc2n1C3CCN(Cc4ccc(cc4)-c5nc6ccc(cc6nc5-c7ccccc7)-n8cnnn8)CC3,,Row2123,58,0.1841807663440704,out,6
892,Row975,Row3654,CHEMBL1257403,,0,398.9,57,IC50,=,63.0,nM,NC[C@@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4[nH]ccc34,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,NC[C@@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4[nH]ccc34,,Row854,17,0.0992626920342445,out,6
893,Row976,Row695,CHEMBL3889695,,0,549.59,BDBM182544,IC50,=,64.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4C[C@@H](F)CC4)-c5cc(F)c(cc5)C(F)(F)F,,329985.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4C[C@@H](F)CC4)-c5cc(F)c(cc5)C(F)(F)F,,Row3753,7,0.113382838666439,out,6
894,Row977,Row1094,CHEMBL404553,,0,571.71,13g,IC50,=,64.0,nM,CSc1nc2nc(-c3ccc(CN4CCC(CC4)c5nc(no5)-c6cnccc6)cc3)c(cc2cn1)-c7ccccc7,,,CHEMBL928491,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141509,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CSc1nc2nc(-c3ccc(CN4CCC(CC4)c5nc(no5)-c6cnccc6)cc3)c(cc2cn1)-c7ccccc7,,Row1163,23,0.2000197172164917,out,6
895,Row981,Row3793,CHEMBL3957354,,0,500.5,BDBM182440,IC50,=,64.5,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CC4CNC4)-c5ccc(F)c(c5)C(F)(F)F,,329881.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CC4CNC4)-c5ccc(F)c(c5)C(F)(F)F,,Row3798,5,0.1102497950196266,out,6
896,Row982,Row978,CHEMBL4460688,,0,539.84,1f,IC50,=,65.2,nM,Cn1ncc(Cl)c1-c2ccc(s2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)c(c4)C(F)(F)F,,,CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4304777,1,Scientific Literature,Eur J Med Chem,2019.0,Cn1ncc(Cl)c1-c2ccc(s2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)c(c4)C(F)(F)F,,Row1315,22,0.10368013381958,out,6
897,Row983,Row1413,CHEMBL229748,,0,394.43,13d,IC50,=,65.5,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4c(F)cccc4F,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4c(F)cccc4F,,Row1976,11,0.1282657235860824,out,6
898,Row984,Row3409,CHEMBL573355,,0,395.41,80,IC50,=,65.5,nM,Cc1n[nH]c2cnc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4c(F)cccc4F,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Cc1n[nH]c2cnc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4c(F)cccc4F,,Row535,12,0.1177543476223945,out,6
899,Row985,Row3520,CHEMBL3917944,,0,499.31,BDBM182300,IC50,=,66.0,nM,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3Br)-c4cc(c(F)cc4)C(F)(F)F,,329769.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3Br)-c4cc(c(F)cc4)C(F)(F)F,,Row3758,45,0.11745236068964,out,6
900,Row986,Row3502,CHEMBL4284420,,0,460.37,10f,IC50,=,66.6,nM,O=C(N1CCN(CC1)c2ncnc3[nH]nc(Cl)c32)C4(CCNCC4)c5ccc(Cl)cc5,,,CHEMBL4259693,Inhibition of AKT1 (unknown origin) using biotin-labelled STK as substrate measured after 45 mins by HTRF method,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4257535,1,Scientific Literature,MedChemComm,2018.0,O=C(N1CCN(CC1)c2ncnc3[nH]nc(Cl)c32)C4(CCNCC4)c5ccc(Cl)cc5,,Row3980,30,0.138407751917839,out,6
901,Row987,Row11,CHEMBL3972543,,0,524.09,BDBM182559,IC50,=,67.0,nM,Nc1ncnc(c1C2CCC2)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6cc(F)c(Cl)cc6,,330000.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C2CCC2)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6cc(F)c(Cl)cc6,,Row3753,7,0.1212464794516563,out,6
902,Row989,Row1172,CHEMBL449200,,0,668.81,20,IC50,=,67.0,nM,[O-][n+]1ccc(cc1)-c2[nH]c(nn2)C3CCN(Cc4ccc(cc4)-c5nc6nc(ncc6cc5-c7ccccc7)N8CCN(CCO)CC8)CC3,,,CHEMBL947433,Inhibition of Akt1 by cellular assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,[O-][n+]1ccc(cc1)-c2[nH]c(nn2)C3CCN(Cc4ccc(cc4)-c5nc6nc(ncc6cc5-c7ccccc7)N8CCN(CCO)CC8)CC3,,Row1163,23,0.1759237796068191,out,6
903,Row991,Row2257,CHEMBL3957688,,0,550.56,BDBM182666,IC50,=,67.0,nM,COCCNCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4ccc(F)c(c4)C(F)(F)F,,330107.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,COCCNCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4ccc(F)c(c4)C(F)(F)F,,Row2044,43,0.1111427769064903,out,6
904,Row993,Row2394,CHEMBL2177380,,0,458.01,29,IC50,=,68.0,nM,CC(C)NC[C@@H](C(=O)N1CCN(CC1)c2ncnc3[C@@H](O)C[C@@H](C)c23)c4ccc(Cl)cc4,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,CC(C)NC[C@@H](C(=O)N1CCN(CC1)c2ncnc3[C@@H](O)C[C@@H](C)c23)c4ccc(Cl)cc4,,Row2863,37,0.0928995683789253,out,6
905,Row994,Row3185,CHEMBL1173272,,0,237.69,4,IC50,=,68.0,nM,N[C@H]1CN(CC1)c2ncnc3[nH]cc(Cl)c23,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,N[C@H]1CN(CC1)c2ncnc3[nH]cc(Cl)c23,,Row1872,62,0.0972220301628112,out,6
906,Row995,Row259,CHEMBL203275,,0,425.54,10h,IC50,=,69.0,nM,N[C@H](COc1cc(/C=C/c2cc(NC3CC3)ncc2)cnc1)Cc4c[nH]c5ccccc45,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@H](COc1cc(/C=C/c2cc(NC3CC3)ncc2)cnc1)Cc4c[nH]c5ccccc45,,Row77,56,0.1393564492464065,out,6
907,Row996,Row750,CHEMBL503652,,0,695.88,23,IC50,=,69.0,nM,CN(C)CCN1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8c[nH]c(=O)cc8)cc5,,,CHEMBL947433,Inhibition of Akt1 by cellular assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN(C)CCN1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8c[nH]c(=O)cc8)cc5,,Row1163,23,0.176208421587944,out,6
908,Row997,Row1804,CHEMBL402579,,0,525.66,13b,IC50,=,69.0,nM,Cc1nc2ccccc2n1C3CCN(Cc4ccc(cc4)-c5nc6ncnc(N)c6cc5-c7ccccc7)CC3,,,CHEMBL951085,Inhibition of human recombinant Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142344,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Cc1nc2ccccc2n1C3CCN(Cc4ccc(cc4)-c5nc6ncnc(N)c6cc5-c7ccccc7)CC3,,Row31,68,0.2047539055347442,out,6
909,Row999,Row1382,CHEMBL499961,,0,637.8,35,IC50,=,70.0,nM,CN1CCN(CC1)c2ccc3nc(c(nc3n2)-c4ccc(CN5CCC(CC5)c6[nH]c(nn6)-c7cnc(N)cc7)cc4)-c8ccccc8,,,CHEMBL947433,Inhibition of Akt1 by cellular assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN1CCN(CC1)c2ccc3nc(c(nc3n2)-c4ccc(CN5CCC(CC5)c6[nH]c(nn6)-c7cnc(N)cc7)cc4)-c8ccccc8,,Row1163,23,0.1758846044540405,out,6
910,Row1000,Row2369,CHEMBL1761084,,0,523.65,"22, 1:1diastereomeric mixture",IC50,=,70.0,nM,CCOCCN(C[C@@H](O)CN1CC2(CCC1)CCc3cc(O)ccc3O2)S(=O)(=O)c4c(C)onc4C,,,CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759945,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CCOCCN(C[C@@H](O)CN1CC2(CCC1)CCc3cc(O)ccc3O2)S(=O)(=O)c4c(C)onc4C,,Row2370,39,0.1077024340629577,out,6
911,Row1001,Row2783,CHEMBL3684369,,0,430.47,BDBM103082,IC50,=,70.0,nM,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccccc6,,220804.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccccc6,,Row2783,67,0.1524790525436401,out,6
912,Row1002,Row3603,CHEMBL1823639,,0,379.89,11,IC50,=,70.0,nM,O=C(NC(C1CCNCC1)c2cc(Cl)ccc2)c3ccc4cnccc4c3,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,O=C(NC(C1CCNCC1)c2cc(Cl)ccc2)c3ccc4cnccc4c3,,Row3192,40,0.1114703118801117,out,6
913,Row1003,Row3454,CHEMBL4526242,,0,497.04,1l,IC50,=,70.4,nM,Cn1ncc(-c2ccccc2)c1-c3ccc(s3)C(=O)N[C@@H]4CNCC[C@H]4c5cc(F)ccc5,,,CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4304777,1,Scientific Literature,Eur J Med Chem,2019.0,Cn1ncc(-c2ccccc2)c1-c3ccc(s3)C(=O)N[C@@H]4CNCC[C@H]4c5cc(F)ccc5,,Row1315,22,0.1476995199918747,out,6
914,Row1004,Row604,CHEMBL450266,,0,638.78,15,IC50,=,71.0,nM,CN1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8c[nH]c(=O)cc8)cc5,,,CHEMBL947433,Inhibition of Akt1 by cellular assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8c[nH]c(=O)cc8)cc5,,Row1163,23,0.1863057166337967,out,6
915,Row1006,Row1553,CHEMBL3805163,,0,435.38,24d,IC50,=,71.0,nM,Cn1nccc1-c2csc(c2)C(=O)NC3(CCNCC3)c4ccc(Cl)c(Cl)c4,,,CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3804794,1,Scientific Literature,Eur. J. Med. Chem.,2016.0,Cn1nccc1-c2csc(c2)C(=O)NC3(CCNCC3)c4ccc(Cl)c(Cl)c4,,Row3848,57,0.1310693025588989,out,6
916,Row1007,Row1907,CHEMBL3950518,,0,582.44,BDBM182528,IC50,=,71.0,nM,Nc1ncnc(c1Br)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)c(cc5)C(F)(F)F,,329969.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Br)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)c(cc5)C(F)(F)F,,Row2590,1,0.1221445575356483,out,6
917,Row1008,Row2190,CHEMBL3917257,,0,489.52,BDBM182520,IC50,=,71.0,nM,Nc1cc(ncn1)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,329961.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1cc(ncn1)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row643,24,0.1265358328819275,out,6
918,Row1009,Row2826,CHEMBL3890270,,0,535.57,BDBM182391,IC50,=,71.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CC(F)C4)-c5ccc(F)c(c5)C(F)(F)F,,329832.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CC(F)C4)-c5ccc(F)c(c5)C(F)(F)F,,Row2164,32,0.1120595261454582,out,6
919,Row1010,Row1122,CHEMBL501612,,0,653.79,37,IC50,=,72.0,nM,OCCN1CCN(CC1)c2ccc3nc(c(nc3n2)-c4ccc(CN5CCC(CC5)c6[nH]c(nn6)-c7ncccn7)cc4)-c8ccccc8,,,CHEMBL947433,Inhibition of Akt1 by cellular assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,OCCN1CCN(CC1)c2ccc3nc(c(nc3n2)-c4ccc(CN5CCC(CC5)c6[nH]c(nn6)-c7ncccn7)cc4)-c8ccccc8,,Row1163,23,0.163363516330719,out,6
920,Row1011,Row2316,CHEMBL493359,,0,390.39,(+/-)-anti-11c,IC50,=,72.0,nM,O=C1C[C@H]2O[C@H](COCc3ccccc3)C4=C([C@H]2O1)C(=O)c5ccccc5C4=O,,,CHEMBL1018804,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153413,1,Scientific Literature,J. Med. Chem.,2009.0,O=C1C[C@H]2O[C@H](COCc3ccccc3)C4=C([C@H]2O1)C(=O)c5ccccc5C4=O,,Row2387,28,0.1275771260261535,out,6
921,Row1012,Row3640,CHEMBL4593509,,0,412.9,D22,IC50,=,72.3,nM,Cn1ncc(Cl)c1-c2ccc(cc2)C(=O)N[C@@H]3CNCC[C@H]3c4cc(F)ccc4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2ccc(cc2)C(=O)N[C@@H]3CNCC[C@H]3c4cc(F)ccc4,,Row1315,22,0.1245552375912666,out,6
922,Row1013,Row2194,CHEMBL3684502,,0,484.56,BDBM103216,IC50,=,73.0,nM,O=C(NC1(CCC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)c7ccccc7,,220938.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(NC1(CCC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)c7ccccc7,,Row2783,67,0.2323143780231475,out,6
923,Row1014,Row2923,CHEMBL4445690,,0,475.34,D21,IC50,=,73.5,nM,Cn1ncc(Br)c1-c2ccc(cc2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(F)c(F)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Br)c1-c2ccc(cc2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(F)c(F)c4,,Row1315,22,0.1141910478472709,out,6
924,Row1015,Row935,CHEMBL2012703,,0,482.94,15,IC50,=,74.0,nM,CN(C)CCNc1cc(Cl)cc(c1C)N2CCN(CC2)c3ncnc4[nH]nc(c34)C(F)(F)F,,,CHEMBL2014740,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2010702,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2012.0,CN(C)CCNc1cc(Cl)cc(c1C)N2CCN(CC2)c3ncnc4[nH]nc(c34)C(F)(F)F,,Row2025,21,0.0737726017832756,out,6
925,Row1016,Row2119,CHEMBL1258551,,0,375.48,8,IC50,=,74.0,nM,Cc1ccc(C[C@@H](N)C(=O)N2CCN(CC2)c3ncnc4ccccc34)cc1,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1ccc(C[C@@H](N)C(=O)N2CCN(CC2)c3ncnc4ccccc34)cc1,,Row875,55,0.1260044276714325,out,6
926,Row1018,Row4003,CHEMBL3952282,,0,501.53,BDBM182482,IC50,=,74.0,nM,C=Cc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CC4CNC4)-c5ccc(F)c(c5)C(F)(F)F,,329923.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,C=Cc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CC4CNC4)-c5ccc(F)c(c5)C(F)(F)F,,Row3798,5,0.1101676449179649,out,6
927,Row1019,Row356,CHEMBL261542,,0,522.66,4,IC50,=,75.0,nM,C(c1ccc(cc1)-c2nc3ccccc3nc2-c4ccccc4)N5CCC(CC5)c6cc([nH]n6)-c7ccncc7,,,CHEMBL937417,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143097,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,C(c1ccc(cc1)-c2nc3ccccc3nc2-c4ccccc4)N5CCC(CC5)c6cc([nH]n6)-c7ccncc7,,Row996,49,0.1872911751270294,out,6
928,Row1020,Row2481,CHEMBL3944868,,0,597.64,BDBM182357,IC50,=,75.0,nM,Nc1ncnc(c1-c2ccccc2F)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6cc(c(F)cc6)C(F)(F)F,,329798.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1-c2ccccc2F)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6cc(c(F)cc6)C(F)(F)F,,Row643,24,0.1443753093481063,out,6
929,Row1021,Row1229,CHEMBL3942559,,0,495.03,BDBM182635,IC50,=,76.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(Cl)ccc5,,330076.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(Cl)ccc5,,Row1206,41,0.137699156999588,out,6
930,Row1022,Row1834,CHEMBL1087281,,0,364.48,1,IC50,=,76.0,nM,Cc1n[nH]c2ccc(cc21)-c3nnc(NC[C@@H](N)Cc4ccccc4)s3,,,CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154933,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3nnc(NC[C@@H](N)Cc4ccccc4)s3,,Row1834,53,0.1374106705188751,out,6
931,Row1023,Row2189,CHEMBL3912087,,0,559.62,BDBM182661,IC50,=,76.0,nM,CN(C)CCN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4ccc(F)c(c4)C(F)(F)F,,330102.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4ccc(F)c(c4)C(F)(F)F,,Row2188,10,0.118416741490364,out,6
932,Row1024,Row3282,CHEMBL3684370,,0,455.48,BDBM103083,IC50,=,76.0,nM,[C-]#[N+]c1cc(ccc1)C(=O)Nc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,220805.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,[C-]#[N+]c1cc(ccc1)C(=O)Nc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,Row2783,67,0.1432965993881225,out,6
933,Row1025,Row3328,CHEMBL3977596,,0,498.05,BDBM182550,IC50,=,76.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)c(Cl)cc5,,329991.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)c(Cl)cc5,,Row3753,7,0.1247522160410881,out,6
934,Row1026,Row3598,CHEMBL3925234,,0,434.59,BDBM182376,IC50,=,76.0,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)C5CCCCC5,,329817.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)C5CCCCC5,,Row3990,26,0.0940150246024131,out,6
935,Row1027,Row3463,CHEMBL4522719,,0,379.44,D26,IC50,=,76.6,nM,Cn1nccc1-c2ccc(nc2)C(=O)N[C@@H]3CNCC[C@H]3c4cc(F)ccc4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1nccc1-c2ccc(nc2)C(=O)N[C@@H]3CNCC[C@H]3c4cc(F)ccc4,,Row1315,22,0.1301299333572387,out,6
936,Row1028,Row1838,CHEMBL1081830,,0,433.46,35,IC50,=,77.0,nM,Nn1nnc2ccc(cc12)-c3cnc(NC[C@@H](N)Cc4ccc(cc4)C(F)(F)F)s3,,,CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154944,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Nn1nnc2ccc(cc12)-c3cnc(NC[C@@H](N)Cc4ccc(cc4)C(F)(F)F)s3,,Row240,47,0.12615367770195,out,6
937,Row1029,Row228,CHEMBL3926246,,0,637.68,BDBM182522,IC50,=,78.0,nM,COC(=O)c1ccc(cc1)-c2c(N)ncnc2N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6ccc(F)c(c6)C(F)(F)F,,329963.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,COC(=O)c1ccc(cc1)-c2c(N)ncnc2N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6ccc(F)c(c6)C(F)(F)F,,Row2044,43,0.1208594515919685,out,6
938,Row1030,Row2330,CHEMBL1096271,,0,516.0,9q,IC50,=,78.0,nM,COc1cc2c(cc1OC)ncc3c2cc(nc3N)-c4cncc(c4)OC[C@@H](N)Cc5cccc(Cl)c5,,,CHEMBL1103721,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157027,1,Scientific Literature,Eur. J. Med. Chem.,2010.0,COc1cc2c(cc1OC)ncc3c2cc(nc3N)-c4cncc(c4)OC[C@@H](N)Cc5cccc(Cl)c5,,Row1813,70,0.1151068583130836,out,6
939,Row1031,Row2972,CHEMBL226797,,0,485.63,13av,IC50,=,78.0,nM,Cc1n[nH]c2ccc(cc12)-c3cncc(c3)OC[C@@H](N)Cc4cccc(c4)OCC5CCN(C)CC5,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc12)-c3cncc(c3)OC[C@@H](N)Cc4cccc(c4)OCC5CCN(C)CC5,,Row1976,11,0.1298024803400039,out,6
940,Row1032,Row267,CHEMBL381703,,0,405.93,16b,IC50,=,79.0,nM,N[C@@H](CC1CNc2ccccc21)CNc3cc(/C=C/c4ccncc4)c(Cl)nc3,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](CC1CNc2ccccc21)CNc3cc(/C=C/c4ccncc4)c(Cl)nc3,,Row77,56,0.1252806186676025,out,6
941,Row1033,Row1185,CHEMBL594748,,0,440.57,9k,IC50,=,79.0,nM,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4cccs4)OC[C@@H](N)Cc5ccccc5,,,CHEMBL1071952,Inhibition of full length AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4cccs4)OC[C@@H](N)Cc5ccccc5,,Row1976,11,0.1586152166128158,out,6
942,Row1034,Row1228,CHEMBL3892087,,0,506.1,BDBM182562,IC50,=,79.0,nM,Nc1ncnc(c1C2CCC2)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6ccc(Cl)cc6,,330003.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C2CCC2)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6ccc(Cl)cc6,,Row643,24,0.1237990409135818,out,6
943,Row1035,Row1584,CHEMBL494882,,0,367.41,12a,IC50,=,79.0,nM,CCn1c2c(cnc(C#CC3CC3)c2nc1-c4nonc4N)OCCCN,,,CHEMBL1028090,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140130,1,Scientific Literature,J. Med. Chem.,2008.0,CCn1c2c(cnc(C#CC3CC3)c2nc1-c4nonc4N)OCCCN,,Row2429,38,0.1252319067716598,out,6
944,Row1036,Row2047,CHEMBL445180,,0,369.39,11b,IC50,=,79.0,nM,CCn1c2c(cnc(c2nc1-c3nonc3N)-c4cocc4)OCCCN,,,CHEMBL1028090,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140130,1,Scientific Literature,J. Med. Chem.,2008.0,CCn1c2c(cnc(c2nc1-c3nonc3N)-c4cocc4)OCCCN,,Row2429,38,0.1172607764601707,out,6
945,Row1037,Row2069,CHEMBL493911,,0,329.36,20,IC50,=,79.0,nM,CCn1c2c(cncc2OC3CCNCC3)nc1-c4nonc4N,,,CHEMBL1111477,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1155389,1,Scientific Literature,J. Med. Chem.,2010.0,CCn1c2c(cncc2OC3CCNCC3)nc1-c4nonc4N,,Row1117,69,0.1426438242197036,out,6
946,Row1038,Row3135,CHEMBL505758,,0,610.77,14,IC50,=,79.0,nM,CN(C)CCNc1nc2nc(-c3ccc(CN4CCC(CC4)c5[nH]c(nn5)-c6ccccn6)cc3)c(cc2cn1)-c7ccccc7,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN(C)CCNc1nc2nc(-c3ccc(CN4CCC(CC4)c5[nH]c(nn5)-c6ccccn6)cc3)c(cc2cn1)-c7ccccc7,,Row1163,23,0.1792777776718139,out,6
947,Row1039,Row3404,CHEMBL595684,,0,450.54,9c,IC50,=,79.0,nM,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4cc(O)ccc4)OC[C@@H](N)Cc5ccccc5,,,CHEMBL1071952,Inhibition of full length AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4cc(O)ccc4)OC[C@@H](N)Cc5ccccc5,,Row1976,11,0.1625413298606872,out,6
948,Row1040,Row1223,CHEMBL3894252,,0,449.58,BDBM182577,IC50,=,79.5,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(F)ccc5,,330018.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(F)ccc5,,Row3753,7,0.1397263258695602,out,6
949,Row1041,Row311,CHEMBL4568087,,0,421.53,19,IC50,=,80.0,nM,Cn1cc(cn1)-c2cn3ncc(c3nc2)-c4csc(c4)C(=O)N[C@@H]5CCCC[C@@H]5N,,,CHEMBL4479691,Inhibition of full-length recombinant human His-tagged AKT1-alpha expressed in baculovirus expression system by Z'-LYTE assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4477252,1,Scientific Literature,Bioorg Med Chem Lett,2016.0,Cn1cc(cn1)-c2cn3ncc(c3nc2)-c4csc(c4)C(=O)N[C@@H]5CCCC[C@@H]5N,,Row39,44,0.0912010893225669,out,6
950,Row1042,Row1530,CHEMBL493360,,0,362.34,(+/-)-syn-11d,IC50,=,80.0,nM,Oc1ccc(cc1)[C@@H]2O[C@@H]3CC(=O)O[C@@H]3C4=C2C(=O)c5ccccc5C4=O,,,CHEMBL1018804,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153413,1,Scientific Literature,J. Med. Chem.,2009.0,Oc1ccc(cc1)[C@@H]2O[C@@H]3CC(=O)O[C@@H]3C4=C2C(=O)c5ccccc5C4=O,,Row2387,28,0.1141480505466461,out,6
951,Row1043,Row1698,CHEMBL1823638,,0,404.9,10,IC50,=,80.0,nM,N#Cc1cc(ccc1Cl)C(NC(=O)c2ccc3cnccc3c2)C4CCNCC4,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,N#Cc1cc(ccc1Cl)C(NC(=O)c2ccc3cnccc3c2)C4CCNCC4,,Row3192,40,0.0969655513763427,out,6
952,Row1044,Row1914,CHEMBL379576,,0,585.71,9q,IC50,=,80.0,nM,CCC1c2cc(ccc2NC1=O)-c3cncc(c3)OC[C@H](Cc4c[nH]c5ccccc45)Nc6cc7C(CC)C(=O)Nc7cc6,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CCC1c2cc(ccc2NC1=O)-c3cncc(c3)OC[C@H](Cc4c[nH]c5ccccc45)Nc6cc7C(CC)C(=O)Nc7cc6,,Row837,29,0.1134357452392578,out,6
953,Row1045,Row2327,CHEMBL575384,,0,438.53,113,IC50,=,80.0,nM,CC(C)=C1C(=O)Nc2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,CC(C)=C1C(=O)Nc2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,Row1726,2,0.1294256001710891,out,6
954,Row1046,Row2841,CHEMBL3894291,,0,506.64,BDBM182654,IC50,=,80.0,nM,CS(=O)(=O)c1cc(ccc1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,330095.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CS(=O)(=O)c1cc(ccc1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C#N,,Row3990,26,0.1303150802850723,out,6
955,Row1047,Row3733,CHEMBL1257628,,0,461.96,28,IC50,=,80.0,nM,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4ccc(cc34)-c5c[nH]nc5,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4ccc(cc34)-c5c[nH]nc5,,Row875,55,0.1158461645245552,out,6
956,Row1048,Row1071,CHEMBL1258899,,0,397.43,14,IC50,=,81.0,nM,N[C@H](Cc1ccc(F)c(F)c1)C(=O)N2CCN(CC2)c3ncnc4ccccc43,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccc(F)c(F)c1)C(=O)N2CCN(CC2)c3ncnc4ccccc43,,Row875,55,0.1303599029779434,out,6
957,Row1049,Row1277,CHEMBL252652,,0,512.68,13b,IC50,=,81.0,nM,CCNC(=O)NC1CCN(CC1)Cc2ccc(cc2)-c3nc4nc(ncc4cc3-c5ccccc5)SC,,,CHEMBL928491,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141509,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CCNC(=O)NC1CCN(CC1)Cc2ccc(cc2)-c3nc4nc(ncc4cc3-c5ccccc5)SC,,Row3742,50,0.197562038898468,out,6
958,Row1050,Row1466,CHEMBL2177389,,0,458.01,27,IC50,=,81.0,nM,CC(C)NC[C@H](c1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4CC[C@@H](CO)c34,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,CC(C)NC[C@H](c1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4CC[C@@H](CO)c34,,Row2863,37,0.0861603766679763,out,6
959,Row1051,Row2125,CHEMBL1760770,,0,504.63,27c,IC50,=,81.0,nM,Nc1ncnc(c1C2CC2)N3C[C@@]4(CN(C[C@H](O)CNS(=O)(=O)c5ccccc5F)CCC4)CC3,,,CHEMBL1763788,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759869,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,Nc1ncnc(c1C2CC2)N3C[C@@]4(CN(C[C@H](O)CNS(=O)(=O)c5ccccc5F)CCC4)CC3,,Row315,48,0.1287050694227218,out,6
960,Row1052,Row2314,CHEMBL247798,,0,476.47,42,IC50,=,81.0,nM,CCNC(=O)Nc1ccc(CNc2ncsc2C(=O)Nc3cc4OC(F)(F)Oc4cc3)cn1,,,CHEMBL922918,Inhibition of pAkt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140657,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CCNC(=O)Nc1ccc(CNc2ncsc2C(=O)Nc3cc4OC(F)(F)Oc4cc3)cn1,,Row2553,9,0.0935411602258682,out,6
961,Row1053,Row2796,CHEMBL3977344,,0,532.55,BDBM182455,IC50,=,81.0,nM,CN1CC(C1)Cn2cc(nc2C3CCN(CC3)c4ncnc(N)c4C(N)=O)-c5ccc(F)c(c5)C(F)(F)F,,329896.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN1CC(C1)Cn2cc(nc2C3CCN(CC3)c4ncnc(N)c4C(N)=O)-c5ccc(F)c(c5)C(F)(F)F,,Row2044,43,0.1142520010471344,out,6
962,Row1054,Row3050,CHEMBL402199,,0,527.63,12c,IC50,=,81.0,nM,Nc1ncnc2nc(c(cc21)-c3ccccc3)-c4ccc(CN5CCC(CC5)n6c(=O)[nH]c7ccccc67)cc4,,,CHEMBL951085,Inhibition of human recombinant Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142344,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Nc1ncnc2nc(c(cc21)-c3ccccc3)-c4ccc(CN5CCC(CC5)n6c(=O)[nH]c7ccccc67)cc4,,Row2123,58,0.2103076130151748,out,6
963,Row1057,Row562,CHEMBL3684335,,0,540.63,BDBM103047,IC50,=,83.0,nM,O=c1[nH]c2ccccc2n1C3CCN(Cc4ccc(cc4)-c5nnc6-c7ccccc7Nc8ncccc8-n65)CC3,,220769.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=c1[nH]c2ccccc2n1C3CCN(Cc4ccc(cc4)-c5nnc6-c7ccccc7Nc8ncccc8-n65)CC3,,Row2452,66,0.1593587547540664,out,6
964,Row1058,Row160,CHEMBL378116,,0,408.51,10h,IC50,=,84.0,nM,Cc1c(cncc1OC[C@@H](N)Cc2c[nH]c3ccccc23)-c4cc5ccncc5cc4,,,CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1147830,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Cc1c(cncc1OC[C@@H](N)Cc2c[nH]c3ccccc23)-c4cc5ccncc5cc4,,Row1996,15,0.1396914571523666,out,6
965,Row1059,Row611,CHEMBL3936329,,0,520.54,BDBM182337,IC50,=,84.0,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4cc(c(F)cc4)C(F)(F)F,,329786.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4cc(c(F)cc4)C(F)(F)F,,Row2044,43,0.1157102584838867,out,6
966,Row1060,Row3105,CHEMBL3684373,,0,552.65,BDBM103086,IC50,=,84.0,nM,C(c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)N6CCC(CC6)c7[nH]c(nn7)-c8ccccn8,,220808.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,C(c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)N6CCC(CC6)c7[nH]c(nn7)-c8ccccn8,,Row2452,66,0.1476982831954956,out,6
967,Row1061,Row690,CHEMBL1081119,,0,413.4,26,IC50,=,85.0,nM,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2nnc(o2)-c3cc4ccncc4cc3,,,CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154944,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2nnc(o2)-c3cc4ccncc4cc3,,Row240,47,0.1092397943139076,out,6
968,Row1062,Row2258,CHEMBL3917106,,0,564.59,BDBM182670,IC50,=,85.0,nM,CC(COC)NCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4ccc(F)c(c4)C(F)(F)F,,330111.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(COC)NCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4ccc(F)c(c4)C(F)(F)F,,Row2044,43,0.1179576739668846,out,6
969,Row1063,Row2442,CHEMBL180231,,0,551.65,16g,IC50,=,85.0,nM,O=c1[nH]c2ccccc2n1C3CCN(Cc4ccc(cc4)-c5nc6cc7cn[nH]c7cc6nc5-c8ccccc8)CC3,,,CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141888,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,O=c1[nH]c2ccccc2n1C3CCN(Cc4ccc(cc4)-c5nc6cc7cn[nH]c7cc6nc5-c8ccccc8)CC3,,Row2123,58,0.182642176747322,out,6
970,Row1064,Row3667,CHEMBL3947929,,0,611.66,BDBM182363,IC50,=,85.0,nM,Nc1ncnc(c1-c2cc(F)ccc2)N3CCC(CC3)c4nc(cn4CCN5CCCCC5)-c6cc(c(F)cc6)C(F)(F)F,,329804.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1-c2cc(F)ccc2)N3CCC(CC3)c4nc(cn4CCN5CCCCC5)-c6cc(c(F)cc6)C(F)(F)F,,Row643,24,0.1385361701250076,out,6
971,Row1065,Row1401,CHEMBL270157,,0,515.62,10a,IC50,=,86.0,nM,Nc1n[nH]c2nc(c(cc21)-c3ccccc3)-c4ccc(CN5CCC(CC5)n6c(=O)[nH]c7ccccc67)cc4,,,CHEMBL951085,Inhibition of human recombinant Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142344,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Nc1n[nH]c2nc(c(cc21)-c3ccccc3)-c4ccc(CN5CCC(CC5)n6c(=O)[nH]c7ccccc67)cc4,,Row2123,58,0.2148355543613433,out,6
972,Row1066,Row2641,CHEMBL3908831,,0,563.62,BDBM182548,IC50,=,86.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC(F)CC4)-c5cc(F)c(cc5)C(F)(F)F,,329989.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC(F)CC4)-c5cc(F)c(cc5)C(F)(F)F,,Row3753,7,0.1142436489462852,out,6
973,Row1069,Row989,CHEMBL1257166,,0,426.95,53,IC50,=,88.0,nM,CN(C)C[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4[nH]ccc34,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,CN(C)C[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4[nH]ccc34,,Row854,17,0.0902827680110931,out,6
974,Row1070,Row2270,CHEMBL507204,,0,638.78,16,IC50,=,88.0,nM,CN1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8cc[n+]([O-])cc8)cc5,,,CHEMBL947433,Inhibition of Akt1 by cellular assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8cc[n+]([O-])cc8)cc5,,Row1163,23,0.1803902983665466,out,6
975,Row1071,Row1298,CHEMBL3926249,,0,523.63,BDBM182501,IC50,=,89.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CC5(COC5)CC4)-c6cc(F)c(F)cc6,,329942.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CC5(COC5)CC4)-c6cc(F)c(F)cc6,,Row3753,7,0.128478541970253,out,6
976,Row1072,Row2219,CHEMBL403354,,0,463.61,12f,IC50,=,90.0,nM,CSc1nc2nc(c(cc2cn1)-c3ccccc3)-c4ccc(CNCCc5cnccc5)cc4,,,CHEMBL928491,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141509,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CSc1nc2nc(c(cc2cn1)-c3ccccc3)-c4ccc(CNCCc5cnccc5)cc4,,Row3742,50,0.1765482276678085,out,6
977,Row1073,Row3800,CHEMBL3956421,,0,515.54,BDBM182427,IC50,=,90.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ncc5)C(F)(F)F,,329868.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ncc5)C(F)(F)F,,Row2044,43,0.1258674412965774,out,6
978,Row1074,Row10,CHEMBL3970947,,0,434.57,BDBM182429,IC50,=,91.0,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cscc5,,329870.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cscc5,,Row3990,26,0.1038163229823112,out,6
979,Row1076,Row1399,CHEMBL252653,,0,540.69,13c,IC50,=,91.0,nM,CSc1nc2nc(-c3ccc(CN4CCC(CC4)C(=O)NCCC(N)=O)cc3)c(cc2cn1)-c5ccccc5,,,CHEMBL928491,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141509,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CSc1nc2nc(-c3ccc(CN4CCC(CC4)C(=O)NCCC(N)=O)cc3)c(cc2cn1)-c5ccccc5,,Row3742,50,0.2048874646425247,out,6
980,Row1077,Row3578,CHEMBL3972161,,0,528.58,BDBM182634,IC50,=,92.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(ccc5)C(F)(F)F,,330075.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(ccc5)C(F)(F)F,,Row2044,43,0.134551852941513,out,6
981,Row1080,Row58,CHEMBL3937511,,0,611.64,BDBM182387,IC50,=,95.0,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4ccc(cc4)C(=O)OC)-c5ccc(F)c(c5)C(F)(F)F,,329828.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4ccc(cc4)C(=O)OC)-c5ccc(F)c(c5)C(F)(F)F,,Row2164,32,0.1130232661962509,out,6
982,Row1081,Row246,CHEMBL1081029,,0,432.47,43,IC50,=,95.0,nM,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2ncc(s2)-c3cc4CNC(=O)c4cc3,,,CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154944,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2ncc(s2)-c3cc4CNC(=O)c4cc3,,Row240,47,0.1334224939346313,out,6
983,Row1082,Row3726,CHEMBL1257163,,0,429.45,16,IC50,=,95.0,nM,N[C@H](Cc1ccc(cc1)C(F)(F)F)C(=O)N2CCN(CC2)c3ncnc4ccccc34,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccc(cc1)C(F)(F)F)C(=O)N2CCN(CC2)c3ncnc4ccccc34,,Row875,55,0.12256371229887,out,6
984,Row1085,Row3913,CHEMBL3684537,,0,631.54,BDBM103251,IC50,=,96.0,nM,Brc1cc2-c3nnc(-c4ccc(CN5CCC(CC5)c6[nH]c(nn6)-c7ccccn7)cc4)n3-c8cccnc8Nc2cc1,,220965.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Brc1cc2-c3nnc(-c4ccc(CN5CCC(CC5)c6[nH]c(nn6)-c7ccccn7)cc4)n3-c8cccnc8Nc2cc1,,Row2452,66,0.1419146656990051,out,6
985,Row1087,Row2361,CHEMBL1257751,,0,424.94,30,IC50,=,98.0,nM,CNc1cc2c(cc1)ncnc2N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,CNc1cc2c(cc1)ncnc2N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,Row875,55,0.0989575982093811,out,6
986,Row1089,Row626,CHEMBL577134,,0,416.51,106,IC50,=,99.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc5[nH]c(=O)sc5c4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc5[nH]c(=O)sc5c4,,Row1996,15,0.1249718964099884,out,6
987,Row1090,Row1537,CHEMBL211434,,0,531.58,9f,IC50,=,99.0,nM,O=C1Cc2ccc(N[C@H](COc3cncc(c3)-c4ccc5CC(=O)Nc5n4)Cc6c[nH]c7ccccc67)nc2N1,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,O=C1Cc2ccc(N[C@H](COc3cncc(c3)-c4ccc5CC(=O)Nc5n4)Cc6c[nH]c7ccccc67)nc2N1,,Row837,29,0.1091781184077262,out,6
988,Row1091,Row2045,CHEMBL521638,,0,352.37,(-)-anti-11e,IC50,=,99.0,nM,O=C1C=2[C@H]3OC(=O)C[C@H]3O[C@@H](C2C(=O)c4ccccc14)c5cscc5,,,CHEMBL1018804,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153413,1,Scientific Literature,J. Med. Chem.,2009.0,O=C1C=2[C@H]3OC(=O)C[C@H]3O[C@@H](C2C(=O)c4ccccc14)c5cscc5,,Row2387,28,0.1195936799049377,out,6
989,Row1093,Row3741,CHEMBL252054,,0,452.59,12c,IC50,=,99.0,nM,CSc1nc2nc(-c3ccc(CNCCc4c[nH]cn4)cc3)c(cc2cn1)-c5ccccc5,,,CHEMBL928491,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141509,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CSc1nc2nc(-c3ccc(CNCCc4c[nH]cn4)cc3)c(cc2cn1)-c5ccccc5,,Row3742,50,0.1689548194408416,out,6
990,Row1095,Row578,CHEMBL4577134,,0,498.03,1m,IC50,=,99.9,nM,Cn1ncc(-c2ccncc2)c1-c3ccc(s3)C(=O)N[C@@H]4CNCC[C@H]4c5cc(F)ccc5,,,CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4304777,1,Scientific Literature,Eur J Med Chem,2019.0,Cn1ncc(-c2ccncc2)c1-c3ccc(s3)C(=O)N[C@@H]4CNCC[C@H]4c5cc(F)ccc5,,Row1315,22,0.1216111779212951,out,6
991,Row1096,Row1118,CHEMBL469560,,0,348.48,14,IC50,=,100.0,nM,NCC(NCc1ccc(s1)-c2ccnc3[nH]ccc23)c4ccccc4,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NCC(NCc1ccc(s1)-c2ccnc3[nH]ccc23)c4ccccc4,,Row1178,46,0.1387948095798492,out,6
992,Row1097,Row1239,CHEMBL3908032,,0,518.52,BDBM182437,IC50,=,100.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3C4CNCC4)-c5cc(c(F)cc5)C(F)(F)F,,329878.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3C4CNCC4)-c5cc(c(F)cc5)C(F)(F)F,,Row2044,43,0.1120328605175018,out,6
993,Row1098,Row1888,CHEMBL604684,,0,464.57,9e,IC50,=,100.0,nM,Cc1n[nH]c2ccc(cc12)-c3cc(cnc3-c4ccccc4OC)OC[C@@H](N)Cc5ccccc5,,,CHEMBL1071952,Inhibition of full length AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc12)-c3cc(cnc3-c4ccccc4OC)OC[C@@H](N)Cc5ccccc5,,Row1976,11,0.1593689322471618,out,6
994,Row1099,Row2443,CHEMBL1257510,,0,409.92,26,IC50,=,100.0,nM,Cc1cccc2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1cccc2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,Row875,55,0.1075368598103523,out,6
995,Row1100,Row2463,CHEMBL3684341,,0,444.5,BDBM103053,IC50,=,100.0,nM,Cc1ccc(cc1)C(=O)Nc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,220775.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cc1ccc(cc1)C(=O)Nc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,Row2783,67,0.1381932497024536,out,6
996,Row1104,Row3680,CHEMBL4461200,,0,464.95,1j,IC50,=,101.0,nM,Cn1ncc(C(O)=O)c1-c2ccc(s2)C(=O)N[C@@H]3CNCC[C@H]3c4cccc(F)c4,,,CHEMBL4307005,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4304777,1,Scientific Literature,Eur J Med Chem,2019.0,Cn1ncc(C(O)=O)c1-c2ccc(s2)C(=O)N[C@@H]3CNCC[C@H]3c4cccc(F)c4,,Row1315,22,0.1094169989228248,out,6
997,Row1105,Row3270,CHEMBL4515689,,0,453.37,D12,IC50,=,101.6,nM,Cn1ncc(Cl)c1-c2cc(sc2Cl)C(=O)N[C@@H]3CNCC[C@H]3c4cc(F)ccc4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(sc2Cl)C(=O)N[C@@H]3CNCC[C@H]3c4cc(F)ccc4,,Row1315,22,0.0982598513364791,out,6
998,Row1107,Row904,CHEMBL226381,,0,375.43,9k,IC50,=,104.0,nM,Cc1n[nH]c2c[n+]([O-])c(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccccc4,,,CHEMBL903964,Inhibition of Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142911,1,Scientific Literature,Bioorg. Med. Chem.,2007.0,Cc1n[nH]c2c[n+]([O-])c(cc21)-c3cncc(c3)OC[C@@H](N)Cc4ccccc4,,Row1976,11,0.127166286110878,out,6
999,Row1108,Row2103,CHEMBL1258553,,0,385.86,45,IC50,=,104.0,nM,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4[nH]ncc34,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4[nH]ncc34,,Row854,17,0.0953026562929153,out,6
1000,Row1109,Row2267,CHEMBL506827,,0,680.86,40,IC50,=,104.0,nM,CN(C)CCN1CCN(CC1)c2ccc3nc(c(nc3n2)-c4ccc(CN5CCC(CC5)c6[nH]c(nn6)-c7ncccn7)cc4)-c8ccccc8,,,CHEMBL947433,Inhibition of Akt1 by cellular assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN(C)CCN1CCN(CC1)c2ccc3nc(c(nc3n2)-c4ccc(CN5CCC(CC5)c6[nH]c(nn6)-c7ncccn7)cc4)-c8ccccc8,,Row1163,23,0.1578861773014068,out,6
1001,Row1110,Row3910,CHEMBL4470602,,0,413.88,D27,IC50,=,104.1,nM,Cn1ncc(Cl)c1-c2ccc(nc2)C(=O)N[C@@H]3CNCC[C@H]3c4cc(F)ccc4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2ccc(nc2)C(=O)N[C@@H]3CNCC[C@H]3c4cc(F)ccc4,,Row1315,22,0.1273001283407211,out,6
1002,Row1111,Row3927,CHEMBL3955055,,0,468.57,BDBM182506,IC50,=,105.0,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc6cn[nH]c6cc5,,329947.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc6cn[nH]c6cc5,,Row3990,26,0.1179302707314491,out,6
1003,Row1113,Row1231,CHEMBL3965063,,0,446.6,BDBM182410,IC50,=,106.0,nM,Cc1cc(ccn1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5CC,,329851.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccn1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5CC,,Row3753,7,0.1314383745193481,out,6
1004,Row1115,Row408,CHEMBL401999,,0,542.65,12b,IC50,=,107.0,nM,Nc1nc(N)c2cc(c(nc2n1)-c3ccc(CN4CCC(CC4)n5c(=O)[nH]c6ccccc56)cc3)-c7ccccc7,,,CHEMBL951085,Inhibition of human recombinant Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142344,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Nc1nc(N)c2cc(c(nc2n1)-c3ccc(CN4CCC(CC4)n5c(=O)[nH]c6ccccc56)cc3)-c7ccccc7,,Row2123,58,0.2129429131746292,out,6
1005,Row1117,Row329,CHEMBL3684428,,0,494.58,BDBM103141,IC50,=,110.0,nM,Cc1ccc(cc1)S(=O)(=O)NCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,220863.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cc1ccc(cc1)S(=O)(=O)NCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,Row3925,73,0.1317436546087265,out,6
1006,Row1118,Row657,CHEMBL3684366,,0,448.46,BDBM103079,IC50,=,110.0,nM,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccc(F)cc6,,220801.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccc(F)cc6,,Row2783,67,0.1404334604740142,out,6
1007,Row1119,Row706,CHEMBL3897494,,0,564.45,BDBM182564,IC50,=,110.0,nM,Nc1ncnc(c1Br)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(cc5)C(F)(F)F,,330005.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Br)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(cc5)C(F)(F)F,,Row2590,1,0.1227329894900322,out,6
1008,Row1120,Row1410,CHEMBL3907965,,0,615.63,BDBM182358,IC50,=,110.0,nM,Nc1ncnc(c1-c2cc(F)c(F)cc2)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6cc(c(F)cc6)C(F)(F)F,,329799.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1-c2cc(F)c(F)cc2)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6cc(c(F)cc6)C(F)(F)F,,Row643,24,0.1239970177412033,out,6
1009,Row1121,Row1953,CHEMBL1800386,,0,1075.38,27,IC50,=,110.0,nM,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCCCCN)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N(CC(N)=O)CCCN,,,CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1799953,1,Scientific Literature,J. Med. Chem.,2011.0,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCCCCN)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N(CC(N)=O)CCCN,,Row2426,74,0.0634719431400299,out,6
1010,Row1122,Row2157,CHEMBL3941307,,0,445.42,BDBM182306,IC50,=,110.0,nM,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4cc(c(F)cc4)C(F)(F)F,,329773.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C#N)-c4cc(c(F)cc4)C(F)(F)F,,Row3758,45,0.1153682544827461,out,6
1011,Row1123,Row2653,CHEMBL3684425,,0,494.58,BDBM103138,IC50,=,110.0,nM,Cc1cccc(c1)S(=O)(=O)NCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,220860.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cc1cccc(c1)S(=O)(=O)NCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,Row3925,73,0.1334037482738495,out,6
1012,Row1124,Row2760,CHEMBL1823656,,0,386.28,(S)-29,IC50,=,110.0,nM,O=C(N[C@@H](C1CNC1)c2ccc(Cl)c(Cl)c2)c3ccc4cnccc4c3,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,O=C(N[C@@H](C1CNC1)c2ccc(Cl)c(Cl)c2)c3ccc4cnccc4c3,,Row3192,40,0.0983943864703178,out,6
1013,Row1126,Row3394,CHEMBL3684361,,0,448.46,BDBM103074,IC50,=,110.0,nM,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)c6ccccc6F,,220796.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)c6ccccc6F,,Row2783,67,0.1338470578193664,out,6
1014,Row1127,Row3513,CHEMBL3684408,,0,487.57,BDBM103121,IC50,=,110.0,nM,CN(C)c1ccc(cc1)C(=O)NCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,220843.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CN(C)c1ccc(cc1)C(=O)NCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,Row2783,67,0.1414587199687957,out,6
1015,Row1130,Row2884,CHEMBL1258216,,0,384.87,39,IC50,=,114.0,nM,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4cc[nH]c34,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4cc[nH]c34,,Row854,17,0.1039874926209449,out,6
1016,Row1131,Row868,CHEMBL447558,,0,667.82,38,IC50,=,115.0,nM,Nc1ccc(cn1)-c2[nH]c(nn2)C3CCN(Cc4ccc(cc4)-c5nc6nc(ccc6nc5-c7ccccc7)N8CCN(CCO)CC8)CC3,,,CHEMBL947433,Inhibition of Akt1 by cellular assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Nc1ccc(cn1)-c2[nH]c(nn2)C3CCN(Cc4ccc(cc4)-c5nc6nc(ccc6nc5-c7ccccc7)N8CCN(CCO)CC8)CC3,,Row1163,23,0.1727286577224731,out,6
1017,Row1132,Row986,CHEMBL4171390,,0,553.58,11f,IC50,=,115.0,nM,Cc1nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc(c1C(=O)OCC)-c5ccc(OC)c(c5)OC,,,CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4130433,1,Scientific Literature,Eur J Med Chem,2017.0,Cc1nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc(c1C(=O)OCC)-c5ccc(OC)c(c5)OC,,Row2772,33,0.1366320103406906,out,6
1018,Row1134,Row2118,CHEMBL1258442,,0,379.44,6,IC50,=,118.0,nM,N[C@H](Cc1ccc(F)cc1)C(=O)N2CCN(CC2)c3ncnc4ccccc34,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccc(F)cc1)C(=O)N2CCN(CC2)c3ncnc4ccccc34,,Row875,55,0.1277273595333099,out,6
1019,Row1136,Row2406,CHEMBL3978853,,0,515.54,BDBM182469,IC50,=,120.0,nM,CNCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C4CON=C4)-c5cc(ncc5)C(F)(F)F,,329910.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CNCCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C4CON=C4)-c5cc(ncc5)C(F)(F)F,,Row2188,10,0.1069228202104568,out,6
1020,Row1137,Row2672,CHEMBL261540,,0,522.66,7a,IC50,=,120.0,nM,C(c1ccc(cc1)-c2nc3ncccc3cc2-c4ccccc4)N5CCC(CC5)c6cc([nH]n6)-c7ccncc7,,,CHEMBL937417,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143097,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,C(c1ccc(cc1)-c2nc3ncccc3cc2-c4ccccc4)N5CCC(CC5)c6cc([nH]n6)-c7ccncc7,,Row996,49,0.2009194195270538,out,6
1021,Row1138,Row2748,CHEMBL3684420,,0,473.54,BDBM103133,IC50,=,120.0,nM,O=C(Nc1ccccc1)NCCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,220855.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Nc1ccccc1)NCCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,Row2783,67,0.1462848037481308,out,6
1022,Row1139,Row3240,CHEMBL3940823,,0,496.57,BDBM182628,IC50,=,120.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)c(F)cc5,,330069.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)c(F)cc5,,Row1206,41,0.1295631527900695,out,6
1023,Row1140,Row3269,CHEMBL1823642,,0,414.34,14,IC50,=,120.0,nM,O=C(NC(C1CCNCC1)c2cccc(Cl)c2Cl)c3ccc4cnccc4c3,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,O=C(NC(C1CCNCC1)c2cccc(Cl)c2Cl)c3ccc4cnccc4c3,,Row3192,40,0.1085829511284828,out,6
1024,Row1141,Row3359,CHEMBL3684414,,0,484.55,BDBM103127,IC50,=,120.0,nM,Cn1ccc(n1)S(=O)(=O)NCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,220849.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cn1ccc(n1)S(=O)(=O)NCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,Row3925,73,0.1362206190824508,out,6
1025,Row1142,Row3849,CHEMBL3684427,,0,498.54,BDBM103140,IC50,=,120.0,nM,O=S(=O)(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccc(F)cc6,,220862.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=S(=O)(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccc(F)cc6,,Row3925,73,0.1336902230978012,out,6
1026,Row1143,Row3850,CHEMBL3639832,,0,435.45,BDBM103071,IC50,=,120.0,nM,Cc1cc(no1)C(=O)Nc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,220793.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cc1cc(no1)C(=O)Nc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,Row2783,67,0.13400399684906,out,6
1027,Row1144,Row882,CHEMBL401622,,0,529.65,10b,IC50,=,121.0,nM,Cn1nc(N)c2cc(c(nc12)-c3ccc(CN4CCC(CC4)n5c(=O)[nH]c6ccccc56)cc3)-c7ccccc7,,,CHEMBL951085,Inhibition of human recombinant Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142344,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Cn1nc(N)c2cc(c(nc12)-c3ccc(CN4CCC(CC4)n5c(=O)[nH]c6ccccc56)cc3)-c7ccccc7,,Row2123,58,0.2160288393497467,out,6
1028,Row1145,Row3306,CHEMBL381075,,0,385.47,10e,IC50,=,121.0,nM,Nc1cc(/C=C/c2cncc(c2)OC[C@@H](N)Cc3c[nH]c4ccccc43)ccn1,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Nc1cc(/C=C/c2cncc(c2)OC[C@@H](N)Cc3c[nH]c4ccccc43)ccn1,,Row77,56,0.1199922114610672,out,6
1029,Row1146,Row1936,CHEMBL209564,,0,471.56,10v,IC50,=,122.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5cc(ncc5cc4)-c6ccncc6,,,CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1147830,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5cc(ncc5cc4)-c6ccncc6,,Row1996,15,0.1336815357208252,out,6
1030,Row1147,Row777,CHEMBL389468,,0,434.54,13an,IC50,=,126.0,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(ccc4)-c5ccccc5,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(ccc4)-c5ccccc5,,Row1976,11,0.1511720567941665,out,6
1031,Row1148,Row1266,CHEMBL506153,GW876790X,0,330.35,2,IC50,=,126.0,nM,CNCCNC(=O)c1cncc2nc(-c3nonc3N)n(CC)c12,,,CHEMBL1028090,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140130,1,Scientific Literature,J. Med. Chem.,2008.0,CNCCNC(=O)c1cncc2nc(-c3nonc3N)n(CC)c12,,Row1117,69,0.1021923497319221,out,6
1032,Row1149,Row2328,CHEMBL502113,,0,668.81,19,IC50,=,127.0,nM,OCCN1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8c[nH]c(=O)cc8)cc5,,,CHEMBL947433,Inhibition of Akt1 by cellular assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,OCCN1CCN(CC1)c2nc3nc(c(cc3cn2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8c[nH]c(=O)cc8)cc5,,Row1163,23,0.1817897111177444,out,6
1033,Row1150,Row3385,CHEMBL1632385,,0,474.07,35,IC50,=,127.0,nM,CC(C)NC[C@@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4CS[C@@H](C)c43,,,CHEMBL1632819,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1629708,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,CC(C)NC[C@@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4CS[C@@H](C)c43,,Row3589,19,0.0843490213155746,out,6
1034,Row1151,Row993,CHEMBL4435138,,0,637.4,"A11; (3R,4R)-A5",IC50,=,127.4,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@H]3CNCC[C@@H]3c4ccc(cc4)C(F)(F)F,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)N[C@H]3CNCC[C@@H]3c4ccc(cc4)C(F)(F)F,,Row39,44,0.0908821895718574,out,6
1035,Row1152,Row1351,CHEMBL1800388,,0,1047.32,29,IC50,=,128.0,nM,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCN)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N(CC(N)=O)CCCCN,,,CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1799953,1,Scientific Literature,J. Med. Chem.,2011.0,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCN)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N(CC(N)=O)CCCCN,,Row2426,74,0.0626890435814857,out,6
1036,Row1154,Row2611,CHEMBL255360,,0,528.62,13a,IC50,=,129.0,nM,Nc1ncnc2nc(c(cc12)-c3ccccc3)-c4ccc(CN5CCC(CC5)n6cnc7c6ncnc7N)cc4,,,CHEMBL951085,Inhibition of human recombinant Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142344,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Nc1ncnc2nc(c(cc12)-c3ccccc3)-c4ccc(CN5CCC(CC5)n6cnc7c6ncnc7N)cc4,,Row996,49,0.2008512765169143,out,6
1037,Row1157,Row1337,CHEMBL1800268,,0,1033.29,25,IC50,=,130.0,nM,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCN)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N(CC(N)=O)CCCN,,,CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1799953,1,Scientific Literature,J. Med. Chem.,2011.0,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCN)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N(CC(N)=O)CCCN,,Row2426,74,0.0629958510398864,out,6
1038,Row1158,Row1471,CHEMBL3909262,,0,491.62,BDBM182496,IC50,=,130.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CC5(C4)COC5)-c6ccc(F)cc6,,329937.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CC5(C4)COC5)-c6ccc(F)cc6,,Row3753,7,0.1245874762535095,out,6
1039,Row1159,Row1626,CHEMBL3896518,,0,399.86,BDBM181322,IC50,=,130.0,nM,NC(=O)c1ccc(NC2CNCCC2c3cc(F)c(Cl)cc3)c4cncnc41,,328345.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(NC2CNCCC2c3cc(F)c(Cl)cc3)c4cncnc41,,Row2729,75,0.0970325618982315,out,6
1040,Row1160,Row2426,CHEMBL1800389,,0,1061.35,30,IC50,=,130.0,nM,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCCN)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N(CC(N)=O)CCCCN,,,CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1799953,1,Scientific Literature,J. Med. Chem.,2011.0,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCCN)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N(CC(N)=O)CCCCN,,Row2426,74,0.0632286071777343,out,6
1041,Row1161,Row3093,CHEMBL3684360,,0,420.43,BDBM103073,IC50,=,130.0,nM,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)c6ccco6,,220795.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)c6ccco6,,Row2783,67,0.1372662931680679,out,6
1042,Row1162,Row3357,CHEMBL3913464,,0,475.45,BDBM182656,IC50,=,130.0,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCO)-c4ccc(F)c(c4)C(F)(F)F,,330097.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCO)-c4ccc(F)c(c4)C(F)(F)F,,Row2188,10,0.1129757836461067,out,6
1043,Row1164,Row3678,CHEMBL3684433,,0,489.54,BDBM103146,IC50,=,130.0,nM,COc1cc(ccc1)NC(=O)NCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,220868.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,COc1cc(ccc1)NC(=O)NCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,Row662,76,0.1611349731683731,out,6
1044,Row1165,Row3699,CHEMBL3977191,,0,611.66,BDBM182362,IC50,=,130.0,nM,Nc1ncnc(c1-c2ccccc2F)N3CCC(CC3)c4nc(cn4CCN5CCCCC5)-c6cc(c(F)cc6)C(F)(F)F,,329803.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1-c2ccccc2F)N3CCC(CC3)c4nc(cn4CCN5CCCCC5)-c6cc(c(F)cc6)C(F)(F)F,,Row643,24,0.1429743468761444,out,6
1045,Row1166,Row1119,CHEMBL255559,,0,559.67,10c,IC50,=,131.0,nM,Nc1nn(CCO)c2nc(c(cc21)-c3ccccc3)-c4ccc(CN5CCC(CC5)n6c(=O)[nH]c7ccccc67)cc4,,,CHEMBL951085,Inhibition of human recombinant Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142344,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Nc1nn(CCO)c2nc(c(cc21)-c3ccccc3)-c4ccc(CN5CCC(CC5)n6c(=O)[nH]c7ccccc67)cc4,,Row2123,58,0.2059767097234726,out,6
1046,Row1168,Row25,CHEMBL252259,,0,466.61,12g,IC50,=,137.0,nM,CSc1nc2nc(-c3ccc(CNCCCn4cncc4)cc3)c(cc2cn1)-c5ccccc5,,,CHEMBL928491,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141509,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CSc1nc2nc(-c3ccc(CNCCCn4cncc4)cc3)c(cc2cn1)-c5ccccc5,,Row3742,50,0.1864515542984008,out,6
1047,Row1169,Row1590,CHEMBL258696,,0,653.83,2,IC50,=,138.0,nM,CCN(CCNC(=O)c1cc2nc(c(nc2cc1)-c3ccccc3)-c4ccc(CN5CCC(CC5)n6c7ccccc7[nH]c6=O)cc4)CC,,,CHEMBL937417,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143097,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CCN(CCNC(=O)c1cc2nc(c(nc2cc1)-c3ccccc3)-c4ccc(CN5CCC(CC5)n6c7ccccc7[nH]c6=O)cc4)CC,,Row2123,58,0.179471954703331,out,6
1048,Row1171,Row3043,CHEMBL252055,,0,453.58,12d,IC50,=,139.0,nM,CSc1nc2nc(-c3ccc(CNCCc4n[nH]cn4)cc3)c(cc2cn1)-c5ccccc5,,,CHEMBL928491,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141509,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CSc1nc2nc(-c3ccc(CNCCc4n[nH]cn4)cc3)c(cc2cn1)-c5ccccc5,,Row3742,50,0.1728122383356094,out,6
1049,Row1172,Row210,CHEMBL1823652,,0,448.78,25,IC50,=,140.0,nM,O=C(NC(C1CCNCC1)c2ccc(Cl)c(Cl)c2)c3ccc4cnc(Cl)cc4c3,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,O=C(NC(C1CCNCC1)c2ccc(Cl)c(Cl)c2)c3ccc4cnc(Cl)cc4c3,,Row3192,40,0.0958296358585357,out,6
1050,Row1173,Row412,CHEMBL3985709,,0,482.54,BDBM182627,IC50,=,140.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(F)c(F)cc5,,330068.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(F)c(F)cc5,,Row1206,41,0.1295631527900695,out,6
1051,Row1174,Row838,CHEMBL3684349,,0,455.48,BDBM103061,IC50,=,140.0,nM,[C-]#[N+]c1ccc(cc1)C(=O)Nc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,220783.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,[C-]#[N+]c1ccc(cc1)C(=O)Nc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,Row2783,67,0.1423945128917694,out,6
1052,Row1175,Row2284,CHEMBL3905622,,0,446.53,BDBM182652,IC50,=,140.0,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccccc5F,,330093.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccccc5F,,Row3990,26,0.126771792769432,out,6
1053,Row1176,Row2480,CHEMBL3916957,,0,597.64,BDBM182356,IC50,=,140.0,nM,Nc1ncnc(c1-c2ccc(F)cc2)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6cc(c(F)cc6)C(F)(F)F,,329797.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1-c2ccc(F)cc2)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6cc(c(F)cc6)C(F)(F)F,,Row643,24,0.1242662891745567,out,6
1054,Row1179,Row3262,CHEMBL1823644,,0,415.32,16,IC50,=,140.0,nM,O=C(NC(C1CCNCC1)c2cnc(Cl)c(Cl)c2)c3ccc4cnccc4c3,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,O=C(NC(C1CCNCC1)c2cnc(Cl)c(Cl)c2)c3ccc4cnccc4c3,,Row3192,40,0.100496232509613,out,6
1055,Row1180,Row3433,CHEMBL3684424,,0,510.58,BDBM103137,IC50,=,140.0,nM,COc1cccc(c1)S(=O)(=O)NCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,220859.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,COc1cccc(c1)S(=O)(=O)NCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,Row3925,73,0.1508994698524475,out,6
1056,Row1181,Row3614,CHEMBL3684430,,0,537.61,BDBM103143,IC50,=,140.0,nM,CC(=O)Nc1ccc(cc1)S(=O)(=O)NCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,220865.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CC(=O)Nc1ccc(cc1)S(=O)(=O)NCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,Row3925,73,0.1271688640117645,out,6
1057,Row1183,Row3925,CHEMBL3684411,,0,480.55,BDBM103124,IC50,=,140.0,nM,O=S(=O)(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccccc6,,220846.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=S(=O)(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccccc6,,Row3925,73,0.1467619240283966,out,6
1058,Row1185,Row1306,CHEMBL1081974,,0,429.47,29,IC50,=,141.0,nM,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2ncc(s2)-c3cc4ccnnc4cc3,,,CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154944,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2ncc(s2)-c3cc4ccnnc4cc3,,Row240,47,0.1058335453271865,out,6
1059,Row1186,Row217,CHEMBL1258779,,0,430.34,12,IC50,=,142.0,nM,N[C@H](Cc1ccc(Cl)cc1Cl)C(=O)N2CCN(CC2)c3ncnc4ccccc43,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccc(Cl)cc1Cl)C(=O)N2CCN(CC2)c3ncnc4ccccc43,,Row875,55,0.1384501904249191,out,6
1060,Row1187,Row614,CHEMBL206183,,0,387.51,2p,IC50,=,142.0,nM,N[C@@H](Cc1csc2ccccc12)COc3cncc(c3)/C=C/c4ccncc4,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1csc2ccccc12)COc3cncc(c3)/C=C/c4ccncc4,,Row77,56,0.1100880056619644,out,6
1061,Row1190,Row111,CHEMBL206924,,0,422.53,10r,IC50,=,144.0,nM,CCc1cc2cc(ccc2cn1)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,,CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1147830,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CCc1cc2cc(ccc2cn1)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,Row1996,15,0.1284933984279632,out,6
1062,Row1193,Row3337,CHEMBL381328,,0,381.48,2o,IC50,=,146.0,nM,N[C@@H](Cc1cc2ccccc2cc1)COc3cc(cnc3)/C=C/c4ccncc4,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1cc2ccccc2cc1)COc3cc(cnc3)/C=C/c4ccncc4,,Row615,77,0.1116797104477882,out,6
1063,Row1194,Row209,CHEMBL209231,,0,531.58,9i,IC50,=,147.0,nM,Oc1[nH]c2ccc(cc2n1)-c3cncc(c3)OC[C@H](Cc4c[nH]c5ccccc45)Nc6cc7nc(O)[nH]c7cc6,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Oc1[nH]c2ccc(cc2n1)-c3cncc(c3)OC[C@H](Cc4c[nH]c5ccccc45)Nc6cc7nc(O)[nH]c7cc6,,Row837,29,0.1136120855808258,out,6
1064,Row1195,Row310,CHEMBL381610,,0,475.6,10i,IC50,=,147.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)/C=C/c4cc(NCc5ccccc5)ncc4,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)/C=C/c4cc(NCc5ccccc5)ncc4,,Row77,56,0.1232665553689003,out,6
1065,Row1197,Row1246,CHEMBL2216825,LACTOQUINOMYCIN,0,457.48,"1, lactoquinomycin",IC50,=,149.0,nM,C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C3=C1C(=O)c4c(ccc([C@H]5C[C@H]([C@H](O)[C@@H](C)O5)N(C)C)c4O)C3=O,,,CHEMBL1018804,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153413,1,Scientific Literature,J. Med. Chem.,2009.0,C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C3=C1C(=O)c4c(ccc([C@H]5C[C@H]([C@H](O)[C@@H](C)O5)N(C)C)c4O)C3=O,,Row2387,28,0.0977844893932342,out,6
1066,Row1198,Row2755,CHEMBL2325986,,0,364.45,39,IC50,=,149.0,nM,CC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc32)c4ccccc4,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,CC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc32)c4ccccc4,,Row3863,35,0.1665579676628112,out,6
1067,Row1199,Row3974,CHEMBL4446884,,0,466.8,D17,IC50,=,149.3,nM,Cn1ncc(Cl)c1-c2cc(C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4)n(C)c2Cl,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4)n(C)c2Cl,,Row39,44,0.0941598638892173,out,6
1068,Row1200,Row475,CHEMBL3684348,,0,466.45,BDBM103060,IC50,=,150.0,nM,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6cc(F)c(F)cc6,,220782.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6cc(F)c(F)cc6,,Row2783,67,0.1442481577396392,out,6
1069,Row1201,Row871,CHEMBL522996,,0,284.27,7-Deoxykalafungin,IC50,=,150.0,nM,C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C3=C1C(=O)c4ccccc4C3=O,,,CHEMBL3100278,Inhibition of AKT1 (unknown origin) by high-throughput screen assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3098129,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2014.0,C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C3=C1C(=O)c4ccccc4C3=O,,Row2387,28,0.1256300210952758,out,6
1070,Row1202,Row1056,CHEMBL3684426,,0,515.0,BDBM103139,IC50,=,150.0,nM,O=S(=O)(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6cc(Cl)ccc6,,220861.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=S(=O)(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6cc(Cl)ccc6,,Row3925,73,0.1317653954029083,out,6
1071,Row1205,Row2212,CHEMBL1800269,,0,1047.32,26,IC50,=,150.0,nM,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCCN)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N(CC(N)=O)CCCN,,,CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1799953,1,Scientific Literature,J. Med. Chem.,2011.0,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCCN)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N(CC(N)=O)CCCN,,Row2426,74,0.0626890435814857,out,6
1072,Row1206,Row2880,CHEMBL1258550,,0,391.48,7,IC50,=,150.0,nM,COc1ccc(C[C@@H](N)C(=O)N2CCN(CC2)c3ncnc4ccccc34)cc1,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,COc1ccc(C[C@@H](N)C(=O)N2CCN(CC2)c3ncnc4ccccc34)cc1,,Row875,55,0.1341486722230911,out,6
1073,Row1207,Row2906,CHEMBL3909655,,0,521.52,BDBM182314,IC50,=,150.0,nM,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4cc(ccc4)C#N)-c5cc(c(F)cc5)C(F)(F)F,,329780.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4cc(ccc4)C#N)-c5cc(c(F)cc5)C(F)(F)F,,Row3758,45,0.1305514872074127,out,6
1074,Row1208,Row3917,CHEMBL3684512,,0,519.01,BDBM103226,IC50,=,150.0,nM,Clc1cc2[nH]c(CCNCc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)nc2cc1,,220948.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Clc1cc2[nH]c(CCNCc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)nc2cc1,,Row3925,73,0.1280278861522674,out,6
1075,Row1209,Row3940,CHEMBL3983786,,0,501.61,BDBM182460,IC50,=,150.0,nM,Cc1cc(ccc1F)-c2cn(CCNC3CC3)c(n2)C4CCN(CC4)c5ncnc(N)c5-c6cn[nH]c6,,329901.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCNC3CC3)c(n2)C4CCN(CC4)c5ncnc(N)c5-c6cn[nH]c6,,Row2590,1,0.1099478304386138,out,6
1076,Row1211,Row2454,CHEMBL428963,,0,291.32,5d,IC50,=,151.0,nM,Cc1[nH]c(nn1)-c2ccccc2Nc3ncnc4[nH]ccc34,,,CHEMBL936668,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143084,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Cc1[nH]c(nn1)-c2ccccc2Nc3ncnc4[nH]ccc34,,Row2454,78,0.1014394089579582,out,6
1077,Row1212,Row236,CHEMBL210237,,0,569.71,11j,IC50,=,153.0,nM,CC(C)(Cc1c[nH]c2ccccc12)C3c4cc(ccc4NC3=O)-c5cncc(c5)OC[C@@H](N)Cc6c[nH]c7ccccc76,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC(C)(Cc1c[nH]c2ccccc12)C3c4cc(ccc4NC3=O)-c5cncc(c5)OC[C@@H](N)Cc6c[nH]c7ccccc76,,Row236,4,0.1275218725204467,out,6
1078,Row1214,Row3222,CHEMBL573096,,0,513.6,121,IC50,=,153.0,nM,N[C@H](COc1cncc(c1)-c2ccc3NC(=O)C(c4c[nH]c5ccccc54)c3c2)Cc6c[nH]c7ccccc67,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@H](COc1cncc(c1)-c2ccc3NC(=O)C(c4c[nH]c5ccccc54)c3c2)Cc6c[nH]c7ccccc67,,Row124,3,0.1257348954677581,out,6
1079,Row1215,Row279,CHEMBL470409,,0,365.26,26,IC50,=,158.0,nM,NCCNC(=O)c1cc(Br)c(s1)-c2ccnc3[nH]ccc23,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NCCNC(=O)c1cc(Br)c(s1)-c2ccnc3[nH]ccc23,,Row284,18,0.1099275946617126,out,6
1080,Row1217,Row90,CHEMBL3113129,,0,377.88,2,IC50,=,160.0,nM,CC(C)NC(c1ccc(Cl)cc1)c2ccc(cc2)-c3ncnc4[nH]cnc34,,,CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3112393,1,Scientific Literature,Eur. J. Med. Chem.,2014.0,CC(C)NC(c1ccc(Cl)cc1)c2ccc(cc2)-c3ncnc4[nH]cnc34,,Row2632,65,0.1032137423753738,out,6
1081,Row1218,Row106,CHEMBL208962,,0,409.49,10n,IC50,=,160.0,nM,Nc1nccc2cc(ccc12)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc54,,,CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1147830,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Nc1nccc2cc(ccc12)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc54,,Row1996,15,0.1315077394247055,out,6
1082,Row1219,Row376,CHEMBL3950201,,0,504.64,BDBM182406,IC50,=,160.0,nM,CCc1c(ncnc1N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(c(cc5)OC)C(N)=O,,329847.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(ncnc1N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(c(cc5)OC)C(N)=O,,Row3753,7,0.1328922659158706,out,6
1083,Row1220,Row600,CHEMBL3684365,,0,482.51,BDBM103078,IC50,=,160.0,nM,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)c6cnc7ccccc7n6,,220800.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)c6cnc7ccccc7n6,,Row2783,67,0.1384595930576324,out,6
1084,Row1221,Row1326,CHEMBL1760774,,0,514.7,27g,IC50,=,160.0,nM,Cc1ccc(c(C)c1)S(=O)(=O)NC[C@@H](O)CN2C[C@@]3(CN(CC3)c4ncnc(N)c4C5CC5)CCC2,,,CHEMBL1763788,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759869,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,Cc1ccc(c(C)c1)S(=O)(=O)NC[C@@H](O)CN2C[C@@]3(CN(CC3)c4ncnc(N)c4C5CC5)CCC2,,Row315,48,0.112251803278923,out,6
1085,Row1222,Row1356,CHEMBL1800390,,0,1089.4,31,IC50,=,160.0,nM,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCCCCN)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N(CC(N)=O)CCCCN,,,CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1799953,1,Scientific Literature,J. Med. Chem.,2011.0,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCCCCN)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N(CC(N)=O)CCCCN,,Row2426,74,0.0640141144394874,out,6
1086,Row1223,Row1820,CHEMBL1800402,,0,1101.37,43,IC50,=,160.0,nM,CC(C)CC[C@@H]1NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCCCCNC(=O)NCCCN(CC(N)=O)C1=O)C(=O)[C@@H](N)CCCNC(N)=N,,,CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1799953,1,Scientific Literature,J. Med. Chem.,2011.0,CC(C)CC[C@@H]1NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCCCCNC(=O)NCCCN(CC(N)=O)C1=O)C(=O)[C@@H](N)CCCNC(N)=N,,Row1816,79,0.081344686448574,out,6
1087,Row1224,Row2095,CHEMBL1204095,,0,526.01,8,IC50,=,160.0,nM,COc1ccc(O)c(c1F)C(=O)c2ccc(cc2)/C=C/[C@@H]3CCCNC[C@H]3NC(=O)c4ccncc4,,,CHEMBL766409,Inhibition of Protein kinase B alpha,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1149095,1,Scientific Literature,J. Med. Chem.,2004.0,COc1ccc(O)c(c1F)C(=O)c2ccc(cc2)/C=C/[C@@H]3CCCNC[C@H]3NC(=O)c4ccncc4,,Row2523,51,0.1002106815576553,out,6
1088,Row1225,Row2409,CHEMBL3906695,,0,514.53,BDBM182454,IC50,=,160.0,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3C4CCNCC4)-c5cc(c(F)cc5)C(F)(F)F,,329895.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3C4CCNCC4)-c5cc(c(F)cc5)C(F)(F)F,,Row2188,10,0.1090783104300499,out,6
1089,Row1226,Row2464,CHEMBL3684342,,0,460.5,BDBM103054,IC50,=,160.0,nM,COc1ccc(cc1)C(=O)Nc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,220776.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,COc1ccc(cc1)C(=O)Nc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,Row2783,67,0.1456862390041351,out,6
1090,Row1228,Row2905,CHEMBL3904322,,0,448.42,BDBM182305,IC50,=,160.0,nM,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C=O)-c4cc(c(F)cc4)C(F)(F)F,,329772.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C=O)-c4cc(c(F)cc4)C(F)(F)F,,Row3758,45,0.1161953434348106,out,6
1091,Row1229,Row4016,CHEMBL3684338,,0,460.5,BDBM103050,IC50,=,160.0,nM,COc1cc(ccc1)C(=O)Nc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,220772.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,COc1cc(ccc1)C(=O)Nc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,Row2783,67,0.1589784026145935,out,6
1092,Row1230,Row1279,CHEMBL403355,,0,467.6,12i,IC50,=,162.0,nM,Cc1[nH]nc(CCNCc2ccc(cc2)-c3nc4nc(ncc4cc3-c5ccccc5)SC)n1,,,CHEMBL928491,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141509,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Cc1[nH]nc(CCNCc2ccc(cc2)-c3nc4nc(ncc4cc3-c5ccccc5)SC)n1,,Row3742,50,0.167848527431488,out,6
1093,Row1231,Row407,CHEMBL4544411,,0,463.76,D7,IC50,=,162.5,nM,Cn1nccc1-c2oc(cc2Br)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1nccc1-c2oc(cc2Br)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,Row39,44,0.0867606177926063,out,6
1094,Row1232,Row2052,CHEMBL382914,,0,413.53,10g,IC50,=,163.0,nM,CCNc1cc(ccn1)/C=C/c2cc(cnc2)OC[C@@H](N)Cc3c[nH]c4ccccc34,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CCNc1cc(ccn1)/C=C/c2cc(cnc2)OC[C@@H](N)Cc3c[nH]c4ccccc34,,Row77,56,0.1167177855968475,out,6
1095,Row1233,Row2387,CHEMBL475826,,0,312.32,(+/-)-anti-11h,IC50,=,163.0,nM,CCC[C@H]1O[C@@H]2CC(=O)O[C@@H]2C3=C1C(=O)c4ccccc4C3=O,,,CHEMBL1018804,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153413,1,Scientific Literature,J. Med. Chem.,2009.0,CCC[C@H]1O[C@@H]2CC(=O)O[C@@H]2C3=C1C(=O)c4ccccc4C3=O,,Row2387,28,0.1238312274217605,out,6
1096,Row1234,Row3930,CHEMBL3931262,,0,428.54,BDBM182430,IC50,=,165.0,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccccc5,,329871.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccccc5,,Row3990,26,0.1592184156179428,out,6
1097,Row1235,Row91,CHEMBL273160,,0,555.64,2b,IC50,=,166.0,nM,OC(=O)c1cc2nc(c(nc2cc1)-c3ccccc3)-c4ccc(CN5CCC(CC5)n6c7ccccc7[nH]c6=O)cc4,,,CHEMBL948032,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,OC(=O)c1cc2nc(c(nc2cc1)-c3ccccc3)-c4ccc(CN5CCC(CC5)n6c7ccccc7[nH]c6=O)cc4,,Row2123,58,0.1838054209947586,out,6
1098,Row1237,Row726,CHEMBL1761087,,0,541.71,29,IC50,=,170.0,nM,CCOCCN(C[C@@H](O)CN1CC2(CCC1)CCc3cc(ccc3O2)C#N)S(=O)(=O)c4c(C)cccc4C,,,CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759945,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CCOCCN(C[C@@H](O)CN1CC2(CCC1)CCc3cc(ccc3O2)C#N)S(=O)(=O)c4c(C)cccc4C,,Row2370,39,0.1190228313207626,out,6
1099,Row1238,Row1816,CHEMBL1800566,,0,1087.34,46,IC50,=,170.0,nM,CC(C)CC[C@@H]1NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCCNC(=O)NCCCCN(CC(N)=O)C1=O)C(=O)[C@@H](N)CCCNC(N)=N,,,CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1799953,1,Scientific Literature,J. Med. Chem.,2011.0,CC(C)CC[C@@H]1NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCCNC(=O)NCCCCN(CC(N)=O)C1=O)C(=O)[C@@H](N)CCCNC(N)=N,,Row1816,79,0.0825803503394126,out,6
1100,Row1241,Row3013,CHEMBL3918747,,0,503.66,BDBM182642,IC50,=,170.0,nM,CC(C)(C)c1cc(ccn1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,330083.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(C)(C)c1cc(ccn1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,Row1206,41,0.1282155066728592,out,6
1101,Row1242,Row3146,CHEMBL3113136,,0,350.89,12c,IC50,=,170.0,nM,CC(C)(C)NC(c1ccc(Cl)cc1)c2ccc(cc2)-c3ccncc3,,,CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3112393,1,Scientific Literature,Eur. J. Med. Chem.,2014.0,CC(C)(C)NC(c1ccc(Cl)cc1)c2ccc(cc2)-c3ccncc3,,Row2632,65,0.1060246601700782,out,6
1102,Row1243,Row3211,CHEMBL3684441,,0,552.65,BDBM103154,IC50,=,170.0,nM,C(c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)N6CCC(CC6)c7[nH]c(nn7)-c8ccncc8,,220876.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,C(c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)N6CCC(CC6)c7[nH]c(nn7)-c8ccncc8,,Row2452,66,0.1513651460409164,out,6
1103,Row1244,Row3633,CHEMBL3684422,,0,498.54,BDBM103135,IC50,=,170.0,nM,O=S(=O)(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccccc6F,,220857.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=S(=O)(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccccc6F,,Row3925,73,0.1298927068710327,out,6
1104,Row1245,Row343,CHEMBL259834,,0,325.76,5e,IC50,=,171.0,nM,Cc1[nH]c(nn1)-c2cc(Cl)ccc2Nc3ncnc4[nH]ccc34,,,CHEMBL936668,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143084,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Cc1[nH]c(nn1)-c2cc(Cl)ccc2Nc3ncnc4[nH]ccc34,,Row2454,78,0.0783175081014633,out,6
1105,Row1249,Row2439,CHEMBL2021429,,0,489.0,33,IC50,=,174.0,nM,CNS(=O)(=O)c1cc2c(ncnc2cc1)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,CNS(=O)(=O)c1cc2c(ncnc2cc1)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,Row875,55,0.0934140384197235,out,6
1106,Row1253,Row620,CHEMBL202787,,0,399.5,10f,IC50,=,176.0,nM,CNc1cc(ccn1)/C=C/c2cc(cnc2)OC[C@@H](N)Cc3c[nH]c4ccccc34,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CNc1cc(ccn1)/C=C/c2cc(cnc2)OC[C@@H](N)Cc3c[nH]c4ccccc34,,Row77,56,0.1162831038236618,out,6
1107,Row1254,Row1338,CHEMBL1800387,,0,1033.29,28,IC50,=,176.0,nM,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCN)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N(CC(N)=O)CCCCN,,,CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1799953,1,Scientific Literature,J. Med. Chem.,2011.0,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCN)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N(CC(N)=O)CCCCN,,Row2426,74,0.062158640474081,out,6
1108,Row1255,Row1638,CHEMBL4159491,,0,511.51,11c,IC50,=,176.0,nM,Cc1nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc(c1C(=O)OCC)-c5ccc(F)cc5,,,CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4130433,1,Scientific Literature,Eur J Med Chem,2017.0,Cc1nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc(c1C(=O)OCC)-c5ccc(F)cc5,,Row2772,33,0.1319699138402938,out,6
1109,Row1257,Row1065,CHEMBL425155,,0,502.61,8b,IC50,=,177.0,nM,C(NCc1ccc(cc1)-c2csnn2)c3ccc(cc3)-c4ncc(cc4-c5ccccc5)-c6n[nH]nn6,,,CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141976,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,C(NCc1ccc(cc1)-c2csnn2)c3ccc(cc3)-c4ncc(cc4-c5ccccc5)-c6n[nH]nn6,,Row3742,50,0.1943323165178299,out,6
1110,Row1259,Row837,CHEMBL377687,,0,557.57,9g,IC50,=,179.0,nM,O=C1Nc2ccc(cc2C1=O)-c3cncc(c3)OC[C@H](Cc4c[nH]c5ccccc45)Nc6cc7c(cc6)NC(=O)C7=O,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,O=C1Nc2ccc(cc2C1=O)-c3cncc(c3)OC[C@H](Cc4c[nH]c5ccccc45)Nc6cc7c(cc6)NC(=O)C7=O,,Row837,29,0.1136081144213676,out,6
1111,Row1262,Row3167,CHEMBL516429,,0,400.51,102,IC50,=,179.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5ccncc5s4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5ccncc5s4,,Row1996,15,0.1283654868602752,out,6
1112,Row1264,Row1872,CHEMBL1173273,,0,217.28,5,IC50,=,180.0,nM,Cc1c[nH]c2ncnc(c21)N3C[C@H](N)CC3,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,Cc1c[nH]c2ncnc(c21)N3C[C@H](N)CC3,,Row1872,62,0.1013545021414756,out,6
1113,Row1265,Row2250,CHEMBL3932730,,0,503.55,BDBM182513,IC50,=,180.0,nM,Nc1cc(ncn1)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)c(c5)C(F)(F)F,,329954.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1cc(ncn1)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row643,24,0.1265358328819275,out,6
1114,Row1266,Row2308,CHEMBL378714,,0,432.53,10w,IC50,=,180.0,nM,CC#Cc1cc2cc(ccc2cn1)-c3cc(cnc3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,,CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1147830,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC#Cc1cc2cc(ccc2cn1)-c3cc(cnc3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,Row1996,15,0.1286001354455948,out,6
1115,Row1267,Row2351,CHEMBL1761086,,0,534.69,27,IC50,=,180.0,nM,CCOCCN(C[C@@H](O)CN1CC2(CCC1)CCc3cc(F)ccc3O2)S(=O)(=O)c4c(C)cccc4C,,,CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759945,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CCOCCN(C[C@@H](O)CN1CC2(CCC1)CCc3cc(F)ccc3O2)S(=O)(=O)c4c(C)cccc4C,,Row2370,39,0.1115581914782524,out,6
1116,Row1268,Row2887,CHEMBL3949232,,0,493.47,BDBM182694,IC50,=,180.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCO)-c4ccc(F)c(c4)C(F)(F)F,,330135.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCO)-c4ccc(F)c(c4)C(F)(F)F,,Row2044,43,0.1178213730454444,out,6
1117,Row1269,Row3314,CHEMBL3973946,,0,569.61,BDBM182369,IC50,=,180.0,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4cnc(N)cc4)-c5cc(c(F)cc5)C(F)(F)F,,329810.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4cnc(N)cc4)-c5cc(c(F)cc5)C(F)(F)F,,Row2164,32,0.114753246307373,out,6
1118,Row1270,Row3457,CHEMBL3950595,,0,513.61,BDBM182570,IC50,=,180.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(cc5)C(F)(F)F,,330011.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(cc5)C(F)(F)F,,Row3753,7,0.1245041713118553,out,6
1119,Row1272,Row2615,CHEMBL1081437,,0,458.51,23,IC50,=,181.0,nM,N[C@H](CNc1nnc(s1)-c2cc3c(n[nH]c3cc2)C4CC4)Cc5ccc(cc5)C(F)(F)F,,,CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154933,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](CNc1nnc(s1)-c2cc3c(n[nH]c3cc2)C4CC4)Cc5ccc(cc5)C(F)(F)F,,Row1834,53,0.1134456843137741,out,6
1120,Row1273,Row709,CHEMBL4544069,,0,458.33,D28,IC50,=,181.8,nM,Cn1ncc(Br)c1-c2ccc(nc2)C(=O)N[C@@H]3CNCC[C@H]3c4cc(F)ccc4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Br)c1-c2ccc(nc2)C(=O)N[C@@H]3CNCC[C@H]3c4cc(F)ccc4,,Row1315,22,0.1273092627525329,out,6
1121,Row1274,Row1380,CHEMBL2325990,,0,442.55,43,IC50,=,183.0,nM,CC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc23)c4ccc(cc4)S(C)(=O)=O,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,CC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc23)c4ccc(cc4)S(C)(=O)=O,,Row3863,35,0.1246046423912048,out,6
1122,Row1275,Row2380,CHEMBL1095621,,0,499.55,9j,IC50,=,183.0,nM,COc1cc2c(cc1OC)ncc3c2cc(nc3N)-c4cncc(c4)OC[C@@H](N)Cc5ccc(F)cc5,,,CHEMBL1103721,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157027,1,Scientific Literature,Eur. J. Med. Chem.,2010.0,COc1cc2c(cc1OC)ncc3c2cc(nc3N)-c4cncc(c4)OC[C@@H](N)Cc5ccc(F)cc5,,Row1813,70,0.1052987948060035,out,6
1123,Row1277,Row3890,CHEMBL4530506,,0,400.94,D10,IC50,=,187.9,nM,Cn1nccc1-c2cc(sc2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1nccc1-c2cc(sc2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,Row39,44,0.0863514840602874,out,6
1124,Row1280,Row51,CHEMBL3945304,,0,480.06,BDBM182572,IC50,=,190.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(Cl)cc5,,330013.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(Cl)cc5,,Row3753,7,0.1275478154420852,out,6
1125,Row1282,Row1167,CHEMBL3913301,,0,546.57,BDBM182587,IC50,=,190.0,nM,CC(=O)Nc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,330028.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(=O)Nc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row2044,43,0.1198745444416999,out,6
1126,Row1283,Row1586,CHEMBL207496,,0,395.47,99,IC50,=,190.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc4nc(ccc43)-c5ccncc5,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc4nc(ccc43)-c5ccncc5,,Row77,56,0.1306385099887848,out,6
1127,Row1284,Row2029,CHEMBL3897534,,0,545.63,BDBM182382,IC50,=,190.0,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3CCC4CC4)-c5cc(c(F)cc5)C(F)(F)F,,329823.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3CCC4CC4)-c5cc(c(F)cc5)C(F)(F)F,,Row2164,32,0.109323114156723,out,6
1128,Row1285,Row2097,CHEMBL1823640,,0,379.89,12,IC50,=,190.0,nM,O=C(NC(C1CCNCC1)c2ccc(Cl)cc2)c3ccc4cnccc4c3,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,O=C(NC(C1CCNCC1)c2ccc(Cl)cc2)c3ccc4cnccc4c3,,Row3192,40,0.1022334769368171,out,6
1129,Row1286,Row2410,CHEMBL3915684,,0,517.58,BDBM182456,IC50,=,190.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3C4CCNCC4)-c5cc(c(F)cc5)C(F)(F)F,,329897.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3C4CCNCC4)-c5cc(c(F)cc5)C(F)(F)F,,Row2164,32,0.1131421625614166,out,6
1130,Row1287,Row2776,CHEMBL3919026,,0,511.6,BDBM182568,IC50,=,190.0,nM,C=Cc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(cc5)C(F)(F)F,,330009.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,C=Cc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(cc5)C(F)(F)F,,Row643,24,0.1201092526316642,out,6
1131,Row1288,Row3952,CHEMBL3904383,,0,611.69,BDBM182386,IC50,=,190.0,nM,CC(C)(O)c1ccc(cc1)-c2c(N)ncnc2N3CCC(CC3)c4nc(cn4CCN(C)C)-c5ccc(F)c(c5)C(F)(F)F,,329827.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CC(C)(O)c1ccc(cc1)-c2c(N)ncnc2N3CCC(CC3)c4nc(cn4CCN(C)C)-c5ccc(F)c(c5)C(F)(F)F,,Row2164,32,0.1134626716375351,out,6
1132,Row1289,Row1205,CHEMBL4570911,,0,536.49,A2,IC50,=,191.0,nM,Cn1nccc1-c2cc(oc2)C(=O)NC3CNCCC3c4ccc(F)c(F)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1nccc1-c2cc(oc2)C(=O)NC3CNCCC3c4ccc(F)c(F)c4,,Row39,44,0.090899221599102,out,6
1133,Row1294,Row201,CHEMBL1088613,,0,382.47,12,IC50,=,198.0,nM,Cc1n[nH]c2ccc(cc21)-c3nnc(NC[C@@H](N)Cc4ccccc4F)s3,,,CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154933,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3nnc(NC[C@@H](N)Cc4ccccc4F)s3,,Row1834,53,0.1256973445415496,out,6
1134,Row1295,Row572,CHEMBL474390,FRENOLICIN B,0,328.32,Frenolicin B,IC50,=,198.0,nM,CCC[C@H]1O[C@@H]2CC(=O)O[C@@H]2C3=C1C(=O)c4c(O)cccc4C3=O,,,CHEMBL3100278,Inhibition of AKT1 (unknown origin) by high-throughput screen assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3098129,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2014.0,CCC[C@H]1O[C@@H]2CC(=O)O[C@@H]2C3=C1C(=O)c4c(O)cccc4C3=O,,Row2387,28,0.1055758967995643,out,6
1135,Row1296,Row628,CHEMBL203329,,0,402.93,15,IC50,=,198.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)CCc3cnc(Cl)c(c3)/C=C/c4ccncc4,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)CCc3cnc(Cl)c(c3)/C=C/c4ccncc4,,Row77,56,0.1124814450740814,out,6
1136,Row1297,Row1366,CHEMBL252056,,0,469.64,12e,IC50,=,198.0,nM,CSc1ncc2cc(-c3ccccc3)c(nc2n1)-c4ccc(CNCCc5nccs5)cc4,,,CHEMBL928491,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141509,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CSc1ncc2cc(-c3ccccc3)c(nc2n1)-c4ccc(CNCCc5nccs5)cc4,,Row3742,50,0.1693460941314697,out,6
1137,Row1300,Row1054,CHEMBL4560290,,0,555.7,D18,IC50,=,199.1,nM,Cn1ncc(Br)c1-c2cc(C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4)n(C)c2Br,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Br)c1-c2cc(C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4)n(C)c2Br,,Row39,44,0.0928570851683616,out,6
1138,Row1301,Row125,CHEMBL188434,,0,342.41,9,IC50,=,200.0,nM,CCn1c2c(cncc2CNC3CCNCC3)nc1-c4nonc4N,,,CHEMBL1028090,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140130,1,Scientific Literature,J. Med. Chem.,2008.0,CCn1c2c(cncc2CNC3CCNCC3)nc1-c4nonc4N,,Row1117,69,0.1193625777959823,out,6
1139,Row1302,Row142,CHEMBL3299032,,0,890.06,"figure5, R2C1",IC50,=,200.0,nM,CN([C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](COC)C(=O)NCCCC(O)=O)C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CCCNC(N)=N,,,CHEMBL3364360,Inhibition of AKT1 (unknown origin) after 30 mins by scintillation counting analysis in presence of 100 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3297689,1,Scientific Literature,ACS Med. Chem. Lett.,2014.0,CN([C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](COC)C(=O)NCCCC(O)=O)C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CCCNC(N)=N,,Row466,80,0.0870838090777397,out,6
1140,Row1303,Row757,CHEMBL1173349,,0,251.72,6,IC50,=,200.0,nM,NC1CN(CCC1)c2ncnc3[nH]cc(Cl)c23,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,NC1CN(CCC1)c2ncnc3[nH]cc(Cl)c23,,Row1872,62,0.1049922108650207,out,6
1141,Row1304,Row1603,CHEMBL1823637,,0,455.99,9,IC50,=,200.0,nM,O=C(NC(C1CCNCC1)c2cc(c(Cl)cc2)-c3ccccc3)c4ccc5cnccc5c4,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,O=C(NC(C1CCNCC1)c2cc(c(Cl)cc2)-c3ccccc3)c4ccc5cnccc5c4,,Row3192,40,0.1597573906183242,out,6
1142,Row1305,Row1751,CHEMBL3684406,,0,445.49,BDBM103119,IC50,=,200.0,nM,O=C(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6cccnc6,,220841.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6cccnc6,,Row2783,67,0.1425498276948928,out,6
1143,Row1306,Row3838,CHEMBL3684409,,0,444.5,BDBM103122,IC50,=,200.0,nM,O=C(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccccc6,,220844.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccccc6,,Row2783,67,0.151418924331665,out,6
1144,Row1313,Row3279,CHEMBL1098302,,0,549.55,9l,IC50,=,209.0,nM,COc1cc2c(cc1OC)ncc3c2cc(nc3N)-c4cncc(c4)OC[C@@H](N)Cc5cc(ccc5)C(F)(F)F,,,CHEMBL1103721,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157027,1,Scientific Literature,Eur. J. Med. Chem.,2010.0,COc1cc2c(cc1OC)ncc3c2cc(nc3N)-c4cncc(c4)OC[C@@H](N)Cc5cc(ccc5)C(F)(F)F,,Row1813,70,0.1088464856147766,out,6
1145,Row1314,Row272,CHEMBL3907714,,0,435.55,BDBM182543,IC50,=,210.0,nM,Nc1cc(ncn1)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)ccc5,,329984.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1cc(ncn1)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)ccc5,,Row3753,7,0.1446697115898132,out,6
1146,Row1315,Row473,CHEMBL3976022,,0,563.62,BDBM182549,IC50,=,210.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CC(F)CCC4)-c5cc(F)c(cc5)C(F)(F)F,,329990.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CC(F)CCC4)-c5cc(F)c(cc5)C(F)(F)F,,Row3753,7,0.1181540936231613,out,6
1147,Row1316,Row1108,CHEMBL575646,,0,372.47,86,IC50,=,210.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(CCc4ccncc4)cnc3,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(CCc4ccncc4)cnc3,,Row77,56,0.1167237535119056,out,6
1148,Row1317,Row1181,CHEMBL3964344,,0,529.59,BDBM182538,IC50,=,210.0,nM,C=Cc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)c(cc5)C(F)(F)F,,329979.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,C=Cc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)c(cc5)C(F)(F)F,,Row643,24,0.1190155372023582,out,6
1149,Row1318,Row1377,CHEMBL206208,,0,368.44,2a,IC50,=,210.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)C#Cc4ccncc4,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)C#Cc4ccncc4,,Row77,56,0.113500140607357,out,6
1150,Row1319,Row1589,CHEMBL206732,,0,409.49,100,IC50,=,210.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)CNc3cc(cnc3)Oc4cccc5cnccc54,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)CNc3cc(cnc3)Oc4cccc5cnccc54,,Row1996,15,0.1205559894442558,out,6
1151,Row1320,Row2072,CHEMBL261204,,0,277.29,1,IC50,=,210.0,nM,c1[nH]c(nn1)-c2ccccc2Nc3ncnc4[nH]ccc43,,,CHEMBL936668,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143084,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,c1[nH]c(nn1)-c2ccccc2Nc3ncnc4[nH]ccc43,,Row2454,78,0.1027427390217781,out,6
1152,Row1321,Row2855,CHEMBL3684511,,0,501.57,BDBM103225,IC50,=,210.0,nM,Fc1cc2[nH]cc(CCNCc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)c2cc1,,220947.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Fc1cc2[nH]cc(CCNCc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)c2cc1,,Row3925,73,0.1335701644420623,out,6
1153,Row1322,Row3628,CHEMBL4457188,,0,432.36,D15,IC50,=,211.9,nM,Cn1ncc(Cl)c1-c2cc(C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4)n(C)c2,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4)n(C)c2,,Row39,44,0.0944557338953018,out,6
1154,Row1324,Row720,CHEMBL573394,,0,395.47,43,IC50,=,215.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5ccnnc5cc4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5ccnnc5cc4,,Row1996,15,0.1261621415615081,out,6
1155,Row1325,Row3909,CHEMBL4451405,,0,431.87,D24,IC50,=,215.0,nM,Cn1ncc(Cl)c1-c2ccc(cn2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(F)c(F)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2ccc(cn2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(F)c(F)c4,,Row1315,22,0.0955914407968521,out,6
1156,Row1328,Row492,CHEMBL3906804,,0,419.49,BDBM182431,IC50,=,220.0,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cnoc5,,329872.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cnoc5,,Row3990,26,0.0914311558008194,out,6
1157,Row1329,Row1017,CHEMBL1800266,,0,1033.29,22,IC50,=,220.0,nM,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCCN)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N(CCN)CC(N)=O,,,CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1799953,1,Scientific Literature,J. Med. Chem.,2011.0,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCCN)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N(CCN)CC(N)=O,,Row2426,74,0.062158640474081,out,6
1158,Row1330,Row1243,CHEMBL3955405,,0,518.52,BDBM182449,IC50,=,220.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CC4CCN4)-c5cc(c(F)cc5)C(F)(F)F,,329890.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CC4CCN4)-c5cc(c(F)cc5)C(F)(F)F,,Row2044,43,0.1166931465268135,out,6
1159,Row1331,Row2782,CHEMBL3927542,,0,495.03,BDBM182645,IC50,=,220.0,nM,Cc1ccc(cc1Cl)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,330086.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1ccc(cc1Cl)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,Row1206,41,0.1252944767475128,out,6
1160,Row1332,Row2795,CHEMBL3901251,,0,532.55,BDBM182452,IC50,=,220.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CC4CCCN4)-c5cc(c(F)cc5)C(F)(F)F,,329893.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CC4CCCN4)-c5cc(c(F)cc5)C(F)(F)F,,Row2044,43,0.1244618222117424,out,6
1161,Row1333,Row3291,CHEMBL3113134,,0,336.87,12a,IC50,=,220.0,nM,CC(C)NC(c1ccc(Cl)cc1)c2ccc(cc2)-c3ccncc3,,,CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3112393,1,Scientific Literature,Eur. J. Med. Chem.,2014.0,CC(C)NC(c1ccc(Cl)cc1)c2ccc(cc2)-c3ccncc3,,Row2632,65,0.1040860414505004,out,6
1162,Row1334,Row3487,CHEMBL3684415,,0,481.54,BDBM103128,IC50,=,220.0,nM,O=S(=O)(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)c6cccnc6,,220850.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=S(=O)(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)c6cccnc6,,Row3925,73,0.138161763548851,out,6
1163,Row1335,Row3989,CHEMBL3684429,,0,515.0,BDBM103142,IC50,=,220.0,nM,O=S(=O)(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccc(Cl)cc6,,220864.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=S(=O)(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccc(Cl)cc6,,Row3925,73,0.1297648847103119,out,6
1164,Row1337,Row3565,CHEMBL4582476,,0,471.36,D13,IC50,=,222.2,nM,Cn1ncc(Cl)c1-c2cc(sc2Cl)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(F)c(F)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(sc2Cl)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(F)c(F)c4,,Row1315,22,0.0880561769008636,out,6
1165,Row1338,Row2289,CHEMBL226331,,0,345.41,9h,IC50,=,223.0,nM,N[C@@H](Cc1ccccc1)COc2cncc(c2)-c3cc4cn[nH]c4cn3,,,CHEMBL903964,Inhibition of Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142911,1,Scientific Literature,Bioorg. Med. Chem.,2007.0,N[C@@H](Cc1ccccc1)COc2cncc(c2)-c3cc4cn[nH]c4cn3,,Row535,12,0.1268724799156189,out,6
1166,Row1340,Row3742,CHEMBL276130,,0,429.55,12a,IC50,=,226.0,nM,CSc1nc2nc(-c3ccc(CNCCC(N)=O)cc3)c(cc2cn1)-c4ccccc4,,,CHEMBL928491,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141509,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CSc1nc2nc(-c3ccc(CNCCC(N)=O)cc3)c(cc2cn1)-c4ccccc4,,Row3742,50,0.1880290210247039,out,6
1167,Row1341,Row158,CHEMBL210093,,0,412.47,10j,IC50,=,227.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5ccnc(F)c5cc4,,,CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1147830,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5ccnc(F)c5cc4,,Row1996,15,0.1307208091020584,out,6
1168,Row1342,Row619,CHEMBL381785,,0,400.48,9m,IC50,=,227.0,nM,CC(=O)Nc1ccc(cc1)-c2cncc(c2)OC[C@@H](N)Cc3c[nH]c4ccccc34,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC(=O)Nc1ccc(cc1)-c2cncc(c2)OC[C@@H](N)Cc3c[nH]c4ccccc34,,Row1726,2,0.1287327259778976,out,6
1169,Row1343,Row729,CHEMBL375486,,0,424.51,25c,IC50,=,228.0,nM,Cn1cccc1-c2n[nH]c3cnc(cc32)-c4cncc(c4)OC[C@@H](N)Cc5ccccc5,,,CHEMBL903964,Inhibition of Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142911,1,Scientific Literature,Bioorg. Med. Chem.,2007.0,Cn1cccc1-c2n[nH]c3cnc(cc32)-c4cncc(c4)OC[C@@H](N)Cc5ccccc5,,Row535,12,0.1386307328939438,out,6
1170,Row1347,Row2255,CHEMBL3933645,,0,571.6,BDBM182367,IC50,=,230.0,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4ccc(F)cc4)-c5cc(c(F)cc5)C(F)(F)F,,329808.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4ccc(F)cc4)-c5cc(c(F)cc5)C(F)(F)F,,Row2164,32,0.1168269738554954,out,6
1171,Row1348,Row2844,CHEMBL3684355,,0,486.58,BDBM103067,IC50,=,230.0,nM,CC(C)(C)c1ccc(cc1)C(=O)Nc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,220789.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CC(C)(C)c1ccc(cc1)C(=O)Nc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,Row2783,67,0.1355708688497543,out,6
1172,Row1350,Row2049,CHEMBL4522820,,0,384.87,D4,IC50,=,230.2,nM,Cn1nccc1-c2ccc(o2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1nccc1-c2ccc(o2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,Row39,44,0.0886746644973754,out,6
1173,Row1353,Row1216,CHEMBL181730,,0,530.61,8c,IC50,=,239.0,nM,Fc1cc2nc([nH]c2cc1)C3CCN(Cc4ccc(cc4)-c5ncc(cc5-c6ccccc6)-c7n[nH]nn7)CC3,,,CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141976,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,Fc1cc2nc([nH]c2cc1)C3CCN(Cc4ccc(cc4)-c5ncc(cc5-c6ccccc6)-c7n[nH]nn7)CC3,,Row2123,58,0.1987398713827133,out,6
1174,Row1354,Row86,CHEMBL272292,,0,555.64,2a,IC50,=,240.0,nM,OC(=O)c1cc2nc(c(nc2cc1)-c3ccc(CN4CCC(CC4)n5c6ccccc6[nH]c5=O)cc3)-c7ccccc7,,,CHEMBL948032,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,OC(=O)c1cc2nc(c(nc2cc1)-c3ccc(CN4CCC(CC4)n5c6ccccc6[nH]c5=O)cc3)-c7ccccc7,,Row2123,58,0.1838054209947586,out,6
1175,Row1355,Row565,CHEMBL3684359,,0,444.5,BDBM103072,IC50,=,240.0,nM,O=C(Cc1ccccc1)Nc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,220794.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Cc1ccccc1)Nc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,Row2783,67,0.1534544080495834,out,6
1176,Row1356,Row1027,CHEMBL2021603,,0,217.28,3,IC50,=,240.0,nM,Cc1c[nH]c2ncnc(c21)N3C[C@@H](N)CC3,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,Cc1c[nH]c2ncnc(c21)N3C[C@@H](N)CC3,,Row1872,62,0.1013545021414756,out,6
1177,Row1357,Row2323,CHEMBL3684515,,0,489.54,BDBM103229,IC50,=,240.0,nM,Cc1cc(no1)C(=O)NC2(CCC2)c3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45,,220951.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cc1cc(no1)C(=O)NC2(CCC2)c3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45,,Row3391,71,0.2053119242191314,out,6
1178,Row1358,Row3268,CHEMBL1823661,,0,504.46,34,IC50,=,240.0,nM,O=C(N[C@H](C1CCN(Cc2ccccc2)CC1)c3ccc(Cl)c(Cl)c3)c4cc5ccncc5cc4,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,O=C(N[C@H](C1CCN(Cc2ccccc2)CC1)c3ccc(Cl)c(Cl)c3)c4cc5ccncc5cc4,,Row3192,40,0.1376217603683471,out,6
1179,Row1359,Row3655,CHEMBL1800699,,0,889.07,57,IC50,=,240.0,nM,CC(C)CC[C@@H]1NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNCCCNC(=O)NCCN(CC(N)=O)C1=O,,,CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1799953,1,Scientific Literature,J. Med. Chem.,2011.0,CC(C)CC[C@@H]1NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNCCCNC(=O)NCCN(CC(N)=O)C1=O,,Row1816,79,0.0873768478631973,out,6
1180,Row1360,Row3833,CHEMBL3684413,,0,484.55,BDBM103126,IC50,=,240.0,nM,Cn1cc(nc1)S(=O)(=O)NCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,220848.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cn1cc(nc1)S(=O)(=O)NCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,Row3925,73,0.1303837448358535,out,6
1181,Row1361,Row3929,CHEMBL3891763,,0,486.48,BDBM182441,IC50,=,240.0,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3C4CNC4)-c5cc(c(F)cc5)C(F)(F)F,,329882.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3C4CNC4)-c5cc(c(F)cc5)C(F)(F)F,,Row2188,10,0.109478048980236,out,6
1182,Row1363,Row1274,CHEMBL270815,,0,543.63,12a,IC50,=,244.0,nM,Nc1nc(O)nc2nc(c(cc21)-c3ccccc3)-c4ccc(CN5CCC(CC5)n6c(=O)[nH]c7ccccc67)cc4,,,CHEMBL951085,Inhibition of human recombinant Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142344,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Nc1nc(O)nc2nc(c(cc21)-c3ccccc3)-c4ccc(CN5CCC(CC5)n6c(=O)[nH]c7ccccc67)cc4,,Row2123,58,0.2073860615491867,out,6
1183,Row1364,Row1724,CHEMBL208199,,0,344.42,47,IC50,=,245.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)-c4ccncc4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)-c4ccncc4,,Row1996,15,0.1281614601612091,out,6
1184,Row1366,Row480,CHEMBL3684439,,0,551.66,BDBM103152,IC50,=,250.0,nM,C(c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ccccc5-n32)N6CCC(CC6)c7[nH]c(nn7)-c8ccccn8,,220874.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,C(c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ccccc5-n32)N6CCC(CC6)c7[nH]c(nn7)-c8ccccn8,,Row2452,66,0.1509773284196853,out,6
1185,Row1367,Row1355,CHEMBL1800259,,0,1019.27,24,IC50,=,250.0,nM,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCN)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N(CC(N)=O)CCCN,,,CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1799953,1,Scientific Literature,J. Med. Chem.,2011.0,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCN)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N(CC(N)=O)CCCN,,Row2426,74,0.0619209706783294,out,6
1186,Row1368,Row1539,CHEMBL3908333,,0,418.51,BDBM182428,IC50,=,250.0,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cocc5,,329869.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cocc5,,Row3990,26,0.0950915813446044,out,6
1187,Row1369,Row1882,CHEMBL469561,,0,348.48,17,IC50,=,250.0,nM,NCC(CNc1ccc(s1)-c2ccnc3[nH]ccc23)c4ccccc4,,,CHEMBL959242,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153968,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,NCC(CNc1ccc(s1)-c2ccnc3[nH]ccc23)c4ccccc4,,Row1178,46,0.1404032111167907,out,6
1188,Row1370,Row2127,CHEMBL1760766,,0,554.76,23b,IC50,=,250.0,nM,Cc1cccc(C)c1S(=O)(=O)N2CCC[C@H]2[C@H](O)CN3C[C@@]4(CN(CC4)c5ncnc(N)c5C6CC6)CCC3,,,CHEMBL1763788,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759869,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,Cc1cccc(C)c1S(=O)(=O)N2CCC[C@H]2[C@H](O)CN3C[C@@]4(CN(CC4)c5ncnc(N)c5C6CC6)CCC3,,Row315,48,0.1198687553405761,out,6
1189,Row1371,Row2298,CHEMBL1823647,,0,403.31,20,IC50,=,250.0,nM,O=C(NC(C1CCNCC1)c2ccc(Cl)c(Cl)c2)c3cc4cn[nH]c4cc3,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,O=C(NC(C1CCNCC1)c2ccc(Cl)c(Cl)c2)c3cc4cn[nH]c4cc3,,Row3192,40,0.0875628292560577,out,6
1190,Row1372,Row2671,CHEMBL407733,,0,522.66,7b,IC50,=,250.0,nM,C(c1ccc(cc1)-c2nc3ncccc3cc2-c4ccccc4)N5CCC(CC5)c6cc([nH]n6)-c7cnccc7,,,CHEMBL937417,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143097,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,C(c1ccc(cc1)-c2nc3ncccc3cc2-c4ccccc4)N5CCC(CC5)c6cc([nH]n6)-c7cnccc7,,Row996,49,0.2037388980388641,out,6
1191,Row1373,Row3739,CHEMBL3910716,,0,526.54,BDBM182313,IC50,=,250.0,nM,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4ccc(CO)cc4)-c5cc(c(F)cc5)C(F)(F)F,,329779.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4ccc(CO)cc4)-c5cc(c(F)cc5)C(F)(F)F,,Row3758,45,0.1177250742912292,out,6
1192,Row1374,Row3278,CHEMBL1095622,,0,499.55,9k,IC50,=,251.0,nM,COc1cc2c(cc1OC)ncc3c2cc(nc3N)-c4cncc(c4)OC[C@H](N)Cc5ccc(F)cc5,,,CHEMBL1103721,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157027,1,Scientific Literature,Eur. J. Med. Chem.,2010.0,COc1cc2c(cc1OC)ncc3c2cc(nc3N)-c4cncc(c4)OC[C@H](N)Cc5ccc(F)cc5,,Row1813,70,0.1052987948060035,out,6
1193,Row1375,Row3744,CHEMBL4163164,,0,523.55,11e,IC50,=,251.0,nM,Cc1nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc(c1C(=O)OCC)-c5cc(ccc5)OC,,,CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4130433,1,Scientific Literature,Eur J Med Chem,2017.0,Cc1nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc(c1C(=O)OCC)-c5cc(ccc5)OC,,Row2772,33,0.1485597640275955,out,6
1194,Row1376,Row1276,CHEMBL270388,,0,520.04,8,IC50,=,253.0,nM,N#Cc1cc(c(nc1Cl)-c2ccc(CN3CCC(CC3)n4c(=O)[nH]c5ccccc45)cc2)-c6ccccc6,,,CHEMBL951085,Inhibition of human recombinant Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142344,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,N#Cc1cc(c(nc1Cl)-c2ccc(CN3CCC(CC3)n4c(=O)[nH]c5ccccc45)cc2)-c6ccccc6,,Row2123,58,0.1980047821998596,out,6
1195,Row1377,Row346,CHEMBL3976391,,0,509.61,BDBM182497,IC50,=,255.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CC5(C4)COC5)-c6cc(F)c(F)cc6,,329938.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CC5(C4)COC5)-c6cc(F)c(F)cc6,,Row3753,7,0.123853750526905,out,6
1196,Row1378,Row3911,CHEMBL4588742,,0,476.81,D16,IC50,=,255.3,nM,Cn1ncc(Br)c1-c2cc(C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4)n(C)c2,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Br)c1-c2cc(C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4)n(C)c2,,Row39,44,0.0919862762093544,out,6
1197,Row1382,Row1813,CHEMBL1095294,,0,481.56,9i,IC50,=,259.0,nM,COc1cc2c(cc1OC)ncc3c2cc(nc3N)-c4cncc(c4)OC[C@H](N)Cc5ccccc5,,,CHEMBL1103721,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157027,1,Scientific Literature,Eur. J. Med. Chem.,2010.0,COc1cc2c(cc1OC)ncc3c2cc(nc3N)-c4cncc(c4)OC[C@H](N)Cc5ccccc5,,Row1813,70,0.1369635015726089,out,6
1198,Row1383,Row476,CHEMBL3684351,,0,431.46,BDBM103063,IC50,=,260.0,nM,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)c6cnccc6,,220785.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)c6cnccc6,,Row2783,67,0.143280491232872,out,6
1199,Row1384,Row1281,CHEMBL1632374,,0,417.97,22,IC50,=,260.0,nM,C[C@H]1SCc2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,,CHEMBL1632819,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1629708,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,C[C@H]1SCc2ncnc(c21)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,Row3589,19,0.0968385264277458,out,6
1200,Row1386,Row3296,CHEMBL1097602,,0,481.56,9h,IC50,=,261.0,nM,COc1cc2c(cc1OC)ncc3c2cc(nc3N)-c4cncc(c4)OC[C@@H](N)Cc5ccccc5,,,CHEMBL1103721,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157027,1,Scientific Literature,Eur. J. Med. Chem.,2010.0,COc1cc2c(cc1OC)ncc3c2cc(nc3N)-c4cncc(c4)OC[C@@H](N)Cc5ccccc5,,Row1813,70,0.1369635015726089,out,6
1201,Row1387,Row3627,CHEMBL4587088,,0,476.33,D25,IC50,=,269.8,nM,Cn1ncc(Br)c1-c2ccc(cn2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(F)c(F)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Br)c1-c2ccc(cn2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(F)c(F)c4,,Row1315,22,0.0955773666501045,out,6
1202,Row1388,Row1612,CHEMBL205994,,0,408.51,11b,IC50,=,270.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)CNc3cc(cnc3)Nc4cccc5cnccc54,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)CNc3cc(cnc3)Nc4cccc5cnccc54,,Row1996,15,0.1129246279597282,out,6
1203,Row1389,Row1215,CHEMBL270847,,0,528.62,8a,IC50,=,273.0,nM,O=c1[nH]c2ccccc2n1C3CCN(Cc4ccc(cc4)-c5ncc(cc5-c6ccccc6)-c7[nH]nnn7)CC3,,,CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141976,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,O=c1[nH]c2ccccc2n1C3CCN(Cc4ccc(cc4)-c5ncc(cc5-c6ccccc6)-c7[nH]nnn7)CC3,,Row2123,58,0.2123758047819137,out,6
1204,Row1390,Row1873,CHEMBL203434,,0,407.52,5,IC50,=,273.0,nM,N[C@H](COc1cncc(/C=C/c2ccncc2)c1)C(c3ccccc3)c4ccccc4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@H](COc1cncc(/C=C/c2ccncc2)c1)C(c3ccccc3)c4ccccc4,,Row615,77,0.1278088539838791,out,6
1205,Row1391,Row1981,CHEMBL206198,,0,404.9,2t,IC50,=,273.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3Cl)/C=C/c4ccncc4,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3Cl)/C=C/c4ccncc4,,Row77,56,0.1153669357299804,out,6
1206,Row1392,Row2005,CHEMBL182101,,0,542.65,15,IC50,=,273.0,nM,Cn1nnnc1-c2cnc(c(c2)-c3ccccc3)-c4ccc(CN5CCC(CC5)n6c(=O)[nH]c7ccccc67)cc4,,,CHEMBL1111477,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1155389,1,Scientific Literature,J. Med. Chem.,2010.0,Cn1nnnc1-c2cnc(c(c2)-c3ccccc3)-c4ccc(CN5CCC(CC5)n6c(=O)[nH]c7ccccc67)cc4,,Row2123,58,0.2166012972593307,out,6
1207,Row1393,Row19,CHEMBL2325742,,0,398.9,33,IC50,=,276.0,nM,C[C@@H](NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc32)c4ccc(Cl)cc4,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,C[C@@H](NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc32)c4ccc(Cl)cc4,,Row3863,35,0.1286319941282272,out,6
1208,Row1394,Row1739,CHEMBL205415,,0,383.46,25,IC50,=,278.0,nM,N[C@@H](Cc1c[nH]c2ccccc21)C(=O)Nc3cncc(c3)/C=C/c4ccncc4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc21)C(=O)Nc3cncc(c3)/C=C/c4ccncc4,,Row77,56,0.1154075562953949,out,6
1209,Row1395,Row264,CHEMBL1081629,,0,443.5,31,IC50,=,280.0,nM,Cc1cc2cc(ccc2cn1)-c3nnc(NC[C@@H](N)Cc4ccc(cc4)C(F)(F)F)s3,,,CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154933,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1cc2cc(ccc2cn1)-c3nnc(NC[C@@H](N)Cc4ccc(cc4)C(F)(F)F)s3,,Row240,47,0.1076355203986167,out,6
1210,Row1396,Row1218,CHEMBL1800567,,0,1115.4,47,IC50,=,280.0,nM,CC(C)CC[C@@H]1NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCCCCNC(=O)NCCCCN(CC(N)=O)C1=O)C(=O)[C@@H](N)CCCNC(N)=N,,,CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1799953,1,Scientific Literature,J. Med. Chem.,2011.0,CC(C)CC[C@@H]1NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCCCCNC(=O)NCCCCN(CC(N)=O)C1=O)C(=O)[C@@H](N)CCCNC(N)=N,,Row1816,79,0.0819578543305397,out,6
1211,Row1397,Row2195,CHEMBL3684504,,0,520.62,BDBM103218,IC50,=,280.0,nM,O=S(=O)(NC1(CCC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)c7ccccc7,,220940.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=S(=O)(NC1(CCC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)c7ccccc7,,Row3925,73,0.2216264307498932,out,6
1212,Row1398,Row3164,CHEMBL3961268,,0,503.55,BDBM182451,IC50,=,280.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CC4CCN4)-c5cc(c(F)cc5)C(F)(F)F,,329892.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CC4CCN4)-c5cc(c(F)cc5)C(F)(F)F,,Row2164,32,0.1163771301507949,out,6
1213,Row1399,Row1217,CHEMBL1800403,,0,1059.29,44,IC50,=,282.0,nM,CC(C)CC[C@@H]1NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCNC(=O)NCCCCN(CC(N)=O)C1=O)C(=O)[C@@H](N)CCCNC(N)=N,,,CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1799953,1,Scientific Literature,J. Med. Chem.,2011.0,CC(C)CC[C@@H]1NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCNC(=O)NCCCCN(CC(N)=O)C1=O)C(=O)[C@@H](N)CCCNC(N)=N,,Row1816,79,0.0819578543305397,out,6
1214,Row1400,Row652,CHEMBL383254,,0,301.39,22a,IC50,=,284.0,nM,NCC(c1cc(cnc1)/C=C/c2ccncc2)c3ccccc3,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,NCC(c1cc(cnc1)/C=C/c2ccncc2)c3ccccc3,,Row615,77,0.1368389129638672,out,6
1215,Row1401,Row1075,CHEMBL1258441,,0,386.46,5,IC50,=,284.0,nM,N[C@H](Cc1ccc(cc1)C#N)C(=O)N2CCN(CC2)c3ncnc4ccccc34,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccc(cc1)C#N)C(=O)N2CCN(CC2)c3ncnc4ccccc34,,Row875,55,0.1236518695950508,out,6
1216,Row1402,Row863,CHEMBL506434,,0,621.79,32,IC50,=,285.0,nM,CN1CCN(CC1)c2nccc3nc(c(cc32)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN1CCN(CC1)c2nccc3nc(c(cc32)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,Row1163,23,0.1879390031099319,out,6
1217,Row1403,Row925,CHEMBL252654,,0,540.69,13d,IC50,=,286.0,nM,CC(=O)NCC(=O)NC1CCN(CC1)Cc2ccc(cc2)-c3nc4nc(ncc4cc3-c5ccccc5)SC,,,CHEMBL928491,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141509,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CC(=O)NCC(=O)NC1CCN(CC1)Cc2ccc(cc2)-c3nc4nc(ncc4cc3-c5ccccc5)SC,,Row3742,50,0.202671617269516,out,6
1218,Row1405,Row31,CHEMBL260397,,0,511.63,128,IC50,=,290.0,nM,Oc1nc2ccccc2n1C3CCN(Cc4ccc(cc4)-c5nc6ccccc6nc5-c7ccccc7)CC3,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Oc1nc2ccccc2n1C3CCN(Cc4ccc(cc4)-c5nc6ccccc6nc5-c7ccccc7)CC3,,Row31,68,0.191670149564743,out,6
1219,Row1406,Row486,CHEMBL1800568,,0,1087.34,48,IC50,=,290.0,nM,CC(C)CC[C@@H]1NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCNC(=O)NCCCCCCN(CC(N)=O)C1=O)C(=O)[C@@H](N)CCCNC(N)=N,,,CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1799953,1,Scientific Literature,J. Med. Chem.,2011.0,CC(C)CC[C@@H]1NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCNC(=O)NCCCCCCN(CC(N)=O)C1=O)C(=O)[C@@H](N)CCCNC(N)=N,,Row1816,79,0.081344686448574,out,6
1220,Row1407,Row894,CHEMBL388310,,0,485.63,13as,IC50,=,290.0,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(ccc4)OCCC5CCNCC5,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(ccc4)OCCC5CCNCC5,,Row1976,11,0.1206557899713516,out,6
1221,Row1408,Row92,CHEMBL407891,,0,240.27,8a,IC50,=,294.0,nM,C1c2nc[nH]c2CCN1c3ncnc4[nH]ccc34,,,CHEMBL936668,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143084,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,C1c2nc[nH]c2CCN1c3ncnc4[nH]ccc34,,Row854,17,0.0792571976780891,out,6
1222,Row1409,Row1831,CHEMBL504537,,0,324.33,(+/-)-11i,IC50,=,295.0,nM,O=C1C[C@H]2OC3(CCCC3)C4=C([C@H]2O1)C(=O)c5ccccc5C4=O,,,CHEMBL1018804,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153413,1,Scientific Literature,J. Med. Chem.,2009.0,O=C1C[C@H]2OC3(CCCC3)C4=C([C@H]2O1)C(=O)c5ccccc5C4=O,,Row2387,28,0.1508851945400238,out,6
1223,Row1410,Row1073,CHEMBL3684405,,0,462.49,BDBM103118,IC50,=,300.0,nM,O=C(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccc(F)cc6,,220840.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccc(F)cc6,,Row2783,67,0.1384714841842651,out,6
1224,Row1411,Row2337,CHEMBL206819,,0,394.48,10a,IC50,=,300.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cnc4ccc(cc4c3)-c5ccncc5,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cnc4ccc(cc4c3)-c5ccncc5,,Row1996,15,0.1370765119791031,out,6
1225,Row1412,Row2370,CHEMBL1761083,,0,546.69,"21, 1:1diastereomeric mixture",IC50,=,300.0,nM,CCOCCN(C[C@@H](O)CN1CC2(CC(=O)c3cc(O)ccc3O2)CCC1)S(=O)(=O)c4c(C)cccc4C,,,CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759945,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CCOCCN(C[C@@H](O)CN1CC2(CC(=O)c3cc(O)ccc3O2)CCC1)S(=O)(=O)c4c(C)cccc4C,,Row2370,39,0.1156535521149635,out,6
1226,Row1414,Row3037,CHEMBL1761072,,0,551.66,"10, 1:1diastereomeric mixture",IC50,=,300.0,nM,CC(C)OCCN(C[C@@H](O)CN1CC2(CCC1)CC(=O)c3cc(O)ccc3O2)S(=O)(=O)c4c(C)noc4C,,,CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759945,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CC(C)OCCN(C[C@@H](O)CN1CC2(CCC1)CC(=O)c3cc(O)ccc3O2)S(=O)(=O)c4c(C)noc4C,,Row2370,39,0.1147481501102447,out,6
1227,Row1416,Row3252,CHEMBL1095612,,0,520.59,9n,IC50,=,302.0,nM,COc1cc2c(cc1OC)ncc3c2cc(nc3N)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc56,,,CHEMBL1103721,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157027,1,Scientific Literature,Eur. J. Med. Chem.,2010.0,COc1cc2c(cc1OC)ncc3c2cc(nc3N)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc56,,Row1813,70,0.1242877766489982,out,6
1228,Row1418,Row1741,CHEMBL210544,,0,470.58,10u,IC50,=,305.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5cc(ncc5cc4)-c6ccccc6,,,CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1147830,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5cc(ncc5cc4)-c6ccccc6,,Row1996,15,0.1527298837900161,out,6
1229,Row1421,Row2939,CHEMBL3684431,,0,477.5,BDBM103144,IC50,=,310.0,nM,O=C(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)Nc6ccccc6F,,220866.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)Nc6ccccc6F,,Row3925,73,0.1364308297634124,out,6
1230,Row1422,Row1513,CHEMBL4160580,,0,539.55,12f,IC50,=,311.0,nM,Cc1nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc(c1C(=O)OC)-c5cc(OC)c(cc5)OC,,,CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4130433,1,Scientific Literature,Eur J Med Chem,2017.0,Cc1nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc(c1C(=O)OC)-c5cc(OC)c(cc5)OC,,Row2772,33,0.1400260776281356,out,6
1231,Row1423,Row1993,CHEMBL573393,,0,394.48,42,IC50,=,312.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5cccnc5cc4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5cccnc5cc4,,Row1996,15,0.1348884999752044,out,6
1232,Row1424,Row1640,CHEMBL4169321,,0,497.49,12c,IC50,=,313.0,nM,Cc1nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc(c1C(=O)OC)-c5ccc(F)cc5,,,CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4130433,1,Scientific Literature,Eur J Med Chem,2017.0,Cc1nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc(c1C(=O)OC)-c5ccc(F)cc5,,Row2772,33,0.1354647874832153,out,6
1233,Row1425,Row2344,CHEMBL1908343,KALAFUNGIN,0,302.24,"2, kalafungin",IC50,=,313.0,nM,CC1OC2OC(=O)OC2C3=C1C(=O)c4c(O)cccc4C3=O,,,CHEMBL1018804,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153413,1,Scientific Literature,J. Med. Chem.,2009.0,CC1OC2OC(=O)OC2C3=C1C(=O)c4c(O)cccc4C3=O,,Row2387,28,0.0947846919298172,out,6
1234,Row1426,Row84,CHEMBL260990,,0,311.74,5c,IC50,=,318.0,nM,Clc1c[nH]c2ncnc(Nc3ccccc3-c4[nH]cnn4)c21,,,CHEMBL936668,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143084,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Clc1c[nH]c2ncnc(Nc3ccccc3-c4[nH]cnn4)c21,,Row2454,78,0.0978971347212791,out,6
1235,Row1427,Row2329,CHEMBL1094320,,0,419.49,9e,IC50,=,318.0,nM,CC[C@@H](N)COc1cncc(c1)-c2cc3c(cnc4cc(OC)c(cc34)OC)c(N)n2,,,CHEMBL1103721,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157027,1,Scientific Literature,Eur. J. Med. Chem.,2010.0,CC[C@@H](N)COc1cncc(c1)-c2cc3c(cnc4cc(OC)c(cc34)OC)c(N)n2,,Row1813,70,0.0984023213386535,out,6
1236,Row1428,Row761,CHEMBL205410,,0,356.43,8,IC50,=,320.0,nM,N[C@@H](Cc1cc(ccc1)C#N)COc2cc(cnc2)/C=C/c3ccncc3,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1cc(ccc1)C#N)COc2cc(cnc2)/C=C/c3ccncc3,,Row615,77,0.107327252626419,out,6
1237,Row1429,Row2424,CHEMBL1800265,,0,1019.27,21,IC50,=,320.0,nM,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCN)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N(CCN)CC(N)=O,,,CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1799953,1,Scientific Literature,J. Med. Chem.,2011.0,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCN)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N(CCN)CC(N)=O,,Row2426,74,0.0619209706783294,out,6
1238,Row1430,Row2425,CHEMBL1800267,,0,1061.35,23,IC50,=,320.0,nM,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCCCCN)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N(CCN)CC(N)=O,,,CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1799953,1,Scientific Literature,J. Med. Chem.,2011.0,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCCCCN)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N(CCN)CC(N)=O,,Row2426,74,0.0629389211535453,out,6
1239,Row1431,Row2593,CHEMBL3806131,,0,418.93,24b,IC50,=,320.0,nM,Cn1ncc(Cl)c1-c2csc(c2)C(=O)NC3(CCNCC3)c4ccc(F)cc4,,,CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3804794,1,Scientific Literature,Eur. J. Med. Chem.,2016.0,Cn1ncc(Cl)c1-c2csc(c2)C(=O)NC3(CCNCC3)c4ccc(F)cc4,,Row3848,57,0.1321606040000915,out,6
1240,Row1433,Row3226,CHEMBL1800569,,0,1101.37,49,IC50,=,320.0,nM,CC(C)CC[C@@H]1NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCNC(=O)NCCCCCCN(CC(N)=O)C1=O)C(=O)[C@@H](N)CCCNC(N)=N,,,CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1799953,1,Scientific Literature,J. Med. Chem.,2011.0,CC(C)CC[C@@H]1NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCNC(=O)NCCCCCCN(CC(N)=O)C1=O)C(=O)[C@@H](N)CCCNC(N)=N,,Row1816,79,0.081344686448574,out,6
1241,Row1435,Row1173,CHEMBL4453662,,0,537.82,D14,IC50,=,321.6,nM,Cn1ncc(Cl)c1-c2cc(sc2Cl)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)c(c4)C(F)(F)F,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(sc2Cl)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)c(c4)C(F)(F)F,,Row1315,22,0.0953845307230949,out,6
1242,Row1436,Row1120,CHEMBL205871,,0,381.48,9,IC50,=,324.0,nM,N[C@@H](Cc1cccc2ccccc12)COc3cc(cnc3)/C=C/c4ccncc4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1cccc2ccccc12)COc3cc(cnc3)/C=C/c4ccncc4,,Row615,77,0.126418799161911,out,6
1243,Row1437,Row1258,CHEMBL1956071,,0,342.36,SB-7720770-B,IC50,=,324.0,nM,CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)-c4nonc4N,,,CHEMBL1960791,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1955726,1,Scientific Literature,J. Pharmacol. Exp. Ther.,2007.0,CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)-c4nonc4N,,Row1117,69,0.119387686252594,out,6
1244,Row1439,Row567,CHEMBL3684474,,0,560.64,BDBM103188,IC50,=,330.0,nM,O=C(Nc1ccc(F)cc1)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,220910.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Nc1ccc(F)cc1)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,Row662,76,0.1460290402173996,out,6
1245,Row1441,Row3827,CHEMBL1823648,,0,415.32,"21, enantiomer",IC50,=,330.0,nM,O=C(NC(C1CCNCC1)c2ccc(Cl)c(Cl)c2)c3ccc4cnncc4c3,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,O=C(NC(C1CCNCC1)c2ccc(Cl)c(Cl)c2)c3ccc4cnncc4c3,,Row3192,40,0.093073770403862,out,6
1246,Row1442,Row2046,CHEMBL523695,,0,342.36,4,IC50,=,331.0,nM,CCn1c(nc2cncc(C(=O)N3CC[C@@H](N)C3)c12)-c4nonc4N,,,CHEMBL1028090,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140130,1,Scientific Literature,J. Med. Chem.,2008.0,CCn1c(nc2cncc(C(=O)N3CC[C@@H](N)C3)c12)-c4nonc4N,,Row1117,69,0.119387686252594,out,6
1247,Row1443,Row2679,CHEMBL581848,,0,394.48,46,IC50,=,331.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)-c4cccc5cnccc54,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)-c4cccc5cnccc54,,Row1996,15,0.1285474747419357,out,6
1248,Row1444,Row3922,CHEMBL493250,,0,379.42,10,IC50,=,331.0,nM,CCn1c2c(cnc(c2nc1-c3nonc3N)-c4ccccc4)OCCCN,,,CHEMBL1028090,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140130,1,Scientific Literature,J. Med. Chem.,2008.0,CCn1c2c(cnc(c2nc1-c3nonc3N)-c4ccccc4)OCCCN,,Row2429,38,0.191125139594078,out,6
1249,Row1445,Row802,CHEMBL3684501,,0,368.44,BDBM103215,IC50,=,340.0,nM,CC(C)(N)c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23,,220937.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CC(C)(N)c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23,,Row3389,81,0.157712772488594,out,6
1250,Row1446,Row1439,CHEMBL3684347,,0,424.51,BDBM103059,IC50,=,340.0,nM,CC(C)(C)CC(=O)Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23,,220781.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CC(C)(C)CC(=O)Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23,,Row2783,67,0.1389120221138,out,6
1251,Row1447,Row2032,CHEMBL3901997,,0,549.62,BDBM182383,IC50,=,340.0,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3CCOCC)-c4ccc(F)c(c4)C(F)(F)F,,329824.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3CCOCC)-c4ccc(F)c(c4)C(F)(F)F,,Row2164,32,0.1117318347096443,out,6
1252,Row1448,Row2183,CHEMBL3924930,,0,440.52,BDBM182695,IC50,=,340.0,nM,Cc1cc(ccc1F)-c2cn(CCO)c(n2)C3CCN(CC3)c4ncnc(N)c4OCC,,330136.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCO)c(n2)C3CCN(CC3)c4ncnc(N)c4OCC,,Row2590,1,0.118569977581501,out,6
1253,Row1449,Row2470,CHEMBL3684507,,0,534.65,BDBM103221,IC50,=,340.0,nM,Cc1ccc(cc1)S(=O)(=O)NC2(CCC2)c3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54,,220943.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cc1ccc(cc1)S(=O)(=O)NC2(CCC2)c3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54,,Row3391,71,0.2023742794990539,out,6
1254,Row1454,Row1415,CHEMBL3932445,,0,611.66,BDBM182361,IC50,=,350.0,nM,Nc1ncnc(c1-c2ccc(F)cc2)N3CCC(CC3)c4nc(cn4CCN5CCCCC5)-c6cc(c(F)cc6)C(F)(F)F,,329802.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1-c2ccc(F)cc2)N3CCC(CC3)c4nc(cn4CCN5CCCCC5)-c6cc(c(F)cc6)C(F)(F)F,,Row643,24,0.1230525523424148,out,6
1255,Row1455,Row2757,CHEMBL474000,,0,362.34,(+/-)-syn-11j,IC50,=,350.0,nM,Oc1cc(ccc1)[C@@H]2O[C@@H]3CC(=O)O[C@@H]3C4=C2C(=O)c5ccccc5C4=O,,,CHEMBL1018804,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153413,1,Scientific Literature,J. Med. Chem.,2009.0,Oc1cc(ccc1)[C@@H]2O[C@@H]3CC(=O)O[C@@H]3C4=C2C(=O)c5ccccc5C4=O,,Row2387,28,0.1165894269943237,out,6
1256,Row1456,Row3381,CHEMBL3684368,,0,431.46,BDBM103081,IC50,=,350.0,nM,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)c6ccncc6,,220803.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)c6ccncc6,,Row2783,67,0.1424627900123596,out,6
1257,Row1457,Row3601,CHEMBL1823645,,0,418.32,18,IC50,=,350.0,nM,O=C1Cc2cc(ccc2N1)C(=O)NC(C3CCNCC3)c4ccc(Cl)c(Cl)c4,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,O=C1Cc2cc(ccc2N1)C(=O)NC(C3CCNCC3)c4ccc(Cl)c(Cl)c4,,Row3192,40,0.0739454552531242,out,6
1258,Row1458,Row230,CHEMBL438431,,0,599.56,11c,IC50,=,352.0,nM,CC(C)(Cc1ccc(Cl)cc1Cl)C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC(C)(Cc1ccc(Cl)cc1Cl)C2c3cc(ccc3NC2=O)-c4cncc(c4)OC[C@@H](N)Cc5c[nH]c6ccccc65,,Row236,4,0.1186039745807647,out,6
1259,Row1459,Row3,CHEMBL1202525,,0,566.46,5,IC50,=,355.0,nM,COc1ccc(O)c(c1F)C(=O)c2ccc(CO[C@@H]3CCCNCC3NC(=O)c4ccncc4)cc2,,,CHEMBL766409,Inhibition of Protein kinase B alpha,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1149095,1,Scientific Literature,J. Med. Chem.,2004.0,COc1ccc(O)c(c1F)C(=O)c2ccc(CO[C@@H]3CCCNCC3NC(=O)c4ccncc4)cc2,,Row2523,51,0.109676219522953,out,6
1260,Row1460,Row2467,CHEMBL381808,,0,370.46,2r,IC50,=,360.0,nM,N[C@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)/C=C/c4ccncc4,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)/C=C/c4ccncc4,,Row77,56,0.113852635025978,out,6
1261,Row1461,Row3383,CHEMBL3684353,,0,486.56,BDBM103065,IC50,=,360.0,nM,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)c6cc7ccccc7s6,,220787.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)c6cc7ccccc7s6,,Row2783,67,0.1257264018058776,out,6
1262,Row1462,Row3616,CHEMBL3805232,,0,463.38,24c,IC50,=,360.0,nM,Cn1ncc(Br)c1-c2csc(c2)C(=O)NC3(CCNCC3)c4ccc(F)cc4,,,CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3804794,1,Scientific Literature,Eur. J. Med. Chem.,2016.0,Cn1ncc(Br)c1-c2csc(c2)C(=O)NC3(CCNCC3)c4ccc(F)cc4,,Row3848,57,0.1318292617797851,out,6
1263,Row1463,Row2132,CHEMBL359864,,0,510.64,5,IC50,=,365.0,nM,Oc1nc2ccccc2n1C3CCN(Cc4ccc(cc4)-c5nc6ccccc6cc5-c7ccccc7)CC3,,,CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141976,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,Oc1nc2ccccc2n1C3CCN(Cc4ccc(cc4)-c5nc6ccccc6cc5-c7ccccc7)CC3,,Row31,68,0.2069412618875503,out,6
1264,Row1464,Row864,CHEMBL1081439,,0,368.44,26,IC50,=,368.0,nM,N[C@@H](Cc1ccc(F)cc1)CNc2nnc(s2)-c3cc4cn[nH]c4cc3,,,CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154933,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@@H](Cc1ccc(F)cc1)CNc2nnc(s2)-c3cc4cn[nH]c4cc3,,Row1834,53,0.0977939367294311,out,6
1265,Row1465,Row1221,CHEMBL3971381,,0,497.59,BDBM182495,IC50,=,370.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCOCC4)-c5cc(F)c(F)cc5,,329936.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCOCC4)-c5cc(F)c(F)cc5,,Row3753,7,0.1185234561562538,out,6
1266,Row1466,Row2614,CHEMBL1081426,,0,378.51,22,IC50,=,370.0,nM,CCc1n[nH]c2ccc(cc21)-c3nnc(NC[C@@H](N)Cc4ccccc4)s3,,,CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154933,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,CCc1n[nH]c2ccc(cc21)-c3nnc(NC[C@@H](N)Cc4ccccc4)s3,,Row1834,53,0.1360188573598861,out,6
1267,Row1467,Row3129,CHEMBL3113143,,0,325.84,22a,IC50,=,370.0,nM,CC(C)NC(c1ccc(cc1)-c2c[nH]nc2)c3ccc(Cl)cc3,,,CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3112393,1,Scientific Literature,Eur. J. Med. Chem.,2014.0,CC(C)NC(c1ccc(cc1)-c2c[nH]nc2)c3ccc(Cl)cc3,,Row2632,65,0.0920540690422058,out,6
1268,Row1468,Row1511,CHEMBL2012701,,0,443.0,13c,IC50,=,371.0,nM,CN(C)CCNc1cc(Cl)cc(c1C)N2CCN(CC2)c3ncnc4[nH]nc(CC)c34,,,CHEMBL2014740,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2010702,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2012.0,CN(C)CCNc1cc(Cl)cc(c1C)N2CCN(CC2)c3ncnc4[nH]nc(CC)c34,,Row2025,21,0.0742325112223625,out,6
1269,Row1471,Row2362,CHEMBL1097955,,0,405.46,9c,IC50,=,377.0,nM,C[C@@H](N)COc1cncc(c1)-c2cc3c(cnc4cc(OC)c(cc34)OC)c(N)n2,,,CHEMBL1103721,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157027,1,Scientific Literature,Eur. J. Med. Chem.,2010.0,C[C@@H](N)COc1cncc(c1)-c2cc3c(cnc4cc(OC)c(cc34)OC)c(N)n2,,Row1813,70,0.0968247279524803,out,6
1270,Row1473,Row3099,CHEMBL3966878,,0,478.58,BDBM182632,IC50,=,380.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)cc5,,330073.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)cc5,,Row1206,41,0.1303745359182357,out,6
1271,Row1474,Row1874,CHEMBL525077,,0,312.32,(+/-)-syn-11k,IC50,=,383.0,nM,CCC[C@@H]1O[C@@H]2CC(=O)O[C@@H]2C3=C1C(=O)c4ccccc4C3=O,,,CHEMBL1018804,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153413,1,Scientific Literature,J. Med. Chem.,2009.0,CCC[C@@H]1O[C@@H]2CC(=O)O[C@@H]2C3=C1C(=O)c4ccccc4C3=O,,Row2387,28,0.1238312274217605,out,6
1272,Row1476,Row3804,CHEMBL3922457,,0,485.56,BDBM182498,IC50,=,385.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CC(F)C4)-c5cc(F)c(F)cc5,,329939.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CC(F)C4)-c5cc(F)c(F)cc5,,Row3753,7,0.1179079860448837,out,6
1273,Row1478,Row1575,CHEMBL1800698,,0,875.05,56,IC50,=,390.0,nM,CC(C)CC[C@@H]1NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNCCNC(=O)NCCN(CC(N)=O)C1=O,,,CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1799953,1,Scientific Literature,J. Med. Chem.,2011.0,CC(C)CC[C@@H]1NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNCCNC(=O)NCCN(CC(N)=O)C1=O,,Row1816,79,0.0816738009452819,out,6
1274,Row1480,Row3749,CHEMBL3805691,,0,437.3,25d,IC50,=,390.0,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)NC3(CCNCC3)c4ccc(F)cc4,,,CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3804794,1,Scientific Literature,Eur. J. Med. Chem.,2016.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)NC3(CCNCC3)c4ccc(F)cc4,,Row3848,57,0.1398799270391464,out,6
1275,Row1482,Row1917,CHEMBL1823633,,0,395.51,5,IC50,=,400.0,nM,O=C(NC(C1CCNCC1)c2ccc3ccccc3c2)c4ccc5cnccc5c4,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,O=C(NC(C1CCNCC1)c2ccc3ccccc3c2)c4ccc5cnccc5c4,,Row3192,40,0.1274962425231933,out,6
1276,Row1483,Row3325,CHEMBL3684423,,0,498.54,BDBM103136,IC50,=,400.0,nM,O=S(=O)(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6cc(F)ccc6,,220858.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=S(=O)(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6cc(F)ccc6,,Row3925,73,0.1356517672538757,out,6
1277,Row1484,Row3727,CHEMBL1090008,,0,919.17,YTG 9a,IC50,=,400.0,nM,CC(C)CC[C@H](NC(=O)[C@@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CCCNC(N)=N)C(N)=O,,,CHEMBL1113529,Inhibition of PKB by radioactive kinase assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1156226,1,Scientific Literature,Bioorg. Med. Chem.,2010.0,CC(C)CC[C@H](NC(=O)[C@@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CCCNC(N)=N)C(N)=O,,Row2426,74,0.0907702147960662,out,6
1278,Row1485,Row169,CHEMBL1095278,,0,391.43,9a,IC50,=,402.0,nM,COc1cc2c(cc1OC)ncc3c2cc(nc3N)-c4cncc(c4)OCCN,,,CHEMBL1103721,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157027,1,Scientific Literature,Eur. J. Med. Chem.,2010.0,COc1cc2c(cc1OC)ncc3c2cc(nc3N)-c4cncc(c4)OCCN,,Row1813,70,0.0984078049659729,out,6
1279,Row1486,Row977,CHEMBL1081425,,0,428.48,10,IC50,=,404.0,nM,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2cnc(s2)-c3cc4ccncc4cc3,,,CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154944,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2cnc(s2)-c3cc4ccncc4cc3,,Row240,47,0.1071413457393646,out,6
1280,Row1487,Row836,CHEMBL379342,,0,609.65,9j,IC50,=,405.0,nM,N#CCn1c2cc(ccc2nc1O)N[C@@H](Cc3c[nH]c4ccccc34)COc5cc(cnc5)-c6cc7c(cc6)nc(O)n7CC#N,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N#CCn1c2cc(ccc2nc1O)N[C@@H](Cc3c[nH]c4ccccc34)COc5cc(cnc5)-c6cc7c(cc6)nc(O)n7CC#N,,Row837,29,0.113313540816307,out,6
1281,Row1488,Row2909,CHEMBL210783,,0,428.92,10p,IC50,=,407.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5cc(Cl)ncc5cc4,,,CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1147830,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5cc(Cl)ncc5cc4,,Row1996,15,0.1293505430221557,out,6
1282,Row1490,Row2899,CHEMBL3939144,,0,517.58,BDBM182365,IC50,=,410.0,nM,Nc1cc(ncn1)N2CCC(CC2)c3nc(cn3CCN4CCCCC4)-c5ccc(F)c(c5)C(F)(F)F,,329806.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1cc(ncn1)N2CCC(CC2)c3nc(cn3CCN4CCCCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row643,24,0.1252538412809372,out,6
1283,Row1491,Row3684,CHEMBL3684499,,0,490.57,BDBM103213,IC50,=,410.0,nM,Cc1noc(n1)C2CN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CCC2,,220935.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cc1noc(n1)C2CN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CCC2,,Row2452,66,0.1500065326690673,out,6
1284,Row1492,Row2616,CHEMBL1081438,,0,494.55,24,IC50,=,413.0,nM,N[C@@H](Cc1cc(ccc1)C(F)(F)F)CNc2nnc(s2)-c3cc4c(n[nH]c4cc3)-c5ccccc5,,,CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154933,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@@H](Cc1cc(ccc1)C(F)(F)F)CNc2nnc(s2)-c3cc4c(n[nH]c4cc3)-c5ccccc5,,Row1834,53,0.140285849571228,out,6
1285,Row1493,Row585,CHEMBL3684354,,0,410.48,BDBM103066,IC50,=,420.0,nM,CC(C)(C)C(=O)Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23,,220788.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CC(C)(C)C(=O)Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23,,Row2783,67,0.1427344977855682,out,6
1286,Row1494,Row1490,CHEMBL3968002,,0,500.57,BDBM182418,IC50,=,420.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cccc(n5)C(F)(F)F,,329859.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cccc(n5)C(F)(F)F,,Row3753,7,0.1158545017242431,out,6
1287,Row1495,Row1637,CHEMBL3920410,,0,528.58,BDBM182639,IC50,=,420.0,nM,Cc1ccc(cc1C(F)(F)F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,330080.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1ccc(cc1C(F)(F)F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,Row2044,43,0.1255560368299484,out,6
1288,Row1496,Row3669,CHEMBL1097956,,0,419.49,9d,IC50,=,422.0,nM,CC[C@H](N)COc1cncc(c1)-c2cc3c(cnc4cc(OC)c(cc34)OC)c(N)n2,,,CHEMBL1103721,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157027,1,Scientific Literature,Eur. J. Med. Chem.,2010.0,CC[C@H](N)COc1cncc(c1)-c2cc3c(cnc4cc(OC)c(cc34)OC)c(N)n2,,Row1813,70,0.0984023213386535,out,6
1289,Row1498,Row1534,CHEMBL444165,DEOXYFRENOLICIN,0,330.34,"5, deoxyfrenolicin",IC50,=,424.0,nM,CCC[C@H]1O[C@H](CC(O)=O)CC2=C1C(=O)c3c(cccc3O)C2=O,,,CHEMBL1018804,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153413,1,Scientific Literature,J. Med. Chem.,2009.0,CCC[C@H]1O[C@H](CC(O)=O)CC2=C1C(=O)c3c(cccc3O)C2=O,,Row2387,28,0.1152048557996749,out,6
1290,Row1499,Row2416,CHEMBL409880,,0,291.32,5b,IC50,=,425.0,nM,Cc1c[nH]c2ncnc(Nc3ccccc3-c4[nH]cnn4)c21,,,CHEMBL936668,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143084,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Cc1c[nH]c2ncnc(Nc3ccccc3-c4[nH]cnn4)c21,,Row2454,78,0.1014173924922943,out,6
1291,Row1500,Row1502,CHEMBL3684444,,0,543.63,BDBM103157,IC50,=,430.0,nM,COc1ccccc1C(=O)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,220879.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,COc1ccccc1C(=O)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,Row2452,66,0.1552802324295044,out,6
1292,Row1501,Row3336,CHEMBL3942949,,0,539.65,BDBM182558,IC50,=,430.0,nM,Nc1ncnc(c1C2CCC2)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6ccc(cc6)C(F)(F)F,,329999.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C2CCC2)N3CCC(CC3)c4nc(cn4CCN5CCCC5)-c6ccc(cc6)C(F)(F)F,,Row643,24,0.1208827793598175,out,6
1293,Row1502,Row4012,CHEMBL3973744,,0,567.58,BDBM182574,IC50,=,430.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CC(F)(F)CC4)-c5cc(c(F)cc5)C(F)(F)F,,330015.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CC(F)(F)CC4)-c5cc(c(F)cc5)C(F)(F)F,,Row2164,32,0.1279310584068298,out,6
1294,Row1503,Row179,CHEMBL4164809,,0,497.49,12b,IC50,=,432.0,nM,Cc1nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc(c1C(=O)OC)-c5ccccc5F,,,CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4130433,1,Scientific Literature,Eur J Med Chem,2017.0,Cc1nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc(c1C(=O)OC)-c5ccccc5F,,Row2772,33,0.1065021678805351,out,6
1295,Row1504,Row3599,CHEMBL3127380,,0,405.3,60d,IC50,=,432.0,nM,Nc1ncnc(c1Br)N2CCN(CC2)C(=O)C(N)Cc3ccccc3,,,CHEMBL3131349,Inhibition of AKT1 (unknown origin) using ATP/eNOS as substrate incubated for 5 mins prior to substrate addition measured after 30 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3124803,1,Scientific Literature,Eur. J. Med. Chem.,2014.0,Nc1ncnc(c1Br)N2CCN(CC2)C(=O)C(N)Cc3ccccc3,,Row875,55,0.1362161934375763,out,6
1296,Row1505,Row2117,CHEMBL1097972,,0,550.45,9r,IC50,=,433.0,nM,COc1cc2c(cc1OC)ncc3c2cc(nc3N)-c4cncc(c4)OC[C@@H](N)Cc5cc(Cl)c(Cl)cc5,,,CHEMBL1103721,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157027,1,Scientific Literature,Eur. J. Med. Chem.,2010.0,COc1cc2c(cc1OC)ncc3c2cc(nc3N)-c4cncc(c4)OC[C@@H](N)Cc5cc(Cl)c(Cl)cc5,,Row1813,70,0.1005804240703582,out,6
1297,Row1506,Row2889,CHEMBL2012699,,0,469.04,1b,IC50,=,434.0,nM,Cc1c(cc(Cl)cc1N2CCN(CC2)c3ncnc4[nH]nc(CC)c34)NCCN5CCCC5,,,CHEMBL2020583,Inhibition of AKT1 after 3 hrs by luciferase based chemiluminescence assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2016487,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2012.0,Cc1c(cc(Cl)cc1N2CCN(CC2)c3ncnc4[nH]nc(CC)c34)NCCN5CCCC5,,Row2025,21,0.0835711285471916,out,6
1298,Row1507,Row704,CHEMBL3897576,,0,564.59,BDBM182665,IC50,=,440.0,nM,CN(CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4ccc(F)c(c4)C(F)(F)F)CCOC,,330106.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4ccc(F)c(c4)C(F)(F)F)CCOC,,Row2044,43,0.1194692626595497,out,6
1299,Row1508,Row1197,CHEMBL3684476,,0,560.64,BDBM103190,IC50,=,440.0,nM,O=C(Nc1ccccc1F)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,220912.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Nc1ccccc1F)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,Row662,76,0.1465803384780883,out,6
1300,Row1509,Row1817,CHEMBL3929608,,0,498.49,BDBM182347,IC50,=,440.0,nM,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4cncnc4)-c5cc(c(F)cc5)C(F)(F)F,,329792.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4cncnc4)-c5cc(c(F)cc5)C(F)(F)F,,Row3758,45,0.1213401779532432,out,6
1301,Row1510,Row2227,CHEMBL3964789,,0,450.44,BDBM182308,IC50,=,440.0,nM,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3OC)-c4ccc(F)c(c4)C(F)(F)F,,329775.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3OC)-c4ccc(F)c(c4)C(F)(F)F,,Row3758,45,0.1258644312620163,out,6
1302,Row1511,Row3246,CHEMBL3684477,,0,556.67,BDBM103191,IC50,=,440.0,nM,Cc1ccc(cc1)NC(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,220913.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cc1ccc(cc1)NC(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,Row662,76,0.1442203819751739,out,6
1303,Row1512,Row3848,CHEMBL3805855,,0,498.21,25c,IC50,=,440.0,nM,Cn1ncc(Br)c1-c2coc(c2)C(=O)NC3(CCNCC3)c4ccc(Cl)c(Cl)c4,,,CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3804794,1,Scientific Literature,Eur. J. Med. Chem.,2016.0,Cn1ncc(Br)c1-c2coc(c2)C(=O)NC3(CCNCC3)c4ccc(Cl)c(Cl)c4,,Row3848,57,0.1316381692886352,out,6
1304,Row1513,Row4008,CHEMBL3900331,,0,421.48,BDBM182683,IC50,=,440.0,nM,Cc1cc(ccc1F)-c2cn(CCO)c(n2)C3CCN(CC3)c4ncnc(N)c4C#N,,330124.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCO)c(n2)C3CCN(CC3)c4ncnc(N)c4C#N,,Row3798,5,0.1168366000056266,out,6
1305,Row1514,Row2048,CHEMBL4543839,,0,469.83,D11,IC50,=,448.9,nM,Cn1ncc(Cl)c1-c2cc(sc2Cl)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(sc2Cl)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,Row39,44,0.0880148112773895,out,6
1306,Row1515,Row658,CHEMBL3684451,,0,531.6,BDBM103164,IC50,=,450.0,nM,O=C(c1ccccc1F)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,220886.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(c1ccccc1F)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,Row2452,66,0.1458050906658172,out,6
1307,Row1516,Row2482,CHEMBL3922652,,0,570.6,BDBM182370,IC50,=,450.0,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4cnc(N)nc4)-c5cc(c(F)cc5)C(F)(F)F,,329811.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4cnc(N)nc4)-c5cc(c(F)cc5)C(F)(F)F,,Row2164,32,0.1152480393648147,out,6
1308,Row1517,Row2837,CHEMBL3913252,,0,475.6,BDBM182640,IC50,=,450.0,nM,CCc1cc(ccn1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,330081.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1cc(ccn1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,Row1206,41,0.1288885623216629,out,6
1309,Row1519,Row1007,CHEMBL1081660,,0,433.46,33,IC50,=,453.0,nM,Nc1noc2ccc(cc12)-c3cnc(NC[C@@H](N)Cc4ccc(cc4)C(F)(F)F)s3,,,CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154944,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Nc1noc2ccc(cc12)-c3cnc(NC[C@@H](N)Cc4ccc(cc4)C(F)(F)F)s3,,Row240,47,0.1196746230125427,out,6
1310,Row1521,Row1425,CHEMBL270444,,0,653.83,6,IC50,=,458.0,nM,CCN(CCNC(=O)c1cc2nc(c(nc2cc1)-c3ccc(CN4CCC(CC4)n5c6ccccc6[nH]c5=O)cc3)-c7ccccc7)CC,,,CHEMBL948032,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CCN(CCNC(=O)c1cc2nc(c(nc2cc1)-c3ccc(CN4CCC(CC4)n5c6ccccc6[nH]c5=O)cc3)-c7ccccc7)CC,,Row2123,58,0.179471954703331,out,6
1311,Row1523,Row1030,CHEMBL1823646,,0,420.3,19,IC50,=,460.0,nM,O=C(NC(C1CCNCC1)c2ccc(Cl)c(Cl)c2)c3ccc4[nH]c(=O)oc4c3,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,O=C(NC(C1CCNCC1)c2ccc(Cl)c(Cl)c2)c3ccc4[nH]c(=O)oc4c3,,Row3192,40,0.0748727396130561,out,6
1312,Row1524,Row3921,CHEMBL3684508,,0,534.65,BDBM103222,IC50,=,460.0,nM,Cc1cc(ccc1)S(=O)(=O)NC2(CCC2)c3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54,,220944.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cc1cc(ccc1)S(=O)(=O)NC2(CCC2)c3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54,,Row3391,71,0.202042818069458,out,6
1313,Row1526,Row1302,CHEMBL3941855,,0,446.6,BDBM182412,IC50,=,465.0,nM,Cc1cc(cnc1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5CC,,329853.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(cnc1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5CC,,Row3753,7,0.1134038195014,out,6
1314,Row1527,Row996,CHEMBL429703,,0,521.67,7e,IC50,=,470.0,nM,C(c1ccc(cc1)-c2nc3ncccc3cc2-c4ccccc4)N5CCC(CC5)c6cc([nH]n6)-c7ccccc7,,,CHEMBL937417,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143097,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,C(c1ccc(cc1)-c2nc3ncccc3cc2-c4ccccc4)N5CCC(CC5)c6cc([nH]n6)-c7ccccc7,,Row996,49,0.2029386013746261,out,6
1315,Row1528,Row2023,CHEMBL3113130,,0,375.86,3,IC50,=,470.0,nM,Clc1ccc(cc1)C(NC2CC2)c3ccc(cc3)-c4ncnc5[nH]cnc45,,,CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3112393,1,Scientific Literature,Eur. J. Med. Chem.,2014.0,Clc1ccc(cc1)C(NC2CC2)c3ccc(cc3)-c4ncnc5[nH]cnc45,,Row3863,35,0.1183895766735076,out,6
1316,Row1529,Row2564,CHEMBL3983416,,0,531.6,BDBM182533,IC50,=,470.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)c(cc5)C(F)(F)F,,329974.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)c(cc5)C(F)(F)F,,Row3753,7,0.1231822147965431,out,6
1317,Row1530,Row2933,CHEMBL3970397,,0,494.55,BDBM182375,IC50,=,479.0,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(cc5)OC(F)F,,329816.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(cc5)OC(F)F,,Row3990,26,0.1178660839796066,out,6
1318,Row1531,Row491,CHEMBL3968856,,0,532.55,BDBM182453,IC50,=,480.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3C4CCNCC4)-c5cc(c(F)cc5)C(F)(F)F,,329894.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3C4CCNCC4)-c5cc(c(F)cc5)C(F)(F)F,,Row2044,43,0.1127494573593139,out,6
1319,Row1532,Row820,CHEMBL3113145,,0,323.83,22d,IC50,=,480.0,nM,Clc1ccc(cc1)C(NC2CC2)c3ccc(cc3)-c4c[nH]nc4,,,CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3112393,1,Scientific Literature,Eur. J. Med. Chem.,2014.0,Clc1ccc(cc1)C(NC2CC2)c3ccc(cc3)-c4c[nH]nc4,,Row2632,65,0.1073070243000984,out,6
1320,Row1533,Row3934,CHEMBL3684435,,0,473.54,BDBM103148,IC50,=,480.0,nM,Cc1cc(ccc1)NC(=O)NCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,220870.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cc1cc(ccc1)NC(=O)NCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,Row662,76,0.1332716047763824,out,6
1321,Row1534,Row3579,CHEMBL4170874,,0,509.52,12e,IC50,=,482.0,nM,Cc1nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc(c1C(=O)OC)-c5cc(ccc5)OC,,,CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4130433,1,Scientific Literature,Eur J Med Chem,2017.0,Cc1nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc(c1C(=O)OC)-c5cc(ccc5)OC,,Row2772,33,0.1509329974651336,out,6
1322,Row1535,Row1483,CHEMBL211224,,0,533.68,9b,IC50,=,488.0,nM,C([C@@H](COc1cc(cnc1)-c2cc3cnccc3s2)Nc4cc5cnccc5s4)c6c[nH]c7ccccc67,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,C([C@@H](COc1cc(cnc1)-c2cc3cnccc3s2)Nc4cc5cnccc5s4)c6c[nH]c7ccccc67,,Row837,29,0.1115643307566642,out,6
1323,Row1536,Row809,CHEMBL3684495,,0,498.55,BDBM103209,IC50,=,490.0,nM,C(OCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6cn(nn6)-c7ccccc7,,220931.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,C(OCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6cn(nn6)-c7ccccc7,,Row3389,81,0.1397782415151596,out,6
1324,Row1537,Row2488,CHEMBL3684374,,0,419.47,BDBM103087,IC50,=,490.0,nM,CS(=O)(=O)OCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,220809.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CS(=O)(=O)OCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,Row3925,73,0.1399677395820617,out,6
1325,Row1539,Row1839,CHEMBL1080892,,0,432.48,14,IC50,=,491.0,nM,Cc1n[nH]c2ccc(cc21)-c3nnc(NC[C@@H](N)Cc4ccccc4C(F)(F)F)s3,,,CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154933,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3nnc(NC[C@@H](N)Cc4ccccc4C(F)(F)F)s3,,Row1834,53,0.1219914406538009,out,6
1326,Row1541,Row1275,CHEMBL429576,,0,500.61,9a,IC50,=,495.0,nM,Nc1nc(c(cc1C#N)-c2ccccc2)-c3ccc(CN4CCC(CC4)n5c(=O)[nH]c6ccccc56)cc3,,,CHEMBL951085,Inhibition of human recombinant Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142344,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Nc1nc(c(cc1C#N)-c2ccccc2)-c3ccc(CN4CCC(CC4)n5c(=O)[nH]c6ccccc56)cc3,,Row2123,58,0.2099496573209762,out,6
1327,Row1542,Row2295,CHEMBL474391,,0,342.35,4,IC50,=,497.0,nM,COc1cccc2c1C(=O)C=3[C@@H](CCC)O[C@@H]4CC(=O)O[C@@H]4C3C2=O,,,CHEMBL1018804,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153413,1,Scientific Literature,J. Med. Chem.,2009.0,COc1cccc2c1C(=O)C=3[C@@H](CCC)O[C@@H]4CC(=O)O[C@@H]4C3C2=O,,Row2387,28,0.1162960231304168,out,6
1328,Row1543,Row353,CHEMBL595685,,0,450.54,9d,IC50,=,500.0,nM,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4ccc(O)cc4)OC[C@@H](N)Cc5ccccc5,,,CHEMBL1071952,Inhibition of full length AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4ccc(O)cc4)OC[C@@H](N)Cc5ccccc5,,Row1976,11,0.1594400554895401,out,6
1329,Row1544,Row513,CHEMBL1761082,,0,532.66,"20, 1:1diastereomeric mixture",IC50,=,500.0,nM,Cc1ccccc1S(=O)(=O)N(C[C@@H](O)CN2CC3(CC(=O)c4cc(O)ccc4O3)CCC2)CCOCC,,,CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759945,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,Cc1ccccc1S(=O)(=O)N(C[C@@H](O)CN2CC3(CC(=O)c4cc(O)ccc4O3)CCC2)CCOCC,,Row2370,39,0.1259762346744537,out,6
1330,Row1545,Row800,CHEMBL3684496,,0,523.64,BDBM103210,IC50,=,500.0,nM,C(c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)N6CCC(CC6)c7c[nH]c8ccccc78,,220932.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,C(c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)N6CCC(CC6)c7c[nH]c8ccccc78,,Row2452,66,0.1508728265762329,out,6
1331,Row1546,Row807,CHEMBL3975126,,0,445.53,BDBM182614,IC50,=,500.0,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(=O)[nH]cc5,,330055.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(=O)[nH]cc5,,Row3990,26,0.0976624712347984,out,6
1332,Row1548,Row1793,CHEMBL593573,,0,469.55,26b,IC50,=,500.0,nM,Cc1n[nH]c2ncc(nc12)-c3cc(OC[C@@H](N)Cc4ccccc4)c(NCC)nc3-c5cocc5,,,CHEMBL1072610,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153244,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ncc(nc12)-c3cc(OC[C@@H](N)Cc4ccccc4)c(NCC)nc3-c5cocc5,,Row2116,20,0.1201509311795234,out,6
1333,Row1549,Row2462,CHEMBL204012,,0,384.48,11,IC50,=,500.0,nM,Cn1cc(C[C@H](N)COc2cncc(c2)/C=C/c3ccncc3)c4ccccc14,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Cn1cc(C[C@H](N)COc2cncc(c2)/C=C/c3ccncc3)c4ccccc14,,Row77,56,0.1254762262105941,out,6
1334,Row1550,Row1679,CHEMBL493066,,0,342.36,5,IC50,=,501.0,nM,CCn1c(nc2cncc(C(=O)N3CCNCC3)c12)-c4nonc4N,,,CHEMBL1028090,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140130,1,Scientific Literature,J. Med. Chem.,2008.0,CCn1c(nc2cncc(C(=O)N3CCNCC3)c12)-c4nonc4N,,Row1117,69,0.1178681552410125,out,6
1335,Row1553,Row639,CHEMBL3985874,,0,526.54,BDBM182310,IC50,=,520.0,nM,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4ccc(cc4)OC)-c5ccc(F)c(c5)C(F)(F)F,,329777.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4ccc(cc4)OC)-c5ccc(F)c(c5)C(F)(F)F,,Row3758,45,0.1247373223304748,out,6
1336,Row1554,Row2419,CHEMBL3931709,,0,548.63,BDBM182394,IC50,=,520.0,nM,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3CN(C)CC)-c4cc(c(F)cc4)C(F)(F)F,,329835.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3CN(C)CC)-c4cc(c(F)cc4)C(F)(F)F,,Row2164,32,0.1114460080862045,out,6
1337,Row1555,Row3948,CHEMBL3684352,,0,460.5,BDBM103064,IC50,=,520.0,nM,COc1ccccc1C(=O)Nc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,220786.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,COc1ccccc1C(=O)Nc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,Row2783,67,0.1429998874664306,out,6
1338,Row1556,Row3956,CHEMBL3913067,,0,581.61,BDBM182546,IC50,=,520.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC(F)(F)CC4)-c5cc(F)c(cc5)C(F)(F)F,,329987.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC(F)(F)CC4)-c5cc(F)c(cc5)C(F)(F)F,,Row3753,7,0.1286994218826294,out,6
1339,Row1559,Row3510,CHEMBL4435265,,0,411.89,C4,IC50,=,529.5,nM,CNc1cc(ncn1)-c2ccc(o2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,CNc1cc(ncn1)-c2ccc(o2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,Row39,44,0.0822772458195686,out,6
1340,Row1561,Row3388,CHEMBL3684484,,0,584.68,BDBM103198,IC50,=,530.0,nM,O=C(NC1CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CC1)Nc7cc8CCOc8cc7,,220920.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(NC1CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CC1)Nc7cc8CCOc8cc7,,Row662,76,0.1385034620761871,out,6
1341,Row1563,Row2881,CHEMBL1257752,,0,438.96,31,IC50,=,536.0,nM,CN(C)c1cc2c(cc1)ncnc2N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,CN(C)c1cc2c(cc1)ncnc2N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,Row875,55,0.0969926193356514,out,6
1342,Row1564,Row3273,CHEMBL4461188,,0,473.28,A9,IC50,=,538.0,nM,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)NC3CNCC3c4ccc(cc4)C(F)(F)F,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2cc(oc2Cl)C(=O)NC3CNCC3c4ccc(cc4)C(F)(F)F,,Row39,44,0.0891845971345901,out,6
1343,Row1571,Row586,CHEMBL3890873,,0,524.65,BDBM182655,IC50,=,560.0,nM,CS(=O)(=O)c1cc(ccc1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,330096.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CS(=O)(=O)c1cc(ccc1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,Row1206,41,0.1343214511871338,out,6
1344,Row1572,Row1117,CHEMBL494662,,0,356.39,8,IC50,=,562.0,nM,CCn1c2c(cncc2nc1-c3nonc3N)C(=O)NC4CCNCC4,,,CHEMBL1028090,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140130,1,Scientific Literature,J. Med. Chem.,2008.0,CCn1c2c(cncc2nc1-c3nonc3N)C(=O)NC4CCNCC4,,Row1117,69,0.1190625801682472,out,6
1345,Row1573,Row3400,CHEMBL3924538,,0,399.86,BDBM181323,IC50,=,570.0,nM,NC(=O)c1ccc(NC2CNCCC2c3cc(Cl)c(F)cc3)c4cncnc41,,328346.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(NC2CNCCC2c3cc(Cl)c(F)cc3)c4cncnc41,,Row2729,75,0.0965563505887985,out,6
1346,Row1575,Row1600,CHEMBL3298512,,0,275.35,3,IC50,=,580.0,nM,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)C=C,,,CHEMBL3364070,Inhibition of AKT1 (unknown origin) after 1 hr by Z'-LYTE kinase assay in presence of 75 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3297689,1,Scientific Literature,ACS Med. Chem. Lett.,2014.0,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)C=C,,Row266,82,0.0980237945914268,out,6
1347,Row1576,Row1712,CHEMBL3684506,,0,538.61,BDBM103220,IC50,=,580.0,nM,O=S(=O)(NC1(CCC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)c7ccc(F)cc7,,220942.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=S(=O)(NC1(CCC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)c7ccc(F)cc7,,Row3391,71,0.205277994275093,out,6
1348,Row1578,Row1270,CHEMBL1800400,,0,1059.29,41,IC50,=,590.0,nM,CC(C)CC[C@@H]1NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCNC(=O)NCCCN(CC(N)=O)C1=O)C(=O)[C@@H](N)CCCNC(N)=N,,,CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1799953,1,Scientific Literature,J. Med. Chem.,2011.0,CC(C)CC[C@@H]1NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCCNC(=O)NCCCN(CC(N)=O)C1=O)C(=O)[C@@H](N)CCCNC(N)=N,,Row1816,79,0.0832124203443527,out,6
1349,Row1580,Row2334,CHEMBL1258778,,0,395.89,11,IC50,=,595.0,nM,N[C@H](Cc1cccc(Cl)c1)C(=O)N2CCN(CC2)c3ncnc4ccccc34,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1cccc(Cl)c1)C(=O)N2CCN(CC2)c3ncnc4ccccc34,,Row875,55,0.1307035535573959,out,6
1350,Row1581,Row2557,CHEMBL1173697,,0,357.44,11,IC50,=,600.0,nM,Cc1c[nH]c2ncnc(c21)N3C[C@@H](CC3)NS(=O)(=O)c4ccccc4,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,Cc1c[nH]c2ncnc(c21)N3C[C@@H](CC3)NS(=O)(=O)c4ccccc4,,Row1872,62,0.1237284690141677,out,6
1351,Row1582,Row3757,CHEMBL3906130,,0,485.28,BDBM182342,IC50,=,600.0,nM,Nc1ncnc(c1Br)N2CCC(CC2)c3[nH]cc(n3)-c4ccc(F)c(c4)C(F)(F)F,,329790.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Br)N2CCC(CC2)c3[nH]cc(n3)-c4ccc(F)c(c4)C(F)(F)F,,Row3758,45,0.1185113415122032,out,6
1352,Row1584,Row2546,CHEMBL1257513,,0,406.53,59,IC50,=,604.0,nM,CC(C)c1ccc(C[C@@H](CN)C(=O)N2CCN(CC2)c3ncnc4[nH]ccc34)cc1,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,CC(C)c1ccc(C[C@@H](CN)C(=O)N2CCN(CC2)c3ncnc4[nH]ccc34)cc1,,Row854,17,0.0978773087263107,out,6
1353,Row1585,Row898,CHEMBL4062453,,0,498.56,42g; MBM-55,IC50,=,608.0,nM,CN(C)CCn1cc(cn1)-c2cc3ncc(-c4cc(OCc5cc(F)ccc5)c(cc4)C(N)=O)n3cc2,,,CHEMBL4003700,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4002599,1,Scientific Literature,Eur J Med Chem,2017.0,CN(C)CCn1cc(cn1)-c2cc3ncc(-c4cc(OCc5cc(F)ccc5)c(cc4)C(N)=O)n3cc2,,Row2492,83,0.1242434382438659,out,6
1354,Row1586,Row3845,CHEMBL3684509,,0,502.55,BDBM103223,IC50,=,610.0,nM,O=C(NC1(CCC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)c7ccc(F)cc7,,220945.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(NC1(CCC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)c7ccc(F)cc7,,Row2783,67,0.2156999856233596,out,6
1355,Row1587,Row766,CHEMBL1079625,,0,417.46,30,IC50,=,613.0,nM,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2ncc(s2)-c3cc4[nH]ncc4cc3,,,CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154944,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2ncc(s2)-c3cc4[nH]ncc4cc3,,Row240,47,0.1036037728190422,out,6
1356,Row1588,Row3556,CHEMBL3933596,,0,478.58,BDBM182633,IC50,=,620.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)ccc5,,330074.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)ccc5,,Row1206,41,0.1399498581886291,out,6
1357,Row1589,Row2742,CHEMBL3684483,,0,610.64,BDBM103197,IC50,=,630.0,nM,O=C(Nc1cc(ccc1)C(F)(F)F)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,220919.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Nc1cc(ccc1)C(F)(F)F)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,Row662,76,0.1422777622938156,out,6
1358,Row1590,Row3876,CHEMBL3684421,,0,458.53,BDBM103134,IC50,=,630.0,nM,O=C(NCCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccccc6,,220856.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(NCCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccccc6,,Row2783,67,0.1531886756420135,out,6
1359,Row1591,Row1722,CHEMBL493067,,0,356.39,6,IC50,=,631.0,nM,CCn1c(nc2cncc(C(=O)NC3CNCCC3)c12)-c4nonc4N,,,CHEMBL1028090,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140130,1,Scientific Literature,J. Med. Chem.,2008.0,CCn1c(nc2cncc(C(=O)NC3CNCCC3)c12)-c4nonc4N,,Row1117,69,0.1241007819771766,out,6
1360,Row1592,Row1174,CHEMBL381273,,0,419.49,10q,IC50,=,640.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5cc(C#N)ncc5cc4,,,CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1147830,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5cc(C#N)ncc5cc4,,Row1996,15,0.1285917162895202,out,6
1361,Row1593,Row1641,CHEMBL4161394,,0,509.52,12d,IC50,=,640.0,nM,Cc1nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc(c1C(=O)OC)-c5ccc(cc5)OC,,,CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4130433,1,Scientific Literature,Eur J Med Chem,2017.0,Cc1nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc(c1C(=O)OC)-c5ccc(cc5)OC,,Row2772,33,0.1415896415710449,out,6
1362,Row1594,Row3128,CHEMBL3113141,,0,417.94,17b,IC50,=,640.0,nM,Clc1ccc(cc1)C(NC2CCCCC2)c3ccc(cc3)-c4ncnc5[nH]cnc45,,,CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3112393,1,Scientific Literature,Eur. J. Med. Chem.,2014.0,Clc1ccc(cc1)C(NC2CCCCC2)c3ccc(cc3)-c4ncnc5[nH]cnc45,,Row3863,35,0.1235973015427589,out,6
1363,Row1595,Row3533,CHEMBL3684345,,0,480.53,BDBM103057,IC50,=,640.0,nM,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6cccc7ccccc76,,220779.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6cccc7ccccc76,,Row2783,67,0.1360407769680023,out,6
1364,Row1597,Row3805,CHEMBL3894443,,0,467.57,BDBM182499,IC50,=,640.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CC(F)C4)-c5ccc(F)cc5,,329940.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CC(F)C4)-c5ccc(F)cc5,,Row3753,7,0.1185252517461776,out,6
1365,Row1598,Row3809,CHEMBL3684514,,0,524.61,BDBM103228,IC50,=,640.0,nM,Cn1ccc(n1)S(=O)(=O)NC2(CCC2)c3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54,,220950.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cn1ccc(n1)S(=O)(=O)NC2(CCC2)c3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54,,Row3391,71,0.2051266729831695,out,6
1366,Row1599,Row2605,CHEMBL3684362,,0,498.47,BDBM103075,IC50,=,650.0,nM,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccc(cc6)C(F)(F)F,,220797.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccc(cc6)C(F)(F)F,,Row2783,67,0.1327438950538635,out,6
1367,Row1600,Row3160,CHEMBL3113149,,0,327.82,22h,IC50,=,650.0,nM,OCCNC(c1ccc(cc1)-c2c[nH]nc2)c3ccc(Cl)cc3,,,CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3112393,1,Scientific Literature,Eur. J. Med. Chem.,2014.0,OCCNC(c1ccc(cc1)-c2c[nH]nc2)c3ccc(Cl)cc3,,Row2632,65,0.0901000052690506,out,6
1368,Row1602,Row662,CHEMBL3684479,,0,556.67,BDBM103193,IC50,=,660.0,nM,Cc1cc(ccc1)NC(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,220915.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cc1cc(ccc1)NC(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,Row662,76,0.1446809917688369,out,6
1369,Row1603,Row1678,CHEMBL207139,,0,523.68,11g,IC50,=,660.0,nM,CC(C)(CC1CCCN1)C2C(=O)Nc3ccc(cc32)-c4cc(cnc4)OC[C@@H](N)Cc5c[nH]c6ccccc56,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC(C)(CC1CCCN1)C2C(=O)Nc3ccc(cc32)-c4cc(cnc4)OC[C@@H](N)Cc5c[nH]c6ccccc56,,Row236,4,0.1361694186925888,out,6
1370,Row1604,Row3964,CHEMBL3684516,,0,552.64,BDBM103230,IC50,=,660.0,nM,C(c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)N6CCC(CC6)c7nnc(o7)-c8ccccc8,,220952.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,C(c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)N6CCC(CC6)c7nnc(o7)-c8ccccc8,,Row2452,66,0.1661793440580368,out,6
1371,Row1605,Row332,CHEMBL383527,,0,394.48,17d,IC50,=,668.0,nM,N[C@@H](Cc1cccc2ccccc21)C(=O)Nc3cncc(c3)/C=C/c4ccncc4,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1cccc2ccccc21)C(=O)Nc3cncc(c3)/C=C/c4ccncc4,,Row615,77,0.1277069598436355,out,6
1372,Row1606,Row1909,CHEMBL3900157,,0,462.53,BDBM182459,IC50,=,670.0,nM,Cc1cc(ccc1F)-c2cn(CCO)c(n2)C3CCN(CC3)c4ncnc(N)c4-c5c[nH]nc5,,329900.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CCO)c(n2)C3CCN(CC3)c4ncnc(N)c4-c5c[nH]nc5,,Row2590,1,0.1156854778528213,out,6
1373,Row1607,Row3557,CHEMBL3952076,,0,504.49,BDBM182442,IC50,=,670.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3C4CNC4)-c5cc(c(F)cc5)C(F)(F)F,,329883.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3C4CNC4)-c5cc(c(F)cc5)C(F)(F)F,,Row2044,43,0.1131791174411773,out,6
1374,Row1608,Row439,CHEMBL3684339,,0,480.53,BDBM103051,IC50,=,680.0,nM,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6cc7ccccc7cc6,,220773.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6cc7ccccc7cc6,,Row2783,67,0.14240363240242,out,6
1375,Row1611,Row615,CHEMBL203673,,0,331.42,2g,IC50,=,690.0,nM,N[C@@H](Cc1ccccc1)COc2cc(cnc2)/C=C/c3ccncc3,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1ccccc1)COc2cc(cnc2)/C=C/c3ccncc3,,Row615,77,0.127658724784851,out,6
1376,Row1612,Row2197,CHEMBL3684372,,0,340.39,BDBM103085,IC50,=,690.0,nM,NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,220807.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,Row3389,81,0.1617889702320099,out,6
1377,Row1613,Row2652,CHEMBL1257280,,0,397.43,18,IC50,=,690.0,nM,N[C@H](Cc1cc(F)cc(F)c1)C(=O)N2CCN(CC2)c3ncnc4ccccc43,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1cc(F)cc(F)c1)C(=O)N2CCN(CC2)c3ncnc4ccccc43,,Row875,55,0.1422185003757476,out,6
1378,Row1615,Row159,CHEMBL210628,,0,445.53,10i,IC50,=,697.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3/C=C/C#N)-c4cc5ccncc5cc4,,,CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1147830,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3/C=C/C#N)-c4cc5ccncc5cc4,,Row1996,15,0.1343184560537338,out,6
1379,Row1616,Row756,CHEMBL1173304,,0,336.4,12,IC50,=,700.0,nM,Cc1c[nH]c2ncnc(c21)N3C[C@@H](CC3)NC(=O)Nc4ccccc4,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,Cc1c[nH]c2ncnc(c21)N3C[C@@H](CC3)NC(=O)Nc4ccccc4,,Row1872,62,0.1232842281460762,out,6
1380,Row1617,Row877,CHEMBL1170238,,0,321.38,9,IC50,=,700.0,nM,Cc1c[nH]c2ncnc(c21)N3C[C@@H](CC3)NC(=O)c4ccccc4,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,Cc1c[nH]c2ncnc(c21)N3C[C@@H](CC3)NC(=O)c4ccccc4,,Row1872,62,0.1284870505332946,out,6
1381,Row1618,Row1438,CHEMBL3684344,,0,410.48,BDBM103056,IC50,=,700.0,nM,CC(C)CC(=O)Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23,,220778.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CC(C)CC(=O)Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23,,Row2783,67,0.1391429901123047,out,6
1382,Row1619,Row1840,CHEMBL3684492,,0,572.67,BDBM103206,IC50,=,700.0,nM,COc1ccccc1NC(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,220928.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,COc1ccccc1NC(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,Row662,76,0.1522263884544372,out,6
1383,Row1620,Row3851,CHEMBL3684367,,0,408.47,BDBM103080,IC50,=,700.0,nM,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)C6CCC6,,220802.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)C6CCC6,,Row2783,67,0.1621425896883011,out,6
1384,Row1621,Row4024,CHEMBL3684488,,0,556.67,BDBM103202,IC50,=,700.0,nM,Cc1ccccc1NC(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,220924.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cc1ccccc1NC(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,Row662,76,0.1439012438058853,out,6
1385,Row1622,Row2750,CHEMBL4446375,,0,500.51,A1,IC50,=,709.6,nM,Cn1nccc1-c2cc(oc2)C(=O)NC3CNCCC3c4ccccc4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1nccc1-c2cc(oc2)C(=O)NC3CNCCC3c4ccccc4,,Row39,44,0.1231080815196037,out,6
1386,Row1623,Row3251,CHEMBL1095279,,0,405.46,9b,IC50,=,712.0,nM,C[C@H](N)COc1cncc(c1)-c2cc3c(cnc4cc(OC)c(cc34)OC)c(N)n2,,,CHEMBL1103721,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157027,1,Scientific Literature,Eur. J. Med. Chem.,2010.0,C[C@H](N)COc1cncc(c1)-c2cc3c(cnc4cc(OC)c(cc34)OC)c(N)n2,,Row1813,70,0.0968247279524803,out,6
1387,Row1624,Row767,CHEMBL443633,,0,621.79,34,IC50,=,720.0,nM,CN1CCN(CC1)c2nccc3cc(c(nc32)-c4ccc(CN5CCC(CC5)c6[nH]c(nn6)-c7ccccn7)cc4)-c8ccccc8,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN1CCN(CC1)c2nccc3cc(c(nc32)-c4ccc(CN5CCC(CC5)c6[nH]c(nn6)-c7ccccn7)cc4)-c8ccccc8,,Row1163,23,0.1883003413677215,out,6
1388,Row1626,Row2809,CHEMBL592898,,0,426.52,9o,IC50,=,720.0,nM,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3C#CCCO)OC[C@@H](N)Cc4ccccc4,,,CHEMBL1071952,Inhibition of full length AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3C#CCCO)OC[C@@H](N)Cc4ccccc4,,Row1976,11,0.133178174495697,out,6
1389,Row1627,Row3245,CHEMBL3684475,,0,586.7,BDBM103189,IC50,=,720.0,nM,Cc1cc(NC(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2)c(cc1)OC,,220911.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cc1cc(NC(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2)c(cc1)OC,,Row662,76,0.1497897207736969,out,6
1390,Row1629,Row2077,CHEMBL3918796,,0,547.56,BDBM182585,IC50,=,730.0,nM,Nc1ncnc(c1C(O)=O)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)c(c5)C(F)(F)F,,330026.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(O)=O)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(F)c(c5)C(F)(F)F,,Row2044,43,0.1220347583293914,out,6
1391,Row1630,Row2465,CHEMBL3684343,,0,396.45,BDBM103055,IC50,=,730.0,nM,CCCC(=O)Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23,,220777.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CCCC(=O)Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23,,Row2783,67,0.1431008130311966,out,6
1392,Row1631,Row3348,CHEMBL3963052,,0,577.63,BDBM182664,IC50,=,730.0,nM,CN(C)CCN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4ccc(F)c(c4)C(F)(F)F,,330105.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)CCN(C)CCn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4ccc(F)c(c4)C(F)(F)F,,Row2044,43,0.1220260336995124,out,6
1393,Row1632,Row3387,CHEMBL3679720,,0,326.36,BDBM103034,IC50,=,730.0,nM,Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,220756.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,Row3389,81,0.1628395617008209,out,6
1394,Row1634,Row180,CHEMBL4176130,,0,493.52,12g,IC50,=,738.0,nM,Cc1ccc(cc1)-c2nc(NNC(=O)c3cccc4c3[nH]c5ccccc5c4=O)nc(C)c2C(=O)OC,,,CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4130433,1,Scientific Literature,Eur J Med Chem,2017.0,Cc1ccc(cc1)-c2nc(NNC(=O)c3cccc4c3[nH]c5ccccc5c4=O)nc(C)c2C(=O)OC,,Row2772,33,0.1350876092910766,out,6
1395,Row1636,Row870,CHEMBL3889930,,0,490.51,BDBM182353,IC50,=,740.0,nM,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3/C=C/COC)-c4ccc(F)c(c4)C(F)(F)F,,329794.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3/C=C/COC)-c4ccc(F)c(c4)C(F)(F)F,,Row3758,45,0.1162102967500686,out,6
1396,Row1637,Row1340,CHEMBL3113140,,0,391.91,17a,IC50,=,740.0,nM,CC(C)CNC(c1ccc(Cl)cc1)c2ccc(cc2)-c3ncnc4[nH]cnc34,,,CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3112393,1,Scientific Literature,Eur. J. Med. Chem.,2014.0,CC(C)CNC(c1ccc(Cl)cc1)c2ccc(cc2)-c3ncnc4[nH]cnc34,,Row2632,65,0.114242136478424,out,6
1397,Row1638,Row3127,CHEMBL3113142,,0,425.92,17c,IC50,=,740.0,nM,Clc1ccc(cc1)C(NCc2ccccc2)c3ccc(cc3)-c4ncnc5[nH]cnc45,,,CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3112393,1,Scientific Literature,Eur. J. Med. Chem.,2014.0,Clc1ccc(cc1)C(NCc2ccccc2)c3ccc(cc3)-c4ncnc5[nH]cnc45,,Row2632,65,0.1337538957595825,out,6
1398,Row1639,Row3139,CHEMBL448196,,0,621.79,38,IC50,=,740.0,nM,CN1CCN(CC1)c2cc3cc(c(nc3cn2)-c4ccc(CN5CCC(CC5)c6[nH]c(nn6)-c7ccccn7)cc4)-c8ccccc8,,,CHEMBL951577,Inhibition of Akt1 phosphorylation by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157492,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN1CCN(CC1)c2cc3cc(c(nc3cn2)-c4ccc(CN5CCC(CC5)c6[nH]c(nn6)-c7ccccn7)cc4)-c8ccccc8,,Row1163,23,0.1908981800079345,out,6
1399,Row1640,Row2473,CHEMBL3684491,,0,576.73,BDBM103205,IC50,=,750.0,nM,O=C(NC1CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CC1)NCCc7cccs7,,220927.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(NC1CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CC1)NCCc7cccs7,,Row662,76,0.14021897315979,out,6
1400,Row1641,Row255,CHEMBL415220,,0,487.6,13ar,IC50,=,751.0,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cccc(c4)OCCN5CCOCC5,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cccc(c4)OCCN5CCOCC5,,Row1976,11,0.1235929131507873,out,6
1401,Row1642,Row1730,CHEMBL575428,,0,488.59,76,IC50,=,751.0,nM,Cc1n[nH]c2cnc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cccc(c4)OCCN5CCOCC5,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Cc1n[nH]c2cnc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cccc(c4)OCCN5CCOCC5,,Row535,12,0.1147411987185478,out,6
1402,Row1643,Row324,CHEMBL178397,,0,491.6,3,IC50,=,760.0,nM,Cc1nc(c([nH]c1=O)-c2ccccc2)-c3ccc(CN4CCC(CC4)n5c6ccccc6[nH]c5=O)cc3,,,CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141976,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,Cc1nc(c([nH]c1=O)-c2ccccc2)-c3ccc(CN4CCC(CC4)n5c6ccccc6[nH]c5=O)cc3,,Row2123,58,0.1738950461149215,out,6
1403,Row1644,Row539,CHEMBL574290,,0,370.46,15,IC50,=,760.0,nM,Cn1cc(C(CN)Oc2cncc(c2)/C=C/c3ccncc3)c4ccccc14,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Cn1cc(C(CN)Oc2cncc(c2)/C=C/c3ccncc3)c4ccccc14,,Row615,77,0.1309379935264587,out,6
1404,Row1645,Row1125,CHEMBL3684513,,0,538.61,BDBM103227,IC50,=,760.0,nM,O=S(=O)(NC1(CCC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)c7cc(F)ccc7,,220949.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=S(=O)(NC1(CCC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)c7cc(F)ccc7,,Row3391,71,0.2052232325077057,out,6
1405,Row1646,Row1478,CHEMBL3929885,,0,437.51,BDBM182434,IC50,=,760.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cnoc5,,329875.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cnoc5,,Row1206,41,0.0963582843542099,out,6
1406,Row1647,Row2946,CHEMBL202937,,0,354.46,22b,IC50,=,760.0,nM,Cn1cc(C(CN)c2cncc(c2)/C=C/c3ccncc3)c4ccccc14,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Cn1cc(C(CN)c2cncc(c2)/C=C/c3ccncc3)c4ccccc14,,Row615,77,0.1311875581741333,out,6
1407,Row1648,Row3563,CHEMBL3986416,,0,596.63,BDBM182667,IC50,=,760.0,nM,CN(Cc1ccccc1)CCn2cc(nc2C3CCN(CC3)c4ncnc(N)c4C(N)=O)-c5ccc(F)c(c5)C(F)(F)F,,330108.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(Cc1ccccc1)CCn2cc(nc2C3CCN(CC3)c4ncnc(N)c4C(N)=O)-c5ccc(F)c(c5)C(F)(F)F,,Row2044,43,0.1383909434080124,out,6
1408,Row1649,Row2123,CHEMBL255212,,0,485.59,7a,IC50,=,762.0,nM,N#Cc1cnc(c(c1)-c2ccccc2)-c3ccc(CN4CCC(CC4)n5c(=O)[nH]c6ccccc56)cc3,,,CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141976,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,N#Cc1cnc(c(c1)-c2ccccc2)-c3ccc(CN4CCC(CC4)n5c(=O)[nH]c6ccccc56)cc3,,Row2123,58,0.2087689489126205,out,6
1409,Row1650,Row328,CHEMBL367601,,0,526.65,8d,IC50,=,763.0,nM,Cc1cc2nc([nH]c2cc1)C3CCN(Cc4ccc(cc4)-c5ncc(cc5-c6ccccc6)-c7n[nH]nn7)CC3,,,CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141976,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,Cc1cc2nc([nH]c2cc1)C3CCN(Cc4ccc(cc4)-c5ncc(cc5-c6ccccc6)-c7n[nH]nn7)CC3,,Row2123,58,0.1983703523874282,out,6
1410,Row1651,Row994,CHEMBL251860,,0,498.7,12b,IC50,=,765.0,nM,CN1CCN(CCCNCc2ccc(cc2)-c3nc4nc(ncc4cc3-c5ccccc5)SC)CC1,,,CHEMBL928491,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141509,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN1CCN(CCCNCc2ccc(cc2)-c3nc4nc(ncc4cc3-c5ccccc5)SC)CC1,,Row3742,50,0.1949748247861862,out,6
1411,Row1652,Row2451,CHEMBL1171841,,0,288.36,26,IC50,=,765.0,nM,Cc1c[nH]c2ncnc(c12)N3CCC(N)(C3)CNC(C)=O,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,Cc1c[nH]c2ncnc(c12)N3CCC(N)(C3)CNC(C)=O,,Row2553,9,0.1210314780473709,out,6
1412,Row1653,Row2453,CHEMBL3684486,,0,584.73,BDBM103200,IC50,=,770.0,nM,CCCc1ccccc1NC(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,220922.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CCCc1ccccc1NC(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,Row662,76,0.1417503654956817,out,6
1413,Row1654,Row1784,CHEMBL208014,,0,428.92,10l,IC50,=,778.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5ccnc(Cl)c5cc4,,,CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1147830,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5ccnc(Cl)c5cc4,,Row1996,15,0.1305166482925415,out,6
1414,Row1655,Row1416,CHEMBL3684480,,0,586.7,BDBM103194,IC50,=,780.0,nM,COc1cc(CNC(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2)ccc1,,220916.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,COc1cc(CNC(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2)ccc1,,Row662,76,0.1597973108291626,out,6
1415,Row1656,Row1444,CHEMBL3684371,,0,506.57,BDBM103084,IC50,=,780.0,nM,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccc(cc6)-c7ccccc7,,220806.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccc(cc6)-c7ccccc7,,Row2783,67,0.1631984859704971,out,6
1416,Row1657,Row1955,CHEMBL379849,,0,311.33,"3, EF24",IC50,=,780.0,nM,O=C\1/C(/CNC/C1=C\c2ccccc2F)=C/c3ccccc3F,,,CHEMBL2344124,Inhibition of recombinant AKT1 (unknown origin) by FRET-based Z'-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2331439,1,Scientific Literature,J. Med. Chem.,2013.0,O=C\1/C(/CNC/C1=C\c2ccccc2F)=C/c3ccccc3F,,Row1473,59,0.112286165356636,out,6
1417,Row1658,Row2411,CHEMBL3905865,,0,467.02,BDBM60651,IC50,=,780.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cccc(Cl)n5,,329863.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cccc(Cl)n5,,Row3753,7,0.1167224645614624,out,6
1418,Row1659,Row3429,CHEMBL3684389,,0,458.57,BDBM103102,IC50,=,780.0,nM,CN(Cc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)CCc6ccccc6,,220824.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CN(Cc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)CCc6ccccc6,,Row2452,66,0.1484159380197525,out,6
1419,Row1661,Row1186,CHEMBL595708,,0,424.5,9i,IC50,=,790.0,nM,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4ccco4)OC[C@@H](N)Cc5ccccc5,,,CHEMBL1071953,Inhibition of truncated AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3cc(cnc3-c4ccco4)OC[C@@H](N)Cc5ccccc5,,Row1976,11,0.1493263393640518,out,6
1420,Row1662,Row2472,CHEMBL3684487,,0,560.64,BDBM103201,IC50,=,790.0,nM,O=C(Nc1cc(F)ccc1)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,220923.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Nc1cc(F)ccc1)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,Row662,76,0.1459914892911911,out,6
1421,Row1663,Row3280,CHEMBL3684455,,0,627.75,BDBM103168,IC50,=,790.0,nM,COC(=O)c1sccc1S(=O)(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,220890.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,COC(=O)c1sccc1S(=O)(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,Row662,76,0.1418681889772415,out,6
1422,Row1664,Row3631,CHEMBL1095931,,0,516.0,9p,IC50,=,793.0,nM,COc1cc2c(cc1OC)ncc3c2cc(nc3N)-c4cncc(c4)OC[C@@H](N)Cc5ccccc5Cl,,,CHEMBL1103721,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157027,1,Scientific Literature,Eur. J. Med. Chem.,2010.0,COc1cc2c(cc1OC)ncc3c2cc(nc3N)-c4cncc(c4)OC[C@@H](N)Cc5ccccc5Cl,,Row1813,70,0.1302860379219055,out,6
1423,Row1665,Row2601,CHEMBL1794064,GSK-561866B,0,470.41,13,IC50,=,794.0,nM,CCn1c2c(cnc(C#CCN)c2nc1-c3nonc3N)OCCCN,,,CHEMBL1028090,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140130,1,Scientific Literature,J. Med. Chem.,2008.0,CCn1c2c(cnc(C#CCN)c2nc1-c3nonc3N)OCCCN,,Row2429,38,0.1100131049752235,out,6
1424,Row1666,Row2654,CHEMBL3684337,,0,554.61,BDBM103049,IC50,=,800.0,nM,O=c1[nH]c2ccccc2n1C3CCN(CC3)C(=O)c4ccc(cc4)-c5nnc6-c7ccccc7Nc8ncccc8-n65,,220771.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=c1[nH]c2ccccc2n1C3CCN(CC3)C(=O)c4ccc(cc4)-c5nnc6-c7ccccc7Nc8ncccc8-n65,,Row2783,67,0.1519843488931656,out,6
1425,Row1667,Row3339,CHEMBL3684412,,0,510.58,BDBM103125,IC50,=,800.0,nM,COc1ccc(cc1)S(=O)(=O)NCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,220847.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,COc1ccc(cc1)S(=O)(=O)NCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,Row3925,73,0.1390682458877563,out,6
1426,Row1668,Row3571,CHEMBL1940997,,0,613.48,5a,IC50,=,800.0,nM,CC(=O)O[C@H]1[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](NC(=O)CCCn2[se]c3ccccc3c2=O)O[C@@H]1COC(C)=O,,,CHEMBL1944084,Inhibition of AKT-1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1938284,1,Scientific Literature,Eur. J. Med. Chem.,2012.0,CC(=O)O[C@H]1[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](NC(=O)CCCn2[se]c3ccccc3c2=O)O[C@@H]1COC(C)=O,,Row2523,51,0.0959512814879417,out,6
1427,Row1669,Row2440,CHEMBL1257985,,0,471.99,34,IC50,=,809.0,nM,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4ccc(cc34)-c5ccccc5,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4ccc(cc34)-c5ccccc5,,Row875,55,0.1654264479875564,out,6
1428,Row1670,Row3700,CHEMBL2063990,,0,530.57,6,IC50,=,810.0,nM,COc1cc(C=C(C(=O)/C=C/c2cccc(OC)c2OC)C(=O)/C=C/c3cccc(OC)c3OC)ccc1O,,,CHEMBL2067501,Inhibition of AKT1 by AKT1/PKBalpha KinEASE FP fluorescein green assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2062524,1,Scientific Literature,Eur. J. Med. Chem.,2012.0,COc1cc(C=C(C(=O)/C=C/c2cccc(OC)c2OC)C(=O)/C=C/c3cccc(OC)c3OC)ccc1O,,Row2523,51,0.0764906406402587,out,6
1429,Row1671,Row1190,CHEMBL3113150,,0,326.83,22i,IC50,=,820.0,nM,NCCNC(c1ccc(cc1)-c2c[nH]nc2)c3ccc(Cl)cc3,,,CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3112393,1,Scientific Literature,Eur. J. Med. Chem.,2014.0,NCCNC(c1ccc(cc1)-c2c[nH]nc2)c3ccc(Cl)cc3,,Row2632,65,0.0988101512193679,out,6
1430,Row1673,Row2471,CHEMBL3684497,,0,500.61,BDBM103211,IC50,=,830.0,nM,C(c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)N6CCC(CC6)Oc7ccccc7,,220933.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,C(c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)N6CCC(CC6)Oc7ccccc7,,Row2452,66,0.1629486232995987,out,6
1431,Row1674,Row2580,CHEMBL1940993,,0,816.62,2d,IC50,=,830.0,nM,CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@@H](O[C@H](COC(C)=O)[C@H]1O[C@@H]2O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]2OC(C)=O)n3[se]c4ccccc4c3=O,,,CHEMBL1944084,Inhibition of AKT-1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1938284,1,Scientific Literature,Eur. J. Med. Chem.,2012.0,CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@@H](O[C@H](COC(C)=O)[C@H]1O[C@@H]2O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]2OC(C)=O)n3[se]c4ccccc4c3=O,,Row2387,28,0.1021119058132171,out,6
1432,Row1675,Row3732,CHEMBL1257281,,0,421.5,19,IC50,=,838.0,nM,COc1cc(C[C@@H](N)C(=O)N2CCN(CC2)c3ncnc4ccccc34)cc(c1)OC,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,COc1cc(C[C@@H](N)C(=O)N2CCN(CC2)c3ncnc4ccccc34)cc(c1)OC,,Row875,55,0.1356592923402786,out,6
1433,Row1676,Row3295,CHEMBL1089990,,0,1058.3,YTG 2a,IC50,=,840.0,nM,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCCNC(N)=N)C(N)=O,,,CHEMBL1113529,Inhibition of PKB by radioactive kinase assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1156226,1,Scientific Literature,Bioorg. Med. Chem.,2010.0,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCCNC(N)=N)C(N)=O,,Row2426,74,0.0884413123130798,out,6
1434,Row1677,Row3683,CHEMBL3684493,,0,586.7,BDBM103207,IC50,=,840.0,nM,Cc1cc(ccc1NC(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2)OC,,220929.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cc1cc(ccc1NC(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2)OC,,Row662,76,0.1581200510263443,out,6
1435,Row1678,Row1611,CHEMBL1823632,,0,345.45,4,IC50,=,850.0,nM,O=C(NC(C1CCNCC1)c2ccccc2)c3ccc4cnccc4c3,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,O=C(NC(C1CCNCC1)c2ccccc2)c3ccc4cnccc4c3,,Row3192,40,0.1401809453964233,out,6
1436,Row1679,Row2341,CHEMBL514989,,0,361.35,(+/-)-syn-11l,IC50,=,850.0,nM,Nc1ccc(cc1)[C@@H]2O[C@@H]3CC(=O)O[C@@H]3C4=C2C(=O)c5ccccc5C4=O,,,CHEMBL1018804,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153413,1,Scientific Literature,J. Med. Chem.,2009.0,Nc1ccc(cc1)[C@@H]2O[C@@H]3CC(=O)O[C@@H]3C4=C2C(=O)c5ccccc5C4=O,,Row2387,28,0.1260580420494079,out,6
1437,Row1680,Row2479,CHEMBL3922417,,0,517.56,BDBM182354,IC50,=,850.0,nM,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4cnc(C)s4)-c5ccc(F)c(c5)C(F)(F)F,,329795.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4cnc(C)s4)-c5ccc(F)c(c5)C(F)(F)F,,Row3758,45,0.1212780475616455,out,6
1438,Row1681,Row3401,CHEMBL4109551,,0,399.86,BDBM181324,IC50,=,850.0,nM,NC(=O)c1ccc(N[C@H]2CNCC[C@@H]2c3cc(Cl)c(F)cc3)c4cncnc41,,328347.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(N[C@H]2CNCC[C@@H]2c3cc(Cl)c(F)cc3)c4cncnc41,,Row2729,75,0.0965563505887985,out,6
1439,Row1682,Row3847,CHEMBL3805319,,0,535.69,27c,IC50,=,850.0,nM,Cn1c(C(=O)NC2(CCNCC2)c3cc(Cl)c(Cl)cc3)c(Cl)c(-c4c(Cl)cnn4C)c1Cl,,,CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3804794,1,Scientific Literature,Eur. J. Med. Chem.,2016.0,Cn1c(C(=O)NC2(CCNCC2)c3cc(Cl)c(Cl)cc3)c(Cl)c(-c4c(Cl)cnn4C)c1Cl,,Row3848,57,0.1414805352687835,out,6
1440,Row1684,Row997,CHEMBL1800260,,0,891.09,14,IC50,=,860.0,nM,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CN)NC(=O)[C@@H](N)CCCNC(N)=N)C(N)=O,,,CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1799953,1,Scientific Literature,J. Med. Chem.,2011.0,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CN)NC(=O)[C@@H](N)CCCNC(N)=N)C(N)=O,,Row2426,74,0.06764417886734,out,6
1441,Row1685,Row2901,CHEMBL3978717,,0,497.5,BDBM182338,IC50,=,860.0,nM,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4ccncc4)-c5cc(c(F)cc5)C(F)(F)F,,329787.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4ccncc4)-c5cc(c(F)cc5)C(F)(F)F,,Row3758,45,0.1238187924027443,out,6
1442,Row1686,Row782,CHEMBL368010,,0,487.58,7c,IC50,=,865.0,nM,N#Cc1cnc(-c2ccc(CN3CCC(CC3)c4[nH]c5ccc(F)cc5n4)cc2)c(c1)-c6ccccc6,,,CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141976,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,N#Cc1cnc(-c2ccc(CN3CCC(CC3)c4[nH]c5ccc(F)cc5n4)cc2)c(c1)-c6ccccc6,,Row2123,58,0.1908879727125167,out,6
1443,Row1687,Row2882,CHEMBL1257873,,0,452.95,32,IC50,=,868.0,nM,CC(=O)Nc1cc2c(ncnc2cc1)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,CC(=O)Nc1cc2c(ncnc2cc1)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,Row875,55,0.0990774035453796,out,6
1444,Row1688,Row2948,CHEMBL4552628,,0,425.89,27,IC50,=,870.0,nM,Cc1sc(cc1-c2cnn3cc(Cl)cnc32)C(=O)N[C@@H]4[C@H](N)CCCC4(F)F,,,CHEMBL4479691,Inhibition of full-length recombinant human His-tagged AKT1-alpha expressed in baculovirus expression system by Z'-LYTE assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4477252,1,Scientific Literature,Bioorg Med Chem Lett,2016.0,Cc1sc(cc1-c2cnn3cc(Cl)cnc32)C(=O)N[C@@H]4[C@H](N)CCCC4(F)F,,Row1315,22,0.1080865561962127,out,6
1445,Row1690,Row2319,CHEMBL203685,,0,347.42,2l,IC50,=,875.0,nM,N[C@@H](Cc1cccc(O)c1)COc2cc(cnc2)/C=C/c3ccncc3,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1cccc(O)c1)COc2cc(cnc2)/C=C/c3ccncc3,,Row615,77,0.0996453016996383,out,6
1446,Row1691,Row913,CHEMBL1940999,,0,445.33,6a,IC50,=,880.0,nM,OC[C@H]1O[C@@H](NC(=O)CCCn2[se]c3ccccc3c2=O)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL1944084,Inhibition of AKT-1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1938284,1,Scientific Literature,Eur. J. Med. Chem.,2012.0,OC[C@H]1O[C@@H](NC(=O)CCCn2[se]c3ccccc3c2=O)[C@H](O)[C@@H](O)[C@@H]1O,,Row2783,67,0.1113955304026603,out,6
1447,Row1692,Row1096,CHEMBL395080,,0,549.63,46c,IC50,=,880.0,nM,COc1cc(ccc1N)-c2ccc3c(c2)Nc4ccc(CC(=O)Nc5ccc(cc5)N6CCOCC6)cc4NC3=O,,,CHEMBL894158,Inhibition of recombinant Akt1 by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1148724,1,Scientific Literature,J. Med. Chem.,2007.0,COc1cc(ccc1N)-c2ccc3c(c2)Nc4ccc(CC(=O)Nc5ccc(cc5)N6CCOCC6)cc4NC3=O,,Row1867,42,0.1413386762142181,out,6
1448,Row1693,Row2834,CHEMBL3958964,,0,497.5,BDBM182352,IC50,=,880.0,nM,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4cnccc4)-c5cc(c(F)cc5)C(F)(F)F,,329793.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4cnccc4)-c5cc(c(F)cc5)C(F)(F)F,,Row3758,45,0.1444007158279419,out,6
1449,Row1694,Row2332,CHEMBL1258329,,0,361.45,2,IC50,=,884.0,nM,N[C@H](Cc1ccccc1)C(=O)N2CCN(CC2)c3ncnc4ccccc34,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccccc1)C(=O)N2CCN(CC2)c3ncnc4ccccc34,,Row875,55,0.1419497579336166,out,6
1450,Row1695,Row234,CHEMBL1095285,,0,549.55,9m,IC50,=,889.0,nM,COc1cc2c(cc1OC)ncc3c2cc(nc3N)-c4cncc(c4)OC[C@H](N)Cc5cc(ccc5)C(F)(F)F,,,CHEMBL1103721,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157027,1,Scientific Literature,Eur. J. Med. Chem.,2010.0,COc1cc2c(cc1OC)ncc3c2cc(nc3N)-c4cncc(c4)OC[C@H](N)Cc5cc(ccc5)C(F)(F)F,,Row1813,70,0.1088464856147766,out,6
1451,Row1697,Row1608,CHEMBL1079626,,0,431.49,31,IC50,=,895.0,nM,Cn1ncc2ccc(cc12)-c3cnc(NC[C@@H](N)Cc4ccc(cc4)C(F)(F)F)s3,,,CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154944,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cn1ncc2ccc(cc12)-c3cnc(NC[C@@H](N)Cc4ccc(cc4)C(F)(F)F)s3,,Row240,47,0.1166122630238533,out,6
1452,Row1698,Row2632,CHEMBL3113144,,0,339.87,22b,IC50,=,900.0,nM,CC(C)CNC(c1ccc(Cl)cc1)c2ccc(cc2)-c3c[nH]nc3,,,CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3112393,1,Scientific Literature,Eur. J. Med. Chem.,2014.0,CC(C)CNC(c1ccc(Cl)cc1)c2ccc(cc2)-c3c[nH]nc3,,Row2632,65,0.1031442284584045,out,6
1453,Row1699,Row2729,CHEMBL3910187,,0,365.41,BDBM181328,IC50,=,900.0,nM,NC(=O)c1ccc(N[C@@H]2CNCC[C@H]2c3ccc(F)cc3)c4cncnc41,,328351.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(N[C@@H]2CNCC[C@H]2c3ccc(F)cc3)c4cncnc41,,Row2729,75,0.1019758582115173,out,6
1454,Row1700,Row1975,CHEMBL2177376,,0,497.95,37,IC50,=,902.0,nM,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CNCC(F)(F)F)c4ccc(Cl)cc4,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,C[C@@H]1C[C@@H](O)c2ncnc(c21)N3CCN(CC3)C(=O)[C@H](CNCC(F)(F)F)c4ccc(Cl)cc4,,Row2863,37,0.0994291603565216,out,6
1455,Row1701,Row2357,CHEMBL1094321,,0,447.54,9f,IC50,=,905.0,nM,CC(C)C[C@H](N)COc1cncc(c1)-c2cc3c(cnc4cc(OC)c(cc34)OC)c(N)n2,,,CHEMBL1103721,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157027,1,Scientific Literature,Eur. J. Med. Chem.,2010.0,CC(C)C[C@H](N)COc1cncc(c1)-c2cc3c(cnc4cc(OC)c(cc34)OC)c(N)n2,,Row1813,70,0.0936611294746398,out,6
1456,Row1702,Row1753,CHEMBL3684482,,0,591.12,BDBM103196,IC50,=,910.0,nM,O=C(NC1CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CC1)NCc7ccccc7Cl,,220918.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(NC1CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CC1)NCc7ccccc7Cl,,Row662,76,0.1422521919012069,out,6
1457,Row1703,Row810,CHEMBL3684498,,0,500.61,BDBM103212,IC50,=,920.0,nM,C1C(CCCN1Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34)Oc7ccccc7,,220934.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,C1C(CCCN1Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34)Oc7ccccc7,,Row2452,66,0.163231536746025,out,6
1458,Row1704,Row1632,CHEMBL1800399,,0,1045.26,40,IC50,=,920.0,nM,CC(C)CC[C@@H]1NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCNC(=O)NCCCN(CC(N)=O)C1=O)C(=O)[C@@H](N)CCCNC(N)=N,,,CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1799953,1,Scientific Literature,J. Med. Chem.,2011.0,CC(C)CC[C@@H]1NC(=O)[C@H](CN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(CCNC(=O)NCCCN(CC(N)=O)C1=O)C(=O)[C@@H](N)CCCNC(N)=N,,Row1816,79,0.0825803503394126,out,6
1459,Row1705,Row2084,CHEMBL3806229,,0,402.86,25a,IC50,=,920.0,nM,Cn1ncc(Cl)c1-c2coc(c2)C(=O)NC3(CCNCC3)c4ccc(F)cc4,,,CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3804794,1,Scientific Literature,Eur. J. Med. Chem.,2016.0,Cn1ncc(Cl)c1-c2coc(c2)C(=O)NC3(CCNCC3)c4ccc(F)cc4,,Row3848,57,0.1341350227594375,out,6
1460,Row1706,Row2924,CHEMBL1090000,,0,916.14,N-Me 1a,IC50,=,920.0,nM,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(N)=N)NC)C(N)=O,,,CHEMBL1113529,Inhibition of PKB by radioactive kinase assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1156226,1,Scientific Literature,Bioorg. Med. Chem.,2010.0,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(N)=N)NC)C(N)=O,,Row2426,74,0.0904558300971984,out,6
1461,Row1707,Row3686,CHEMBL3805292,,0,384.48,24a,IC50,=,920.0,nM,Cn1nccc1-c2csc(c2)C(=O)NC3(CCNCC3)c4ccc(F)cc4,,,CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3804794,1,Scientific Literature,Eur. J. Med. Chem.,2016.0,Cn1nccc1-c2csc(c2)C(=O)NC3(CCNCC3)c4ccc(F)cc4,,Row3848,57,0.1331249326467514,out,6
1462,Row1709,Row479,CHEMBL3684438,,0,539.64,BDBM103151,IC50,=,940.0,nM,O=c1[nH]c2ccccc2n1C3CCN(Cc4ccc(cc4)-c5nnc6-c7ccccc7Nc8ccccc8-n65)CC3,,220873.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=c1[nH]c2ccccc2n1C3CCN(Cc4ccc(cc4)-c5nnc6-c7ccccc7Nc8ccccc8-n65)CC3,,Row2123,58,0.1619258671998977,out,6
1463,Row1710,Row769,CHEMBL3904876,,0,462.6,BDBM182411,IC50,=,940.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ncc5)OC,,329852.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ncc5)OC,,Row3753,7,0.1368550360202789,out,6
1464,Row1711,Row2013,CHEMBL1089661,,0,902.12,"1, PTR6154",IC50,=,940.0,nM,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CCCNC(N)=N)C(N)=O,,,CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1799953,1,Scientific Literature,J. Med. Chem.,2011.0,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CCCNC(N)=N)C(N)=O,,Row2426,74,0.0888259559869766,out,6
1465,Row1712,Row3090,CHEMBL3684489,,0,605.15,BDBM103203,IC50,=,940.0,nM,O=C(NC1CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CC1)NCCc7ccc(Cl)cc7,,220925.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(NC1CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CC1)NCCc7ccc(Cl)cc7,,Row662,76,0.1424826681613922,out,6
1466,Row1713,Row2001,CHEMBL1800146,,0,958.22,3,IC50,=,950.0,nM,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC2CCCCC2)NC(=O)[C@@H](N)CCCNC(N)=N)C(N)=O,,,CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1799953,1,Scientific Literature,J. Med. Chem.,2011.0,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC2CCCCC2)NC(=O)[C@@H](N)CCCNC(N)=N)C(N)=O,,Row2426,74,0.0843739658594131,out,6
1467,Row1714,Row2321,CHEMBL3684346,,0,494.56,BDBM103058,IC50,=,950.0,nM,O=C(Cc1cccc2ccccc21)Nc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45,,220780.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Cc1cccc2ccccc21)Nc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45,,Row2783,67,0.1371763199567794,out,6
1468,Row1715,Row2739,CHEMBL3684471,,0,554.66,BDBM103185,IC50,=,950.0,nM,O=C1NCN(c2ccccc2)C13CCN(Cc4ccc(cc4)-c5nnc6-c7ccccc7Nc8ncccc8-n56)CC3,,220907.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C1NCN(c2ccccc2)C13CCN(Cc4ccc(cc4)-c5nnc6-c7ccccc7Nc8ncccc8-n56)CC3,,Row2452,66,0.1721920818090438,out,6
1469,Row1716,Row817,CHEMBL225788,,0,428.45,9c,IC50,=,953.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5cn[nH]c5cc4[N+]([O-])=O,,,CHEMBL903964,Inhibition of Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142911,1,Scientific Literature,Bioorg. Med. Chem.,2007.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5cn[nH]c5cc4[N+]([O-])=O,,Row1726,2,0.1098963469266891,out,6
1470,Row1717,Row3171,CHEMBL220241,GSK-269962A,0,570.61,GSK269962A,IC50,=,955.0,nM,CCn1c(nc2cnc(cc12)Oc3cc(ccc3)NC(=O)c4ccc(cc4)OCCN5CCOCC5)-c6nonc6N,,,CHEMBL1960791,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1955726,1,Scientific Literature,J. Pharmacol. Exp. Ther.,2007.0,CCn1c(nc2cnc(cc12)Oc3cc(ccc3)NC(=O)c4ccc(cc4)OCCN5CCOCC5)-c6nonc6N,,Row1117,69,0.1369082927703857,out,6
1471,Row1719,Row1639,CHEMBL4161273,,0,507.55,11g,IC50,=,980.0,nM,CCOC(=O)c1c(nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc1C)-c5ccc(C)cc5,,,CHEMBL4133625,Inhibition of PH domain lacking AKT1 (unknown origin) using Tamara-labeled GRPRTSSFAEG peptide as substrate after 90 mins by fluorescence polarization IMAP assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4130433,1,Scientific Literature,Eur J Med Chem,2017.0,CCOC(=O)c1c(nc(NNC(=O)c2cccc3c2[nH]c4ccccc4c3=O)nc1C)-c5ccc(C)cc5,,Row2772,33,0.1315280944108963,out,6
1472,Row1721,Row3347,CHEMBL3912088,,0,511.03,BDBM182646,IC50,=,990.0,nM,COc1ccc(cc1Cl)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,330087.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,COc1ccc(cc1Cl)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,Row1206,41,0.1320269256830215,out,6
1473,Row1722,Row3988,CHEMBL3684449,,0,538.62,BDBM103162,IC50,=,990.0,nM,[C-]#[N+]c1ccc(cc1)C(=O)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,220884.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,[C-]#[N+]c1ccc(cc1)C(=O)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,Row2452,66,0.1512840390205383,out,6
1474,Row1723,Row1391,CHEMBL208961,,0,408.51,10aa,IC50,=,995.0,nM,Cc1cc(cc2ccncc21)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,,CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1147830,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Cc1cc(cc2ccncc21)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,Row1996,15,0.1251795142889022,out,6
1475,Row1724,Row78,CHEMBL4454985,,0,454.98,C5,IC50,>,1000.0,nM,OC1CCc2c(ncnc21)-c3ccc(s3)C(=O)N[C@@H]4CNCC[C@H]4c5ccc(Cl)cc5,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,OC1CCc2c(ncnc21)-c3ccc(s3)C(=O)N[C@@H]4CNCC[C@H]4c5ccc(Cl)cc5,,Row1315,22,0.1016723737120628,out,6
1476,Row1725,Row632,CHEMBL3953761,,0,479.6,BDBM182494,IC50,>,1000.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCOCC4)-c5ccc(F)cc5,,329935.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCOCC4)-c5ccc(F)cc5,,Row3753,7,0.1192515566945076,out,6
1477,Row1726,Row686,CHEMBL215803,,0,403.44,14,IC50,>,1000.0,nM,C[C@@H]1C[C@H]2CN1CCn3nc4c(cccc4-c5nc6c(cccc6O2)nc5O)c3O,,,CHEMBL910939,Inhibition of PKBalpha,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1149510,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,C[C@@H]1C[C@H]2CN1CCn3nc4c(cccc4-c5nc6c(cccc6O2)nc5O)c3O,,Row31,68,0.1116749942302703,out,6
1478,Row1727,Row929,CHEMBL3593777,,0,379.4,31,IC50,>,1000.0,nM,NC(=O)c1cnc2[nH]ccc2c1N[C@@H]3CCN(C[C@@H]3F)c4ccc(cn4)C#N,,,CHEMBL3595097,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3593212,1,Scientific Literature,Bioorg. Med. Chem.,2015.0,NC(=O)c1cnc2[nH]ccc2c1N[C@@H]3CCN(C[C@@H]3F)c4ccc(cn4)C#N,,Row854,17,0.103644847869873,out,6
1479,Row1728,Row1039,CHEMBL281957,,0,484.43,43,IC50,>,1000.0,nM,Cn1c(Nc2c(Cl)cccc2Cl)nc3ccc4c(c13)c(O)nc(/C=C/CN(CC)CC)c4C,,,CHEMBL768270,Inhibition of Protein kinase B alpha,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1136753,1,Scientific Literature,J. Med. Chem.,2003.0,Cn1c(Nc2c(Cl)cccc2Cl)nc3ccc4c(c13)c(O)nc(/C=C/CN(CC)CC)c4C,,Row1528,84,0.1048935577273368,out,6
1480,Row1729,Row1222,CHEMBL3943713,,0,505.64,BDBM182500,IC50,>,1000.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CC5(COC5)CC4)-c6ccc(F)cc6,,329941.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CC5(COC5)CC4)-c6ccc(F)cc6,,Row3753,7,0.1292765289545059,out,6
1481,Row1730,Row1432,CHEMBL4531682,,0,384.87,C1,IC50,>,1000.0,nM,Cn1cc(cn1)-c2ccc(o2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1cc(cn1)-c2ccc(o2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,Row39,44,0.0876763835549354,out,6
1482,Row1731,Row1452,CHEMBL1761071,,0,537.64,"9, 1:1diastereomeric mixture",IC50,=,1000.0,nM,CCOCCN(C[C@@H](O)CN1CC2(CC(=O)c3cc(O)ccc3O2)CCC1)S(=O)(=O)c4c(C)noc4C,,,CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759945,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CCOCCN(C[C@@H](O)CN1CC2(CC(=O)c3cc(O)ccc3O2)CCC1)S(=O)(=O)c4c(C)noc4C,,Row2370,39,0.1152069866657257,out,6
1483,Row1732,Row1974,CHEMBL3613624,,0,493.61,27,IC50,>,1000.0,nM,CN(C)CC1(CCN(CC1)c2ncnc3[nH]c(C)c(C)c32)C(=O)Nc4cc(ccc4)OC(=O)N(C)C,,,CHEMBL3615480,Inhibition of AKT1 (unknown origin) by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3611979,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2015.0,CN(C)CC1(CCN(CC1)c2ncnc3[nH]c(C)c(C)c32)C(=O)Nc4cc(ccc4)OC(=O)N(C)C,,Row3863,35,0.1101370453834533,out,6
1484,Row1733,Row2121,CHEMBL590109,,0,425.52,31a,IC50,=,1000.0,nM,Nc1nc2c(cn(CCN)c2cn1)-c3cc(-c4cc5ccccc5s4)c6[nH]ncc6c3,,,CHEMBL1072678,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153138,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Nc1nc2c(cn(CCN)c2cn1)-c3cc(-c4cc5ccccc5s4)c6[nH]ncc6c3,,Row2116,20,0.1389851421117782,out,6
1485,Row1734,Row2136,CHEMBL3890965,,0,485.56,BDBM182569,IC50,=,1000.0,nM,Nc1cc(ncn1)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(cc5)C(F)(F)F,,330010.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1cc(ncn1)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5ccc(cc5)C(F)(F)F,,Row643,24,0.1318120509386062,out,6
1486,Row1735,Row2140,CHEMBL4097778,,0,458.54,None,IC50,=,1000.0,nM,CN1c2ccccc2OC[C@@H](C1=O)N3CCc4cn(CC5CCS(=O)(=O)CC5)nc4C3=O,,,CHEMBL4512995,Akt1 [PKBalpha(AKT1PHFB)] Takeda global kinase panel,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4507326,54,Donated Chemical Probes - SGC Frankfurt,,,CN1c2ccccc2OC[C@@H](C1=O)N3CCc4cn(CC5CCS(=O)(=O)CC5)nc4C3=O,Compound concentration None 1.0 uM,Row1473,59,0.114709734916687,out,6
1487,Row1736,Row2534,CHEMBL3684334,,0,341.37,BDBM103046,IC50,=,1000.0,nM,OCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,220768.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,OCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,Row3389,81,0.1467575281858444,out,6
1488,Row1737,Row2585,CHEMBL1082030,,0,445.47,41,IC50,>,1000.0,nM,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2ncc(s2)-c3cc4c(=O)[nH]ncc4cc3,,,CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154944,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNc2ncc(s2)-c3cc4c(=O)[nH]ncc4cc3,,Row240,47,0.1235894337296485,out,6
1489,Row1738,Row2617,CHEMBL219557,,0,552.46,"10, SKI-758",IC50,>,1000.0,nM,CN1CCN(Cc2cc(co2)-c3cc4ncc(C#N)c(Nc5cc(OC)c(Cl)cc5Cl)c4cc3OC)CC1,,,CHEMBL911091,Inhibition of AKT,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138859,1,Scientific Literature,J. Med. Chem.,2006.0,CN1CCN(Cc2cc(co2)-c3cc4ncc(C#N)c(Nc5cc(OC)c(Cl)cc5Cl)c4cc3OC)CC1,,Row1867,42,0.0933439210057258,out,6
1490,Row1739,Row2932,CHEMBL1243200,,0,488.55,6j,IC50,>,1000.0,nM,CNc1nc(ccn1)-c2cccnc2Oc3ccc(cc3)NC(=O)c4ccccc4Nc5ccccc5,,,CHEMBL1247975,Inhibition of PKBalpha by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1240487,1,Scientific Literature,J. Med. Chem.,2010.0,CNc1nc(ccn1)-c2cccnc2Oc3ccc(cc3)NC(=O)c4ccccc4Nc5ccccc5,,Row2783,67,0.1157286837697029,out,6
1491,Row1740,Row2979,CHEMBL1761077,,0,553.08,"15, 1:1diastereomeric mixture",IC50,=,1000.0,nM,CCOCCN(C[C@@H](O)CN1CC2(CC(=O)c3cc(O)ccc3O2)CCC1)S(=O)(=O)c4ccccc4Cl,,,CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759945,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CCOCCN(C[C@@H](O)CN1CC2(CC(=O)c3cc(O)ccc3O2)CCC1)S(=O)(=O)c4ccccc4Cl,,Row2370,39,0.1235895603895187,out,6
1492,Row1741,Row3398,CHEMBL3613623,,0,464.57,26,IC50,>,1000.0,nM,CN(C)CC1(CCN(CC1)c2ncnc3[nH]c(C)c(C)c23)C(=O)Nc4cc(ccc4)C(=O)OC,,,CHEMBL3615480,Inhibition of AKT1 (unknown origin) by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3611979,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2015.0,CN(C)CC1(CCN(CC1)c2ncnc3[nH]c(C)c(C)c23)C(=O)Nc4cc(ccc4)C(=O)OC,,Row3863,35,0.111278235912323,out,6
1493,Row1742,Row3535,CHEMBL4585334,,0,384.87,C3,IC50,>,1000.0,nM,Cn1cc(cn1)-c2cc(oc2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1cc(cn1)-c2cc(oc2)C(=O)N[C@@H]3CNCC[C@H]3c4ccc(Cl)cc4,,Row39,44,0.0892022401094436,out,6
1494,Row1743,Row3594,CHEMBL3950042,,0,581.61,BDBM182547,IC50,=,1000.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CC(F)(F)CCC4)-c5cc(F)c(cc5)C(F)(F)F,,329988.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CC(F)(F)CCC4)-c5cc(F)c(cc5)C(F)(F)F,,Row3753,7,0.1346626132726669,out,6
1495,Row1744,Row3690,CHEMBL3929830,,0,537.99,BDBM182534,IC50,=,1000.0,nM,Nc1ncnc(c1Cl)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)c(cc5)C(F)(F)F,,329975.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Cl)N2CCC(CC2)c3nc(cn3CCN4CCCC4)-c5cc(F)c(cc5)C(F)(F)F,,Row643,24,0.1256178915500641,out,6
1496,Row1745,Row3792,CHEMBL3912226,,0,446.48,BDBM182466,IC50,>,1000.0,nM,CNCCn1cc(nc1C2CCN(CC2)c3cc(N)ncn3)-c4cc(ncc4)C(F)(F)F,,329907.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CNCCn1cc(nc1C2CCN(CC2)c3cc(N)ncn3)-c4cc(ncc4)C(F)(F)F,,Row2188,10,0.1197670921683311,out,6
1497,Row1746,Row3860,CHEMBL4225923,,0,459.58,16,IC50,>,1000.0,nM,Cc1cn2c(ncc2-c3c[nH]nc3)c(Nc4cc(ns4)C(NC(C)(C)C)c5ccccn5)n1,,,CHEMBL4222453,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4219148,1,Scientific Literature,Bioorg Med Chem Lett,2018.0,Cc1cn2c(ncc2-c3c[nH]nc3)c(Nc4cc(ns4)C(NC(C)(C)C)c5ccccn5)n1,,Row2632,65,0.0881373658776283,out,6
1498,Row1747,Row1738,CHEMBL572629,,0,491.6,136,IC50,=,1003.0,nM,Cc1nc(c([nH]c1=O)-c2ccc(CN3CCC(CC3)n4c5ccccc5[nH]c4=O)cc2)-c6ccccc6,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Cc1nc(c([nH]c1=O)-c2ccc(CN3CCC(CC3)n4c5ccccc5[nH]c4=O)cc2)-c6ccccc6,,Row2123,58,0.1738950461149215,out,6
1499,Row1749,Row2858,CHEMBL209005,,0,709.85,9r,IC50,=,1020.0,nM,O=C1Nc2ccc(cc2C1Cc3ccccc3)-c4cncc(c4)OC[C@H](Cc5c[nH]c6ccccc56)Nc7ccc8NC(=O)C(Cc9ccccc9)c8c7,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,O=C1Nc2ccc(cc2C1Cc3ccccc3)-c4cncc(c4)OC[C@H](Cc5c[nH]c6ccccc56)Nc7ccc8NC(=O)C(Cc9ccccc9)c8c7,,Row837,29,0.1185830235481262,out,6
1500,Row1750,Row1105,CHEMBL207215,,0,410.48,44,IC50,=,1022.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5ccnc(O)c5cc4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5ccnc(O)c5cc4,,Row1996,15,0.1432220786809921,out,6
1501,Row1753,Row1111,CHEMBL583982,,0,593.7,133,IC50,=,1089.0,nM,O=c1[nH]c2ccccc2n1C3CCN(Cc4ccc(cc4)-c5nc6ccc(Cn7cnnn7)cc6nc5-c8ccccc8)CC3,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,O=c1[nH]c2ccccc2n1C3CCN(Cc4ccc(cc4)-c5nc6ccc(Cn7cnnn7)cc6nc5-c8ccccc8)CC3,,Row2123,58,0.1844515949487686,out,6
1502,Row1754,Row1365,CHEMBL181419,,0,593.7,16e,IC50,=,1089.0,nM,Cn1nc(nn1)-c2cc3nc(c(nc3cc2)-c4ccc(CN5CCC(CC5)n6c(O)nc7ccccc67)cc4)-c8ccccc8,,,CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141888,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,Cn1nc(nn1)-c2cc3nc(c(nc3cc2)-c4ccc(CN5CCC(CC5)n6c(O)nc7ccccc67)cc4)-c8ccccc8,,Row31,68,0.2006154954433441,out,6
1503,Row1755,Row803,CHEMBL3684505,,0,380.46,BDBM103219,IC50,=,1100.0,nM,C1CCC(N1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,220941.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,C1CCC(N1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,Row3389,81,0.1802947521209716,out,6
1504,Row1756,Row1327,CHEMBL1760775,,0,501.66,27h,IC50,=,1100.0,nM,Cc1ccncc1S(=O)(=O)NC[C@@H](O)CN2C[C@@]3(CCC2)CCN(C3)c4ncnc(N)c4C5CC5,,,CHEMBL1763788,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759869,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,Cc1ccncc1S(=O)(=O)NC[C@@H](O)CN2C[C@@]3(CCC2)CCN(C3)c4ncnc(N)c4C5CC5,,Row315,48,0.1194129288196563,out,6
1505,Row1757,Row1451,CHEMBL1761073,,0,535.66,"11, 1:1diastereomeric mixture",IC50,=,1100.0,nM,CCCCCN(C[C@@H](O)CN1CC2(CC(=O)c3cc(O)ccc3O2)CCC1)S(=O)(=O)c4c(C)noc4C,,,CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759945,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CCCCCN(C[C@@H](O)CN1CC2(CC(=O)c3cc(O)ccc3O2)CCC1)S(=O)(=O)c4c(C)noc4C,,Row2370,39,0.1253617256879806,out,6
1506,Row1758,Row2707,CHEMBL202893,,0,398.51,14,IC50,=,1100.0,nM,CN(C)[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)/C=C/c4ccncc4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,CN(C)[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)/C=C/c4ccncc4,,Row77,56,0.1006522849202156,out,6
1507,Row1759,Row3069,CHEMBL3684407,,0,434.46,BDBM103120,IC50,=,1100.0,nM,O=C(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccco6,,220842.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccco6,,Row3925,73,0.1358052492141723,out,6
1508,Row1760,Row3285,CHEMBL3684432,,0,477.5,BDBM103145,IC50,=,1100.0,nM,O=C(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)Nc6cc(F)ccc6,,220867.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)Nc6cc(F)ccc6,,Row662,76,0.1362014710903167,out,6
1509,Row1761,Row3575,CHEMBL3113146,,0,365.91,22e,IC50,=,1100.0,nM,Clc1ccc(cc1)C(NC2CCCCC2)c3ccc(cc3)-c4c[nH]nc4,,,CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3112393,1,Scientific Literature,Eur. J. Med. Chem.,2014.0,Clc1ccc(cc1)C(NC2CCCCC2)c3ccc(cc3)-c4c[nH]nc4,,Row2632,65,0.113533891737461,out,6
1510,Row1762,Row3668,CHEMBL3927385,,0,450.44,BDBM182335,IC50,=,1100.0,nM,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3CO)-c4cc(c(F)cc4)C(F)(F)F,,329784.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3CO)-c4cc(c(F)cc4)C(F)(F)F,,Row3758,45,0.1165379285812377,out,6
1511,Row1763,Row3945,CHEMBL3684385,,0,459.56,BDBM103098,IC50,=,1100.0,nM,CN(Cc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)CCc6ccccn6,,220820.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CN(Cc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)CCc6ccccn6,,Row3389,81,0.1297238022089004,out,6
1512,Row1764,Row2686,CHEMBL564795,,0,393.49,41,IC50,=,1117.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5ccccc5cc4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cc5ccccc5cc4,,Row1996,15,0.1322362422943115,out,6
1513,Row1765,Row1392,CHEMBL378589,,0,478.56,9r,IC50,=,1120.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cnc(cc4)NC(=O)Nc5ccccc5,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4cnc(cc4)NC(=O)Nc5ccccc5,,Row1996,15,0.1352134943008422,out,6
1514,Row1766,Row3446,CHEMBL572859,,0,478.56,93,IC50,=,1120.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc(cn4)NC(=O)Nc5ccccc5,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc(cn4)NC(=O)Nc5ccccc5,,Row1996,15,0.1267268359661102,out,6
1515,Row1770,Row2404,CHEMBL2177383,,0,477.99,32,IC50,=,1169.0,nM,CC(C)NC[C@@H](C(=O)N1CCN(CC1)c2ncnc3c2[C@H](C)CC3(F)F)c4ccc(Cl)cc4,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,CC(C)NC[C@@H](C(=O)N1CCN(CC1)c2ncnc3c2[C@H](C)CC3(F)F)c4ccc(Cl)cc4,,Row2863,37,0.0910872891545295,out,6
1516,Row1771,Row1091,CHEMBL1089991,,0,1100.34,YTG 2c,IC50,=,1170.0,nM,CC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(N)=O,,,CHEMBL1113529,Inhibition of PKB by radioactive kinase assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1156226,1,Scientific Literature,Bioorg. Med. Chem.,2010.0,CC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CN)C(=O)N[C@@H](CCC(C)C)C(N)=O,,Row2426,74,0.0907965376973152,out,6
1517,Row1773,Row1379,CHEMBL2325991,,0,424.51,44,IC50,=,1192.0,nM,COc1ccc(cc1OC)C(C)NC(=O)C2(N)CCN(CC2)c3ncnc4[nH]ccc34,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,COc1ccc(cc1OC)C(C)NC(=O)C2(N)CCN(CC2)c3ncnc4[nH]ccc34,,Row3863,35,0.1365200281143188,out,6
1518,Row1774,Row139,CHEMBL3684485,,0,577.09,BDBM103199,IC50,=,1200.0,nM,O=C(Nc1cc(Cl)ccc1)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,220921.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Nc1cc(Cl)ccc1)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,Row662,76,0.1430701315402984,out,6
1519,Row1775,Row1086,CHEMBL3684503,,0,499.58,BDBM103217,IC50,=,1200.0,nM,O=C(Nc1ccccc1)NC2(CCC2)c3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54,,220939.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Nc1ccccc1)NC2(CCC2)c3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54,,Row2783,67,0.2202881425619125,out,6
1520,Row1776,Row3190,CHEMBL3684490,,0,570.7,BDBM103204,IC50,=,1200.0,nM,Cc1ccccc1CNC(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,220926.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cc1ccccc1CNC(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,Row662,76,0.1420788764953613,out,6
1521,Row1777,Row3286,CHEMBL3684434,,0,477.5,BDBM103147,IC50,=,1200.0,nM,O=C(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)Nc6ccc(F)cc6,,220869.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)Nc6ccc(F)cc6,,Row2783,67,0.1359937489032745,out,6
1522,Row1778,Row3425,CHEMBL3684481,,0,607.12,BDBM103195,IC50,=,1200.0,nM,COc1ccc(cc1Cl)NC(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,220917.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,COc1ccc(cc1Cl)NC(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,Row662,76,0.1484579145908355,out,6
1523,Row1781,Row1742,CHEMBL207545,,0,494.6,10f,IC50,=,1240.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(c(C#Cc4ccccc4)nc3)-c5cc6ccncc6cc5,,,CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1147830,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(c(C#Cc4ccccc4)nc3)-c5cc6ccncc6cc5,,Row1996,15,0.1395107954740524,out,6
1524,Row1782,Row3596,CHEMBL3113139,,0,384.91,12f,IC50,=,1250.0,nM,Clc1ccc(cc1)C(NCc2ccccc2)c3ccc(cc3)-c4ccncc4,,,CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3112393,1,Scientific Literature,Eur. J. Med. Chem.,2014.0,Clc1ccc(cc1)C(NCc2ccccc2)c3ccc(cc3)-c4ccncc4,,Row2632,65,0.1396252959966659,out,6
1525,Row1783,Row413,CHEMBL3805443,,0,511.25,27a,IC50,=,1260.0,nM,Cn1cc(cc1C(=O)NC2(CCNCC2)c3cc(Cl)c(Cl)cc3)-c4c(Br)cnn4C,,,CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3804794,1,Scientific Literature,Eur. J. Med. Chem.,2016.0,Cn1cc(cc1C(=O)NC2(CCNCC2)c3cc(Cl)c(Cl)cc3)-c4c(Br)cnn4C,,Row3848,57,0.1364334374666214,out,6
1526,Row1784,Row794,CHEMBL3113137,,0,376.93,12d,IC50,=,1260.0,nM,Clc1ccc(cc1)C(NC2CCCCC2)c3ccc(cc3)-c4ccncc4,,,CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3112393,1,Scientific Literature,Eur. J. Med. Chem.,2014.0,Clc1ccc(cc1)C(NC2CCCCC2)c3ccc(cc3)-c4ccncc4,,Row2632,65,0.1277896612882614,out,6
1527,Row1785,Row1156,CHEMBL2436727,,0,393.41,5i,IC50,=,1260.0,nM,[O-][N+](=O)c1ccc(cc1)S(=O)(=O)Nc2cc(Sc3[nH]ncn3)c(O)cc2,,,CHEMBL2438112,Inhibition of AKT (unknown origin) after 30 mins by fluorescence assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2434840,1,Scientific Literature,Eur. J. Med. Chem.,2013.0,[O-][N+](=O)c1ccc(cc1)S(=O)(=O)Nc2cc(Sc3[nH]ncn3)c(O)cc2,,Row438,85,0.0653301775455474,out,6
1528,Row1788,Row1570,CHEMBL360333,,0,459.58,7b,IC50,=,1288.0,nM,N#Cc1cnc(c(c1)-c2ccccc2)-c3ccc(CNCc4ccc(cc4)-c5csnn5)cc3,,,CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141976,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,N#Cc1cnc(c(c1)-c2ccccc2)-c3ccc(CNCc4ccc(cc4)-c5csnn5)cc3,,Row2123,58,0.2001411616802215,out,6
1529,Row1789,Row3104,CHEMBL3684446,,0,527.63,BDBM103159,IC50,=,1300.0,nM,Cc1cc(ccc1)C(=O)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,220881.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cc1cc(ccc1)C(=O)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,Row662,76,0.14871247112751,out,6
1530,Row1790,Row3257,CHEMBL1761081,,0,586.63,"19, 1:1diastereomeric mixture",IC50,=,1300.0,nM,CCOCCN(C[C@@H](O)CN1CC2(CC(=O)c3cc(O)ccc3O2)CCC1)S(=O)(=O)c4ccccc4C(F)(F)F,,,CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759945,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CCOCCN(C[C@@H](O)CN1CC2(CC(=O)c3cc(O)ccc3O2)CCC1)S(=O)(=O)c4ccccc4C(F)(F)F,,Row2370,39,0.1232615485787391,out,6
1531,Row1791,Row3968,CHEMBL2325988,,0,365.44,41,IC50,=,1313.0,nM,CC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc23)c4cnccc4,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,CC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc23)c4cnccc4,,Row3863,35,0.1483875513076782,out,6
1532,Row1793,Row3567,CHEMBL3113148,,0,373.89,22g,IC50,=,1320.0,nM,Clc1ccc(cc1)C(NCc2ccccc2)c3ccc(cc3)-c4c[nH]nc4,,,CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3112393,1,Scientific Literature,Eur. J. Med. Chem.,2014.0,Clc1ccc(cc1)C(NCc2ccccc2)c3ccc(cc3)-c4c[nH]nc4,,Row2632,65,0.1245887726545333,out,6
1533,Row1794,Row3718,CHEMBL1097604,,0,520.59,9o,IC50,=,1324.0,nM,COc1cc2c(cc1OC)ncc3c2cc(nc3N)-c4cncc(c4)OC[C@H](N)Cc5c[nH]c6ccccc56,,,CHEMBL1103721,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157027,1,Scientific Literature,Eur. J. Med. Chem.,2010.0,COc1cc2c(cc1OC)ncc3c2cc(nc3N)-c4cncc(c4)OC[C@H](N)Cc5c[nH]c6ccccc56,,Row1813,70,0.1242877766489982,out,6
1534,Row1795,Row1005,CHEMBL411276,,0,395.51,13i,IC50,=,1330.0,nM,C(c1c[nH]c2ncnc(c12)N3CC4(CCNCC4)c5ccccc35)c6ccccc6,,,CHEMBL936668,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143084,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,C(c1c[nH]c2ncnc(c12)N3CC4(CCNCC4)c5ccccc35)c6ccccc6,,Row2845,36,0.1430445909500122,out,6
1535,Row1796,Row774,CHEMBL268054,,0,413.48,9a,IC50,=,1340.0,nM,Cc1c(cc(C#N)c(=O)n1C)-c2cncc(c2)OC[C@@H](N)Cc3c[nH]c4ccccc34,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Cc1c(cc(C#N)c(=O)n1C)-c2cncc(c2)OC[C@@H](N)Cc3c[nH]c4ccccc34,,Row1996,15,0.1250640004873275,out,6
1536,Row1797,Row1430,CHEMBL574978,,0,471.61,78,IC50,=,1360.0,nM,Cc1n[nH]c2cnc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cccc(c4)OCC5CCCCC5,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Cc1n[nH]c2cnc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cccc(c4)OCC5CCCCC5,,Row535,12,0.1229186877608299,out,6
1537,Row1798,Row2405,CHEMBL226796,,0,470.62,13au,IC50,=,1360.0,nM,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(ccc4)OCC5CCCCC5,,,CHEMBL889241,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145373,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1n[nH]c2ccc(cc21)-c3cncc(c3)OC[C@@H](N)Cc4cc(ccc4)OCC5CCCCC5,,Row1976,11,0.1323303580284118,out,6
1538,Row1801,Row1426,CHEMBL206746,,0,400.48,91,IC50,=,1390.0,nM,NC(=O)Cc1cc(ccc1)-c2cc(cnc2)OC[C@@H](N)Cc3c[nH]c4ccccc34,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,NC(=O)Cc1cc(ccc1)-c2cc(cnc2)OC[C@@H](N)Cc3c[nH]c4ccccc34,,Row1726,2,0.1288268268108368,out,6
1539,Row1802,Row235,CHEMBL1094637,,0,447.54,9g,IC50,=,1395.0,nM,CC(C)C[C@@H](N)COc1cncc(c1)-c2cc3c(cnc4cc(OC)c(cc34)OC)c(N)n2,,,CHEMBL1103721,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157027,1,Scientific Literature,Eur. J. Med. Chem.,2010.0,CC(C)C[C@@H](N)COc1cncc(c1)-c2cc3c(cnc4cc(OC)c(cc34)OC)c(N)n2,,Row1813,70,0.0936611294746398,out,6
1540,Row1803,Row248,CHEMBL3805037,,0,508.25,28b,IC50,=,1400.0,nM,Cn1ncc(Br)c1-c2ccc(cc2)C(=O)NC3(CCNCC3)c4ccc(Cl)c(Cl)c4,,,CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3804794,1,Scientific Literature,Eur. J. Med. Chem.,2016.0,Cn1ncc(Br)c1-c2ccc(cc2)C(=O)NC3(CCNCC3)c4ccc(Cl)c(Cl)c4,,Row3848,57,0.1626920104026794,out,6
1541,Row1804,Row1191,CHEMBL3684530,,0,466.55,BDBM103244,IC50,=,1400.0,nM,CC(C)(C)OC(=O)NC1(CC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,220958.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CC(C)(C)OC(=O)NC1(CC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,Row3391,71,0.1858808547258377,out,6
1542,Row1805,Row1744,CHEMBL3684447,,0,543.63,BDBM103160,IC50,=,1400.0,nM,COc1ccc(cc1)C(=O)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,220882.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,COc1ccc(cc1)C(=O)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,Row2452,66,0.1545808464288711,out,6
1543,Row1806,Row2085,CHEMBL3684402,,0,503.57,BDBM103115,IC50,=,1400.0,nM,O=C(c1ccco1)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,220837.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(c1ccco1)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,Row2452,66,0.1475089788436889,out,6
1544,Row1808,Row2902,CHEMBL3892829,,0,484.3,BDBM182340,IC50,=,1400.0,nM,Cn1cc(nc1C2CCN(CC2)c3ncncc3Br)-c4cc(c(F)cc4)C(F)(F)F,,329789.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cn1cc(nc1C2CCN(CC2)c3ncncc3Br)-c4cc(c(F)cc4)C(F)(F)F,,Row3758,45,0.1144050732254982,out,6
1545,Row1809,Row3301,CHEMBL3961623,,0,452.61,BDBM182379,IC50,=,1400.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)C5CCCCC5,,329820.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)C5CCCCC5,,Row1206,41,0.0981633365154266,out,6
1546,Row1810,Row80,CHEMBL452823,,0,622.78,33,IC50,=,1408.0,nM,CN1CCN(CC1)c2ccc3nc(c(nc3n2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,,CHEMBL947433,Inhibition of Akt1 by cellular assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157525,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN1CCN(CC1)c2ccc3nc(c(nc3n2)-c4ccccc4)-c5ccc(CN6CCC(CC6)c7[nH]c(nn7)-c8ccccn8)cc5,,Row1163,23,0.1670420616865158,out,6
1547,Row1811,Row605,CHEMBL485214,,0,321.34,3,IC50,=,1410.0,nM,O=C(Nc1ccc(cc1)-c2c[nH]cn2)C3COc4ccccc4O3,,,CHEMBL1030560,Inhibition of AKT1 after 55 mins,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142492,1,Scientific Literature,J. Med. Chem.,2008.0,O=C(Nc1ccc(cc1)-c2c[nH]cn2)C3COc4ccccc4O3,,Row2492,83,0.1363841295242309,out,6
1548,Row1812,Row2022,CHEMBL3113135,,0,350.89,12b,IC50,=,1430.0,nM,CC(C)CNC(c1ccc(Cl)cc1)c2ccc(cc2)-c3ccncc3,,,CHEMBL3118849,Inhibition of Akt1 (unknown origin) using ATP/eNOS as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3112393,1,Scientific Literature,Eur. J. Med. Chem.,2014.0,CC(C)CNC(c1ccc(Cl)cc1)c2ccc(cc2)-c3ccncc3,,Row2632,65,0.1168120428919792,out,6
1549,Row1813,Row1390,CHEMBL475840,,0,298.29,(+/-)-11m,IC50,=,1440.0,nM,CC1(C)O[C@@H]2CC(=O)O[C@@H]2C3=C1C(=O)c4ccccc4C3=O,,,CHEMBL1018804,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153413,1,Scientific Literature,J. Med. Chem.,2009.0,CC1(C)O[C@@H]2CC(=O)O[C@@H]2C3=C1C(=O)c4ccccc4C3=O,,Row2387,28,0.1322808861732483,out,6
1550,Row1814,Row715,CHEMBL439340,,0,497.0,9w,IC50,=,1450.0,nM,Nc1ccc(cc1C(=O)c2cc(Cl)ccc2)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Nc1ccc(cc1C(=O)c2cc(Cl)ccc2)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,Row1996,15,0.1207298785448074,out,6
1551,Row1815,Row3723,CHEMBL1257986,,0,452.0,35,IC50,=,1460.0,nM,CC(C)(C)c1ccc2ncnc(c2c1)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,CC(C)(C)c1ccc2ncnc(c2c1)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,Row875,55,0.0976236462593078,out,6
1552,Row1816,Row962,CHEMBL369094,,0,469.59,7e,IC50,=,1471.0,nM,N#Cc1cnc(-c2ccc(CN3CCC(CC3)c4[nH]c5ccccc5n4)cc2)c(c1)-c6ccccc6,,,CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141976,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,N#Cc1cnc(-c2ccc(CN3CCC(CC3)c4[nH]c5ccccc5n4)cc2)c(c1)-c6ccccc6,,Row2123,58,0.1978871971368789,out,6
1553,Row1817,Row2529,CHEMBL3805457,,0,532.65,26b,IC50,=,1480.0,nM,Cn1ncc(Cl)c1-c2oc(cc2Br)C(=O)NC3(CCNCC3)c4ccc(Cl)c(Cl)c4,,,CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3804794,1,Scientific Literature,Eur. J. Med. Chem.,2016.0,Cn1ncc(Cl)c1-c2oc(cc2Br)C(=O)NC3(CCNCC3)c4ccc(Cl)c(Cl)c4,,Row3848,57,0.1341592222452163,out,6
1554,Row1818,Row846,CHEMBL3684363,,0,398.43,BDBM103076,IC50,=,1500.0,nM,COCC(=O)Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23,,220798.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,COCC(=O)Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23,,Row2783,67,0.1404663324356079,out,6
1555,Row1819,Row2706,CHEMBL577792,,0,477.57,135,IC50,=,1500.0,nM,O=c1cnc(c([nH]1)-c2ccc(CN3CCC(CC3)n4c5ccccc5[nH]c4=O)cc2)-c6ccccc6,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,O=c1cnc(c([nH]1)-c2ccc(CN3CCC(CC3)n4c5ccccc5[nH]c4=O)cc2)-c6ccccc6,,Row2123,58,0.1724626719951629,out,6
1556,Row1821,Row638,CHEMBL1823635,,0,393.46,7,IC50,=,1510.0,nM,COc1ccc(cc1F)C(NC(=O)c2ccc3cnccc3c2)C4CCNCC4,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,COc1ccc(cc1F)C(NC(=O)c2ccc3cnccc3c2)C4CCNCC4,,Row3192,40,0.1179937347769737,out,6
1557,Row1823,Row2093,CHEMBL252260,,0,466.61,12h,IC50,=,1521.0,nM,CN(Cc1ccc(cc1)-c2nc3nc(ncc3cc2-c4ccccc4)SC)CCc5cn[nH]c5,,,CHEMBL928491,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141509,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN(Cc1ccc(cc1)-c2nc3nc(ncc3cc2-c4ccccc4)SC)CCc5cn[nH]c5,,Row3742,50,0.1670337468385696,out,6
1558,Row1824,Row2675,CHEMBL382397,,0,361.42,9c,IC50,=,1560.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc(F)cc4,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc(F)cc4,,Row1726,2,0.133867084980011,out,6
1559,Row1825,Row293,CHEMBL4473634,,0,406.82,A7,IC50,=,1566.0,nM,Cn1ncc(Cl)c1-c2coc(c2)C(=O)NC3CNCC3c4ccc(F)c(F)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Cl)c1-c2coc(c2)C(=O)NC3CNCC3c4ccc(F)c(F)c4,,Row39,44,0.0873455852270126,out,6
1560,Row1826,Row922,CHEMBL1823634,,0,352.46,6,IC50,=,1570.0,nM,O=C(NC(C1CCNCC1)c2nccs2)c3ccc4cnccc4c3,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,O=C(NC(C1CCNCC1)c2nccs2)c3ccc4cnccc4c3,,Row3192,40,0.1059073358774185,out,6
1561,Row1827,Row303,CHEMBL3679721,,0,354.42,BDBM103035,IC50,=,1600.0,nM,CN(C)c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,220757.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CN(C)c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,Row3389,81,0.1554932594299316,out,6
1562,Row1828,Row326,CHEMBL3964726,,0,463.44,BDBM182336,IC50,=,1600.0,nM,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4cc(c(F)cc4)C(F)(F)F,,329785.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3C(N)=O)-c4cc(c(F)cc4)C(F)(F)F,,Row2044,43,0.1181046143174171,out,6
1563,Row1829,Row577,CHEMBL104264,,0,446.37,H-89,IC50,=,1600.0,nM,O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c2cccc3cnccc32,,,CHEMBL1061585,Inhibition of AKT1 by FRET based assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153468,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c2cccc3cnccc32,,Row615,77,0.0840363204479217,out,6
1564,Row1830,Row1649,CHEMBL3934633,,0,553.56,BDBM182393,IC50,=,1600.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CC(F)(F)C4)-c5cc(c(F)cc5)C(F)(F)F,,329834.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CC(F)(F)C4)-c5cc(c(F)cc5)C(F)(F)F,,Row2164,32,0.1215010955929756,out,6
1565,Row1831,Row1783,CHEMBL2420911,,0,272.36,14,IC50,=,1600.0,nM,C1NCCCC12CCN(CC2)c3ncnc4[nH]cnc34,,,CHEMBL2424130,Inhibition of AKT1 (unknown origin) by microfluidic mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2417369,1,Scientific Literature,Bioorg. Med. Chem.,2013.0,C1NCCCC12CCN(CC2)c3ncnc4[nH]cnc34,,Row3980,30,0.1067923679947853,out,6
1566,Row1832,Row2108,CHEMBL1081118,,0,412.42,22,IC50,=,1600.0,nM,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CCc2nc(no2)-c3cc4ccncc4cc3,,,CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154944,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CCc2nc(no2)-c3cc4ccncc4cc3,,Row240,47,0.1242427825927734,out,6
1567,Row1833,Row3147,CHEMBL3684394,,0,410.48,BDBM103107,IC50,=,1600.0,nM,C(c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)N6CCOCC6,,220829.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,C(c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)N6CCOCC6,,Row2452,66,0.153731033205986,out,6
1568,Row1838,Row1734,CHEMBL208499,,0,387.44,48,IC50,=,1659.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)C(=O)Nc4ccncc4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)C(=O)Nc4ccncc4,,Row77,56,0.1119995042681694,out,6
1569,Row1839,Row2474,CHEMBL2064009,,0,530.57,26,IC50,=,1660.0,nM,COc1cc(OC)c(cc1)/C=C/C(=O)C(=Cc2cc(O)c(cc2)OC)C(=O)/C=C/c3ccc(cc3OC)OC,,,CHEMBL2067501,Inhibition of AKT1 by AKT1/PKBalpha KinEASE FP fluorescein green assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2062524,1,Scientific Literature,Eur. J. Med. Chem.,2012.0,COc1cc(OC)c(cc1)/C=C/C(=O)C(=Cc2cc(O)c(cc2)OC)C(=O)/C=C/c3ccc(cc3OC)OC,,Row2523,51,0.096572645008564,out,6
1570,Row1840,Row1072,CHEMBL3684440,,0,552.64,BDBM103153,IC50,=,1700.0,nM,[C-]#[N+]c1ccc(cc1)C(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,220875.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,[C-]#[N+]c1ccc(cc1)C(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,Row662,76,0.1505866050720214,out,6
1571,Row1841,Row1827,CHEMBL3926903,,0,467.29,BDBM182302,IC50,=,1700.0,nM,Nc1ncnc(c1Br)N2CCC(CC2)c3[nH]cc(n3)-c4cc(ccc4)C(F)(F)F,,329770.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1Br)N2CCC(CC2)c3[nH]cc(n3)-c4cc(ccc4)C(F)(F)F,,Row2590,1,0.1303659975528717,out,6
1572,Row1842,Row3313,CHEMBL3901580,,0,511.53,BDBM182318,IC50,=,1700.0,nM,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4cnc(C)cc4)-c5ccc(F)c(c5)C(F)(F)F,,329782.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4cnc(C)cc4)-c5ccc(F)c(c5)C(F)(F)F,,Row3758,45,0.1175445765256881,out,6
1573,Row1844,Row862,CHEMBL3113284,,0,509.57,9n,IC50,=,1730.0,nM,COc1ccc(cc1OC)S(=O)(=O)Nc2cc(Sc3ncnc4nc[nH]c34)c(O)c5ccccc52,,,CHEMBL3117479,Inhibition of AKT1 (unknown origin) after 30 mins,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3112530,1,Scientific Literature,Bioorg. Med. Chem.,2014.0,COc1ccc(cc1OC)S(=O)(=O)Nc2cc(Sc3ncnc4nc[nH]c34)c(O)c5ccccc52,,Row3570,86,0.0960477441549301,out,6
1574,Row1845,Row2331,CHEMBL1097973,,0,482.54,9s,IC50,=,1750.0,nM,COc1cc2c(cc1OC)ncc3c2cc(nc3N)-c4cncc(c4)OC[C@@H](N)Cc5ccncc5,,,CHEMBL1103721,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157027,1,Scientific Literature,Eur. J. Med. Chem.,2010.0,COc1cc2c(cc1OC)ncc3c2cc(nc3N)-c4cncc(c4)OC[C@@H](N)Cc5ccncc5,,Row1813,70,0.1096966415643692,out,6
1575,Row1847,Row1443,CHEMBL3684473,,0,530.61,BDBM103187,IC50,=,1800.0,nM,O=C(C1CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34)CC1)c7ccc(F)cc7,,220909.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(C1CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34)CC1)c7ccc(F)cc7,,Row2452,66,0.1552544832229614,out,6
1576,Row1848,Row2485,CHEMBL3684364,,0,458.53,BDBM103077,IC50,=,1800.0,nM,O=C(CCc1ccccc1)Nc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,220799.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(CCc1ccccc1)Nc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,Row2783,67,0.1523474305868148,out,6
1577,Row1849,Row2865,CHEMBL3684350,,0,382.43,BDBM103062,IC50,=,1800.0,nM,CCC(=O)Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23,,220784.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CCC(=O)Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23,,Row2783,67,0.1439057737588882,out,6
1578,Row1850,Row3839,CHEMBL3684410,,0,422.49,BDBM103123,IC50,=,1800.0,nM,O=C(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)C6CCC6,,220845.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)C6CCC6,,Row3925,73,0.160997599363327,out,6
1579,Row1851,Row3873,CHEMBL3679731,,0,325.38,BDBM103045,IC50,=,1800.0,nM,Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ccccc5-n32,,220767.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ccccc5-n32,,Row3389,81,0.1622868329286575,out,6
1580,Row1852,Row3984,CHEMBL3684461,,0,577.71,BDBM103175,IC50,=,1800.0,nM,O=S(=O)(Cc1ccccc1)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,220897.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=S(=O)(Cc1ccccc1)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,Row2452,66,0.1545974016189575,out,6
1581,Row1854,Row3201,CHEMBL3127377,,0,360.85,60a,IC50,=,1819.7,nM,Nc1ncnc(c1Cl)N2CCN(CC2)C(=O)[C@@H](N)Cc3ccccc3,,,CHEMBL3131349,Inhibition of AKT1 (unknown origin) using ATP/eNOS as substrate incubated for 5 mins prior to substrate addition measured after 30 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3124803,1,Scientific Literature,Eur. J. Med. Chem.,2014.0,Nc1ncnc(c1Cl)N2CCN(CC2)C(=O)[C@@H](N)Cc3ccccc3,,Row875,55,0.1381434053182602,out,6
1582,Row1855,Row398,CHEMBL3124965,,0,366.3,56a,IC50,=,1830.0,nM,CNc1cc(ncn1)N2CCC(CN)(CC2)c3cc(Cl)c(Cl)cc3,,,CHEMBL3131349,Inhibition of AKT1 (unknown origin) using ATP/eNOS as substrate incubated for 5 mins prior to substrate addition measured after 30 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3124803,1,Scientific Literature,Eur. J. Med. Chem.,2014.0,CNc1cc(ncn1)N2CCC(CN)(CC2)c3cc(Cl)c(Cl)cc3,,Row3848,57,0.1449208706617355,out,6
1583,Row1856,Row2017,CHEMBL427388,,0,368.44,9b,IC50,=,1830.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc(cc4)C#N,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc(cc4)C#N,,Row1996,15,0.1417547464370727,out,6
1584,Row1857,Row544,CHEMBL574774,,0,411.47,63,IC50,=,1848.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc5[nH]nc(C=O)c5c4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc5[nH]nc(C=O)c5c4,,Row1726,2,0.123561680316925,out,6
1585,Row1858,Row3725,CHEMBL3764886,,0,227.19,PI-1,IC50,=,1850.0,nM,NC(=N)NC(=N)N/C(=N/O)/c1nonc1N,,,CHEMBL3767267,"Antagonist activity at human AKT1-PH domain (1 to 121 residues) assessed as reduction of AKT1-PH interaction with PC/PE/PS/PI(3,4,5)P3 after 30 mins by competitive SPR analysis",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3763051,1,Scientific Literature,MedChemComm,2015.0,NC(=N)NC(=N)N/C(=N/O)/c1nonc1N,,Row3384,87,0.064715176820755,out,6
1586,Row1859,Row174,CHEMBL3684454,,0,513.61,BDBM103167,IC50,=,1900.0,nM,O=C(c1ccccc1)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,220889.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(c1ccccc1)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,Row2452,66,0.1627032458782196,out,6
1587,Row1860,Row795,CHEMBL3684437,,0,359.82,BDBM103150,IC50,=,1900.0,nM,ClCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,220872.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,ClCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,Row3389,81,0.1560098379850387,out,6
1588,Row1861,Row796,CHEMBL3684356,,0,473.54,BDBM103068,IC50,=,1900.0,nM,CN(C)c1ccc(cc1)C(=O)Nc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,220790.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CN(C)c1ccc(cc1)C(=O)Nc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,Row2783,67,0.1433842927217483,out,6
1589,Row1862,Row847,CHEMBL3684510,,0,523.64,BDBM103224,IC50,=,1900.0,nM,CC(C)(C)OC(=O)NC1CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CC1,,220946.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CC(C)(C)OC(=O)NC1CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CC1,,Row662,76,0.1465417295694351,out,6
1590,Row1863,Row927,CHEMBL3679729,,0,310.36,BDBM103043,IC50,=,1900.0,nM,c1ccccc1-c2nnc3-c4ccccc4Nc5ccccc5-n32,,220765.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,c1ccccc1-c2nnc3-c4ccccc4Nc5ccccc5-n32,,Row3389,81,0.1719819605350494,out,6
1591,Row1864,Row2144,CHEMBL3922482,,0,452.59,BDBM182433,IC50,=,1900.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cscc5,,329874.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cscc5,,Row1206,41,0.1099902316927909,out,6
1592,Row1865,Row2166,CHEMBL3913487,,0,446.56,BDBM182435,IC50,=,1900.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccccc5,,329876.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccccc5,,Row1206,41,0.164993941783905,out,6
1593,Row1866,Row2245,CHEMBL3684390,,0,500.61,BDBM103103,IC50,=,1900.0,nM,OC1(CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CC1)c7ccccc7,,220825.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,OC1(CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CC1)c7ccccc7,,Row2452,66,0.1948090940713882,out,6
1594,Row1867,Row2851,CHEMBL3684376,,0,430.52,BDBM103089,IC50,=,1900.0,nM,C(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)c6ccccc6,,220811.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,C(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)c6ccccc6,,Row2452,66,0.1525777876377105,out,6
1595,Row1868,Row3184,CHEMBL1173305,,0,245.33,13,IC50,=,1900.0,nM,Cc1c[nH]c2ncnc(c12)N3C[C@@H](CC3)NCC,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,Cc1c[nH]c2ncnc(c12)N3C[C@@H](CC3)NCC,,Row1872,62,0.0863374397158622,out,6
1596,Row1869,Row3188,CHEMBL505637,BASTADIN 3,0,942.25,2,IC50,=,1900.0,nM,Oc1ccc(CCNC(=O)/C(/Cc2cc(Br)c(O)c(c2)-c3cc(C/C(=N/O)/C(=O)NCCc4cc(Br)c(O)cc4)cc(Br)c3O)=N\O)cc1Br,,,CHEMBL2344170,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2331160,1,Scientific Literature,J. Nat. Prod.,2013.0,Oc1ccc(CCNC(=O)/C(/Cc2cc(Br)c(O)c(c2)-c3cc(C/C(=N/O)/C(=O)NCCc4cc(Br)c(O)cc4)cc(Br)c3O)=N\O)cc1Br,,Row438,85,0.0602763555943965,out,6
1597,Row1870,Row3507,CHEMBL4217649,,0,509.62,12c,IC50,=,1900.0,nM,CCN1CCN(CC1)c2ccc(cn2)-c3nn(Cc4cn(Cc5ccccc5)nn4)c6nc(NC)ncc63,,,CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4184298,1,Scientific Literature,J Med Chem,2018.0,CCN1CCN(CC1)c2ccc(cn2)-c3nn(Cc4cn(Cc5ccccc5)nn4)c6nc(NC)ncc63,,Row286,88,0.1469697207212448,out,6
1598,Row1872,Row3447,CHEMBL3805006,,0,463.8,28a,IC50,=,1910.0,nM,Cn1ncc(Cl)c1-c2ccc(cc2)C(=O)NC3(CCNCC3)c4ccc(Cl)c(Cl)c4,,,CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3804794,1,Scientific Literature,Eur. J. Med. Chem.,2016.0,Cn1ncc(Cl)c1-c2ccc(cc2)C(=O)NC3(CCNCC3)c4ccc(Cl)c(Cl)c4,,Row3848,57,0.1650039255619049,out,6
1599,Row1874,Row558,CHEMBL2177386,,0,456.03,25,IC50,>,2000.0,nM,CC(C)NC[C@H](c1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4CCC(C)(C)c34,,,CHEMBL2187635,Competitive inhibition of wild-type full-length amino-terminal polyhistidine-tagged human Akt1 expressed in recombinant baculovirus system using fluorescence labeled substrate after 60 mins by fluorescence polarization assay in presence of ATP,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177010,1,Scientific Literature,J. Med. Chem.,2012.0,CC(C)NC[C@H](c1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ncnc4CCC(C)(C)c34,,Row2863,37,0.1044505536556243,out,6
1600,Row1875,Row3063,CHEMBL3684465,,0,621.72,BDBM103179,IC50,=,2000.0,nM,O=S(=O)(NC1CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CC1)c7ccc8OCCOc8c7,,220901.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=S(=O)(NC1CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CC1)c7ccc8OCCOc8c7,,Row2452,66,0.141658678650856,out,6
1601,Row1876,Row3103,CHEMBL3684468,,0,538.62,BDBM103182,IC50,=,2000.0,nM,[C-]#[N+]c1cc(ccc1)C(=O)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,220904.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,[C-]#[N+]c1cc(ccc1)C(=O)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,Row2452,66,0.1520289182662964,out,6
1602,Row1877,Row3221,CHEMBL3980317,,0,365.41,BDBM181326,IC50,=,2000.0,nM,NC(=O)c1ccc(NC2CNCCC2c3ccc(F)cc3)c4cncnc41,,328349.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(NC2CNCCC2c3ccc(F)cc3)c4cncnc41,,Row2729,75,0.1019758582115173,out,6
1603,Row1878,Row873,CHEMBL3805617,,0,447.31,25b,IC50,=,2020.0,nM,Cn1ncc(Br)c1-c2coc(c2)C(=O)NC3(CCNCC3)c4ccc(F)cc4,,,CHEMBL3807471,Inhibition of Akt1 (unknown origin) expressed in Escherichia coli using peptide substrate after 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3804794,1,Scientific Literature,Eur. J. Med. Chem.,2016.0,Cn1ncc(Br)c1-c2coc(c2)C(=O)NC3(CCNCC3)c4ccc(F)cc4,,Row3848,57,0.1337777227163314,out,6
1604,Row1879,Row1109,CHEMBL576565,,0,387.44,87,IC50,=,2020.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)NC(=O)c4ccncc4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)NC(=O)c4ccncc4,,Row77,56,0.1234337165951728,out,6
1605,Row1880,Row1703,CHEMBL1090001,,0,890.1,N-Me 2a,IC50,=,2030.0,nM,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)N(C)C(=O)[C@@H](N)CCCNC(N)=N)C(N)=O,,,CHEMBL1113529,Inhibition of PKB by radioactive kinase assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1156226,1,Scientific Literature,Bioorg. Med. Chem.,2010.0,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)N(C)C(=O)[C@@H](N)CCCNC(N)=N)C(N)=O,,Row2426,74,0.0698409229516983,out,6
1606,Row1881,Row853,CHEMBL1258444,,0,383.88,43,IC50,=,2048.0,nM,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ccnc4cc[nH]c34,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ccnc4cc[nH]c34,,Row854,17,0.1234466359019279,out,6
1607,Row1882,Row908,CHEMBL3933453,,0,415.42,BDBM181321,IC50,=,2100.0,nM,NC(=O)c1ccc(NC2CNCCC2c3cc(ccc3)C(F)(F)F)c4cncnc41,,328344.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(NC2CNCCC2c3cc(ccc3)C(F)(F)F)c4cncnc41,,Row2729,75,0.1048718094825744,out,6
1608,Row1883,Row2735,CHEMBL3679714,,0,327.35,BDBM103028,IC50,=,2100.0,nM,Nc1ccc(cn1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,220750.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Nc1ccc(cn1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,Row3389,81,0.1617966294288635,out,6
1609,Row1884,Row2784,CHEMBL3684380,,0,459.56,BDBM103093,IC50,=,2100.0,nM,CCN(Cc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)Cc6ccncc6,,220815.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CCN(Cc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)Cc6ccncc6,,Row3389,81,0.1563186645507812,out,6
1610,Row1885,Row2864,CHEMBL3684494,,0,436.48,BDBM103208,IC50,=,2100.0,nM,Cc1cc(COCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34)no1,,220930.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cc1cc(COCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34)no1,,Row3925,73,0.1321328729391098,out,6
1611,Row1886,Row3005,CHEMBL1761069,,0,523.61,7-d1,IC50,=,2100.0,nM,COCCN(C[C@@H](O)CN1CC2(CC(=O)c3cc(O)ccc3O2)CCC1)S(=O)(=O)c4c(C)noc4C,,,CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759945,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,COCCN(C[C@@H](O)CN1CC2(CC(=O)c3cc(O)ccc3O2)CCC1)S(=O)(=O)c4c(C)noc4C,,Row2370,39,0.1184538006782531,out,6
1612,Row1888,Row252,CHEMBL1823660,,0,470.44,33,IC50,=,2140.0,nM,CC(C)CN1CCC(CC1)[C@@H](NC(=O)c2ccc3cnccc3c2)c4ccc(Cl)c(Cl)c4,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CC(C)CN1CCC(CC1)[C@@H](NC(=O)c2ccc3cnccc3c2)c4ccc(Cl)c(Cl)c4,,Row3192,40,0.1052721887826919,out,6
1613,Row1890,Row1826,CHEMBL1800262,,0,933.17,16,IC50,=,2150.0,nM,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(N)=N)C(N)=O,,,CHEMBL1804368,Inhibition of Akt using RPRTSSF peptide and [gamma32]ATP by cell-free radioactive assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1799953,1,Scientific Literature,J. Med. Chem.,2011.0,CC(C)CC[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(N)=N)C(N)=O,,Row2426,74,0.0657017454504966,out,6
1614,Row1891,Row3041,CHEMBL3104851,,0,374.3,1,IC50,=,2150.0,nM,Cc1c(C=O)c2[C@@H]3O[C@H](Oc2c(O)c1O)c4c(C3=O)c(O)c(O)c(O)c4C,,,CHEMBL3108329,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3102702,1,Scientific Literature,J. Nat. Prod.,2014.0,Cc1c(C=O)c2[C@@H]3O[C@H](Oc2c(O)c1O)c4c(C3=O)c(O)c(O)c(O)c4C,,Row2857,89,0.039718572050333,out,6
1615,Row1892,Row716,CHEMBL207671,,0,359.43,7b,IC50,=,2160.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)Nc4cccnc4,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)Nc4cccnc4,,Row77,56,0.1216902732849121,out,6
1616,Row1893,Row933,CHEMBL205781,,0,436.52,95,IC50,=,2170.0,nM,NC(=O)c1cccc2c(cccc21)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,NC(=O)c1cccc2c(cccc21)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc45,,Row1996,15,0.1196643188595771,out,6
1617,Row1894,Row444,CHEMBL3925871,,0,514.5,BDBM182309,IC50,=,2200.0,nM,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4ccc(F)cc4)-c5cc(c(F)cc5)C(F)(F)F,,329776.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4ccc(F)cc4)-c5cc(c(F)cc5)C(F)(F)F,,Row3758,45,0.1205778121948242,out,6
1618,Row1895,Row1082,CHEMBL3679728,,0,327.35,BDBM103042,IC50,=,2200.0,nM,Oc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,220764.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Oc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,Row3389,81,0.1482146680355072,out,6
1619,Row1896,Row1210,CHEMBL3963232,,0,436.52,BDBM182444,IC50,=,2200.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cn[nH]c5,,329885.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cn[nH]c5,,Row1206,41,0.0965184867382049,out,6
1620,Row1897,Row1968,CHEMBL1088612,,0,364.48,R-1,IC50,>,2200.0,nM,Cc1n[nH]c2ccc(cc21)-c3nnc(NC[C@H](N)Cc4ccccc4)s3,,,CHEMBL1104218,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154933,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc21)-c3nnc(NC[C@H](N)Cc4ccccc4)s3,,Row1834,53,0.1374106705188751,out,6
1621,Row1898,Row2287,CHEMBL4106661,,0,365.41,BDBM181327,IC50,=,2200.0,nM,NC(=O)c1ccc(N[C@H]2CNCC[C@@H]2c3ccc(F)cc3)c4cncnc41,,328350.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(N[C@H]2CNCC[C@@H]2c3ccc(F)cc3)c4cncnc41,,Row2729,75,0.1019758582115173,out,6
1622,Row1899,Row2533,CHEMBL3684448,,0,543.63,BDBM103161,IC50,=,2200.0,nM,COc1cc(ccc1)C(=O)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,220883.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,COc1cc(ccc1)C(=O)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,Row2452,66,0.1671331226825714,out,6
1623,Row1900,Row1676,CHEMBL255772,,0,514.63,9b,IC50,=,2249.0,nM,CNc1nc(c(cc1C#N)-c2ccccc2)-c3ccc(CN4CCC(CC4)n5c(=O)[nH]c6ccccc56)cc3,,,CHEMBL951085,Inhibition of human recombinant Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142344,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CNc1nc(c(cc1C#N)-c2ccccc2)-c3ccc(CN4CCC(CC4)n5c(=O)[nH]c6ccccc56)cc3,,Row2123,58,0.1977847814559936,out,6
1624,Row1902,Row150,CHEMBL86755,,0,210.24,1,IC50,=,2300.0,nM,O=C\1Nc2ccccc2/C1=C/c3ccc[nH]3,,,CHEMBL896554,Inhibition of cAKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1149536,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,O=C\1Nc2ccccc2/C1=C/c3ccc[nH]3,,Row837,29,0.0935034900903701,out,6
1625,Row1903,Row253,CHEMBL1823662,,0,572.46,35,IC50,=,2300.0,nM,O=C(N[C@H](C1CCN(Cc2ccc(cc2)C(F)(F)F)CC1)c3ccc(Cl)c(Cl)c3)c4cc5ccncc5cc4,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,O=C(N[C@H](C1CCN(Cc2ccc(cc2)C(F)(F)F)CC1)c3ccc(Cl)c(Cl)c3)c4cc5ccncc5cc4,,Row3192,40,0.1028872430324554,out,6
1626,Row1904,Row2586,CHEMBL3684399,,0,495.59,BDBM103112,IC50,=,2300.0,nM,CCOC(=O)N1CCC(CC1)NCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,220834.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CCOC(=O)N1CCC(CC1)NCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,Row2452,66,0.1423908770084381,out,6
1627,Row1905,Row3789,CHEMBL3684457,,0,581.68,BDBM103170,IC50,=,2300.0,nM,O=S(=O)(NC1CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CC1)c7ccccc7F,,220892.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=S(=O)(NC1CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CC1)c7ccccc7F,,Row2452,66,0.1423386186361313,out,6
1628,Row1907,Row222,CHEMBL1258663,,0,395.89,10,IC50,=,2346.0,nM,N[C@H](Cc1ccccc1Cl)C(=O)N2CCN(CC2)c3ncnc4ccccc34,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccccc1Cl)C(=O)N2CCN(CC2)c3ncnc4ccccc34,,Row875,55,0.134543091058731,out,6
1629,Row1908,Row703,CHEMBL3922125,,0,478.58,BDBM182643,IC50,=,2400.0,nM,Cc1ccc(cc1F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,330084.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1ccc(cc1F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,Row1206,41,0.1288661509752273,out,6
1630,Row1909,Row2819,CHEMBL1173306,,0,307.4,14,IC50,=,2400.0,nM,Cc1c[nH]c2ncnc(c21)N3C[C@@H](CC3)NCc4ccccc4,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,Cc1c[nH]c2ncnc(c21)N3C[C@@H](CC3)NCc4ccccc4,,Row1872,62,0.1282118409872055,out,6
1631,Row1910,Row2967,CHEMBL606245,,0,400.53,19,IC50,=,2400.0,nM,Cc1c2cc[nH]c2ccc1Nc3c(/C=C/CCN4C[C@H](N)CCC4)cncc3C#N,,,CHEMBL1067365,Inhibition of PKBalpha,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153090,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,Cc1c2cc[nH]c2ccc1Nc3c(/C=C/CCN4C[C@H](N)CCC4)cncc3C#N,,Row3990,26,0.1040253117680549,out,6
1632,Row1911,Row3881,CHEMBL3968412,,0,310.33,BDBM181346,IC50,=,2400.0,nM,NC(=O)c1ccc(NCCc2cccc(F)c2)c3cncnc31,,328360.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(NCCc2cccc(F)c2)c3cncnc31,,Row2156,90,0.102036215364933,out,6
1633,Row1912,Row368,CHEMBL1079627,,0,446.5,32,IC50,=,2406.0,nM,Cn1nc(N)c2ccc(cc12)-c3cnc(NC[C@@H](N)Cc4ccc(cc4)C(F)(F)F)s3,,,CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154944,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cn1nc(N)c2ccc(cc12)-c3cnc(NC[C@@H](N)Cc4ccc(cc4)C(F)(F)F)s3,,Row240,47,0.1239714175462722,out,6
1634,Row1913,Row1790,CHEMBL3903158,,0,365.41,BDBM181317,IC50,=,2500.0,nM,NC(=O)c1ccc(NC2CCNCC2c3ccc(F)cc3)c4cncnc41,,328340.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(NC2CCNCC2c3ccc(F)cc3)c4cncnc41,,Row2729,75,0.1019215211272239,out,6
1635,Row1914,Row1925,CHEMBL3684400,,0,396.5,BDBM103113,IC50,=,2500.0,nM,CN(Cc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)CCC,,220835.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CN(Cc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)CCC,,Row2452,66,0.1364831626415252,out,6
1636,Row1915,Row2249,CHEMBL3971435,,0,509.61,BDBM182502,IC50,=,2500.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC45COC5)-c6cc(F)c(F)cc6,,329943.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC45COC5)-c6cc(F)c(F)cc6,,Row3753,7,0.1329108476638794,out,6
1637,Row1916,Row3582,CHEMBL3684340,,0,566.47,BDBM103052,IC50,=,2500.0,nM,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6cc(cc(c6)C(F)(F)F)C(F)(F)F,,220774.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6cc(cc(c6)C(F)(F)F)C(F)(F)F,,Row2783,67,0.1338228285312652,out,6
1638,Row1917,Row126,CHEMBL192519,,0,442.86,1,IC50,=,2600.0,nM,Cc1c\2c(nc(N)c1C#N)C(C#N)=C(C)/C2=C\c3ccc(o3)-c4cc(Cl)c(cc4)C(O)=O,,,CHEMBL828149,Inhibition of protein kinase B alpha (Akt1) in fluorescent enzymatic assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143561,1,Scientific Literature,J. Med. Chem.,2005.0,Cc1c\2c(nc(N)c1C#N)C(C#N)=C(C)/C2=C\c3ccc(o3)-c4cc(Cl)c(cc4)C(O)=O,,Row3798,5,0.11029714345932,out,6
1639,Row1918,Row661,CHEMBL3684336,,0,369.38,BDBM103048,IC50,=,2600.0,nM,COC(=O)c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23,,220770.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,COC(=O)c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23,,Row2783,67,0.1454935520887375,out,6
1640,Row1920,Row1473,CHEMBL2338333,,0,291.35,"5, UBS109",IC50,=,2600.0,nM,CN1C/C(=C\c2ccccn2)/C(=O)/C(/C1)=C/c3ccccn3,,,CHEMBL2344124,Inhibition of recombinant AKT1 (unknown origin) by FRET-based Z'-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2331439,1,Scientific Literature,J. Med. Chem.,2013.0,CN1C/C(=C\c2ccccn2)/C(=O)/C(/C1)=C/c3ccccn3,,Row1473,59,0.1431405991315841,out,6
1641,Row1921,Row1542,CHEMBL564972,,0,435.44,3,IC50,=,2600.0,nM,O=c1[nH]c2cc(ccc2o1)-c3cc(cc(n3)-c4cc5NC(=O)COc5cc4)-c6ccccc6,,,CHEMBL1061585,Inhibition of AKT1 by FRET based assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153468,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,O=c1[nH]c2cc(ccc2o1)-c3cc(cc(n3)-c4cc5NC(=O)COc5cc4)-c6ccccc6,,Row2123,58,0.1690091341733932,out,6
1642,Row1924,Row1357,CHEMBL377294,,0,400.48,10a,IC50,=,2670.0,nM,COc1cc(ccn1)/C=C/c2cncc(c2)OC[C@@H](N)Cc3c[nH]c4ccccc43,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,COc1cc(ccn1)/C=C/c2cncc(c2)OC[C@@H](N)Cc3c[nH]c4ccccc43,,Row77,56,0.1298612356185913,out,6
1643,Row1925,Row1339,CHEMBL1823636,,0,381.43,8,IC50,=,2680.0,nM,O=C(NC(C1CCNCC1)c2ccc(F)c(F)c2)c3ccc4cnccc4c3,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,O=C(NC(C1CCNCC1)c2ccc(F)c(F)c2)c3ccc4cnccc4c3,,Row3192,40,0.1110218316316604,out,6
1644,Row1926,Row566,CHEMBL3684466,,0,581.68,BDBM103180,IC50,=,2700.0,nM,O=S(=O)(NC1CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CC1)c7cc(F)ccc7,,220902.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=S(=O)(NC1CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CC1)c7cc(F)ccc7,,Row2452,66,0.1461604982614517,out,6
1645,Row1927,Row3688,CHEMBL3940535,,0,516.57,BDBM182319,IC50,=,2700.0,nM,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4ccc(C)s4)-c5ccc(F)c(c5)C(F)(F)F,,329783.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4ccc(C)s4)-c5ccc(F)c(c5)C(F)(F)F,,Row3758,45,0.1261734962463379,out,6
1646,Row1928,Row3871,CHEMBL3904694,,0,512.52,BDBM182339,IC50,=,2700.0,nM,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4cnc(N)cc4)-c5cc(c(F)cc5)C(F)(F)F,,329788.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4cnc(N)cc4)-c5cc(c(F)cc5)C(F)(F)F,,Row3758,45,0.1181628704071044,out,6
1647,Row1929,Row1394,CHEMBL208406,,0,451.53,9s,IC50,=,2710.0,nM,Nc1nc(ccn1)Nc2ccc(cc2)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc54,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Nc1nc(ccn1)Nc2ccc(cc2)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc54,,Row1996,15,0.1319183260202407,out,6
1648,Row1931,Row3089,CHEMBL2325989,,0,365.44,42,IC50,=,2753.0,nM,CC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc23)c4ccccn4,,,CHEMBL2330886,Inhibition of recombinant Akt1 (unknown origin) using 5-FAM-labeled peptide as substrate after 1 hr by caliper off-chip incubation mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2321772,1,Scientific Literature,J. Med. Chem.,2013.0,CC(NC(=O)C1(N)CCN(CC1)c2ncnc3[nH]ccc23)c4ccccn4,,Row3863,35,0.152910977602005,out,6
1649,Row1932,Row3042,CHEMBL411718,,0,365.41,13e,IC50,=,2790.0,nM,CC(=O)N1CCC2(CN(c3ncnc4[nH]ccc34)c5ccc(F)cc25)CC1,,,CHEMBL936668,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143084,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CC(=O)N1CCC2(CN(c3ncnc4[nH]ccc34)c5ccc(F)cc25)CC1,,Row2845,36,0.1163167431950569,out,6
1650,Row1934,Row839,CHEMBL3684401,,0,513.65,BDBM103114,IC50,=,2800.0,nM,Cc1ccc(CN2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2)cc1,,220836.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cc1ccc(CN2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2)cc1,,Row2452,66,0.1569970548152923,out,6
1651,Row1935,Row3389,CHEMBL3679710,,0,311.35,BDBM103024,IC50,=,2800.0,nM,c1ccccc1-c2nnc3-c4ccccc4Nc5ncccc5-n32,,220746.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,c1ccccc1-c2nnc3-c4ccccc4Nc5ncccc5-n32,,Row3389,81,0.1695424020290374,out,6
1652,Row1936,Row3985,CHEMBL3684377,,0,503.59,BDBM103090,IC50,=,2800.0,nM,Fc1ccccc1N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,220812.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Fc1ccccc1N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,Row2452,66,0.1549797505140304,out,6
1653,Row1937,Row2318,CHEMBL383223,,0,359.43,7a,IC50,=,2860.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)Nc4ccncc4,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)Nc4ccncc4,,Row77,56,0.1253709346055984,out,6
1654,Row1938,Row1067,CHEMBL181927,,0,483.62,7d,IC50,=,2874.0,nM,Cc1cc2nc([nH]c2cc1)C3CCN(Cc4ccc(cc4)-c5ncc(cc5-c6ccccc6)C#N)CC3,,,CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141976,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,Cc1cc2nc([nH]c2cc1)C3CCN(Cc4ccc(cc4)-c5ncc(cc5-c6ccccc6)C#N)CC3,,Row2123,58,0.1905132681131363,out,6
1655,Row1939,Row218,CHEMBL1257164,,0,437.55,17,IC50,=,2883.0,nM,N[C@H](Cc1ccc(cc1)-c2ccccc2)C(=O)N3CCN(CC3)c4ncnc5ccccc45,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccc(cc1)-c2ccccc2)C(=O)N3CCN(CC3)c4ncnc5ccccc45,,Row875,55,0.1750277876853943,out,6
1656,Row1940,Row2588,CHEMBL3684452,,0,518.58,BDBM103165,IC50,=,2900.0,nM,Cc1cc(no1)C(=O)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,220887.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cc1cc(no1)C(=O)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,Row2452,66,0.144392043352127,out,6
1657,Row1941,Row3987,CHEMBL3684417,,0,459.51,BDBM103130,IC50,=,2900.0,nM,O=C(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)Nc6ccccc6,,220852.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)Nc6ccccc6,,Row2783,67,0.1467028856277465,out,6
1658,Row1942,Row2570,CHEMBL3099612,,0,258.23,3,IC50,=,2940.0,nM,O[C@@H]1CC(=O)O[C@@H]1C2=CC(=O)c3ccccc3C2=O,,,CHEMBL3100280,Inhibition of recombinant AKT1 (unknown origin) using serine/threonine 06 peptide as substrate after 1 hr by FRET based Z'-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3098129,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2014.0,O[C@@H]1CC(=O)O[C@@H]1C2=CC(=O)c3ccccc3C2=O,,Row2387,28,0.1408150196075439,out,6
1659,Row1944,Row663,CHEMBL1081028,,0,420.46,42,IC50,>,3000.0,nM,NC(=O)c1ccc(cc1)-c2cnc(NC[C@@H](N)Cc3ccc(cc3)C(F)(F)F)s2,,,CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154944,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,NC(=O)c1ccc(cc1)-c2cnc(NC[C@@H](N)Cc3ccc(cc3)C(F)(F)F)s2,,Row240,47,0.1101020872592926,out,6
1660,Row1945,Row1441,CHEMBL3684469,,0,527.63,BDBM103183,IC50,=,3000.0,nM,Cc1ccc(cc1)C(=O)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,220905.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cc1ccc(cc1)C(=O)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,Row2452,66,0.1478696316480636,out,6
1661,Row1946,Row1904,CHEMBL1202519,,0,529.01,7,IC50,=,3000.0,nM,COc1ccc(O)c(c1F)C(=O)c2ccc(CN[C@@H]3CCCNC[C@H]3NC(=O)c4ccncc4)cc2,,,CHEMBL766409,Inhibition of Protein kinase B alpha,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1149095,1,Scientific Literature,J. Med. Chem.,2004.0,COc1ccc(O)c(c1F)C(=O)c2ccc(CN[C@@H]3CCCNC[C@H]3NC(=O)c4ccncc4)cc2,,Row2523,51,0.104417435824871,out,6
1662,Row1947,Row3428,CHEMBL3684459,,0,593.71,BDBM103173,IC50,=,3000.0,nM,COc1cc(ccc1)S(=O)(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,220895.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,COc1cc(ccc1)S(=O)(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,Row2452,66,0.1599604189395904,out,6
1663,Row1948,Row341,CHEMBL440560,,0,477.57,13a,IC50,=,3029.0,nM,O=c1cnc(c([nH]1)-c2ccccc2)-c3ccc(CN4CCC(CC4)n5c6ccccc6[nH]c5=O)cc3,,,CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141888,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,O=c1cnc(c([nH]1)-c2ccccc2)-c3ccc(CN4CCC(CC4)n5c6ccccc6[nH]c5=O)cc3,,Row2123,58,0.1724626719951629,out,6
1664,Row1949,Row3176,CHEMBL1922695,,0,825.97,"11, diastereomeric mixture",IC50,=,3100.0,nM,CC(C)[C@H](NC(=O)[C@@H]1CC[C@H]2[C@@H](COC(=O)N12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)OCc3ccccc3)C(=O)NC(Cc4ccccc4)C(=O)NCc5ccccc5,,,CHEMBL1924333,Inhibition of His-tagged ATP-binding domain of AKT1 assessed as GRPRTSSFAEG crosstide phosphorylation using [33P]ATP,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1921701,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CC(C)[C@H](NC(=O)[C@@H]1CC[C@H]2[C@@H](COC(=O)N12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)OCc3ccccc3)C(=O)NC(Cc4ccccc4)C(=O)NCc5ccccc5,,Row466,80,0.1189470887184143,out,6
1665,Row1950,Row3266,CHEMBL2312654,,0,461.4,21,IC50,=,3100.0,nM,Cc1cc(on1)-c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC4CCC(CC4)N(C)C,,,CHEMBL2317787,Inhibition of AKT1 (unknown origin) in presence of ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2311250,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2013.0,Cc1cc(on1)-c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC4CCC(CC4)N(C)C,,Row3186,60,0.0887651368975639,out,6
1666,Row1951,Row3539,CHEMBL3930070,,0,346.43,BDBM181311,IC50,=,3100.0,nM,NC(=O)c1ccc(c2cncnc12)N3CC(CCc4ccccc4)CC3,,328334.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(c2cncnc12)N3CC(CCc4ccccc4)CC3,,Row1630,91,0.155033141374588,out,6
1667,Row1952,Row1469,CHEMBL381260,,0,492.65,10d,IC50,=,3110.0,nM,N[C@H](COc1cc(cnc1)/C=C/c2cc(ncc2)SCc3ccccc3)Cc4c[nH]c5ccccc45,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@H](COc1cc(cnc1)/C=C/c2cc(ncc2)SCc3ccccc3)Cc4c[nH]c5ccccc45,,Row77,56,0.122455708682537,out,6
1668,Row1953,Row3638,CHEMBL178349,,0,510.64,6,IC50,=,3136.0,nM,Oc1nc2ccccc2n1C3CCN(Cc4ccc(cc4)-c5cc6ccccc6nc5-c7ccccc7)CC3,,,CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141976,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,Oc1nc2ccccc2n1C3CCN(Cc4ccc(cc4)-c5cc6ccccc6nc5-c7ccccc7)CC3,,Row31,68,0.2069412618875503,out,6
1669,Row1954,Row173,CHEMBL450487,,0,369.39,11d,IC50,=,3160.0,nM,CCn1c2c(cnc(c2nc1-c3nonc3N)-c4cn[nH]c4)OCCCN,,,CHEMBL1028090,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140130,1,Scientific Literature,J. Med. Chem.,2008.0,CCn1c2c(cnc(c2nc1-c3nonc3N)-c4cn[nH]c4)OCCCN,,Row2429,38,0.1147490665316581,out,6
1670,Row1955,Row282,CHEMBL410235,,0,401.47,13f,IC50,=,3190.0,nM,CS(=O)(=O)N1CCC2(CN(c3ncnc4[nH]ccc34)c5ccc(F)cc25)CC1,,,CHEMBL936668,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143084,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CS(=O)(=O)N1CCC2(CN(c3ncnc4[nH]ccc34)c5ccc(F)cc25)CC1,,Row2845,36,0.1147908270359039,out,6
1671,Row1956,Row2054,CHEMBL205514,,0,344.42,17c,IC50,=,3200.0,nM,N[C@@H](Cc1ccccc1)C(=O)Nc2cc(cnc2)/C=C/c3ccncc3,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1ccccc1)C(=O)Nc2cc(cnc2)/C=C/c3ccncc3,,Row615,77,0.128719225525856,out,6
1672,Row1957,Row3864,CHEMBL3684442,,0,531.6,BDBM103155,IC50,=,3200.0,nM,O=C(c1ccc(F)cc1)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,220877.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(c1ccc(F)cc1)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,Row2452,66,0.1498557180166244,out,6
1673,Row1958,Row239,CHEMBL1255592,,0,409.92,24,IC50,=,3203.0,nM,Cc1cc2ncnc(c2cc1)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1cc2ncnc(c2cc1)N3CCN(CC3)C(=O)[C@H](N)Cc4ccc(Cl)cc4,,Row875,55,0.1019421890377998,out,6
1674,Row1959,Row3492,CHEMBL3764684,,0,267.25,PI-4,IC50,=,3230.0,nM,Nc1nonc1/C(/NC(=N)N2CCCN=C2N)=N\O,,,CHEMBL3767267,"Antagonist activity at human AKT1-PH domain (1 to 121 residues) assessed as reduction of AKT1-PH interaction with PC/PE/PS/PI(3,4,5)P3 after 30 mins by competitive SPR analysis",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3763051,1,Scientific Literature,MedChemComm,2015.0,Nc1nonc1/C(/NC(=N)N2CCCN=C2N)=N\O,,Row3384,87,0.0937805324792862,out,6
1675,Row1960,Row677,CHEMBL1082017,,0,446.5,40,IC50,=,3315.0,nM,N[C@H](CNc1ncc(s1)-c2cc3CCC(=O)Nc3cc2)Cc4ccc(cc4)C(F)(F)F,,,CHEMBL1102921,Inhibition of AKT1 after 10 mins by [gamma33]ATP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154944,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](CNc1ncc(s1)-c2cc3CCC(=O)Nc3cc2)Cc4ccc(cc4)C(F)(F)F,,Row240,47,0.1164319142699241,out,6
1676,Row1961,Row2129,CHEMBL1258215,,0,384.87,38,IC50,=,3321.0,nM,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ccnc4ccnn34,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ccnc4ccnn34,,Row875,55,0.0987066626548767,out,6
1677,Row1962,Row327,CHEMBL178872,,0,512.62,8e,IC50,=,3323.0,nM,C(c1ccc(cc1)-c2ncc(cc2-c3ccccc3)-c4n[nH]nn4)N5CCC(CC5)c6[nH]c7ccccc7n6,,,CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141976,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,C(c1ccc(cc1)-c2ncc(cc2-c3ccccc3)-c4n[nH]nn4)N5CCC(CC5)c6[nH]c7ccccc7n6,,Row2123,58,0.2061261981725692,out,6
1678,Row1963,Row71,CHEMBL206708,,0,485.59,22,IC50,=,3340.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)/C=C/c4cc(ncc4)-n5ccc6ccccc56,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)/C=C/c4cc(ncc4)-n5ccc6ccccc56,,Row77,56,0.1310692578554153,out,6
1679,Row1964,Row1234,CHEMBL1823631,,0,373.38,3,IC50,=,3380.0,nM,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNC(=O)c2cc3ccncc3cc2,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,N[C@@H](Cc1ccc(cc1)C(F)(F)F)CNC(=O)c2cc3ccncc3cc2,,Row240,47,0.0971280932426452,out,6
1680,Row1965,Row481,CHEMBL3684443,,0,505.63,BDBM103156,IC50,=,3400.0,nM,O=C(C1CCCC1)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,220878.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(C1CCCC1)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,Row2452,66,0.1628294736146927,out,6
1681,Row1966,Row1057,CHEMBL3684445,,0,541.66,BDBM103158,IC50,=,3400.0,nM,O=C(CCc1ccccc1)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,220880.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(CCc1ccccc1)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,Row2452,66,0.1589310020208358,out,6
1682,Row1967,Row1128,CHEMBL362455,,0,339.44,138,IC50,=,3400.0,nM,CC(C)(N)c1ccc(cc1)-c2nc3ccccc3nc2-c4ccccc4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,CC(C)(N)c1ccc(cc1)-c2nc3ccccc3nc2-c4ccccc4,,Row31,68,0.2036939114332199,out,6
1683,Row1968,Row1498,CHEMBL3684396,,0,451.53,BDBM103109,IC50,=,3400.0,nM,CC(=O)NC1CN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CC1,,220831.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CC(=O)NC1CN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CC1,,Row662,76,0.1502213031053543,out,6
1684,Row1969,Row3113,CHEMBL1761067,,0,523.61,1,IC50,=,3400.0,nM,COCCN(CC(O)CN1CC2(CC(=O)c3cc(O)ccc3O2)CCC1)S(=O)(=O)c4c(C)noc4C,,,CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759945,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,COCCN(CC(O)CN1CC2(CC(=O)c3cc(O)ccc3O2)CCC1)S(=O)(=O)c4c(C)noc4C,,Row2370,39,0.1184538006782531,out,6
1685,Row1970,Row3281,CHEMBL3639833,,0,583.76,BDBM103171,IC50,=,3400.0,nM,O=S(=O)(CC1CCCCC1)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,220893.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=S(=O)(CC1CCCCC1)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,Row2452,66,0.1487989127635955,out,6
1686,Row1971,Row3426,CHEMBL3684464,,0,605.72,BDBM103178,IC50,=,3400.0,nM,CC(=O)c1ccc(cc1)S(=O)(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,220900.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CC(=O)c1ccc(cc1)S(=O)(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,Row662,76,0.141172394156456,out,6
1687,Row1973,Row3277,CHEMBL3679730,,0,353.43,BDBM103044,IC50,=,3500.0,nM,CN(C)c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ccccc5-n32,,220766.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CN(C)c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ccccc5-n32,,Row3389,81,0.156676173210144,out,6
1688,Row1974,Row3920,CHEMBL2333365,,0,455.51,"28, XL388",IC50,>,3500.0,nM,Cc1c(ccc(c1F)S(C)(=O)=O)C(=O)N2CCOc3ccc(cc3C2)-c4ccc(N)nc4,,,CHEMBL2341972,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2331117,1,Scientific Literature,J. Med. Chem.,2013.0,Cc1c(ccc(c1F)S(C)(=O)=O)C(=O)N2CCOc3ccc(cc3C2)-c4ccc(N)nc4,,Row3570,86,0.1185830608010292,out,6
1689,Row1975,Row1467,CHEMBL3941846,,0,491.62,BDBM182503,IC50,=,3600.0,nM,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC45COC5)-c6ccc(F)cc6,,329944.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CCc1c(N)ncnc1N2CCC(CC2)c3nc(cn3CCN4CCC45COC5)-c6ccc(F)cc6,,Row3753,7,0.1319000273942947,out,6
1690,Row1976,Row1472,CHEMBL2036343,,0,294.38,"7, SEF31",IC50,=,3600.0,nM,O=C\1/C(/CSC/C1=C\c2ccccn2)=C/c3ccccn3,,,CHEMBL2344124,Inhibition of recombinant AKT1 (unknown origin) by FRET-based Z'-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2331439,1,Scientific Literature,J. Med. Chem.,2013.0,O=C\1/C(/CSC/C1=C\c2ccccn2)=C/c3ccccn3,,Row1473,59,0.1286784410476684,out,6
1691,Row1977,Row1946,CHEMBL2152253,,0,449.9,32,IC50,>,3600.0,nM,Cc1c(F)cccc1NS(=O)(=O)c2cc(ccc2Cl)-c3cnc(N)c(n3)C(=O)NC,,,CHEMBL2156891,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2150966,1,Scientific Literature,J. Med. Chem.,2012.0,Cc1c(F)cccc1NS(=O)(=O)c2cc(ccc2Cl)-c3cnc(N)c(n3)C(=O)NC,,Row3570,86,0.1099613383412361,out,6
1692,Row1978,Row2071,CHEMBL2152252,,0,453.86,31,IC50,>,3600.0,nM,CNC(=O)c1nc(cnc1N)-c2ccc(Cl)c(c2)S(=O)(=O)Nc3cccc(F)c3F,,,CHEMBL2156891,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2150966,1,Scientific Literature,J. Med. Chem.,2012.0,CNC(=O)c1nc(cnc1N)-c2ccc(Cl)c(c2)S(=O)(=O)Nc3cccc(F)c3F,,Row3570,86,0.1148478388786315,out,6
1693,Row1979,Row2432,CHEMBL3962137,,0,436.52,BDBM182432,IC50,=,3600.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cocc5,,329873.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cocc5,,Row1206,41,0.1000599041581153,out,6
1694,Row1980,Row2749,CHEMBL4449288,,0,451.27,A8,IC50,=,3646.0,nM,Cn1ncc(Br)c1-c2coc(c2)C(=O)NC3CNCC3c4ccc(F)c(F)c4,,,CHEMBL4407340,Inhibition of human Akt1 expressed in Escherichia coli using STK Substrate 2-biotin as substrate incubated for 1 hr by HTRF assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4406807,1,Scientific Literature,J Med Chem,2019.0,Cn1ncc(Br)c1-c2coc(c2)C(=O)NC3CNCC3c4ccc(F)c(F)c4,,Row3848,57,0.086894653737545,out,6
1695,Row1981,Row1393,CHEMBL202972,,0,436.52,9u,IC50,=,3670.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)-c4cc(ccc4)Nc5ncccn5,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)-c4cc(ccc4)Nc5ncccn5,,Row1996,15,0.1306294500827789,out,6
1696,Row1982,Row3203,CHEMBL3684538,,0,484.61,BDBM103252,IC50,=,3800.0,nM,C(CNC1(CCC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34)c7ccccc7,,220966.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,C(CNC1(CCC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34)c7ccccc7,,Row3391,71,0.2269990146160125,out,6
1697,Row1983,Row514,CHEMBL1761068,,0,555.65,2,IC50,=,3900.0,nM,Cc1onc(C)c1S(=O)(=O)N(Cc2ccccc2)CC(O)CN3CC4(CC(=O)c5cc(O)ccc5O4)CCC3,,,CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759945,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,Cc1onc(C)c1S(=O)(=O)N(Cc2ccccc2)CC(O)CN3CC4(CC(=O)c5cc(O)ccc5O4)CCC3,,Row2370,39,0.1471196264028549,out,6
1698,Row1984,Row2609,CHEMBL1783943,,0,354.36,80,IC50,=,3900.0,nM,CC(C)=CCc1c2oc(cc(=O)c2c(O)cc1O)-c3cc(O)c(O)cc3,,,CHEMBL1918853,Inhibition of GST-tagged PKB/Akt1 incubated for 5 mins before eNOS substrate and ATP addition measured after 30 mins by kinase assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1914446,1,Scientific Literature,Eur. J. Med. Chem.,2011.0,CC(C)=CCc1c2oc(cc(=O)c2c(O)cc1O)-c3cc(O)c(O)cc3,,Row2857,89,0.0952937677502632,out,6
1699,Row1985,Row1188,CHEMBL524266,,0,275.29,S-89,IC50,>,4000.0,nM,Nc1nc(ccn1)-c2cc3C(=O)NC[C@H](CCF)c3[nH]2,,,CHEMBL1022473,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139384,1,Scientific Literature,J. Med. Chem.,2009.0,Nc1nc(ccn1)-c2cc3C(=O)NC[C@H](CCF)c3[nH]2,,Row3515,16,0.1188280880451202,out,6
1700,Row1986,Row2075,CHEMBL1173696,,0,295.37,10,IC50,=,4000.0,nM,Cc1c[nH]c2ncnc(c12)N3C[C@@H](CC3)NS(C)(=O)=O,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,Cc1c[nH]c2ncnc(c12)N3C[C@@H](CC3)NS(C)(=O)=O,,Row1872,62,0.0838102027773857,out,6
1701,Row1987,Row3475,CHEMBL1761074,,0,547.67,"12, 1:1diastereomeric mixture",IC50,=,4000.0,nM,Cc1onc(C)c1S(=O)(=O)N(C[C@@H](O)CN2CC3(CC(=O)c4cc(O)ccc4O3)CCC2)C5CCCCC5,,,CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759945,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,Cc1onc(C)c1S(=O)(=O)N(C[C@@H](O)CN2CC3(CC(=O)c4cc(O)ccc4O3)CCC2)C5CCCCC5,,Row2370,39,0.1228200942277908,out,6
1702,Row1988,Row1725,CHEMBL576761,,0,373.46,49,IC50,=,4022.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc(CO)cc4,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc(CO)cc4,,Row1996,15,0.1310022175312042,out,6
1703,Row1989,Row543,CHEMBL206236,,0,361.45,7,IC50,=,4040.0,nM,N[C@H](COc1cc(cnc1)/C=C/c2ccncc2)COCc3ccccc3,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@H](COc1cc(cnc1)/C=C/c2ccncc2)COCc3ccccc3,,Row615,77,0.136208564043045,out,6
1704,Row1990,Row674,CHEMBL3104855,,0,358.3,10,IC50,=,4070.0,nM,Cc1c(C=O)c2cc(oc2c(O)c1O)-c3c(C=O)c(O)c(O)c(O)c3C,,,CHEMBL3108329,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3102702,1,Scientific Literature,J. Nat. Prod.,2014.0,Cc1c(C=O)c2cc(oc2c(O)c1O)-c3c(C=O)c(O)c(O)c(O)c3C,,Row2857,89,0.0426873378455638,out,6
1705,Row1991,Row3986,CHEMBL3684470,,0,514.59,BDBM103184,IC50,=,4200.0,nM,O=C(c1ccccn1)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,220906.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(c1ccccn1)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,Row2452,66,0.1476950347423553,out,6
1706,Row1992,Row1571,CHEMBL178445,,0,512.62,8f,IC50,=,4237.0,nM,C(c1ccc(cc1)-c2ncc(cc2-c3ccccc3)-c4n[nH]nn4)N5CCC(CC5)n6cnc7ccccc67,,,CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141976,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,C(c1ccc(cc1)-c2ncc(cc2-c3ccccc3)-c4n[nH]nn4)N5CCC(CC5)n6cnc7ccccc67,,Row2123,58,0.2126999795436859,out,6
1707,Row1993,Row3338,CHEMBL3684375,,0,394.48,BDBM103088,IC50,=,4300.0,nM,C(c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)N6CCCC6,,220810.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,C(c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)N6CCCC6,,Row2452,66,0.1676158905029297,out,6
1708,Row1994,Row3919,CHEMBL3684521,,0,454.53,BDBM103235,IC50,=,4300.0,nM,CC(C)(C)OC(=O)NCCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,220972.0,CHEMBL3705043,Biochemical Assay: Biochemical assay using CisBio KinEASE HTRF Assay technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CC(C)(C)OC(=O)NCCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,Row3925,73,0.1335999369621276,out,6
1709,Row1995,Row3674,CHEMBL3127376,,0,352.27,56b,IC50,=,4320.0,nM,Nc1cc(ncn1)N2CCC(CC2)(CN)c3ccc(Cl)c(Cl)c3,,,CHEMBL3131349,Inhibition of AKT1 (unknown origin) using ATP/eNOS as substrate incubated for 5 mins prior to substrate addition measured after 30 mins by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3124803,1,Scientific Literature,Eur. J. Med. Chem.,2014.0,Nc1cc(ncn1)N2CCC(CC2)(CN)c3ccc(Cl)c(Cl)c3,,Row3848,57,0.1511529386043548,out,6
1710,Row1996,Row336,CHEMBL361391,,0,469.59,7f,IC50,=,4397.0,nM,N#Cc1cc(c(nc1)-c2ccc(CN3CCC(CC3)n4cnc5ccccc45)cc2)-c6ccccc6,,,CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141976,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,N#Cc1cc(c(nc1)-c2ccc(CN3CCC(CC3)n4cnc5ccccc45)cc2)-c6ccccc6,,Row2123,58,0.2043977975845337,out,6
1711,Row1997,Row335,CHEMBL438439,,0,529.6,9d,IC50,=,4400.0,nM,O=C1Cc2ccc(cc2N1)N[C@H](COc3cncc(c3)-c4cc5NC(=O)Cc5cc4)Cc6c[nH]c7ccccc67,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,O=C1Cc2ccc(cc2N1)N[C@H](COc3cncc(c3)-c4cc5NC(=O)Cc5cc4)Cc6c[nH]c7ccccc67,,Row837,29,0.1209646537899971,out,6
1712,Row1998,Row2199,CHEMBL3684388,,0,465.56,BDBM103101,IC50,=,4400.0,nM,O=C1CCCN1CCCNCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,220823.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C1CCCN1CCCNCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,Row3925,73,0.1571433395147323,out,6
1713,Row1999,Row2489,CHEMBL3684378,,0,410.53,BDBM103091,IC50,=,4400.0,nM,CC(C)CCNCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,220813.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CC(C)CCNCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,Row3925,73,0.1318963170051574,out,6
1714,Row2000,Row3437,CHEMBL1761080,,0,543.64,"18, 1:1diastereomeric mixture",IC50,=,4400.0,nM,CCOCCN(C[C@@H](O)CN1CC2(CC(=O)c3cc(O)ccc3O2)CCC1)S(=O)(=O)c4ccccc4C#N,,,CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759945,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CCOCCN(C[C@@H](O)CN1CC2(CC(=O)c3cc(O)ccc3O2)CCC1)S(=O)(=O)c4ccccc4C#N,,Row2370,39,0.1227424815297126,out,6
1715,Row2001,Row2814,CHEMBL438485,,0,465.55,14,IC50,=,4430.0,nM,Oc1ccc(cc1)-c2ccc(cc2)-c3n[nH]c4-c5ccc(cc5Cc43)C(=O)N[C@@H]6CC[C@@H](O)CC6,,,CHEMBL1114557,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1156260,1,Scientific Literature,J. Med. Chem.,2010.0,Oc1ccc(cc1)-c2ccc(cc2)-c3n[nH]c4-c5ccc(cc5Cc43)C(=O)N[C@@H]6CC[C@@H](O)CC6,,Row3192,40,0.116869106888771,out,6
1716,Row2002,Row269,CHEMBL3298516,,0,387.44,8,IC50,=,4480.0,nM,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)NCCN2C(=O)C=CC2=O,,,CHEMBL3364070,Inhibition of AKT1 (unknown origin) after 1 hr by Z'-LYTE kinase assay in presence of 75 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3297689,1,Scientific Literature,ACS Med. Chem. Lett.,2014.0,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)NCCN2C(=O)C=CC2=O,,Row266,82,0.1047329306602478,out,6
1717,Row2003,Row445,CHEMBL3684379,,0,394.48,BDBM103092,IC50,=,4500.0,nM,C(NC1CCC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,220814.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,C(NC1CCC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,Row3925,73,0.1607666909694671,out,6
1718,Row2004,Row906,CHEMBL3921054,,0,401.39,BDBM181318,IC50,=,4500.0,nM,NC(=O)c1ccc(NC2CNCC2c3cc(ccc3)C(F)(F)F)c4cncnc14,,328341.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(NC2CNCC2c3cc(ccc3)C(F)(F)F)c4cncnc14,,Row2729,75,0.1035844683647155,out,6
1719,Row2005,Row1323,CHEMBL190313,,0,425.88,2,IC50,=,4500.0,nM,Oc1nc2ccc(Cl)cc2c(c1C(=O)/C=C/c3[nH]c4ccccc4n3)-c5ccccc5,,,CHEMBL828149,Inhibition of protein kinase B alpha (Akt1) in fluorescent enzymatic assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143561,1,Scientific Literature,J. Med. Chem.,2005.0,Oc1nc2ccc(Cl)cc2c(c1C(=O)/C=C/c3[nH]c4ccccc4n3)-c5ccccc5,,Row31,68,0.1392731964588165,out,6
1720,Row2006,Row2549,CHEMBL3684383,,0,398.47,BDBM103096,IC50,=,4600.0,nM,COCCNCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,220818.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,COCCNCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,Row3925,73,0.1338864415884018,out,6
1721,Row2007,Row1374,CHEMBL3298929,,0,359.38,16,IC50,=,4680.0,nM,CC(C)(C)OC(=O)NN(Cc1ccccc1)C(=O)CN2C(=O)C=CC2=O,,,CHEMBL3364070,Inhibition of AKT1 (unknown origin) after 1 hr by Z'-LYTE kinase assay in presence of 75 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3297689,1,Scientific Literature,ACS Med. Chem. Lett.,2014.0,CC(C)(C)OC(=O)NN(Cc1ccccc1)C(=O)CN2C(=O)C=CC2=O,,Row266,82,0.1086885333061218,out,6
1722,Row2009,Row624,CHEMBL3684387,,0,412.5,BDBM103100,IC50,=,4700.0,nM,CN(CCOC)Cc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,220822.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CN(CCOC)Cc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,Row3389,81,0.133096307516098,out,6
1723,Row2010,Row2779,CHEMBL3679716,,0,367.46,BDBM103030,IC50,=,4700.0,nM,CC(C)(C)c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23,,220752.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CC(C)(C)c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23,,Row3389,81,0.1463937014341354,out,6
1724,Row2011,Row1964,CHEMBL2381116,,0,450.52,39,IC50,=,4800.0,nM,COc1cc2c(CN(c3nc(cs3)C(=O)Nc4cnccc4N5CCNCC5)C2=O)cc1,,,CHEMBL2382842,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2380296,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2013.0,COc1cc2c(CN(c3nc(cs3)C(=O)Nc4cnccc4N5CCNCC5)C2=O)cc1,,Row2523,51,0.1238492354750633,out,6
1725,Row2012,Row2152,CHEMBL3949722,,0,310.33,BDBM181347,IC50,=,4800.0,nM,NC(=O)c1ccc(NCCc2ccc(F)cc2)c3cncnc31,,328361.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(NCCc2ccc(F)cc2)c3cncnc31,,Row2156,90,0.0907884538173675,out,6
1726,Row2013,Row2551,CHEMBL3684391,,0,507.64,BDBM103104,IC50,=,4800.0,nM,CCN(CC)C(=O)C1CN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CCC1,,220826.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CCN(CC)C(=O)C1CN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CCC1,,Row2452,66,0.1533364057540893,out,6
1727,Row2014,Row1766,CHEMBL375985,,0,317.73,145,IC50,=,4900.0,nM,CCOc1ccc(cc1)NC2=C(Cl)C(=O)c3[nH]ncc3C2=O,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,CCOc1ccc(cc1)NC2=C(Cl)C(=O)c3[nH]ncc3C2=O,,Row788,92,0.0835088044404983,out,6
1728,Row2015,Row2852,CHEMBL3684453,,0,549.59,BDBM103166,IC50,=,4900.0,nM,O=C(c1cc(F)c(F)cc1)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,220888.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(c1cc(F)c(F)cc1)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,Row2452,66,0.1539319604635238,out,6
1729,Row2016,Row8,CHEMBL391738,,0,524.45,"4, SKS-927",IC50,>,5000.0,nM,CN1CCN(CCC#Cc2cc3ncc(C#N)c(Nc4cc(OC)c(Cl)cc4Cl)c3cc2OC)CC1,,,CHEMBL885862,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139073,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CN1CCN(CCC#Cc2cc3ncc(C#N)c(Nc4cc(OC)c(Cl)cc4Cl)c3cc2OC)CC1,,Row1867,42,0.0927787274122238,out,6
1730,Row2017,Row763,CHEMBL3185148,,0,486.32,2,IC50,>,5000.0,nM,Nc1nc(ccc1[N+]([O-])=O)NCCNc2nc(-c3ccc(Cl)cc3Cl)c(cn2)-n4cncc4,,,CHEMBL4022690,Inhibition of human AKT1/PKB using phospho-AKT peptide substrate after 1 hr by scintillation counting method,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4020814,1,Scientific Literature,J Med Chem,2017.0,Nc1nc(ccc1[N+]([O-])=O)NCCNc2nc(-c3ccc(Cl)cc3Cl)c(cn2)-n4cncc4,,Row3186,60,0.1164483204483985,out,6
1731,Row2018,Row1078,CHEMBL4564126,,0,411.82,18,IC50,>=,5000.0,nM,Cc1cnc(cc1-n2c3ccncc3n(CC(N)=O)c2=O)-c4cc(Cl)ccc4F,,,CHEMBL4427679,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4425174,1,Scientific Literature,Bioorg Med Chem Lett,2016.0,Cc1cnc(cc1-n2c3ccncc3n(CC(N)=O)c2=O)-c4cc(Cl)ccc4F,,Row1206,41,0.1118954643607139,out,6
1732,Row2020,Row1289,CHEMBL452598,,0,391.41,32,IC50,=,5000.0,nM,COc1cc2CC(COc2cc1)c3[nH]c4cc(cc(F)c4n3)-c5ccnc(N)n5,,,CHEMBL1009214,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152196,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,COc1cc2CC(COc2cc1)c3[nH]c4cc(cc(F)c4n3)-c5ccnc(N)n5,,Row3570,86,0.148948386311531,out,6
1733,Row2021,Row2430,CHEMBL2312185,,0,420.55,12u,IC50,>,5000.0,nM,Cc1nc(NC)sc1-c2nc(Nc3cc(ccc3)N4CCNCCC4)ncc2C#N,,,CHEMBL2350816,Inhibition of PKBalpha (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2346630,1,Scientific Literature,J. Med. Chem.,2013.0,Cc1nc(NC)sc1-c2nc(Nc3cc(ccc3)N4CCNCCC4)ncc2C#N,,Row286,88,0.1329042166471481,out,6
1734,Row2022,Row2737,CHEMBL3684460,,0,620.74,BDBM103174,IC50,=,5000.0,nM,CC(=O)Nc1ccc(cc1)S(=O)(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,220896.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CC(=O)Nc1ccc(cc1)S(=O)(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n45)CC2,,Row662,76,0.1378447562456131,out,6
1735,Row2023,Row3406,CHEMBL4251324,,0,436.58,30,IC50,>,5000.0,nM,O=C(Cc1cc(ccc1)OCCCC2CCNCC2)Nc3nc(cs3)-c4ccncc4,,,CHEMBL4233284,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4229420,1,Scientific Literature,Bioorg Med Chem Lett,2018.0,O=C(Cc1cc(ccc1)OCCCC2CCNCC2)Nc3nc(cs3)-c4ccncc4,,Row3192,40,0.1243892312049865,out,6
1736,Row2024,Row3545,CHEMBL519693,,0,383.47,17,IC50,=,5011.87,nM,NS(=O)(=O)c1ccc(cc1)-c2cc3ccncc3cc2OC4CCNCC4,,,CHEMBL985019,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138455,1,Scientific Literature,J. Med. Chem.,2009.0,NS(=O)(=O)c1ccc(cc1)-c2cc3ccncc3cc2OC4CCNCC4,,Row3192,40,0.1574925780296325,out,6
1737,Row2025,Row1646,CHEMBL2064002,,0,609.47,19,IC50,=,5020.0,nM,COc1cc(/C=C/C(=O)C(=Cc2cc(Br)c(O)c(c2)OC)C(=O)/C=C/c3cc(ccc3OC)OC)c(cc1)OC,,,CHEMBL2067501,Inhibition of AKT1 by AKT1/PKBalpha KinEASE FP fluorescein green assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2062524,1,Scientific Literature,Eur. J. Med. Chem.,2012.0,COc1cc(/C=C/C(=O)C(=Cc2cc(Br)c(O)c(c2)OC)C(=O)/C=C/c3cc(ccc3OC)OC)c(cc1)OC,,Row2523,51,0.0763070657849311,out,6
1738,Row2026,Row2324,CHEMBL206382,,0,241.29,2a,IC50,=,5080.0,nM,NCCOc1cc(cnc1)/C=C/c2ccncc2,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,NCCOc1cc(cnc1)/C=C/c2ccncc2,,Row615,77,0.0950643867254257,out,6
1739,Row2027,Row844,CHEMBL3679718,,0,345.79,BDBM103032,IC50,=,5100.0,nM,Clc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,220754.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Clc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,Row3389,81,0.1473795175552368,out,6
1740,Row2028,Row3345,CHEMBL3679722,,0,380.24,BDBM103036,IC50,=,5100.0,nM,Clc1cc(ccc1Cl)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,220758.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Clc1cc(ccc1Cl)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,Row3389,81,0.1457348465919494,out,6
1741,Row2029,Row2550,CHEMBL3684384,,0,500.61,BDBM103097,IC50,=,5200.0,nM,C(c1ccncc1)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,220819.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,C(c1ccncc1)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,Row2452,66,0.1616020202636718,out,6
1742,Row2030,Row3125,CHEMBL3684534,,0,420.27,BDBM103248,IC50,=,5200.0,nM,OCc1ccc(cc1)-c2nnc3-c4cc(Br)ccc4Nc5ncccc5-n32,,220962.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,OCc1ccc(cc1)-c2nnc3-c4cc(Br)ccc4Nc5ncccc5-n32,,Row2452,66,0.1288655996322631,out,6
1743,Row2032,Row892,CHEMBL419932,,0,289.77,1,IC50,=,5290.0,nM,C[C@H](N)COc1cc(/C=C/c2ccncc2)c(Cl)nc1,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,C[C@H](N)COc1cc(/C=C/c2ccncc2)c(Cl)nc1,,Row615,77,0.090669922530651,out,6
1744,Row2033,Row656,CHEMBL3684357,,0,516.46,BDBM103069,IC50,=,5300.0,nM,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)c6ccc(F)c(c6)C(F)(F)F,,220791.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)c6ccc(F)c(c6)C(F)(F)F,,Row2783,67,0.1349082440137863,out,6
1745,Row2034,Row2452,CHEMBL3684392,,0,499.62,BDBM103105,IC50,=,5300.0,nM,C(c1ccccc1)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,220827.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,C(c1ccccc1)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,Row2452,66,0.1721456944942474,out,6
1746,Row2035,Row3071,CHEMBL3684458,,0,527.65,BDBM103172,IC50,=,5300.0,nM,O=S(=O)(NC1CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34)CC1)C7CC7,,220894.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=S(=O)(NC1CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34)CC1)C7CC7,,Row2452,66,0.1498552560806274,out,6
1747,Row2036,Row3072,CHEMBL3684462,,0,598.76,BDBM103176,IC50,=,5300.0,nM,Cc1nc(C)sc1S(=O)(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,220898.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cc1nc(C)sc1S(=O)(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,Row2452,66,0.1400321125984192,out,6
1748,Row2037,Row772,CHEMBL50,QUERCETIN,3,302.24,Quercetin,IC50,=,5390.0,nM,Oc1cc2oc(-c3cc(O)c(O)cc3)c(O)c(=O)c2c(O)c1,,,CHEMBL3108329,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3102702,1,Scientific Literature,J. Nat. Prod.,2014.0,Oc1cc2oc(-c3cc(O)c(O)cc3)c(O)c(=O)c2c(O)c1,,Row2857,89,0.0990593358874321,out,6
1749,Row2038,Row2857,CHEMBL1915459,,0,354.36,79,IC50,=,5400.0,nM,CC(C)=CCc1c(O)c2c(=O)cc(oc2cc1O)-c3cc(O)c(O)cc3,,,CHEMBL1918853,Inhibition of GST-tagged PKB/Akt1 incubated for 5 mins before eNOS substrate and ATP addition measured after 30 mins by kinase assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1914446,1,Scientific Literature,Eur. J. Med. Chem.,2011.0,CC(C)=CCc1c(O)c2c(=O)cc(oc2cc1O)-c3cc(O)c(O)cc3,,Row2857,89,0.1015807464718818,out,6
1750,Row2040,Row2526,CHEMBL307152,,0,494.6,14m,IC50,=,5480.0,nM,Cn1ccc2ccc3c4[nH]c5c(CCCN[C@@H]6CC[C@@H](O)CC6)cccc5c4c7C(=O)NC(=O)c7c3c12,,,CHEMBL766860,"Inhibition of Protein kinase B, Akt-1",B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1136094,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2003.0,Cn1ccc2ccc3c4[nH]c5c(CCCN[C@@H]6CC[C@@H](O)CC6)cccc5c4c7C(=O)NC(=O)c7c3c12,,Row662,76,0.1170302927494049,out,6
1751,Row2041,Row664,CHEMBL3684398,,0,451.58,BDBM103111,IC50,=,5500.0,nM,CN1CCC(CC1)N(C)Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,220833.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CN1CCC(CC1)N(C)Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,Row2452,66,0.1534481197595596,out,6
1752,Row2042,Row2305,CHEMBL402355,,0,515.62,9d,IC50,=,5548.0,nM,COc1nc(c(cc1C#N)-c2ccccc2)-c3ccc(CN4CCC(CC4)n5c(=O)[nH]c6ccccc56)cc3,,,CHEMBL951085,Inhibition of human recombinant Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142344,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,COc1nc(c(cc1C#N)-c2ccccc2)-c3ccc(CN4CCC(CC4)n5c(=O)[nH]c6ccccc56)cc3,,Row2123,58,0.2103746831417083,out,6
1753,Row2043,Row2156,CHEMBL3891824,,0,292.34,BDBM181345,IC50,=,5600.0,nM,NC(=O)c1ccc(NCCc2ccccc2)c3cncnc13,,328359.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(NCCc2ccccc2)c3cncnc13,,Row2156,90,0.1243322342634201,out,6
1754,Row2046,Row374,CHEMBL3982217,,0,476.63,BDBM182651,IC50,=,5700.0,nM,CN(C)c1ncc(cn1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5CC,,330092.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CN(C)c1ncc(cn1)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5CC,,Row3753,7,0.1058204770088195,out,6
1755,Row2047,Row469,CHEMBL3684393,,0,424.51,BDBM103106,IC50,=,5700.0,nM,OC1CN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CCC1,,220828.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,OC1CN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CCC1,,Row2452,66,0.1620577722787857,out,6
1756,Row2048,Row1627,CHEMBL3919102,,0,399.86,BDBM181325,IC50,=,5700.0,nM,NC(=O)c1ccc(N[C@@H]2CNCC[C@H]2c3cc(Cl)c(F)cc3)c4cncnc41,,328348.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(N[C@@H]2CNCC[C@H]2c3cc(Cl)c(F)cc3)c4cncnc41,,Row2729,75,0.0965563505887985,out,6
1757,Row2049,Row2794,CHEMBL3923651,,0,470.0,BDBM182492,IC50,=,5700.0,nM,Cc1cc(ccc1F)-c2cn(CC3CNC3)c(n2)C4CCN(CC4)c5ncnc(NC)c5Cl,,329933.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cc1cc(ccc1F)-c2cn(CC3CNC3)c(n2)C4CCN(CC4)c5ncnc(NC)c5Cl,,Row3798,5,0.1037175580859184,out,6
1758,Row2050,Row197,CHEMBL1823657,,0,413.35,30,IC50,=,5800.0,nM,O=C(NC(C1CCCCC1)c2ccc(Cl)c(Cl)c2)c3ccc4cnccc4c3,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,O=C(NC(C1CCCCC1)c2ccc(Cl)c(Cl)c2)c3ccc4cnccc4c3,,Row3192,40,0.1083619743585586,out,6
1759,Row2051,Row1195,CHEMBL3684418,,0,494.58,BDBM103131,IC50,=,5800.0,nM,O=S(=O)(NCCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccccc6,,220853.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=S(=O)(NCCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccccc6,,Row3925,73,0.1463228017091751,out,6
1760,Row2052,Row1224,CHEMBL3948232,,0,463.55,BDBM182638,IC50,=,5800.0,nM,NC(=O)c1c(ncnc1N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(=O)[nH]cc5,,330079.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,NC(=O)c1c(ncnc1N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(=O)[nH]cc5,,Row1206,41,0.1011354252696037,out,6
1761,Row2053,Row2226,CHEMBL3684404,,0,513.65,BDBM103117,IC50,=,5800.0,nM,C(c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)N6CCN(CCc7ccccc7)CC6,,220839.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,C(c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)N6CCN(CCc7ccccc7)CC6,,Row2452,66,0.1655570268630981,out,6
1762,Row2054,Row3064,CHEMBL3684397,,0,382.47,BDBM103110,IC50,=,5800.0,nM,CCCNCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,220832.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CCCNCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,Row2452,66,0.1380289494991302,out,6
1763,Row2055,Row1842,CHEMBL3684478,,0,630.75,BDBM103192,IC50,=,6000.0,nM,COc1ccc(CCNC(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2)cc1OC,,220914.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,COc1ccc(CCNC(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2)cc1OC,,Row662,76,0.1499363780021667,out,6
1764,Row2056,Row3685,CHEMBL3684450,,0,527.63,BDBM103163,IC50,=,6000.0,nM,O=C(Cc1ccccc1)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,220885.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(Cc1ccccc1)N2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,Row2452,66,0.1606453657150268,out,6
1765,Row2057,Row3312,CHEMBL3895400,,0,452.28,BDBM182303,IC50,=,6100.0,nM,FC(F)(F)c1cc(ccc1)-c2c[nH]c(n2)C3CCN(CC3)c4ncncc4Br,,329771.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,FC(F)(F)c1cc(ccc1)-c2c[nH]c(n2)C3CCN(CC3)c4ncncc4Br,,Row3758,45,0.1267695724964141,out,6
1766,Row2058,Row3965,CHEMBL3684536,,0,419.29,BDBM103250,IC50,=,6100.0,nM,NCc1ccc(cc1)-c2nnc3-c4cc(Br)ccc4Nc5ncccc5-n32,,220964.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,NCc1ccc(cc1)-c2nnc3-c4cc(Br)ccc4Nc5ncccc5-n32,,Row2452,66,0.1425953656435012,out,6
1767,Row2059,Row3036,CHEMBL1761079,,0,536.62,"17, 1:1diastereomeric mixture",IC50,=,6200.0,nM,CCOCCN(C[C@@H](O)CN1CC2(CC(=O)c3cc(O)ccc3O2)CCC1)S(=O)(=O)c4ccccc4F,,,CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759945,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CCOCCN(C[C@@H](O)CN1CC2(CC(=O)c3cc(O)ccc3O2)CCC1)S(=O)(=O)c4ccccc4F,,Row2370,39,0.1256673634052276,out,6
1768,Row2060,Row921,CHEMBL380542,,0,441.56,9v,IC50,=,6230.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)-c4cc(ccc4)Nc5nccs5,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)-c4cc(ccc4)Nc5nccs5,,Row1996,15,0.1262382417917251,out,6
1769,Row2061,Row2656,CHEMBL3679711,,0,301.31,BDBM103025,IC50,=,6300.0,nM,c1ccc-2c(Nc3ccccc3-c4nnc(-c5ccco5)n24)n1,,220747.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,c1ccc-2c(Nc3ccccc3-c4nnc(-c5ccco5)n24)n1,,Row3389,81,0.1198011711239814,out,6
1770,Row2062,Row1255,CHEMBL203483,,0,478.62,10c,IC50,=,6350.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)/C=C/c4cc(ncc4)Sc5ccccc5,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)/C=C/c4cc(ncc4)Sc5ccccc5,,Row77,56,0.1251153200864792,out,6
1771,Row2063,Row1918,CHEMBL451523,,0,617.77,17,IC50,=,6400.0,nM,COc1c(cc(cc1NC(=O)Nc2ccc(c3ccccc32)-c4cnc(CN5CCOCC5)cc4)C(C)(C)C)NS(C)(=O)=O,,,CHEMBL984183,Inhibition of PKBalpha/Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138470,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,COc1c(cc(cc1NC(=O)Nc2ccc(c3ccccc32)-c4cnc(CN5CCOCC5)cc4)C(C)(C)C)NS(C)(=O)=O,,Row662,76,0.1412961333990097,out,6
1772,Row2064,Row2244,CHEMBL3684381,,0,396.5,BDBM103094,IC50,=,6400.0,nM,CC(C)CNCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,220816.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CC(C)CNCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,Row3925,73,0.1365261226892471,out,6
1773,Row2065,Row2738,CHEMBL3684463,,0,543.7,BDBM103177,IC50,=,6400.0,nM,CC(C)CS(=O)(=O)NC1CCN(CC1)Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,220899.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CC(C)CS(=O)(=O)NC1CCN(CC1)Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,Row662,76,0.1498786807060241,out,6
1774,Row2066,Row3647,CHEMBL3918934,,0,351.39,BDBM181342,IC50,=,6400.0,nM,NC(=O)c1ccc(c2cncnc21)N3CCN(CC3)c4cc(F)ccc4,,328356.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(c2cncnc21)N3CCN(CC3)c4cc(F)ccc4,,Row1630,91,0.1392926275730133,out,6
1775,Row2067,Row2082,CHEMBL485213,,0,332.36,2,IC50,=,6436.0,nM,O=C(Nc1ccc(cc1)-c2ccncc2)C3COc4ccccc4O3,,,CHEMBL1030560,Inhibition of AKT1 after 55 mins,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142492,1,Scientific Literature,J. Med. Chem.,2008.0,O=C(Nc1ccc(cc1)-c2ccncc2)C3COc4ccccc4O3,,Row2492,83,0.1453223824501037,out,6
1776,Row2068,Row2053,CHEMBL378823,,0,462.55,10b,IC50,=,6450.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)/C=C/c4cc(ncc4)Oc5ccccc5,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)/C=C/c4cc(ncc4)Oc5ccccc5,,Row77,56,0.1259190887212753,out,6
1777,Row2069,Row3070,CHEMBL3684416,,0,466.53,BDBM103129,IC50,=,6600.0,nM,O=S(=O)(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccccc6,,220851.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=S(=O)(Nc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)c6ccccc6,,Row3925,73,0.158346951007843,out,6
1778,Row2070,Row3360,CHEMBL3684403,,0,394.48,BDBM103116,IC50,=,6700.0,nM,C(NCC1CC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,220838.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,C(NCC1CC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,Row3925,73,0.1520256847143173,out,6
1779,Row2071,Row2487,CHEMBL3684456,,0,582.69,BDBM103169,IC50,=,6800.0,nM,Cc1noc(C)c1S(=O)(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,220891.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cc1noc(C)c1S(=O)(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,Row2452,66,0.1380436718463897,out,6
1780,Row2072,Row3232,CHEMBL1823650,,0,520.46,23,IC50,=,6850.0,nM,COc1ccc(cc1)-c2cc3cnccc3cc2C(=O)NC(C4CCNCC4)c5ccc(Cl)c(Cl)c5,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,COc1ccc(cc1)-c2cc3cnccc3cc2C(=O)NC(C4CCNCC4)c5ccc(Cl)c(Cl)c5,,Row3192,40,0.1275809109210968,out,6
1781,Row2073,Row3780,CHEMBL3684467,,0,557.61,BDBM103181,IC50,=,6900.0,nM,O=C(c1cc2OCOc2cc1)N3CCN(Cc4ccc(cc4)-c5nnc6-c7ccccc7Nc8ncccc8-n65)CC3,,220903.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(c1cc2OCOc2cc1)N3CCN(Cc4ccc(cc4)-c5nnc6-c7ccccc7Nc8ncccc8-n65)CC3,,Row2452,66,0.14500692486763,out,6
1782,Row2074,Row2101,CHEMBL369532,,0,526.65,8g,IC50,=,6915.0,nM,Cc1nc2ccccc2n1C3CCN(Cc4ccc(cc4)-c5ncc(cc5-c6ccccc6)-c7n[nH]nn7)CC3,,,CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141976,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,Cc1nc2ccccc2n1C3CCN(Cc4ccc(cc4)-c5ncc(cc5-c6ccccc6)-c7n[nH]nn7)CC3,,Row2123,58,0.2104792445898056,out,6
1783,Row2075,Row2312,CHEMBL206179,,0,358.45,9e,IC50,=,6940.0,nM,Nc1ccc(cc1)-c2cncc(c2)OC[C@@H](N)Cc3c[nH]c4ccccc34,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Nc1ccc(cc1)-c2cncc(c2)OC[C@@H](N)Cc3c[nH]c4ccccc34,,Row1996,15,0.1316815912723541,out,6
1784,Row2076,Row30,CHEMBL382379,,0,320.4,97,IC50,=,6970.0,nM,N[C@@H](Cc1ccccc1)COc2cncc(c2)Nc3cnccc3,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@@H](Cc1ccccc1)COc2cncc(c2)Nc3cnccc3,,Row615,77,0.1360393762588501,out,6
1785,Row2077,Row2061,CHEMBL3787112,,0,349.44,2,IC50,=,7000.0,nM,Nc1ncnc2c1c(cn2[C@@H]3C[C@H](CN4CCC4)C3)-c5cc(O)ccc5,,,CHEMBL3789974,Inhibition of AKT1 (unknown origin) in presence of [gamma33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3785066,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2016.0,Nc1ncnc2c1c(cn2[C@@H]3C[C@H](CN4CCC4)C3)-c5cc(O)ccc5,,Row2590,1,0.1493802070617675,out,6
1786,Row2079,Row714,CHEMBL205324,,0,394.48,10b,IC50,=,7090.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cnc4ccc(cc4c3)-c5cnccc5,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cnc4ccc(cc4c3)-c5cnccc5,,Row1996,15,0.1466970294713974,out,6
1787,Row2080,Row1546,CHEMBL3684395,,0,410.53,BDBM103108,IC50,=,7100.0,nM,CN(Cc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)CC(C)C,,220830.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CN(Cc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32)CC(C)C,,Row3389,81,0.1340779513120651,out,6
1788,Row2081,Row3109,CHEMBL3764457,,0,246.23,PI-2,IC50,=,7190.0,nM,Nc1nonc1/C(/NC(=N)c2ccccc2)=N\O,,,CHEMBL3767267,"Antagonist activity at human AKT1-PH domain (1 to 121 residues) assessed as reduction of AKT1-PH interaction with PC/PE/PS/PI(3,4,5)P3 after 30 mins by competitive SPR analysis",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3763051,1,Scientific Literature,MedChemComm,2015.0,Nc1nonc1/C(/NC(=N)c2ccccc2)=N\O,,Row3384,87,0.1329861283302307,out,6
1789,Row2082,Row1220,CHEMBL3984446,,0,520.99,BDBM182491,IC50,=,7200.0,nM,CNc1ncnc(c1Cl)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ncc5)C(F)(F)F,,329932.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,CNc1ncnc(c1Cl)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ncc5)C(F)(F)F,,Row643,24,0.1126077771186828,out,6
1790,Row2083,Row3075,CHEMBL3679726,,0,347.33,BDBM103040,IC50,=,7200.0,nM,Fc1cc(F)c(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23,,220762.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Fc1cc(F)c(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23,,Row3389,81,0.1425720304250717,out,6
1791,Row2084,Row1442,CHEMBL3684472,,0,509.62,BDBM103186,IC50,=,7300.0,nM,[C-]#[N+]C1(CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CC1)c7ccccc7,,220908.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,[C-]#[N+]C1(CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CC1)c7ccccc7,,Row2452,66,0.1958791762590408,out,6
1792,Row2085,Row1214,CHEMBL425338,,0,483.62,7g,IC50,=,7407.0,nM,Cc1nc2ccccc2n1C3CCN(Cc4ccc(cc4)-c5ncc(cc5-c6ccccc6)C#N)CC3,,,CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141976,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,Cc1nc2ccccc2n1C3CCN(Cc4ccc(cc4)-c5ncc(cc5-c6ccccc6)C#N)CC3,,Row2123,58,0.2022956311702728,out,6
1793,Row2086,Row2492,CHEMBL521179,SR-3677,0,408.46,"5, SR-3677",IC50,=,7491.0,nM,CN(C)CCOc1cc(ccc1NC(=O)C2COc3ccccc3O2)-c4c[nH]nc4,,,CHEMBL1030560,Inhibition of AKT1 after 55 mins,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142492,1,Scientific Literature,J. Med. Chem.,2008.0,CN(C)CCOc1cc(ccc1NC(=O)C2COc3ccccc3O2)-c4c[nH]nc4,,Row2492,83,0.1208660006523132,out,6
1794,Row2087,Row2414,CHEMBL3684524,,0,557.66,BDBM103238,IC50,=,7600.0,nM,COc1cc(ccc1)C(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,220975.0,CHEMBL3705043,Biochemical Assay: Biochemical assay using CisBio KinEASE HTRF Assay technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,COc1cc(ccc1)C(=O)NC2CCN(Cc3ccc(cc3)-c4nnc5-c6ccccc6Nc7ncccc7-n54)CC2,,Row662,76,0.1667641103267669,out,6
1795,Row2088,Row3778,CHEMBL3679713,,0,300.33,BDBM103027,IC50,=,7900.0,nM,c1ccc-2c(Nc3ccccc3-c4nnc(-c5ccc[nH]5)n24)n1,,220749.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,c1ccc-2c(Nc3ccccc3-c4nnc(-c5ccc[nH]5)n24)n1,,Row3389,81,0.1249027848243713,out,6
1796,Row2089,Row2333,CHEMBL1242977,,0,479.46,6a,IC50,>,8000.0,nM,Cc1cc(ccc1Oc2ncccc2-c3ccnc(NC)n3)NC(=O)c4cc(ccc4)C(F)(F)F,,,CHEMBL1247975,Inhibition of PKBalpha by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1240487,1,Scientific Literature,J. Med. Chem.,2010.0,Cc1cc(ccc1Oc2ncccc2-c3ccnc(NC)n3)NC(=O)c4cc(ccc4)C(F)(F)F,,Row2783,67,0.094437301158905,out,6
1797,Row2090,Row2548,CHEMBL3684382,,0,494.6,BDBM103095,IC50,=,8000.0,nM,CN(C)C(=O)CN1CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CC1,,220817.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CN(C)C(=O)CN1CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CC1,,Row2452,66,0.1526989489793777,out,6
1798,Row2091,Row2461,CHEMBL381829,,0,345.45,6,IC50,=,8020.0,nM,N[C@H](COc1cc(cnc1)/C=C/c2ccncc2)CCc3ccccc3,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,N[C@H](COc1cc(cnc1)/C=C/c2ccncc2)CCc3ccccc3,,Row615,77,0.1233555302023887,out,6
1799,Row2092,Row350,CHEMBL3679727,,0,326.36,BDBM103041,IC50,=,8100.0,nM,Nc1cc(ccc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,220763.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Nc1cc(ccc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,Row3389,81,0.1621343791484832,out,6
1800,Row2093,Row1747,CHEMBL3948252,,0,415.42,BDBM181354,IC50,=,8100.0,nM,NC(=O)c1ccc(c2cncnc21)N3CC(N)C(CC3)c4cc(ccc4)C(F)(F)F,,328367.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(c2cncnc21)N3CC(N)C(CC3)c4cc(ccc4)C(F)(F)F,,Row1630,91,0.1224274784326553,out,6
1801,Row2094,Row238,CHEMBL1258332,,0,383.88,41,IC50,=,8122.0,nM,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3cnc4ccccn34,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3cnc4ccccn34,,Row854,17,0.1100812405347824,out,6
1802,Row2095,Row429,CHEMBL3940185,,0,362.43,BDBM181314,IC50,=,8200.0,nM,Cc1cc(ccc1)[C@@H]2CN(C[C@H]2CO)c3ccc(C(N)=O)c4ncncc34,,328337.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,Cc1cc(ccc1)[C@@H]2CN(C[C@H]2CO)c3ccc(C(N)=O)c4ncncc34,,Row1630,91,0.1315893828868866,out,6
1803,Row2096,Row141,CHEMBL3684386,,0,438.54,BDBM103099,IC50,=,8300.0,nM,OCC1CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CC1,,220821.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,OCC1CCN(Cc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43)CC1,,Row2452,66,0.154384508728981,out,6
1804,Row2097,Row3758,CHEMBL3980785,,0,510.54,BDBM182312,IC50,=,8300.0,nM,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4ccc(C)cc4)-c5ccc(F)c(c5)C(F)(F)F,,329778.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Cn1cc(nc1C2CCN(CC2)c3ncnc(N)c3-c4ccc(C)cc4)-c5ccc(F)c(c5)C(F)(F)F,,Row3758,45,0.1175756081938743,out,6
1805,Row2098,Row2371,CHEMBL257441,,0,528.66,9c,IC50,=,8457.0,nM,CN(C)c1nc(c(cc1C#N)-c2ccccc2)-c3ccc(CN4CCC(CC4)n5c(=O)[nH]c6ccccc56)cc3,,,CHEMBL951085,Inhibition of human recombinant Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142344,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN(C)c1nc(c(cc1C#N)-c2ccccc2)-c3ccc(CN4CCC(CC4)n5c(=O)[nH]c6ccccc56)cc3,,Row2123,58,0.194271832704544,out,6
1806,Row2099,Row2446,CHEMBL1271447,,0,549.7,8j,IC50,=,8500.0,nM,O=S(=O)(Nc1nc(NCCc2ccccc2)nc3CCN(Cc4ccccc4)Cc31)c5cc6ccccc6cc5,,,CHEMBL1274490,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1268914,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,O=S(=O)(Nc1nc(NCCc2ccccc2)nc3CCN(Cc4ccccc4)Cc31)c5cc6ccccc6cc5,,Row996,49,0.1227596476674079,out,6
1807,Row2100,Row3384,CHEMBL3763907,,0,261.25,PI-3,IC50,=,8610.0,nM,Nc1ccccc1C(=N)N/C(=N/O)/c2nonc2N,,,CHEMBL3767267,"Antagonist activity at human AKT1-PH domain (1 to 121 residues) assessed as reduction of AKT1-PH interaction with PC/PE/PS/PI(3,4,5)P3 after 30 mins by competitive SPR analysis",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3763051,1,Scientific Literature,MedChemComm,2015.0,Nc1ccccc1C(=N)N/C(=N/O)/c2nonc2N,,Row3384,87,0.1125341802835464,out,6
1808,Row2102,Row1787,CHEMBL485215,,0,351.36,4,IC50,=,8819.0,nM,COc1cc(ccc1NC(=O)C2COc3ccccc3O2)-c4c[nH]nc4,,,CHEMBL1030560,Inhibition of AKT1 after 55 mins,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142492,1,Scientific Literature,J. Med. Chem.,2008.0,COc1cc(ccc1NC(=O)C2COc3ccccc3O2)-c4c[nH]nc4,,Row2492,83,0.1407243013381958,out,6
1809,Row2104,Row1083,CHEMBL489083,,0,441.52,11a,IC50,=,9000.0,nM,NC(=N)SCCCn1c(=O)c2c(c1=O)n3ccc4cccc(c34)c5cc6ccccc6n52,,,CHEMBL961569,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1151764,1,Scientific Literature,J. Med. Chem.,2008.0,NC(=N)SCCCn1c(=O)c2c(c1=O)n3ccc4cccc(c34)c5cc6ccccc6n52,,Row2527,93,0.1353323012590408,out,6
1810,Row2105,Row1360,CHEMBL199996,,0,315.36,13h,IC50,=,9000.0,nM,Cc1n[nH]c2sc(C(N)=O)c(NC(=O)Nc3ccccc3)c21,,,CHEMBL864555,Inhibitory activity against Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Cc1n[nH]c2sc(C(N)=O)c(NC(=O)Nc3ccccc3)c21,,Row1352,94,0.1170559599995613,out,6
1811,Row2106,Row2810,CHEMBL3909073,,0,361.45,BDBM181320,IC50,=,9000.0,nM,Cc1cccc(c1)C2CCNCC2Nc3ccc(C(N)=O)c4ncncc34,,328343.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,Cc1cccc(c1)C2CCNCC2Nc3ccc(C(N)=O)c4ncncc34,,Row2729,75,0.1103984490036964,out,6
1812,Row2107,Row3333,CHEMBL3684419,,0,524.61,BDBM103132,IC50,=,9100.0,nM,COc1ccc(cc1)S(=O)(=O)NCCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,220854.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,COc1ccc(cc1)S(=O)(=O)NCCc2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,Row3925,73,0.1386699080467224,out,6
1813,Row2108,Row1362,CHEMBL192161,,0,373.8,2e,IC50,=,9210.0,nM,CC1(COC1)COc2ccc(Cl)cc2NC(=O)Nc3cnc(cn3)C#N,,,CHEMBL829440,"Inhibition of Protein kinase B, alpha (Akt1)",B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143624,1,Scientific Literature,J. Med. Chem.,2005.0,CC1(COC1)COc2ccc(Cl)cc2NC(=O)Nc3cnc(cn3)C#N,,Row2492,83,0.1092041432857513,out,6
1814,Row2109,Row804,CHEMBL3684535,,0,510.91,BDBM103249,IC50,=,9300.0,nM,O=C(NC1(CCC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6nc(Cl)ccc6-n43)C(F)(F)F,,220963.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(NC1(CCC1)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6nc(Cl)ccc6-n43)C(F)(F)F,,Row3391,71,0.1989753693342209,out,6
1815,Row2110,Row1288,CHEMBL426126,,0,386.46,9g,IC50,=,9310.0,nM,NC(=O)c1ccc(cc1)-c2cncc(c2)OC[C@@H](N)Cc3c[nH]c4ccccc34,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,NC(=O)c1ccc(cc1)-c2cncc(c2)OC[C@@H](N)Cc3c[nH]c4ccccc34,,Row1996,15,0.1331113427877426,out,6
1816,Row2111,Row2041,CHEMBL207530,,0,388.5,6c,IC50,=,9350.0,nM,N[C@@H](Cc1ccccc1)COc2cncc(c2)-c3nc(cs3)-c4cnccc4,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1ccccc1)COc2cncc(c2)-c3nc(cs3)-c4cnccc4,,Row615,77,0.1403698027133941,out,6
1817,Row2112,Row3662,CHEMBL3979925,,0,500.48,BDBM182343,IC50,=,9500.0,nM,Nc1ncnc(c1-c2ccc(F)cc2)N3CCC(CC3)c4[nH]cc(n4)-c5cc(c(F)cc5)C(F)(F)F,,329791.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1-c2ccc(F)cc2)N3CCC(CC3)c4[nH]cc(n4)-c5cc(c(F)cc5)C(F)(F)F,,Row3758,45,0.121645338833332,out,6
1818,Row2113,Row119,CHEMBL377771,,0,388.5,6b,IC50,=,9870.0,nM,N[C@@H](Cc1ccccc1)COc2cc(cnc2)-c3nc(cs3)-c4ccncc4,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1ccccc1)COc2cc(cnc2)-c3nc(cs3)-c4ccncc4,,Row615,77,0.1315839290618896,out,6
1819,Row2114,Row104,CHEMBL221959,TOFACITINIB,4,312.38,CP-690550,IC50,>,10000.0,nM,CN([C@H]1CN(CC[C@H]1C)C(=O)CC#N)c2ncnc3[nH]ccc32,,,CHEMBL1015224,Inhibition of PKBa,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152817,1,Scientific Literature,Science,2003.0,CN([C@H]1CN(CC[C@H]1C)C(=O)CC#N)c2ncnc3[nH]ccc32,,Row854,17,0.0877990275621414,out,6
1820,Row2115,Row136,CHEMBL412142,CHIR-99021,0,465.35,1,IC50,>,10000.0,nM,Cc1c[nH]c(n1)-c2cnc(NCCNc3ccc(cn3)C#N)nc2-c4ccc(Cl)cc4Cl,,,CHEMBL4022690,Inhibition of human AKT1/PKB using phospho-AKT peptide substrate after 1 hr by scintillation counting method,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4020814,1,Scientific Literature,J Med Chem,2017.0,Cc1c[nH]c(n1)-c2cnc(NCCNc3ccc(cn3)C#N)nc2-c4ccc(Cl)cc4Cl,,Row3186,60,0.1141621395945549,out,6
1821,Row2116,Row148,CHEMBL213423,,0,358.32,21,IC50,>,10000.0,nM,CC(C)c1nnc2ccc(cn21)-c3ocnc3-c4cc(F)c(F)cc4F,,,CHEMBL869145,Inhibition of PKBalpha,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145312,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC(C)c1nnc2ccc(cn21)-c3ocnc3-c4cc(F)c(F)cc4F,,Row148,95,0.0775517523288726,out,6
1822,Row2117,Row175,CHEMBL3357634,,0,447.87,1a(Z),IC50,>,10000.0,nM,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C(/F)=C/CN(C)C,,,CHEMBL3385203,Inhibition of wild type AKT1 (unknown origin) incubated for 5 mins by HTRF assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3351667,1,Scientific Literature,J. Med. Chem.,2014.0,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C(/F)=C/CN(C)C,,Row1867,42,0.0773740485310554,out,6
1823,Row2118,Row273,CHEMBL565061,,0,454.41,1,IC50,>,10000.0,nM,CCOC(=O)c1cnn2c1nccc2-c3cc(ccc3)NC(=O)c4cc(ccc4)C(F)(F)F,,,CHEMBL1035535,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1151868,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CCOC(=O)c1cnn2c1nccc2-c3cc(ccc3)NC(=O)c4cc(ccc4)C(F)(F)F,,Row2772,33,0.103805661201477,out,6
1824,Row2119,Row286,CHEMBL4213003,,0,392.51,7f,IC50,>,10000.0,nM,CNc1ncc2c(n1)n(CC3CCCC3)nc2-c4ccc(nc4)N5CCNCC5,,,CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4184298,1,Scientific Literature,J Med Chem,2018.0,CNc1ncc2c(n1)n(CC3CCCC3)nc2-c4ccc(nc4)N5CCNCC5,,Row286,88,0.1333674043416977,out,6
1825,Row2120,Row290,CHEMBL1788116,,0,600.5,59,IC50,>,10000.0,nM,N#C/C(=C\1/Nc2ccccc2S1)/c3ccnc(NCCc4cnccc4)n3,,,CHEMBL828489,Inhibition of AKT kinase,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140315,1,Scientific Literature,J. Med. Chem.,2005.0,N#C/C(=C\1/Nc2ccccc2S1)/c3ccnc(NCCc4cnccc4)n3,,Row2156,90,0.1093492582440376,out,6
1826,Row2121,Row349,CHEMBL1080901,,0,486.32,36b,IC50,>,10000.0,nM,Nc1nc(ccc1[N+]([O-])=O)NCCNc2nc(-c3ccc(Cl)cc3Cl)c(cn2)-c4[nH]ccn4,,,CHEMBL4022690,Inhibition of human AKT1/PKB using phospho-AKT peptide substrate after 1 hr by scintillation counting method,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4020814,1,Scientific Literature,J Med Chem,2017.0,Nc1nc(ccc1[N+]([O-])=O)NCCNc2nc(-c3ccc(Cl)cc3Cl)c(cn2)-c4[nH]ccn4,,Row3186,60,0.1065553948283195,out,6
1827,Row2122,Row426,CHEMBL4069365,,0,421.38,13,IC50,>,10000.0,nM,CC1(C)OCC(=O)Nc2cc(ccc12)Nc3nc4ccoc4c(NCC(F)(F)F)n3,,,CHEMBL4007682,Inhibition of AKT (unknown origin) after 60 mins by TR-FRET assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4007384,1,Scientific Literature,Bioorg Med Chem Lett,2016.0,CC1(C)OCC(=O)Nc2cc(ccc12)Nc3nc4ccoc4c(NCC(F)(F)F)n3,,Row837,29,0.1010711193084716,out,6
1828,Row2123,Row595,CHEMBL389745,,0,577.69,46d,IC50,>,10000.0,nM,COc1cc(ccc1N)-c2cc3Nc4ccc(cc4NC(=O)c3cc2)C(C)(C)C(=O)Nc5ccc(cc5)N6CCOCC6,,,CHEMBL894158,Inhibition of recombinant Akt1 by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1148724,1,Scientific Literature,J. Med. Chem.,2007.0,COc1cc(ccc1N)-c2cc3Nc4ccc(cc4NC(=O)c3cc2)C(C)(C)C(=O)Nc5ccc(cc5)N6CCOCC6,,Row1867,42,0.1337234377861023,out,6
1829,Row2124,Row655,CHEMBL589630,,0,433.41,22,IC50,>,10000.0,nM,NC(=O)c1c([nH]c(C(=O)c2c(F)cccc2F)c1N)-c3ccc(cc3)Oc4ccccc4,,,CHEMBL1049496,Inhibition of PKB,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153156,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,NC(=O)c1c([nH]c(C(=O)c2c(F)cccc2F)c1N)-c3ccc(cc3)Oc4ccccc4,,Row919,96,0.1203088760375976,out,6
1830,Row2125,Row687,CHEMBL3884319,,0,386.45,33,IC50,=,10000.0,nM,CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c4nc(Nc5ccccc5)ncc14,,,CHEMBL3876093,Inhibition of human recombinant full length His-tagged AKT1alpha expressed in baculovirus expression system,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3875183,1,Scientific Literature,Bioorg Med Chem Lett,2017.0,CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c4nc(Nc5ccccc5)ncc14,,Row1528,84,0.1422525942325592,out,6
1831,Row2126,Row778,CHEMBL235157,,0,334.38,1,IC50,>,10000.0,nM,Cc1c2nc(N)c3cnc4cc(OC)c(cc4c3c2ccc1N)OC,,,CHEMBL900103,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138235,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1c2nc(N)c3cnc4cc(OC)c(cc4c3c2ccc1N)OC,,Row1813,70,0.1047103554010391,out,6
1832,Row2127,Row786,CHEMBL1916359,,0,419.67,20,IC50,>,10000.0,nM,[O-][n+]1ccc2c(nccc2-c3ccc(F)cc3Cl)c1-c4c(Cl)cccc4Cl,,,CHEMBL1919620,Inhibition of human PKBalpha,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1914450,1,Scientific Literature,J. Med. Chem.,2011.0,[O-][n+]1ccc2c(nccc2-c3ccc(F)cc3Cl)c1-c4c(Cl)cccc4Cl,,Row788,92,0.1053335815668106,out,6
1833,Row2128,Row821,CHEMBL214198,,0,339.35,79,IC50,>,10000.0,nM,CC(C)c1nnc2ccc(cn21)-c3c[nH]nc3-c4cc(F)ccc4F,,,CHEMBL869145,Inhibition of PKBalpha,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145312,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC(C)c1nnc2ccc(cn21)-c3c[nH]nc3-c4cc(F)ccc4F,,Row148,95,0.09189273416996,out,6
1834,Row2129,Row829,CHEMBL1933576,,0,475.48,13,IC50,>,10000.0,nM,CN1CCN(CC1)c2cc(Nc3nc(ccn3)-c4cc(cn4C)C(N)=O)c(cc2)OC(F)(F)F,,,CHEMBL1936504,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1933058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2012.0,CN1CCN(CC1)c2cc(Nc3nc(ccn3)-c4cc(cn4C)C(N)=O)c(cc2)OC(F)(F)F,,Row1867,42,0.1084637120366096,out,6
1835,Row2130,Row833,CHEMBL379929,,0,304.35,2,IC50,>,10000.0,nM,CC(C)c1nnc2ccc(cn21)-c3ocnc3-c4ccccc4,,,CHEMBL869145,Inhibition of PKBalpha,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145312,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC(C)c1nnc2ccc(cn21)-c3ocnc3-c4ccccc4,,Row148,95,0.1472311913967132,out,6
1836,Row2131,Row843,CHEMBL1258913,,0,544.68,38,IC50,>,10000.0,nM,O=C(N[C@H](CN1CCCC1)c2ccccc2)c3cc4[nH]nc(NC(=O)c5ccc(cc5)N6CCOCC6)c4s3,,,CHEMBL1260179,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255180,1,Scientific Literature,Bioorg. Med. Chem.,2010.0,O=C(N[C@H](CN1CCCC1)c2ccccc2)c3cc4[nH]nc(NC(=O)c5ccc(cc5)N6CCOCC6)c4s3,,Row1178,46,0.1315987259149551,out,6
1837,Row2132,Row869,CHEMBL2333445,,0,339.42,1,IC50,>,10000.0,nM,CCc1ccc(cc1)-c2cc3-c4[nH]ncc4S(=O)(=O)N(C)c3cc2,,,CHEMBL2345797,Inhibition of Akt1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2331389,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2013.0,CCc1ccc(cc1)-c2cc3-c4[nH]ncc4S(=O)(=O)N(C)c3cc2,,Row1834,53,0.1230086833238601,out,6
1838,Row2133,Row968,CHEMBL3651966,,0,440.47,8; PIM447,IC50,>,10000.0,nM,C[C@H]1C[C@H](C[C@@H](N)C1)c2ccncc2NC(=O)c3ccc(F)c(n3)-c4c(F)cccc4F,,,CHEMBL3750421,Inhibition of PKBalpha (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3745712,1,Scientific Literature,J. Med. Chem.,2015.0,C[C@H]1C[C@H](C[C@@H](N)C1)c2ccncc2NC(=O)c3ccc(F)c(n3)-c4c(F)cccc4F,,Row1630,91,0.1281408071517944,out,6
1839,Row2134,Row985,CHEMBL3309998,,0,378.39,12b,IC50,>,10000.0,nM,Nc1nc2c3ccc(cc3nc(Cc4cc5OCOc5cc4)n2n1)NCCO,,,CHEMBL3381058,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3352169,1,Scientific Literature,Bioorg. Med. Chem.,2014.0,Nc1nc2c3ccc(cc3nc(Cc4cc5OCOc5cc4)n2n1)NCCO,,Row3515,16,0.1146245896816253,out,6
1840,Row2135,Row1006,CHEMBL599428,,0,431.5,52,IC50,>,10000.0,nM,Cn1nc(C(N)=O)c2CCc3cnc(NC4CCN(CC4)C(=O)c5ccccc5)nc3-c12,,,CHEMBL1072190,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157561,1,Scientific Literature,J. Med. Chem.,2010.0,Cn1nc(C(N)=O)c2CCc3cnc(NC4CCN(CC4)C(=O)c5ccccc5)nc3-c12,,Row1867,42,0.1649917662143707,out,6
1841,Row2136,Row1018,CHEMBL535,SUNITINIB,4,398.48,NSC 750690,IC50,>,10000.0,nM,Cc1c(/C=C\2/c3cc(F)ccc3NC2=O)[nH]c(C)c1C(=O)NCCN(CC)CC,,,CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2034932,1,Scientific Literature,Eur. J. Med. Chem.,2012.0,Cc1c(/C=C\2/c3cc(F)ccc3NC2=O)[nH]c(C)c1C(=O)NCCN(CC)CC,,Row662,76,0.0800977200269699,out,6
1842,Row2137,Row1034,CHEMBL564829,MILCICLIB,2,460.59,"28, PHA-848125",IC50,>,10000.0,nM,CNC(=O)c1nn(C)c-2c1C(C)(C)Cc3cnc(Nc4ccc(cc4)N5CCN(C)CC5)nc32,,,CHEMBL1058614,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1151962,1,Scientific Literature,J. Med. Chem.,2009.0,CNC(=O)c1nn(C)c-2c1C(C)(C)Cc3cnc(Nc4ccc(cc4)N5CCN(C)CC5)nc32,,Row1867,42,0.1168957725167274,out,6
1843,Row2138,Row1077,CHEMBL3426225,,0,576.63,1j,IC50,>,10000.0,nM,CN1CCN(Cc2ccc(cc2C(F)(F)F)NC(=O)c3cc(C#Cc4nn(CC)c5ncnc(N)c45)c(C)cc3)CC1,,,CHEMBL3430009,Inhibition of human PKBalpha,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3425429,1,Scientific Literature,J. Med. Chem.,2015.0,CN1CCN(Cc2ccc(cc2C(F)(F)F)NC(=O)c3cc(C#Cc4nn(CC)c5ncnc(N)c45)c(C)cc3)CC1,,Row3758,45,0.1051758155226707,out,6
1844,Row2139,Row1113,CHEMBL410659,,0,460.59,"2f, AQIP",IC50,>,10000.0,nM,Nc1nccn2c1c(nc2[C@@H]3C[C@H](CN4CCC4)C3)-c5cc6nc(ccc6cc5)-c7ccccc7,,,CHEMBL938203,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143953,1,Scientific Literature,Bioorg. Med. Chem.,2008.0,Nc1nccn2c1c(nc2[C@@H]3C[C@H](CN4CCC4)C3)-c5cc6nc(ccc6cc5)-c7ccccc7,,Row3990,26,0.1860216856002807,out,6
1845,Row2140,Row1137,CHEMBL1614712,,0,439.56,NVP-AEW541,IC50,>,10000.0,nM,Nc1ncnc2c1c(cn2[C@@H]3C[C@H](CN4CCC4)C3)-c5cc(ccc5)OCc6ccccc6,,,CHEMBL3789974,Inhibition of AKT1 (unknown origin) in presence of [gamma33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3785066,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2016.0,Nc1ncnc2c1c(cn2[C@@H]3C[C@H](CN4CCC4)C3)-c5cc(ccc5)OCc6ccccc6,,Row3990,26,0.1721238046884536,out,6
1846,Row2141,Row1138,CHEMBL3785951,,0,508.6,33,IC50,>,10000.0,nM,CC(=O)N1CCN(CC1)[C@@H]2C[C@@H](C2)n3cc(c4c(N)ncnc34)-c5cc(ccc5F)OC[C@@H]6CCCO6,,,CHEMBL3789974,Inhibition of AKT1 (unknown origin) in presence of [gamma33P]ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3785066,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2016.0,CC(=O)N1CCN(CC1)[C@@H]2C[C@@H](C2)n3cc(c4c(N)ncnc34)-c5cc(ccc5F)OC[C@@H]6CCCO6,,Row1206,41,0.1093078106641769,out,6
1847,Row2142,Row1146,CHEMBL1270230,,0,279.3,18,IC50,>,10000.0,nM,Nc1nc(ccn1)-c2cc(c([nH]2)-c3ccccc3)C(N)=O,,,CHEMBL1275208,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1268909,1,Scientific Literature,J. Med. Chem.,2010.0,Nc1nc(ccn1)-c2cc(c([nH]2)-c3ccccc3)C(N)=O,,Row919,96,0.1709997802972793,out,6
1848,Row2143,Row1152,CHEMBL4174909,,0,557.58,43,IC50,>,10000.0,nM,Cc1nc(NC)nc2c1cc(cc2O[C@H]3COCC3)-c4cc(NS(=O)(=O)c5ccc(F)cc5F)c(nc4)OC,,,CHEMBL4150391,Inhibition of AKT1 (unknown origin) using FAM-labeled peptide as substrate by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4145625,1,Scientific Literature,J Med Chem,2018.0,Cc1nc(NC)nc2c1cc(cc2O[C@H]3COCC3)-c4cc(NS(=O)(=O)c5ccc(F)cc5F)c(nc4)OC,,Row3570,86,0.1122207790613174,out,6
1849,Row2144,Row1176,CHEMBL484967,,0,333.44,20,IC50,>,10000.0,nM,NCc1ccc(cc1)-c2cc3ccncc3cc2OC4CCNCC4,,,CHEMBL985019,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138455,1,Scientific Literature,J. Med. Chem.,2009.0,NCc1ccc(cc1)-c2cc3ccncc3cc2OC4CCNCC4,,Row3192,40,0.1646023243665695,out,6
1850,Row2145,Row1179,CHEMBL484968,,0,304.39,21,IC50,>,10000.0,nM,C1CC(CCN1)Oc2cc3cnccc3cc2-c4ccccc4,,,CHEMBL985019,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138455,1,Scientific Literature,J. Med. Chem.,2009.0,C1CC(CCN1)Oc2cc3cnccc3cc2-c4ccccc4,,Row3192,40,0.1845103204250335,out,6
1851,Row2146,Row1194,CHEMBL3297762,,0,512.1,15a,IC50,>,10000.0,nM,CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(cn32)-c4cc(Cl)ccc4)C5CCCCC5)CC1,,,CHEMBL3301291,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg. Med. Chem.,2013.0,CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(cn32)-c4cc(Cl)ccc4)C5CCCCC5)CC1,,Row3186,60,0.1107464879751205,out,6
1852,Row2147,Row1358,CHEMBL3606021,,0,395.43,"20by, NMS-P118",IC50,>,10000.0,nM,NC(=O)c1cc(F)cc2CN(C3CCN(CC3)C4CCC(F)(F)CC4)C(=O)c21,,,CHEMBL3607946,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3603755,1,Scientific Literature,J. Med. Chem.,2015.0,NC(=O)c1cc(F)cc2CN(C3CCN(CC3)C4CCC(F)(F)CC4)C(=O)c21,,Row1206,41,0.1226304024457931,out,6
1853,Row2148,Row1417,CHEMBL597754,,0,530.66,59,IC50,>,10000.0,nM,Cn1nc(c2CCc3cnc(NC4CCN(CC4)C(=O)C5CCN(CC5)S(C)(=O)=O)nc3-c12)C(=O)NC,,,CHEMBL1072190,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157561,1,Scientific Literature,J. Med. Chem.,2010.0,Cn1nc(c2CCc3cnc(NC4CCN(CC4)C(=O)C5CCN(CC5)S(C)(=O)=O)nc3-c12)C(=O)NC,,Row1867,42,0.0976147726178169,out,6
1854,Row2149,Row1433,CHEMBL2031893,,0,528.54,1,IC50,=,10000.0,nM,Cn1c(C)c(C(=O)Nc2cc(F)c(cc2)Oc3ccnc4cc(OC)c(cc43)OC)c(=O)n1-c5ccccc5,,,CHEMBL2032470,Inhibition of PKBalpha,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2029218,1,Scientific Literature,J. Med. Chem.,2012.0,Cn1c(C)c(C(=O)Nc2cc(F)c(cc2)Oc3ccnc4cc(OC)c(cc43)OC)c(=O)n1-c5ccccc5,,Row2783,67,0.1309248208999633,out,6
1855,Row2150,Row1437,CHEMBL2333435,,0,353.45,17,IC50,>,10000.0,nM,CCc1ccc(cc1)-c2cc3-c4c(cnn4C)S(=O)(=O)N(C)c3cc2,,,CHEMBL2345797,Inhibition of Akt1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2331389,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2013.0,CCc1ccc(cc1)-c2cc3-c4c(cnn4C)S(=O)(=O)N(C)c3cc2,,Row662,76,0.11387699842453,out,6
1856,Row2151,Row1457,CHEMBL460472,,0,539.59,"59e, AMG-458",IC50,=,10000.0,nM,Cc1c(c(=O)n(-c2ccccc2)n1CC(C)(C)O)C(=O)Nc3ccc(cn3)Oc4ccnc5cc(ccc54)OC,,,CHEMBL2032470,Inhibition of PKBalpha,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2029218,1,Scientific Literature,J. Med. Chem.,2012.0,Cc1c(c(=O)n(-c2ccccc2)n1CC(C)(C)O)C(=O)Nc3ccc(cn3)Oc4ccnc5cc(ccc54)OC,,Row1813,70,0.129557728767395,out,6
1857,Row2152,Row1494,CHEMBL3133821,,0,275.31,4f,IC50,>,10000.0,nM,Oc1cc(ccc1)Nc2ccnc3[nH]c4ccccc4c23,,,CHEMBL3241187,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3232836,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2014.0,Oc1cc(ccc1)Nc2ccnc3[nH]c4ccccc4c23,,Row2452,66,0.1203812286257743,out,6
1858,Row2153,Row1514,CHEMBL2333444,,0,410.54,30,IC50,>,10000.0,nM,CC(C)(C)c1ccc(CNc2cc3-c4c(cnn4C)S(=O)(=O)N(C)c3cc2)cc1,,,CHEMBL2345797,Inhibition of Akt1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2331389,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2013.0,CC(C)(C)c1ccc(CNc2cc3-c4c(cnn4C)S(=O)(=O)N(C)c3cc2)cc1,,Row662,76,0.0958128497004509,out,6
1859,Row2154,Row1545,CHEMBL3309995,,0,334.34,10b,IC50,>,10000.0,nM,Nc1cc2nc(Cc3cc4OCOc4cc3)n5nc(N)nc5c2cc1,,,CHEMBL3381058,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3352169,1,Scientific Literature,Bioorg. Med. Chem.,2014.0,Nc1cc2nc(Cc3cc4OCOc4cc3)n5nc(N)nc5c2cc1,,Row3008,34,0.1167452484369278,out,6
1860,Row2155,Row1566,CHEMBL1945559,,0,363.25,20,IC50,>,10000.0,nM,Cn1c2C(=O)NC3(CCNCC3)C(C#N)c2c4ccc(Cl)c(Cl)c14,,,CHEMBL1947858,Inhibition of PKBalpha using ATP as substrate,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1944596,1,Scientific Literature,J. Med. Chem.,2012.0,Cn1c2C(=O)NC3(CCNCC3)C(C#N)c2c4ccc(Cl)c(Cl)c14,,Row3848,57,0.1236561760306358,out,6
1861,Row2156,Row1573,CHEMBL115220,,0,291.35,41,IC50,>,10000.0,nM,O=C(Cc1cc2ccccc2cc1)Nc3cc(n[nH]3)C4CC4,,,CHEMBL766866,Inhibition of Protein kinase B (Akt-1),B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1148336,1,Scientific Literature,J. Med. Chem.,2004.0,O=C(Cc1cc2ccccc2cc1)Nc3cc(n[nH]3)C4CC4,,Row996,49,0.1165756955742836,out,6
1862,Row2157,Row1574,CHEMBL3298400,,0,345.47,1,IC50,>,10000.0,nM,CC(C)(C)CNC(=O)CC1CNC(=O)c2cc(cn21)-c3cscc3,,,CHEMBL3301291,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3297733,1,Scientific Literature,Bioorg. Med. Chem.,2013.0,CC(C)(C)CNC(=O)CC1CNC(=O)c2cc(cn21)-c3cscc3,,Row3515,16,0.0821487978100776,out,6
1863,Row2158,Row1593,CHEMBL3309997,,0,363.38,12a,IC50,>,10000.0,nM,OCCCNc1cc2nc(-c3cc4OCOc4cc3)n5ncnc5c2cc1,,,CHEMBL3381058,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3352169,1,Scientific Literature,Bioorg. Med. Chem.,2014.0,OCCCNc1cc2nc(-c3cc4OCOc4cc3)n5ncnc5c2cc1,,Row3515,16,0.1394097656011581,out,6
1864,Row2159,Row1642,CHEMBL3809489,BEMCENTINIB,2,506.66,BGB324,IC50,>,10000.0,nM,Nc1nc(Nc2cc3CC[C@H](CCc3cc2)N4CCCC4)nn1-c5cc6CCCc7ccccc7-c6nn5,,,CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4184298,1,Scientific Literature,J Med Chem,2018.0,Nc1nc(Nc2cc3CC[C@H](CCc3cc2)N4CCCC4)nn1-c5cc6CCCc7ccccc7-c6nn5,,Row31,68,0.1485258340835571,out,6
1865,Row2160,Row1647,CHEMBL4204515,,0,476.63,13d,IC50,>,10000.0,nM,CC(C)(C)C(=O)N1CCN(CC1)c2ccc(cn2)-c3nn(CC4CCCC4)c5nc(NC)ncc53,,,CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4184298,1,Scientific Literature,J Med Chem,2018.0,CC(C)(C)C(=O)N1CCN(CC1)c2ccc(cn2)-c3nn(CC4CCCC4)c5nc(NC)ncc53,,Row286,88,0.1298820227384567,out,6
1866,Row2161,Row1648,CHEMBL4218369,,0,495.6,12b,IC50,>,10000.0,nM,CN1CCN(CC1)c2ccc(cn2)-c3nn(Cc4cn(Cc5ccccc5)nn4)c6nc(NC)ncc63,,,CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4184298,1,Scientific Literature,J Med Chem,2018.0,CN1CCN(CC1)c2ccc(cn2)-c3nn(Cc4cn(Cc5ccccc5)nn4)c6nc(NC)ncc63,,Row286,88,0.1438876688480377,out,6
1867,Row2162,Row1661,CHEMBL412114,,0,325.76,5f,IC50,>,10000.0,nM,Cc1[nH]c(nn1)-c2ccc(Cl)cc2Nc3ncnc4[nH]ccc34,,,CHEMBL936668,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143084,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Cc1[nH]c(nn1)-c2ccc(Cl)cc2Nc3ncnc4[nH]ccc34,,Row2454,78,0.082456350326538,out,6
1868,Row2163,Row1669,CHEMBL1088240,,0,526.47,20,IC50,>,10000.0,nM,CN1CCN(CC/C=C/c2cc3ncc(C#N)c(Nc4cc(OC)c(Cl)cc4Cl)c3cc2OC)CC1,,,CHEMBL1117424,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157919,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,CN1CCN(CC/C=C/c2cc3ncc(C#N)c(Nc4cc(OC)c(Cl)cc4Cl)c3cc2OC)CC1,,Row1867,42,0.0939951539039611,out,6
1869,Row2164,Row1674,CHEMBL4245507,,0,437.57,28,IC50,>,10000.0,nM,O=C(Cc1cc(ccc1)OCCCN2CCNCC2)Nc3nc(cs3)-c4ccncc4,,,CHEMBL4233284,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4229420,1,Scientific Literature,Bioorg Med Chem Lett,2018.0,O=C(Cc1cc(ccc1)OCCCN2CCNCC2)Nc3nc(cs3)-c4ccncc4,,Row3192,40,0.128092885017395,out,6
1870,Row2165,Row1682,CHEMBL212382,,0,354.36,64,IC50,>,10000.0,nM,CC(C)(C)c1nnc2ccc(cn21)-c3ocnc3-c4ccc(F)cc4F,,,CHEMBL869145,Inhibition of PKBalpha,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145312,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC(C)(C)c1nnc2ccc(cn21)-c3ocnc3-c4ccc(F)cc4F,,Row148,95,0.0936793982982635,out,6
1871,Row2166,Row1689,CHEMBL4214476,,0,396.46,7g,IC50,>,10000.0,nM,CNc1ncc2c(n1)n(CC3OCCO3)nc2-c4ccc(nc4)N5CCNCC5,,,CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4184298,1,Scientific Literature,J Med Chem,2018.0,CNc1ncc2c(n1)n(CC3OCCO3)nc2-c4ccc(nc4)N5CCNCC5,,Row286,88,0.122747927904129,out,6
1872,Row2167,Row1706,CHEMBL1983268,ENTRECTINIB,4,560.65,2; entrectinib,IC50,>,10000.0,nM,CN1CCN(CC1)c2cc(NC3CCOCC3)c(cc2)C(=O)Nc4n[nH]c5ccc(Cc6cc(F)cc(F)c6)cc54,,,CHEMBL3807432,Inhibition of AKT1 (unknown origin) in presence of gamma33-ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3804811,1,Scientific Literature,J. Med. Chem.,2016.0,CN1CCN(CC1)c2cc(NC3CCOCC3)c(cc2)C(=O)Nc4n[nH]c5ccc(Cc6cc(F)cc(F)c6)cc54,,Row3186,60,0.1073081418871879,out,6
1873,Row2168,Row1743,CHEMBL1765740,,0,462.6,"(3S,6R)-28d, GSK-2334470",IC50,>,10000.0,nM,C[C@@H]1CC[C@@H](CN1c2cc(nc(NC)n2)-c3cc4[nH]nc(N)c4cc3)C(=O)NC5CCCCC5,,,CHEMBL1769079,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1765070,1,Scientific Literature,J. Med. Chem.,2011.0,C[C@@H]1CC[C@@H](CN1c2cc(nc(NC)n2)-c3cc4[nH]nc(N)c4cc3)C(=O)NC5CCCCC5,,Row286,88,0.1507737934589386,out,6
1874,Row2169,Row1798,CHEMBL2178352,,0,468.61,9e,IC50,>,10000.0,nM,CN1CCN(CC1)c2ccc(cc2)Nc3nc4c(cn3)nc(Nc5ccccc5)n4C6CCCC6,,,CHEMBL2188514,Inhibition of human recombinant PKBalpha by radiometric kinase assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2177100,1,Scientific Literature,J. Med. Chem.,2012.0,CN1CCN(CC1)c2ccc(cc2)Nc3nc4c(cn3)nc(Nc5ccccc5)n4C6CCCC6,,Row1528,84,0.1402001678943634,out,6
1875,Row2170,Row1841,CHEMBL1200485,SORAFENIB TOSYLATE,4,637.04,NSC 747971,IC50,>,10000.0,nM,CNC(=O)c1cc(ccn1)Oc2ccc(cc2)NC(=O)Nc3cc(c(Cl)cc3)C(F)(F)F,,,CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2034932,1,Scientific Literature,Eur. J. Med. Chem.,2012.0,CNC(=O)c1cc(ccn1)Oc2ccc(cc2)NC(=O)Nc3cc(c(Cl)cc3)C(F)(F)F,,Row2783,67,0.0955220609903335,out,6
1876,Row2171,Row1843,CHEMBL2063926,,0,505.7,17,IC50,<,10000.0,nM,CSc1ccccc1Nc2nc(nc3c(NCC4CC4)ncnc32)N5CCN(CC5)C6CCNCC6,,,CHEMBL2065136,Inhibition of AKT1 by FRET assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2062359,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2012.0,CSc1ccccc1Nc2nc(nc3c(NCC4CC4)ncnc32)N5CCN(CC5)C6CCNCC6,,Row2454,78,0.1212252974510192,out,6
1877,Row2172,Row1867,CHEMBL1094408,NMS-1286937,0,448.53,49,IC50,>,10000.0,nM,CN1CCN(CC1)c2cc(Nc3nc4-c5c(CCc4cn3)c(nn5C)C(N)=O)c(cc2)OC,,,CHEMBL1109159,Inhibition of AKT1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157785,1,Scientific Literature,J. Med. Chem.,2010.0,CN1CCN(CC1)c2cc(Nc3nc4-c5c(CCc4cn3)c(nn5C)C(N)=O)c(cc2)OC,,Row1867,42,0.1366643160581588,out,6
1878,Row2173,Row1881,CHEMBL1272116,,0,440.98,63,IC50,>,10000.0,nM,CN(C)C1CCN(CC1)c2cnc(cc2)Nc3nc(ccn3)-c4c(Cl)[nH]nc4C(C)C,,,CHEMBL1273652,Inhibition of PKBalpha,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1269009,1,Scientific Literature,J. Med. Chem.,2010.0,CN(C)C1CCN(CC1)c2cnc(cc2)Nc3nc(ccn3)-c4c(Cl)[nH]nc4C(C)C,,Row1528,84,0.1010797619819641,out,6
1879,Row2174,Row1884,CHEMBL1688215,,0,226.24,19,IC50,>,10000.0,nM,Nc1n[nH]c2cc(ccc12)-c3ccnc(N)n3,,,CHEMBL1696296,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1687694,1,Scientific Literature,ACS Med. Chem. Lett.,2010.0,Nc1n[nH]c2cc(ccc12)-c3ccnc(N)n3,,Row1976,11,0.141163632273674,out,6
1880,Row2175,Row1912,CHEMBL261205,,0,291.32,5a,IC50,>,10000.0,nM,Cn1ccc2c(Nc3ccccc3-c4[nH]cnn4)ncnc12,,,CHEMBL936668,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143084,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Cn1ccc2c(Nc3ccccc3-c4[nH]cnn4)ncnc12,,Row2454,78,0.1169006824493408,out,6
1881,Row2176,Row1934,CHEMBL604712,,0,376.41,1,IC50,>,10000.0,nM,CC(C)(C)C(=O)N1Cc2c([nH]nc2NC(=O)c3cc(F)cc(F)c3)C1(C)C,,,CHEMBL1074428,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157586,1,Scientific Literature,Bioorg. Med. Chem.,2010.0,CC(C)(C)C(=O)N1Cc2c([nH]nc2NC(=O)c3cc(F)cc(F)c3)C1(C)C,,Row2553,9,0.117108829319477,out,6
1882,Row2177,Row1961,CHEMBL215652,,0,356.79,18,IC50,>,10000.0,nM,CC(C)c1nnc2ccc(cn21)-c3ocnc3-c4ccc(F)cc4Cl,,,CHEMBL869145,Inhibition of PKBalpha,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145312,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC(C)c1nnc2ccc(cn21)-c3ocnc3-c4ccc(F)cc4Cl,,Row148,95,0.0895812064409256,out,6
1883,Row2178,Row1980,CHEMBL571040,,0,513.96,19c,IC50,>,10000.0,nM,COCCOc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1NC(=O)[C@@H]4CCCN4C(=O)C=C,,,CHEMBL1044077,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154692,1,Scientific Literature,J. Med. Chem.,2009.0,COCCOc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1NC(=O)[C@@H]4CCCN4C(=O)C=C,,Row1206,41,0.1012495532631874,out,6
1884,Row2179,Row2094,CHEMBL565612,SOTRASTAURIN,2,438.49,1,IC50,>,10000.0,nM,CN1CCN(CC1)c2nc3ccccc3c(n2)C4=C(c5c[nH]c6ccccc56)C(=O)NC4=O,,,CHEMBL1040931,Inhibition of human recombinant Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1156112,1,Scientific Literature,J. Med. Chem.,2009.0,CN1CCN(CC1)c2nc3ccccc3c(n2)C4=C(c5c[nH]c6ccccc56)C(=O)NC4=O,,Row2527,93,0.1280170083045959,out,6
1885,Row2180,Row2170,CHEMBL402548,DANUSERTIB,2,474.57,9d,IC50,>,10000.0,nM,CN1CCN(CC1)c2ccc(cc2)C(=O)Nc3[nH]nc4CN(Cc43)C(=O)[C@H](OC)c5ccccc5,,,CHEMBL913517,Inhibition of AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1137365,1,Scientific Literature,J. Med. Chem.,2006.0,CN1CCN(CC1)c2ccc(cc2)C(=O)Nc3[nH]nc4CN(Cc43)C(=O)[C@H](OC)c5ccccc5,,Row1867,42,0.1124846339225769,out,6
1886,Row2181,Row2176,CHEMBL1270795,,0,343.44,10i,IC50,>,10000.0,nM,Cc1cc(Nc2nc(cn3c2ncc3-c4cn[nH]c4)SC)sn1,,,CHEMBL1805343,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1799927,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1cc(Nc2nc(cn3c2ncc3-c4cn[nH]c4)SC)sn1,,Row2632,65,0.0654052942991256,out,6
1887,Row2182,Row2203,CHEMBL1738758,ONVANSERTIB,2,532.53,7g,IC50,>,10000.0,nM,CN1CCN(CC1)c2cc(Nc3nc4-c5c(CCc4cn3)c(nn5CCO)C(N)=O)c(cc2)OC(F)(F)F,,,CHEMBL1776512,Inhibition of AKT1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1773059,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CN1CCN(CC1)c2cc(Nc3nc4-c5c(CCc4cn3)c(nn5CCO)C(N)=O)c(cc2)OC(F)(F)F,,Row1867,42,0.1193162277340889,out,6
1888,Row2183,Row2296,CHEMBL1834657,INFIGRATINIB PHOSPHATE,0,658.48,"1h, NVP-BGJ398",IC50,>,10000.0,nM,CN(C(=O)Nc1c(Cl)c(cc(OC)c1Cl)OC)c2cc(Nc3ccc(cc3)N4CCN(CC4)CC)ncn2,,,CHEMBL1839916,Inhibition of recombinant PKBalpha,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1833940,1,Scientific Literature,J. Med. Chem.,2011.0,CN(C(=O)Nc1c(Cl)c(cc(OC)c1Cl)OC)c2cc(Nc3ccc(cc3)N4CCN(CC4)CC)ncn2,,Row1867,42,0.1133747324347496,out,6
1889,Row2184,Row2320,CHEMBL1085511,,0,499.62,4c,IC50,>,10000.0,nM,CN1CCN(CC1)c2ccc(cc2)-c3cnn4c(N)c(cnc43)-c5ccc(cc5)NC(=O)OCC(C)C,,,CHEMBL1120251,Inhibition of PKBalpha,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1158604,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,CN1CCN(CC1)c2ccc(cc2)-c3cnn4c(N)c(cnc43)-c5ccc(cc5)NC(=O)OCC(C)C,,Row1867,42,0.1246266812086105,out,6
1890,Row2185,Row2390,CHEMBL3745885,,0,467.46,7ao; ON1231320,IC50,>,10000.0,nM,Cn1c2nc(Nc3cc4cc[nH]c4cc3)ncc2cc(c1=O)S(=O)(=O)c5ccc(F)cc5F,,,CHEMBL3749731,Inhibition of human AKT1 using [KGSGSGRPRTSSFAEG] as substrate,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3745707,1,Scientific Literature,Bioorg. Med. Chem.,2016.0,Cn1c2nc(Nc3cc4cc[nH]c4cc3)ncc2cc(c1=O)S(=O)(=O)c5ccc(F)cc5F,,Row3570,86,0.0965053662657737,out,6
1891,Row2186,Row2459,CHEMBL461139,,0,413.48,16,IC50,>,10000.0,nM,O=c1[nH]cnc2[nH]c(cc21)-c3cc(/C=C/c4ccc(CN5CCOCC5)cc4)ncc3,,,CHEMBL956581,Inhibition of PKB,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152141,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,O=c1[nH]cnc2[nH]c(cc21)-c3cc(/C=C/c4ccc(CN5CCOCC5)cc4)ncc3,,Row2452,66,0.1258908659219741,out,6
1892,Row2187,Row2522,CHEMBL492251,,0,370.41,4p,IC50,>,10000.0,nM,COc1ccc(cc1OC)-c2cncc(C#N)c2Nc3cc4cc[nH]c4cc3,,,CHEMBL1034885,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140097,1,Scientific Literature,J. Med. Chem.,2008.0,COc1ccc(cc1OC)-c2cncc(C#N)c2Nc3cc4cc[nH]c4cc3,,Row837,29,0.1146646812558174,out,6
1893,Row2188,Row2558,CHEMBL1173351,,0,259.31,8,IC50,=,10000.0,nM,Cc1c[nH]c2ncnc(c12)N3C[C@@H](CC3)NC(C)=O,,,CHEMBL1176552,Inhibition of AKT1 after 90 mins by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1177702,1,Scientific Literature,J. Med. Chem.,2010.0,Cc1c[nH]c2ncnc(c12)N3C[C@@H](CC3)NC(C)=O,,Row1872,62,0.0853737369179725,out,6
1894,Row2189,Row2575,CHEMBL253292,,0,489.41,1,IC50,>,10000.0,nM,CCN(CCOc1ccc(cc1)Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)CC,,,CHEMBL928479,Inhibition of PKB,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141507,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CCN(CCOc1ccc(cc1)Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)CC,,Row2492,83,0.1052878275513649,out,6
1895,Row2190,Row2613,CHEMBL1090143,,0,476.48,11b,IC50,>,10000.0,nM,O=C(Nc1cc(ccc1)-c2ncnc3sc(cc23)-c4ccncc4)c5cc(ccc5)C(F)(F)F,,,CHEMBL1117089,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1156181,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,O=C(Nc1cc(ccc1)-c2ncnc3sc(cc23)-c4ccncc4)c5cc(ccc5)C(F)(F)F,,Row240,47,0.1210922524333,out,6
1896,Row2191,Row2618,CHEMBL569880,,0,531.95,19d,IC50,>,10000.0,nM,COCCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3F)c2cc1NC(=O)[C@@H]4CCCN4C(=O)C=C,,,CHEMBL1044077,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154692,1,Scientific Literature,J. Med. Chem.,2009.0,COCCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3F)c2cc1NC(=O)[C@@H]4CCCN4C(=O)C=C,,Row1206,41,0.0996645241975784,out,6
1897,Row2193,Row2685,CHEMBL406375,,0,234.26,"K00035, GTP-14564",IC50,>=,10000.0,nM,c1ccccc1-c2n[nH]c3c2oc4ccccc43,,,CHEMBL939373,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145498,1,Scientific Literature,Proc. Natl. Acad. Sci. U.S.A.,2007.0,c1ccccc1-c2n[nH]c3c2oc4ccccc43,,Row919,96,0.1710798591375351,out,6
1898,Row2194,Row2824,CHEMBL4205191,,0,531.61,10d,IC50,>,10000.0,nM,CNc1nc2c(cn1)c(nn2Cc3cn(nn3)-c4ccsc4C(=O)OC)-c5cnc(cc5)N6CCNCC6,,,CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4184298,1,Scientific Literature,J Med Chem,2018.0,CNc1nc2c(cn1)c(nn2Cc3cn(nn3)-c4ccsc4C(=O)OC)-c5cnc(cc5)N6CCNCC6,,Row286,88,0.1132678240537643,out,6
1899,Row2195,Row2953,CHEMBL1957085,,0,309.32,11,IC50,>,10000.0,nM,COc1ccc(cc1)-c2ocnc2C(=O)NCc3ccncc3,,,CHEMBL1960376,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1955730,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2012.0,COc1ccc(cc1)-c2ocnc2C(=O)NCc3ccncc3,,Row919,96,0.1122087612748146,out,6
1900,Row2196,Row2960,CHEMBL1230607,PHA-793887,1,361.49,31,IC50,>,10000.0,nM,CN1CCC(CC1)C(=O)N2Cc3c([nH]nc3NC(=O)CC(C)C)C2(C)C,,,CHEMBL1074428,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157586,1,Scientific Literature,Bioorg. Med. Chem.,2010.0,CN1CCC(CC1)C(=O)N2Cc3c([nH]nc3NC(=O)CC(C)C)C2(C)C,,Row3186,60,0.0882270187139511,out,6
1901,Row2197,Row2973,CHEMBL213451,,0,323.33,43,IC50,>,10000.0,nM,CCNc1nnc2ccc(cn21)-c3ocnc3-c4ccc(F)cc4,,,CHEMBL869145,Inhibition of PKBalpha,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145312,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CCNc1nnc2ccc(cn21)-c3ocnc3-c4ccc(F)cc4,,Row148,95,0.1108230203390121,out,6
1902,Row2198,Row2974,CHEMBL212968,,0,372.35,75,IC50,>,10000.0,nM,CC(C)(C)c1nnc2ccc(cn21)-c3ocnc3-c4cc(F)c(F)cc4F,,,CHEMBL869145,Inhibition of PKBalpha,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145312,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC(C)(C)c1nnc2ccc(cn21)-c3ocnc3-c4cc(F)c(F)cc4F,,Row148,95,0.0775917842984199,out,6
1903,Row2199,Row2999,CHEMBL3741589,,0,366.24,29; A-971432,IC50,>,10000.0,nM,OC(=O)C1CN(Cc2ccc(cc2)OCc3cc(Cl)c(Cl)cc3)C1,,,CHEMBL3743742,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3739276,1,Scientific Literature,J. Med. Chem.,2015.0,OC(=O)C1CN(Cc2ccc(cc2)OCc3cc(Cl)c(Cl)cc3)C1,,Row662,76,0.1135665774345398,out,6
1904,Row2200,Row3111,CHEMBL4207004,,0,565.69,12d,IC50,>,10000.0,nM,CC(C)(C)C(=O)N1CCN(CC1)c2ccc(cn2)-c3nn(Cc4cn(Cc5ccccc5)nn4)c6nc(NC)ncc63,,,CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4184298,1,Scientific Literature,J Med Chem,2018.0,CC(C)(C)C(=O)N1CCN(CC1)c2ccc(cn2)-c3nn(Cc4cn(Cc5ccccc5)nn4)c6nc(NC)ncc63,,Row286,88,0.1417426764965057,out,6
1905,Row2201,Row3126,CHEMBL591325,,0,483.57,25,IC50,>,10000.0,nM,CN(C)CCOc1ccc2Nc3c(C(N)=O)c(nn3CCc2c1)-c4ccc(cc4)Oc5ccccc5,,,CHEMBL1049483,Inhibition of PKBalpha,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153155,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,CN(C)CCOc1ccc2Nc3c(C(N)=O)c(nn3CCc2c1)-c4ccc(cc4)Oc5ccccc5,,Row2492,83,0.1559519171714782,out,6
1906,Row2202,Row3204,CHEMBL1933582,,0,501.51,25,IC50,>,10000.0,nM,CN1CCN(CC1)c2cc(Nc3nc(ccn3)-c4cc5C(=O)NCCc5n4C)c(cc2)OC(F)(F)F,,,CHEMBL1936504,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1933058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2012.0,CN1CCN(CC1)c2cc(Nc3nc(ccn3)-c4cc5C(=O)NCCc5n4C)c(cc2)OC(F)(F)F,,Row1867,42,0.0995357781648635,out,6
1907,Row2203,Row3218,CHEMBL599224,,0,369.43,50,IC50,>,10000.0,nM,Cn1nc(C(N)=O)c2CCc3cnc(NC4CCN(CC4)C(C)=O)nc3-c12,,,CHEMBL1072190,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157561,1,Scientific Literature,J. Med. Chem.,2010.0,Cn1nc(C(N)=O)c2CCc3cnc(NC4CCN(CC4)C(C)=O)nc3-c12,,Row1867,42,0.1238699629902839,out,6
1908,Row2204,Row3234,CHEMBL4211308,,0,480.58,12a,IC50,>,10000.0,nM,CNc1nc2c(cn1)c(nn2Cc3cn(Cc4ccccc4)nn3)-c5ccc(cc5)N6CCNCC6,,,CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4184298,1,Scientific Literature,J Med Chem,2018.0,CNc1nc2c(cn1)c(nn2Cc3cn(Cc4ccccc4)nn3)-c5ccc(cc5)N6CCNCC6,,Row286,88,0.1461533904075622,out,6
1909,Row2205,Row3235,CHEMBL4218175,,0,405.55,13a,IC50,>,10000.0,nM,CN1CCN(CC1)c2ccc(cc2)-c3nn(CC4CCCC4)c5nc(NC)ncc35,,,CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4184298,1,Scientific Literature,J Med Chem,2018.0,CN1CCN(CC1)c2ccc(cc2)-c3nn(CC4CCCC4)c5nc(NC)ncc35,,Row286,88,0.1349310427904129,out,6
1910,Row2206,Row3297,CHEMBL141247,,0,308.34,1,IC50,>,10000.0,nM,O=C(Nc1cccc2c1[C@H]3CCCN3C2=O)Nc4ccccn4,,,CHEMBL874644,Inhibition of PKBalpha (Akt1) ser/thr kinase.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1134322,1,Scientific Literature,J. Med. Chem.,2001.0,O=C(Nc1cccc2c1[C@H]3CCCN3C2=O)Nc4ccccn4,,Row1473,59,0.138838917016983,out,6
1911,Row2207,Row3322,CHEMBL3903725,,0,450.38,BDBM236557,IC50,>,10000.0,nM,Nc1ccc(cn1)-c2ccc3ncc4c(c3n2)n(-c5cc(ccc5)C(F)(F)F)c(=O)[nH]c4=O,,412002.0,CHEMBL3888646,"Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 M at maximum. Firstly, a 50-fold concentration (i.e. 500 M) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 M, 100 M, 20 M, 4 M, and 0.8 M). After diluting with 1-fold kinase buffer by 10 folds, 5 l of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 l of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 l/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 l/well. The plate was incubated at 28 C. for a certain period. 25 l termination solution was added to terminate the reaction.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886794,37,BindingDB Database,,2016.0,Nc1ccc(cn1)-c2ccc3ncc4c(c3n2)n(-c5cc(ccc5)C(F)(F)F)c(=O)[nH]c4=O,,Row366,27,0.1330626010894775,out,6
1912,Row2208,Row3505,CHEMBL4213775,,0,420.57,13c,IC50,>,10000.0,nM,CCN1CCN(CC1)c2ccc(cn2)-c3nn(CC4CCCC4)c5nc(NC)ncc53,,,CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4184298,1,Scientific Literature,J Med Chem,2018.0,CCN1CCN(CC1)c2ccc(cn2)-c3nn(CC4CCCC4)c5nc(NC)ncc53,,Row286,88,0.1345365941524505,out,6
1913,Row2209,Row3506,CHEMBL4208852,,0,406.54,13b,IC50,>,10000.0,nM,CN1CCN(CC1)c2ccc(cn2)-c3nn(CC4CCCC4)c5nc(NC)ncc35,,,CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4184298,1,Scientific Literature,J Med Chem,2018.0,CN1CCN(CC1)c2ccc(cn2)-c3nn(CC4CCCC4)c5nc(NC)ncc35,,Row286,88,0.1328233480453491,out,6
1914,Row2210,Row3509,CHEMBL4209569,,0,341.37,7h,IC50,>,10000.0,nM,COc1ccc(cc1)-c2nn(CC3OCCO3)c4nc(NC)ncc42,,,CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4184298,1,Scientific Literature,J Med Chem,2018.0,COc1ccc(cc1)-c2nn(CC3OCCO3)c4nc(NC)ncc42,,Row286,88,0.1383398920297622,out,6
1915,Row2211,Row3550,CHEMBL3979122,,0,507.62,BDBM182653,IC50,>,10000.0,nM,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ccc5)S(N)(=O)=O,,330094.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C#N)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5cc(ccc5)S(N)(=O)=O,,Row3990,26,0.1294063776731491,out,6
1916,Row2212,Row3570,CHEMBL4166144,,0,557.58,19,IC50,>,10000.0,nM,Cc1nc(N)nc2c1cc(cc2OC3CCOCC3)-c4cnc(OC)c(c4)NS(=O)(=O)c5ccc(F)cc5F,,,CHEMBL4150391,Inhibition of AKT1 (unknown origin) using FAM-labeled peptide as substrate by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4145625,1,Scientific Literature,J Med Chem,2018.0,Cc1nc(N)nc2c1cc(cc2OC3CCOCC3)-c4cnc(OC)c(c4)NS(=O)(=O)c5ccc(F)cc5F,,Row3570,86,0.126259371638298,out,6
1917,Row2213,Row3608,CHEMBL4210084,,0,481.57,10a,IC50,>,10000.0,nM,CNc1nc2c(cn1)c(nn2Cc3cn(Cc4ccccc4)nn3)-c5ccc(nc5)N6CCNCC6,,,CHEMBL4188970,"Inhibition of AKT (unknown origin) using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4184298,1,Scientific Literature,J Med Chem,2018.0,CNc1nc2c(cn1)c(nn2Cc3cn(Cc4ccccc4)nn3)-c5ccc(nc5)N6CCNCC6,,Row286,88,0.1441766619682312,out,6
1918,Row2214,Row3747,CHEMBL3310151,,0,435.46,17,IC50,>,10000.0,nM,CN1CCN(CC1)c2cc3nc(Cc4cc5OCOc5cc4)n6nc(N)nc6c3c(F)c2,,,CHEMBL3381058,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3352169,1,Scientific Literature,Bioorg. Med. Chem.,2014.0,CN1CCN(CC1)c2cc3nc(Cc4cc5OCOc5cc4)n6nc(N)nc6c3c(F)c2,,Row1867,42,0.105005070567131,out,6
1919,Row2215,Row3760,CHEMBL225519,,0,213.24,"1, PHA-767491",IC50,>,10000.0,nM,O=C1NCCc2[nH]c(cc21)-c3ccncc3,,,CHEMBL1226922,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1221210,1,Scientific Literature,Nat. Chem. Biol.,2008.0,O=C1NCCc2[nH]c(cc21)-c3ccncc3,,Row1883,97,0.1198825016617775,out,6
1920,Row2216,Row3898,CHEMBL1272171,,0,474.54,64,IC50,>,10000.0,nM,CN(C)C1CCN(CC1)c2cnc(cc2)Nc3nc(ccn3)-c4c([nH]nc4C(C)C)C(F)(F)F,,,CHEMBL1273652,Inhibition of PKBalpha,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1269009,1,Scientific Literature,J. Med. Chem.,2010.0,CN(C)C1CCN(CC1)c2cnc(cc2)Nc3nc(ccn3)-c4c([nH]nc4C(C)C)C(F)(F)F,,Row1528,84,0.1013182327151298,out,6
1921,Row2217,Row3905,CHEMBL4166594,,0,571.61,37,IC50,>,10000.0,nM,Cc1nc(NC)nc2c1cc(cc2OC3CCOCC3)-c4cc(NS(=O)(=O)c5ccc(F)cc5F)c(nc4)OC,,,CHEMBL4150391,Inhibition of AKT1 (unknown origin) using FAM-labeled peptide as substrate by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4145625,1,Scientific Literature,J Med Chem,2018.0,Cc1nc(NC)nc2c1cc(cc2OC3CCOCC3)-c4cc(NS(=O)(=O)c5ccc(F)cc5F)c(nc4)OC,,Row3570,86,0.1133005023002624,out,6
1922,Row2218,Row3906,CHEMBL4176771,,0,543.55,20,IC50,>,10000.0,nM,Cc1nc(N)nc2c1cc(cc2O[C@H]3COCC3)-c4cc(NS(=O)(=O)c5ccc(F)cc5F)c(nc4)OC,,,CHEMBL4150391,Inhibition of AKT1 (unknown origin) using FAM-labeled peptide as substrate by mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4145625,1,Scientific Literature,J Med Chem,2018.0,Cc1nc(N)nc2c1cc(cc2O[C@H]3COCC3)-c4cc(NS(=O)(=O)c5ccc(F)cc5F)c(nc4)OC,,Row3570,86,0.125905841588974,out,6
1923,Row2219,Row3907,CHEMBL3309990,,0,337.31,7o,IC50,>,10000.0,nM,Nc1nc2c3c(F)cccc3nc(Cc4cc5OCOc5cc4)n2n1,,,CHEMBL3381058,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3352169,1,Scientific Literature,Bioorg. Med. Chem.,2014.0,Nc1nc2c3c(F)cccc3nc(Cc4cc5OCOc5cc4)n2n1,,Row3008,34,0.1229764968156814,out,6
1924,Row2220,Row3916,CHEMBL461140,,0,401.47,17,IC50,>,10000.0,nM,CN(C)CCOc1ccc(cc1)/C=C/c2cc(ccn2)-c3cc4c(=O)[nH]cnc4[nH]3,,,CHEMBL956581,Inhibition of PKB,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152141,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN(C)CCOc1ccc(cc1)/C=C/c2cc(ccn2)-c3cc4c(=O)[nH]cnc4[nH]3,,Row2492,83,0.1112830117344856,out,6
1925,Row2221,Row2484,CHEMBL504547,,0,486.26,89d,IC50,=,10200.0,nM,Oc1cc(CN/C=C\2/c3cc(I)ccc3C(=O)NC2=O)ccc1-c4cocc4,,,CHEMBL1016204,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153424,1,Scientific Literature,J. Med. Chem.,2009.0,Oc1cc(CN/C=C\2/c3cc(I)ccc3C(=O)NC2=O)ccc1-c4cocc4,,Row2857,89,0.0634897798299789,out,6
1926,Row2222,Row2815,CHEMBL594750,,0,440.55,9n,IC50,=,10500.0,nM,Cc1n[nH]c2ccc(cc12)-c3cc(cnc3C#CC(C)(C)O)OC[C@@H](N)Cc4ccccc4,,,CHEMBL1071953,Inhibition of truncated AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153241,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2ccc(cc12)-c3cc(cnc3C#CC(C)(C)O)OC[C@@H](N)Cc4ccccc4,,Row1976,11,0.1357171684503555,out,6
1927,Row2223,Row616,CHEMBL204213,,0,267.33,2e,IC50,=,10870.0,nM,C(Oc1cc(cnc1)/C=C/c2ccncc2)[C@@H]3CCN3,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,C(Oc1cc(cnc1)/C=C/c2ccncc2)[C@@H]3CCN3,,Row615,77,0.0999967530369758,out,6
1928,Row2224,Row734,CHEMBL577186,,0,267.33,12,IC50,=,10870.0,nM,C(Oc1cc(cnc1)/C=C/c2ccncc2)C3CCN3,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,C(Oc1cc(cnc1)/C=C/c2ccncc2)C3CCN3,,Row615,77,0.0999967530369758,out,6
1929,Row2225,Row3174,CHEMBL55934,NAPHTHOQUINONE,0,158.16,8,IC50,=,10980.0,nM,O=C1C=CC(=O)c2ccccc12,,,CHEMBL3100280,Inhibition of recombinant AKT1 (unknown origin) using serine/threonine 06 peptide as substrate after 1 hr by FRET based Z'-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3098129,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2014.0,O=C1C=CC(=O)c2ccccc12,,Row2387,28,0.1226546615362167,out,6
1930,Row2226,Row2113,CHEMBL603097,,0,243.27,"32, SCH-47089",IC50,=,11400.0,nM,Cc1n[nH]c2nc3ccc(cc3c(OC)c12)OC,,,CHEMBL1067153,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1156890,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1n[nH]c2nc3ccc(cc3c(OC)c12)OC,,Row1976,11,0.1046976298093795,out,6
1931,Row2227,Row1945,CHEMBL375142,,0,291.67,5b,IC50,=,11800.0,nM,O=C1C(Cl)=C(Nc2cc(F)ccc2)C(=O)c3cn[nH]c13,,,CHEMBL908452,Inhibition of Akt1 activity assessed as decrease in GSK3 phosphorylation,F,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145295,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,O=C1C(Cl)=C(Nc2cc(F)ccc2)C(=O)c3cn[nH]c13,,Row788,92,0.0880513861775398,out,6
1932,Row2228,Row2159,CHEMBL445038,,0,682.79,29b,IC50,=,12000.0,nM,NC(=N)NCC(=O)Nc1ccc(cc1-c2ccc3ccccc3c2)C(=O)Nc4ccc(cc4)N(Cc5ccc(cc5)C#N)Cc6ccc(cc6)C#N,,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,NC(=N)NCC(=O)Nc1ccc(cc1-c2ccc3ccccc3c2)C(=O)Nc4ccc(cc4)N(Cc5ccc(cc5)C#N)Cc6ccc(cc6)C#N,,Row1533,98,0.1189684271812439,out,6
1933,Row2229,Row3737,CHEMBL3954224,,0,312.76,BDBM181310,IC50,=,12000.0,nM,NC(=O)c1ccc(NCc2cc(Cl)ccc2)c3cncnc13,,328333.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(NCc2cc(Cl)ccc2)c3cncnc13,,Row2156,90,0.1062144041061401,out,6
1934,Row2230,Row618,CHEMBL205422,,0,400.48,9n,IC50,=,12030.0,nM,CC(=O)Nc1cc(ccc1)-c2cncc(c2)OC[C@@H](N)Cc3c[nH]c4ccccc34,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC(=O)Nc1cc(ccc1)-c2cncc(c2)OC[C@@H](N)Cc3c[nH]c4ccccc34,,Row1726,2,0.125731959939003,out,6
1935,Row2231,Row3021,CHEMBL3099615,,0,132.16,7,IC50,=,12270.0,nM,C=CC(=O)c1ccccc1,,,CHEMBL3100280,Inhibition of recombinant AKT1 (unknown origin) using serine/threonine 06 peptide as substrate after 1 hr by FRET based Z'-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3098129,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2014.0,C=CC(=O)c1ccccc1,,Row2783,67,0.1112013980746269,out,6
1936,Row2232,Row146,CHEMBL221064,,0,359.62,6b,IC50,=,12300.0,nM,O=C1c2[nH]ncc2C(=O)C(Sc3cc(Cl)c(Cl)cc3)=C1Cl,,,CHEMBL908452,Inhibition of Akt1 activity assessed as decrease in GSK3 phosphorylation,F,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145295,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,O=C1c2[nH]ncc2C(=O)C(Sc3cc(Cl)c(Cl)cc3)=C1Cl,,Row788,92,0.0725029110908508,out,6
1937,Row2233,Row506,CHEMBL572400,,0,359.62,148,IC50,=,12300.0,nM,O=C1C(Sc2cccc(Cl)c2Cl)=C(Cl)C(=O)c3[nH]ncc13,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,O=C1C(Sc2cccc(Cl)c2Cl)=C(Cl)C(=O)c3[nH]ncc13,,Row788,92,0.0772004947066307,out,6
1938,Row2234,Row1965,CHEMBL222254,,0,341.68,5g,IC50,=,12400.0,nM,O=C1C(Cl)=C(Nc2ccc(cc2)C(F)(F)F)C(=O)c3cn[nH]c13,,,CHEMBL908452,Inhibition of Akt1 activity assessed as decrease in GSK3 phosphorylation,F,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145295,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,O=C1C(Cl)=C(Nc2ccc(cc2)C(F)(F)F)C(=O)c3cn[nH]c13,,Row788,92,0.0696252658963203,out,6
1939,Row2235,Row2096,CHEMBL1823658,,0,409.28,31,IC50,=,12650.0,nM,O=C(NC(c1cncnc1)c2cc(Cl)c(Cl)cc2)c3cc4ccncc4cc3,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,O=C(NC(c1cncnc1)c2cc(Cl)c(Cl)cc2)c3cc4ccncc4cc3,,Row3192,40,0.0845927745103836,out,6
1940,Row2237,Row3422,CHEMBL3899515,,0,494.58,BDBM182644,IC50,=,13000.0,nM,COc1ccc(cc1F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,330085.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,COc1ccc(cc1F)-c2cn(CCN3CCC3)c(n2)C4CCN(CC4)c5ncnc(N)c5C(N)=O,,Row1206,41,0.1348751634359359,out,6
1941,Row2238,Row3777,CHEMBL3679712,,0,327.35,BDBM103026,IC50,=,13000.0,nM,Nc1cc(ccn1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,220748.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Nc1cc(ccn1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,Row3389,81,0.1595547497272491,out,6
1942,Row2239,Row3779,CHEMBL3679715,,0,325.38,BDBM103029,IC50,=,13000.0,nM,Cc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,220751.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Cc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,Row3389,81,0.1497838944196701,out,6
1943,Row2240,Row3713,CHEMBL3693949,,0,376.48,BDBM112790,IC50,=,13400.0,nM,Cc1cc(cc(C)c1)C(=O)NC(=S)Nc2cc(ccc2O)-c3ccccc3,,234069.0,CHEMBL3706030,"Fluorescence Polarization Assay: In order to identify compounds that disrupt the interaction between PIP3 and PH domains, a high-throughput fluorescence polarization (FP)-binding assay was developed using recombinant 1-123 amino acid N-terminal fragment of human Akt1 (also referred to herein simply as Akt), encompassing the PH domain (PH123 protein), and fluorescent NBD-labeled PIP3 molecule. The amino acid sequence of human Akt1 is publicly available as, for example, GenBank Accession No. NP001014432.1 (SEQ ID NO:1), and the corresponding DNA sequence is publicly available as, for example, GenBank Accession No. NM001014432. Briefly, 5 M recombinant GST fusion proteins containing 1-123 a.a. N-terminal fragment of human Akt1 (PH 123) or 100 nM 441-551 a.a. region of human PDK1 were incubated with 15 nM TMR-labeled PIP3, PIP2, or PIP5 in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 5 mM b-ME for 15 min at room temperature in the dark.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638437,37,BindingDB Database,,2014.0,Cc1cc(cc(C)c1)C(=O)NC(=S)Nc2cc(ccc2O)-c3ccccc3,,Row438,85,0.1344214528799057,out,6
1944,Row2241,Row2959,CHEMBL3099614,,0,218.25,6,IC50,=,13670.0,nM,COC(=O)CC/C=C/C(=O)c1ccccc1,,,CHEMBL3100280,Inhibition of recombinant AKT1 (unknown origin) using serine/threonine 06 peptide as substrate after 1 hr by FRET based Z'-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3098129,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2014.0,COC(=O)CC/C=C/C(=O)c1ccccc1,,Row266,82,0.1046026945114135,out,6
1945,Row2242,Row1686,CHEMBL374701,,0,352.57,5h,IC50,=,13900.0,nM,O=C1C(Cl)=C(Nc2cc(Br)ccc2)C(=O)c3cn[nH]c13,,,CHEMBL908452,Inhibition of Akt1 activity assessed as decrease in GSK3 phosphorylation,F,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145295,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,O=C1C(Cl)=C(Nc2cc(Br)ccc2)C(=O)c3cn[nH]c13,,Row788,92,0.0835580602288246,out,6
1946,Row2243,Row2336,CHEMBL3684522,,0,440.51,BDBM103236,IC50,=,14000.0,nM,CC(C)(C)OC(=O)NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,220973.0,CHEMBL3705043,Biochemical Assay: Biochemical assay using CisBio KinEASE HTRF Assay technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CC(C)(C)OC(=O)NCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,Row3925,73,0.1335999369621276,out,6
1947,Row2244,Row2608,CHEMBL3933947,,0,306.37,BDBM181350,IC50,=,14000.0,nM,CN(CCc1ccccc1)c2ccc(C(N)=O)c3ncncc23,,328364.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,CN(CCc1ccccc1)c2ccc(C(N)=O)c3ncncc23,,Row2156,90,0.1378807127475738,out,6
1948,Row2245,Row2965,CHEMBL395685,,0,760.94,36a,IC50,=,14000.0,nM,CC(C)[C@H](NC(=O)c1ccc(cc1)N(CC(=O)NCc2ccccc2)C(=O)CCCCNC(N)=N)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCc4ccccc4,,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(C)[C@H](NC(=O)c1ccc(cc1)N(CC(=O)NCc2ccccc2)C(=O)CCCCNC(N)=N)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCc4ccccc4,,Row41,99,0.1033756658434867,out,6
1949,Row2246,Row3132,CHEMBL3684523,,0,354.42,BDBM103237,IC50,=,14000.0,nM,NCCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,220974.0,CHEMBL3705043,Biochemical Assay: Biochemical assay using CisBio KinEASE HTRF Assay technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,NCCc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,Row3389,81,0.1579604744911193,out,6
1950,Row2247,Row3141,CHEMBL2420909,,0,272.36,12,IC50,=,14000.0,nM,C1CCCC2(CCN(CC2)c3ncnc4[nH]cnc34)N1,,,CHEMBL2424130,Inhibition of AKT1 (unknown origin) by microfluidic mobility shift assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2417369,1,Scientific Literature,Bioorg. Med. Chem.,2013.0,C1CCCC2(CCN(CC2)c3ncnc4[nH]cnc34)N1,,Row1872,62,0.1044556275010109,out,6
1951,Row2248,Row1658,CHEMBL207031,,0,436.52,9t,IC50,=,14330.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)-c4ccc(cc4)Nc5ncccn5,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cc(cnc3)-c4ccc(cc4)Nc5ncccn5,,Row1996,15,0.1333421766757965,out,6
1952,Row2249,Row1343,CHEMBL205820,,0,255.32,2b,IC50,=,14710.0,nM,NCCCOc1cc(cnc1)/C=C/c2ccncc2,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,NCCCOc1cc(cnc1)/C=C/c2ccncc2,,Row615,77,0.1039523929357528,out,6
1953,Row2250,Row919,CHEMBL200499,,0,333.42,9c,IC50,=,15000.0,nM,O=C(NCc1ccccc1)c2cc3c([nH]nc3s2)-c4ccccc4,,,CHEMBL864555,Inhibitory activity against Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,O=C(NCc1ccccc1)c2cc3c([nH]nc3s2)-c4ccccc4,,Row919,96,0.1297083497047424,out,6
1954,Row2251,Row1154,CHEMBL3314140,,0,404.9,13a,IC50,>,15000.0,nM,Clc1ccc(cc1)-c2ccc(o2)-c3nccn3-c4ccc(cc4)N5CCNCC5,,,CHEMBL3369600,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3351352,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2014.0,Clc1ccc(cc1)-c2ccc(o2)-c3nccn3-c4ccc(cc4)N5CCNCC5,,Row3008,34,0.1206459999084472,out,6
1955,Row2252,Row1630,CHEMBL3905526,,0,333.4,BDBM181338,IC50,=,15000.0,nM,NC(=O)c1ccc(c2cncnc21)N3CCN(CC3)c4ccccc4,,328353.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(c2cncnc21)N3CCN(CC3)c4ccccc4,,Row1630,91,0.1658464223146438,out,6
1956,Row2253,Row2348,CHEMBL242237,,0,321.34,2b,IC50,=,15000.0,nM,NC(=O)c1ccccc1Nc2ccnc(Nc3cc(O)ccc3)n2,,,CHEMBL905889,Inhibition at AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143787,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,NC(=O)c1ccccc1Nc2ccnc(Nc3cc(O)ccc3)n2,,Row1528,84,0.1301644444465637,out,6
1957,Row2254,Row3175,CHEMBL1922694,,0,809.97,"10, diastereomeric mixture",IC50,=,15000.0,nM,CC(C)[C@H](NC(=O)[C@@H]1CC[C@H]2[C@@H](COC(=O)N12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)Cc3ccccc3)C(=O)NC(Cc4ccccc4)C(=O)NCc5ccccc5,,,CHEMBL1924333,Inhibition of His-tagged ATP-binding domain of AKT1 assessed as GRPRTSSFAEG crosstide phosphorylation using [33P]ATP,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1921701,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CC(C)[C@H](NC(=O)[C@@H]1CC[C@H]2[C@@H](COC(=O)N12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)Cc3ccccc3)C(=O)NC(Cc4ccccc4)C(=O)NCc5ccccc5,,Row466,80,0.1194954365491867,out,6
1958,Row2255,Row3323,CHEMBL3972226,,0,512.57,BDBM182380,IC50,=,15000.0,nM,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(cc5)OC(F)F,,329821.0,CHEMBL3887297,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.5 .mu.l: 0.1 ng/.mu.l His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 .mu.M substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338)0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 .mu.l of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886265,37,BindingDB Database,,2015.0,Nc1ncnc(c1C(N)=O)N2CCC(CC2)c3nc(cn3CCN4CCC4)-c5ccc(cc5)OC(F)F,,Row1206,41,0.1224675178527832,out,6
1959,Row2256,Row623,CHEMBL378977,,0,603.69,9n,IC50,=,15600.0,nM,O=S1(=O)Nc2ccc(cc2N1)N[C@@H](Cc3c[nH]c4ccccc34)COc5cncc(c5)-c6cc7NS(=O)(=O)Nc7cc6,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,O=S1(=O)Nc2ccc(cc2N1)N[C@@H](Cc3c[nH]c4ccccc34)COc5cncc(c5)-c6cc7NS(=O)(=O)Nc7cc6,,Row837,29,0.1131804510951042,out,6
1960,Row2257,Row787,CHEMBL220006,,0,291.67,5a,IC50,=,15800.0,nM,O=C1C(Cl)=C(Nc2ccccc2F)C(=O)c3cn[nH]c13,,,CHEMBL908452,Inhibition of Akt1 activity assessed as decrease in GSK3 phosphorylation,F,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145295,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,O=C1C(Cl)=C(Nc2ccccc2F)C(=O)c3cn[nH]c13,,Row788,92,0.0941574499011039,out,6
1961,Row2258,Row973,CHEMBL2385543,,0,561.09,2n,IC50,=,16000.0,nM,O=C1c2oc(cc2Cc3cc(ccc3N1Cc4ccccc4-c5cnccc5)N6CCNCC6)-c7ccc(Cl)cc7,,,CHEMBL2388368,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2384992,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2013.0,O=C1c2oc(cc2Cc3cc(ccc3N1Cc4ccccc4-c5cnccc5)N6CCNCC6)-c7ccc(Cl)cc7,,Row3008,34,0.1465653777122497,out,6
1962,Row2259,Row1927,CHEMBL223314,,0,309.66,5e,IC50,=,16000.0,nM,O=C1C(Cl)=C(Nc2ccc(F)cc2F)C(=O)c3cn[nH]c13,,,CHEMBL908452,Inhibition of Akt1 activity assessed as decrease in GSK3 phosphorylation,F,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145295,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,O=C1C(Cl)=C(Nc2ccc(F)cc2F)C(=O)c3cn[nH]c13,,Row788,92,0.0750933662056922,out,6
1963,Row2260,Row3034,CHEMBL584181,,0,309.66,144,IC50,=,16000.0,nM,O=C1C(Cl)=C(Nc2cc(F)ccc2F)C(=O)c3cn[nH]c13,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,O=C1C(Cl)=C(Nc2cc(F)ccc2F)C(=O)c3cn[nH]c13,,Row788,92,0.0772438645362854,out,6
1964,Row2261,Row3166,CHEMBL449564,,0,1057.27,5,IC50,=,16000.0,nM,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc2cc(c(cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCc4ccccc4)-c5ccccc5,,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc2cc(c(cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCc4ccccc4)-c5ccccc5,,Row466,80,0.1396332532167434,out,6
1965,Row2262,Row3639,CHEMBL200796,,0,273.32,7a,IC50,=,16000.0,nM,COC(=O)c1cc2c(Nc3ccccc3)[nH]nc2s1,,,CHEMBL864555,Inhibitory activity against Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,COC(=O)c1cc2c(Nc3ccccc3)[nH]nc2s1,,Row919,96,0.1088646203279495,out,6
1966,Row2263,Row3288,CHEMBL3298792,,0,390.22,13,IC50,=,16130.0,nM,CC(C)(C)OC(=O)NN(Cc1ccccc1)C(=O)CI,,,CHEMBL3364070,Inhibition of AKT1 (unknown origin) after 1 hr by Z'-LYTE kinase assay in presence of 75 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3297689,1,Scientific Literature,ACS Med. Chem. Lett.,2014.0,CC(C)(C)OC(=O)NN(Cc1ccccc1)C(=O)CI,,Row266,82,0.104222223162651,out,6
1967,Row2264,Row247,CHEMBL1922693,,0,795.94,"9, diastereomeric mixture",IC50,=,16300.0,nM,CC(C)[C@H](NC(=O)[C@@H]1CC[C@H]2[C@@H](COC(=O)N12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)c3ccccc3)C(=O)NC(Cc4ccccc4)C(=O)NCc5ccccc5,,,CHEMBL1924333,Inhibition of His-tagged ATP-binding domain of AKT1 assessed as GRPRTSSFAEG crosstide phosphorylation using [33P]ATP,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1921701,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CC(C)[C@H](NC(=O)[C@@H]1CC[C@H]2[C@@H](COC(=O)N12)NC(=O)[C@H](CCCNC(N)=N)NC(=O)c3ccccc3)C(=O)NC(Cc4ccccc4)C(=O)NCc5ccccc5,,Row41,99,0.1226428374648094,out,6
1968,Row2265,Row3724,CHEMBL3764688,,0,325.13,PI-5,IC50,=,16350.0,nM,Nc1nonc1/C(/NC(=N)c2ccccc2Br)=N\O,,,CHEMBL3767267,"Antagonist activity at human AKT1-PH domain (1 to 121 residues) assessed as reduction of AKT1-PH interaction with PC/PE/PS/PI(3,4,5)P3 after 30 mins by competitive SPR analysis",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3763051,1,Scientific Literature,MedChemComm,2015.0,Nc1nonc1/C(/NC(=N)c2ccccc2Br)=N\O,,Row3384,87,0.1105775237083435,out,6
1969,Row2266,Row917,CHEMBL428861,,0,533.68,13e,IC50,=,17000.0,nM,CC(CC)c1nc(c(nc1O)-c2ccccc2)-c3ccc(CN4CCC(CC4)n5c6ccccc6nc5O)cc3,,,CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141888,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,CC(CC)c1nc(c(nc1O)-c2ccccc2)-c3ccc(CN4CCC(CC4)n5c6ccccc6nc5O)cc3,,Row31,68,0.1789170503616333,out,6
1970,Row2267,Row1504,CHEMBL382070,,0,306.37,13d,IC50,=,17000.0,nM,Cc1n[nH]c2sc(C(N)=O)c(NC(=O)c3cccs3)c21,,,CHEMBL864555,Inhibitory activity against Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Cc1n[nH]c2sc(C(N)=O)c(NC(=O)c3cccs3)c21,,Row1352,94,0.0681758821010589,out,6
1971,Row2268,Row1536,CHEMBL438332,,0,716.93,29a,IC50,=,17000.0,nM,CC(C)c1ccc(CN(Cc2ccc(cc2)C(C)C)c3ccc(cc3)NC(=O)c4ccc(NC(=O)CNC(N)=N)c(c4)-c5ccc6ccccc6c5)cc1,,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,CC(C)c1ccc(CN(Cc2ccc(cc2)C(C)C)c3ccc(cc3)NC(=O)c4ccc(NC(=O)CNC(N)=N)c(c4)-c5ccc6ccccc6c5)cc1,,Row1533,98,0.1081767529249191,out,6
1972,Row2269,Row1877,CHEMBL509490,,0,668.81,21ci,IC50,=,17000.0,nM,NC(=N)NCCNc1ccc(cc1-c2cc3ccccc3cc2)C(=O)Nc4ccc(cc4)N(Cc5ccc(cc5)C#N)Cc6ccc(cc6)C#N,,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,NC(=N)NCCNc1ccc(cc1-c2cc3ccccc3cc2)C(=O)Nc4ccc(cc4)N(Cc5ccc(cc5)C#N)Cc6ccc(cc6)C#N,,Row1533,98,0.1194334179162979,out,6
1973,Row2270,Row3476,CHEMBL180580,,0,567.69,13c,IC50,=,17000.0,nM,Oc1nc2ccccc2n1C3CCN(Cc4ccc(cc4)-c5nc(Cc6ccccc6)c(O)nc5-c7ccccc7)CC3,,,CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141888,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,Oc1nc2ccccc2n1C3CCN(Cc4ccc(cc4)-c5nc(Cc6ccccc6)c(O)nc5-c7ccccc7)CC3,,Row31,68,0.1833468228578567,out,6
1974,Row2272,Row3914,CHEMBL3684518,,0,423.48,BDBM103232,IC50,=,17000.0,nM,O=C(c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)N6CCNCC6,,220969.0,CHEMBL3705043,Biochemical Assay: Biochemical assay using CisBio KinEASE HTRF Assay technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,O=C(c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23)N6CCNCC6,,Row2783,67,0.1503100246191024,out,6
1975,Row2273,Row1696,CHEMBL3693945,,0,362.88,BDBM112786,IC50,=,17500.0,nM,Cc1cc(O)c(NC(=S)NC(=O)c2cc(C)cc(C)c2)c(C)c1Cl,,234065.0,CHEMBL3706030,"Fluorescence Polarization Assay: In order to identify compounds that disrupt the interaction between PIP3 and PH domains, a high-throughput fluorescence polarization (FP)-binding assay was developed using recombinant 1-123 amino acid N-terminal fragment of human Akt1 (also referred to herein simply as Akt), encompassing the PH domain (PH123 protein), and fluorescent NBD-labeled PIP3 molecule. The amino acid sequence of human Akt1 is publicly available as, for example, GenBank Accession No. NP001014432.1 (SEQ ID NO:1), and the corresponding DNA sequence is publicly available as, for example, GenBank Accession No. NM001014432. Briefly, 5 M recombinant GST fusion proteins containing 1-123 a.a. N-terminal fragment of human Akt1 (PH 123) or 100 nM 441-551 a.a. region of human PDK1 were incubated with 15 nM TMR-labeled PIP3, PIP2, or PIP5 in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 5 mM b-ME for 15 min at room temperature in the dark.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638437,37,BindingDB Database,,2014.0,Cc1cc(O)c(NC(=S)NC(=O)c2cc(C)cc(C)c2)c(C)c1Cl,,Row438,85,0.0466158464550972,out,6
1976,Row2274,Row44,CHEMBL3933454,,0,299.38,BDBM181306,IC50,=,18000.0,nM,CNCC1CN(CCC1)c2ccc(C(N)=O)c3ncncc23,,328329.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,CNCC1CN(CCC1)c2ccc(C(N)=O)c3ncncc23,,Row1630,91,0.1320423334836959,out,6
1977,Row2275,Row1672,CHEMBL3693948,,0,407.33,BDBM112789,IC50,=,18100.0,nM,Cc1cc(O)c(NC(=S)NC(=O)c2cc(C)cc(C)c2)c(C)c1Br,,234068.0,CHEMBL3706030,"Fluorescence Polarization Assay: In order to identify compounds that disrupt the interaction between PIP3 and PH domains, a high-throughput fluorescence polarization (FP)-binding assay was developed using recombinant 1-123 amino acid N-terminal fragment of human Akt1 (also referred to herein simply as Akt), encompassing the PH domain (PH123 protein), and fluorescent NBD-labeled PIP3 molecule. The amino acid sequence of human Akt1 is publicly available as, for example, GenBank Accession No. NP001014432.1 (SEQ ID NO:1), and the corresponding DNA sequence is publicly available as, for example, GenBank Accession No. NM001014432. Briefly, 5 M recombinant GST fusion proteins containing 1-123 a.a. N-terminal fragment of human Akt1 (PH 123) or 100 nM 441-551 a.a. region of human PDK1 were incubated with 15 nM TMR-labeled PIP3, PIP2, or PIP5 in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 5 mM b-ME for 15 min at room temperature in the dark.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638437,37,BindingDB Database,,2014.0,Cc1cc(O)c(NC(=S)NC(=O)c2cc(C)cc(C)c2)c(C)c1Br,,Row438,85,0.047618843615055,out,6
1978,Row2276,Row3186,CHEMBL2312646,,0,477.44,12,IC50,=,18580.0,nM,CN1CCC(CC1)NC(=O)c2cnc(NCc3cc(Cl)ccc3Cl)nc2NC4CCCC4,,,CHEMBL2317787,Inhibition of AKT1 (unknown origin) in presence of ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2311250,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2013.0,CN1CCC(CC1)NC(=O)c2cnc(NCc3cc(Cl)ccc3Cl)nc2NC4CCCC4,,Row3186,60,0.1045047417283058,out,6
1979,Row2277,Row1660,CHEMBL207699,,0,320.4,7c,IC50,=,18830.0,nM,N[C@@H](Cc1ccccc1)COc2cncc(c2)Nc3ccncc3,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1ccccc1)COc2cncc(c2)Nc3ccncc3,,Row615,77,0.140529066324234,out,6
1980,Row2278,Row2039,CHEMBL449678,,0,618.75,21bi,IC50,=,19000.0,nM,NC(=N)NCCNc1ccc(cc1-c2ccccc2)C(=O)Nc3ccc(cc3)N(Cc4ccc(cc4)C#N)Cc5ccc(cc5)C#N,,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,NC(=N)NCCNc1ccc(cc1-c2ccccc2)C(=O)Nc3ccc(cc3)N(Cc4ccc(cc4)C#N)Cc5ccc(cc5)C#N,,Row1533,98,0.1382206678390503,out,6
1981,Row2279,Row2460,CHEMBL204059,,0,283.38,3,IC50,=,19320.0,nM,CC(C)[C@H](N)COc1cncc(/C=C/c2ccncc2)c1,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,CC(C)[C@H](N)COc1cncc(/C=C/c2ccncc2)c1,,Row615,77,0.0935810059309005,out,6
1982,Row2281,Row331,CHEMBL486813,,0,196.16,1,IC50,=,19700.0,nM,CC1OC(=O)c2cc(O)c(O)c(O)c21,,,CHEMBL954509,Inhibition of sulfhydryl-labeled human recombinant Akt1 expressed in baculovirus by affinity capillary electrophoresis assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1148981,1,Scientific Literature,J. Nat. Prod.,2004.0,CC1OC(=O)c2cc(O)c(O)c(O)c21,,Row943,100,0.0643512681126594,out,6
1983,Row2282,Row22,CHEMBL186290,,0,508.58,9,IC50,>,20000.0,nM,Cc1cc2c3c(CN(CCn3cc2C4=C(c5cnc6ccccn65)C(=O)NC4=O)C(=O)N7CCCCC7)c1,,,CHEMBL828500,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138659,1,Scientific Literature,J. Med. Chem.,2004.0,Cc1cc2c3c(CN(CCn3cc2C4=C(c5cnc6ccccn65)C(=O)NC4=O)C(=O)N7CCCCC7)c1,,Row2527,93,0.1162449717521667,out,6
1984,Row2283,Row23,CHEMBL363058,,0,469.5,7,IC50,>,20000.0,nM,CC(C)OC(=O)N1Cc2cccc3c2n(CC1)cc3C4=C(c5cnc6ccccn56)C(=O)NC4=O,,,CHEMBL828500,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138659,1,Scientific Literature,J. Med. Chem.,2004.0,CC(C)OC(=O)N1Cc2cccc3c2n(CC1)cc3C4=C(c5cnc6ccccn56)C(=O)NC4=O,,Row2527,93,0.1239860728383064,out,6
1985,Row2284,Row38,CHEMBL371242,,0,237.33,8b,IC50,>,20000.0,nM,Cc1n[nH]c2sc(cc12)C(=O)NCCCC,,,CHEMBL864555,Inhibitory activity against Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Cc1n[nH]c2sc(cc12)C(=O)NCCCC,,Row919,96,0.071705937385559,out,6
1986,Row2285,Row678,CHEMBL199755,,0,325.44,9b,IC50,>,20000.0,nM,O=C(NC1CCCCC1)c2cc3c([nH]nc3s2)-c4ccccc4,,,CHEMBL864555,Inhibitory activity against Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,O=C(NC1CCCCC1)c2cc3c([nH]nc3s2)-c4ccccc4,,Row919,96,0.1529990881681442,out,6
1987,Row2286,Row775,CHEMBL482336,,0,436.51,38,IC50,>,20000.0,nM,COc1cc2CC(COc2cc1)C(=O)Nc3ccc(cc3OCCN(C)C)-c4c[nH]nc4,,,CHEMBL942700,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141010,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,COc1cc2CC(COc2cc1)C(=O)Nc3ccc(cc3OCCN(C)C)-c4c[nH]nc4,,Row2492,83,0.122373342514038,out,6
1988,Row2287,Row1264,CHEMBL199737,,0,238.27,13a,IC50,>,20000.0,nM,CC(=O)Nc1c(sc2[nH]nc(C)c12)C(N)=O,,,CHEMBL864555,Inhibitory activity against Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC(=O)Nc1c(sc2[nH]nc(C)c12)C(N)=O,,Row1352,94,0.0568122491240501,out,6
1989,Row2288,Row1283,CHEMBL371239,,0,326.43,9f,IC50,>,20000.0,nM,CN1CCN(CC1)C(=O)c2cc3c([nH]nc3s2)-c4ccccc4,,,CHEMBL864555,Inhibitory activity against Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CN1CCN(CC1)C(=O)c2cc3c([nH]nc3s2)-c4ccccc4,,Row919,96,0.1519763022661209,out,6
1990,Row2289,Row1328,CHEMBL362558,LY-2090314,2,512.55,12,IC50,>,20000.0,nM,O=C1NC(=O)C(=C1c2cn3CCN(Cc4cc(F)cc2c34)C(=O)N5CCCCC5)c6cnc7ccccn76,,,CHEMBL828500,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138659,1,Scientific Literature,J. Med. Chem.,2004.0,O=C1NC(=O)C(=C1c2cn3CCN(Cc4cc(F)cc2c34)C(=O)N5CCCCC5)c6cnc7ccccn76,,Row2527,93,0.1274683028459549,out,6
1991,Row2290,Row1329,CHEMBL362814,,0,454.49,11,IC50,>,20000.0,nM,CN(C)C(=O)N1Cc2cccc3c2n(CC1)cc3C4=C(c5cnc6ccccn56)C(=O)NC4=O,,,CHEMBL828500,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138659,1,Scientific Literature,J. Med. Chem.,2004.0,CN(C)C(=O)N1Cc2cccc3c2n(CC1)cc3C4=C(c5cnc6ccccn56)C(=O)NC4=O,,Row2527,93,0.1264893412590026,out,6
1992,Row2291,Row1453,CHEMBL1761075,,0,553.08,"13, 1:1diastereomeric mixture",IC50,>,20000.0,nM,CCOCCN(C[C@@H](O)CN1CC2(CC(=O)c3cc(O)ccc3O2)CCC1)S(=O)(=O)c4cccc(Cl)c4,,,CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759945,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CCOCCN(C[C@@H](O)CN1CC2(CC(=O)c3cc(O)ccc3O2)CCC1)S(=O)(=O)c4cccc(Cl)c4,,Row2370,39,0.1154618635773658,out,6
1993,Row2292,Row1506,CHEMBL199528,,0,313.43,9a,IC50,>,20000.0,nM,CCCCN(C)C(=O)c1cc2c([nH]nc2s1)-c3ccccc3,,,CHEMBL864555,Inhibitory activity against Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CCCCN(C)C(=O)c1cc2c([nH]nc2s1)-c3ccccc3,,Row919,96,0.1360554099082946,out,6
1994,Row2293,Row1516,CHEMBL402818,,0,437.57,29,IC50,>,20000.0,nM,Cc1c(ccc2[nH]ccc12)Nc3c(cnc4sc(cc43)-c5cc(CN(C)C)ccc5)C#N,,,CHEMBL927988,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145639,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Cc1c(ccc2[nH]ccc12)Nc3c(cnc4sc(cc43)-c5cc(CN(C)C)ccc5)C#N,,Row2454,78,0.1055564507842063,out,6
1995,Row2294,Row1685,CHEMBL481545,,0,424.48,41,IC50,>,20000.0,nM,CN(C)CCOc1cc(ccc1NC(=O)C2Cc3cc(F)ccc3OC2)-c4c[nH]nc4,,,CHEMBL942700,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141010,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN(C)CCOc1cc(ccc1NC(=O)C2Cc3cc(F)ccc3OC2)-c4c[nH]nc4,,Row2492,83,0.1073290333151817,out,6
1996,Row2295,Row2020,CHEMBL199383,,0,363.44,9e,IC50,>,20000.0,nM,COc1ccc(CNC(=O)c2cc3c([nH]nc3s2)-c4ccccc4)cc1,,,CHEMBL864555,Inhibitory activity against Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,COc1ccc(CNC(=O)c2cc3c([nH]nc3s2)-c4ccccc4)cc1,,Row919,96,0.134623721241951,out,6
1997,Row2296,Row2021,CHEMBL200657,,0,251.35,8c,IC50,>,20000.0,nM,Cc1n[nH]c2sc(cc12)C(=O)N(C)CCCC,,,CHEMBL864555,Inhibitory activity against Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Cc1n[nH]c2sc(cc12)C(=O)N(C)CCCC,,Row1352,94,0.0663655549287796,out,6
1998,Row2297,Row2293,CHEMBL1761078,,0,548.66,"16, 1:1diastereomeric mixture",IC50,>,20000.0,nM,COc1ccccc1S(=O)(=O)N(C[C@@H](O)CN2CC3(CC(=O)c4cc(O)ccc4O3)CCC2)CCOCC,,,CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759945,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,COc1ccccc1S(=O)(=O)N(C[C@@H](O)CN2CC3(CC(=O)c4cc(O)ccc4O3)CCC2)CCOCC,,Row2370,39,0.1332967728376388,out,6
1999,Row2298,Row2335,CHEMBL199951,,0,263.37,8d,IC50,>,20000.0,nM,Cc1n[nH]c2sc(cc21)C(=O)NC3CCCCC3,,,CHEMBL864555,Inhibitory activity against Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Cc1n[nH]c2sc(cc21)C(=O)NC3CCCCC3,,Row1352,94,0.0840063691139221,out,6
2000,Row2299,Row2340,CHEMBL510515,,0,339.38,1,IC50,>,20000.0,nM,O=C(Nc1nc(cs1)-c2ccncc2)C3COc4ccccc4O3,,,CHEMBL1030560,Inhibition of AKT1 after 55 mins,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142492,1,Scientific Literature,J. Med. Chem.,2008.0,O=C(Nc1nc(cs1)-c2ccncc2)C3COc4ccccc4O3,,Row2492,83,0.1251048147678375,out,6
2001,Row2300,Row2527,CHEMBL362588,,0,494.56,8,IC50,>,20000.0,nM,O=C1NC(=O)C(c2cn3CCN(Cc4cccc2c34)C(=O)N5CCCCC5)=C1c6cnc7ccccn67,,,CHEMBL828500,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138659,1,Scientific Literature,J. Med. Chem.,2004.0,O=C1NC(=O)C(c2cn3CCN(Cc4cccc2c34)C(=O)N5CCCCC5)=C1c6cnc7ccccn67,,Row2527,93,0.1321824342012405,out,6
2002,Row2301,Row2535,CHEMBL178737,,0,496.53,10,IC50,>,20000.0,nM,O=C1NC(=O)C(c2cn3CCN(Cc4cccc2c34)C(=O)N5CCOCC5)=C1c6cnc7ccccn67,,,CHEMBL828500,Inhibition of human Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138659,1,Scientific Literature,J. Med. Chem.,2004.0,O=C1NC(=O)C(c2cn3CCN(Cc4cccc2c34)C(=O)N5CCOCC5)=C1c6cnc7ccccn67,,Row2527,93,0.1210710182785987,out,6
2003,Row2302,Row2696,CHEMBL197923,,0,347.44,9d,IC50,>,20000.0,nM,O=C(NCCc1ccccc1)c2cc3c([nH]nc3s2)-c4ccccc4,,,CHEMBL864555,Inhibitory activity against Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,O=C(NCCc1ccccc1)c2cc3c([nH]nc3s2)-c4ccccc4,,Row919,96,0.1299585253000259,out,6
2004,Row2303,Row2992,CHEMBL1761076,,0,553.08,"14, 1:1diastereomeric mixture",IC50,=,20000.0,nM,CCOCCN(C[C@@H](O)CN1CC2(CC(=O)c3cc(O)ccc3O2)CCC1)S(=O)(=O)c4ccc(Cl)cc4,,,CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759945,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CCOCCN(C[C@@H](O)CN1CC2(CC(=O)c3cc(O)ccc3O2)CCC1)S(=O)(=O)c4ccc(Cl)cc4,,Row2370,39,0.1089213266968727,out,6
2005,Row2304,Row3205,CHEMBL474425,,0,406.49,23,IC50,>,20000.0,nM,CN(C)CCOc1cc(ccc1NC(=O)C2Cc3ccccc3OC2)-c4c[nH]nc4,,,CHEMBL942700,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141010,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,CN(C)CCOc1cc(ccc1NC(=O)C2Cc3ccccc3OC2)-c4c[nH]nc4,,Row2492,83,0.1243587806820869,out,6
2006,Row2305,Row3494,CHEMBL178468,,0,533.68,4,IC50,>,20000.0,nM,CC(C)Cc1nc(-c2ccccc2)c(nc1O)-c3ccc(CN4CCC(CC4)n5c(O)nc6ccccc56)cc3,,,CHEMBL832702,Inhibitory concentration against Akt1 kinase,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141976,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,CC(C)Cc1nc(-c2ccccc2)c(nc1O)-c3ccc(CN4CCC(CC4)n5c(O)nc6ccccc56)cc3,,Row31,68,0.1787527501583099,out,6
2007,Row2306,Row3644,CHEMBL373001,,0,271.35,8e,IC50,>,20000.0,nM,Cc1n[nH]c2sc(cc21)C(=O)NCc3ccccc3,,,CHEMBL864555,Inhibitory activity against Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Cc1n[nH]c2sc(cc21)C(=O)NCc3ccccc3,,Row919,96,0.1059565991163253,out,6
2008,Row2307,Row3720,CHEMBL198022,,0,181.22,8a,IC50,>,20000.0,nM,Cc1n[nH]c2sc(cc21)C(N)=O,,,CHEMBL864555,Inhibitory activity against Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Cc1n[nH]c2sc(cc21)C(N)=O,,Row1352,94,0.0870267376303672,out,6
2009,Row2308,Row2338,CHEMBL1823659,,0,408.29,32,IC50,=,20440.0,nM,O=C(NC(c1cc(Cl)c(Cl)cc1)c2ccncc2)c3cc4ccncc4cc3,,,CHEMBL1825378,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821694,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,O=C(NC(c1cc(Cl)c(Cl)cc1)c2ccncc2)c3cc4ccncc4cc3,,Row3192,40,0.0856508314609527,out,6
2010,Row2309,Row2309,CHEMBL263512,,0,609.65,9k,IC50,=,20700.0,nM,N#CCn1c2ccc(cc2nc1O)-c3cc(cnc3)OC[C@H](Cc4c[nH]c5ccccc45)Nc6cc7nc(O)n(CC#N)c7cc6,,,CHEMBL866644,Inhibition of AKT1 in presence of 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138086,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N#CCn1c2ccc(cc2nc1O)-c3cc(cnc3)OC[C@H](Cc4c[nH]c5ccccc45)Nc6cc7nc(O)n(CC#N)c7cc6,,Row837,29,0.1133226603269577,out,6
2011,Row2310,Row1359,CHEMBL3693947,,0,436.38,BDBM112788,IC50,=,20800.0,nM,Cc1cc(cc(C)c1)C(=O)NC(=S)Nc2c(O)cc(cc2C(F)(F)F)C(F)(F)F,,234067.0,CHEMBL3706030,"Fluorescence Polarization Assay: In order to identify compounds that disrupt the interaction between PIP3 and PH domains, a high-throughput fluorescence polarization (FP)-binding assay was developed using recombinant 1-123 amino acid N-terminal fragment of human Akt1 (also referred to herein simply as Akt), encompassing the PH domain (PH123 protein), and fluorescent NBD-labeled PIP3 molecule. The amino acid sequence of human Akt1 is publicly available as, for example, GenBank Accession No. NP001014432.1 (SEQ ID NO:1), and the corresponding DNA sequence is publicly available as, for example, GenBank Accession No. NM001014432. Briefly, 5 M recombinant GST fusion proteins containing 1-123 a.a. N-terminal fragment of human Akt1 (PH 123) or 100 nM 441-551 a.a. region of human PDK1 were incubated with 15 nM TMR-labeled PIP3, PIP2, or PIP5 in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 5 mM b-ME for 15 min at room temperature in the dark.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638437,37,BindingDB Database,,2014.0,Cc1cc(cc(C)c1)C(=O)NC(=S)Nc2c(O)cc(cc2C(F)(F)F)C(F)(F)F,,Row438,85,0.0476718321442604,out,6
2012,Row2311,Row3407,CHEMBL575838,,0,519.65,137,IC50,=,21200.0,nM,CC(C)c1nc(-c2ccccc2)c([nH]c1=O)-c3ccc(CN4CCC(CC4)n5c(=O)[nH]c6ccccc56)cc3,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,CC(C)c1nc(-c2ccccc2)c([nH]c1=O)-c3ccc(CN4CCC(CC4)n5c(=O)[nH]c6ccccc56)cc3,,Row2123,58,0.1696901768445968,out,6
2013,Row2312,Row2359,CHEMBL1258102,,0,395.89,37,IC50,=,21233.0,nM,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3cnnc4ccccc34,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3cnnc4ccccc34,,Row875,55,0.1330934166908264,out,6
2014,Row2313,Row736,CHEMBL178133,,0,583.69,141,IC50,=,21670.0,nM,Oc1ccc(Cc2nc(c([nH]c2=O)-c3ccccc3)-c4ccc(CN5CCC(CC5)n6c7ccccc7[nH]c6=O)cc4)cc1,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Oc1ccc(Cc2nc(c([nH]c2=O)-c3ccccc3)-c4ccc(CN5CCC(CC5)n6c7ccccc7[nH]c6=O)cc4)cc1,,Row2123,58,0.1622055470943451,out,6
2015,Row2314,Row954,CHEMBL1254209,,0,389.26,"7, DG2",IC50,=,22000.0,nM,COc1ccccc1N2CCN(CC2)c3ncnc4[nH]nc(Br)c34,,,CHEMBL1252170,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1250448,1,Scientific Literature,Nat. Chem. Biol.,2009.0,COc1ccccc1N2CCN(CC2)c3ncnc4[nH]nc(Br)c34,,Row2025,21,0.1399817019701004,out,6
2016,Row2315,Row834,CHEMBL3693946,,0,368.38,BDBM112787,IC50,=,22600.0,nM,Cc1cc(cc(C)c1)C(=O)NC(=S)Nc2cc(ccc2O)C(F)(F)F,,234066.0,CHEMBL3706030,"Fluorescence Polarization Assay: In order to identify compounds that disrupt the interaction between PIP3 and PH domains, a high-throughput fluorescence polarization (FP)-binding assay was developed using recombinant 1-123 amino acid N-terminal fragment of human Akt1 (also referred to herein simply as Akt), encompassing the PH domain (PH123 protein), and fluorescent NBD-labeled PIP3 molecule. The amino acid sequence of human Akt1 is publicly available as, for example, GenBank Accession No. NP001014432.1 (SEQ ID NO:1), and the corresponding DNA sequence is publicly available as, for example, GenBank Accession No. NM001014432. Briefly, 5 M recombinant GST fusion proteins containing 1-123 a.a. N-terminal fragment of human Akt1 (PH 123) or 100 nM 441-551 a.a. region of human PDK1 were incubated with 15 nM TMR-labeled PIP3, PIP2, or PIP5 in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 5 mM b-ME for 15 min at room temperature in the dark.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638437,37,BindingDB Database,,2014.0,Cc1cc(cc(C)c1)C(=O)NC(=S)Nc2cc(ccc2O)C(F)(F)F,,Row438,85,0.0605059713125228,out,6
2017,Row2316,Row363,CHEMBL1761070,,0,523.61,"8, 1:1diastereomeric mixture",IC50,=,22800.0,nM,COCCN(C[C@H](O)CN1CC2(CC(=O)c3cc(O)ccc3O2)CCC1)S(=O)(=O)c4c(C)noc4C,,,CHEMBL1764865,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1759945,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,COCCN(C[C@H](O)CN1CC2(CC(=O)c3cc(O)ccc3O2)CCC1)S(=O)(=O)c4c(C)noc4C,,Row2370,39,0.1184538006782531,out,6
2018,Row2317,Row1062,CHEMBL1258443,,0,345.83,42,IC50,=,22920.0,nM,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ccncn3,,,CHEMBL1259574,Inhibition of AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1255571,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,N[C@H](Cc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ccncn3,,Row875,55,0.1104239970445633,out,6
2019,Row2318,Row211,CHEMBL3679724,,0,329.34,BDBM103038,IC50,=,23000.0,nM,Fc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,220760.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Fc1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n32,,Row3389,81,0.1524663418531417,out,6
2020,Row2319,Row348,CHEMBL3939475,,0,401.39,BDBM181356,IC50,=,23000.0,nM,NC(=O)c1ccc(c2cncnc12)N3CCN(CC3)c4cc(ccc4)C(F)(F)F,,273529.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(c2cncnc12)N3CCN(CC3)c4cc(ccc4)C(F)(F)F,,Row1630,91,0.1316817551851272,out,6
2021,Row2320,Row2034,CHEMBL446829,,0,668.85,21bh,IC50,=,23000.0,nM,NC(=N)NCCNc1ccc(cc1-c2ccccc2)C(=O)Nc3ccc(cc3)N(Cc4cc5ccccc5cc4)Cc6cc7ccccc7cc6,,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,NC(=N)NCCNc1ccc(cc1-c2ccccc2)C(=O)Nc3ccc(cc3)N(Cc4cc5ccccc5cc4)Cc6cc7ccccc7cc6,,Row1533,98,0.1290581375360489,out,6
2022,Row2321,Row1508,CHEMBL3104854,,0,196.16,7,IC50,=,23200.0,nM,Cc1c2COC(=O)c2c(O)c(O)c1O,,,CHEMBL3108329,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3102702,1,Scientific Literature,J. Nat. Prod.,2014.0,Cc1c2COC(=O)c2c(O)c(O)c1O,,Row2857,89,0.0475381165742874,out,6
2023,Row2322,Row260,CHEMBL206654,,0,370.46,6c,IC50,=,23270.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cccc(/C=C/c4ccncc4)n3,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cccc(/C=C/c4ccncc4)n3,,Row77,56,0.109105460345745,out,6
2024,Row2323,Row299,CHEMBL205645,,0,281.36,2f,IC50,=,23910.0,nM,C(Oc1cc(cnc1)/C=C/c2ccncc2)[C@@H]3CCCN3,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,C(Oc1cc(cnc1)/C=C/c2ccncc2)[C@@H]3CCCN3,,Row615,77,0.11061742156744,out,6
2025,Row2324,Row285,CHEMBL4569508,,0,529.59,1,IC50,=,24000.0,nM,O=C(NCC(F)(F)F)c1cc(cs1)-c2cnn3cc(cnc32)-c4ccc(cc4)OCCN5CCCCC5,,,CHEMBL4479691,Inhibition of full-length recombinant human His-tagged AKT1-alpha expressed in baculovirus expression system by Z'-LYTE assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4477252,1,Scientific Literature,Bioorg Med Chem Lett,2016.0,O=C(NCC(F)(F)F)c1cc(cs1)-c2cnn3cc(cnc32)-c4ccc(cc4)OCCN5CCCCC5,,Row2044,43,0.108170710504055,out,6
2026,Row2325,Row622,CHEMBL380958,,0,371.44,7a,IC50,=,24010.0,nM,OC(Cc1c[nH]c2ccccc12)COc3cncc(c3)/C=C/c4ccncc4,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,OC(Cc1c[nH]c2ccccc12)COc3cncc(c3)/C=C/c4ccncc4,,Row77,56,0.1049866750836372,out,6
2027,Row2326,Row512,CHEMBL3298611,,0,343.22,12,IC50,=,24660.0,nM,CC(C)(C)OC(=O)NN(Cc1ccccc1)C(=O)CBr,,,CHEMBL3364070,Inhibition of AKT1 (unknown origin) after 1 hr by Z'-LYTE kinase assay in presence of 75 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3297689,1,Scientific Literature,ACS Med. Chem. Lett.,2014.0,CC(C)(C)OC(=O)NN(Cc1ccccc1)C(=O)CBr,,Row266,82,0.1053952947258949,out,6
2028,Row2327,Row547,CHEMBL1243326,,0,515.55,8b,IC50,>,25000.0,nM,CNc1nccc(n1)-c2cccnc2Oc3ccc(cc3)Nc4nnc(-c5ccc(F)cc5)c6ccccc64,,,CHEMBL1247975,Inhibition of PKBalpha by HTRF assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1240487,1,Scientific Literature,J. Med. Chem.,2010.0,CNc1nccc(n1)-c2cccnc2Oc3ccc(cc3)Nc4nnc(-c5ccc(F)cc5)c6ccccc64,,Row1528,84,0.1274631321430206,out,6
2029,Row2328,Row832,CHEMBL595786,,0,460.56,9,IC50,=,25000.0,nM,Cc1nnc(NS(=O)(=O)c2ccc(cc2)NS(=O)(=O)c3cc4ccccc4cc3)s1,,,CHEMBL1068578,Inhibition of pleckstrin homology domain of AKT by surface plasmon resonance spectroscopy,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152590,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,Cc1nnc(NS(=O)(=O)c2ccc(cc2)NS(=O)(=O)c3cc4ccccc4cc3)s1,,Row1834,53,0.105208896100521,out,6
2030,Row2329,Row1609,CHEMBL1204097,,0,529.01,6,IC50,=,25000.0,nM,COc1ccc(O)c(c1F)C(=O)c2ccc(cc2)NC[C@@H]3CCCNCC3NC(=O)c4ccncc4,,,CHEMBL766409,Inhibition of Protein kinase B alpha,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1149095,1,Scientific Literature,J. Med. Chem.,2004.0,COc1ccc(O)c(c1F)C(=O)c2ccc(cc2)NC[C@@H]3CCCNCC3NC(=O)c4ccncc4,,Row2523,51,0.1059813052415847,out,6
2031,Row2330,Row1772,CHEMBL386661,,0,549.6,32,IC50,>,25000.0,nM,Cc1ccc(cc1-c2cc3cnc(NC)nc3cc2)C(=O)Nc4cc(ccc4OC5CCN(C)CC5)C(F)(F)F,,,CHEMBL871549,Inhibition of PKBalpha by HTRF kinase assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1149344,1,Scientific Literature,J. Med. Chem.,2006.0,Cc1ccc(cc1-c2cc3cnc(NC)nc3cc2)C(=O)Nc4cc(ccc4OC5CCN(C)CC5)C(F)(F)F,,Row3186,60,0.1303564608097076,out,6
2032,Row2331,Row2099,CHEMBL220290,,0,364.52,SWU2009,IC50,=,25000.0,nM,COC(=O)C1=C(C(=S)C2SC(=S)SC2C1=S)C(=O)OC,,,CHEMBL908452,Inhibition of Akt1 activity assessed as decrease in GSK3 phosphorylation,F,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145295,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,COC(=O)C1=C(C(=S)C2SC(=S)SC2C1=S)C(=O)OC,,Row1473,59,0.0346667356789112,out,6
2033,Row2332,Row2375,CHEMBL215943,,0,535.57,47,IC50,>,25000.0,nM,Cc1ccc(cc1-c2cc3cnc(NCCN4CCOCC4)nc3cc2)C(=O)Nc5cc(ccc5)C(F)(F)F,,,CHEMBL871549,Inhibition of PKBalpha by HTRF kinase assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1149344,1,Scientific Literature,J. Med. Chem.,2006.0,Cc1ccc(cc1-c2cc3cnc(NCCN4CCOCC4)nc3cc2)C(=O)Nc5cc(ccc5)C(F)(F)F,,Row3186,60,0.1279544532299041,out,6
2034,Row2333,Row3451,CHEMBL1807446,,0,425.49,24,IC50,>,25000.0,nM,Cc1ccc(cc1Nc2ncnn3cc(C(=O)c4ccccc4)c(C)c32)C(=O)NC5CC5,,,CHEMBL1811572,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1806462,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,Cc1ccc(cc1Nc2ncnn3cc(C(=O)c4ccccc4)c(C)c32)C(=O)NC5CC5,,Row3186,60,0.1413675099611282,out,6
2035,Row2334,Row2596,CHEMBL175828,,0,360.32,3,IC50,=,25100.0,nM,OC(=O)c1cc(ccc1O)-c2ccc(C=C3C(=O)c4ccccc4C3=O)o2,,,CHEMBL828149,Inhibition of protein kinase B alpha (Akt1) in fluorescent enzymatic assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143561,1,Scientific Literature,J. Med. Chem.,2005.0,OC(=O)c1cc(ccc1O)-c2ccc(C=C3C(=O)c4ccccc4C3=O)o2,,Row2857,89,0.1168313547968864,out,6
2036,Row2335,Row400,CHEMBL205349,,0,368.44,2b,IC50,=,25200.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)C#Cc4cnccc4,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)C#Cc4cnccc4,,Row1996,15,0.112868808209896,out,6
2037,Row2336,Row1966,CHEMBL398606,,0,414.51,10a,IC50,=,26890.0,nM,CC(C)NCc1ccc(cc1)Nc2cc([nH]n2)-c3ccc(cc3)-c4ccc(O)cc4O,,,CHEMBL899084,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1137531,1,Scientific Literature,J. Med. Chem.,2007.0,CC(C)NCc1ccc(cc1)Nc2cc([nH]n2)-c3ccc(cc3)-c4ccc(O)cc4O,,Row996,49,0.1044657304883003,out,6
2038,Row2337,Row438,CHEMBL3596524,,0,345.38,BDBM112785,IC50,=,27100.0,nM,Cc1cc(cc(C)c1)C(=O)NC(=S)Nc2cc(ccc2O)[N+]([O-])=O,,234064.0,CHEMBL3706030,"Fluorescence Polarization Assay: In order to identify compounds that disrupt the interaction between PIP3 and PH domains, a high-throughput fluorescence polarization (FP)-binding assay was developed using recombinant 1-123 amino acid N-terminal fragment of human Akt1 (also referred to herein simply as Akt), encompassing the PH domain (PH123 protein), and fluorescent NBD-labeled PIP3 molecule. The amino acid sequence of human Akt1 is publicly available as, for example, GenBank Accession No. NP001014432.1 (SEQ ID NO:1), and the corresponding DNA sequence is publicly available as, for example, GenBank Accession No. NM001014432. Briefly, 5 M recombinant GST fusion proteins containing 1-123 a.a. N-terminal fragment of human Akt1 (PH 123) or 100 nM 441-551 a.a. region of human PDK1 were incubated with 15 nM TMR-labeled PIP3, PIP2, or PIP5 in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 5 mM b-ME for 15 min at room temperature in the dark.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638437,37,BindingDB Database,,2014.0,Cc1cc(cc(C)c1)C(=O)NC(=S)Nc2cc(ccc2O)[N+]([O-])=O,,Row438,85,0.0622898414731025,out,6
2039,Row2338,Row466,CHEMBL245565,,0,981.17,10,IC50,=,28000.0,nM,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc2ccc(cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCc4ccccc4,,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc2ccc(cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCc4ccccc4,,Row466,80,0.1196274310350418,out,6
2040,Row2339,Row3122,CHEMBL450225,,0,652.89,21bg,IC50,=,28000.0,nM,CC(C)c1ccc(CN(Cc2ccc(cc2)C(C)C)c3ccc(cc3)NC(=O)c4cc(c(cc4)NCCNC(N)=N)-c5ccccc5)cc1,,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,CC(C)c1ccc(CN(Cc2ccc(cc2)C(C)C)c3ccc(cc3)NC(=O)c4cc(c(cc4)NCCNC(N)=N)-c5ccccc5)cc1,,Row1533,98,0.1264882981777191,out,6
2041,Row2340,Row3361,CHEMBL3679725,,0,347.33,BDBM103039,IC50,=,28000.0,nM,Fc1cccc(F)c1-c2nnc3-c4ccccc4Nc5ncccc5-n23,,220761.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,Fc1cccc(F)c1-c2nnc3-c4ccccc4Nc5ncccc5-n23,,Row3389,81,0.1219549775123596,out,6
2042,Row2341,Row2587,CHEMBL3679719,,0,361.41,BDBM103033,IC50,=,29000.0,nM,c1c(ccc2ccccc21)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,220755.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,c1c(ccc2ccccc21)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,Row3389,81,0.1509116888046264,out,6
2043,Row2342,Row257,CHEMBL489058,,0,558.15,5m,IC50,>,30000.0,nM,Cn1ccnc1Sc2ccc(cc2Cl)Nc3c4ccc(cc4ncc3C#N)/C=C/CCN5CCN(CC5)CC,,,CHEMBL991663,Inhibition of AKT in presence of 20 uM ATP,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142456,1,Scientific Literature,Bioorg. Med. Chem.,2008.0,Cn1ccnc1Sc2ccc(cc2Cl)Nc3c4ccc(cc4ncc3C#N)/C=C/CCN5CCN(CC5)CC,,Row1163,23,0.0942270159721374,out,6
2044,Row2343,Row446,CHEMBL103667,DORAMAPIMOD,2,527.67,"2, BIRB-796",IC50,>,30000.0,nM,Cc1ccc(cc1)-n2nc(cc2NC(=O)Nc3ccc(OCCN4CCOCC4)c5ccccc35)C(C)(C)C,,,CHEMBL1932322,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1926590,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,Cc1ccc(cc1)-n2nc(cc2NC(=O)Nc3ccc(OCCN4CCOCC4)c5ccccc35)C(C)(C)C,,Row2492,83,0.1130765154957771,out,6
2045,Row2344,Row912,CHEMBL1933552,,0,432.54,26,IC50,>,30000.0,nM,C[C@@H]1CCC(CN1)N2C[C@@]3(CN(C(=O)c4cc5ccc(F)cc5[nH]4)c6ccccc36)CC2,,,CHEMBL1935935,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1933021,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2012.0,C[C@@H]1CCC(CN1)N2C[C@@]3(CN(C(=O)c4cc5ccc(F)cc5[nH]4)c6ccccc36)CC2,,Row1315,22,0.1248145401477813,out,6
2046,Row2345,Row974,CHEMBL1929238,,0,554.54,27,IC50,>,30000.0,nM,CN(C)CCN1CCN(CCC1=O)C(=O)c2cc(sc2NC(=O)Nc3cccc(Cl)c3Cl)C(C)(C)C,,,CHEMBL1932322,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1926590,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CN(C)CCN1CCN(CCC1=O)C(=O)c2cc(sc2NC(=O)Nc3cccc(Cl)c3Cl)C(C)(C)C,,Row2492,83,0.0954019874334335,out,6
2047,Row2346,Row1092,CHEMBL4448494,,0,506.61,3c,IC50,>,30000.0,nM,CN(C)CCN1Cc2ccc(Nc3nc(-c4cc(F)c5nc(C)n(C(C)C)c5c4)c(F)cn3)nc2CC1,,,CHEMBL4305834,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4304763,1,Scientific Literature,Eur J Med Chem,2019.0,CN(C)CCN1Cc2ccc(Nc3nc(-c4cc(F)c5nc(C)n(C(C)C)c5c4)c(F)cn3)nc2CC1,,Row1867,42,0.1084054335951805,out,6
2048,Row2347,Row1375,CHEMBL237570,,0,467.59,23,IC50,>,30000.0,nM,Cc1cc(ccc1-c2nc(c(-c3cc4ccc(cc4cc3)OC)n2C)-c5ccncc5)[S+](C)[O-],,,CHEMBL899824,Inhibition of AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1137478,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,Cc1cc(ccc1-c2nc(c(-c3cc4ccc(cc4cc3)OC)n2C)-c5ccncc5)[S+](C)[O-],,Row199,52,0.1382395029067993,out,6
2049,Row2348,Row1423,CHEMBL2312301,,0,466.59,29,IC50,>,30000.0,nM,COc1ccccc1CNc2nc(NC3CCCC3)c(cn2)C(=O)NCCCN4CCCC4=O,,,CHEMBL2319139,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2311468,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2013.0,COc1ccccc1CNc2nc(NC3CCCC3)c(cn2)C(=O)NCCCN4CCCC4=O,,Row3186,60,0.1290780305862426,out,6
2050,Row2349,Row1424,CHEMBL2381601,,0,384.87,8e,IC50,>,30000.0,nM,NC(=O)c1cnc(N[C@@H]2CC[C@@H](N)CC2)c3nc(cn31)-c4ccc(Cl)cc4,,,CHEMBL2383903,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2380230,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2013.0,NC(=O)c1cnc(N[C@@H]2CC[C@@H](N)CC2)c3nc(cn31)-c4ccc(Cl)cc4,,Row1206,41,0.1294015944004058,out,6
2051,Row2350,Row1485,CHEMBL2312645,,0,438.58,11,IC50,=,30000.0,nM,CN1CCC(CC1)NC(=O)c2cnc(NCc3ccccc3OC)nc2NC4CCCC4,,,CHEMBL2317787,Inhibition of AKT1 (unknown origin) in presence of ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2311250,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2013.0,CN1CCC(CC1)NC(=O)c2cnc(NCc3ccccc3OC)nc2NC4CCCC4,,Row3186,60,0.1309236288070678,out,6
2052,Row2351,Row1554,CHEMBL3818247,,0,461.48,4d,IC50,>,30000.0,nM,Cn1cc(cn1)-c2cn3c(nnc3c(F)c2)Sc4cc5c6OCC(=O)N(C)c6cnc5cc4,,,CHEMBL3820468,Inhibition of AKT1 (unknown origin) incubated for 1 hr by spectrophotometric analysis,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3817824,1,Scientific Literature,Bioorg. Med. Chem.,2016.0,Cn1cc(cn1)-c2cn3c(nnc3c(F)c2)Sc4cc5c6OCC(=O)N(C)c6cnc5cc4,,Row148,95,0.1045781075954437,out,6
2053,Row2352,Row1818,CHEMBL1270331,,0,548.11,8p,IC50,=,30000.0,nM,Cc1c(Cl)cccc1S(=O)(=O)Nc2nc(NCCc3ccccc3)nc4CCN(Cc5ccccc5)Cc42,,,CHEMBL1274490,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1268914,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,Cc1c(Cl)cccc1S(=O)(=O)Nc2nc(NCCc3ccccc3)nc4CCN(Cc5ccccc5)Cc42,,Row2452,66,0.1141726523637771,out,6
2054,Row2353,Row1900,CHEMBL2312649,,0,520.51,15,IC50,=,30000.0,nM,CN(C)C1CCC(CC1)Nc2nc(Nc3cc(Cl)cc(Cl)c3)ncc2C(=O)NC4CCN(C)CC4,,,CHEMBL2317787,Inhibition of AKT1 (unknown origin) in presence of ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2311250,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2013.0,CN(C)C1CCC(CC1)Nc2nc(Nc3cc(Cl)cc(Cl)c3)ncc2C(=O)NC4CCN(C)CC4,,Row3186,60,0.0834674686193466,out,6
2055,Row2354,Row1982,CHEMBL2312304,,0,507.42,32,IC50,>,30000.0,nM,O=C1OCCN1CCCNC(=O)c2cnc(NCc3cc(Cl)ccc3Cl)nc2NC4CCCC4,,,CHEMBL2319139,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2311468,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2013.0,O=C1OCCN1CCCNC(=O)c2cnc(NCc3cc(Cl)ccc3Cl)nc2NC4CCCC4,,Row3186,60,0.1155823767185211,out,6
2056,Row2355,Row1991,CHEMBL2312652,,0,481.38,19,IC50,=,30000.0,nM,CN1CCC(CC1)NC(=O)c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2N[C@@H]4COC[C@H]4O,,,CHEMBL2317787,Inhibition of AKT1 (unknown origin) in presence of ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2311250,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2013.0,CN1CCC(CC1)NC(=O)c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2N[C@@H]4COC[C@H]4O,,Row3186,60,0.0931894108653068,out,6
2057,Row2356,Row2400,CHEMBL1938680,,0,381.86,1,IC50,>,30000.0,nM,O=C(Nc1ccc(cc1)N2CCNCC2)c3ccc(o3)-c4ccc(Cl)cc4,,,CHEMBL2019915,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2016522,1,Scientific Literature,ACS Med. Chem. Lett.,2011.0,O=C(Nc1ccc(cc1)N2CCNCC2)c3ccc(o3)-c4ccc(Cl)cc4,,Row39,44,0.0992650911211967,out,6
2058,Row2357,Row2655,CHEMBL3104853,,0,212.2,5,IC50,>,30000.0,nM,Cc1c(COC)c(C=O)c(O)c(O)c1O,,,CHEMBL3108329,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3102702,1,Scientific Literature,J. Nat. Prod.,2014.0,Cc1c(COC)c(C=O)c(O)c(O)c1O,,Row2857,89,0.030601505190134,out,6
2059,Row2358,Row2730,CHEMBL271190,,0,547.65,8,IC50,>,30000.0,nM,CC(C)(C)N(CCO)/C=C/1\C2=C(O)C(=O)C=3[C@@H]4CC[C@H](O)[C@@]4(C)C[C@@H](OC(C)=O)C3[C@@]2(C)[C@@H](COC)OC1=O,,,CHEMBL950970,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143164,1,Scientific Literature,J. Med. Chem.,2008.0,CC(C)(C)N(CCO)/C=C/1\C2=C(O)C(=O)C=3[C@@H]4CC[C@H](O)[C@@]4(C)C[C@@H](OC(C)=O)C3[C@@]2(C)[C@@H](COC)OC1=O,,Row2492,83,0.063012845814228,out,6
2060,Row2359,Row2736,CHEMBL3679717,,0,379.35,BDBM103031,IC50,=,30000.0,nM,FC(F)(F)c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23,,220753.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,FC(F)(F)c1ccc(cc1)-c2nnc3-c4ccccc4Nc5ncccc5-n23,,Row3389,81,0.1429542303085327,out,6
2061,Row2360,Row2934,CHEMBL410643,,0,546.66,13,IC50,>,30000.0,nM,CN(C)CCCN(C)/C=C\1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C=3[C@@H]4CC[C@H](O)[C@@]4(C)C[C@@H](OC(C)=O)C23,,,CHEMBL950970,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143164,1,Scientific Literature,J. Med. Chem.,2008.0,CN(C)CCCN(C)/C=C\1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C=3[C@@H]4CC[C@H](O)[C@@]4(C)C[C@@H](OC(C)=O)C23,,Row2492,83,0.0703059285879135,out,6
2062,Row2361,Row3233,CHEMBL3104852,,0,226.18,3,IC50,>,30000.0,nM,Cc1c2C(OC(=O)c2c(O)c(O)c1O)OC,,,CHEMBL3108329,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3102702,1,Scientific Literature,J. Nat. Prod.,2014.0,Cc1c2C(OC(=O)c2c(O)c(O)c1O)OC,,Row2857,89,0.0419255085289478,out,6
2063,Row2362,Row3477,CHEMBL2312290,,0,510.64,18,IC50,>,30000.0,nM,COc1ccc(CCNc2nc(NC3CCCC3)c(cn2)C(=O)NCCCN4CCCC4=O)cc1OC,,,CHEMBL2319139,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2311468,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2013.0,COc1ccc(CCNc2nc(NC3CCCC3)c(cn2)C(=O)NCCCN4CCCC4=O)cc1OC,,Row3186,60,0.111514888703823,out,6
2064,Row2363,Row3493,CHEMBL2312303,,0,505.45,31,IC50,>,30000.0,nM,O=C1CCCN1CCCNC(=O)c2cnc(NCc3cc(Cl)ccc3Cl)nc2NC4CCCC4,,,CHEMBL2319139,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2311468,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2013.0,O=C1CCCN1CCCNC(=O)c2cnc(NCc3cc(Cl)ccc3Cl)nc2NC4CCCC4,,Row3186,60,0.1099681705236435,out,6
2065,Row2364,Row3501,CHEMBL3356117,,0,484.98,4,IC50,>,30000.0,nM,CC(=O)c1ccc(cc1)N2CCN(CC2)C(=O)CN3C[C@@H](CC3)C(=O)Nc4cc(Cl)c(O)cc4,,,CHEMBL3376471,Inhibition of AKT1 (unknown origin),B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3351461,1,Scientific Literature,J. Med. Chem.,2014.0,CC(=O)c1ccc(cc1)N2CCN(CC2)C(=O)CN3C[C@@H](CC3)C(=O)Nc4cc(Cl)c(O)cc4,,Row2863,37,0.081243485212326,out,6
2066,Row2365,Row3161,CHEMBL3596523,,0,351.77,BDBM112784,IC50,=,31000.0,nM,[O-][N+](=O)c1cc(NC(=S)NC(=O)c2ccccc2)c(O)c(Cl)c1,,234063.0,CHEMBL3706030,"Fluorescence Polarization Assay: In order to identify compounds that disrupt the interaction between PIP3 and PH domains, a high-throughput fluorescence polarization (FP)-binding assay was developed using recombinant 1-123 amino acid N-terminal fragment of human Akt1 (also referred to herein simply as Akt), encompassing the PH domain (PH123 protein), and fluorescent NBD-labeled PIP3 molecule. The amino acid sequence of human Akt1 is publicly available as, for example, GenBank Accession No. NP001014432.1 (SEQ ID NO:1), and the corresponding DNA sequence is publicly available as, for example, GenBank Accession No. NM001014432. Briefly, 5 M recombinant GST fusion proteins containing 1-123 a.a. N-terminal fragment of human Akt1 (PH 123) or 100 nM 441-551 a.a. region of human PDK1 were incubated with 15 nM TMR-labeled PIP3, PIP2, or PIP5 in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 5 mM b-ME for 15 min at room temperature in the dark.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638437,37,BindingDB Database,,2014.0,[O-][N+](=O)c1cc(NC(=S)NC(=O)c2ccccc2)c(O)c(Cl)c1,,Row438,85,0.0956402793526649,out,6
2067,Row2366,Row2297,CHEMBL204892,,0,387.44,9f,IC50,=,31280.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc(cc4)C(O)=O,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc(cc4)C(O)=O,,Row1996,15,0.1312638074159622,out,6
2068,Row2367,Row2977,CHEMBL3818018,,0,584.77,3a,IC50,=,31330.0,nM,CCCCCCCCCCCCCCCCCC(=O)OCC(CO)O[C@@H]1O[C@H](CS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]1O,,,CHEMBL3821461,Inhibition of human Akt1 PH domain using AKTide-2T as substrate by ELISA,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3817785,1,Scientific Literature,Bioorg. Med. Chem.,2016.0,CCCCCCCCCCCCCCCCCC(=O)OCC(CO)O[C@@H]1O[C@H](CS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]1O,,Row1816,79,0.0536089651286602,out,6
2069,Row2368,Row1262,CHEMBL414861,,0,348.41,4a,IC50,=,31950.0,nM,N[C@@H](Cc1ccccc1)COc2cncc(c2)NC(=O)c3ccncc3,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1ccccc1)COc2cncc(c2)NC(=O)c3ccncc3,,Row615,77,0.1373527944087982,out,6
2070,Row2369,Row1885,CHEMBL448803,,0,552.64,36b,IC50,=,32000.0,nM,NC(=N)NCC(=O)Nc1ccc(cc1)-c2cc3cc(ccc3[nH]2)N(Cc4ccc(cc4)C#N)Cc5ccc(cc5)C#N,,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,NC(=N)NCC(=O)Nc1ccc(cc1)-c2cc3cc(ccc3[nH]2)N(Cc4ccc(cc4)C#N)Cc5ccc(cc5)C#N,,Row1533,98,0.0988284423947334,out,6
2071,Row2370,Row1592,CHEMBL206328,,0,436.35,13,IC50,=,32250.0,nM,Brc1ccc(/C=C/CNCCOc2cc(cnc2)/C=C/c3ccncc3)cc1,,,CHEMBL1049250,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154070,1,Scientific Literature,Eur. J. Med. Chem.,2009.0,Brc1ccc(/C=C/CNCCOc2cc(cnc2)/C=C/c3ccncc3)cc1,,Row615,77,0.0724679678678512,out,6
2072,Row2371,Row397,CHEMBL383702,,0,436.54,9p,IC50,=,33010.0,nM,CS(=O)(=O)Nc1ccc(cc1)-c2cncc(c2)OC[C@@H](N)Cc3c[nH]c4ccccc34,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CS(=O)(=O)Nc1ccc(cc1)-c2cncc(c2)OC[C@@H](N)Cc3c[nH]c4ccccc34,,Row1726,2,0.1347385644912719,out,6
2073,Row2372,Row117,CHEMBL206581,,0,411.47,9q,IC50,=,33160.0,nM,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc(cc4)-c5n[nH]nn5,,,CHEMBL862611,Inhibition of Akt1 at 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146102,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1c[nH]c2ccccc12)COc3cncc(c3)-c4ccc(cc4)-c5n[nH]nn5,,Row1726,2,0.1464437991380691,out,6
2074,Row2373,Row2966,CHEMBL245965,,0,1045.26,11,IC50,=,36000.0,nM,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc2ccc(cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCCc4cc5ccccc5cc4,,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc2ccc(cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCCc4cc5ccccc5cc4,,Row466,80,0.117562748491764,out,6
2075,Row2374,Row1876,CHEMBL447960,,0,702.95,21cg,IC50,=,38000.0,nM,CC(C)c1ccc(CN(Cc2ccc(cc2)C(C)C)c3ccc(cc3)NC(=O)c4cc(c(cc4)NCCNC(N)=N)-c5cc6ccccc6cc5)cc1,,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,CC(C)c1ccc(CN(Cc2ccc(cc2)C(C)C)c3ccc(cc3)NC(=O)c4cc(c(cc4)NCCNC(N)=N)-c5cc6ccccc6cc5)cc1,,Row1533,98,0.1086186692118644,out,6
2076,Row2375,Row2519,CHEMBL3361128,,0,254.24,S6,IC50,=,38600.0,nM,Oc1ccc(/C=C\2/Oc3ccccc3C2=O)cc1O,,,CHEMBL3372235,Inhibition of recombinant AKT1 (unknown origin) after 60 mins by z'-lyte kinase assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3351909,1,Scientific Literature,Eur. J. Med. Chem.,2015.0,Oc1ccc(/C=C\2/Oc3ccccc3C2=O)cc1O,,Row2857,89,0.1084276363253593,out,6
2077,Row2376,Row1371,CHEMBL210337,,0,424.5,10m,IC50,=,39500.0,nM,COc1nccc2cc(ccc21)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc54,,,CHEMBL861320,Inhibition of Akt1 at 5 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1147830,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,COc1nccc2cc(ccc21)-c3cncc(c3)OC[C@@H](N)Cc4c[nH]c5ccccc54,,Row1996,15,0.1406422555446624,out,6
2078,Row2377,Row971,CHEMBL2017214,,0,422.56,8,IC50,>,40000.0,nM,CSc1ccccc1Nc2nc(nc3c(NCC4CC4)ncnc32)N5CCNCC5,,,CHEMBL2019658,Inhibition of AKT1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2016462,1,Scientific Literature,ACS Med. Chem. Lett.,2011.0,CSc1ccccc1Nc2nc(nc3c(NCC4CC4)ncnc32)N5CCNCC5,,Row286,88,0.125776007771492,out,6
2079,Row2378,Row1833,CHEMBL1922692,,0,676.82,"8, diastereomeric mixture",IC50,=,40200.0,nM,CC(C)[C@H](NC(=O)[C@@H]1CC[C@H]2[C@@H](COC(=O)N12)NC(=O)CCCCNC(N)=N)C(=O)NC(Cc3ccccc3)C(=O)NCc4ccccc4,,,CHEMBL1924333,Inhibition of His-tagged ATP-binding domain of AKT1 assessed as GRPRTSSFAEG crosstide phosphorylation using [33P]ATP,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1921701,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CC(C)[C@H](NC(=O)[C@@H]1CC[C@H]2[C@@H](COC(=O)N12)NC(=O)CCCCNC(N)=N)C(=O)NC(Cc3ccccc3)C(=O)NCc4ccccc4,,Row466,80,0.1264523714780807,out,6
2080,Row2379,Row411,CHEMBL3942274,,0,328.32,BDBM181348,IC50,=,41000.0,nM,NC(=O)c1ccc(NCCc2cc(F)c(F)cc2)c3cncnc31,,328362.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(NCCc2cc(F)c(F)cc2)c3cncnc31,,Row2156,90,0.0934982970356941,out,6
2081,Row2380,Row949,CHEMBL2036727,,0,335.8,2c,IC50,=,41000.0,nM,Cn1c(nc2ccccc12)-c3ccnc(Nc4ccc(Cl)cc4)n3,,,CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2034932,1,Scientific Literature,Eur. J. Med. Chem.,2012.0,Cn1c(nc2ccccc12)-c3ccnc(Nc4ccc(Cl)cc4)n3,,Row1528,84,0.1299535483121872,out,6
2082,Row2381,Row2220,CHEMBL396643,,0,896.06,18,IC50,=,41000.0,nM,CC(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc2ccc(cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCc4ccccc4,,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc2ccc(cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCc4ccccc4,,Row466,80,0.1192098930478096,out,6
2083,Row2382,Row2567,CHEMBL3684517,,0,523.6,BDBM103231,IC50,=,41000.0,nM,CC(C)(C)OC(=O)N1CCN(CC1)C(=O)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,220968.0,CHEMBL3705043,Biochemical Assay: Biochemical assay using CisBio KinEASE HTRF Assay technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CC(C)(C)OC(=O)N1CCN(CC1)C(=O)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,Row2783,67,0.1454195976257324,out,6
2084,Row2384,Row1886,CHEMBL453745,,0,668.85,21bf,IC50,=,43000.0,nM,NC(=N)NCCNc1ccc(cc1-c2ccccc2)C(=O)Nc3ccc(cc3)N(Cc4cccc5ccccc45)Cc6cccc7ccccc67,,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,NC(=N)NCCNc1ccc(cc1-c2ccccc2)C(=O)Nc3ccc(cc3)N(Cc4cccc5ccccc45)Cc6cccc7ccccc67,,Row1533,98,0.141510397195816,out,6
2085,Row2385,Row903,CHEMBL203004,,0,331.42,6e,IC50,=,43010.0,nM,N[C@@H](Cc1ccccc1)COc2ccc(cn2)/C=C/c3ccncc3,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,N[C@@H](Cc1ccccc1)COc2ccc(cn2)/C=C/c3ccncc3,,Row615,77,0.1312178671360016,out,6
2086,Row2386,Row3832,CHEMBL372764,PERIFOSINE,3,461.67,Perifosine,IC50,=,43350.0,nM,CCCCCCCCCCCCCCCCCCOP([O-])(=O)OC1CC[N+](C)(C)CC1,,,CHEMBL3821461,Inhibition of human Akt1 PH domain using AKTide-2T as substrate by ELISA,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3817785,1,Scientific Literature,Bioorg. Med. Chem.,2016.0,CCCCCCCCCCCCCCCCCCOP([O-])(=O)OC1CC[N+](C)(C)CC1,,Row2387,28,0.0454747639596462,out,6
2087,Row2387,Row2036,CHEMBL444730,,0,618.79,22fa,IC50,=,44000.0,nM,NC(=N)NCCNc1ccc(cc1-c2cc3ccccc3cc2)C(=O)Nc4ccc(cc4)N(Cc5ccccc5)Cc6ccccc6,,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,NC(=N)NCCNc1ccc(cc1-c2cc3ccccc3cc2)C(=O)Nc4ccc(cc4)N(Cc5ccccc5)Cc6ccccc6,,Row1533,98,0.1245555877685546,out,6
2088,Row2388,Row3444,CHEMBL459729,,0,512.03,"10, BMS-695735",IC50,=,48390.0,nM,Cc1cc(cc2[nH]c(nc21)-c3c(=O)[nH]ccc3NCCn4cc(Cl)cn4)C5CCN(CCCF)CC5,,,CHEMBL980899,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140084,1,Scientific Literature,J. Med. Chem.,2008.0,Cc1cc(cc2[nH]c(nc21)-c3c(=O)[nH]ccc3NCCn4cc(Cl)cn4)C5CCN(CCCF)CC5,,Row1206,41,0.0893147140741348,out,6
2089,Row2389,Row1548,CHEMBL3109404,,0,372.51,8,IC50,=,48400.0,nM,CC1=CCC[C@@H]2[C@@]1(C)CC[C@H](C)[C@@]2(C)Cc3cc(cc(O)c3O)C(=O)OC,,,CHEMBL3111649,Inhibition of recombinant AKT1 (unknown origin) using GSK3 (14 to 27) as substrate assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3108666,1,Scientific Literature,J. Nat. Prod.,2014.0,CC1=CCC[C@@H]2[C@@]1(C)CC[C@H](C)[C@@]2(C)Cc3cc(cc(O)c3O)C(=O)OC,,Row943,100,0.0932936146855354,out,6
2090,Row2390,Row207,CHEMBL561708,,0,495.54,19,IC50,>,50000.0,nM,COC(=O)N1CCC(CC1)n2ncc3c2nc(nc3N4CCOCC4)-c5ccc(cc5)NC(=O)OC,,,CHEMBL1060460,Inhibition of PKBalpha after 1 hr by mobility shift electrophoresis assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1151963,1,Scientific Literature,J. Med. Chem.,2009.0,COC(=O)N1CCC(CC1)n2ncc3c2nc(nc3N4CCOCC4)-c5ccc(cc5)NC(=O)OC,,Row286,88,0.108988307416439,out,6
2091,Row2391,Row683,CHEMBL3099613,,0,176.21,5,IC50,=,50000.0,nM,COC/C=C/C(=O)c1ccccc1,,,CHEMBL3100280,Inhibition of recombinant AKT1 (unknown origin) using serine/threonine 06 peptide as substrate after 1 hr by FRET based Z'-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3098129,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2014.0,COC/C=C/C(=O)c1ccccc1,,Row266,82,0.1179783642292022,out,6
2092,Row2392,Row724,CHEMBL221222,,0,318.79,6a,IC50,>,50000.0,nM,Cc1cc(cc(C)c1)SC2=C(Cl)C(=O)c3[nH]ncc3C2=O,,,CHEMBL908452,Inhibition of Akt1 activity assessed as decrease in GSK3 phosphorylation,F,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145295,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Cc1cc(cc(C)c1)SC2=C(Cl)C(=O)c3[nH]ncc3C2=O,,Row788,92,0.061863325536251,out,6
2093,Row2393,Row752,CHEMBL1089082,,0,459.43,9,IC50,>,50000.0,nM,O=C(Nc1cc(ccc1)-c2ccnc3cc(nn32)-c4ccncc4)c5cc(ccc5)C(F)(F)F,,,CHEMBL1109839,Inhibition of PKBalpha,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1156255,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,O=C(Nc1cc(ccc1)-c2ccnc3cc(nn32)-c4ccncc4)c5cc(ccc5)C(F)(F)F,,Row2783,67,0.1119167804718017,out,6
2094,Row2394,Row788,CHEMBL223410,,0,291.67,5c,IC50,>,50000.0,nM,O=C1C(Cl)=C(Nc2ccc(F)cc2)C(=O)c3cn[nH]c13,,,CHEMBL908452,Inhibition of Akt1 activity assessed as decrease in GSK3 phosphorylation,F,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145295,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,O=C1C(Cl)=C(Nc2ccc(F)cc2)C(=O)c3cn[nH]c13,,Row788,92,0.0740863308310508,out,6
2095,Row2395,Row789,CHEMBL425904,,0,374.83,2d,IC50,>,50000.0,nM,CC(CN(C)C)Oc1ccc(Cl)cc1NC(=O)Nc2cnc(cn2)C#N,,,CHEMBL829440,"Inhibition of Protein kinase B, alpha (Akt1)",B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1143624,1,Scientific Literature,J. Med. Chem.,2005.0,CC(CN(C)C)Oc1ccc(Cl)cc1NC(=O)Nc2cnc(cn2)C#N,,Row2492,83,0.0780935436487197,out,6
2096,Row2396,Row793,CHEMBL259922,,0,411.43,2x,IC50,>,50000.0,nM,Cc1ccc(cc1Nc2ncnc3c2cnn3-c4ccccc4)C(=O)Nc5ccon5,,,CHEMBL922525,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1144728,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Cc1ccc(cc1Nc2ncnc3c2cnn3-c4ccccc4)C(=O)Nc5ccon5,,Row2454,78,0.1240097358822822,out,6
2097,Row2397,Row888,CHEMBL3822972,,0,336.38,Compound 1,IC50,>,50000.0,nM,COc1cc2ncccc2cc1NC(=O)c3csc4cncnc34,,,CHEMBL4004227,Inhibition of recombinant human N-terminal GST-tagged AKT1 catalytic domain (104 to 480 residues) expressed in baculovirus expression system,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4002626,1,Scientific Literature,Bioorg Med Chem Lett,2017.0,COc1cc2ncccc2cc1NC(=O)c3csc4cncnc34,,Row2156,90,0.1053430140018463,out,6
2098,Row2398,Row900,CHEMBL205836,,0,355.44,7b,IC50,>,50000.0,nM,C(CCOc1cncc(c1)/C=C/c2ccncc2)c3c[nH]c4ccccc34,,,CHEMBL867719,Inhibition of Akt1 using 10 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146058,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,C(CCOc1cncc(c1)/C=C/c2ccncc2)c3c[nH]c4ccccc34,,Row77,56,0.1155464500188827,out,6
2099,Row2399,Row928,CHEMBL1915460,,0,388.48,HTS-02143,IC50,>,50000.0,nM,CC(=O)Nc1cc(ccc1)-n2nc(nn2)SCC(=O)NCc3cccs3,,,CHEMBL1918853,Inhibition of GST-tagged PKB/Akt1 incubated for 5 mins before eNOS substrate and ATP addition measured after 30 mins by kinase assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1914446,1,Scientific Literature,Eur. J. Med. Chem.,2011.0,CC(=O)Nc1cc(ccc1)-n2nc(nn2)SCC(=O)NCc3cccs3,,Row662,76,0.0825005769729614,out,6
2100,Row2400,Row1074,CHEMBL1081198,,0,503.49,2,IC50,=,50000.0,nM,O=C(Nc1cc(ccc1)-c2cn3ccnc3c(NCc4ccncc4)n2)Nc5cc(ccc5)C(F)(F)F,,,CHEMBL1109421,Inhibition of Akt after 1 hr,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1153704,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,O=C(Nc1cc(ccc1)-c2cn3ccnc3c(NCc4ccncc4)n2)Nc5cc(ccc5)C(F)(F)F,,Row662,76,0.1227217018604278,out,6
2101,Row2401,Row1260,CHEMBL602472,,0,419.28,14,IC50,>,50000.0,nM,C[C@@H](Oc1cc2cc(cnc2cc1)C3CC3C(N)=O)c4c(Cl)c(F)ccc4Cl,,,CHEMBL1066414,Inhibition of recombinant AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1156877,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,C[C@@H](Oc1cc2cc(cnc2cc1)C3CC3C(N)=O)c4c(Cl)c(F)ccc4Cl,,Row3192,40,0.0952723398804664,out,6
2102,Row2402,Row1269,CHEMBL223360,LINIFANIB,3,375.41,"17p, ABT-869",IC50,=,50000.0,nM,Cc1cc(NC(=O)Nc2ccc(cc2)-c3cccc4[nH]nc(N)c43)c(F)cc1,,,CHEMBL919919,Inhibition of AKT using 5 to 10 ATP umol/L,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1142982,1,Scientific Literature,J. Med. Chem.,2007.0,Cc1cc(NC(=O)Nc2ccc(cc2)-c3cccc4[nH]nc(N)c43)c(F)cc1,,Row662,76,0.13908651471138,out,6
2103,Row2403,Row1322,CHEMBL362016,,0,533.68,13f,IC50,>,50000.0,nM,CC(C)Cc1nc(-c2ccc(CN3CCC(CC3)n4c(O)nc5ccccc45)cc2)c(nc1O)-c6ccccc6,,,CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141888,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,CC(C)Cc1nc(-c2ccc(CN3CCC(CC3)n4c(O)nc5ccccc45)cc2)c(nc1O)-c6ccccc6,,Row31,68,0.1787527501583099,out,6
2104,Row2404,Row1531,CHEMBL505490,,0,995.2,3,IC50,=,50000.0,nM,CC(C)[C@H](NC(=O)c1cc(C)c(cc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(C)=O)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCc4ccccc4,,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,CC(C)[C@H](NC(=O)c1cc(C)c(cc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(C)=O)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCc4ccccc4,,Row466,80,0.1173953264951706,out,6
2105,Row2405,Row1560,CHEMBL209148,,0,623.85,3,IC50,>,50000.0,nM,CC(=O)N1CCN(CC1)C(=O)c2cc(Sc3cnc(NC(=O)c4ccc(CNC(C)C(C)(C)C)cc4)s3)c(C)cc2OC,,,CHEMBL865417,Inhibition of Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138957,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,CC(=O)N1CCN(CC1)C(=O)c2cc(Sc3cnc(NC(=O)c4ccc(CNC(C)C(C)(C)C)cc4)s3)c(C)cc2OC,,Row3589,19,0.0863350108265876,out,6
2106,Row2406,Row1653,CHEMBL1779202,,0,425.53,27,IC50,>,50000.0,nM,CC1(C)c2[nH]c3cc(ccc3c2C(=O)c4ccc(cc14)C5CCN(CC5)C6COC6)C#N,,,CHEMBL1781778,Inhibition of AKT1 assessed as FI-H1-peptide phosphorylation by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1777813,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2011.0,CC1(C)c2[nH]c3cc(ccc3c2C(=O)c4ccc(cc14)C5CCN(CC5)C6COC6)C#N,,Row2123,58,0.1176555827260017,out,6
2107,Row2407,Row1683,CHEMBL3143722,,0,567.69,14c,IC50,>,50000.0,nM,O=c1[nH]c2ccccc2n1C3CCN(Cc4ccc(cc4)-c5[nH]c(=O)c(Cc6ccccc6)nc5-c7ccccc7)CC3,,,CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141888,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,O=c1[nH]c2ccccc2n1C3CCN(Cc4ccc(cc4)-c5[nH]c(=O)c(Cc6ccccc6)nc5-c7ccccc7)CC3,,Row2123,58,0.1670353710651397,out,6
2108,Row2408,Row1687,CHEMBL376871,,0,148.17,3,IC50,>,50000.0,nM,Nc1ccc(N)c2cn[nH]c12,,,CHEMBL908452,Inhibition of Akt1 activity assessed as decrease in GSK3 phosphorylation,F,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145295,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Nc1ccc(N)c2cn[nH]c12,,Row788,92,0.1035999879240989,out,6
2109,Row2409,Row1717,CHEMBL602471,,0,405.26,(R)-3,IC50,>,50000.0,nM,C[C@@H](Oc1cc2cc(cnc2cc1)/C=C/C(N)=O)c3c(Cl)c(F)ccc3Cl,,,CHEMBL1066414,Inhibition of recombinant AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1156877,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,C[C@@H](Oc1cc2cc(cnc2cc1)/C=C/C(N)=O)c3c(Cl)c(F)ccc3Cl,,Row77,56,0.0932584255933761,out,6
2110,Row2410,Row1782,CHEMBL3143723,,0,583.69,14d,IC50,>,50000.0,nM,Oc1ccc(Cc2nc(c([nH]c2=O)-c3ccc(CN4CCC(CC4)n5c6ccccc6[nH]c5=O)cc3)-c7ccccc7)cc1,,,CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141888,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,Oc1ccc(Cc2nc(c([nH]c2=O)-c3ccc(CN4CCC(CC4)n5c6ccccc6[nH]c5=O)cc3)-c7ccccc7)cc1,,Row2123,58,0.1622055470943451,out,6
2111,Row2411,Row2131,CHEMBL3143721,,0,533.68,14e,IC50,>,50000.0,nM,CC(CC)c1nc(c([nH]c1=O)-c2ccc(CN3CCC(CC3)n4c5ccccc5[nH]c4=O)cc2)-c6ccccc6,,,CHEMBL832603,"Inhibitory concentration against human Protein kinase B, alpha ",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141888,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2005.0,CC(CC)c1nc(c([nH]c1=O)-c2ccc(CN3CCC(CC3)n4c5ccccc5[nH]c4=O)cc2)-c6ccccc6,,Row2123,58,0.1680178195238113,out,6
2112,Row2412,Row2531,CHEMBL600795,,0,336.19,(R)-2,IC50,>,50000.0,nM,C[C@@H](Oc1cc2cccnc2cc1)c3c(Cl)c(F)ccc3Cl,,,CHEMBL1066414,Inhibition of recombinant AKT1 by IMAP assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1156877,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2010.0,C[C@@H](Oc1cc2cccnc2cc1)c3c(Cl)c(F)ccc3Cl,,Row1473,59,0.0881164968013763,out,6
2113,Row2413,Row2606,CHEMBL1823221,,0,454.57,13d,IC50,>,50000.0,nM,CCc1cc2C(=O)c3c([nH]c4cc(ccc43)C#N)C(C)(C)c2cc1N5CCN(CC5)C6COC6,,,CHEMBL1828185,Inhibition of AKT1 activity by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1821705,1,Scientific Literature,J. Med. Chem.,2011.0,CCc1cc2C(=O)c3c([nH]c4cc(ccc43)C#N)C(C)(C)c2cc1N5CCN(CC5)C6COC6,,Row2123,58,0.1147744879126548,out,6
2114,Row2414,Row2627,CHEMBL223464,,0,309.66,5d,IC50,>,50000.0,nM,O=C1C(Cl)=C(Nc2cc(F)cc(F)c2)C(=O)c3cn[nH]c13,,,CHEMBL908452,Inhibition of Akt1 activity assessed as decrease in GSK3 phosphorylation,F,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1145295,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,O=C1C(Cl)=C(Nc2cc(F)cc(F)c2)C(=O)c3cn[nH]c13,,Row788,92,0.0766219049692154,out,6
2115,Row2415,Row1663,CHEMBL246327,,0,734.9,21,IC50,=,51000.0,nM,CC(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc1ccc(cc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCCc3cc4ccccc4cc3,,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc1ccc(cc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCCc3cc4ccccc4cc3,,Row41,99,0.1053570285439491,out,6
2116,Row2416,Row1520,CHEMBL396589,,0,975.21,12,IC50,=,52000.0,nM,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc2ccc(cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCCCCCC,,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc2ccc(cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCCCCCC,,Row466,80,0.1198236346244812,out,6
2117,Row2417,Row1535,CHEMBL444400,,0,610.81,22ea,IC50,=,52000.0,nM,CC(C)c1ccc(cc1)-c2cc(ccc2NCCNC(N)=N)C(=O)Nc3ccc(cc3)N(Cc4ccccc4)Cc5ccccc5,,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,CC(C)c1ccc(cc1)-c2cc(ccc2NCCNC(N)=N)C(=O)Nc3ccc(cc3)N(Cc4ccccc4)Cc5ccccc5,,Row1533,98,0.1255535930395126,out,6
2118,Row2418,Row2010,CHEMBL1915458,,0,354.36,78,IC50,=,54480.0,nM,CC(C)=CCc1c(O)c2c(=O)cc(oc2cc1O)-c3ccc(O)cc3O,,,CHEMBL1918853,Inhibition of GST-tagged PKB/Akt1 incubated for 5 mins before eNOS substrate and ATP addition measured after 30 mins by kinase assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1914446,1,Scientific Literature,Eur. J. Med. Chem.,2011.0,CC(C)=CCc1c(O)c2c(=O)cc(oc2cc1O)-c3ccc(O)cc3O,,Row2857,89,0.081109382212162,out,6
2119,Row2419,Row2038,CHEMBL448003,,0,604.71,21be,IC50,=,55000.0,nM,NC(=N)NCCNc1ccc(cc1-c2ccccc2)C(=O)Nc3ccc(cc3)N(Cc4ccc(F)cc4)Cc5ccc(F)cc5,,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,NC(=N)NCCNc1ccc(cc1-c2ccccc2)C(=O)Nc3ccc(cc3)N(Cc4ccc(F)cc4)Cc5ccc(F)cc5,,Row1533,98,0.1343787014484405,out,6
2120,Row2420,Row805,CHEMBL3684519,,0,537.62,BDBM103233,IC50,=,56000.0,nM,CC(C)(C)OC(=O)NC1CCN(CC1)C(=O)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,220970.0,CHEMBL3705043,Biochemical Assay: Biochemical assay using CisBio KinEASE HTRF Assay technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CC(C)(C)OC(=O)NC1CCN(CC1)C(=O)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n43,,Row662,76,0.140872836112976,out,6
2121,Row2421,Row3759,CHEMBL3960835,,0,278.32,BDBM181344,IC50,=,57000.0,nM,NC(=O)c1ccc(NCc2ccccc2)c3cncnc31,,328358.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(NCc2ccccc2)c3cncnc31,,Row2156,90,0.1275651603937149,out,6
2122,Row2422,Row467,CHEMBL391132,,0,726.92,36b,IC50,=,58000.0,nM,CC(C)[C@H](NC(=O)c1ccc(cc1)N(CC(=O)NC(C)(C)C)C(=O)CCCCNC(N)=N)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc3ccccc3,,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(C)[C@H](NC(=O)c1ccc(cc1)N(CC(=O)NC(C)(C)C)C(=O)CCCCNC(N)=N)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc3ccccc3,,Row41,99,0.0984755679965019,out,6
2123,Row2423,Row2098,CHEMBL1448,NICLOSAMIDE,4,327.12,5,IC50,=,59400.0,nM,[O-][N+](=O)c1cc(Cl)c(cc1)NC(=O)c2cc(Cl)ccc2O,,,CHEMBL1697109,Inhibition of Akt1 after 60 mins by radiometric assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1687697,1,Scientific Literature,ACS Med. Chem. Lett.,2010.0,[O-][N+](=O)c1cc(Cl)c(cc1)NC(=O)c2cc(Cl)ccc2O,,Row438,85,0.0567874237895011,out,6
2124,Row2424,Row905,CHEMBL193261,,0,408.42,1,IC50,=,60200.0,nM,Cc1c\2c(nc(N)c1C#N)C(C#N)=C(C)/C2=C\c3ccc(o3)-c4cc(ccc4)C(O)=O,,,CHEMBL1108601,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154821,1,Scientific Literature,Eur. J. Med. Chem.,2010.0,Cc1c\2c(nc(N)c1C#N)C(C#N)=C(C)/C2=C\c3ccc(o3)-c4cc(ccc4)C(O)=O,,Row2116,20,0.1160874217748642,out,6
2125,Row2425,Row1529,CHEMBL269433,,0,1045.26,13,IC50,=,62000.0,nM,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc2ccc(cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCCc4cccc5ccccc45,,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc2ccc(cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCCc4cccc5ccccc45,,Row466,80,0.117895059287548,out,6
2126,Row2426,Row3076,CHEMBL3679723,,0,374.45,BDBM103037,IC50,=,67000.0,nM,CN1c2ccccc2-n3c(nnc3-c4ccccc14)-c5cc6ccccc6cc5,,220759.0,CHEMBL3705356,Biochemical Assay: Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,CN1c2ccccc2-n3c(nnc3-c4ccccc14)-c5cc6ccccc6cc5,,Row3389,81,0.1567874103784561,out,6
2127,Row2427,Row2124,CHEMBL44,GENISTEIN,2,270.24,Genistein,IC50,>,70000.0,nM,Oc1cc(O)cc2occ(c(=O)c12)-c3ccc(O)cc3,,,CHEMBL853526,Inhibition of Akt by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138054,1,Scientific Literature,J. Med. Chem.,2006.0,Oc1cc(O)cc2occ(c(=O)c12)-c3ccc(O)cc3,,Row2857,89,0.1061731949448585,out,6
2128,Row2428,Row2704,CHEMBL3972029,,0,279.3,BDBM181309,IC50,=,70000.0,nM,NC(=O)c1ccc(NCc2cnccc2)c3cncnc13,,328332.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(NCc2cnccc2)c3cncnc13,,Row2156,90,0.1078517064452171,out,6
2129,Row2429,Row3287,CHEMBL3684520,,0,437.51,BDBM103234,IC50,=,70000.0,nM,NC1CCN(CC1)C(=O)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,220971.0,CHEMBL3705043,Biochemical Assay: Biochemical assay using CisBio KinEASE HTRF Assay technology.,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3638978,37,BindingDB Database,,2013.0,NC1CCN(CC1)C(=O)c2ccc(cc2)-c3nnc4-c5ccccc5Nc6ncccc6-n34,,Row2783,67,0.1639452129602432,out,6
2130,Row2430,Row1655,CHEMBL3109401,,0,413.6,5,IC50,=,73200.0,nM,CC1=CCC[C@@H]2[C@@]1(C)CC[C@H](C)[C@@]2(C)CC3=C(O)C(=O)C=C(NCCC(C)C)C3=O,,,CHEMBL3111649,Inhibition of recombinant AKT1 (unknown origin) using GSK3 (14 to 27) as substrate assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3108666,1,Scientific Literature,J. Nat. Prod.,2014.0,CC1=CCC[C@@H]2[C@@]1(C)CC[C@H](C)[C@@]2(C)CC3=C(O)C(=O)C=C(NCCC(C)C)C3=O,,Row943,100,0.0851755961775779,out,6
2131,Row2431,Row1449,CHEMBL2036868,,0,331.38,2f,IC50,=,75000.0,nM,COc1ccc(cc1)Nc2nc(ccn2)-c3nc4ccccc4n3C,,,CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2034932,1,Scientific Literature,Eur. J. Med. Chem.,2012.0,COc1ccc(cc1)Nc2nc(ccn2)-c3nc4ccccc4n3C,,Row1528,84,0.1403146982192993,out,6
2132,Row2432,Row1286,CHEMBL393645,,0,514.63,32a,IC50,=,77000.0,nM,CC(C)[C@H](NC(=O)c1ccc(cc1)NC(N)=N)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc3ccccc3,,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(C)[C@H](NC(=O)c1ccc(cc1)NC(N)=N)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc3ccccc3,,Row41,99,0.1076424345374107,out,6
2133,Row2433,Row27,CHEMBL451291,,0,593.74,22da,IC50,=,78000.0,nM,NC(=N)NCCNc1ccc(cc1-c2ccc(cc2)C#N)C(=O)Nc3ccc(cc3)N(Cc4ccccc4)Cc5ccccc5,,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,NC(=N)NCCNc1ccc(cc1-c2ccc(cc2)C#N)C(=O)Nc3ccc(cc3)N(Cc4ccccc4)Cc5ccccc5,,Row1533,98,0.1372576504945755,out,6
2134,Row2434,Row2836,CHEMBL507059,,0,1107.33,6,IC50,=,78000.0,nM,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc2cc(-c3cccc4ccccc43)c(cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc5ccccc5)C(=O)NCc6ccccc6,,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc2cc(-c3cccc4ccccc43)c(cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc5ccccc5)C(=O)NCc6ccccc6,,Row466,80,0.1203357204794883,out,6
2135,Row2435,Row1832,CHEMBL396644,,0,896.06,19,IC50,=,79000.0,nM,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)Nc2ccc(cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCc4ccccc4,,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)Nc2ccc(cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCc4ccccc4,,Row466,80,0.118387684226036,out,6
2136,Row2436,Row1285,CHEMBL228114,,0,158.2,"Figure 1, A",IC50,=,80000.0,nM,Cc1n[nH]cc1-c2ccccc2,,,CHEMBL958718,Inhibition of protein kinase B,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157388,1,Scientific Literature,J. Med. Chem.,2008.0,Cc1n[nH]cc1-c2ccccc2,,Row1976,11,0.1544389277696609,out,6
2137,Row2437,Row2162,CHEMBL469523,,0,644.82,22ca,IC50,=,83000.0,nM,NC(=N)NCCNc1ccc(cc1-c2ccc(cc2)-c3ccccc3)C(=O)Nc4ccc(cc4)N(Cc5ccccc5)Cc6ccccc6,,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,NC(=N)NCCNc1ccc(cc1-c2ccc(cc2)-c3ccccc3)C(=O)Nc4ccc(cc4)N(Cc5ccccc5)Cc6ccccc6,,Row1533,98,0.1428616344928741,out,6
2138,Row2438,Row1533,CHEMBL444649,,0,568.73,21ba,IC50,=,84000.0,nM,NC(=N)NCCNc1ccc(cc1-c2ccccc2)C(=O)Nc3ccc(cc3)N(Cc4ccccc4)Cc5ccccc5,,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,NC(=N)NCCNc1ccc(cc1-c2ccccc2)C(=O)Nc3ccc(cc3)N(Cc4ccccc4)Cc5ccccc5,,Row1533,98,0.1340250372886657,out,6
2139,Row2439,Row2008,CHEMBL510540,,0,720.92,21bd,IC50,=,84000.0,nM,NC(=N)NCCNc1ccc(cc1-c2ccccc2)C(=O)Nc3ccc(cc3)N(Cc4ccc(cc4)-c5ccccc5)Cc6ccc(cc6)-c7ccccc7,,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,NC(=N)NCCNc1ccc(cc1-c2ccccc2)C(=O)Nc3ccc(cc3)N(Cc4ccc(cc4)-c5ccccc5)Cc6ccc(cc6)-c7ccccc7,,Row1533,98,0.1431427001953125,out,6
2140,Row2440,Row1796,CHEMBL1915456,,0,324.38,75,IC50,=,85900.0,nM,CC(C)=CCc1cc(C(=O)/C=C/c2cc(O)ccc2)c(O)cc1O,,,CHEMBL1918853,Inhibition of GST-tagged PKB/Akt1 incubated for 5 mins before eNOS substrate and ATP addition measured after 30 mins by kinase assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1914446,1,Scientific Literature,Eur. J. Med. Chem.,2011.0,CC(C)=CCc1cc(C(=O)/C=C/c2cc(O)ccc2)c(O)cc1O,,Row2857,89,0.0919805318117141,out,6
2148,Row2448,Row215,CHEMBL3298513,,0,418.28,5,IC50,>,100000.0,nM,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)NCCI,,,CHEMBL3364070,Inhibition of AKT1 (unknown origin) after 1 hr by Z'-LYTE kinase assay in presence of 75 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3297689,1,Scientific Literature,ACS Med. Chem. Lett.,2014.0,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)NCCI,,Row266,82,0.1004360765218734,out,6
2150,Row2450,Row377,CHEMBL3923951,,0,351.38,BDBM181355,IC50,>,100000.0,nM,NC(=O)c1ccc(c2cncnc21)N3CCN(CC3)c4ccc(F)cc4,,328368.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(c2cncnc21)N3CCN(CC3)c4ccc(F)cc4,,Row1630,91,0.1257820576429367,out,6
2151,Row2451,Row394,CHEMBL3298610,,0,298.77,11,IC50,>,100000.0,nM,CC(C)(C)OC(=O)NN(Cc1ccccc1)C(=O)CCl,,,CHEMBL3364070,Inhibition of AKT1 (unknown origin) after 1 hr by Z'-LYTE kinase assay in presence of 75 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3297689,1,Scientific Literature,ACS Med. Chem. Lett.,2014.0,CC(C)(C)OC(=O)NN(Cc1ccccc1)C(=O)CCl,,Row266,82,0.0922591686248779,out,6
2152,Row2452,Row430,CHEMBL3932697,,0,369.38,BDBM181339,IC50,>,100000.0,nM,NC(=O)c1ccc(c2cncnc12)N3CCN(CC3)c4cc(F)c(F)cc4,,328354.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(c2cncnc12)N3CCN(CC3)c4cc(F)c(F)cc4,,Row1630,91,0.1312578320503235,out,6
2153,Row2453,Row463,CHEMBL599518,,0,317.42,BI-98A10,IC50,>,100000.0,nM,CCC(C)Nc1nnc(Sc2ncc(s2)[N+]([O-])=O)s1,,,CHEMBL1070205,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1159095,1,Scientific Literature,Bioorg. Med. Chem.,2010.0,CCC(C)Nc1nnc(Sc2ncc(s2)[N+]([O-])=O)s1,,Row438,85,0.0579618476331234,out,6
2157,Row2457,Row688,CHEMBL599111,,0,425.52,BI-90H10,IC50,>,100000.0,nM,COc1ccc(CCNc2nnc(Sc3ncc(s3)[N+]([O-])=O)s2)cc1OC,,,CHEMBL1070205,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1159095,1,Scientific Literature,Bioorg. Med. Chem.,2010.0,COc1ccc(CCNc2nnc(Sc3ncc(s3)[N+]([O-])=O)s2)cc1OC,,Row1834,53,0.0799248814582824,out,6
2160,Row2460,Row889,CHEMBL370199,,0,282.28,13b,IC50,>,100000.0,nM,Cc1n[nH]c2sc(C(N)=O)c(NC(=O)C(=O)OC)c12,,,CHEMBL864555,Inhibitory activity against Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Cc1n[nH]c2sc(C(N)=O)c(NC(=O)C(=O)OC)c12,,Row1352,94,0.0564132332801818,out,6
2161,Row2461,Row942,CHEMBL518060,CALICOFEROL A,0,396.62,15,IC50,>,100000.0,nM,Cc1ccc(O)cc1CC[C@H]2[C@@H]3CC[C@H]([C@H](C)/C=C/CC(C)C)[C@@]3(C)CCC2=O,,,CHEMBL1926219,Inhibition of recombinant human AKT1 using GSK3 (amino acids 14 to 27) as substrate,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1921742,1,Scientific Literature,Bioorg. Med. Chem.,2011.0,Cc1ccc(O)cc1CC[C@H]2[C@@H]3CC[C@H]([C@H](C)/C=C/CC(C)C)[C@@]3(C)CCC2=O,,Row943,100,0.0975904539227485,out,6
2164,Row2464,Row990,CHEMBL476124,CYCLAPOLIN 9,0,307.21,cyclapolin 9,IC50,>,100000.0,nM,NC(=O)c1sc2c(cc(cc2[n+]1[O-])C(F)(F)F)[N+]([O-])=O,,,CHEMBL1228778,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1221191,1,Scientific Literature,Nat. Chem. Biol.,2006.0,NC(=O)c1sc2c(cc(cc2[n+]1[O-])C(F)(F)F)[N+]([O-])=O,,Row1352,94,0.0709034726023674,out,6
2165,Row2465,Row1042,CHEMBL517956,ASTROGORGIADIOL,0,400.65,20,IC50,>,100000.0,nM,Cc1ccc(O)cc1CC[C@@H]2[C@H](O)CC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)C,,,CHEMBL1926219,Inhibition of recombinant human AKT1 using GSK3 (amino acids 14 to 27) as substrate,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1921742,1,Scientific Literature,Bioorg. Med. Chem.,2011.0,Cc1ccc(O)cc1CC[C@@H]2[C@H](O)CC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)C,,Row943,100,0.1167863979935646,out,6
2166,Row2466,Row1079,CHEMBL260620,,0,288.74,2c,IC50,>,100000.0,nM,Nc1nc2NCCC(=Nc2c(N)n1)c3ccc(Cl)cc3,,,CHEMBL928166,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1144750,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Nc1nc2NCCC(=Nc2c(N)n1)c3ccc(Cl)cc3,,Row1883,97,0.1220737174153328,out,6
2167,Row2467,Row1099,CHEMBL466154,NORLICHEXANTHONE,0,258.23,7,IC50,>,100000.0,nM,Cc1cc(O)cc2oc3cc(O)cc(O)c3c(=O)c21,,,CHEMBL1816862,Inhibition of recombinant AKT1 assessed as 33Pi incorporation after 60 mins by scintillation counting,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1811781,1,Scientific Literature,Bioorg. Med. Chem.,2011.0,Cc1cc(O)cc2oc3cc(O)cc(O)c3c(=O)c21,,Row2857,89,0.0658249333500862,out,6
2168,Row2468,Row1157,CHEMBL467321,,0,452.56,12d,IC50,>,100000.0,nM,CN1CCN(CCOc2cc(ccc2)-c3cncc(C#N)c3Nc4cccc5[nH]ccc45)CC1,,,CHEMBL978881,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1138615,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2009.0,CN1CCN(CCOc2cc(ccc2)-c3cncc(C#N)c3Nc4cccc5[nH]ccc45)CC1,,Row2123,58,0.1228002905845642,out,6
2169,Row2469,Row1209,CHEMBL3931144,,0,376.46,BDBM181316,IC50,>,100000.0,nM,NC(=O)c1ccc(NCC(c2ccccc2)N3CCNCC3)c4cncnc14,,328339.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(NCC(c2ccccc2)N3CCNCC3)c4cncnc14,,Row2156,90,0.1378199011087417,out,6
2170,Row2470,Row1212,CHEMBL3947957,,0,285.35,BDBM181303,IC50,>,100000.0,nM,NC(=O)c1ccc(c2cncnc21)N3CC(CCC3)CN,,328326.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(c2cncnc21)N3CC(CCC3)CN,,Row1630,91,0.1352162957191467,out,6
2171,Row2471,Row1263,CHEMBL199657,,0,334.79,13f,IC50,>,100000.0,nM,Cc1n[nH]c2sc(C(N)=O)c(NC(=O)c3cc(Cl)ccc3)c21,,,CHEMBL864555,Inhibitory activity against Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Cc1n[nH]c2sc(C(N)=O)c(NC(=O)c3cc(Cl)ccc3)c21,,Row1352,94,0.0960362032055854,out,6
2172,Row2472,Row1295,CHEMBL454440,ANOMALIN A,0,274.23,8,IC50,>,100000.0,nM,Cc1c2c(=O)c3c(cc(O)cc3O)oc2cc(O)c1O,,,CHEMBL1816862,Inhibition of recombinant AKT1 assessed as 33Pi incorporation after 60 mins by scintillation counting,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1811781,1,Scientific Literature,Bioorg. Med. Chem.,2011.0,Cc1c2c(=O)c3c(cc(O)cc3O)oc2cc(O)c1O,,Row2857,89,0.0635002851486206,out,6
2173,Row2473,Row1352,CHEMBL371695,,0,334.79,13e,IC50,>,100000.0,nM,Cc1n[nH]c2sc(C(N)=O)c(NC(=O)c3ccccc3Cl)c21,,,CHEMBL864555,Inhibitory activity against Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Cc1n[nH]c2sc(C(N)=O)c(NC(=O)c3ccccc3Cl)c21,,Row1352,94,0.1002780050039291,out,6
2174,Row2474,Row1378,CHEMBL201511,MALEIMIDE,0,378.38,1,IC50,>,100000.0,nM,COc1c(cc(cc1OC)C2=C(c3c[nH]c4ccccc43)C(=O)NC2=O)OC,,,CHEMBL912727,Inhibition of human AKT1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1137241,1,Scientific Literature,J. Med. Chem.,2006.0,COc1c(cc(cc1OC)C2=C(c3c[nH]c4ccccc43)C(=O)NC2=O)OC,,Row837,29,0.1186569556593895,out,6
2175,Row2475,Row1474,CHEMBL4108594,,0,375.48,BDBM181352,IC50,>,100000.0,nM,NC(=O)c1ccc(c2cncnc12)N(CCc3ccccc3)[C@H]4CNCCC4,,328366.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(c2cncnc12)N(CCc3ccccc3)[C@H]4CNCCC4,,Row2156,90,0.1479680836200714,out,6
2176,Row2476,Row1505,CHEMBL199759,,0,330.37,13c,IC50,>,100000.0,nM,Cc1n[nH]c2sc(C(N)=O)c(NC(=O)COc3ccccc3)c21,,,CHEMBL864555,Inhibitory activity against Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Cc1n[nH]c2sc(C(N)=O)c(NC(=O)COc3ccccc3)c21,,Row1352,94,0.1228772476315498,out,6
2177,Row2477,Row1518,CHEMBL259381,,0,288.74,2b,IC50,>,100000.0,nM,Nc1nc2NCCC(=Nc2c(N)n1)c3cc(Cl)ccc3,,,CHEMBL928166,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1144750,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Nc1nc2NCCC(=Nc2c(N)n1)c3cc(Cl)ccc3,,Row1883,97,0.1365062594413757,out,6
2178,Row2478,Row1528,CHEMBL2036725,,0,301.35,2a,IC50,>,100000.0,nM,Cn1c(nc2ccccc12)-c3ccnc(Nc4ccccc4)n3,,,CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2034932,1,Scientific Literature,Eur. J. Med. Chem.,2012.0,Cn1c(nc2ccccc12)-c3ccnc(Nc4ccccc4)n3,,Row1528,84,0.1479521989822387,out,6
2179,Row2479,Row1552,CHEMBL2036867,,0,345.41,2e,IC50,>,100000.0,nM,CCOc1ccc(cc1)Nc2nc(ccn2)-c3nc4ccccc4n3C,,,CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2034932,1,Scientific Literature,Eur. J. Med. Chem.,2012.0,CCOc1ccc(cc1)Nc2nc(ccn2)-c3nc4ccccc4n3C,,Row1528,84,0.1385822892189026,out,6
2180,Row2480,Row1770,CHEMBL3911505,,0,402.29,BDBM181357,IC50,>,100000.0,nM,NC(=O)c1ccc(c2cncnc12)N3CCN(CC3)c4cc(Cl)c(Cl)cc4,,328369.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(c2cncnc12)N3CCN(CC3)c4cc(Cl)c(Cl)cc4,,Row1630,91,0.1249686107039451,out,6
2181,Row2481,Row1781,CHEMBL505896,,0,610.69,22,IC50,>,100000.0,nM,Cn1c(=O)c(cnc1Cc2ccccc2)-c3ccc(Oc4ccnc5cc(OCCCN6CCOCC6)c(cc45)OC)c(F)c3,,,CHEMBL970670,Inhibition of PKBalpha,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140082,1,Scientific Literature,J. Med. Chem.,2008.0,Cn1c(=O)c(cnc1Cc2ccccc2)-c3ccc(Oc4ccnc5cc(OCCCN6CCOCC6)c(cc45)OC)c(F)c3,,Row1813,70,0.145779862999916,out,6
2182,Row2482,Row1844,CHEMBL2036869,,0,317.35,2g,IC50,>,100000.0,nM,Cn1c(nc2ccccc12)-c3ccnc(Nc4ccc(O)cc4)n3,,,CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2034932,1,Scientific Literature,Eur. J. Med. Chem.,2012.0,Cn1c(nc2ccccc12)-c3ccnc(Nc4ccc(O)cc4)n3,,Row1528,84,0.1313225626945495,out,6
2183,Row2483,Row1949,CHEMBL2036865,,0,351.8,2i,IC50,>,100000.0,nM,Cn1c(nc2ccccc12)-c3ccnc(Nc4cc(Cl)c(O)cc4)n3,,,CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2034932,1,Scientific Literature,Eur. J. Med. Chem.,2012.0,Cn1c(nc2ccccc12)-c3ccnc(Nc4cc(Cl)c(O)cc4)n3,,Row1528,84,0.1271688789129257,out,6
2184,Row2484,Row1970,CHEMBL1222044,CYCLAPOLIN 1,0,339.28,1,IC50,>,100000.0,nM,NC(=O)c1sc2c(cc(cc2[n+]1[O-])SC(F)(F)F)[N+]([O-])=O,,,CHEMBL1228778,Inhibition of Akt,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1221191,1,Scientific Literature,Nat. Chem. Biol.,2006.0,NC(=O)c1sc2c(cc(cc2[n+]1[O-])SC(F)(F)F)[N+]([O-])=O,,Row1352,94,0.0716632530093193,out,6
2185,Row2485,Row2143,CHEMBL609039,,0,303.39,BI-90H6,IC50,>,100000.0,nM,CCCNc1nnc(Sc2ncc(s2)[N+]([O-])=O)s1,,,CHEMBL1070205,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1159095,1,Scientific Literature,Bioorg. Med. Chem.,2010.0,CCCNc1nnc(Sc2ncc(s2)[N+]([O-])=O)s1,,Row1834,53,0.0609282180666923,out,6
2186,Row2486,Row2238,CHEMBL3906249,,0,385.83,BDBM181341,IC50,>,100000.0,nM,NC(=O)c1ccc(c2cncnc21)N3CCN(CC3)c4cc(Cl)c(F)cc4,,328355.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(c2cncnc21)N3CCN(CC3)c4cc(Cl)c(F)cc4,,Row1630,91,0.1225851848721504,out,6
2187,Row2487,Row2269,CHEMBL2338334,,0,293.37,6R,IC50,>,100000.0,nM,CN1C/C(=C\c2ccccn2)/C(=O)[C@H](Cc3ccccn3)C1,,,CHEMBL2344124,Inhibition of recombinant AKT1 (unknown origin) by FRET-based Z'-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2331439,1,Scientific Literature,J. Med. Chem.,2013.0,CN1C/C(=C\c2ccccn2)/C(=O)[C@H](Cc3ccccn3)C1,,Row1473,59,0.1266503781080246,out,6
2188,Row2488,Row2311,CHEMBL611079,,0,319.39,BI-90H9,IC50,>,100000.0,nM,COCCNc1nnc(Sc2ncc(s2)[N+]([O-])=O)s1,,,CHEMBL1070205,Inhibition of AKT,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1159095,1,Scientific Literature,Bioorg. Med. Chem.,2010.0,COCCNc1nnc(Sc2ncc(s2)[N+]([O-])=O)s1,,Row1834,53,0.0619156062602996,out,6
2189,Row2489,Row2392,CHEMBL373882,,0,598.61,63,IC50,=,100000.0,nM,CN(C)CCCN(C)c1ccc(cc1NC(=O)c2cc(ccc2F)Oc3ncccc3-c4nc(NC)ncn4)C(F)(F)F,,,CHEMBL910143,Inhibition of PKBalpha,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1141380,1,Scientific Literature,J. Med. Chem.,2007.0,CN(C)CCCN(C)c1ccc(cc1NC(=O)c2cc(ccc2F)Oc3ncccc3-c4nc(NC)ncn4)C(F)(F)F,,Row3570,86,0.0844806879758834,out,6
2190,Row2490,Row2468,CHEMBL263902,,0,253.31,1b,IC50,>,100000.0,nM,Cc1cc(ccc1)C=2CCNc3ncnc(N)c3N2,,,CHEMBL928166,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1144750,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Cc1cc(ccc1)C=2CCNc3ncnc(N)c3N2,,Row1883,97,0.1378039270639419,out,6
2191,Row2491,Row2469,CHEMBL407532,,0,273.73,1d,IC50,>,100000.0,nM,Nc1ncnc2NCCC(=Nc21)c3cc(Cl)ccc3,,,CHEMBL928166,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1144750,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Nc1ncnc2NCCC(=Nc21)c3cc(Cl)ccc3,,Row1883,97,0.134247601032257,out,6
2192,Row2492,Row2539,CHEMBL2036728,,0,386.46,2d,IC50,>,100000.0,nM,Cn1c(nc2ccccc12)-c3ccnc(Nc4ccc(cc4)N5CCOCC5)n3,,,CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2034932,1,Scientific Literature,Eur. J. Med. Chem.,2012.0,Cn1c(nc2ccccc12)-c3ccnc(Nc4ccc(cc4)N5CCOCC5)n3,,Row1528,84,0.1341341882944107,out,6
2193,Row2493,Row2589,CHEMBL3908671,,0,369.86,BDBM181315,IC50,>,100000.0,nM,CN(C)C(CNc1ccc(C(N)=O)c2ncncc12)c3cc(Cl)ccc3,,328338.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,CN(C)C(CNc1ccc(C(N)=O)c2ncncc12)c3cc(Cl)ccc3,,Row2156,90,0.0936752036213874,out,6
2194,Row2494,Row2634,CHEMBL2338335,,0,293.37,6S,IC50,>,100000.0,nM,CN1C/C(=C\c2ccccn2)/C(=O)[C@@H](Cc3ccccn3)C1,,,CHEMBL2344124,Inhibition of recombinant AKT1 (unknown origin) by FRET-based Z'-LYTE assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2331439,1,Scientific Literature,J. Med. Chem.,2013.0,CN1C/C(=C\c2ccccn2)/C(=O)[C@@H](Cc3ccccn3)C1,,Row1473,59,0.1266503781080246,out,6
2195,Row2495,Row2650,CHEMBL200586,,0,196.23,5,IC50,>,100000.0,nM,Cc1n[nH]c2sc(cc12)C(=O)OC,,,CHEMBL864555,Inhibitory activity against Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,Cc1n[nH]c2sc(cc12)C(=O)OC,,Row1352,94,0.0598398447036743,out,6
2196,Row2496,Row2697,CHEMBL200348,,0,279.37,7b,IC50,>,100000.0,nM,COC(=O)c1cc2c([nH]nc2CN3CCCCC3)s1,,,CHEMBL864555,Inhibitory activity against Akt1,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1148538,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,COC(=O)c1cc2c([nH]nc2CN3CCCCC3)s1,,Row919,96,0.0896181687712669,out,6
2197,Row2497,Row2703,CHEMBL3942427,,0,271.32,BDBM181308,IC50,>,100000.0,nM,NC(=O)c1ccc(NC[C@@H]2CNCC2)c3cncnc31,,328331.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(NC[C@@H]2CNCC2)c3cncnc31,,Row2729,75,0.1040067598223686,out,6
2198,Row2498,Row2727,CHEMBL447602,,0,612.66,62,IC50,>,100000.0,nM,Cn1c(=O)c(cnc1Nc2ccc(F)cc2)-c3ccc(cn3)Oc4ccnc5cc(OCCCN6CCOCC6)c(cc45)OC,,,CHEMBL970670,Inhibition of PKBalpha,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140082,1,Scientific Literature,J. Med. Chem.,2008.0,Cn1c(=O)c(cnc1Nc2ccc(F)cc2)-c3ccc(cn3)Oc4ccnc5cc(OCCCN6CCOCC6)c(cc45)OC,,Row3570,86,0.1062962785363197,out,6
2199,Row2499,Row2785,CHEMBL453737,,0,629.66,51,IC50,>,100000.0,nM,Cn1c(=O)c(cnc1Nc2ccc(F)cc2)-c3cc(F)c(cc3)Oc4ccnc5cc(OCCCN6CCOCC6)c(cc45)OC,,,CHEMBL970670,Inhibition of PKBalpha,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1140082,1,Scientific Literature,J. Med. Chem.,2008.0,Cn1c(=O)c(cnc1Nc2ccc(F)cc2)-c3cc(F)c(cc3)Oc4ccnc5cc(OCCCN6CCOCC6)c(cc45)OC,,Row3570,86,0.1167914867401123,out,6
2200,Row2500,Row2846,CHEMBL405233,,0,253.31,1c,IC50,>,100000.0,nM,Cc1ccc(cc1)C=2CCNc3ncnc(N)c3N2,,,CHEMBL928166,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1144750,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Cc1ccc(cc1)C=2CCNc3ncnc(N)c3N2,,Row1883,97,0.1219484806060791,out,6
2201,Row2501,Row2847,CHEMBL259380,,0,254.3,2a,IC50,>,100000.0,nM,Nc1nc2NCCC(=Nc2c(N)n1)c3ccccc3,,,CHEMBL928166,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1144750,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Nc1nc2NCCC(=Nc2c(N)n1)c3ccccc3,,Row1883,97,0.1695783138275146,out,6
2202,Row2502,Row2853,CHEMBL3298515,,0,326.82,7,IC50,>,100000.0,nM,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCl,,,CHEMBL3364070,Inhibition of AKT1 (unknown origin) after 1 hr by Z'-LYTE kinase assay in presence of 75 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3297689,1,Scientific Literature,ACS Med. Chem. Lett.,2014.0,CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCl,,Row266,82,0.0885983258485794,out,6
2203,Row2503,Row2861,CHEMBL515982,CALICOFEROL C,0,412.66,19,IC50,>,100000.0,nM,Cc1ccc(O)cc1CC[C@@H]2[C@H](O)CC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCC(=C)C(C)C,,,CHEMBL1926219,Inhibition of recombinant human AKT1 using GSK3 (amino acids 14 to 27) as substrate,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1921742,1,Scientific Literature,Bioorg. Med. Chem.,2011.0,Cc1ccc(O)cc1CC[C@@H]2[C@H](O)CC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCC(=C)C(C)C,,Row943,100,0.1055906265974044,out,6
2204,Row2504,Row2878,CHEMBL3919249,,0,401.39,BDBM181337,IC50,>,100000.0,nM,NC(=O)c1ccc(c2cncnc21)N3CCN(CC3)c4ccc(cc4)C(F)(F)F,,328352.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(c2cncnc21)N3CCN(CC3)c4ccc(cc4)C(F)(F)F,,Row1630,91,0.1195751652121543,out,6
2205,Row2505,Row2915,CHEMBL3902499,,0,361.23,BDBM181351,IC50,>,100000.0,nM,NC(=O)c1ccc(NCCc2cc(Cl)c(Cl)cc2)c3cncnc31,,328365.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(NCCc2cc(Cl)c(Cl)cc2)c3cncnc31,,Row2156,90,0.0872668027877807,out,6
2206,Row2506,Row2928,CHEMBL2036871,,0,321.34,7,IC50,>,100000.0,nM,Cn1c(nc2ccccc12)-c3ccc4c(n3)n(C)c(=O)n(C)c4=O,,,CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2034932,1,Scientific Literature,Eur. J. Med. Chem.,2012.0,Cn1c(nc2ccccc12)-c3ccc4c(n3)n(C)c(=O)n(C)c4=O,,Row1528,84,0.1321117877960205,out,6
2207,Row2507,Row2950,CHEMBL407265,,0,273.73,1e,IC50,>,100000.0,nM,Nc1ncnc2NCCC(=Nc21)c3ccc(Cl)cc3,,,CHEMBL928166,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1144750,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2008.0,Nc1ncnc2NCCC(=Nc21)c3ccc(Cl)cc3,,Row1883,97,0.1195827201008796,out,6
2208,Row2508,Row2996,CHEMBL3109402,,0,383.53,6,IC50,>,100000.0,nM,C[C@H]1CC[C@]2(C)[C@@H](CCC=C2C)[C@]1(C)Cc3c(O)c(cc4nc(C)oc34)OC,,,CHEMBL3111649,Inhibition of recombinant AKT1 (unknown origin) using GSK3 (14 to 27) as substrate assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3108666,1,Scientific Literature,J. Nat. Prod.,2014.0,C[C@H]1CC[C@]2(C)[C@@H](CCC=C2C)[C@]1(C)Cc3c(O)c(cc4nc(C)oc34)OC,,Row943,100,0.1121303290128707,out,6
2209,Row2509,Row3056,CHEMBL464351,CALICOFEROL B,0,416.65,22,IC50,>,100000.0,nM,Cc1ccc(O)cc1CC[C@H]2[C@@H]3C[C@H](O)[C@H]([C@H](C)CCCC(C)C)[C@@]3(C)CC[C@H]2O,,,CHEMBL1926219,Inhibition of recombinant human AKT1 using GSK3 (amino acids 14 to 27) as substrate,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1921742,1,Scientific Literature,Bioorg. Med. Chem.,2011.0,Cc1ccc(O)cc1CC[C@H]2[C@@H]3C[C@H](O)[C@H]([C@H](C)CCCC(C)C)[C@@]3(C)CC[C@H]2O,,Row943,100,0.1139805242419242,out,6
2210,Row2510,Row3194,CHEMBL3969122,,0,381.87,BDBM181358,IC50,>,100000.0,nM,Cc1ccc(Cl)cc1N2CCN(CC2)c3ccc(C(N)=O)c4ncncc34,,328370.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,Cc1ccc(Cl)cc1N2CCN(CC2)c3ccc(C(N)=O)c4ncncc34,,Row1630,91,0.1395050287246704,out,6
2211,Row2511,Row3206,CHEMBL3948835,,0,271.32,BDBM181305,IC50,>,100000.0,nM,CN1CC(CC1)Nc2ccc(C(N)=O)c3ncncc23,,328328.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,CN1CC(CC1)Nc2ccc(C(N)=O)c3ncncc23,,Row2729,75,0.1147118285298347,out,6
2212,Row2512,Row3244,CHEMBL2036726,,0,315.38,2b,IC50,>,100000.0,nM,Cc1ccc(cc1)Nc2nc(ccn2)-c3nc4ccccc4n3C,,,CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2034932,1,Scientific Literature,Eur. J. Med. Chem.,2012.0,Cc1ccc(cc1)Nc2nc(ccn2)-c3nc4ccccc4n3C,,Row1528,84,0.1320563554763794,out,6
2213,Row2513,Row3255,CHEMBL1922224,,0,398.63,6,IC50,>,100000.0,nM,Cc1ccc(O)cc1CC[C@@H]2[C@@H](O)CC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)/C=C/CC(C)C,,,CHEMBL1926219,Inhibition of recombinant human AKT1 using GSK3 (amino acids 14 to 27) as substrate,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1921742,1,Scientific Literature,Bioorg. Med. Chem.,2011.0,Cc1ccc(O)cc1CC[C@@H]2[C@@H](O)CC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)/C=C/CC(C)C,,Row943,100,0.1066277101635932,out,6
2214,Row2514,Row3274,CHEMBL2036870,,0,317.35,2h,IC50,>,100000.0,nM,Cn1c(nc2ccccc12)-c3ccnc(Nc4cc(O)ccc4)n3,,,CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2034932,1,Scientific Literature,Eur. J. Med. Chem.,2012.0,Cn1c(nc2ccccc12)-c3ccnc(Nc4cc(O)ccc4)n3,,Row1528,84,0.1319047659635543,out,6
2215,Row2515,Row3399,CHEMBL4110740,,0,271.32,BDBM181307,IC50,>,100000.0,nM,NC(=O)c1ccc(NC[C@H]2CNCC2)c3cncnc31,,328330.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(NC[C@H]2CNCC2)c3cncnc31,,Row2729,75,0.1040067598223686,out,6
2216,Row2516,Row3524,CHEMBL3298928,,0,276.34,14,IC50,>,100000.0,nM,CC(C)(C)OC(=O)NN(Cc1ccccc1)C(=O)C=C,,,CHEMBL3364070,Inhibition of AKT1 (unknown origin) after 1 hr by Z'-LYTE kinase assay in presence of 75 uM ATP,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3297689,1,Scientific Literature,ACS Med. Chem. Lett.,2014.0,CC(C)(C)OC(=O)NN(Cc1ccccc1)C(=O)C=C,,Row266,82,0.0913839861750602,out,6
2217,Row2517,Row3543,CHEMBL3890779,,0,334.38,BDBM181313,IC50,>,100000.0,nM,NC(=O)c1ccc(c2cncnc21)N3CC(O)(CC3)c4ccccc4,,328336.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(c2cncnc21)N3CC(O)(CC3)c4ccccc4,,Row1630,91,0.1913157552480697,out,6
2218,Row2518,Row3661,CHEMBL3921030,,0,361.45,BDBM181304,IC50,>,100000.0,nM,Cc1cc(ccc1)N2CCC(CC2)Nc3ccc(C(N)=O)c4ncncc34,,328327.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,Cc1cc(ccc1)N2CCC(CC2)Nc3ccc(C(N)=O)c4ncncc34,,Row1630,91,0.1223675906658172,out,6
2219,Row2519,Row3696,CHEMBL3945508,,0,348.41,BDBM181312,IC50,>,100000.0,nM,NC(=O)c1ccc(c2cncnc12)N3CC(CC3)OCc4ccccc4,,328335.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(c2cncnc12)N3CC(CC3)OCc4ccccc4,,Row1630,91,0.1696613579988479,out,6
2220,Row2520,Row3815,CHEMBL4550702,,0,406.39,9,IC50,>,100000.0,nM,Cn1cc(cn1)-c2cn3ncc(c3nc2)-c4cc(sc4)C(=O)NCC(F)(F)F,,,CHEMBL4479691,Inhibition of full-length recombinant human His-tagged AKT1-alpha expressed in baculovirus expression system by Z'-LYTE assay,B,BAO_0000019,assay format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL4477252,1,Scientific Literature,Bioorg Med Chem Lett,2016.0,Cn1cc(cn1)-c2cn3ncc(c3nc2)-c4cc(sc4)C(=O)NCC(F)(F)F,,Row3515,16,0.0606463812291622,out,6
2221,Row2521,Row3949,CHEMBL3943330,,0,367.84,BDBM181343,IC50,>,100000.0,nM,NC(=O)c1ccc(c2cncnc21)N3CCN(CC3)c4cc(Cl)ccc4,,328357.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(c2cncnc21)N3CCN(CC3)c4cc(Cl)ccc4,,Row1630,91,0.1370927989482879,out,6
2222,Row2522,Row3967,CHEMBL603463,,0,348.36,"1, NSC 743304",IC50,>,100000.0,nM,COc1ccc(cc1O)Nc2nc-3c(CC(=O)Nc4ccccc43)cn2,,,CHEMBL2038022,Inhibition of recombinant AKT1 using GSK3 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 mins by scintillation counting,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL2034932,1,Scientific Literature,Eur. J. Med. Chem.,2012.0,COc1ccc(cc1O)Nc2nc-3c(CC(=O)Nc4ccccc43)cn2,,Row1867,42,0.1459904909133911,out,6
2223,Row2523,Row4015,CHEMBL3896544,,0,417.39,BDBM181319,IC50,>,100000.0,nM,NC(=O)c1ccc(NC2CNCC2c3cccc(c3)OC(F)(F)F)c4cncnc14,,328342.0,CHEMBL3887082,"AKT Enzyme Assay: A TTP Mosquito liquid handling instrument is used to place 125 ul of the appropriate concentration of inhibitor in 100% DMSO (for a dose response curve calculation) into each well of a 384-well plate. To this reaction components are added to a final volume of 12.50 0.1 ng/uL His-AKT (Full Length), (Invitrogen, Part # P2999, Lot #641228C). 160 uM ATP (Fluka, 02055) 1 mM DTT (Sigma, D0632) 1 mM MgCl2 (Sigma, M1028) 1 uM substrate peptide (sequence FITC-AHA-GRPRTSSFAEG-NH2), synthesized by Tufts Peptide Synthesis service. 100 mM HEPES pH 7.5 (Calbiochem, 391338) 0.015% Brij-35 (Sigma, B4184)The reaction is incubated for 90 min at 25 C, and then stopped by the addition of 70 ul of Stop buffer (100 mM HEPES pH 7.5, 0.015% Brij-35, 10 mM EDTA (Sigma, E7889)).The plate is read on a Caliper LC 3000 in an Off-Chip mobility shift assay format, using the following parameters for a 12-sipper chip: screening pressure -2.3 psi, upstream voltage -500, and downstream voltage -3000.",B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL3886157,37,BindingDB Database,,2015.0,NC(=O)c1ccc(NC2CNCC2c3cccc(c3)OC(F)(F)F)c4cncnc14,,Row2729,75,0.1026763021945953,out,6
2224,Row2524,Row1656,CHEMBL394250,,0,740.95,23,IC50,=,104000.0,nM,CC(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc1ccc(cc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc3ccc(CCCCC)cc3,Outside typical range,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc1ccc(cc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc3ccc(CCCCC)cc3,,Row41,99,0.1018296182155609,out,6
2225,Row2525,Row2386,CHEMBL501390,,0,674.76,15a,IC50,=,112000.0,nM,CC(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc1ccc(cc1)C(=O)Nc2cc3c(cc2)c(=O)n(Cc4ccccc4)c(=O)n3Cc5ccccc5,Outside typical range,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,CC(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc1ccc(cc1)C(=O)Nc2cc3c(cc2)c(=O)n(Cc4ccccc4)c(=O)n3Cc5ccccc5,,Row41,99,0.124292217195034,out,6
2226,Row2526,Row41,CHEMBL245659,,0,670.82,24,IC50,=,119000.0,nM,CC(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc1ccc(cc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc3ccccc3,Outside typical range,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc1ccc(cc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc3ccccc3,,Row41,99,0.1068631336092948,out,6
2227,Row2527,Row907,CHEMBL248369,,0,542.68,32c,IC50,=,120000.0,nM,CC(C)[C@H](NC(=O)c1ccc(CCNC(N)=N)cc1)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc3ccccc3,Outside typical range,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(C)[C@H](NC(=O)c1ccc(CCNC(N)=N)cc1)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc3ccccc3,,Row41,99,0.1052742227911949,out,6
2228,Row2528,Row621,CHEMBL606964,,0,449.49,Ro-4396686,IC50,>,125000.0,nM,COc1ccc(cc1)N2Cc3cnc(Nc4ccc(F)cc4)nc3N([C@@H]5CC[C@@H](O)C5)C2=O,Outside typical range,,CHEMBL864436,Inhibitory activity against AKT,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1146929,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2006.0,COc1ccc(cc1)N2Cc3cnc(Nc4ccc(F)cc4)nc3N([C@@H]5CC[C@@H](O)C5)C2=O,,Row1867,42,0.1214510947465896,out,6
2229,Row2529,Row625,CHEMBL471216,,0,502.62,36a,IC50,=,126000.0,nM,NC(=N)NCC(=O)Nc1ccc(cc1)-c2cc3cc(ccc3[nH]2)N(Cc4ccccc4)Cc5ccccc5,Outside typical range,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,NC(=N)NCC(=O)Nc1ccc(cc1)-c2cc3cc(ccc3[nH]2)N(Cc4ccccc4)Cc5ccccc5,,Row1533,98,0.1232963427901268,out,6
2230,Row2530,Row3284,CHEMBL365978,,0,408.42,3,IC50,=,126000.0,nM,Cc1c\2c(nc(N)c1C#N)C(C#N)=C(C)/C2=C\c3ccc(o3)-c4ccc(cc4)C(O)=O,Outside typical range,,CHEMBL1108601,Inhibition of Akt1,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1154821,1,Scientific Literature,Eur. J. Med. Chem.,2010.0,Cc1c\2c(nc(N)c1C#N)C(C#N)=C(C)/C2=C\c3ccc(o3)-c4ccc(cc4)C(O)=O,,Row3798,5,0.1042414233088493,out,6
2231,Row2531,Row2698,CHEMBL390066,,0,144.18,"Figure 1, B",IC50,=,135000.0,nM,c1[nH]ncc1-c2ccccc2,,,CHEMBL958718,Inhibition of protein kinase B,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1157388,1,Scientific Literature,J. Med. Chem.,2008.0,c1[nH]ncc1-c2ccccc2,,Row2632,65,0.1576491892337799,out,6
2232,Row2532,Row1919,CHEMBL466143,DEMETHYLXANTHOHUMOL,0,340.38,76,IC50,=,143900.0,nM,CC(C)=CCc1c(O)c(C(=O)/C=C/c2ccc(O)cc2)c(O)cc1O,Outside typical range,,CHEMBL1918853,Inhibition of GST-tagged PKB/Akt1 incubated for 5 mins before eNOS substrate and ATP addition measured after 30 mins by kinase assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1914446,1,Scientific Literature,Eur. J. Med. Chem.,2011.0,CC(C)=CCc1c(O)c(C(=O)/C=C/c2ccc(O)cc2)c(O)cc1O,,Row2857,89,0.0582139082252979,out,6
2233,Row2533,Row1619,CHEMBL499846,,0,596.78,21bc,IC50,=,152000.0,nM,Cc1cc(CN(Cc2cc(C)ccc2)c3ccc(cc3)NC(=O)c4cc(c(cc4)NCCNC(N)=N)-c5ccccc5)ccc1,Outside typical range,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,Cc1cc(CN(Cc2cc(C)ccc2)c3ccc(cc3)NC(=O)c4cc(c(cc4)NCCNC(N)=N)-c5ccccc5)ccc1,,Row1533,98,0.1293973624706268,out,6
2234,Row2534,Row2397,CHEMBL457309,,0,626.76,22ba,IC50,=,158000.0,nM,COC(=O)c1ccc(cc1)-c2cc(ccc2NCCNC(N)=N)C(=O)Nc3ccc(cc3)N(Cc4ccccc4)Cc5ccccc5,Outside typical range,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,COC(=O)c1ccc(cc1)-c2cc(ccc2NCCNC(N)=N)C(=O)Nc3ccc(cc3)N(Cc4ccccc4)Cc5ccccc5,,Row1533,98,0.127249389886856,out,6
2235,Row2535,Row518,CHEMBL391793,,0,664.85,25,IC50,=,163000.0,nM,CC(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc1ccc(cc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCCCCCC,Outside typical range,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc1ccc(cc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCCCCCC,,Row41,99,0.1073604002594947,out,6
2236,Row2536,Row2161,CHEMBL505303,,0,746.91,8,IC50,=,173000.0,nM,CC(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc1cc(c(cc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc3ccccc3)-c4ccccc4,Outside typical range,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,CC(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc1cc(c(cc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc3ccccc3)-c4ccccc4,,Row41,99,0.1312445551156997,out,6
2237,Row2537,Row1962,CHEMBL396530,,0,613.76,26,IC50,=,193000.0,nM,CC(C)[C@H](NC(=O)c1ccc(cc1)NC(=O)CCCCNC(N)=N)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc3ccccc3,Outside typical range,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(C)[C@H](NC(=O)c1ccc(cc1)NC(=O)CCCCNC(N)=N)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc3ccccc3,,Row41,99,0.1099173426628112,out,6
2238,Row2538,Row1618,CHEMBL446065,,0,596.78,21bb,IC50,=,215000.0,nM,Cc1ccc(CN(Cc2ccc(C)cc2)c3ccc(cc3)NC(=O)c4cc(c(cc4)NCCNC(N)=N)-c5ccccc5)cc1,Outside typical range,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,Cc1ccc(CN(Cc2ccc(C)cc2)c3ccc(cc3)NC(=O)c4cc(c(cc4)NCCNC(N)=N)-c5ccccc5)cc1,,Row1533,98,0.1306985467672348,out,6
2239,Row2539,Row1367,CHEMBL231257,,0,992.06,7,IC50,=,229000.0,nM,C[C@@H](O)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc2ccccc2)C(O)=O,Outside typical range,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,C[C@@H](O)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc2ccccc2)C(O)=O,,Row466,80,0.122287131845951,out,6
2240,Row2540,Row300,CHEMBL471217,,0,674.76,15b,IC50,=,232000.0,nM,CC(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc1ccc(cc1)C(=O)Nc2cc3c(cc2)n(Cc4ccccc4)c(=O)n(Cc5ccccc5)c3=O,Outside typical range,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,CC(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc1ccc(cc1)C(=O)Nc2cc3c(cc2)n(Cc4ccccc4)c(=O)n(Cc5ccccc5)c3=O,,Row41,99,0.1236547604203224,out,6
2241,Row2541,Row2629,CHEMBL245933,,0,1064.26,8,IC50,=,239000.0,nM,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc3ccccc3,Outside typical range,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc3ccccc3,,Row466,80,0.129128560423851,out,6
2242,Row2542,Row3443,CHEMBL437388,,0,979.13,6,IC50,=,241000.0,nM,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc2ccccc2)C(O)=O,Outside typical range,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc2ccccc2)C(O)=O,,Row466,80,0.1254202276468277,out,6
2243,Row2543,Row2035,CHEMBL457630,,0,625.78,22aa,IC50,=,253000.0,nM,CC(=O)Nc1ccc(cc1)-c2cc(ccc2NCCNC(N)=N)C(=O)Nc3ccc(cc3)N(Cc4ccccc4)Cc5ccccc5,Outside typical range,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,CC(=O)Nc1ccc(cc1)-c2cc(ccc2NCCNC(N)=N)C(=O)Nc3ccc(cc3)N(Cc4ccccc4)Cc5ccccc5,,Row1533,98,0.1309008747339248,out,6
2244,Row2544,Row1532,CHEMBL444220,,0,746.91,7,IC50,=,288000.0,nM,CC(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc1ccc(cc1-c2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCc4ccccc4,Outside typical range,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,CC(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc1ccc(cc1-c2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCc4ccccc4,,Row41,99,0.1328554153442382,out,6
2245,Row2545,Row1963,CHEMBL395678,,0,1082.28,16,IC50,=,322000.0,nM,CC(C)[C@H](NC(=O)c1ccc(cc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(C)=O)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCCCOc4cccc(c4)NC(C)=O,Outside typical range,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(C)[C@H](NC(=O)c1ccc(cc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(C)=O)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCCCOc4cccc(c4)NC(C)=O,,Row466,80,0.1211516037583351,out,6
2246,Row2546,Row2964,CHEMBL245587,,0,557.7,31,IC50,=,390000.0,nM,CC(C)[C@H](NC(=O)c1ccc(cc1)NCCNC(N)=N)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc3ccccc3,Outside typical range,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(C)[C@H](NC(=O)c1ccc(cc1)NCCNC(N)=N)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc3ccccc3,,Row41,99,0.1041457056999206,out,6
2247,Row2547,Row1595,CHEMBL245918,,0,947.06,5,IC50,=,409000.0,nM,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc2ccccc2)C(O)=O,Outside typical range,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc2ccccc2)C(O)=O,,Row466,80,0.1234141066670417,out,6
2248,Row2548,Row1299,CHEMBL246137,,0,1004.21,9,IC50,=,438000.0,nM,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc3ccccc3,Outside typical range,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc3ccccc3,,Row466,80,0.128641128540039,out,6
2249,Row2549,Row642,CHEMBL269244,,0,975.12,4,IC50,=,445000.0,nM,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C(O)=O,Outside typical range,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C(O)=O,,Row466,80,0.1335554271936416,out,6
2250,Row2550,Row464,CHEMBL246330,,0,1002.24,17,IC50,>,500000.0,nM,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc2ccc(cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCCN4CCCCC4,Outside typical range,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc2ccc(cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCCN4CCCCC4,,Row466,80,0.1165721416473388,out,6
2251,Row2551,Row517,CHEMBL245987,,0,528.66,32b,IC50,>,500000.0,nM,CC(C)[C@H](NC(=O)c1ccc(CNC(N)=N)cc1)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc3ccccc3,Outside typical range,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(C)[C@H](NC(=O)c1ccc(CNC(N)=N)cc1)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc3ccccc3,,Row41,99,0.1118435338139534,out,6
2252,Row2552,Row792,CHEMBL437750,,0,1062.2,1,IC50,>,500000.0,nM,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](Cc4ccccc4)C(O)=O,Outside typical range,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](Cc4ccccc4)C(O)=O,,Row466,80,0.1225313693284988,out,6
2253,Row2553,Row1020,CHEMBL394715,,0,1013.13,3,IC50,>,500000.0,nM,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](Cc3ccccc3)C(O)=O,Outside typical range,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](Cc3ccccc3)C(O)=O,,Row466,80,0.128348633646965,out,6
2254,Row2554,Row1954,CHEMBL391820,,0,1023.16,2,IC50,>,500000.0,nM,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc3ccccc3)C(O)=O,Outside typical range,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc3ccccc3)C(O)=O,,Row466,80,0.1270678788423538,out,6
2255,Row2555,Row2986,CHEMBL394041,,0,810.95,20,IC50,>,500000.0,nM,CC(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)Nc2ccc(cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCc4ccccc4,Outside typical range,,CHEMBL903578,Inhibition of Akt after 1 hr by fluorescence polarization assay,B,BAO_0000357,single protein format,Homo sapiens,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1139137,1,Scientific Literature,Bioorg. Med. Chem. Lett.,2007.0,CC(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)Nc2ccc(cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCc4ccccc4,,Row466,80,0.109943613409996,out,6
2256,Row2556,Row3165,CHEMBL486269,,0,1057.27,4,IC50,>,500000.0,nM,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc2ccc(cc2-c3ccccc3)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc4ccccc4)C(=O)NCc5ccccc5,Outside typical range,,CHEMBL1034080,Inhibition of Akt1 by fluorescence polarization assay,B,BAO_0000357,single protein format,None,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,SINGLE PROTEIN,CHEMBL1152730,1,Scientific Literature,Bioorg. Med. Chem.,2009.0,CC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)Nc2ccc(cc2-c3ccccc3)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc4ccccc4)C(=O)NCc5ccccc5,,Row466,80,0.1408829689025879,out,6
